<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:MLYF="http://westernmagnesium.com/20220131">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_MLYF_westernmagnesium.com_20220131 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20211101_20220131 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001801762 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_07C_XDX_forms%2D1.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06E_CA_0_iso4217%2D%2DCAD -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_Acre_0_utr%2D%2Dacre -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_CAPShares_0_iso4217%2D%2DCAD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_061_Days_0_Days -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_061_Hectares_0_utr%2D%2Dha -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:EntityCentralIndexKey">0001801762</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:DepositsAssetsCurrent" contextRef="AsOf2020-10-31" id="xdx2ixbrl0053" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OtherDepositsNonCurrent" contextRef="AsOf2020-10-31" id="xdx2ixbrl0074" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2021-10-31" id="xdx2ixbrl0094" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SubsidiesAndRecoveries" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl0214" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:GainLossOnRecognitionOfDebtHostLiability" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl0232" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnSalesOfAssets" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl0234" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:WriteoffOfEquipment" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl0238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0271" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0274" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0281" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0290" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0291" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0326" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0327" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" id="xdx2ixbrl0332" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0334" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0336" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0349" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" id="xdx2ixbrl0360" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0361" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0380" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0387" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0407" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForEquipment" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForEquipment" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForEquipment" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForEquipment" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0445" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0446" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0453" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0459" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:GainLossOnRecognitionOfDebtHostLiability" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnSalesOfAssets" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl0502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:WriteoffOfEquipment" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl0512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDepositOtherAssets" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl0524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForOtherDeposits" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl0542" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl0544" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl0587" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" id="xdx2ixbrl0696" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" id="xdx2ixbrl0697" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl0698" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2019-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl0722" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-11-012020-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl0728" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2019-11-012020-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl0734" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl0740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl0746" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" id="xdx2ixbrl0756" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" id="xdx2ixbrl0757" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl0758" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2019-10-31_custom_VancouverOfficeMember" id="xdx2ixbrl0801" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2019-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0802" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2019-10-31_custom_NevadaOfficeMember" id="xdx2ixbrl0803" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2019-10-31_custom_PilotPlantMember" id="xdx2ixbrl0804" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2019-10-31" id="xdx2ixbrl0805" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:RightOfUseAssetsInitialAdoptionOfAccountingStandardsUpdates" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0808" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:RightOfUseAssetsInitialAdoptionOfAccountingStandardsUpdates" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember" id="xdx2ixbrl0810" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember" id="xdx2ixbrl0813" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0814" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember" id="xdx2ixbrl0815" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0820" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0826" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0832" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember" id="xdx2ixbrl0839" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember" id="xdx2ixbrl0840" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2019-10-31_custom_VancouverOfficeMember" id="xdx2ixbrl0861" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2019-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0862" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2019-10-31_custom_NevadaOfficeMember" id="xdx2ixbrl0863" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2019-10-31_custom_PilotPlantMember" id="xdx2ixbrl0864" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2019-10-31" id="xdx2ixbrl0865" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0868" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0874" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0880" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0886" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl0916" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" id="xdx2ixbrl0923" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" id="xdx2ixbrl0929" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-10-31_custom_VancouverOfficeMember50338000" id="xdx2ixbrl0947" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-10-31_custom_VirginiaOfficeMember50338015" id="xdx2ixbrl0948" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-10-31_custom_NevadaOfficeMember50338015" id="xdx2ixbrl0949" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-10-31_custom_PilotPlantMember50338031" id="xdx2ixbrl0950" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-10-31" id="xdx2ixbrl0951" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseInitialAdoption" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember50338062" id="xdx2ixbrl0954" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseInitialAdoption" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember50338078" id="xdx2ixbrl0956" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember50338046" id="xdx2ixbrl0959" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember50338062" id="xdx2ixbrl0960" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember50338078" id="xdx2ixbrl0961" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember50338062" id="xdx2ixbrl0966" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember50338062" id="xdx2ixbrl0972" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2019-11-012020-10-31_custom_VirginiaOfficeMember50338062" id="xdx2ixbrl0978" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember50338203" id="xdx2ixbrl0984" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" id="xdx2ixbrl0991" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" id="xdx2ixbrl0992" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" id="xdx2ixbrl1007" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" id="xdx2ixbrl1008" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" id="xdx2ixbrl1010" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember50338468" id="xdx2ixbrl1021" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember50338468" id="xdx2ixbrl1027" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember50338468" id="xdx2ixbrl1033" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember50338468" id="xdx2ixbrl1039" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SaleOfMineralProperty" contextRef="From2019-11-012020-10-31_custom_SilveradoPropertyMember" id="xdx2ixbrl1057" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SaleOfMineralProperty" contextRef="From2019-11-012020-10-31_custom_TamiMosiPropertyMember" id="xdx2ixbrl1059" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2020-10-31_custom_BeaverdellPropertyMember" id="xdx2ixbrl1063" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SaleOfMineralProperty" contextRef="From2020-11-012021-10-31_custom_BeaverdellPropertyMember" id="xdx2ixbrl1071" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SaleOfMineralProperty" contextRef="From2020-11-012021-10-31_custom_SilveradoPropertyMember" id="xdx2ixbrl1073" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SaleOfMineralProperty" contextRef="From2020-11-012021-10-31_custom_TamiMosiPropertyMember" id="xdx2ixbrl1075" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SaleOfMineralProperty" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl1077" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2021-10-31_custom_BeaverdellPropertyMember" id="xdx2ixbrl1079" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:DirectorsAndOfficersBenefitsPayable" contextRef="AsOf2020-10-31" id="xdx2ixbrl1135" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:InterestsDueToShareholder" contextRef="AsOf2020-10-31" id="xdx2ixbrl1141" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2020-10-31" id="xdx2ixbrl1199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-10-31_custom_PromissoryNoteMember" id="xdx2ixbrl1245" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2021-10-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1295" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-10-31" id="xdx2ixbrl1299" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertiblesDebentureMember" id="xdx2ixbrl1301" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember" id="xdx2ixbrl1311" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44</ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2020-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember" id="xdx2ixbrl1312" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1313" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,700</ix:nonFraction>
  <ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1314" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1315" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,744</ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1316" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-11-012021-10-31_custom_OctoberThirtyOneTwentyThousandTwentyOneMember" id="xdx2ixbrl1344" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-11-012021-10-31_custom_JuneFifteenTwentyThousandTwentyOneMember" id="xdx2ixbrl1345" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-11-012021-10-31_custom_JulyTwentySevenTwentyThousandTwentyOneMember" id="xdx2ixbrl1346" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2019-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2019-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2019-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1352" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2019-10-31_custom_DebtHostLiabilityMember" id="xdx2ixbrl1353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1369" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1378" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1381" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2019-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2019-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1410" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2019-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1411" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2019-10-31_custom_EmbeddedDerivativeLiabilityMember" id="xdx2ixbrl1412" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1422" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1433" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1436" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1439" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1445" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1460" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2019-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2019-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2019-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1464" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2019-10-31_custom_CombinedValueOfConvertibleDebentureMember" id="xdx2ixbrl1465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2019-11-012020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2019-11-012020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2019-11-012020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2019-11-012020-10-31_custom_CombinedValueOfConvertibleDebentureMember" id="xdx2ixbrl1471" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1474" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2020-11-012021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2020-11-012021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1478" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2020-11-012021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl1479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2020-11-012021-10-31_custom_CombinedValueOfConvertibleDebentureMember" id="xdx2ixbrl1481" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl1482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2021-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl1671" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl1673" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl1676" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl1679" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl1682" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl1686" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl1689" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1693" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1695" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1696" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1701" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1702" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1703" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" id="xdx2ixbrl1707" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" id="xdx2ixbrl1710" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl1715" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl1717" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl1721" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl1724" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl1729" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl1731" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MayThirtyTwoThousandTwentyTwoMember" id="xdx2ixbrl1735" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember" id="xdx2ixbrl1737" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember" id="xdx2ixbrl1738" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl1742" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl1745" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember" id="xdx2ixbrl1749" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember" id="xdx2ixbrl1751" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember" id="xdx2ixbrl1752" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl1757" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl1759" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" id="xdx2ixbrl1763" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" id="xdx2ixbrl1765" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" id="xdx2ixbrl1766" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2020-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember" id="xdx2ixbrl1784" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember" id="xdx2ixbrl1785" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember" id="xdx2ixbrl1787" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember" id="xdx2ixbrl1788" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1793" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1794" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl1795" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl1800" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl1802" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl1807" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl1809" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl1814" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl1816" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2020-10-31_custom_MaySevenTwoThousandTwentyMember" id="xdx2ixbrl1819" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_MaySevenTwoThousandTwentyMember" id="xdx2ixbrl1821" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MaySevenTwoThousandTwentyMember" id="xdx2ixbrl1824" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2020-10-31_custom_OctoberFourTwoThousandTwentyMember" id="xdx2ixbrl1826" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_OctoberFourTwoThousandTwentyMember" id="xdx2ixbrl1828" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OctoberFourTwoThousandTwentyMember" id="xdx2ixbrl1831" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2020-10-31_custom_NovemberThirtyTwoThousandTwentyMember" id="xdx2ixbrl1833" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_NovemberThirtyTwoThousandTwentyMember" id="xdx2ixbrl1835" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_NovemberThirtyTwoThousandTwentyMember" id="xdx2ixbrl1838" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2020-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember" id="xdx2ixbrl1840" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember" id="xdx2ixbrl1842" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember" id="xdx2ixbrl1845" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2020-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember" id="xdx2ixbrl1847" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember" id="xdx2ixbrl1849" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember" id="xdx2ixbrl1852" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2020-10-31_custom_MayThirteenTwoThousandTwentyOneMember" id="xdx2ixbrl1856" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_MayThirteenTwoThousandTwentyOneMember" id="xdx2ixbrl1859" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MayThirteenTwoThousandTwentyOneMember" id="xdx2ixbrl1862" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MinimumMember" id="xdx2ixbrl1899" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">P2Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl1959" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl1960" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember" id="xdx2ixbrl1973" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember" id="xdx2ixbrl1975" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember" id="xdx2ixbrl1979" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember" id="xdx2ixbrl1981" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember" id="xdx2ixbrl1988" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember" id="xdx2ixbrl1990" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember" id="xdx2ixbrl1991" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember" id="xdx2ixbrl1992" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl2000" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl2002" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember" id="xdx2ixbrl2010" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember" id="xdx2ixbrl2011" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember" id="xdx2ixbrl2013" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember" id="xdx2ixbrl2014" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember" id="xdx2ixbrl2021" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember" id="xdx2ixbrl2032" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember" id="xdx2ixbrl2033" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember" id="xdx2ixbrl2035" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember" id="xdx2ixbrl2036" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember" id="xdx2ixbrl2044" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember" id="xdx2ixbrl2056" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember" id="xdx2ixbrl2058" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember" id="xdx2ixbrl2068" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember" id="xdx2ixbrl2069" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember" id="xdx2ixbrl2080" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember" id="xdx2ixbrl2081" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember" id="xdx2ixbrl2082" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember" id="xdx2ixbrl2092" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember" id="xdx2ixbrl2104" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember" id="xdx2ixbrl2106" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember" id="xdx2ixbrl2116" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember" id="xdx2ixbrl2127" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember" id="xdx2ixbrl2129" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember" id="xdx2ixbrl2130" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember" id="xdx2ixbrl2139" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember" id="xdx2ixbrl2141" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember" id="xdx2ixbrl2142" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember" id="xdx2ixbrl2151" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember" id="xdx2ixbrl2153" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember" id="xdx2ixbrl2154" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember" id="xdx2ixbrl2187" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2020-11-012021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember" id="xdx2ixbrl2190" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-10-31_custom_AugustThirtyTwoThousandTwentySixMember" id="xdx2ixbrl2195" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2020-11-012021-10-31_custom_AugustThirtyTwoThousandTwentySixMember" id="xdx2ixbrl2197" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2020-11-012021-10-31_custom_AugustThirtyTwoThousandTwentySixMember" id="xdx2ixbrl2198" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl2203" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2019-10-31" id="xdx2ixbrl2205" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl2208" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageGrantDateFairValue" contextRef="AsOf2020-10-31" id="xdx2ixbrl2210" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValueTotal" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl2213" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember" id="xdx2ixbrl2218" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember" id="xdx2ixbrl2220" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember" id="xdx2ixbrl2221" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember" id="xdx2ixbrl2222" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember" id="xdx2ixbrl2226" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember" id="xdx2ixbrl2227" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember" id="xdx2ixbrl2229" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember" id="xdx2ixbrl2230" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember" id="xdx2ixbrl2235" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember" id="xdx2ixbrl2236" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember" format="ixt-sec:duryear" id="xdx2ixbrl2242" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.04</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember" id="xdx2ixbrl2244" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember" id="xdx2ixbrl2245" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember" id="xdx2ixbrl2253" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember" id="xdx2ixbrl2254" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember" id="xdx2ixbrl2260" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember" id="xdx2ixbrl2262" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember" id="xdx2ixbrl2263" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember" id="xdx2ixbrl2265" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember" id="xdx2ixbrl2270" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember" id="xdx2ixbrl2271" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember" id="xdx2ixbrl2272" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember" id="xdx2ixbrl2279" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember" id="xdx2ixbrl2288" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember" id="xdx2ixbrl2289" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember" id="xdx2ixbrl2297" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember" id="xdx2ixbrl2298" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember" id="xdx2ixbrl2305" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember" id="xdx2ixbrl2307" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember" id="xdx2ixbrl2308" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember" id="xdx2ixbrl2314" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember" id="xdx2ixbrl2316" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember" id="xdx2ixbrl2317" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember" id="xdx2ixbrl2323" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember" id="xdx2ixbrl2325" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember" id="xdx2ixbrl2326" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember" id="xdx2ixbrl2332" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember" id="xdx2ixbrl2334" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_country_US" id="xdx2ixbrl2428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl2477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-11-012020-10-31" id="xdx2ixbrl2478" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:DeferredTaxAssetsConvertibleDebenture" contextRef="AsOf2020-10-31" id="xdx2ixbrl2492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:DeferredTaxAssetsConvertibleDebentureAndDerivativeLiability" contextRef="AsOf2020-10-31" id="xdx2ixbrl2495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:DeferredTaxAssetsExplorationAndEvaluationAsset" contextRef="AsOf2020-10-31" id="xdx2ixbrl2498" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:DeferredTaxAssetsShareIssueCost" contextRef="AsOf2021-10-31" id="xdx2ixbrl2500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-10-31" id="xdx2ixbrl2506" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-10-31" id="xdx2ixbrl2507" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:DerivativeLiabilityCurrent" contextRef="AsOf2021-10-31" id="xdx2ixbrl2659" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:BusinessDevelopment" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl2720" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareholderCommunicationsExpense" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl2759" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SubsidiesAndRecoveries" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl2762" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:GainLossOnRecognitionOfDebtHostLiability" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl2780" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2813" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2815" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2816" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl2870" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2872" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2873" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2874" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl2898" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2899" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2900" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2902" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl2905" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2906" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2907" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2908" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2914" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2931" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2933" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2934" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2940" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2941" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2942" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2943" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2949" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2950" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2951" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2952" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharesIssuedForFindersFeesValue" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl2957" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharesIssuedForFindersFeesValue" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2958" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharesIssuedForFindersFeesValue" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2959" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharesIssuedForFindersFeesValue" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2960" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharesIssuedForFindersFeesValue" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2961" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharesIssuedForFindersFeesValue" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl2962" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2967" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2968" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2969" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2970" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl2973" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2975" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2976" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2977" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnConvertibleDebentures" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl2980" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnConvertibleDebentures" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2982" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnConvertibleDebentures" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2983" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnConvertibleDebentures" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2984" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnBrokerWarrants" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl2987" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnBrokerWarrants" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl2989" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnBrokerWarrants" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2990" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnBrokerWarrants" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2991" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl2994" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2995" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2997" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2998" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl3001" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3002" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl3003" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3005" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" id="xdx2ixbrl3008" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3009" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" id="xdx2ixbrl3010" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl3011" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl3037" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:GainLossOnRecognitionOfDebtHostLiability" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl3043" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDepositOtherAssets" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl3070" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ProceedsFromShareSubscriptions" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl3097" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl3099" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3140" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3147" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" id="xdx2ixbrl3151" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" id="xdx2ixbrl3152" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl3153" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3154" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3161" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3168" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2021-11-012022-01-31_us-gaap_ComputerEquipmentMember" id="xdx2ixbrl3178" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2021-11-012022-01-31_us-gaap_ComputerEquipmentMember" id="xdx2ixbrl3185" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl3209" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3210" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3217" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" id="xdx2ixbrl3221" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" id="xdx2ixbrl3222" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" id="xdx2ixbrl3223" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3224" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3231" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3245" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2021-11-012022-01-31_us-gaap_ComputerEquipmentMember" id="xdx2ixbrl3255" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3284" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_VehiclesMember" id="xdx2ixbrl3296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl3317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember" id="xdx2ixbrl3324" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember" id="xdx2ixbrl3325" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2021-11-012022-01-31_custom_VancouverOfficeMember" id="xdx2ixbrl3346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2021-11-012022-01-31_custom_VirginiaOfficeMember" id="xdx2ixbrl3347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2021-11-012022-01-31_custom_NevadaOfficeMember" id="xdx2ixbrl3348" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl3365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-11-012022-01-31_custom_NevadaOfficeMember" id="xdx2ixbrl3396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2021-11-012022-01-31_custom_VancouverOfficeMember" id="xdx2ixbrl3400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2021-11-012022-01-31_custom_VirginiaOfficeMember" id="xdx2ixbrl3401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2021-11-012022-01-31_custom_NevadaOfficeMember" id="xdx2ixbrl3402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember" id="xdx2ixbrl3420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" id="xdx2ixbrl3432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember" id="xdx2ixbrl3442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_VirginiaOfficeMember50338203" id="xdx2ixbrl3469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" id="xdx2ixbrl3476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" id="xdx2ixbrl3477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" id="xdx2ixbrl3492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" id="xdx2ixbrl3493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" id="xdx2ixbrl3495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember50338468" id="xdx2ixbrl3506" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember50338468" id="xdx2ixbrl3512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-11-012022-01-31_custom_VirginiaOfficeMember50338671" id="xdx2ixbrl3517" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-11-012022-01-31_custom_NevadaOfficeMember50338703" id="xdx2ixbrl3518" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-11-012022-01-31_custom_NevadaOfficeMember50338703" id="xdx2ixbrl3524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2021-11-012022-01-31_custom_VancouverOfficeMember50338640" id="xdx2ixbrl3528" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2021-11-012022-01-31_custom_VirginiaOfficeMember50338671" id="xdx2ixbrl3529" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2021-11-012022-01-31_custom_NevadaOfficeMember50338703" id="xdx2ixbrl3530" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember50338812" id="xdx2ixbrl3536" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember50338812" id="xdx2ixbrl3542" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember50338812" id="xdx2ixbrl3548" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember50338812" id="xdx2ixbrl3554" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember50338812" id="xdx2ixbrl3560" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember50338812" id="xdx2ixbrl3566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2020-10-31_custom_RelatedPartyAMember" id="xdx2ixbrl3591" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2020-10-31_custom_RelatedPartyBMember" id="xdx2ixbrl3592" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2020-10-31" id="xdx2ixbrl3593" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-01-31" id="xdx2ixbrl3698" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl3700" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-222022-01-31" id="xdx2ixbrl3895" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-10-222021-11-02" id="xdx2ixbrl3897" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-09-222021-10-31" id="xdx2ixbrl3899" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-06-102021-06-15" id="xdx2ixbrl3901" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-07-222020-07-27" id="xdx2ixbrl3903" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3908" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3909" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3912" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3914" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3923" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3924" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3928" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3929" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3932" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3937" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3939" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3942" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3947" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3949" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3952" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3953" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3957" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3963" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3964" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3967" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3969" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3978" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3979" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3984" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3987" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3989" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3991" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl3996" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl3997" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl4001" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4002" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl4006" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4007" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-10-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl4011" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-10-31_custom_DebtDiscountMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4012" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-10-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4013" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-10-31_custom_DebtDiscountMember" id="xdx2ixbrl4014" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl4015" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4017" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl4020" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4024" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl4028" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4030" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4034" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" id="xdx2ixbrl4035" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl4038" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" id="xdx2ixbrl4043" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl4251" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl4254" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4259" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4262" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4267" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4270" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4275" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4276" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4277" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" id="xdx2ixbrl4284" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" id="xdx2ixbrl4286" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4293" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4294" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4295" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4302" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4304" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4311" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4312" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4313" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember" id="xdx2ixbrl4320" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember" id="xdx2ixbrl4322" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4329" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4331" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4338" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4340" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4347" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4349" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4350" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" id="xdx2ixbrl4356" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" id="xdx2ixbrl4357" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" id="xdx2ixbrl4358" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantOneMember" id="xdx2ixbrl4364" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantOneMember" id="xdx2ixbrl4371" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4379" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4381" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4382" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JuneTenTwoThousandTwentySixMember" id="xdx2ixbrl4388" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixMember" id="xdx2ixbrl4390" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixMember" id="xdx2ixbrl4391" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JuneTenTwoThousandTwentySixOneMember" id="xdx2ixbrl4397" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixOneMember" id="xdx2ixbrl4399" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixOneMember" id="xdx2ixbrl4400" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_PurchaseWarrantTwoMember" id="xdx2ixbrl4405" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantTwoMember" id="xdx2ixbrl4409" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantTwoMember" id="xdx2ixbrl4411" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-10-31_custom_PurchaseWarrantTwoMember" id="xdx2ixbrl4414" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantTwoMember" id="xdx2ixbrl4418" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantMember" id="xdx2ixbrl4420" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl4433" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl4434" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl4435" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl4439" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl4440" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="xdx2ixbrl4441" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl4449" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl4451" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl4452" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl4455" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl4457" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" id="xdx2ixbrl4458" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4463" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4465" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4466" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4469" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4471" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" id="xdx2ixbrl4472" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4477" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4479" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4480" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4483" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4485" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4486" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4492" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4493" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4494" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4498" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4499" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" id="xdx2ixbrl4500" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4506" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4507" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4508" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4512" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4513" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" id="xdx2ixbrl4514" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4520" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4521" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4522" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4526" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4527" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember" id="xdx2ixbrl4528" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4534" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4535" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4536" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4540" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4541" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" id="xdx2ixbrl4542" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-01-31_custom_PurchaseWarrantMember" id="xdx2ixbrl4552" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-01-31_custom_PurchaseWarrantMember" id="xdx2ixbrl4554" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised" contextRef="From2020-11-012021-01-31_custom_PurchaseWarrantMember" id="xdx2ixbrl4562" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled" contextRef="From2020-11-012021-01-31_custom_PurchaseWarrantMember" id="xdx2ixbrl4564" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4636" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2020-11-012021-10-31" id="xdx2ixbrl4638" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionOneMember" id="xdx2ixbrl4647" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionOneMember" id="xdx2ixbrl4648" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" id="xdx2ixbrl4657" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" id="xdx2ixbrl4658" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" id="xdx2ixbrl4659" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionThreeMember" id="xdx2ixbrl4667" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionThreeMember" id="xdx2ixbrl4668" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionFourMember" id="xdx2ixbrl4677" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionFourMember" id="xdx2ixbrl4678" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionFiveMember" id="xdx2ixbrl4687" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionFiveMember" id="xdx2ixbrl4688" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionSixMember" id="xdx2ixbrl4697" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionSixMember" id="xdx2ixbrl4698" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionSixMember" id="xdx2ixbrl4699" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionSevenMember" id="xdx2ixbrl4707" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionSevenMember" id="xdx2ixbrl4708" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionSevenMember" id="xdx2ixbrl4709" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionEightMember" id="xdx2ixbrl4717" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionEightMember" id="xdx2ixbrl4718" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionEightMember" id="xdx2ixbrl4719" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionNineMember" id="xdx2ixbrl4727" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionNineMember" id="xdx2ixbrl4728" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionNineMember" id="xdx2ixbrl4729" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionTenMember" id="xdx2ixbrl4737" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionTenMember" id="xdx2ixbrl4738" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionTenMember" id="xdx2ixbrl4739" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionElevenMember" id="xdx2ixbrl4747" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionElevenMember" id="xdx2ixbrl4748" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionElevenMember" id="xdx2ixbrl4749" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionTwelveMember" id="xdx2ixbrl4757" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionTwelveMember" id="xdx2ixbrl4758" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionTwelveMember" id="xdx2ixbrl4759" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionThirteenMember" id="xdx2ixbrl4766" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-012022-01-31_custom_OptionThirteenMember" id="xdx2ixbrl4768" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionThirteenMember" id="xdx2ixbrl4769" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4779" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4791" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionOneMember" id="xdx2ixbrl4815" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2021-11-012022-01-31_custom_OptionOneMember" id="xdx2ixbrl4817" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-01-31_custom_OptionOneMember" id="xdx2ixbrl4818" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" id="xdx2ixbrl4824" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" id="xdx2ixbrl4826" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4833" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4837" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4843" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4847" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsWeightedAverageGrantDateFairValue" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4853" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValueTotal" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl4857" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionOneMember" id="xdx2ixbrl4863" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionOneMember" id="xdx2ixbrl4864" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionOneMember" id="xdx2ixbrl4865" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionTwoMember" id="xdx2ixbrl4873" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionTwoMember" id="xdx2ixbrl4874" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionTwoMember" id="xdx2ixbrl4875" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionThreeMember" id="xdx2ixbrl4883" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionThreeMember" id="xdx2ixbrl4884" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionThreeMember" id="xdx2ixbrl4885" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionFourMember" id="xdx2ixbrl4893" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionFourMember" id="xdx2ixbrl4894" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionFourMember" id="xdx2ixbrl4896" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionFourMember" id="xdx2ixbrl4897" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFiveMember" id="xdx2ixbrl4900" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionFiveMember" id="xdx2ixbrl4902" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionFiveMember" id="xdx2ixbrl4903" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionSixMember" id="xdx2ixbrl4911" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionSixMember" id="xdx2ixbrl4912" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionSixMember" id="xdx2ixbrl4913" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionSevenMember" id="xdx2ixbrl4921" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionSevenMember" id="xdx2ixbrl4922" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionSevenMember" id="xdx2ixbrl4923" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionEightMember" id="xdx2ixbrl4931" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionEightMember" id="xdx2ixbrl4932" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionEightMember" id="xdx2ixbrl4933" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionNineMember" id="xdx2ixbrl4941" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionNineMember" id="xdx2ixbrl4942" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionNineMember" id="xdx2ixbrl4943" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionTenMember" id="xdx2ixbrl4951" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionTenMember" id="xdx2ixbrl4952" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionTenMember" id="xdx2ixbrl4953" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionElevenMember" id="xdx2ixbrl4961" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionElevenMember" id="xdx2ixbrl4962" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionElevenMember" id="xdx2ixbrl4963" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionTwelveMember" id="xdx2ixbrl4971" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionTwelveMember" id="xdx2ixbrl4972" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionTwelveMember" id="xdx2ixbrl4973" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionThirteenMember" id="xdx2ixbrl4981" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionThirteenMember" id="xdx2ixbrl4982" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFourteenMember" id="xdx2ixbrl4990" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31_custom_OptionFourteenMember" id="xdx2ixbrl4992" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionFourteenMember" id="xdx2ixbrl4993" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl5003" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl5015" unitRef="CAPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2021-11-01to2022-01-31" id="xdx2ixbrl5035" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2020-11-012021-01-31" id="xdx2ixbrl5037" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="mlyf-20220131.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-11-01to2022-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_ObligationToIssueSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:ObligationToIssueSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_FurnaceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:FurnaceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_RightOfUseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:RightOfUseAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_FurnaceAndPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:FurnaceAndPlantEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_FurnaceAndPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:FurnaceAndPlantEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:FurnaceAndPlantEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:FurnaceAndPlantEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:FurnaceAndPlantEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_FurnaceAndPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:FurnaceAndPlantEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_FurnaceAndPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:FurnaceAndPlantEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_VancouverOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_VirginiaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_NevadaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_PilotPlantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_VancouverOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_VirginiaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_NevadaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_PilotPlantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_VancouverOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_VirginiaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_NevadaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_PilotPlantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_VancouverOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_VirginiaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_NevadaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_PilotPlantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_VancouverOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_VirginiaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_NevadaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_PilotPlantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_VancouverOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_VirginiaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_NevadaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_PilotPlantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_VancouverOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_VirginiaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_NevadaOfficeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_PilotPlantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_BritishColumbiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:BritishColumbiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_BritishColumbiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:BritishColumbiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_McLeanAndVirginiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:McLeanAndVirginiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_VancouverOfficeMember50338000">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_VirginiaOfficeMember50338015">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_NevadaOfficeMember50338015">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_PilotPlantMember50338031">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_VancouverOfficeMember50338046">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_VirginiaOfficeMember50338062">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_NevadaOfficeMember50338078">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_PilotPlantMember50338078">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_VancouverOfficeMember50338187">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_VirginiaOfficeMember50338203">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_NevadaOfficeMember50338218">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_PilotPlantMember50338234">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_PilotPlantMember50338312">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_VancouverOfficeMember50338437">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_VirginiaOfficeMember50338453">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_NevadaOfficeMember50338468">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_PilotPlantMember50338500">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_VancouverOfficeMember50338640">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_VirginiaOfficeMember50338671">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_NevadaOfficeMember50338703">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_PilotPlantMember50338718">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_VancouverOfficeMember50338781">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VancouverOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_VirginiaOfficeMember50338796">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:VirginiaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_NevadaOfficeMember50338812">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:NevadaOfficeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_PilotPlantMember50338828">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:PilotPlantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_BeaverdellPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:BeaverdellPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_SilveradoPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:SilveradoPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_TamiMosiPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:TamiMosiPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_BeaverdellPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:BeaverdellPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_SilveradoPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:SilveradoPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_TamiMosiPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:TamiMosiPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_BeaverdellPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:BeaverdellPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_SilveradoPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:SilveradoPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_TamiMosiPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:TamiMosiPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_BeaverdellPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:BeaverdellPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_SilveradoPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:SilveradoPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_TamiMosiPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:TamiMosiPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_BeaverdellPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:BeaverdellPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_SilveradoPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:SilveradoPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_TamiMosiPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:TamiMosiPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-052020-04-07_custom_BeaverdellPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">MLYF:BeaverdellPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-05</xbrli:startDate>
        <xbrli:endDate>2020-04-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_SilveradoPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:SilveradoPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_TamiMosiPropertyMember_custom_WhitePineCountyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:TamiMosiPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:WhitePineCountyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_TamiMosiPropertyMember_custom_MoorMiningDistrictMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:TamiMosiPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">MLYF:MoorMiningDistrictMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_TamiMosiPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">MLYF:TamiMosiPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_srt_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_srt_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_DirectorsAndOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MLYF:DirectorsAndOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_DirectorsAndOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MLYF:DirectorsAndOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-082018-09-12_custom_DirectorAndrOfficerMember_custom_RelatedPartyAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MLYF:DirectorAndrOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MLYF:RelatedPartyAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-08</xbrli:startDate>
        <xbrli:endDate>2018-09-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-222018-08-28_custom_RelatedPartyAgreementMember_custom_DirectorAndrOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MLYF:RelatedPartyAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MLYF:DirectorAndrOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-22</xbrli:startDate>
        <xbrli:endDate>2018-08-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-302021-11-03_custom_RelatedPartyAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MLYF:RelatedPartyAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-30</xbrli:startDate>
        <xbrli:endDate>2021-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_custom_RelatedPartyAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MLYF:RelatedPartyAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-272020-09-29_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-27</xbrli:startDate>
        <xbrli:endDate>2020-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-292020-12-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-29</xbrli:startDate>
        <xbrli:endDate>2020-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-292020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-29</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-062021-02-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-06</xbrli:startDate>
        <xbrli:endDate>2021-02-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-08_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-19_custom_LampertAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MLYF:LampertAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-11-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-012021-09-30_custom_LeaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MLYF:LeaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-012019-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-012020-10-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-012020-10-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-012019-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2019-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-172021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-17</xbrli:startDate>
        <xbrli:endDate>2021-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-302021-10-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-30</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-07-30_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-252021-07-30_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-25</xbrli:startDate>
        <xbrli:endDate>2021-07-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-102021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-10</xbrli:startDate>
        <xbrli:endDate>2021-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-302021-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-30</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_CombinedValueOfConvertiblesDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertiblesDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_CombinedValueOfConvertiblesDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertiblesDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">MLYF:ConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">MLYF:ConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-282022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-28</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-282021-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-28</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-07-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-282022-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-28</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-282021-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-28</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-282021-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-28</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">MLYF:ConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-02_custom_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-02_custom_BrokerWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:BrokerWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_BrokerWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:BrokerWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OctoberThirtyOneTwentyThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:OctoberThirtyOneTwentyThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_JuneFifteenTwentyThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneFifteenTwentyThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_JulyTwentySevenTwentyThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwentySevenTwentyThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OctoberThirtyOneTwentyThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:OctoberThirtyOneTwentyThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JuneFifteenTwentyThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneFifteenTwentyThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JulyTwentySevenTwentyThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwentySevenTwentyThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-222022-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-22</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-222021-11-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-22</xbrli:startDate>
        <xbrli:endDate>2021-11-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-282021-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-28</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-102021-06-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-10</xbrli:startDate>
        <xbrli:endDate>2021-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-222020-07-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-22</xbrli:startDate>
        <xbrli:endDate>2020-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-222021-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-22</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_DebtHostLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_DebtHostLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_DebtHostLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_DebtHostLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DebtHostLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_CombinedValueOfConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_CombinedValueOfConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_CombinedValueOfConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_DebtHostLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DebtHostLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtHostLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DebtDiscountMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DebtDiscountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_DebtDiscountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DebtDiscountMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DebtDiscountMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DebtDiscountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:DebtDiscountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_CombinedValueOfConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:CombinedValueOfConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-182020-02-19_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-18</xbrli:startDate>
        <xbrli:endDate>2020-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-162020-01-17_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-16</xbrli:startDate>
        <xbrli:endDate>2020-01-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-17_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-252020-05-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-25</xbrli:startDate>
        <xbrli:endDate>2020-05-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-092020-09-10_custom_NonBrokeredPrivatePlacementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-09</xbrli:startDate>
        <xbrli:endDate>2020-09-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-10_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-092020-09-10_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-09</xbrli:startDate>
        <xbrli:endDate>2020-09-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-192020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-19</xbrli:startDate>
        <xbrli:endDate>2020-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-142021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-14</xbrli:startDate>
        <xbrli:endDate>2021-01-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-282021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-28</xbrli:startDate>
        <xbrli:endDate>2021-01-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-232021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">MLYF:ShareBasedCompensationAwardTrancheFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-23</xbrli:startDate>
        <xbrli:endDate>2021-03-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">MLYF:ShareBasedCompensationAwardTrancheFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">MLYF:ShareBasedCompensationAwardTrancheFiveAndFinalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-26</xbrli:startDate>
        <xbrli:endDate>2021-04-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">MLYF:ShareBasedCompensationAwardTrancheFiveAndFinalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-192021-04-27_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-19</xbrli:startDate>
        <xbrli:endDate>2021-04-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-27_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-26</xbrli:startDate>
        <xbrli:endDate>2021-04-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-05_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-042021-05-05_custom_NonBrokeredPrivatePlacementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-04</xbrli:startDate>
        <xbrli:endDate>2021-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-272021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-27</xbrli:startDate>
        <xbrli:endDate>2021-05-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">MLYF:ShareBasedCompensationAwardTrancheTwoAndFinalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-16</xbrli:startDate>
        <xbrli:endDate>2021-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">MLYF:ShareBasedCompensationAwardTrancheTwoAndFinalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-16</xbrli:startDate>
        <xbrli:endDate>2021-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">MLYF:ShareBasedCompensationAwardTrancheFiveAndFinalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-292021-06-17_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-29</xbrli:startDate>
        <xbrli:endDate>2021-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-172021-05-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-17</xbrli:startDate>
        <xbrli:endDate>2021-05-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-172021-10-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-17</xbrli:startDate>
        <xbrli:endDate>2021-10-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-07_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-152021-07-16_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-15</xbrli:startDate>
        <xbrli:endDate>2021-07-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-16_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-10</xbrli:startDate>
        <xbrli:endDate>2021-08-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-11_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_srt_MinimumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_srt_MaximumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_srt_MinimumMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012022-10-31_srt_MaximumMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2022-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-28_custom_DirectorAndOfficersMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MLYF:DirectorAndOfficersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-08_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-072018-08-08_custom_TwoThousandSeventeenStockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-07</xbrli:startDate>
        <xbrli:endDate>2018-08-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-11_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-292020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-29</xbrli:startDate>
        <xbrli:endDate>2020-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember_custom_ExercisableAtFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:ExercisableAtFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember_custom_ExercisableAtTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:ExercisableAtTwoYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-292021-08-30_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-29</xbrli:startDate>
        <xbrli:endDate>2021-08-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-30_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-292021-10-01_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-29</xbrli:startDate>
        <xbrli:endDate>2021-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-01_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_us-gaap_StockOptionMember50365765">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyFirstTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyFirstTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyFirstTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyFirstTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneThreeTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneThreeTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneThreeTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneThreeTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryElevenTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryElevenTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryElevenTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryElevenTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustSixteenTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustSixteenTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustSixteenTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustSixteenTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwentySixTwoThousandTwentyTwoOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwentySixTwoThousandTwentyTwoOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwentySixTwoThousandTwentyTwoOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwentySixTwoThousandTwentyTwoOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilNinteenTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilNinteenTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilNinteenTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilNinteenTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwelveTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwelveTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwelveTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwelveTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThreeTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionTenMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThreeTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThreeTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThreeTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThreeTwoThousandTwentyThreeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayTwentyTwoTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayTwentyTwoTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayTwentyTwoTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayTwentyTwoTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThreeTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThreeTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThreeTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThreeTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyFourTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyFourTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyFourTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyFourTwoThousandTwentyFourOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySixTwoThousandTwentyFiveOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySixTwoThousandTwentyFiveOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySixTwoThousandTwentyFiveOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySixTwoThousandTwentyFiveOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionFourteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentyThreeTwoThousandTwentyFiveOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentyThreeTwoThousandTwentyFiveOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentyThreeTwoThousandTwentyFiveOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentyThreeTwoThousandTwentyFiveOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JulyTwoThousandTwentyOneConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_NonBrokeredPrivatePlacementOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-062021-06-07_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-06</xbrli:startDate>
        <xbrli:endDate>2021-06-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-07_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-142021-07-16_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-14</xbrli:startDate>
        <xbrli:endDate>2021-07-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_NonBrokeredPrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">MLYF:NonBrokeredPrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_StockOptionMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_StockOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-29_custom_DirectorAndOfficersMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">MLYF:DirectorAndOfficersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-04_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-04_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-04_custom_ClassAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-04_custom_ClassBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-122021-12-13_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-12</xbrli:startDate>
        <xbrli:endDate>2021-12-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-122021-12-13_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-12</xbrli:startDate>
        <xbrli:endDate>2021-12-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-13_custom_ClassAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-13_custom_ClassBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-192022-01-20_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-19</xbrli:startDate>
        <xbrli:endDate>2022-01-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-192022-01-20_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-19</xbrli:startDate>
        <xbrli:endDate>2022-01-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-20_custom_ClassBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-20_custom_ClassAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-192022-01-20_custom_ClassBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-19</xbrli:startDate>
        <xbrli:endDate>2022-01-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-252021-11-26_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-25</xbrli:startDate>
        <xbrli:endDate>2021-11-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-26_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_CommonStockTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_CommonStockTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_CommonStockThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_CommonStockThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-302022-01-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-30</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_TwoThousandSeventeenStockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandSeventeenStockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-022021-12-03_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-02</xbrli:startDate>
        <xbrli:endDate>2021-12-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-03_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustThirtyOneTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustThirtyOneTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustThirtyOneTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyTwoTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyTwoTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyTwoTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryThirtyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryThirtyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryThirtyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentyFourTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentyFourTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentyFourTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_MayThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneSeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneSeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneSeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneEighteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneEighteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneEighteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruarythirteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruarythirteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruarythirteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_MaySevenTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MaySevenTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_MaySevenTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MaySevenTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_MaySevenTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MaySevenTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OctoberFourTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:OctoberFourTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_OctoberFourTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:OctoberFourTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_OctoberFourTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:OctoberFourTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_NovemberThirtyTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThirtyTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_NovemberThirtyTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThirtyTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_NovemberThirtyTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThirtyTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryTwentyThreeTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryTwentyThreeTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryTwentyThreeTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentyNineTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentyNineTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentyNineTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_MayThirteenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirteenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-31_custom_MayThirteenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirteenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012020-10-31_custom_MayThirteenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirteenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyTwoTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyTwoTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryThirtyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryThirtyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentyFourTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentyFourTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneSeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneSeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JulyEighteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JulyEighteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JulyEighteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JulyEighteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruarythirteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruarythirteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_PurchaseWarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_PurchaseWarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_PurchaseWarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneTenTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JuneTenTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneTenTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JuneTenTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneTenTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneTenTwoThousandTwentySixOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_JuneTenTwoThousandTwentySixOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneTenTwoThousandTwentySixOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_JuneTenTwoThousandTwentySixOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JuneTenTwoThousandTwentySixOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_PurchaseWarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_PurchaseWarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_PurchaseWarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_PurchaseWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_PurchaseWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_PurchaseWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustThirtyOneTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustThirtyOneTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyTwoTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyTwoTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuarySeventeenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryThirtyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:JanuaryThirtyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryTwentyOneTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_MayNineTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayNineTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustFourteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_PurchaseWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_PurchaseWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_PurchaseWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_PurchaseWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:PurchaseWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-122021-01-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-12</xbrli:startDate>
        <xbrli:endDate>2021-01-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryElevenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryElevenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:FebruaryElevenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustSixteenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustSixteenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustSixteenTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySevenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwentySixTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwentySixTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwentySixTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilNinteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilNinteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilNinteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwelveTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwelveTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustTwelveTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThreeTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThreeTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThreeTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayTwentyTwoTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayTwentyTwoTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MayTwentyTwoTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThreeTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThreeTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberThreeTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyFourTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyFourTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:NovemberTwentyFourTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySixTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySixTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:MarchTwentySixTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentyThreeTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentyThreeTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AprilTwentyThreeTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFourteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThirtyTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThirtyTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:DecemberThirtyTwoThousandTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustThirtyTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustThirtyTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:AugustThirtyTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:OctoberOneTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:OctoberOneTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">MLYF:OctoberOneTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_OptionThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_OptionThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_OptionThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-01-31_custom_OptionFourteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_OptionFourteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_OptionFourteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:OptionFourteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:DecemberThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:DecemberThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:DecemberThirtyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_AugustThirtyTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:AugustThirtyTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_AugustThirtyTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:AugustThirtyTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_AugustThirtyTwoThousandTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">MLYF:AugustThirtyTwoThousandTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_CashMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DepositsHeldByRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">MLYF:DepositsHeldByRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_DueToRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">MLYF:DueToRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_ConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">MLYF:ConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_CashMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_AmountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">MLYF:AmountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_DueToRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">MLYF:DueToRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_ConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">MLYF:ConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-10_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-10_us-gaap_SubsequentEventMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-28_custom_AgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MLYF:AgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-28_custom_AgreementMember_us-gaap_CommonStockMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">MLYF:AgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-03_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-04_us-gaap_SubsequentEventMember_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-04_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-04_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-04_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-122021-12-13_us-gaap_SubsequentEventMember_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-12</xbrli:startDate>
        <xbrli:endDate>2021-12-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-122021-12-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-12</xbrli:startDate>
        <xbrli:endDate>2021-12-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-13_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-13_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-192022-01-20_us-gaap_SubsequentEventMember_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-19</xbrli:startDate>
        <xbrli:endDate>2022-01-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-192022-01-20_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-19</xbrli:startDate>
        <xbrli:endDate>2022-01-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-20_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-20_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-252021-11-26_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-25</xbrli:startDate>
        <xbrli:endDate>2021-11-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-26_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-022021-12-03_us-gaap_SubsequentEventMember_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-02</xbrli:startDate>
        <xbrli:endDate>2021-12-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-03_us-gaap_SubsequentEventMember_custom_TwoThousandTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-082022-03-10_us-gaap_SubsequentEventMember_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">MLYF:JuneTwoThousandTwentyOneConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-08</xbrli:startDate>
        <xbrli:endDate>2022-03-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-082022-03-10_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-08</xbrli:startDate>
        <xbrli:endDate>2022-03-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-10_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-10_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">MLYF:ClassBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-012022-03-15_custom_CommonStockPurchaseWarrantMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockPurchaseWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-01</xbrli:startDate>
        <xbrli:endDate>2022-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-15_custom_CommonStockPurchaseWarrantMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockPurchaseWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-012022-03-15_custom_CommonStockPurchaseWarrantOneMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockPurchaseWarrantOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-01</xbrli:startDate>
        <xbrli:endDate>2022-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-15_custom_CommonStockPurchaseWarrantOneMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">MLYF:CommonStockPurchaseWarrantOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-012022-03-15_custom_TwoThousandTwentyOneEquityIncentivePlanMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-01</xbrli:startDate>
        <xbrli:endDate>2022-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-15_custom_TwoThousandTwentyOneEquityIncentivePlanMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">MLYF:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_RelatedPartyAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_RelatedPartyBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_RelatedPartyAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-012021-10-31_custom_RelatedPartyBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_RelatedPartyAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_RelatedPartyBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_RelatedPartyAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012022-01-31_custom_RelatedPartyBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_RelatedPartyAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_RelatedPartyBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001801762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">MLYF:RelatedPartyBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="CA">
      <xbrli:measure>iso4217:CAD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Acre">
      <xbrli:measure>utr:acre</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="CAPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:CAD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Days">
      <xbrli:measure>MLYF:Days</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Hectares">
      <xbrli:measure>utr:ha</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001670" toRefs="Footnote001778"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1671" toRefs="Footnote001778"></ix:relationship>
  <ix:relationship fromRefs="Fact001672" toRefs="Footnote001778"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1673" toRefs="Footnote001778"></ix:relationship>
  <ix:relationship fromRefs="Fact001674" toRefs="Footnote001778"></ix:relationship>
  <ix:relationship fromRefs="Fact001675" toRefs="Footnote001778"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1676" toRefs="Footnote001778"></ix:relationship>
  <ix:relationship fromRefs="Fact001818" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1819" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001820" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1821" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001822" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001823" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1824" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001825" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1826" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001827" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1828" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001829" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001830" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1831" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001832" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1833" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001834" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1835" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001836" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001837" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1838" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001839" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1840" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001841" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1842" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001843" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001844" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1845" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001846" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1847" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001848" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1849" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001850" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001851" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1852" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001854" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1856" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001858" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1859" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001860" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="Fact001861" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1862" toRefs="Footnote001883"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3591" toRefs="Footnote003622"></ix:relationship>
  <ix:relationship fromRefs="Fact003595" toRefs="Footnote003622"></ix:relationship>
  <ix:relationship fromRefs="Fact003599" toRefs="Footnote003622"></ix:relationship>
  <ix:relationship fromRefs="Fact003603" toRefs="Footnote003622"></ix:relationship>
  <ix:relationship fromRefs="Fact003607" toRefs="Footnote003622"></ix:relationship>
  <ix:relationship fromRefs="Fact003611" toRefs="Footnote003622"></ix:relationship>
  <ix:relationship fromRefs="Fact003615" toRefs="Footnote003622"></ix:relationship>
  <ix:relationship fromRefs="Fact003619" toRefs="Footnote003622"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3592" toRefs="Footnote003623"></ix:relationship>
  <ix:relationship fromRefs="Fact003596" toRefs="Footnote003623"></ix:relationship>
  <ix:relationship fromRefs="Fact003600" toRefs="Footnote003623"></ix:relationship>
  <ix:relationship fromRefs="Fact003604" toRefs="Footnote003623"></ix:relationship>
  <ix:relationship fromRefs="Fact003608" toRefs="Footnote003623"></ix:relationship>
  <ix:relationship fromRefs="Fact003612" toRefs="Footnote003623"></ix:relationship>
  <ix:relationship fromRefs="Fact003616" toRefs="Footnote003623"></ix:relationship>
  <ix:relationship fromRefs="Fact003620" toRefs="Footnote003623"></ix:relationship>
  <ix:relationship fromRefs="Fact004446" toRefs="Footnote004567"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the Securities and Exchange Commission on May [&#9679;], 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 4pt solid; font: 1pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_900_edei--DocumentType_c20211101__20220131_zTJUvKINWV9g"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:DocumentType">S-1</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNDER
THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20211101__20220131_zSCbeRv9wCX2"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:EntityRegistrantName">WESTERN
MAGNESIUM CORPORATION</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20211101__20220131_zgHaTgt1581i"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3339</b></span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20211101__20220131_zEvGhAMVlNxk"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:EntityTaxIdentificationNumber">61-1934413</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or Other Jurisdiction of</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
    Standard Industrial</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation
    or Organization)</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Classification
    Code Number)</span></td>
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Identification
    Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20211101__20220131_zERDT2rf59lk"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:EntityAddressAddressLine1">8180
Greensboro Drive</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20211101__20220131_zjOhOl3sKX7l"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:EntityAddressAddressLine2">Suite 720</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressCityOrTown_c20211101__20220131_zphXT6ygM9cc"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:EntityAddressCityOrTown">McLean</ix:nonNumeric></span>,
<span id="xdx_904_edei--EntityAddressStateOrProvince_c20211101__20220131_zJdjjBa1cIc9"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Virginia</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20211101__20220131_zcwRR2c0rST4"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:EntityAddressPostalZipCode">22102</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Telephone:
<span id="xdx_90F_edei--CityAreaCode_c20211101__20220131_zIemhaF1xFb7"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:CityAreaCode">(571)</ix:nonNumeric></span> <span id="xdx_903_edei--LocalPhoneNumber_c20211101__20220131_zSzFXcD5khp2"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="dei:LocalPhoneNumber">378-0762</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Corporation Trust Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporation
Trust Center</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20211101__20220131__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zA9PJeXIFNVh"><ix:nonNumeric contextRef="From2021-11-012022-01-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine1">1209
Orange Street</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressCityOrTown_c20211101__20220131__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zlDUkwWNG0G4"><ix:nonNumeric contextRef="From2021-11-012022-01-31_dei_BusinessContactMember" name="dei:EntityAddressCityOrTown">Wilmington</ix:nonNumeric></span>,
<span id="xdx_90C_edei--EntityAddressStateOrProvince_c20211101__20220131__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zC1Mm5IAqNk9"><ix:nonNumeric contextRef="From2021-11-012022-01-31_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Delaware</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20211101__20220131__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zeYBF3YRxkOl"><ix:nonNumeric contextRef="From2021-11-012022-01-31_dei_BusinessContactMember" name="dei:EntityAddressPostalZipCode">19801</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Telephone:
<span id="xdx_902_edei--CityAreaCode_c20211101__20220131__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zOXP3VQJmmod"><ix:nonNumeric contextRef="From2021-11-012022-01-31_dei_BusinessContactMember" name="dei:CityAreaCode">(302)</ix:nonNumeric></span> <span id="xdx_905_edei--LocalPhoneNumber_c20211101__20220131__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zQE5EtxPDrpa"><ix:nonNumeric contextRef="From2021-11-012022-01-31_dei_BusinessContactMember" name="dei:LocalPhoneNumber">658-7581</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Copies
to:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Laura
Anthony, Esq.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Craig
D. Linder, Esq.<br /> Anthony L.G., PLLC<br /> 625 N. Flagler Drive, Suite 600<br /> West Palm Beach, Florida 33401<br /> Telephone: (561) 514-0936
</b>&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
date of commencement of proposed sale to the public: <b>As soon as practicable after the effective date of this registration statement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box: &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityFilerCategory_c20211101__20220131_ztCVDhq6h8of"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-Accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_900_edei--EntitySmallBusiness_c20211101__20220131_zjVU47W3NuU9"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20211101__20220131_zxkUJuBACeKg"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span id="xdx_906_edei--EntityExTransitionPeriod_c20211101__20220131_zlr0wVhERW9f"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date
as the commission, acting pursuant to section 8(a) may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif; border-bottom: Black 4pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities,
and it is not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>PRELIMINARY
    PROSPECTUS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT
    TO COMPLETION </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>DATED
    MAY [&#9679;], 2022</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #4472C4"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #4472C4"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WESTERN
MAGNESIUM CORPORATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,240,256
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of Common Stock Underlying Convertible Debentures</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,240,256
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of Common Stock Underlying Warrants</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,774,500
Shares of Common Stock for Resale by Selling Securityholder</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_001.jpg" alt="" style="height: 131.25pt; width: 250.5pt" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #4472C4"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #4472C4"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the issuance by us of up to 19,240,256 shares of our common stock, par value $0.001 per share (&#8220;common
stock&#8221;) upon the conversion of the outstanding principal amount and accrued interest thereon of certain convertible debentures
(&#8220;Convertible Debentures&#8221;) held by the selling securityholder named in this prospectus or their permitted transferees (&#8220;Selling
Securityholder&#8221;), which entitle them to convert into our common stock at the conversion rate of $0.10 per share for $900,000
principal amount convertible debenture and $0.30 per share for a $2,000,000 principal amount convertible debenture. For purposes of this
prospectus, we have assumed a conversion prices of $0.10 per share and $0.30 per share of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, this prospectus relates to the issuance by us of up to 25,240,256 shares of our common stock upon the exercise of 25,240,256
warrants (&#8220;Warrants&#8221;) issuable by us upon conversion of the Convertible Debentures, which we are obligated to issue in
connection with the conversion of the Convertible Debentures, which will entitle them to purchase our common stock at an exercise prices
of $0.13 per share for 8,536,110 warrants, $0.19 per share for 8,536,110 warrants and $0.40 per share for 8,168,037
warrants. For purposes of this prospectus, we have assumed exercise prices of $0.13, $0.19 and $0.40 per share of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
this prospectus relates to the resale from time to time by Selling Securityholder of 1,774,500 shares of Common Stock which we issued
to the Selling Securityholder upon the partial exercise of the Convertible Debentures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholder will sell its shares registered for resale in this prospectus at fixed prices, at prevailing market prices at
the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale or at negotiated
prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale of the securities owned by the Selling Securityholder. We will not receive any proceeds
from the conversion of the Convertible Debentures, but will receive the proceeds of any cash exercise of the Warrants. See &#8220;Use
of Proceeds&#8221; beginning on page 19 of this prospectus. We will bear all costs, expenses and fees in connection with the registration
of these securities, including with regard to compliance with state securities or &#8220;blue sky&#8221; laws. The Selling Securityholder
will bear all commissions and discounts, if any, attributable to their sale of securities. See &#8220;Plan of Distribution&#8221; beginning
on page 76 of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently quoted on the OTC Market Group, Inc.&#8217;s OTCQB tier under the symbol &#8220;MLYF.&#8221; On May 18,
2022, the last reported sale price of our common stock was $0.255.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at 8180 Greensboro Drive, Suite 720, McLean, Virginia 22102.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our common stock involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page </b>9 <b>of this prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these
securities or passed on the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is ____________, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #4472C4"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_001">CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_002">CAUTIONARY
    NOTE REGARDING MINERALIZED MATERIAL</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_003">INDUSTRY
    AND MARKET DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_004">TRADEMARKS
    AND COPYRIGHTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_005">CURRENCY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_006">PROSPECTUS
    SUMMARY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_007">THE
    OFFERING</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_008">SELECTED
    HISTORICAL CONSOLIDATED FINANCIAL DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_009">RISK
    FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_010">USE
    OF PROCEEDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_011">CAPITALIZATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_012">DETERMINATION
    OF OFFERING PRICE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_013">DIVIDEND
    POLICY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_014">MARKET
    PRICE FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_015">DESCRIPTION
    OF BUSINESS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#psi_016">MANAGEMENT&#8217;S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_001">MANAGEMENT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_002">EXECUTIVE
    COMPENSATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">61</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_003">SECURITY
    OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_004">CERTAIN
    RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_005">DESCRIPTION
    OF SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">72</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_006">SELLING
    SECURITYHOLDER</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">75</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_007">PLAN
    OF DISTRIBUTION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_008">MATERIAL
    UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">78</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_009">LEGAL
    MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">82</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_010">EXPERTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">83</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_011">DISCLOSURE
    OF COMMISSION&#8217;S POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">83</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_012">WHERE
    YOU CAN FIND ADDITIONAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">83</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sur_013">INDEX
    TO FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-1</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
dealer, salesperson or other individual has been authorized to give any information or to make any representation other than those contained
in this prospectus in connection with the offer made by this prospectus and, if given or made, such information or representations must
not be relied upon as having been authorized by us or the selling stockholder. This prospectus does not constitute an offer to sell or
a solicitation of an offer to buy any securities in any jurisdiction in which such an offer or solicitation is not authorized or in which
the person making such offer or solicitation is not qualified to do so, or to any person to whom it is unlawful to make such offer or
solicitation. Neither the delivery of this prospectus nor any sale made hereunder shall, under any circumstances, create any implication
that there has been no change in our affairs or that information contained herein is correct as of any time subsequent to the date hereof.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
investors outside the United States: We have not, and the selling stockholder has not, done anything that would permit this offering
or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United
States. Persons outside the United States who come into possession of this prospectus must inform themselves, and observe any restrictions
relating to, the offering of the shares of our common stock and the distribution of this prospectus outside the United States.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="psi_001"></span>Cautionary
Note Regarding Forward-Looking Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements. Specifically, forward-looking statements may include statements relating to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    future financial performance;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the market for our products and services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expansion plans and opportunities; and</span></td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    statements preceded by, followed by or that include the words &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221;
    &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;seek,&#8221;
    &#8220;target&#8221; or similar expressions.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are based on information available as of the date of this prospectus and current expectations, forecasts and
assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied
upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements
to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise,
except as may be required under applicable securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from
those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    losses and inability to provide assurance as to when or if we will become profitable and generate cash in our operating activities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    need for substantial additional financing to operate our business and difficulties we may face acquiring additional financing on
    terms acceptable to us or at all;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    significant indebtedness and significant restrictions on our operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    inability to implement our plans to construct and operate our planned magnesium research and development pilot plant and obtain necessary
    permits and authorizations to construct and operate the facility;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dilutive effect of additional issuances of our common stock, or securities convertible into our common stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to raise further working capital as a result of a decline in the price of our common stock could affect our ability to continue
    operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    increased costs as a result of being a public company in Canada and the United States; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    risks and uncertainties indicated in this prospectus, including those under &#8220;Risk Factors.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="psi_002"></span>CAUTIONARY
NOTE REGARDING MINERALIZED MATERIAL</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#8220;Mineralized
material&#8221; as used in this prospectus, although permissible under the United States Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;)
Industry Guide 7, does not indicate &#8220;reserves&#8221; by SEC standards. We cannot be certain that any mineralized materials will
ever be converted into SEC Industry Guide 7-compliant &#8220;reserves.&#8221; Investors are cautioned not to assume that all or any part
of the disclosed mineralized material estimates will ever be confirmed or converted into reserves or that mineralized material can be
economically or legally extracted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_003"></span>INDUSTRY
AND MARKET DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are responsible for the disclosure in this prospectus. However, this prospectus includes industry data that we obtained from internal
surveys, market research, publicly available information and industry publications. The market research, publicly available information
and industry publications that we use generally state that the information contained therein has been obtained from sources believed
to be reliable. The information therein represents the most recently available data from the relevant sources and publications and we
believe remains reliable. We did not fund and are not otherwise affiliated with any of the sources cited in this prospectus. Forward-looking
information obtained from these sources is subject to the same qualifications and additional uncertainties regarding the other forward-looking
statements in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_004"></span>TRADEMARKS
AND COPYRIGHTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own or have rights to trademarks or trade names that we use in connection with the operation of our business, including our corporate
name, logo and website names. In addition, we own or have the rights to copyrights, trade secrets and other proprietary rights that protect
the pilot magnesium production facility we are developing and the formulations for our planned magnesium production. This prospectus
may also contain trademarks, service marks and trade names of other companies, which are the property of their respective owners. Our
use or display of third parties&#8217; trademarks, service marks, trade names or products in this prospectus is not intended to, and
should not be read to, imply a relationship with or endorsement or sponsorship of us. Solely for convenience, some of the copyrights,
trade names and trademarks referred to in this prospectus are listed without their &#169;, &#174; and &#8482; symbols, but we will assert,
to the fullest extent under applicable law, our rights to our copyrights, trade names and trademarks. All other trademarks are the property
of their respective owners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="psi_005"></span>CURRENCY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, all references to &#8220;$&#8221; or &#8220;US$&#8221; in this registration statement refer to United States dollars,
and all references to &#8220;CAD$&#8221; refer to Canadian dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_006"></span>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary highlights certain information about us, this offering, and selected information contained in this prospectus. This summary is
not complete and does not contain all of the information that you should consider before deciding whether to invest in our common stock.
For a more complete understanding of the Company and this offering, we encourage you to read and consider the more detailed information
in this prospectus, including &#8220;Risk Factors&#8221; and the financial statements and related notes. Unless the context otherwise
requires, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or &#8220;the Company&#8221; refers to &#8220;Western Magnesium Corporation,&#8221;
a Delaware corporation, and its consolidated subsidiaries.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
otherwise indicated, all references to &#8220;$&#8221; or &#8220;US$&#8221; in this prospectus refer to United States dollars, and all
references to &#8220;CAD$&#8221; refer to Canadian dollars.</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
Company</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a reporting issuer in Canada listed for trading on the TSX Venture Exchange (the &#8220;TSXV&#8221;) under the symbol &#8220;<b>WMG</b>&#8221;.
Our common stock is also traded in the United States on the OTCQB tier of the OTC Markets (the &#8220;OTCQB&#8221;) under the symbol
&#8220;<b>MLYF</b>&#8221; and in Germany on the Frankfurt Stock Exchange under the symbol &#8220;<b>3WM</b>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production of magnesium at a research and development pilot plant
in metropolitan Vancouver, British Columbia, Canada. We have commenced testing at this facility in the last calendar quarter of 2021
with full pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete.
Our proprietary technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor
and energy costs while generating minimal waste and toxic by-products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we own a 100% interest in 81 unpatented lode mining claims totaling approximately 1,673 acres (the &#8220;Tami Mosi Mining
Claim&#8221;), four unpatented lode mining claims totaling approximately 10 acres located in the Moor Mining District in Elco County,
Nevada and a 100% interest in three patented mining claims located in the Pinto mining district of Nevada totaling approximately 296
acres (the &#8220;Silverado Mining Claim&#8221;). We do not plan on commencing extraction of minerals at this time from any mining claims
we hold because we have identified alternative sources of supply of dolomite and ferrosilicon, the primary raw materials used to produce
pure magnesium. We may in the future, however, commence extraction of minerals from the Tami Mosi Mining Claim if we are unable to purchase
raw materials from the alternative sources we have identified at commercially reasonable rates. In addition, we do not consider our mining
claims to be material to our business or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
History</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated under the Company Act (British Columbia) on March 24, 1966 as &#8220;Ft. Lauderdale Resources Inc.&#8221; We changed
our name to Amcorp Industries Inc. on July 20, 1990, to Molycor Gold Corporation on May 17, 1996, to Nevada Clean Magnesium Inc. on April
16, 2012 and to Western Magnesium Corporation on May 14, 2019. On May 14, 2019, we discontinued from the jurisdiction of the Business
Corporations Act (British Columbia) and domesticated under the General Corporation Law of the State of Delaware under the name &#8220;Western
Magnesium Corporation.&#8221; In connection with the name change, we also changed our stock symbol to &#8220;WMG&#8221; on the TSXV.
We have two wholly-owned subsidiaries: Western Magnesium Corp., incorporated in the State of Nevada in the United States which owns our
mining claim in the Schell Creek Range located southeast of Ely, Nevada and manages the Company&#8217;s Nevada properties; and Western
Magnesium Canada Corp., incorporated on May 3, 2019 in British Columbia, Canada which manages our Canadian operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
Development of Our Business</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2006, we acquired the Silverado Mining Claim. During the year ended October 31, 2013, an impairment was recorded on this claim for $412,793
reducing its book value to $1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2009, we acquired 27 mining claims totaling approximately 1,744 acres on property located southeast of Beaverdell, British Columbia (the
&#8220;Beaverdell Mining Claim&#8221;). During the year ended October 31, 2013, an impairment was recorded on this claim for $335,133
reducing its book value to $1. During the year ended October 31, 2020, we sold our interest in the Beaverdell Mining Claim for $50,000
and recognized a gain on sale of $37,156.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 9, 2006, we acquired the Tami Mosi Mining Claim. On May 1, 2009, an Initial Resource Estimate was completed by Norm Tribe &amp;
Associates, Ltd. On June 11, 2010, a Phase 1 Process Development Study for Exploitation of the Tami Mosi Mining Claim was completed by
Haze Research, Inc. On August 3, 2011, an updated resource estimate was completed by Tetra Tech, Inc. (&#8220;Tetra Tech&#8221;), on
September 15, 2011 a Preliminary Economic Assessment and Technical Report of the Tami-Mosi Magnesium Project was completed by Tetra Tech
and amended on July 4, 2014.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 4, 2017, we completed construction of a bench scale test furnace that employed our proprietary continuous silicothermic process
and in October 2017, we successfully completed furnace preparations - a major milestone in the testing of our bench scale pilot furnace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2017, we completed &#8220;proof of concept&#8221; in the production of magnesium metal from our bench scale test furnace. The
metal produced was a result from a partial test charge being conducted in order to identify any operational deficiencies in the furnace
prior to a full charge test of dolime material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2018, we received a final assay report assessing the purity of the raw magnesium metal produced from our bench scale pilot furnace
test program. In accordance with ASTM International standard ASTM E1479-16, the testing was analyzed via inductively coupled plasma (ICP).
This unrefined magnesium metal was found to have a very good metal purity capable of producing ASTM B92 grade metal with minimal treatment.
No impurities were found which would impact food grade applications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2018, we entered into an agreement with Industrial Surplus Ltd. (&#8220;ISL&#8221;) to build a silicothermic reduction furnace based
on our bench scale test furnace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2018, our technical team produced a magnesium ingot from dolomite obtained from the Tami Mosi Mining Claim. This accomplishment
completed the proof-of-concept stage allowing us to develop a pilot magnesium furnace based on the bench scale furnace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
Business</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production at a research and development pilot plant in Metropolitan
Vancouver, British Columbia, Canada. We have commenced test production at this facility in the last calendar quarter of 2021 with full
pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete. Our proprietary
technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor and energy costs
while generating minimal toxic by-products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
of Operations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to complete construction and commencing testing at our planned research and development pilot plant, the following are the key
milestones that we expect to achieve over the next 12 months following the date of this prospectus:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete
    construction of the plant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
    the plant and complete final training of operations staff;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commence
    metal production under various scenarios to ensure sufficient data is collected;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Begin
    the request for proposal process for commercial engineering, procurement and construction management (&#8220;EPCM&#8221;) firm;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Select
    EPCM firm;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    all pilot data with chosen EPCM firm and validate proposed required operational scenarios; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Begin
    geotechnical assessments of proposed full-scale magnesium production facility in Harrison County, Ohio.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that the costs to complete this work will be approximately $8,000,000. We have commenced testing in the pilot reactor in the
last calendar quarter of 2021 with full pilot facility operations expected to commence in the second calendar quarter of 2022 after all
safety testing is complete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
completion of our magnesium research and development pilot plant, we intend to construct a full-scale magnesium production facility with
expected capacity to produce 100,000 metric tons per year that will be scalable for greater production levels located on 122 acre property
located in Harrison County, Ohio. The proposed plant will be adjacent to the future home of a modern mixed fuels power plant which is
expected to provide power to our planned magnesium production plant. The proposed Harrison County, Ohio location is close to a dolomite
supply and has an infrastructure of rail and highway that is capable of transporting our magnesium finished product to industries across
the United States. Our plans will require a significant amount of additional capital. See &#8220;Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations &#8211; Liquidity and Capital Resources.&#8221; We have no current plans to extract
minerals from any of our mining claims. See &#8220;Description of Business &#8211; Properties.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magnesium
and Its Production</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magnesium
is the lightest of all commonly used structural metal, following steel and aluminum. It is the lightest and strongest of the structural
metals, it is one fourth the weight of steel, two fifths the weight of titanium and two thirds the weight of aluminum. Magnesium has
multiple industrial and consumer applications. Magnesium ingots are a prime raw material input for the production of titanium and aluminum
alloys and magnesium alloys. Magnesium powder and granules are used to remove sulfur in the production of steel. Due to their unique
light weight and high strength properties, magnesium alloys are used in a variety of aircraft and automobile parts, as well as in electronic
equipment such as computers, cameras and cellular phones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
magnesium produced globally comes from natural minerals such as dolomite and magnesite in the form of magnesium carbonate. It can also
be found in seawater and in salt lakes brines or underground mineral salt deposits. Magnesium can be produced through several different
methods including the electrolytic process or thermal-reduction as practiced in the most commonly used Pidgeon process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
electrolytic process involves the electrolysis of molten magnesium chloride which produces molten magnesium and chlorine. The metal is
cast into ingots for further processing as needed and the chlorine by-product may be sold for use in the production of polymers such
as polyvinyl chloride pipe (PVC).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the thermal-reduction method calcined magnesium containing ores (magnesite and dolomite) are broken down into fine powder and mixed with
reducing agents and catalyst agent. The mixture is heated in a vacuum chamber producing magnesium vapors which later condense into crystals.
The crystals are then melted, refined and poured into ingots for further processing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pidgeon process, using ferrosilicon as a catalyst, is most commonly used for production of magnesium as its operation is relatively easy
and has a low capital cost. The traditional process using horizontal retorts is high in energy consumption and has low productivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
Property&#8212;Patents, Trademarks</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
regularly seek to protect our intellectual property rights in connection with our production process and methods. We rely on non-disclosure/confidentiality
agreements and segregate development and engineering duties among certain members of our development team to protect our intellectual
property rights. To the extent we describe or disclose our proprietary production techniques, we redact or request redaction of such
information prior to public disclosure. Despite these measures, we may be unable to detect the unauthorized use of, or take appropriate
steps to enforce our intellectual property rights. Effective trade secret protection may not be available in every country in which we
offer or intend to produce magnesium or offer our products for sale to the same extent as in the United States. Failure to adequately
protect our intellectual property could impair our ability to compete effectively. Further, enforcing our intellectual property rights
could result in the expenditure of significant financial and managerial resources and may not prove successful. Although we intend to
protect our rights vigorously, there can be no assurance that these measures will be successful. See &#8220;Risk Factors&#8221; with
respect to intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own the website domain <span style="text-decoration: underline">www.westernmagnesium.com</span> and <span style="text-decoration: underline">www.westmagcorp.com</span> and social media accounts across certain major
platforms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any patents or trademarks nor have we filed any patent or trademark applications in the United States or Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2022, we had 31 employees. We consider our relations with our employees to be good.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>COVID-19</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely
concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections
have been reported globally. In March 2020, the World Health Organization declared COVID-19 a global pandemic. In order to combat the
spread of COVID-19, governments worldwide, including the Unites States and Canada, have enacted emergency measures including travel bans,
legally enforced or self-imposed quarantine periods, social distancing and business and organization closures. These measures have adversely
affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on us has not been significant
but could affect our ability to raise financings in the future and restrict travel. Management continues to monitor the situation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Selling
Stockholder</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>June
2021 Securities Purchase Agreement and 12% Convertible Debenture</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 10, 2021, we entered into a securities purchase agreement (the &#8220;2021 SPA&#8221;) with Alpha Capital Anstalt (the &#8220;Selling
Securityholder&#8221;), pursuant to which we issued a 12% convertible debenture (the &#8220;2021 Debenture&#8221;) with a maturity date
of December 10, 2022, in the principal sum of $1,500,000. Pursuant to the terms of the 2021 Debenture, we agreed to pay to the Selling
Securityholder interest on the principal balance at the rate of 12% per annum. We intend to use the proceeds for working capital. The
Selling Securityholder may convert the principal amount of the 2021 Debenture and, upon receipt of TSXV approval, accrued interest
into our common stock (subject to the beneficial ownership limitation of 9.99% in the 2021 Debenture; provided however, that the
limitation on conversion may be waived by the Selling Securityholder upon, at the election of the Selling Securityholder, not less than
61 days&#8217; prior notice to us) at any time at a conversion price equal to $0.10 per share (the &#8220;2021 Conversion Price&#8221;),
as the same may be adjusted as provided in the 2021 Debenture. In addition, upon each conversion of the 2021 Debenture, the Selling Securityholder
is entitled to receive (i) Class A Warrants exercisable into 50% of the conversion shares being issued on such conversion at an exercise
price of $0.13 (the &#8220;Class A Warrants&#8221;); and (ii) Class B Warrants exercisable into 50% of the conversion shares being issued
on such conversion at an exercise price of $0.19 per share (the &#8220;Class B Warrants,&#8221; together with the Class A Warrants, the
&#8220;2021 Warrants&#8221;). The 2021 Warrants may be exercised until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Debenture may be prepaid by the Company so long as an event of default has not occurred, upon 20 days&#8217; prior written notice
received by the holder, by paying 125% of the amounts owed on the 2021 Debenture, including all principal, interest and other fees. The
holder of this debenture may, however, convert all or a portion of the debenture during the 20-day notice period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
event of default under the 2021 Debenture, the interest rate shall increase to the lesser of 20% per annum or the maximum rate permitted
under applicable law until paid and the following &#8220;Mandatory Default Amount&#8221; shall be paid by us, if demanded by the Purchaser:
the sum of (a) the greater of (i) the outstanding principal amount of the 2021 Debenture divided by the 2021 Conversion Price on the
date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an event of default) or otherwise
due or (B) paid in full, whichever has a lower 2021 Conversion Price, multiplied by the VWAP on the date the Mandatory Default Amount
is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 125% of the outstanding principal amount of the 2021
Debenture plus (b) all other amounts, costs, expenses and liquidated damages due in respect of the 2021 Debenture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the 2021 SPA, we agreed to use commercially reasonable efforts to file with the SEC a registration statement covering
the resale of all shares issued or issuable upon conversion of the 2021 Debenture and upon exercise of the 2021 Warrants. We agreed to
file the registration statement with the SEC within 60 days following June 10, 2021 and to have the registration statement declared effective
by the SEC within 120 days following June 10, 2021. In addition, pursuant to the 2021 SPA, we agreed to give the Selling Securityholder
certain piggy-back registration rights if we do not have an effective registration statement covering the shares issuable upon conversion
of the 2021 Debenture and the 2021 Warrants and we propose to file any registration statement under the Securities Act with respect to
our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>April
2022 Securities Purchase Agreement and 15% Convertible Debenture</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 14, 2022, we entered into a securities purchase agreement (the &#8220;2022 SPA&#8221;) with the Selling Securityholder, pursuant
to which we issued a 15% convertible debenture (the &#8220;2022 Debenture&#8221;) with a maturity date of October 14, 2023, in the principal
sum of $2,000,000. Pursuant to the terms of the 2022 Debenture, we agreed to pay to the Selling Securityholder interest on the principal
balance at the rate of 15% per annum. We intend to use the proceeds for working capital. The Selling Securityholder may convert the principal
amount of the 2022 Debenture and, upon receipt of TSXV approval, accrued interest **into our common stock (subject to the
beneficial ownership limitation of 9.99% in the 2022 Debenture; provided however, that the limitation on conversion may be waived by
the Selling Securityholder upon, at the election of the Selling Securityholder, not less than 61 days&#8217; prior notice to us) at any
time at a conversion price equal to $0.30 per share (the &#8220;2022 Conversion Price&#8221;), as the same may be adjusted as provided
in the 2022 Debenture. In addition, upon each conversion of the 2022 Debenture, the Selling Securityholder is entitled to receive a warrant
(the &#8220;2022 Warrants&#8221;) to purchase a number of shares of our common stock equal to 100% of the conversion shares being issued
on such conversion. The 2022 Warrants may be exercised for a period of five years after the date of issuance at an exercise price of
$0.40 per share, subject to adjustment as provided in the 2022 Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Debenture may not prepaid prior to maturity and contains customary events of default relating to, among other things, payment defaults,
breach of representations and warranties, and breach of provisions of the 2022 Debenture or the 2022 SPA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
event of default under the 2022 Debenture, the interest rate shall increase to the lesser of 20% per annum or the maximum rate permitted
under applicable law until paid and the following &#8220;Mandatory Default Amount&#8221; shall be paid by us, if demanded by the Purchaser:
the sum of (a) the greater of (i) the outstanding principal amount of the 2022 Debenture divided by the 2022 Conversion Price on the
date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an event of default) or otherwise
due or (B) paid in full, whichever has a lower 2021 Conversion Price, multiplied by the VWAP on the date the Mandatory Default Amount
is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 125% of the outstanding principal amount of the 2022
Debenture plus (b) all other amounts, costs, expenses and liquidated damages due in respect of the 2022 Debenture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the 2022 SPA, on April 14, 2022, we also entered into a registration rights agreement, dated April 14, 2022, by and between
us and the Selling Securityholder (the &#8220;Registration Rights Agreement&#8221;). Pursuant to the terms of the Registration Rights
Agreement, we agreed to prepare and file with the SEC a registration statement covering the resale of all shares issued or issuable upon
conversion of the 2022 Debenture, upon exercise of the 2022 Warrants, upon conversion of the 2021 Debenture and upon exercise of the
2021 Warrants. We agreed to file the registration statement with the SEC within 30 days following April 14, 2022 and to use our best
efforts to have the registration statement declared effective by the SEC within 60 days following April 14, 2022 if the SEC does not
review it or by August 12, 2022 if the SEC reviews it. In the event we fail to file the registration statement or such registration statement
is not declared effective within the time periods noted above or such registration statement is not kept effective while any of the securities
registered pursuant to such registration statement, we will be obligated to pay the holder of the debentures a penalty in cash, in the
amount of $20,000 on the date of such failure and on the 30th day of each month following such failure. The Registration Rights Agreement
contains customary indemnification provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Debenture and the 2022 Debenture are collectively referred to hereinafter as the &#8220;Convertible Debentures&#8221;. The 2021
Warrants and the 2022 Warrants are collectively referred to hereinafter as the &#8220;Warrants&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Developments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a detailed description of recent developments of the Company, see &#8220;Description of Business &#8211; General Development of Our Business&#8221;
on page 28 of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Summary
Risk Factors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to numerous risks and uncertainties, including those in the section entitled &#8220;Risk Factors&#8221; and elsewhere
in this prospectus. These risks include, but are not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    losses and inability to provide assurance as to when or if we will become profitable and generate cash in our operating activities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    need for substantial additional financing to operate our business and difficulties we may face acquiring additional financing on
    terms acceptable to us or at all.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    significant indebtedness and significant restrictions on our operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    inability to implement our plans to construct and operate our planned magnesium research and development pilot plant and obtain necessary
    permits and authorizations to construct and operate the facility.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    related to health, safety and environmental laws, regulations and other requirements in Canada and the United States that may expose
    us to substantial claims, costs, and liabilities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    impact of global climate change on our ability to conduct future operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    lack of a diversified portfolio of assets.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    related to our information technology systems, and potential cyber-attacks and security and privacy breaches.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    related to our insurance coverage and uninsurable risks.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    dependence on key inputs, suppliers, and skilled labor for the production of magnesium.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    inability to attract and retain key personnel.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Growth-related
    risks, including capacity constraints and pressure on our internal systems and controls.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    adverse consequences of litigation we are currently involved in and litigation we may face from time to time.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    related to the protection of our intellectual and our exposure to infringement or misappropriation claims by third parties.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    related to competition.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    related to our lack of internal controls over financial reporting and their effectiveness.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    related to elimination of monetary liability against our directors, officers, and employees under Delaware law and the existence
    of indemnification rights for our obligations to our directors, officers, and employees.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Difficulty
    in enforcing judgments and effecting service of process on directors and officers that are not citizens of the United States.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    lack of a guarantee on a return on our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dilutive effect of additional issuances of our common stock, or securities convertible into our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    adverse effect on the market price of our common stock related to sales of substantial amounts of our common stock or shares issuable
    upon conversion of our convertible debt securities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    volatility of the market price for our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to raise further working capital as a result of a decline in the price of our common stock could affect our ability to continue
    operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    stock price and trading volume could decline if securities or industry analysts do not publish or cease publishing research or reports
    or publish misleading, inaccurate or unfavorable research about us, our business or our market.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    investor may face liquidity risks with an investment in our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
    related to a lack of dividend payments by us on our common stock and, consequently, the ability of investors to achieve a return
    on their investment.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    increased costs as a result of being a public company in Canada and the United States.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our management has concluded that our historical recurring losses from operations and negative cash flows from operations as
well as our dependence on securing private equity and other financings raise substantial doubt about our ability to continue as a going
concern and our auditor has included an explanatory paragraph relating to our ability to continue as a going concern in its audit reports
for the fiscal years ended October 31, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corporate
Information</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at 8180 Greensboro Drive, Suite 720, McLean, Virginia 22102, and our telephone number at that
location is (571) 378-0762. The address of our website is www.westernmagnesium.com. The inclusion of our website address in this prospectus
does not include or incorporate by reference the information on our website into this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
name of the Company, our logos and other trade names, trademarks or service marks appearing in this prospectus are the property of our
company. Trade names, trademarks and service marks of other organizations appearing in this prospectus are the property of their respective
holders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_007"></span>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19,240,256
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of Common Stock Underlying Convertible
Debentures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>25,240,256
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of Common Stock Underlying Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,774,500
Shares of Common Stock for Resale by Selling Securityholder</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering (i) the issuance by us of up to 19,240,256 shares of our Common Stock which may be issued upon the conversion
of the Convertible Debentures held by the Selling Securityholder, (ii) the issuance by us of up to 25,240,256 shares of our Common
Stock which may be issued upon the exercise of the warrants held by the Selling Securityholder or which may be issued to the Selling
Securityholder in connection with the conversion of such Convertible Debentures and (iii) 1,774,500 shares of our Common Stock which
we issued to the Selling Securityholder upon the partial exercise of the Convertible Debentures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Issuance
of Shares Underlying the Warrants and Convertible Debentures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    to be Issued upon Exercise of Warrants and Conversion of Convertible Debentures</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,480,511
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock underlying the Warrants
    and Convertible Debentures.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    held by Selling Securityholder</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,774,500</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    Outstanding Prior to Exercise of Warrants and Conversion of Convertible Debentures</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437,926,611
    shares of Common Stock as of May 16, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    to be Outstanding Assuming Exercise of All Warrants and Conversion of the Entire Principal and Interest of Convertible Debentures</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">482,407,122
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms
    of Convertible Debentures</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021
                                            Debenture. </i></b>The per share conversion price into which the principal amount and accrued
                                            interest upon receipt of TSXV approval (including any default interest) under
                                            the 2021 Debenture shall be convertible into shares of Common Stock hereunder is $0.10 per
                                            share.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022
    Debenture. </i></b>The per share conversion price into which the principal amount and accrued interest upon receipt of
    TSXV approval (including any default interest) under the 2022 Debenture shall be convertible into shares of Common Stock hereunder
    is $0.30 per share.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms
    of Warrants</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021
                                            Warrants</i></b>. Each Class A Warrant entitles the holder to purchase one share of our Common
                                            Stock at an exercise price of $0.13 per share and each Class B Warrant entitles the holder
                                            to purchase one share of our Common Stock at an exercise price of $0.19 per share. Each 2021
                                            Warrant may be exercised at any time commencing on the date of issuance until June 10, 2026.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022
    Warrants</i></b>. Each 2022 Warrant entitles the holder to purchase one share of our Common Stock at an exercise price of $0.40 per
    share. Each 2022 Warrant may be exercised at any time commencing on the date of issuance until the fifth anniversary following the
    date of issuance.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provisions
    Common to the Class A Warrants, the Class B Warrants and the 2022 Warrants</i></b>. In the event that there is no effective registration
    statement registering the shares underlying the warrants, then the warrants may be exercised by means of a &#8220;cashless exercise&#8221;
    at the holder&#8217;s option, such that the holder may use the appreciated value of the warrants (the difference between the market
    price of the underlying shares of common stock and the exercise price of the underlying warrants) to exercise the warrants without
    the payment of any cash.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
    of Proceeds</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 58%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    expect to receive approximately $5,998,770 in gross proceeds assuming the cash exercise of all of the warrants being registered
    hereby at the applicable exercise price stated above. However, the warrants may be exercised on a cashless basis, in which case we
    would not expect to receive any gross proceeds from the cash exercise of the warrants. We intend to use any net proceeds from the
    cash exercise of the warrants for working capital and general corporate purposes. We will not receive any of the proceeds from the
    conversion of the 2021 Debenture or the 2022 Debenture into shares of our Common Stock. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Market</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s Common Stock is currently quoted on the OTCQB under the symbol &#8220;MLYF.&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_008"></span>SELECTED
HISTORICAL CONSOLIDATED FINANCIAL DATA</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents our selected historical consolidated financial data for the periods indicated. The selected historical consolidated
financial data for the years ended October 31, 2021 and 2020 and the balance sheet data as of October 31, 2021 and 2020 are derived from
the audited financial statements. The summary historical consolidated financial data for the three months ended January 31, 2022 and
2021 and the balance sheet data as of January 31, 2022 and 2021 are derived from our unaudited financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historical
results are included for illustrative and informational purposes only and are not necessarily indicative of results we expect in future
periods, and results of interim periods are not necessarily indicative of results for the entire year. The data presented below should
be read in conjunction with, and are qualified in their entirety by reference to, &#8220;Management&#8217;s Discussion and Analysis of
Financial Condition and Results of Operations&#8221; <span style="background-color: white">and our consolidated financial statements
and the notes thereto included elsewhere in this prospectus.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years
    Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">January
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">October
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    Expenses</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,045,185</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,108,476</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,705,211</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,714,740</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    Income (Expense)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11,901,344</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14,534</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,844,401</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42,135</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14,946,529</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,123,010</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(23,549,612</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,672,605</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Loss Per Share</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.04</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.07</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    Assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,500,498</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">900,088</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,513,512</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">708,763</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current
    Liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,602,730</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,638,085</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,891,270</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,551,448</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long-Term
    Liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,045</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">246,754</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">392,280</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">237,218</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="psi_009"></span>RISK
FACTORS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
following are certain factors relating to our business. These risks and uncertainties are not the only ones we face. Additional risks
and uncertainties not presently known to us or currently deemed immaterial by us, may also impair our operations. If any such risks actually
occur, our shareholders could lose all or part of their investment and its business, financial condition, liquidity, results of operations
and prospects could be materially adversely affected and its ability to implement its growth plans could be adversely affected. Our shareholders
should evaluate carefully the following risk factors associated with the shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to our Business and Operations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Although
our financial statements have been prepared on a going concern basis, we must raise additional capital to fund our operations in order
to continue as a going concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dale
Matheson Carr-Hilton Labonte LLP, our independent registered public accounting firm for the fiscal year ended October 31, 2021, has included
an explanatory paragraph in their opinion that accompanies our audited consolidated financial statements as of and for the year ended
October 31, 2021, indicating that we have <span style="background-color: white">not generated revenues since inception, have incurred
losses in developing our business, anticipate further losses and we require additional funds to meet our obligations and the costs of
our operations. These factors raise substantial doubt about our ability to continue as a going concern. </span>If we are unable to improve
our liquidity position, we may not be able to continue as a going concern. The accompanying consolidated financial statements do not
include any adjustments that might result if we are unable to continue as a going concern and, therefore, be required to realize our
assets and discharge our liabilities other than in the normal course of business. In addition, trading in our common stock is subject
to the &#8220;Penny Stock&#8221; rules adopted by the SEC which regulate broker-dealer practices in connection with Penny Stocks quoted
on the OTC Markets is often thin and characterized by wide fluctuations in trading prices. Consequently, these factors could make it
difficult for investors to sell their shares and cause them to suffer the loss of all or a substantial portion of their investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that our principal sources of liquidity will only be sufficient to fund our activities over the next twelve months. In order
to have sufficient cash to fund our operations after this time period, we will need to raise additional equity or debt capital in order
to continue as a going concern and we cannot provide any assurance that we will be successful in doing so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
incurred net losses in the three months ended January 31, 2022 and fiscal years 2021 and 2020 with net cash used in operating activities
and cannot provide assurance as to when or if we will become profitable and generate cash in our operating activities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred net losses of $23,549,612 and $4,672,605 and net cash used in operating activities of $6,367,567 and $3,270,534 for the fiscal
years ended October 31, 2021 and 2020, respectively. In addition, we incurred net losses of $14,946,529 and $2,123,010 and net cash used
in operating activities of $1,798,902 and $990,364 for the three months ended January 31, 2022 and 2021, respectively. As of January
31, 2022, we had an aggregate accumulated deficit of $67,076,150. Such losses have historically required us to seek additional funding
through the issuance of debt or equity securities. In addition, we have historically experienced and may prospectively experience fluctuations
in our quarterly earnings due to the nature of our business. Our long-term success is dependent upon among other things, completion of
an operational magnesium production facility and generating revenue from sales of magnesium to reduce our cash needs, and there is no
assurance that we will be able to achieve sales of magnesium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
anticipate requiring substantial additional financing to operate our business and we may face difficulties acquiring additional financing
on terms acceptable to us or at all.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will need additional capital in the approximate amount of $8,000,000 to complete the buildout of our planned research and development
pilot magnesium production plant and ultimately a full-scale production facility as well as sustain our operations and will need to seek
further financing. If we fail to raise additional capital, as needed, our ability to implement these plans will be compromised. To date,
our operations and production plant development have been funded from the proceeds of debt and equity financings. We expect to require
substantial additional capital in the future primarily to fund working capital requirements of our business, including operational expenses,
planned capital expenditures for our research and development pilot plant and ultimately a full-scale production facility and debt service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we obtain financing for our near-term operations and capital expenditures, we expect that we will require additional capital thereafter.
Our capital needs will depend on numerous factors including: (i) the costs and timing of completion of construction of a full- scale
magnesium production facility; (ii) achieving magnesium sales; (iii) the level of our investment in research and development; and (iv)
the amount of our capital expenditures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership held by our existing
shareholders will be reduced and our shareholders may experience significant dilution. In addition, new securities may contain rights,
preferences, or privileges that are senior to those of existing securities. If we raise additional capital by incurring debt, this will
result in increased interest expense. If we raise additional funds through the issuance of equity securities, market fluctuations in
the price of our securities could limit our ability to obtain equity financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
assurance can be given that any additional financing will be available to us, or if available, will be on terms favorable to us. If we
are unable to raise capital when needed, our business, financial condition and results of operations would be materially adversely affected,
and we could be forced to reduce or discontinue our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have significant indebtedness under our debt obligations, which also include significant restrictions on our operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant level of indebtedness represented by the Convertible Debentures could have important consequences to our shareholders due
to the following potential factors: (i) difficulty in satisfying obligations and covenants with respect to indebtedness; (ii) limitations
on the ability to obtain additional financing to fund future working capital, capital expenditures or other general corporate requirements
and increased cost of any additional borrowing; (iii) a requirement to pay the full principal amount plus accrued interest upon maturity
on December 10, 2022 with respect to the 2021 Debenture and October 14, 2023 with respect to the 2022 Debenture, thereby reducing the
amount of cash available for working capital, capital expenditures, acquisitions and other general corporate purposes; and (iv) placing
us at a disadvantage compared to our less leveraged competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to repay the principal and accrued interest upon maturity, or to refinance, our indebtedness will depend on our stock price and
our ability to raise additional equity and/or indebtedness and future cash flow, which is subject to our completion of a full-scale magnesium
production facility, future sales of magnesium, prevailing economic conditions, prevailing interest rate levels, and financial, competitive,
business and other factors, many of which are beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Debentures contain numerous restrictive covenants that limit our discretion with respect to certain business matters, including
our ability to incur additional indebtedness, to create liens or other encumbrances, to sell additional securities and to merge or consolidate
with another entity or to make certain restricted payments, including declaring or paying dividends or other distributions. Our failure
to comply with our obligations under the Convertible Debentures could result in a default, which, if not waived, could permit acceleration
of the Convertible Debentures. If the Convertible Debentures were to be accelerated, there can be no assurance that our assets would
be sufficient to repay in full that indebtedness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Debenture will need to be repaid, renewed, refinanced or converted no later than December 10, 2022 and the 2022 Debenture will need
to be repaid, renewed, refinanced or converted no later than October 14, 2023. Although we believe that we can negotiate an extension
or renewal of the Convertible Debentures or obtain replacement financing, if necessary, prior to the maturity of each of the Convertible
Debentures, there can be no assurance that the maturity date under either of the Convertible Debentures will be extended or renewed or
that future borrowings will be available to us, or available on acceptable terms, in an amount sufficient to meet our financing requirements
at their respective maturity dates. If such an extension or renewal or future borrowings were not available, or not available on acceptable
terms, in each case, as necessary at the applicable time, it would have a material adverse impact on our business and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to risks associated with increased liabilities and the ability to meet our debt obligations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred substantial liabilities, in addition to the Convertible Debentures, to invest in the businesses of our subsidiaries. These
liabilities have increased the risk of an investment in our common stock because the liabilities increase our need for capital to pay
them. Our ability to pay our accounts payable and other liabilities and comply with the terms and conditions of our Convertible Debentures
will depend upon our future performance and will be subject to financial, business and other factors affecting our business and operations,
including general economic conditions. There are no assurances that we will be able to pay all of our liabilities as they become due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to implement our development plans, our financial condition and results of operations could be materially and adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
fundamental part of our strategy is to construct and operate a research and development pilot magnesium production facility using a continuous
silicothermic reactor system technology we have developed. Although we have already commenced production for the purposes of testing
and certification in the last calendar quarter of 2021 and have raised approximately $15,989,098 in fiscal 2021 and through the date
of this prospectus, we will need additional financing to implement our development strategy to construct a full-scale magnesium production
facility. We may not have access to the funding required for this plan on acceptable terms. Our development plans may also suffer significant
delays as a result of a variety of factors, such as legal and regulatory requirements, either of which could prevent us from completing
our plans as currently expected. In addition, even if we can implement our strategy, development in the magnesium market, increased sales
to various industries, including the automobile industry may not materialize to the extent we expect, or at all, resulting in unutilized
magnesium production capacity. Any failure to successfully implement our business strategy, including for any of the above reasons, could
materially and adversely affect our financial condition and results of operations. We may, in addition, decide to alter or discontinue
certain aspects of our business strategy at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to obtain necessary permits and authorizations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to obtain the necessary licenses, permits, certificates, or authorizations to operate our planned research and development
pilot magnesium production facility in Metropolitan Vancouver, British Columbia, Canada and commence mining activities on our Tami Mosi
Mining Claim, or may only be able to do so at great cost. In addition, we may not be able to comply fully with the wide variety of laws
and regulations applicable to magnesium production and mineral mining. Failure to comply with or to obtain the necessary licenses, permits,
certificates, or authorizations could result in a delay in our ability to operate our planned research and development pilot magnesium
production facility, which could have a material adverse effect on our business, financial condition or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to a broad range of health, safety and environmental laws, regulations and other requirements in Canada and the U.S. that
may expose us to substantial claims, costs, and liabilities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magnesium
production and mining is subject to numerous complex and stringent federal, state, and local laws, regulations, policies, and other requirements,
including those related to health, safety, environmental, and waste management and disposal matters, which may expose us to substantial
claims, costs, and liabilities. We may be subject to fines, penalties and other damages, such as natural resource damages and the costs
associated with the investigation and cleanup of soil, surface water, groundwater, and other media under laws such as CERCLA (commonly
known as Superfund) or similar U.S. and foreign regulations. These laws, regulations, policies, and other requirements could change or
be applied or interpreted in ways that could (i) require us to enjoin, curtail, development of our planned research and development pilot
magnesium production facility and mining operations in Nevada, including the implementation of corrective measures, the installation
of additional equipment, or the undertaking of other remedial actions, or (ii) subject us to enforcement risk or impose on or require
us to incur additional capital expenditures, compliance or other costs, fines, or penalties, any of which could adversely affect our
results of operations, cash flows and financial condition, and the trading price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
we commence magnesium production at our planned research and development pilot facility in Canada, the costs of complying with such laws,
regulations, policies and other requirements, including participation in assessments, remediation activities, and cleanups of sites,
as well as internal voluntary programs, are expected to be significant for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, because environmental laws, regulations, policies and other requirements are constantly evolving, we expect to incur costs
to maintain compliance and such costs could increase materially and prove to be more limiting and costly than we anticipate. Evolving
standards and expectations can result in increased litigation and/or increased costs, all of which can have a material and adverse effect
on our business operations, expected revenues and cash flows. Future compliance with environmental, health and safety legislation and
other regulatory requirements or expectations may prove to be more limiting and costly than we anticipate and may disrupt our plans for
development of a magnesium production facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Global
climate change is an international concern and could impact our ability to conduct future operations</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
climate change is an international issue and receives an enormous amount of publicity. We would expect that the imposition of international
treaties or federal, state or local laws or regulations pertaining to mandatory reductions in energy consumption or emissions of greenhouse
gases could affect the feasibility of our magnesium production and increase our operating costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
legislation and increased regulation regarding climate change could impose significant costs on us and/or our suppliers, including costs
related to increased energy requirements, capital equipment, environmental monitoring and reporting and/or other costs to comply with
such regulations. Any adopted future climate change regulations could also negatively impact our ability to compete with companies situated
in areas not subject to such regulations. Given the political significance and uncertainty around the impact of climate change and how
it should be dealt with, we cannot predict how legislation and regulation will affect our financial condition, operating performance
or ability to compete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will not have a highly diversified portfolio of assets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have invested in and plan to operate solely within the magnesium industry. Thus, an investment in our company will provide limited diversity
as to asset type. Additionally, the assets to be held by us will be geographically concentrated as we intend to operate a single magnesium
production facility in the United States. This lack of diversification could increase the risk associated with the revenue stream we
expect to receive from the production and sale of magnesium and, as a result, could have a material adverse effect on our business, financial
condition or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
face risks related to our information technology systems, and potential cyber-attacks and security and privacy breaches.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
use of technology is critical in our continued operations. We are susceptible to operational, financial and information security risks
resulting from cyber-attacks and/or technological malfunctions. Successful cyber-attacks and/or technological malfunctions affecting
us, or our service providers can result in, among other things, financial losses, the inability to operate our planned magnesium production
facility, the unauthorized release of customer information or confidential information and reputational risk. We have not experienced
any material losses to date relating to cybersecurity attacks, other information breaches or technological malfunctions. However, there
can be no assurance that we will not incur such losses in the future. As cybersecurity threats continue to evolve, we may be required
to use additional resources to continue to modify or enhance protective measures or to investigate security vulnerabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may store and collect personal information about future customers and will be responsible for protecting that information from privacy
breaches that may occur through procedural or process failure, information technology malfunction or deliberate unauthorized intrusions.
Any such theft or privacy breach would have a material adverse effect on our business, prospects, revenue, results of operation and financial
condition. We are subject to laws, rules and regulations in the United States and other jurisdictions relating to the collection, processing,
storage, transfer and use of personal data. Our ability to execute transactions and to possess and use personal information and data
in conducting our business subjects us to legislative and regulatory burdens that may require us to notify regulators and customers,
employees and other individuals of a data security breach. Evolving compliance and operational requirements under the privacy laws, rules
and regulations of jurisdictions in which we operate impose significant costs that are likely to increase over time. In addition, non-compliance
could result in proceedings against us by governmental entities and/or significant fines, could negatively impact our reputation and
may otherwise adversely impact our business, financial condition and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
face risks related to our insurance coverage and uninsurable risks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a number of risks and hazards generally, including adverse environmental conditions, accidents, fires, labor disputes
and changes in the regulatory environment. Such occurrences could result in damage to assets, personal injury or death, environmental
damage, delays in operations, monetary losses and possible legal liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we intend to continue to maintain insurance to protect against certain risks in such amounts as we consider to be reasonable, our insurance
will not cover all the potential risks associated with our operations. We may also be unable to maintain insurance to cover these risks
at economically feasible premiums. Insurance coverage may not continue to be available or may not be adequate to cover any resulting
liability. Moreover, insurance against risks such as environmental pollution or other hazards encountered in our operations is not generally
available on acceptable terms. We might also become subject to liability for pollution or other hazards which we may not be insured against
or which we may elect not to insure against because of premium costs or other reasons. Losses from these events may cause us to incur
significant costs that could have a material adverse effect upon our financial performance and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are dependent on key inputs, suppliers and skilled labor for the production of magnesium.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
production of magnesium is dependent on a number of key inputs and their related costs, including raw materials and supplies related
to smelting operations, as well as electricity and other local utilities. Any significant interruption or negative change in the availability
or economics of the supply chain for key inputs, such as dolomite, could materially impact our business, financial condition, results
of operations or prospects. Some of these inputs may only be available from a single supplier or a limited group of suppliers. If a sole
source supplier was to go out of business, we might be unable to find a replacement for such source in a timely manner, or at all. If
a sole source supplier were to be acquired by a competitor, that competitor may elect not to sell to us in the future. Any inability
to secure required supplies and services, or to do so on appropriate terms, could have a materially adverse impact on our business, prospects,
revenue, results of operation and financial condition. We plan to purchase key inputs on a purchase order basis from suppliers at market
prices based on its production requirements and anticipated demand. We believe that we will have access to a sufficient supply of the
key inputs for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
planned magnesium production operations are expected to consume considerable energy, which makes us vulnerable to rising energy costs.
Accordingly, rising or volatile energy costs may adversely affect our business and our ability to operate profitably.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to compete and grow will be dependent on us having access, at a reasonable cost and in a timely manner, to skilled labor, equipment,
parts and components. No assurances can be given that we will be successful in maintaining our required supply of skilled labor, equipment,
parts and components. This could have a material effect on our financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
inability to attract and retain key personnel could materially adversely affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success is dependent upon the ability, expertise, judgment, discretion and good faith of our senior management and key personnel. We
compete with other companies both within and outside the magnesium industry to recruit and retain competent employees. If we cannot maintain
qualified employees to meet the needs of our anticipated growth, our business and financial condition could be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to growth-related risks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to growth-related risks, including capacity constraints and pressure on our internal systems and controls. Our ability
to manage growth effectively will require us to implement and improve our operational and financial systems and to expand, train and
manage our employee base. Our inability to deal with this growth may have a material adverse effect on our business, prospects, revenue,
results of operation and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are currently involved in litigation, and there may be additional litigation in which we will be involved in the future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently involved in litigation. An adverse decision in the litigation could have a material adverse effect on our business, financial
condition or results of operations. Furthermore, even if we are successful in the litigation, we will likely incur substantial legal
fees in asserting our claims against the respondents and in defending against the counterclaims and, thus, these legal fees could have
a material adverse effect on our anticipated business, financial condition or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may become party to litigation from time to time in the ordinary course of business which could adversely affect our business. Should
any litigation in which we become involved be determined against us such a decision could materially adversely affect our ability to
continue operating and the market price for our common stock and could use significant resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
intellectual property may be difficult to protect.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely upon certain proprietary intellectual property, including but not limited to proprietary processes as it relates to magnesium production.
Our success will depend, in part, on our ability to maintain and enhance protection over our intellectual property, know-how and other
proprietary information. We enter into confidentiality or non-disclosure agreements with our corporate partners, employees, consultants,
outside scientific collaborators, developers, and other advisors. These agreements generally require that the receiving party keep confidential
and not disclose to third-parties confidential information developed by the receiving party or made known to the receiving party by us
during the course of the receiving party&#8217;s relationship with us. These agreements also generally provide that inventions conceived
by the receiving party in the course of rendering services to us will be our exclusive property, and we enter into assignment agreements
to perfect our rights. These confidentiality, inventions, and assignment agreements may be breached and may not effectively assign rights
to proprietary information to us. In addition, our proprietary information could be independently discovered by competitors, in which
case we may not be able to prevent the use of such proprietary information by our competitors. The enforcement of a claim alleging that
a party illegally obtained and was using our proprietary information could be difficult, expensive, and time consuming and the outcome
would be unpredictable. In addition, courts outside the United States may be less willing to protect such proprietary information. The
failure to obtain or maintain meaningful intellectual property protection could adversely affect our ability to compete with other magnesium
producers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
failure to adequately maintain and enhance protection over our proprietary information could have a material adverse effect on our business,
financial condition or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be exposed to infringement or misappropriation claims by third parties, which, if determined adversely to us, could subject us to
significant liabilities and other costs.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends on our ability to use and develop new production technologies without infringing the intellectual property rights of
third parties. We cannot assure that third parties will not assert intellectual property claims against us. If third parties assert copyright
or patent infringement or violation of other intellectual property rights against us, we will be required to defend our self in litigation
or administrative proceedings, which can be both costly and time consuming and may significantly divert the efforts and resources of
management personnel. An adverse determination in any such litigation or proceedings to which we may become a party could subject us
to significant liability to third parties, require us to seek licenses from third parties, require us to pay ongoing royalties or subject
us to injunctions that may prohibit the development and operation of our planned magnesium production facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
expect to face significant competition, which may have an adverse effect on expected revenues.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to compete with a variety of both U.S. and non-U.S. magnesium producers as well as with producers of other materials, such as
aluminum alloy, steel, titanium, plastics, composites, ceramics, and glass, among others. Use of such materials could reduce the demand
for magnesium products, which may reduce our expected revenues once we complete construction of our planned full-scale magnesium production
facility. Factors affecting our ability to compete include increased competition from overseas producers, our competitors&#8217; pricing
strategies, the introduction or advancement of new technologies and equipment by our competitors or our customers, changes in our customers&#8217;
strategy or material requirements, and our ability to achieve cost-efficiency of our planned facility. See &#8220;Description of Business
&#8211; Competitive Conditions and Our Position&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to taxation both in Canada and the United States.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are treated as a Canadian resident company (as defined in the Income Tax Act (Canada) (the &#8220;<b>Tax Act</b>&#8221;)) subject to
Canadian income taxes. We are also treated as a U.S. corporation subject to U.S. federal income tax pursuant to Section 7874 of the Code
and are subject to U.S. federal income tax on our worldwide income. As a result, we are subject to taxation both in Canada and the United
States, which could have a material adverse effect on our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is unlikely that we will pay any dividends on our common stock in the foreseeable future. However, dividends received by shareholders
who are residents of Canada for purposes of the Tax Act will be subject to U.S. withholding tax. Any such dividends may not qualify for
a reduced rate of withholding tax under the Canada-United States tax treaty. In addition, a foreign tax credit or a deduction in respect
of foreign taxes may not be available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
received by U.S. shareholders will not be subject to U.S. withholding tax but will be subject to Canadian withholding tax. Dividends
paid by us will be characterized as U.S. source income for purposes of the foreign tax credit rules under the Code. Accordingly, U.S.
shareholders generally will not be able to claim a credit for any Canadian tax withheld unless, depending on the circumstances, they
have an excess foreign tax credit limitation due to other foreign source income that is subject to a low or zero rate of foreign tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
received by shareholders that are neither Canadian nor U.S. shareholders will be subject to U.S. withholding tax and will also be subject
to Canadian withholding tax. These dividends may not qualify for a reduced rate of U.S. withholding tax under any income tax treaty otherwise
applicable to our shareholders, subject to examination of the relevant treaty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
our common stock is treated as shares of a U.S. domestic corporation, the U.S. gift, estate and generation-skipping transfer tax rules
generally apply to a non-U.S. shareholder of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
shareholder should seek tax advice, based on such shareholder&#8217;s particular circumstances, from an independent tax advisor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
internal controls over financial reporting may not be effective, and our independent auditors may not be able to certify as to their
effectiveness, which could have a material and adverse effect on our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to various Canadian and U.S. reporting and other regulatory requirements. We have incurred and will continue to incur expenses
and, to a lesser extent, diversion of our management&#8217;s time in our efforts to comply with Section 404 of the Sarbanes-Oxley Act
and applicable Canadian securities laws regarding internal controls over financial reporting. Effective internal controls over financial
reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures,
are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation
could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of
the Sarbanes-Oxley Act and applicable Canadian securities laws, or the subsequent testing by our independent registered public accounting
firm when required, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses
or that may require prospective or retrospective changes to our consolidated financial statements or identify other areas for further
attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information,
which could have a negative effect on the trading price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
elimination of monetary liability against our directors, officers, and employees under Delaware law and the existence of indemnification
rights for our obligations to our directors, officers, and employees may result in substantial expenditures by us and may discourage
lawsuits against our directors, officers, and employees.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws, as amended, contain a provision permitting us to eliminate the personal liability of our directors to us and our shareholders
for damages incurred as a director or officer to the extent provided by Delaware law. We may also have contractual indemnification obligations
under any future employment agreements with our officers or agreements entered into with our directors. The foregoing indemnification
obligations could result in us incurring substantial expenditures to cover the cost of settlement or damage awards against directors
and officers, which we may be unable to recoup. These provisions and the resulting costs may also discourage us from bringing a lawsuit
against directors and officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative litigation
by our shareholders against our directors and officers even though such actions, if successful, might otherwise benefit us and our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>An
exclusive forum provision in our bylaws, as amended, and Delaware law may limit a stockholder&#8217;s ability to bring claims in a judicial
forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws, as amended, provide that the Court of Chancery of the State of Delaware will be the exclusive forum for any derivative action
or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising
under the Delaware General Corporation Law, our certificate of incorporation or our bylaws, as amended; any action to interpret, apply,
enforce or determine the validity of our certificate of incorporation or our bylaws, as amended; and any action asserting a claim against
us that is governed by the internal affairs doctrine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
exclusive forum provision may limit a stockholder&#8217;s ability to bring certain claims in a judicial forum that it finds favorable
for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors,
officers and other employees. Alternatively, if a court were to find either exclusive forum provision in our bylaws, as amended, to be
inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving such action in
other jurisdictions, all of which could have a material adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
exclusive forum provision will not apply, however, to actions arising under the Securities Act or the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
may be difficulty in enforcing judgments and effecting service of process on directors and officers that are not citizens of the United
States.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our directors and officers reside outside of the United States and some or all of the assets of such persons are located outside of
the United States. Therefore, it may not be possible for shareholders to collect or to enforce judgments or liabilities against them
under U.S. securities laws. Moreover, it may not be possible for shareholders to effect service of process within the United States upon
such persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
original actions to enforce liabilities under U.S. federal securities laws may not be brought in a Canadian court. Such actions must
be brought in a court in the United States with applicable jurisdiction. Persons obtaining judgments against us in United States courts,
including judgments obtained under U.S. federal securities laws, will then be required to bring an application in a Canadian court to
enforce such judgments in Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to our Securities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
return on our common stock is not guaranteed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no guarantee that our common stock will earn any positive return in the short term or long term. A holding of our common stock is
speculative and involves a high degree of risk and should be undertaken only by holders whose financial resources are sufficient to enable
them to assume such risks and who have no need for immediate liquidity in their investment. A holding of our common stock is appropriate
only for holders who have the capacity to absorb a loss of some or all of their holdings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Additional
issuances of our common stock, or securities convertible into our common stock, may result in dilution.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue additional equity or convertible debt securities in the future, which may dilute our existing shareholder&#8217;s holdings.
Our certificate of incorporation permits the issuance of 1,000,000,000 shares of common stock and our Amended and Restated Certificate
of Incorporation permits the issuance of 100,000,000 shares of undesignated preferred stock, and existing shareholders will have no pre-emptive
rights in connection with such further issuances. Our board of directors has discretion to determine the price and the terms of further
issuances, and such terms could include rights, preferences and privileges superior to those existing holders of our common stock. Moreover,
additional shares of our common stock will be issued by us on the conversion of the Convertible Debentures in accordance with its terms.
To the extent holders of our options or other convertible securities convert or exercise their securities and sell our common stock they
receive, the trading price of our common stock may decrease due to the additional amount of common stock available in the market. Further,
we may issue additional shares of our common stock in connection with strategic acquisitions. We cannot predict the size or nature of
future issuances or the effect that future issuances and sales of our common stock (or securities convertible into our common stock)
will have on the market price of our common stock. Issuances of a substantial number of additional shares of our common stock, or the
perception that such issuances could occur, may adversely affect prevailing market prices for our common stock. With any additional issuance
of our common stock or preferred stock, investors will suffer dilution to their voting power and economic interest in our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
of substantial amounts of our common stock may have an adverse effect on their market price.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a substantial number of shares of our common stock in the public market could occur at any time either by existing holders of our
common stock, by the holder of the Convertible Debentures that is convertible into our common stock and the holders of warrants that
may be exercised to acquire our common stock. These sales, or the market perception that the holders of a large number of shares of our
common stock, Convertible Debentures or warrants intend to sell shares of our common stock, could reduce the market price of our common
stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
sales of common stock by management and other stockholders may have an adverse effect on the then prevailing market price of our common
stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event a public market for our common stock is sustained in the future, sales of our common stock may be made by holders of our public
float or by holders of restricted securities in compliance with the provisions of Rule 144 of the Securities Act of 1933. In general,
under Rule 144, a non-affiliated person who has satisfied a six-month holding period in a fully reporting company under the Securities
Exchange Act of 1934, as amended, may, sell their restricted common stock without volume limitation, so long as the issuer is current
with all reports under the Exchange Act in order for there to be adequate common public information. Affiliated persons may also sell
their common shares held for at least six months, but affiliated persons will be required to meet certain other requirements, including
manner of sale, notice requirements and volume limitations. Non-affiliated persons who hold their common shares for at least one year
will be able to sell their common stock without the need for there to be current public information in the hands of the public. Future
sales of shares of our public float or by restricted common stock made in compliance with Rule 144 may have an adverse effect on the
then prevailing market price, if any, of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market price for our common stock may be volatile.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price for securities of early-stage magnesium companies generally are likely to be volatile. In addition, the market price for
our common stock has been and may be subject to wide fluctuations in response to numerous factors beyond our control, including, but
not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated fluctuations in our quarterly results of operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommendations
    by securities research analysts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the economic performance or market valuations of companies in the industry in which we operate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">addition
    or departure of our executive officers and other key personnel;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">registration
    of shares of our common stock issuable upon conversion of the Convertible Debentures or exercise of the Warrants;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    or perceived sales of additional shares of our common stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
    and financial performance that varies from the expectations of management, securities analysts and investors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    changes affecting our industry generally and our business and operations both domestically and abroad;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    of developments and other material events by us or our competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
    in the costs of vital production materials and energy;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in global financial markets, global economies and general market conditions, such as interest rates and price volatility of competitive
    products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    acquisitions or business combinations, strategic partnerships, joint ventures or capital commitments by or involving us or our competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
    and share price performance of other companies that investors deem comparable to us or from a lack of market comparable companies;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">news
    reports relating to trends, concerns, technological or competitive developments, regulatory changes and other related issues in our
    industry or target markets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
markets have at times historically experienced significant price and volume fluctuations that: (i) have particularly affected the market
prices of equity securities of companies and (ii) have often been unrelated to the operating performance, underlying asset values or
prospects of such companies. Accordingly, the market price of our common stock from time to time may decline even if our operating results,
underlying asset values or prospects have not changed. Additionally, these factors, as well as other related factors, may cause decreases
in asset values that may result in impairment losses to us. There can be no assurance that further fluctuations in price and volume of
equity securities will not occur. If increased levels of volatility and market turmoil continue, our operations could be adversely impacted,
and the trading price of our common stock may be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
common stock is or may become subject to the &#8220;penny stock&#8221; rules of the SEC and the trading market in the securities is limited,
which makes transactions in the stock cumbersome and may reduce the value of an investment in the stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
15g-9 under the Exchange Act establishes the definition of a &#8220;penny stock,&#8221; for the purposes relevant to us, as any equity
security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain
exceptions. For any transaction involving a penny stock, unless exempt, the rules require: (a) that a broker or dealer approve a person&#8217;s
account for transactions in penny stocks; and (b) the broker or dealer receive from the investor a written agreement to the transaction,
setting forth the identity and quantity of the penny stock to be purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to approve a person&#8217;s account for transactions in penny stocks, the broker or dealer must: (a) obtain financial information
and investment experience objectives of the person and (b) make a reasonable determination that the transactions in penny stocks are
suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the
risks of transactions in penny stocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to
the penny stock market, which, in highlight form: (a) sets forth the basis on which the broker or dealer made the suitability determination;
and (b) confirms that the broker or dealer received a signed, written agreement from the investor prior to the transaction. Generally,
brokers may be less willing to execute transactions in securities subject to the &#8220;penny stock&#8221; rules. If our common stock
is or becomes subject to the &#8220;penny stock&#8221; rules, it may be more difficult for investors to dispose of our common stock and
cause a decline in the market value of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions
payable to both the broker or dealer and the registered representative, current quotations for the securities and the rights and remedies
available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent
price information for the penny stock held in the account and information on the limited market in penny stocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
decline in the price of our common stock could affect our ability to raise further working capital and adversely impact our ability to
continue operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prolonged decline in the price of our common stock could result in a reduction in the liquidity of our common stock and a reduction in
our ability to raise capital. Because all of our operations have been and will be financed through the sale of convertible debt and equity
securities, a decline in the price of our common stock could be especially detrimental to our liquidity and our operations. Such reductions
may force us to reallocate funds from other planned uses and may have a material adverse effect on our business plan and operations,
including our ability to commence production of magnesium at our research and development pilot plant and ultimately at a full-scale
production plant. If the price of our common stock declines, there can be no assurance that we will be able to raise additional capital
or generate funds from operations sufficient to meet our obligations. If we are unable to raise sufficient capital in the future, we
may not be able to have the resources to continue our plans to develop a full-scale magnesium production plant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish or cease publishing research or reports or publish misleading, inaccurate or unfavorable
research about us, our business or our market, our stock price and trading volume could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our common stock will be influenced by the research and reports that securities or industry analysts publish about
us, our business, our market or our competitors. If no or few securities or industry analysts cover us, the trading price and volume
of our common stock would likely be negatively impacted. If one or more of the analysts who covers us downgrades our shares or publishes
inaccurate or unfavorable research about our business, or provides more favorable relative recommendations about our competitors, our
stock price would likely decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly,
demand for our common stock could decrease, which could cause our stock price or trading volume to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>An
investor may face liquidity risks with an investment in our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock currently trades on the TSXV in Canada and is quoted on the OTCQB in the United States. We cannot predict at what prices
our common stock will continue to trade, and there is no assurance that an active trading market will be sustained. Our common stock
does not currently trade on any U.S. national securities exchange. In the event our common stock begins trading on any U.S. national
securities exchange, we cannot predict at what prices it will trade and there is no assurance that an active trading market will develop
or be sustained. There is a material liquidity risk associated with an investment in our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
in securities quoted on the OTC Markets is often thin and characterized by wide fluctuations in trading prices, due to many factors,
some of which may have little to do with our operations or business prospects. This volatility could depress the market price of our
common stock for reasons unrelated to operating performance. Moreover, the OTC Markets is not a U.S. national securities exchange, and
trading of securities on the OTC Markets is often more sporadic than the trading of securities listed on a U.S. national securities exchange
like the Nasdaq or the NYSE. These factors may result in investors having difficulty reselling our common stock on the OTC Markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not intend to pay dividends on our common stock and, consequently, the ability of investors to achieve a return on their investment
will depend on appreciation in the price of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividend on our common stock and do not currently intend to do so in the foreseeable future. We
currently anticipate that we will retain future earnings, if materialized, for the development, operation and expansion of our business
and do not anticipate declaring or paying any cash dividends in the foreseeable future. Therefore, the success of an investment in our
common stock will depend upon any future appreciation in its value. There is no guarantee that our common stock will appreciate in value
or even maintain the price at which it was purchased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
Risks</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be negatively impacted by challenging global economic conditions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business, financial condition, results of operations and cash flow may be negatively impacted by challenging global economic conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
global economic slowdown would cause disruptions and extreme volatility in global financial markets, increased rates of default and bankruptcy
and declining consumer and business confidence, including as a result of COVID-19, which can lead to decreased levels of consumer spending.
These macroeconomic developments could negatively impact our business, which depends on the general economic environment and levels of
consumer spending. As a result, we may not be able to attract customers once we begin magnesium production, or we may be forced to reduce
the price of our products. We are unable to predict the likelihood of the occurrence, duration or severity of such disruptions in the
credit and financial markets or adverse global economic conditions. Any general or market-specific economic downturn could have a material
adverse effect on our business, financial condition, results of operations and cash flow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to increased costs as a result of being a public company in Canada and the United States.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company in Canada and the United States, we are subject to the reporting requirements, rules and regulations under the applicable
Canadian and American securities laws and rules of stock exchanges on which our securities may be listed. There are increased costs associated
with legal, accounting and other expenses related to such regulatory compliance. Securities legislation and the rules and policies of
the TSXV require listed companies to, among other things, adopt corporate governance and related practices, and to continuously prepare
and disclose material information, all of which add to a company&#8217;s legal and financial compliance costs. We may also elect to devote
greater resources than we otherwise would have on communication and other activities typically considered important by publicly traded
companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are eligible to be treated as an &#8220;emerging growth company&#8221; as defined in the JOBS Act, and we cannot be certain if the reduced
disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company.&#8221; as defined in the JOBS Act. For as long as we continue to be an emerging growth company,
we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies, including (1) not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act of 2002, (2) reduced disclosure obligations regarding executive compensation in this registration statement and periodic reports
and proxy statements, and (3) exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder
approval of any golden parachute payments not previously approved. We could be an emerging growth company for up to five years, although
circumstances could cause us to lose that status earlier, including if the market value of our common stock held by non-affiliates exceeds
$700 million as of July 31, 2022, or if we have total annual gross revenue of $1.07 billion or more during any fiscal year before that
time, in which case we would no longer be an emerging growth company as of the following October 31. Additionally, if we issue more than
$1.0 billion in non-convertible debt during any three-year period before July 31, 2022, we would cease to be an emerging growth company
immediately. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some
investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and the
stock price may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards
apply to private companies. We have elected to take advantage of the extended transition period allowed for emerging growth companies
for complying with new or revised accounting guidance as allowed by Section 107 of the JOBS Act and Section 7(a)(2)(B) of the Securities
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="psi_010"></span>USE
OF PROCEEDS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the shares of Common Stock offered by the Selling Securityholder pursuant to this prospectus will be sold by the Selling Securityholder
for its own account. We will not receive any of the proceeds from these sales. We will not receive any proceeds from the conversion of
the Convertible Debentures, but we will receive up to an aggregate of approximately $5,998,770 from the exercise of Warrants,
assuming the exercise in full of all of the Warrants for cash. We expect to use the net proceeds from the exercise of the Warrants for
general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_011"></span>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our cash and amounts held by related parties and capitalization as of January 31, 2022 on an actual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
table should be read in conjunction with the information contained in this prospectus, including &#8220;Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and the related notes thereto appearing
elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of <br />
January 31, 2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Actual</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    and amounts held by related parties</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,338,263</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current
    portion of convertible note payable</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221,599</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long-term
    convertible notes payable</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Shareholders&#8217;
    deficit:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock &#8211; $0.001 par value; 1,000,000,000 shares authorized; 421,871,770 shares issued and outstanding on an actual basis</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,637,228</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional
    paid-in capital</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,684,015</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Obligations
    to issue shares</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,741</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    other comprehensive income</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">285,889</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(67,076,150</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    shareholders&#8217; deficit</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,422,277</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    capitalization</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,200,678</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="psi_012"></span>DETERMINATION
OF OFFERING PRICE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resale
of Common Stock by Selling Securityholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is quoted on the OTCQB under the symbol &#8220;MLYF.&#8221; The shares registered for resale in this prospectus being offered
by the Selling Securityholders will be sold at fixed prices, at prevailing market prices at the time of sale, at prices related to the
prevailing market price, at varying prices determined at the time of sale or at negotiated prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
of Shares of Common Stock Underlying Convertible Debentures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price of the shares of Common Stock underlying the Convertible Debentures is determined by reference to the conversion price in each
of the respective Convertible Debentures, such that the principal amount and accrued interest upon receipt of TSXV approval
(including any default interest) under each of the Convertible Debentures shall be convertible into shares of Common Stock at a rate
of $0.10 per share and $0.30 per share, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
of Shares of Common Stock Underlying Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price of the shares of Common Stock underlying the Warrants is determined by reference to the exercise price of the Warrants, such that
each warrant entitles the holder to purchase one share of our Common Stock at per share exercise prices of $0.13, $0.19 and $0.40, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_013"></span>DIVIDEND
POLICY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any cash dividends on our common stock and do not currently anticipate paying cash dividends in the foreseeable future.
The agreements into which we may enter in the future, including indebtedness, may impose limitations on our ability to pay dividends
or make other distributions on our capital stock. Payment of future dividends on our common stock, if any, will be at the discretion
of our board of directors and will depend on, among other things, our results of operations, cash requirements and surplus, financial
condition, contractual restrictions and other factors that our board of directors may deem relevant. We intend to retain future earnings,
if any, for reinvestment in the development and expansion of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_014"></span>MARKET
PRICE FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
Information</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #4472C4"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is traded in the United States on the OTCQB tier of the OTC Markets (the &#8220;OTCQB&#8221;) under the symbol &#8220;<b>MLYF</b>&#8221;.
The OTC Market is a network of security dealers who buy and sell stock. The dealers are connected by a computer network that provides
information on current &#8220;bids&#8221; and &#8220;asks&#8221;, as well as volume information. We are also a reporting issuer in Canada
and our common stock is listed for trading on the TSX Venture Exchange (the &#8220;TSXV&#8221;) under the symbol &#8220;<b>WMG</b>&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><sup>&#160;</sup></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
                                            Price and Volume</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth trading information for our common stock for the periods indicated, as quoted on the OTCQB.<sup>(1) </sup>These
quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Low
    Trading Price</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">High
    Trading Price</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Period</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">($)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">($)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 50%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">First
    Quarter (January 31, 2022)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 21%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.2604</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 21%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.6320</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year
    Ended October 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fourth
    Quarter (October 31, 2021)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.2410</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7625</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Third
    Quarter (July 31, 2021)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0850</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.2661</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Second
    Quarter (April 30, 2021)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0811</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1400</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">First
    Quarter (January 31, 2021)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0769</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1500</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year
    Ended October 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fourth
    Quarter (October 31, 2020)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0810</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1153</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Third
    Quarter (July 31, 2020)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0761</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1200</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Second
    Quarter (April 30, 2020)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0680</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1279</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">First
    Quarter (January 31, 2020)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0794</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.1740</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
    Yahoo Finance.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth trading information for our common stock for the periods indicated, as quoted on the TSXV.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Low
    Trading Price</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">High
    Trading Price</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Period</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(CAD$)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(CAD$)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 50%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">First
    Quarter (January 31, 2022)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 21%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.21</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 21%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.77</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year
    Ended October 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fourth
    Quarter (October 31, 2021)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.355</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.960</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Third
    Quarter (July 31, 2021)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.105</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.330</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Second
    Quarter (April 30, 2021)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.105</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.175</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">First
    Quarter (January 31, 2021)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.100</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.180</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year
    Ended October 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fourth
    Quarter (October 31, 2020)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.115</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.150</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Third
    Quarter (July 31, 2020)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.105</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.170</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Second
    Quarter (April 30, 2020)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.085</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.175</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">First
    Quarter (January 31, 2020)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.105</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.230</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
    Yahoo Finance.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Common Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 16, 2022 there were approximately 678 record holders of our common stock. The number of record holders does not include beneficial
owners of common stock whose shares are held in the names of banks, brokers, nominees or other fiduciaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
have not paid any cash dividends on our common stock and do not currently anticipate paying cash dividends in the foreseeable future.
We intend to retain future earnings, if any, for reinvestment in the development and expansion of our business.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
Compensation Plans</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017
Stock Option Plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shareholders and board of directors approved a stock option plan effective on August 8, 2017 (the &#8220;2017 Stock Option Plan&#8221;)
which consisted of a fixed number stock option plan reserving for issuance pursuant to the exercise of stock options a maximum of 35,219,701
shares of our common stock. At our shareholder meeting on August 8, 2018, our shareholders approved an increase in the number of shares
of common stock reserved for issuance under the 2017 Stock Option Plan to 36,643,701 (the &#8220;2017 Stock Option Plan Limit&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2017 Stock Option Plan is to attract and retain employees, officers, directors, consultants and management company employees
to motivate them to advance our interests by affording them the opportunity to acquire an equity interest in our company through stock
options. The 2017 Stock Option Plan was expected to benefit our shareholders by enabling us to attract and retain personnel of the highest
caliber by offering to them an opportunity to share in any increase in the value of our common stock to which they have contributed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2017 Stock Option Plan, the option exercise price must not be less than the last closing price of our common stock before the issuance
of the required news release disclosing the grant of stock options (subject to the exceptions prescribed by the TSXV, less the applicable
discount permitted by the policies of the TSXV). A stock option granted under the 2017 Stock Option Plan must, unless sooner terminated,
expire on a date to be determined by our board of directors which cannot exceed ten years from the date the stock option is granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of our common stock reserved for issuance to any one optionee pursuant to stock options granted under the 2017 Stock
Option Plan, together with any shares of our common stock reserved for issuance pursuant to stock options granted to that optionee during
the previous 12 months must not exceed 5% of the issued and outstanding common stock at the time of granting of the stock options, provided
that the aggregate number of stock options granted to each of the following categories of optionee: (a) each individual consultant; and
(b) persons performing investor relations activities on our behalf, must not exceed 2% of the outstanding Shares at the time of grant
unless the TSXV permits otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discretion of our board of directors to apply vesting to the grant of any stock option, the stock options granted to an optionee
under the 2017 Stock Option Plan will fully vest on the date of grant of such stock options. In accordance with the policies of the TSXV,
and subject to the TSXV&#8217;s approval to the contrary, stock options granted to consultants performing investor relations activities
must vest (and not otherwise be exercisable) in stages over a minimum of 12 months with no more than &#188; of the stock options vesting
in any three-month period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an optionee dies prior to the expiry of the optionee&#8217;s stock option, the optionee&#8217;s heirs, administrators or legal representatives
may, by the earlier of: (a) one year from the date of the optionee&#8217;s death (or such lesser period as may be specified by our board
of directors at the time of granting the stock option); and (b) the expiry date of the stock option; exercise any portion of such stock
option. If an optionee ceases to be a director, officer, employee or consultant for any reason other than death, then such optionee&#8217;s
stock option will terminate within a reasonable period to be determined by our board of directors commencing on the effective date the
optionee ceases to be employed by or provide services to us (but only to the extent that such stock option has vested on or before the
date the optionee ceased to be so employed or provide services to us) as provided for in the written option agreement between us and
the optionee. The maximum exercise period upon such cessation is six months unless the optionee has entered into a valid employment or
consulting agreement that provides for a longer exercise period, but in no case will the exercise period in such cessation be greater
than one year unless prior TSXV approval has been given.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to August 8, 2018 and up to June 11, 2021, we granted additional stock options and there were 42,170,000 stock options issued and outstanding,
which was in excess of the 2017 Stock Option Plan Limit. Under TSXV policies, at our annual shareholders&#8217; meeting on June 11, 2021
(the &#8220;2021 Annual Meeting&#8221;), we obtained (a) shareholder approval for the increase in the number of shares of our common
stock reserved for issuance under the 2017 Stock Option Plan to 42,370,000 shares of our common stock (the &#8220;Increased Stock Option
Limit&#8221;); and (b) Disinterested Shareholder Approval for the grant of 6,626,299 stock options on December 30, 2020 that resulted
in the 2017 Stock Option Plan Limit being exceeded (the &#8220;Excess Stock Option Grant&#8221;). &#8220;Disinterested Shareholder Approval&#8221;
means approval by a majority of the votes cast by all our shareholders at a duly constituted shareholders&#8217; meeting, excluding votes
attached to common stock beneficially owned by insiders that received the Excess Stock Option Grants. Edward Lee, our Executive Chairman,
was granted 5,000,000 stock options on December 30, 2020, and Sam Ataya, our Executive President and CEO, was granted 4,500,000 stock
options on December 30, 2020. These options have an exercise price of CAD$0.13 and expire on December 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the shareholder approval of the Increased Stock Option Limit, the Excess Stock Option Grant and the 2021 Equity Incentive Plan discussed
below, we do not intend to grant additional stock options under the 2017 Stock Option Plan. Any shares of our common stock reserved for
issuance under the 2017 Stock Option Plan that are forfeited as a result of the expiration or termination of any awards under that plan
after the date of adoption of the 2021 Equity Incentive Plan will, however, be added to the 2021 Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #0F0F0F"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021
Equity Incentive Plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shareholders and our board of directors approved the 2021 Equity Incentive Plan effective June 11, 2021 and to reserve for the grant
of awards under that plan up to 27,312,368 shares of our common stock. We are awaiting the TSXV&#8217;s approval of the 2021 Equity Incentive
Plan prior to it becoming effective.&#160; The granting of awards under the 2021 Equity Incentive Plan is intended to attract and retain
the highly qualified employees essential for the execution of our business strategy. We believe the 2021 Equity Incentive Plan will (i)
attract and retain key personnel, and (ii) provide a means whereby our directors, officers, employees, consultants, and advisors and
our subsidiaries can acquire and maintain an equity interest in our company, or be paid incentive compensation, including incentive compensation
measure by reference to the value of our common stock, thereby strengthening their commitment to our welfare and aligning their interests
with those of our stockholders. Eligible participants under the 2021 Equity Incentive Plan include employees, directors and independent
contractors (except those performing services in connection with the offer or sale of our securities in a capital raising transaction,
or promoting or maintaining a market for our securities) of our company or our subsidiaries will be eligible to receive awards under
the 2021 Equity Incentive Plan. The 2021 Equity Incentive Plan will be administered by our board of directors or such other committee
appointed by our board of directors (the &#8220;Administrator&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Equity Incentive Plan provides for various equity-based and cash-based incentive awards, including incentive stock options (&#8220;ISOs&#8221;),
non-statutory stock options (&#8220;NSOs&#8221;), stock appreciation rights (&#8220;SARs&#8221;), restricted stock and restricted stock
units (&#8220;RSUs&#8221;), performance units and shares and other equity-based or cash-based awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator or its permitted delegates has the power and discretionary authority to determine the amount, terms and conditions of the
2021 Equity Incentive Plan awards, including, without limitation, (i) the exercise price of any stock options or stock appreciation rights,
(ii) the method of payment for shares purchased pursuant to any award, (iii) the method for satisfying any tax withholding obligation
arising in connection with any award, including by net exercise or the withholding or delivery of shares, (iv) the timing, terms and
conditions of the exercisability, vesting or payout of any award or any shares acquired pursuant thereto, (v) the performance criteria,
if any, applicable to any award and the extent to which such performance criteria have been attained, (vi) the time of the expiration
of any award, (vii) the effect of the participant&#8217;s termination of service on any of the foregoing, and (viii) all other terms,
conditions and restrictions applicable to any award or shares acquired pursuant thereto as our board of directors shall consider to be
appropriate and not inconsistent with the terms of the 2021 Equity Incentive Plan. A non-employee director may not be granted 2021 Equity
Incentive Plan awards that exceed in the aggregate $300,000 in any calendar year. The foregoing limit does not apply to any award made
pursuant to any election by the director to receive an award in lieu of all or a portion of annual and committee retainers and meeting
fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth securities authorized for issuance under the 2017 Stock Option Plan and the 2021 Equity Incentive Plan as
of January 31, 2022 and compensation plans not approved by our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            be issued upon</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding
                                            options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrant
                                            and rights</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise
                                            price of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding
                                            options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants
                                            and rights</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining
                                            available</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            future issuance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>under
                                            equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>compensation
                                            plans</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Plan
    Category</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(#)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(CAD$)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(#)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity
    compensation plans approved by security holders</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,510,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.34</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,642,368</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Equity
    compensation plans not approved by security holders</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">59,510,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.34</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,642,368</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information represents securities sold by us within the past three years through January 31, 2022 which were not registered
under the Securities Act. Included are new issues, securities issued in exchange for property, services or other securities, securities
issued upon conversion from our other share classes and new securities resulting from the modification of outstanding securities. We
sold all of the securities listed below pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act,
or Regulation D or Regulation S promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Historical
Common Equity Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of transactions by us since November 1, 2018 involving unregistered issuances of our common equity securities.
Included are new issues, securities issued in exchange for property, services or other securities, securities issued upon conversion
from our other share classes and new securities resulting from the modification of outstanding securities. We sold all of the securities
listed below pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), or Regulation D or Regulation S promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">During
the Fiscal Year ended October 31, 2019</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2018, in connection with a non-brokered private placement, 7,699,760 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$384,988 (USD equivalent $289,443). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 145,960 shares of common stock were issued to agents at a price of CAD$0.05 for a
fair value of CAD$7,298 (USD equivalent $5,487). Finder&#8217;s fees of $18,097 were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 23, 2019, in connection with a non-brokered private placement, 6,348,435 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$317,422 (USD equivalent $237,805). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 597,001 shares of common stock at a price of CAD$0.05 for a fair value of CAD$29,850
(USD equivalent $22,363) and 40,000 broker&#8217;s warrants exercisable at a price of CAD$0.08 per share for a period of two years were
issued to agents. Finder&#8217;s fees of $5,530 were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 29, 2019, in connection with a non-brokered private placement, 11,750,464 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$587,523 (USD equivalent $439,664). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 218,287 shares of common stock were issued to agents at a price of CAD$0.05 for a
fair value of CAD$10,914 (USD equivalent $8,168). Finder&#8217;s fees of $28,262 were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 13, 2019, in connection with a non-brokered private placement, 34,712,595 units were issued to private investors at a price of CAD$0.05
per share for gross proceeds of CAD$1,735,630 (USD equivalent $1,289,053). Each unit consists of one common share and one common share
purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were subject
to an acceleration clause whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require a holder
to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive trading
days. Finder&#8217;s fees of $94,216 were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 6, 2019, 328,571 shares of common stock were issued to a non-arm&#8217;s length party for settlement of debt at a price of
CAD$0.175 per share for a fair value of CAD$57,500 (USD equivalent $43,647).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, an aggregate of 3,455,235 shares of common stock were issued to private investors upon the exercise
of warrants at a price of CAD$0.05 per share for gross proceeds of CAD$172,762 (USD equivalent $131,071).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, an aggregate of 11,600,109 shares of common stock were issued to private investors upon the exercise
of warrants at a price of CAD$0.08 per share for gross proceeds of CAD$928,009 (USD equivalent $706,111).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, an aggregate of 1,100,000 shares of common stock were issued to certain officers and consultants
upon the exercise of options at a price CAD$0.05 per share for gross proceeds of CAD$55,000 (USD equivalent $41,553). Upon exercise,
CAD$36,750 (USD equivalent $27,723) previously recorded in reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, in consideration of services provided to the Company, an aggregate of 150,000 shares of common
stock were issued to a service provider at a price of CAD$0.05 per share for a fair value of CAD$7,500 (USD equivalent 5,668).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">During
the Fiscal Year ended October 31, 2020</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 20, 2019, the Company exercised its right to call all outstanding common share purchase warrants set to expire between May 7,
2020 and May 13, 2021 to expiry on January 19, 2020, and then extended the expiration date to February 19, 2020. Any unexercised warrants
were voided and of no value after February 19, 2020. From November 13, 2019 through March 11, 2020, an aggregate of 32,472,661shares
of common stock were issued to private investors upon the exercise of warrants at a price of CAD$0.08 per share for gross proceeds of
CAD$2,597,813 (USD equivalent $1,969,797), an aggregate of 3,000,000 shares of common stock were issued to private investors upon the
exercise of warrants at a price of CAD$0.07 per share for gross proceeds of CAD$210,000 (USD equivalent $158,718), and a further 4,864,000
shares of common stock were issued to private investors upon the exercise of warrants at a price of CAD$0.05 per share for gross proceeds
of CAD$243,200 (USD equivalent $184,769). 24,794,484 warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2020, in connection with a non-brokered private placement, 3,643,791 units were issued to private investors at a price of
CAD$0.15 per share for gross proceeds of CAD$546,569 (USD equivalent $416,719). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.21 per share for a period of one year. Subsequent to October
31, 2020, we extended the expiration date of the warrants to August 31, 2021. The warrants were subject to an acceleration clause whereby
the Company had the right, upon provision of thirty days&#8217; written notice, to require a holder to exercise the warrants should the
closing price of our common stock exceeds CAD$0.30 per share for at least ten consecutive trading days. Finder&#8217;s fees of $41,275
were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2020, 100,000 shares of common stock were issued to a consultant upon the exercise of options at a price CAD$0.05 per share for
gross proceeds of CAD$5,000 (USD equivalent 3,568).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2020, 400,000 shares of common stock were issued to a consultant upon the exercise of options at a price CAD$0.08 per share for
gross proceeds of CAD$32,000 (USD equivalent $22,833). Upon exercise, CAD$27,715 (USD equivalent $19,775) previously recorded in equity
reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">During
the Fiscal Year ended October 31, 2021</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2020, in connection with a non-brokered private placement, 5,599,171 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$727,892 (USD equivalent $556,876). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2021, in connection with a non-brokered private placement, 7,337,914 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$953,930 (USD equivalent $749,435). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2021, in connection with a non-brokered private placement, 5,382,303 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$699,699 (USD equivalent $547,496). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 24, 2021, in connection with a non-brokered private placement, 6,554,172 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$852,042 (USD equivalent $678,270). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 27, 2021, in connection with a non-brokered private placement, 851,395 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$110,681 (USD equivalent $89,237). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2021, in connection with the conversion of the July 2020 Convertible Debenture including accrued interest and transaction costs,
a total of 1,360,959 common shares were issued to private investors with a value of $162,829.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 28, 2021, in connection with a non-brokered private placement, 5,223,420 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$679,044 (USD equivalent $561,844). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 7, 2021, in consideration of equipment, 1,538,461 common shares were issued to Industrial Surplus Supplies Ltd. at a price of CAD$0.24
per share for a fair value of CAD$369,231 (USD equivalent $305,832).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2021, in connection with a non-brokered private placement, 17,853,506 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$2,320,956 (USD equivalent $1,880,687). Each unit consists of one common share and one common share
purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 16, 2021, in connection with a non-brokered private placement, 4,350,000 units were issued to private investors at a price of CAD$0.20
per share for gross proceeds of CAD$870,000 (USD equivalent $690,860). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.30 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 11, 2021, in connection with a non-brokered private placement, 3,827,601 units were issued to private investors at a price of
CAD$0.55 (USD$0.44) per share for gross proceeds of CAD$2,105,180 (USD equivalent $1,683,336). Each unit consists of one common share
and one common share purchase warrant exercisable into one common share at a price of CAD$0.65 (USD$0.52) per share for a period of eighteen
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2021, the Company issued to private investors upon the exercise of common share purchase warrants an
aggregate 1,964,901 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$98,245 (USD equivalent $77,896), an aggregate
1,931,450 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$366,976 (USD equivalent $292,890), and an aggregate
3,118,618 common shares at a price of CAD$0.21 per share for gross proceeds of CAD$654,910 (USD equivalent $516,735). Upon exercise,
CAD$5,333 (USD equivalent $4,291) previously recorded in equity reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2021, the Company issued to certain directors, officers, employees and consultants upon the exercise
of options an aggregate 2,000,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$100,000 (USD equivalent $80,058),
an aggregate 200,000 common shares at a price of CAD$0.11 per share for gross proceeds of CAD$22,000 (USD equivalent $17,456), an aggregate
300,000 common shares at a price of CAD$0.12 per share for gross proceeds of CAD$36,000 (USD equivalent $29,096), an aggregate 100,000
common shares at a price of CAD$0.13 per share for gross proceeds of CAD$13,000 (USD equivalent $10,315), and an aggregate 30,000 common
shares at a price of CAD$0.16 per share for gross proceeds of CAD$4,800 (USD equivalent $3,809). Upon exercise, CAD$152,218 (USD equivalent
$121,932) previously recorded in equity reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">During
the three months ended January 31, 2022</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an agreement entered on August 29, 2018 and which was approved by the TSXV on September 12, 2018, a company controlled by Sam Ataya,
a director and officer of our Company, is eligible to receive up to 5% of the issued and outstanding common shares of the Company as
at August 28, 2018 for up to $5 million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3,
2021, the Company issued 9,163,425 common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614)
as share issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2021, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling Securityholder
1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable
at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 26, 2021, in connection with a non-brokered private placement, 1,375,499 units were issued to private investors at a price of
$0.55 per unit for gross proceeds of $756,524. Each unit consists of one common share and one common share purchase warrant exercisable
into one common share at a price of $0.75 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 13, 2021, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling
Securityholder 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class
B Warrants exercisable at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 20, 2022, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling Securityholder
1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable
at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended January 31, 2022, upon the exercise of common share purchase warrants the Company issued to private investors
an aggregate 15,159,448 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$2,880,295 (USD equivalent $2,279,136),
200,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$10,000 (USD equivalent $7,830), and 30,000 common shares
at a price of CAD$0.30 per share for gross proceeds of CAD$9,000 (USD equivalent $6,981). A total of 2,428,363 warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Debt
Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, we received an unsecured loan of CAD$150,000 (USD equivalent $112,895) from a director and officer.
The loan bore interest at 18% and was due on demand. During the fiscal year ended October 31, 2020, the loan was increased by an additional
CAD$60,000 (USD equivalent $44,588), to CAD$210,000 (USD equivalent $157,483), and was due on September 24, 2021. During the fiscal year
ended October 31, 2021, we have made repayments of the entire balance of principal and all interests accrued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2020, we issued to a private investor a CAD$150,000 (USD equivalent $112,124, the &#8220;July 2020 Convertible Debenture&#8221;)
principal amount 12% convertible debenture convertible at the option of the holder to our common stock at the greater of CAD$0.15 per
share and the market price on the date of the conversion notice. Any accrued but unpaid interest will be payable on the earlier of the
maturity date and the date of conversion in cash or shares of our common stock. The net proceeds from this transaction were used to fund
working capital and general corporate purposes. On May 18, 2021, 1,360,959 shares of common stock were issued in connection with the
conversion of the July 2020 Convertible Debenture including conversion of accrued interest and 263,973 common shares valued at $26,286
in transaction costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2021, we issued an unsecured convertible note in the principal amount of $1,500,000 (the &#8220;June 2021 Convertible Debenture&#8221;).
The June 2021 Convertible Debenture bears interest at 12% per annum and matures on December 10, 2022. The June 2021 Convertible Debenture
is convertible into 15,000,000 units, where each unit consists of (i) one share of our common stock, (ii) one-half of one Class A common
stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one
Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively,
the &#8220;Class A and B Warrants&#8221;). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii)
the minimum conversion price permitted by the TSXV at the time of conversion (should our common stock then be listed on such exchange).
Upon TSXV approval, accrued interest on the June 2021 Convertible Debenture is convertible into our common stock on the same terms
as the principal amount of such debtenture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 15, 2021, we issued to a private investor a CAD$100,000 (USD equivalent $79,542, the &#8220;July 2021 Convertible Debenture&#8221;)
principal amount 12% convertible debenture convertible at the option of the holder to common shares at a price of CAD$0.12 per share
and common share purchase warrants exercisable at a price of CAD$0.20 per share for a period of two years. Any accrued but unpaid interest
will be payable on the earlier of the maturity date and the date of conversion in cash or common shares. The net proceeds from this transaction
were used to fund working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Issuances</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2018, 9,600,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and
consultants as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.05 per share. These options
vested immediately on the grant date and expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2019, 10,000,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.12 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, we extended the expiration date of 400,000 options from May 9, 2019 to May 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2019, 700,000 options to purchase shares of our common stock were granted to certain officer, employee and consultant as
additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.15 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 25, 2019, 900,000 options to purchase shares of our common stock were granted to certain employees and consultants as additional
compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.16 per share. 400,000 options vested immediately on
the grant date and 500,000 options vest 25% every three-month period. These options expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, 300,000 options to purchase shares of our common stock were granted to an officer as additional compensation pursuant
to our 2017 Stock Option Plan at an exercise price of CAD$0.11 per share. These options vested immediately on the grant date and expire
5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 24, 2020, 4,200,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.12 per share. 3,750,000 options vested
immediately on the grant date and 450,000 options vest 25% every three-month period. These options expire five years after the grant
date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 26, 2020, 500,000 options to purchase shares of our common stock were granted to certain consultant as additional compensation
pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.13 per share. These options vest 25% every three-month period and
expire 2 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2020, 15,650,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and
consultants as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.13 per share. 15,000,000
options vested immediately on the grant date and 650,000 options vest 25% every three-month period. 9,500,000 of these options expire
five years after the grant date and 6,150,000 of these options expire two years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 30, 2021, 21,700,000 options to purchase common shares were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2021 Equity Incentive Plan at an exercise price of CAD$0.70 per share. 21,400,000 options
vested immediately on the grant date and 300,000 options vest 25% every three-month period. These options expire 5 years after the grant
date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.2pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2021, 1,450,000 options to purchase common shares were granted to certain officer, employee and consultants as additional
compensation pursuant to our 2021 Equity Incentive Plan at an exercise price of CAD$0.50 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 3, 2021, 250,000 options to purchase common shares were granted to an employee as additional compensation pursuant to our 2021
Equity Incentive Plan at an exercise price of CAD$0.58 per share. These options vested immediately on the grant date and expire 5 years
after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="psi_015"></span>DESCRIPTION
OF BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or &#8220;the Company&#8221; refers to &#8220;Western
Magnesium Corporation,&#8221; a Delaware corporation, and its consolidated subsidiaries.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
otherwise indicated, all references to &#8220;$&#8221; or &#8220;US$&#8221; in this prospectus refer to United States dollars, and all
references to &#8220;CAD$&#8221; refer to Canadian dollars.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Background</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production of magnesium at a research and development pilot plant
in metropolitan Vancouver, British Columbia, Canada. We have commenced testing at this facility in the last calendar quarter of 2021
with full pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete.
Our proprietary technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor
and energy costs while generating minimal waste and toxic by-products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we own a 100% interest in 81 unpatented lode mining claims totaling approximately 1,673 acres (the &#8220;Tami Mosi Mining
Claim&#8221;), four unpatented lode mining claims totaling approximately 10 acres located in the Moor Mining District in Elco County,
Nevada and a 100% interest in three patented mining claims located in the Pinto mining district of Nevada totaling approximately 296
acres (the &#8220;Silverado Mining Claim&#8221;). We do not plan on commencing extraction of minerals at this time from any mining claims
we hold because we have identified alternative sources of supply of dolomite and ferrosilicon, the primary raw materials used to produce
pure magnesium. We may in the future, however, commence extraction of minerals from the Tami Mosi Mining Claim if we are unable to purchase
raw materials from the alternative sources we have identified at commercially reasonable rates. In addition, we do not consider our mining
claims to be material to our business or financial condition. See &#8220;Description of Business &#8211; Properties.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corporate
History</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated under the Company Act (British Columbia) on March 24, 1966 as &#8220;Ft. Lauderdale Resources Inc.&#8221; We changed
our name to Amcorp Industries Inc. on July 20, 1990, to Molycor Gold Corporation on May 17, 1996, to Nevada Clean Magnesium Inc. on April
16, 2012 and to Western Magnesium Corporation on May 14, 2019. On May 14, 2019, we discontinued from the jurisdiction of the Business
Corporations Act (British Columbia) and domesticated under the General Corporation Law of the State of Delaware under the name &#8220;Western
Magnesium Corporation.&#8221; In connection with the name change, we also changed our stock symbol to &#8220;WMG&#8221; on the TSX Venture
Exchange. The Company has two wholly-owned subsidiaries: Western Magnesium Corp., incorporated in the State of Nevada in the United States
which owns our mining claim in the Schell Creek Range located southeast of Ely, Nevada and manages the Company&#8217;s Nevada properties;
and Western Magnesium Canada Corp., incorporated on May 3, 2019 in British Columbia, Canada which manages our Canadian operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
Development of Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2006, we acquired the Silverado Mining Claim. During the year ended October 31, 2013, an impairment was recorded on this claim for $412,793
reducing its book value to $1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2009, we acquired 27 mining claims totaling approximately 1,744 acres on property located southeast of Beaverdell, British Columbia (the
&#8220;Beaverdell Mining Claim&#8221;). During the year ended October 31, 2013, an impairment was recorded on this claim for $335,133
reducing its book value to $1. During the year ended October 31, 2020, we sold our interest in the Beaverdell Mining Claim for $50,000
and recognized a gain on sale of $37,156.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 9, 2006, we acquired the Tami Mosi Mining Claim. On May 1, 2009, an Initial Resource Estimate was completed by Norm Tribe &amp;
Associates, Ltd. On June 11, 2010, a Phase 1 Process Development Study for Exploitation of the Tami Mosi Mining Claim was completed by
Haze Research, Inc. On August 3, 2011, an updated resource estimate was completed by Tetra Tech, Inc. (&#8220;Tetra Tech&#8221;), on
September 15, 2011 a Preliminary Economic Assessment and Technical Report of the Tami-Mosi Magnesium Project was completed by Tetra Tech
and amended on July 4, 2014.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 4, 2017, we completed construction of a bench scale test furnace that employed our proprietary continuous silicothermic process
and in October 2017, we successfully completed furnace preparations - a major milestone in the testing of our bench scale pilot furnace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2017, we completed &#8220;proof of concept&#8221; in the production of magnesium metal from our bench scale test furnace. The
metal produced was a result from a partial test charge being conducted in order to identify any operational deficiencies in the furnace
prior to a full charge test of dolime material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2018, we received a final assay report assessing the purity of the raw magnesium metal produced from our bench scale pilot furnace
test program. In accordance with ASTM International standard ASTM E1479-16, the testing was analyzed via inductively coupled plasma (ICP).
This unrefined magnesium metal was found to have a very good metal purity capable of producing ASTM B92 grade metal with minimal treatment.
No impurities were found which would impact food grade applications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2018, we entered into an agreement with Industrial Surplus Ltd. (&#8220;ISL&#8221;) to build a silicothermic reduction furnace based
on our bench scale test furnace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2018, our technical team produced a magnesium ingot from dolomite obtained from the Tami Mosi Mining Claim. This accomplishment
completed the proof of concept stage allowing us to develop a pilot magnesium furnace based on the bench scale furnace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production at a research and development pilot plant in Metropolitan
Vancouver, British Columbia, Canada. We have commenced test production at this facility in the last calendar quarter of 2021 with full
pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete. Our proprietary
technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor and energy costs
while generating minimal toxic by-products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Plan
of Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to complete construction and commencing testing at our planned research and development pilot plant, the following are the key
milestones that expect to achieve over the next 12 months following the date of this prospectus:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete
    construction of the plant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
    the plant and complete final training of operations staff;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commence
    metal production under various scenarios to ensure sufficient data is collected;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Begin
    the request for proposal process for commercial engineering, procurement and construction management (&#8220;EPCM&#8221;) firm;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Select
    EPCM firm;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
    all pilot data with chosen EPCM firm and validate proposed required operational scenarios; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Begin
    geotechnical assessments of proposed full-scale magnesium production facility in Harrison County, Ohio.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that the costs to complete this work will be approximately $8,000,000. We have commenced testing in the pilot reactor by the
end of 2021 with full pilot facility operations expected to commence in the first calendar quarter of 2022 after all safety testing is
complete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
completion of our magnesium research and development pilot plant, we intend to construct a full-scale magnesium production facility with
expected capacity to produce 100,000 metric tons per year that will be scalable for greater production levels located on 122 acre property
located in Harrison County, Ohio. The proposed plant will be adjacent to the future home of a modern mixed fuels power plant which is
expected to provide power to our planned magnesium production plant. The proposed Harrison County, Ohio location is close to a dolomite
supply and has an infrastructure of rail and highway that is capable of transporting our magnesium finished product to industries across
the United States. Our plans will require a significant amount of additional capital. See &#8220;Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations &#8211; Liquidity and Capital Resources.&#8221; We have no current plans to extract
minerals from any of our mining claims. See &#8220;Description of Business &#8211; Properties.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Magnesium
and Its Production</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magnesium
is the lightest of all commonly used structural metal, following steel and aluminum. It is the lightest and strongest of the structural
metals, it is one fourth the weight of steel, two fifths the weight of titanium and two thirds the weight of aluminum. Magnesium has
multiple industrial and consumer applications. Magnesium ingots are a prime raw material input for the production of titanium and aluminum
alloys and magnesium alloys. Magnesium powder and granules are used to remove sulfur in the production of steel. Due to their unique
light weight and high strength properties, magnesium alloys are used in a variety of aircraft and automobile parts, as well as in electronic
equipment such as computers, cameras and cellular phones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
magnesium produced globally comes from natural minerals such as dolomite and magnesite in the form of magnesium carbonate. It can also
be found in seawater and in salt lakes brines or underground mineral salt deposits. Magnesium can be produced through several different
methods including the electrolytic process or thermal-reduction as practiced in the most commonly used Pidgeon process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
electrolytic process involves the electrolysis of molten magnesium chloride which produces molten magnesium and chlorine. The metal is
cast into ingots for further processing as needed and the chlorine by product may be sold for use in the production of polymers such
as polyvinyl chloride pipe (PVC).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the thermal-reduction method calcined magnesium containing ores (magnesite and dolomite) are broken down into fine powder and mixed with
reducing agents and catalyst agent. The mixture is heated in a vacuum chamber producing magnesium vapors which later condense into crystals.
The crystals are then melted, refined and poured into ingots for further processing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pidgeon process, using ferrosilicon as s catalyst, is most commonly used for production of magnesium as its operation is relatively easy
and has a low capital cost. The traditional process using horizontal retorts is high in energy consumption and has low productivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dependence
on Customers, Principal Products or Services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
we have not commenced production of magnesium and have no revenues, we are currently not dependent on any customers. In addition, we
do not anticipate producing any significant quantities of magnesium until we launch a full-scale production facility following the launch
and testing of our magnesium research and development pilot facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Competitive
Conditions and Our Position</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magnesium
production is highly competitive and is dominated by several large producers in China, the United States, Israel, Brazil, Russia, Kazakhstan
and Turkey. Once we commence magnesium, we will compete with existing producers that may have greater resources, access to public equity
markets, more experienced management or may be more mature as a business. Production costs associated with the energy needed to fuel
the magnesium refinery and raw material costs are a significant challenge facing all producers. We believe that the more energy efficient
proprietary silicothermic magnesium production technology we are developing will enable us to be competitive with other magnesium producers
who use the less energy efficient electrolytic process or thermal-reduction as practiced in the most commonly used Pidgeon process that
consumes significantly greater resources. Further, we believe we face competition from manufacturers of other products, such as aluminum
alloys, steel, titanium, plastics, composites, ceramics, and glass, among others. Product quality, price and availability are important
differentiating factors. See &#8220;Risk Factors.&#8221; We expect to face significant competition, which may have an adverse effect
on expected revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sources
and Availability of Materials</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, we are currently in the final stages of developing a research and development pilot magnesium production facility and
consequently have no current need to obtain dolomite and ferrosilicon, the primary raw materials used to produce pure magnesium. The
production of magnesium products is dependent, however, on a number of key inputs and their related costs, including raw materials and
supplies related to production, as well as electricity and other local utilities. Dolomite and ferrosilicon are in abundant supply in
Canada, where our research and development pilot plant is being constructed, and the United States, where we intend to construct our
full-scale production facility. Once we commence commercial production of magnesium, any significant interruption or negative change
in the availability or economics of the supply chain for key inputs, such as the raw material cost of dolomite and ferrosilicon, could,
however, materially impact our business, financial condition, results of operations or prospects. We intend to purchase dolomite and
ferrosilicon on a purchase order basis from local suppliers at market prices based on our production requirements. In addition, we believe
there will be adequate availability of electricity needed to power our magnesium furnace and operate our production facility. Consequently,
our management believes that we will have access to a sufficient supply of the key inputs for the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intellectual
Property&#8212;Patents, Trademarks</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
regularly seek to protect our intellectual property rights in connection with our production process and methods. We rely on non-disclosure/confidentiality
agreements and segregate development and engineering duties among certain members of our development team to protect our intellectual
property rights. To the extent we describe or disclose our proprietary production techniques, we redact or request redaction of such
information prior to public disclosure. Despite these measures, we may be unable to detect the unauthorized use of, or take appropriate
steps to enforce our intellectual property rights. Effective trade secret protection may not be available in every country in which we
offer or intend to produce magnesium or offer our products for sale to the same extent as in the United States. Failure to adequately
protect our intellectual property could impair our ability to compete effectively. Further, enforcing our intellectual property rights
could result in the expenditure of significant financial and managerial resources and may not prove successful. Although we intend to
protect our rights vigorously, there can be no assurance that these measures will be successful. See &#8220;Risk Factors&#8221; with
respect to intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own the website domain <span style="text-decoration: underline">www.westernmagnesium.com</span> and <span style="text-decoration: underline">www.westmagcorp.com</span> and social media accounts across certain major
platforms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any patents or trademarks nor have we filed any patent or trademark applications in the United States or Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Regulation
of Magnesium Production and Mining, Environmental Compliance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pilot magnesium production facility that we are currently developing in Metropolitan Vancouver, British Columbia, Canada, will require
local governmental approval before pilot operations can commence. We have applied for a business license, building permit, and all sub
trade permits, which all have been issued along with a conditional business license. This license allows us to currently operate our
Vancouver facility until we receive a final license which we expect to be issued in the first half of 2022 following a final inspection
of the facility. A final inspection has been delayed due to a backlog in the permitting process due to COVID-19. Once operational, we
will be subject to compliance with various types of government laws and regulations which often provide discretion to government authorities
and could be interpreted, applied, or modified in ways to make our operations or compliance activities more costly. These laws and regulations
include those relating to health and safety (WorkSafe BC, ASME, OSHA) (including those promulgated in response to the ongoing COVID-19
pandemic), competition, data privacy and security and environmental compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
we commence pilot magnesium production in Canada and mining in the U.S., we will be subject to extensive provincial environmental laws
and regulations, including those relating to the release or discharge of materials into the air, water and soil, waste management, pollution
prevention measures, the generation, storage, handling, use, transportation and disposal of hazardous materials, the exposure of persons
to hazardous materials, and greenhouse gas emissions. Since our planned pilot magnesium production facility is not currently operational,
we have not incurred any material costs for compliance with environmental laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our planned operations in Canada and the holding of mining claims in the U.S. comply with the current environmental protection
requirements. We are not subject to any admonition, penalty, investigations or inquiries imposed by the environmental regulators in Canada
and the U.S., nor are we subject to any claims or legal proceedings to which we are named as a defendant for violation of any environmental
laws and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employees</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2022, we had 31 employees. We consider our relations with our employees to be good.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legal
Proceedings</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, to our knowledge, there are no legal proceedings or regulatory actions material to us to which we are
a party, or have been a party to, or of which any of our property is or was the subject matter of, and no such proceedings or actions
are known by us to be contemplated except as provided below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>James
Sever Claim</i></b>. On September 29, 2020, James Sever filed a Notice of Civil Claim against us in the Supreme Court of British Columbia
(Court File No. S-209728) (the &#8220;Sever Claim&#8221;). The Sever Claim alleges that Mr. Sever had an employment and/or other similar
contractual relationship with us, and that we breached such contractual relationship by way of constructive dismissal or similar conduct.
The Sever Claim seeks damages in excess of $2,500,000, certain equity compensation, prejudgment garnishment, costs, interest and other
non-monetary relief. On July 27, 2021, we filed a response to the Sever Claim, which included the following pleadings: (a) that we were
never properly served with the Sever Claim; (b) that we have never had any form of employment, independent or consulting relationship
or agreement with Mr. Sever; (c) that we had no debts, liabilities or obligations to Mr. Sever; (d) that to the extent that Mr. Sever
had some form of employment, independent or consulting or similar relationship or agreement as alleged in the Sever Claim (the existence
of which we denied) such contract or relationship, if one existed, was never with us and was with some other corporate entity and, furthermore:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any such contract or relationship would be governed by laws of the United States;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all, many or some of the claims in the Sever Claim would be barred by the British Columbia <i>Limitation Act</i> to the extent British
Columbia law applies;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
any such contract or relationship did not exist as alleged in the Sever Claim;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Mr. Sever was not terminated or constructively dismissed and, instead, Mr. Sever never provided any services under any such contract
or relationship because Mr. Sever abandoned or resigned from, and/or failed to fulfil any of his obligations under, any and all contracts
and relationships; and/or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
Mr. Sever failed to mitigate or alternatively has mitigated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to vigorously defend against the Sever Claim, and we believe that the Sever Claim is without merit. We cannot predict the outcome
of the claim, however.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>GEM
Yield Bahamas Limited Arbitration</i>. </b>On December 31, 2020, GEM Yield Bahamas Limited (&#8220;GEM&#8221;) served us with a Notice
of Intention to Arbitrate (the &#8220;New York Arbitration Notice&#8221;) before the American Arbitration Association in New York, New
York (Case No. 01-21-0004-2162) (the &#8220;GEM New York Arbitration&#8221;). The New York Arbitration Notice alleges we breached a Share
Subscription Agreement dated November 15, 2019 entered into between us and GEM (the &#8220;GEM Agreement&#8221;), among other things,
claiming damages of CAD$4.2 million (USD equivalent $3.3 million). On January 19, 2021, we filed a petition in the New York Supreme Court
(Index No. 650401/2021 (the &#8220;New York State Action&#8221;) to stay the GEM New York Arbitration claiming the GEM Agreement was
not valid. The Court in the New York State Action ruled on March 19, 2021 that there is an arbitration clause in the GEM Agreement but
it is up the arbitrator in the GEM New York Arbitration to determine if the arbitration clause is valid. Following this ruling, the New
York State Action was closed. GEM filed a Statement of Claim in the GEM New York Arbitration on June 9, 2021 and on June 25, 2021, we
filed a Statement of Answer denying the existence of any binding agreement between us and GEM, among other defenses. In January 2022,
we filed a Modified Statement of Defense and Counterclaims. Furthermore, we intend to vigorously defend ourselves and believe the allegations
against us in the GEM New York Arbitration lack merit. We cannot predict the outcome of this arbitration proceeding, however.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no substantive motions or pleadings in the GEM New York Arbitration aside from the Statement of Claim and Statement of Answer
discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 39.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>GEM
Yield Bahamas Limited and GEM Global Yield LLC SCS Arbitration</i>.</b> On or about February 8, 2021, GEM instituted another arbitration
against us before the International Centre for Dispute Resolution in Montreal Canada (Case No. 01-21-0001-1245) (the &#8220;GEM Montreal
Arbitration&#8221;) and joined, GEM&#8217;s affiliate, GEM Global Yield LLC SCS (&#8220;GEM Global Yield&#8221; together with GEM, the
&#8220;GEM Parties&#8221;). Similar to the allegations in the GEM New York Arbitration, the Statement of Claim filed by the GEM Parties
alleges we breached a Share Subscription Agreement dated November 15, 2019 and promissory note, among other things, claiming damages
of CAD$4.9 million (USD equivalent $3.8 million), in addition to costs and expenses stemming from our alleged failure to issue to GEM
Global Yield warrants to purchase up to 33,000,000 shares of our common stock. We filed a Statement of Defense, denying the existence
of any binding agreement between us and GEM, among other defenses. In January 2022, we filed an Amended Statement of Defense and Cross-claim.
We intend to vigorously defend ourselves in the GEM Montreal Arbitration and believe the allegations against us in this arbitration proceeding
lack merit. We cannot predict, however, the outcome of this arbitration proceeding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no substantive motions or pleadings or rulings aside from the Statement of Claim and Statement of Answer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lampert
Advisors, LLC Claim</i></b>. On April 19, 2021, Lampert Advisors, LLC (&#8220;Lampert&#8221;) filed a Verified Complaint against our
wholly owned subsidiary Western Magnesium Corporation, a Nevada corporation (&#8220;Western Magnesium &#8211; Nevada&#8221;) in the Supreme
Court of the State of New York, County of New York (Index No. 652738/2021) (the &#8220;Lampert Lawsuit&#8221;). The complaint filed in
the Lampert Lawsuit alleges that Lampert entered into an agreement with Western Magnesium &#8211; Nevada to provide various financial
advisory services including acquisition advisory services and act as an exclusive placement agent for a debt and equity securities (the
&#8220;Lampert Agreement&#8221;), that it performed all services required under that agreement and such services were received and accepted
by our subsidiary, that it is owed $367,227.32 plus interest at the rate of 9% from February 3, 2021 and that it has a right of first
refusal to act as financial advisor in connection with any debt, equity or debt restructuring assignments on terms, conditions and compensation
customary for Lampert for a transaction of the type contemplated. Although Lampert claims to have personally served Western Magnesium
&#8211; Nevada, the company never received the Summons and Complaint and therefore, never submitted a response.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 9, 2021, Lampert filed a Motion seeking the entry of a default judgment (the &#8220;Motion&#8221;) alleging that Western Magnesium
&#8211; Nevada failed to file an answer or motion with respect to the complaint in this lawsuit within the time period provided under
the civil rules of procedure. We opposed Lambert&#8217;s motion for entry of a default judgment and filed a cross-motion to compel Lampert
to accept our answer. The Court granted our cross-motion seeking to compel Lampert to accept our answer and denied Lampert&#8217;s Motion
seeking the entry of a default judgment as moot. The Court scheduled a preliminary conference for the parties on March 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to vigorously defend ourselves and believe the allegations against us in the Lampert Lawsuit lack merit. We cannot predict the
outcome of this lawsuit, however.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation
Assessment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have evaluated the foregoing claims to assess the likelihood of any unfavorable outcome and to estimate, if possible, the amount of potential
loss as it relates to the litigation discussed above. Based on this assessment and estimate, which includes an understanding of our intention
to vigorously defend the claims against us, we believe that the claims of any of the plaintiffs lack merit, however, and we cannot predict
the likelihood of any recoveries by any of the plaintiffs against us. This assessment and estimate is based on the information available
to management as of the date of this prospectus and involves a significant amount of management judgment, including the inherent difficulty
associated with assessing litigation matters in their early stages. As a result, the actual outcome or loss may differ materially from
those envisioned by the current assessment and estimate. Our failure to successfully defend or settle these claims could have a material
adverse effect on our financial condition, revenue and profitability and could cause the market value of our common stock to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Properties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth our principal physical properties as of the date of this prospectus, unless otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="5" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
    Properties</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leased
    / Owned</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8180
    Greensboro Drive, Suite 720, McLean, Virginia</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">580
    Hornby Street, Suite 900, Vancouver, British Columbia, Canada</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="5" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Production
    Properties</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description/Location</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leased
    / Owned</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Claim</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tami
    Mosi Magnesium Claim, Ely, Nevada</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Claim</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Silverado
    Property, Pinto Mining District, Nevada</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and Development Pilot Production Facility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5140
    North Fraser Way, Unit 102, Burnaby, British Columbia, Canada</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leased</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Tami
Mosi Mining Claim</i></b>. We hold a 100% interest in 81 unpatented lode mining claims issued by the U.S. Bureau of Land Management totaling
approximately 1,637 acres located in White Pine County, Nevada (the &#8220;Tami Mosi Mining Claim&#8221;) and four unpatented lode mining
claims totaling approximately 10 acres located in the Moor Mining District, Elco County, Nevada. These mining claims are subject to a
2% net smelter royalty in favor of the prior owner of the claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tami Mosi Mining Claim are located in the Duck Creek Range, a mountain range located in central Nevada. The area is underlain by more
than 10,900 feet of mineral fragments and carbonate rocks, including a geological formation known as the Devonian Guilmette Formation.
Bands of dolomite altered from the limestone are characteristic within this formation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Silverado
Mining Claim</i></b>. We hold a 100% interest in three patented mining claims located in the Pinto mining district of Nevada totaling
approximately 296 acres. This claim has been impaired to $1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mining
Plans</i></b>. We do not plan on commencing extraction of minerals from any mining claims we hold at this time. In addition, we do not
consider our mining claims to be material to our business or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Pilot Production Facility</i></b>. In October 2020, we leased a 12,493 square foot facility in Burnaby, British Columbia,
Canada for a term of three years with a first right of offer to lease the premises beyond the expiration of the term if the landlord&#8217;s
other tenant does not require the premises for the expansion of its business operations at the expiration of the term. We have commenced
construction of a research and development pilot plant at this facility which is in the Vancouver metropolitan area and is located near
major transportation routes and the Vancouver International Airport.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="psi_016"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
management discussion and analysis (&#8220;MD&amp;A&#8221;) of the financial condition and results of operations of Western Magnesium
Corporation (the &#8220;Company,&#8221; &#8220;Western Magnesium,&#8221; &#8220;our&#8221; or &#8220;we&#8221;) is for the three months
ended January 31, 2022 and 2021 and for the years ended October 31, 2021 and 2020. It is supplemental to, and should be read in conjunction
with, our interim condensed consolidated financial statements for the three months ended January 31, 2022 and 2021 and our consolidated
financial statements for the years ended October 31, 2021 and 2020 and the accompanying notes for each respective period. Our financial
statements are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).
Financial information presented in this MD&amp;A is presented in United States dollars (&#8220;$&#8221; or &#8220;US$&#8221;), unless
otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information about us provided in this MD&amp;A, including information incorporated by reference, may contain &#8220;forward-looking statements&#8221;
and certain &#8220;forward-looking information&#8221; as defined under applicable United States securities laws and Canadian securities
laws. All statements, other than statements of historical fact, made by us that address activities, events or developments that we expect
or anticipate will or may occur in the future are forward-looking statements, including, but not limited to, statements preceded by,
followed by or that include words such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;would&#8221;, &#8220;could&#8221;, &#8220;should&#8221;,
&#8220;believes&#8221;, &#8220;estimates&#8221;, &#8220;projects&#8221;, &#8220;potential&#8221;, &#8220;expects&#8221;, &#8220;plans&#8221;,
&#8220;intends&#8221;, &#8220;anticipates&#8221;, &#8220;targeted&#8221;, &#8220;continues&#8221;, &#8220;forecasts&#8221;, &#8220;designed&#8221;,
&#8220;goal&#8221;, or the negative of those words or other similar or comparable words and includes, among others, information regarding:
our ability to become profitable and generate cash in our operating activities; our need for substantial additional financing to operate
our business and difficulties we may face acquiring additional financing on terms acceptable to us or at all; our significant indebtedness
and significant restrictions on our operations; our ability to construct and operate our planned a magnesium research and development
pilot plant and obtain necessary permits and authorizations to construct and operate the facility; the impact of global climate change
on our ability to conduct future operations.; our lack of a diversified portfolio of assets; our dependence on key inputs, suppliers
and skilled labor for the production of magnesium.; our ability to attract and retain key personnel; growth-related risks, including
capacity constraints and pressure on our internal systems and controls; the adverse consequences of litigation we are currently involved
in and litigation we may face from time to time; risk related to the protection of our intellectual and our exposure to infringement
or misappropriation claims by third parties; risks related to competition; risks related to our lack of internal controls over financial
reporting and their effectiveness; increased costs we are subject to as a result of being a public company in Canada and the United States;
and other events or conditions that may occur in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements may relate to future financial conditions, results of operations, plans, objectives, performance or business developments.
These statements speak only as at the date they are made and are based on information currently available and on the then current expectations
of the party making the statement and assumptions concerning future events, which are subject to a number of known and unknown risks,
uncertainties and other factors that may cause actual results, performance or achievements to be materially different from that which
was expressed or implied by such forward-looking statements, including, but not limited to, risks and uncertainties described in &#8220;Risk
Factors.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should
not be placed on the forward-looking statements, because no assurance can be given that they will prove to be correct. Since forward-looking
statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results
could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to
the risks described in &#8220;Risk Factors.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
all forward-looking statements made in this MD&amp;A and other documents, as applicable, are qualified by such cautionary statements,
and there can be no assurance that the anticipated results or developments will actually be realized or, even if realized, that they
will have the expected consequences to or effects on us. The cautionary statements contained or referred to in this section should be
considered in connection with any subsequent written or oral forward-looking statements that we and/or persons acting on its behalf may
issue. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise, other than as required under securities legislation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview
of the Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production of magnesium at a research and development pilot plant
in metropolitan Vancouver, British Columbia, Canada. We have commenced test production at this facility in the last calendar quarter
of 2021 with full pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete.
Our proprietary technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor
and energy costs while generating minimal waste and toxic by-products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we own a 100% interest in 81 unpatented lode mining claims totaling approximately 1,673 acres (the &#8220;Tami Mosi Mining
Claim&#8221;), four unpatented lode mining claims totaling approximately 10 acres located in the Moor Mining District in Elco County,
Nevada and a 100% interest in three patented mining claims located in the Pinto mining district of Nevada totaling approximately 296
acres (the &#8220;Silverado Mining Claim&#8221;). We do not plan on commencing extraction of minerals at this time from any mining claims
we hold because we have identified alternative sources of supply of dolomite and ferrosilicon, the primary raw materials used to produce
pure magnesium. We may in the future, however, commence extraction of minerals from the Tami Mosi Mining Claim if we are unable to purchase
raw materials from the alternative sources we have identified at commercially reasonable rates. In addition, we do not consider our mining
claims to be material to our business or financial condition. See &#8220;Description of Business &#8211; Properties.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selected
Financial Information</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is selected financial data derived from our consolidated financial statements for the three months ended January 31, 2022 and
2021 and for the years ended October 31, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selected consolidated financial information set out below may not be indicative of our future performance:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years
    Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">January
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">October
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    Expenses</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,045,185</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,108,476</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,705,211</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,714,740</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    Income (Expense)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11,901,344</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14,534</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,844,401</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42,135</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14,946,529</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,123,010</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(23,549,612</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,672,605</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Loss Per Share</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.04</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.07</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    Assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,500,498</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">900,088</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,513,512</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">708,763</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current
    Liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,602,730</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,638,085</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,891,270</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,551,448</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long-Term
    Liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">320,045</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">246,754</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">392,280</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">237,218</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Three
months ended January 31, 2022 Compared to three months ended January 31, 2021</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Total
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
expenses were $3,045,185 for the three months ended January 31, 2022 (&#8220;First Quarter 2022&#8221;), as compared to $2,108,476 for
the three months ended January 31, 2021 (&#8220;First Quarter 2021&#8221;). The increase of $936,709 in operating expenditures was due
primarily to increases in legal and professional fees, interest and accretion and salaries and benefits, partly offset by a decrease
in stock-based compensation. The variance was primarily comprised of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Legal
and professional fees (First Quarter 2022 &#8211; $606,848; First Quarter 2021 &#8211; $23,744; Variance &#8211; $583,104)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred legal and professional fees of $606,848 during the first quarter of Fiscal 2022, as compared to $23,744 during the first
quarter of Fiscal 2021. The increase of $583,104 in legal and professional fees was attributable to litigations discussed elsewhere in
this Quarterly Report on Form 10-Q, the Company&#8217;s registration of its Common Stock with the US Securities and Exchange Commission
and other securities related matters, the setup of the new headquarter and management team in McLean, Virginia close to the Washington
DC metropolitan area, as well as for other general and corporate objectives during the first quarter of Fiscal 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Interest
and accretion (First Quarter 2022 &#8211; $322,280; First Quarter 2021 &#8211; $18,574; Variance &#8211; $303,706)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred interest and accretion of $322,280 during the first quarter of Fiscal 2022, as compared to $18,574 during the first
quarter of Fiscal 2021. On November 1, 2021, the Company&#8217;s functional currency change resulted in the reclassification of the June
2021 Convertible Debenture from a hybrid financial instrument to a convertible debt instrument with a beneficial conversion feature.
The Company allocated the intrinsic value of the beneficial conversion feature of the June 2021 Convertible Debenture capped at the face
value of $1,500,000 to additional paid-in capital, and recognized a debt discount of the same amount to be amortized as interest costs
over the period from issuance date to maturity date using the effective interest method. The increase of $303,706 in interest and accretion
during the first quarter of Fiscal 2022 was attributable to the interest costs of $300,034 from amortizing the debt discount on partial
conversion of the June 2021 Convertible Debenture during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Salaries
and benefits (First Quarter 2022 </span></i><span style="text-decoration: underline">&#8211; <i>$995,542; First Quarter 2021 </i>&#8211; <i>$735,648; Variance </i>&#8211; <i>$259,894)</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred salaries and benefits of $995,542 during the first quarter of Fiscal 2022, as compared to $735,648 during the first
quarter of Fiscal 2021, representing an increase of $259,894. This was due mainly to increased personnel headcount as the Company set
up its new headquarter and management team in McLean, Virginia close to the Washington DC metropolitan area and its continued effort
in the buildout of its research and development pilot plant. As at January 31, 2022, the Company had 30 employees including 12 executives.
While at January 31, 2021, the Company had 23 employees including 7 executives. Certain senior management members&#8217; salaries were
also adjusted to be in line with industry standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Engineering
expenses [First Quarter 2022 </span></i><span style="text-decoration: underline">&#8211; <i>$118,373; First Quarter 2021 </i>&#8211; (<i>$63,612); Variance </i>&#8211; <i>$181,985]</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engineering
expenses were $118,373 for the first quarter of Fiscal 2022 as the Company has completed the initial design and modeling of the magnesium
pilot plant and advanced into the final stage of the buildout of the pilot plant facility. While for the first quarter of Fiscal 2021,
the Company recorded a net recovery of $63,612 in engineering expenses due to a reclassification of certain expenses as capital assets.
This resulted in a variance of $181,985 between the two periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Consultant
and management fees (First Quarter 2022 </span></i><span style="text-decoration: underline">&#8211; <i>$197,927; First Quarter 2021 </i>&#8211; <i>$67,101; Variance </i>&#8211;
<i>$130,826)</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting
and management fees were $197,927 in the first quarter of Fiscal 2022, as compared to $67,101 in the first quarter of Fiscal 2021. The
increase of $130,826 was a result of the Company advancing as a reporting issuer in the US and preparing for listing on other exchanges,
ramping up its operations towards the buildout of its research and development pilot plant facility, and commencing business development
activities in its new headquarter in McLean, Virginia close to the Washington DC metropolitan area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock-based
compensation [First Quarter 2022 &#8211; $131,575; First Quarter 2021 &#8211; $1,048,990; Variance &#8211; ($917,415)]</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
first quarter of Fiscal 2022, the Company recorded stock-based compensation of $131,575 upon the grant of 250,000 stock options to an
employee. While during the first quarter of Fiscal 2021, the Company recorded stock-based compensation of $1,048,990 for the 15,650,000
stock options granted to directors, officers, employees and consultants. This resulted in a non-cash variance of $917,415. The adoption
of our 2021 Equity Incentive Plan which was approved by our shareholders during Fiscal 2021 is intended to promote our long-term financial
interests and growth by attracting and retaining management and other personnel and key service providers with the training, experience
and ability to enable them to make a substantial contribution to the success of our business. Moreover, our 2021 Equity Incentive Plan
aims to align the interests of eligible participants with those of our shareholders through opportunities for increased equity-based
ownership in our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Items</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
other loss was $11,901,344 for the first quarter of Fiscal 2022, as compared to $14,534 for the first quarter of Fiscal 2021. The variance
of $11,886,810 in other items was non-cash and was due to the reclassification of warrants and broker warrants as derivative liability
and the accounting treatment of its convertible debentures resulted from the Company&#8217;s functional currency change. The variance
was comprised of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Change
in fair value of derivative liability [First Quarter 2022 &#8211; ($11,559,791); First Quarter 2021 &#8211; ($14,534); Variance &#8211;
($11,545,257)]</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2021, the Company&#8217;s functional currency change resulted in the reclassification of its outstanding warrants and broker
warrants denominated in the Canadian dollars as derivative liabilities measured at fair value through profit and loss at the end of each
reporting period. For the first quarter of Fiscal 2022, the Company recognized a non-cash loss of $11,765,241 on reclassification and
re-measurement of its derivative liability of warrants and broker warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s functional currency change also resulted in the reclassification of the July 2021 Convertible Debenture from a convertible
debt instrument with a beneficial conversion feature to a hybrid financial instrument comprised of a debt host liability and an embedded
derivative liability. The debt host liability of the convertible note will be amortized at cost, with the embedded derivative liability
measured at fair value through profit and loss at the end of each reporting period. For the first quarter of Fiscal 2022, the Company
recognized a non-cash gain of $205,450 on re-measurement of its July 2021 Convertible Debenture. While for the first quarter of Fiscal
2021, the Company recognized a non-cash loss $14,534 on re-measurement of its July 2020 Convertible Debenture. This resulted in a variance
of $219,984 between the two periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Loss
on recognition of debt host liability [First Quarter 2022 &#8211; ($341,553); First Quarter 2021 &#8211; $Nil; Variance &#8211; ($341,553)]</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2021, the Company&#8217;s functional currency change resulted in the reclassification of the July 2021 Convertible Debenture
from a convertible debt instrument with a beneficial conversion feature to a hybrid financial instrument. The embedded derivative liability
was valued at CA$529,400 (USD equivalent $421,095) which exceeded the face value of the note itself of CA$100,000 (USD equivalent $79,542),
the debt host liability was then assigned a face value of $1, with an immediate loss of CA$429,400 (USD equivalent $341,553) on recognition
of the debt host liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Loss</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, net loss for the three months ended January 31, 2022 and 2021 was $14,946,529 and $2,123,010, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Drivers
of Results of Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Total
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
expenses consist of general and administrative, research and development, stock-based compensation and depreciation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses primarily include salaries and benefits, consulting, management, legal and professional fees, travel expenses,
investor relations, shareholder communications, regulatory fees, facilities and rent, computer system and software, and office and other
general and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses include engineering expenses which are in relation to the design and modeling of the magnesium pilot plant facility
and the magnesium furnace reactor, as well as the commercialization of our technology, and due diligence expenses which pertain to those
incurred in the potential acquisition of a smelter site for magnesium metal production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation on stock options issued to directors, officers and employees is measured at the fair value on the date of grant and expensed
over the vesting period. For stock options issued to consultants, the fair value is periodically re-measured until the counterparty performance
is complete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
includes recognition of depreciation of property, plant and equipment and right-of-use assets over their depreciable lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
Ended October 31, 2021 Compared to Year Ended October 31, 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Total
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
expenses were $17,705,211 for the twelve months ended October 31, 2021 (&#8220;Fiscal 2021&#8221;), as compared to $4,714,740 for the
preceding year ended October 31, 2020 (&#8220;Fiscal 2020&#8221;). The increase of $12,990,471 in operating expenditures was due primarily
to a significant increase in stock-based compensation, a non-cash item, during the current fiscal. The variance was primarily comprised
of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock-based
compensation (2021 &#8211; $11,051,124; 2020 &#8211; $666,259; Variance &#8211; $10,384,865)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
Fiscal 2021, the Company recorded stock-based compensation of $11,051,124 upon the grant of 38,800,000 stock options to directors, officers,
employees and consultants. While during Fiscal 2020, the Company recorded stock-based compensation of $666,259 for the 6,700,000 stock
options granted. This resulted in a non-cash variance of $10,384,865. The adoption of our 2021 Equity Incentive Plan which was approved
by our shareholders during Fiscal 2021 is intended to promote our long-term financial interests and growth by attracting and retaining
management and other personnel and key service providers with the training, experience and ability to enable them to make a substantial
contribution to the success of our business. Moreover, our 2021 Equity Incentive Plan aims to align the interests of eligible participants
with those of our shareholders through opportunities for increased equity-based ownership in our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Salaries
and benefits (2021 </span></i><span style="text-decoration: underline">&#8211; <i>$3,168,008; 2020 </i>&#8211; <i>$1,797,783; Variance </i>&#8211; <i>$1,370,225)</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred salaries and benefits of $3,168,008 during Fiscal 2021, as compared to $1,797,783 during Fiscal 2020, representing an
increase of $1,370,225. This was due mainly to increased personnel headcount as the Company continued to ramp up its operations as it
moves towards the buildout of its research and development pilot plant facility as well as setting up a new corporate office in McLean
in Virginia. As at October 31, 2021, the Company had 19 full-time employees including 6 executives. While at October 31, 2020, the Company
had 10 full-time employees including 7 executives. Certain senior management members&#8217; salaries were also adjusted during Fiscal
2021 to be in line with industry standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Legal
and professional fees (2021 &#8211; $889,175; 2020 &#8211; $138,916; Variance &#8211; $750,259)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred legal and professional fees of $889,175 during Fiscal 2021, as compared to $138,916 during Fiscal 2020. The increase
of $750,259 in legal and professional fees was attributable to litigations discussed elsewhere in this Annual Report, transaction costs
related to the June 2021 Convertible Debenture, and the Company&#8217;s registration of its Common Stock with the Securities and Exchange
Commission, site plant selection purposes and other general and corporate objectives during Fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Consultant
and management fees (2021 </span></i><span style="text-decoration: underline">&#8211; <i>$914,617; 2020 </i>&#8211; <i>$598,574; Variance </i>&#8211; <i>$316,043)</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting
and management fees were $914,617 in Fiscal 2021, as compared to $598,574 in Fiscal 2020. The increase of $316,043 was a result of the
Company ramping up its operations towards the buildout of its research and development pilot plant facility, commencement of business
development activities in its new corporate office in McLean in Virginia, as well as for advancing the Company as a reporting issuer
in the US and preparing for listing on other exchanges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Travel
expenses (2021 &#8211; $409,528; 2020 &#8211; $104,880; Variance &#8211; $304,648)</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel
expenses were $409,528 for Fiscal 2021 and $104,880 for Fiscal 2020, representing an increase of $304,648. As economies began to reopen
and recover from the COVID-19 pandemic, the Company continued to ramp up its operations and travelling activities for financing and site
plant selection purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Engineering
expenses [2020 </span></i><span style="text-decoration: underline">&#8211; <i>$105,706; 2019 </i>&#8211; <i>$569,145; Variance </i>&#8211; <i>($463,439)]</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engineering
expenses were $105,706 for Fiscal 2021 and $569,145 for Fiscal 2020. The decrease of $463,439 was as a result of the Company having completed
the initial design and modeling of the magnesium pilot plant and advancing into the final stage of the buildout of the pilot plant facility
during Fiscal 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Items</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
other loss was $5,844,401 for Fiscal 2021, and total other gain was $42,135 for Fiscal 2020. The variance of $5,886,536 in other items
was due primarily from the accounting treatment of its convertible debentures, partly offset by a gain on the sale of its exploration
and evaluation assets previously written off of $37,156. The variance was primarily comprised of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Change
in fair value of derivative liability [2021 &#8211; ($5,701,270); 2020 &#8211; $4,979; Variance &#8211; ($5,706,249)]</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s July 2020 Convertible Debenture and June 2021 Convertible Debenture were determined to be hybrid financial instruments
comprised of a debt host liability and an embedded derivative liability. The debt host liability of the convertible note will be amortized
at cost, with the embedded derivative liability measured at fair value through profit and loss at the end of each reporting period. For
Fiscal 2021, the Company recognized a non-cash gain of $16,058 and a non-cash loss of $5,717,328 on re-measurement of its July 2020 Convertible
Debenture and June 2021 Convertible Debenture, respectively. This resulted in an aggregate non-cash loss of $5,701,270 for Fiscal 2021,
compared to a non-cash gain of $4,979 on re-measurement of its July 2020 Convertible Debenture in Fiscal 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Loss
on recognition of debt host liability [2021 &#8211; ($140,943); 2020 &#8211; $Nil; Variance &#8211; ($140,943)]</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
issuance date of the June 2021 Convertible Debenture, its embedded derivative liability was valued at $1,646,600 which exceeded the face
value of the note itself of $1,500,000, the debt host liability was then assigned a face value of $1, with an immediate loss of $146,601
on recognition of the debt host liability in Fiscal 2021, in addition to foreign exchange effect of $5,658.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Loss</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, net loss for the twelve months ended October 31, 2021 and 2020 was $23,549,612 and $4,672,605, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Drivers
of Results of Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Total
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
expenses consist of general and administrative, research and development, stock-based compensation and depreciation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses primarily include salaries and benefits, consulting, management, legal and professional fees, travel expenses,
investor relations, shareholder communications, regulatory fees, facilities and rent, computer system and software, and office and other
general and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses include engineering expenses which are in relation to the design and modeling of the magnesium pilot plant facility
and the magnesium furnace reactor, as well as the commercialization of our technology, and due diligence expenses which pertain to those
incurred in the potential acquisition of a smelter site for magnesium metal production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation on stock options issued to directors, officers and employees is measured at the fair value on the date of grant and expensed
over the vesting period. For stock options issued to consultants, the fair value is periodically re-measured until the counterparty performance
is complete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
includes recognition of depreciation of property, plant and equipment and right-of-use assets over their depreciable lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
Capital</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of Working Capital provides additional information and is not defined under GAAP. We define Working Capital as current assets
less current liabilities. This measure should not be considered in isolation or as a substitute for any standardized measure under GAAP.
This information is intended to provide investors with information about our liquidity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
and Capital Resources</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of January 31, 2022 and October 31, 2021, we had total current liabilities of $12,602,730 and $10,891,270, respectively, and current
assets of $1,701,956 and $1,233,954, respectively, to meet our current obligations. As of January 31, 2022, we had working capital deficiency
of $10,900,774, a decrease of working capital of $1,243,458 as compared to October 31, 2021, driven primarily by non-cash items including
the reclassification of warrants and broker warrants as derivative liabilities resulted from the Company&#8217;s functional currency
change, partly offset by a decrease in derivative liabilities due to reclassifications of convertible debentures also resulted from the
Company&#8217;s functional currency change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2021, the Company&#8217;s functional currency change resulted in the reclassification of its outstanding warrants and broker
warrants denominated in the Canadian dollars as derivative liabilities measured at fair value through profit and loss at the end of each
reporting period. As at January 31, 2022, the derivative liability of warrants and broker warrants were valued at $8,246,718 and $41,670,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2021, the Company&#8217;s functional currency change resulted in the reclassification of the June 2021 Convertible Debenture
from a hybrid financial instrument accounted for in accordance with ASU 815-15 to a convertible debt instrument with a beneficial conversion
feature accounted for in accordance with ASU 470-20. The value of the embedded derivative liability of $7,449,700 was reclassified to
additional paid-in capital. The Company&#8217;s functional currency change also resulted in the reclassification of the July 2021 Convertible
Debenture from a convertible debt instrument with a beneficial conversion feature accounted for in accordance with ASU 470-20 to a hybrid
financial instrument accounted for in accordance with ASU 815-15. As at January 31, 2022, the amortized cost of the July 2021 Convertible
Debenture&#8217;s debt host liability was CAD$11,780 (USD equivalent $9,262) and the fair value of the embedded derivative liability
was CAD$269,300 (USD equivalent $211,730), with a combined value of CAD$281,080 (USD equivalent $220,992).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a history of operating losses. We have not yet achieved profitable operations and expect to incur further losses. We have funded
our operations primarily from equity and debt financing. As of January 31, 2022, cash generated from financing activities was not sufficient
to fund operations and, in particular, to fund our growth strategy in the short-term or long-term. As a result, we raised additional
funds from equity and debt financing transactions in 2022, 2021 and 2020 as discussed below under &#8220;Recent Financing Transactions.&#8221;
The primary need for liquidity is to fund working capital requirements of the business, including operational expenses, develop and construct
our planned research and development pilot magnesium production facility and the capital expenditures associated with that project. The
primary source of liquidity has primarily been private financing transactions. The ability to fund operations, to make planned capital
expenditures, to execute on the development and operation of our planned research and development pilot facility, to develop a full-scale
commercial magnesium production facility and to make scheduled debt and rent payments and to repay or refinance indebtedness depends
on our ability to raise funds from debt and/or equity financing which is subject to prevailing economic conditions and financial, business
and other factors, some of which are beyond our control. There can be no assurance that additional financing will be available to us
when needed or, if available, that it can be obtained on commercially reasonable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of January 31, 2022, there have not been any meaningful impact or disruptions to our operations as a result of the COVID-19 pandemic.
We continue to assess the impact of COVID-19 on an ongoing basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
Financing Transactions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2019, we received an unsecured loan of CAD$150,000 (USD equivalent $112,895) from a director and officer.
The loan bore interest at 18% and was due on demand. During the year ended October 31, 2020, the loan was increased by an additional
CAD$60,000 (USD equivalent $44,588), to CAD$210,000 (USD equivalent $157,483) and was due on September 24, 2021. During the fiscal year
ended October 31, 2021, we have made repayments of the entire balance of principal and all interest accrued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 20, 2019, we exercised our right and called all outstanding common share purchase warrants set to expire between May 7, 2020
and May 13, 2021 to expiry on January 19, 2020, and then extended the expiration date to February 19, 2020. Any unexercised warrants
were voided and of no value after February 19, 2020. In all, a total of 40,336,661 warrants were exercised for gross proceeds of CAD$3,050,668
(USD equivalent $2,313,284).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2020, we completed a non-brokered private placement consisting of 3,643,791 units at a price of CAD$0.15 per unit for gross
proceeds of CAD$546,569 (USD equivalent $416,719). Each unit consists of one share of our common stock and one common share purchase
warrant exercisable at a price of CAD$0.21 per share for a period of one year from the date of issuance. Subsequent to October 31, 2020,
we extended the expiration date of the warrants to August 31, 2021. The common share purchase warrants were subject to an expiry acceleration
provision, upon thirty days&#8217; written notice, should the price of our common stock exceed CAD$0.30 for at least ten consecutive
trading days. Finder&#8217;s fees of $41,275 were paid in connection with this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2020, we closed a non-brokered private placement of an unsecured convertible note in the principal amount of CAD$150,000 (USD
equivalent $112,124, the &#8220;July 2020 Convertible Debenture&#8221;). The note bears interest at 12% per annum, and any accrued but
unpaid interest, matures on the date that is one year following the closing date. Each July 2020 Convertible Debenture may be convertible
into our common stock at the prevailing market price and any accrued but unpaid interest thereon will be convertible into our common
stock at a price which is the greater of (i) CAD$0.15 or (ii) the Market Price (as defined in the policies of the TSXV) on the date of
a conversion notice. No finder&#8217;s fees were paid in connection with this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 10, 2020, we announced a non-brokered private placement of up to 53,846,154 units priced at CAD$0.13 per unit (the &#8220;Unit&#8221;)
for an aggregate offering of up to CAD$7,000,000 (USD$ 5,318,600) (the &#8220;September 2020 Private Placement&#8221;). Each Unit is
comprised of one share of our common stock and one common share purchase warrant exercisable at CAD$0.19 per share for a period of one
year from the date of issuance. On November 20, 2020, we closed the first tranche of the September 2020 Private Placement of 5,599,171
Units for gross proceeds of CAD$727,892 (USD equivalent $556,876). On January 15, 2021, we closed the second tranche of the September
2020 Private Placement consisting of 7,337,914 Units for gross proceeds of CAD$953,930 (USD equivalent $749,435). On January 29, 2021,
we closed the third tranche of the September 2020 Private Placement consisting of 5,382,303 Units for gross proceeds of CAD$699,699 (USD
equivalent $547,496). On March 24, 2021, we closed the fourth tranche of this offering and issued 6,554,172 Units for gross proceeds
of CAD$852,042 (USD equivalent $678,270). On April 27, 2021, we closed the fifth and final tranche of this offering and issued 851,395
Units for gross proceeds of CAD$110,681 (USD equivalent $89,237). We closed an aggregate 25,724,955 Units for aggregate gross proceeds
of CAD$3,344,244 (USD equivalent $2,621,314) and incurred aggregate share issue costs of $195,614 in connection to this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 5, 2021, we announced a non-brokered private placement priced at CAD$0.13 per unit (the &#8220;Unit&#8221;) to raise gross proceeds
of up to CAD$3,000,000 (the &#8220;May 2021 Private Placement&#8221;). Each Unit in this offering consists of one share of our common
stock and one common share purchase warrant exercisable at a price of CAD$0.19 per share for a period of one year from the date of issuance.
On May 28, 2021, we closed the first tranche of the May 2021 Private Placement issuing 5,223,420 Units for gross proceeds of CAD$679,044
(USD equivalent $561,844). On June 17, 2021, we closed the second and final tranche of this offering consisting of 17,853,506 Units for
gross proceeds of CAD$2,320,956 (USD equivalent $1,880,687). We closed at the maximum offering and issued an aggregate 23,076,926 Units
for aggregate gross proceeds of CAD$3,000,000 (USD equivalent $2,442,531). We incurred aggregate share issue costs of $154,336 in connection
with this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2021, we issued 1,360,959 shares of common stock on the conversion of the July 2020 Convertible Debenture including conversion
of accrued interest and 263,973 common shares valued at $26,286 in transaction costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 7, 2021, we received final approval from the TSXV for an agreement with Industrial Surplus Supplies Ltd. (&#8220;ISL&#8221;), pursuant
to which ISL will build a prototype internally heated testing lab furnace for the testing of a magnesium production process. We issued
1,538,461 shares of common stock at a price of CAD$0.24 per share with a total fair value of CAD$369,231 (USD equivalent $305,832) for
equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2021, we closed a non-brokered private placement of an unsecured convertible note in the principal amount of $1,500,000 (the
&#8220;June 2021 Convertible Debenture&#8221;). The June 2021 Convertible Debenture bears interest at 12% per annum and matures on December
10, 2022. The principal amount of the June 2021 Convertible Debenture is convertible into 15,000,000 units, where each unit consists
of (i) one share of our common stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable
at a price of $0.13 until June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being
exercisable at a price of $0.19 until June 10, 2026 (collectively, the &#8220;Class A and B Warrants&#8221;). In addition, the conversion
price for accrued interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSXV at the time of conversion
(should our common stock then be listed on such exchange).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the June 10, 2021 Securities Purchase Agreement we entered into as part of the offering of the June 2021 Convertible Debenture
(the &#8220;Securities Purchase Agreement&#8221;), we agreed to use commercially reasonable efforts to file a registration statement
with the Securities and Exchange Commission by August 14, 2021, covering the public resale of the shares of common stock underlying such
debenture and, upon its conversion, the Class A and Class B Warrants issuable upon such conversion (the &#8220;Underlying Shares&#8221;),
and to use our best efforts to cause the registration statement to be declared effective on October 13, 2021. In addition, we agreed
to provide the holder to the June 2021 Convertible Debenture certain piggy-back registration rights if we do not have an effective registration
statement covering the Underlying Shares and we propose to file any registration statement under the Securities Act with respect to our
common stock. We will pay all costs associated with the registration statements, other than underwriting commissions and discounts. On
December 13, 2021, our Form 10 Registration Statement filed with the SEC was declared effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to certain covenants contained in the Securities Purchase Agreement, the terms of the June 2021 Convertible Debenture contain
certain negative covenants by us, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    than certain permitted indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed
    money of any kind, including, but not limited to, a guarantee, on or with respect to any of our property or assets now owned or hereafter
    acquired or any interest therein or any income or profits therefrom;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    than certain permitted liens, enter into, create, incur, assume or suffer to exist any liens of any kind, on or with respect to any
    of our property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend
    our charter documents, including, without limitation, our certificate of incorporation and bylaws, in any manner that materially
    adversely affects any rights of the Convertible Debenture Holder (notwithstanding the foregoing, we are entitled to proceed with
    the amendments to the charter documents as set out in our proxy materials for our shareholder meeting to be held in 2021);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">repay,
    repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of our common stock or common
    stock equivalents other than as to the Underlying Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">redeem,
    defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether
    by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any of our indebtedness
    (other than the Convertible Debentures if on a pro-rata basis), whether by way of payment in respect of principal of (or premium,
    if any) or interest on, such indebtedness, in any case unless such indebtedness or interest is due and payable in accordance with
    the initial terms of such debt prior to any default thereunder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">declare
    or make any dividend or other distribution of our assets or rights to acquire our assets to holders of shares of our common stock,
    preferred stock, or any other equity security by way of return of capital or otherwise including, without limitation, any distribution
    of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
    scheme of arrangement or other similar transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sell
    or offer to sell any securities with non-fixed or floating price features, issue any common stock or common stock equivalents at
    a price lower than the conversion price herein then in effect, or issue any equity or debt instruments with anti-dilution provisions;
    or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
    into any agreement with respect to any of the foregoing.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event we issue or sell any common stock or common stock equivalents with terms that the purchaser then holding outstanding June 2021
Convertible Debenture (the &#8220;Convertible Debenture Holder&#8221;) or the Class A and B Warrants reasonably believes are more favorable
to such holder than are the terms of the June 2021 Convertible Debenture or the Class A and B Warrants (the &#8220;MFN Securities&#8221;),
then upon notice to us by such holder within five trading days after notice to such holder by us, we will use commercially reasonable
efforts to obtain the approval of the TSXV and any additional required regulatory approval to amend the terms of the June 2021 Convertible
Debenture or the Class A and B Warrants as required, as the case may be, so as to give such holder the benefit of such more favorable
terms or conditions. If we fail to obtain such regulatory approvals and the approval of the TSXV, then absent such approval we are forbidden
to issue the MFN Securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion price of the June 2021 Convertible Debenture is subject to proportional adjustment in the event of stock splits, stock dividends
and similar corporate events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if, at any time while the June 2021 Convertible Debenture is outstanding, we, directly or indirectly, effect any merger or
consolidation of our company with or into another person or engage in a &#8220;Fundamental Transaction&#8221; as defined in the June
2021 Convertible Debenture, the Convertible Debenture Holder shall have the right to receive, for each Conversion Share that would have
been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, the number of shares of our common
stock of the successor or acquiring corporation or us, if we are the surviving corporation, and any additional consideration (the &#8220;Alternate
Consideration&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of our common stock
for which the June 2021 Convertible Debenture is convertible immediately prior to such Fundamental Transaction. In addition, the Conversion
Price will be subject to certain adjustments so that the economic value of such shares and such conversion price are protected and which
is reasonably satisfactory in form and substance to the Convertible Debenture Holder. Alternatively, the Convertible Debenture Holder
may demand that we redeem the June 2021 Convertible Debenture at a rate equal to 125% of the principal and interest due thereon, to be
paid in full contemporaneously with consummation of the Fundamental Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
granted the investor certain rights of first refusal on our future offerings for so long as the June 2021 Convertible Debenture or the
Class A and B Warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may prepay and satisfy the June 2021 Convertible Debenture so long as an event of default has not occurred, upon 20 days&#8217; prior
written notice received by us to the holder, by paying 125% of the amounts owed on the June 2021 Convertible Debenture, including all
principal, interest and other fees. The holder of this debenture may, however, convert all or a portion of the debenture during the 20
day notice period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
June 2021 Convertible Debenture is not exercisable if the number of shares to be issued to the holder upon such exercise, together with
all other shares then owned by the holder and our affiliates, would result in the holder beneficially owning more than 9.99% of our outstanding
common stock. The holder may increase or decrease this ownership limitation to any percentage not exceeding 9.99% upon 61 days prior
written notice to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Class
A and Class B Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
conversion of the June 2021 Convertible Debenture, we will issue the Class A and B Warrants. The holders may exercise the Class A and
B Warrants on a cashless basis at any time that there is not an effective registration statement covering the underlying shares of common
stock and the volume weighted average price of our common stock is greater than the exercise price at the time of exercise. The Class
A and Class B Warrants are not exercisable, however, if the number of shares to be issued to the holder upon such exercise, together
with all other shares then owned by the holder and our affiliates, would result in the holder beneficially owning more than 9.99% of
our outstanding common stock. The holder may increase or decrease this ownership limitation to any percentage not exceeding 9.99% upon
61 days prior written notice to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price of the Class A and Class B Warrants is subject to proportional adjustment in the event of stock splits, recapitalizations
and similar corporate events. In addition, the exercise price are each subject to adjustment if we issue or sell shares of our common
stock for a consideration per share less than the exercise price then in effect, or issue options, warrants or other securities convertible
or exchange for shares of our common stock at an exercise price less than the exercise price then in effect. If any of these events should
occur, the exercise price each will be reduced to the lowest price at which these securities were issued or are exercisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if, at any time while the Class A and Class B Warrants are outstanding, we engage in a Fundamental Transaction, the exercise
price thereof is subject to adjustment similar to the adjustment as provided for in the June 2021 Convertible Debenture. In addition,
we may not enter into a Fundamental Transaction unless the holders of our common stock receive securities of an entity that is listed
on a stock exchange in Canada or the United States, or cash, equal to the Black Scholes value of the remaining unexercised portion of
the Class A and Class B Warrants on the date of the consummation of such Fundamental Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 15, 2021, we closed a non-brokered private placement of an unsecured convertible note in the principal amount of CAD$100,000 (USD
equivalent $79,542, the &#8220;July 2021 Convertible Debenture&#8221;). The note bears interest at 12% per annum and is due on the date
that is one year following the closing date. The note is convertible into common shares of the Company at the price of CAD$0.12 per share
and will have warrants exercisable for a price of CAD$0.20 for a period of two years. Any accrued but unpaid interest will be payable
on the earlier of the maturity date and the date of conversion in cash or common shares. No finder&#8217;s fees were paid in connection
with this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 16, 2021, we closed a non-brokered private placement and issued 4,350,000 units at a price of CAD$0.20 per unit (the &#8220;Unit&#8221;)
for gross proceeds of CAD$870,000 (USD equivalent $690,860, the &#8220;July 2021 Private Placement&#8221;). Each Unit in this offering
consists of one share of our common stock and one common share purchase warrant exercisable at a price of CAD$0.30 per share for a period
of one year from the date of issuance. We incurred aggregate share issue costs of $48,319 in connection with this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 11, 2021, we closed a non-brokered private placement and issued 3,827,601 units at a price of CAD$0.55 (USD$0.44) per unit (the
&#8220;Unit&#8221;) for gross proceeds of CAD$2,105,180 (USD equivalent $1,683,336, the &#8220;August 2021 Private Placement&#8221;).
Each Unit in this offering consists of one share of our common stock and one common share purchase warrant exercisable at a price of
CAD$0.65 (USD$0.52) per share for a period of eighteen months from the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2021, upon the exercise of common share purchase warrants we issued an aggregate 1,964,901 common shares
at a price of CAD$0.05 per share for gross proceeds of CAD$98,245 (USD equivalent $77,896), an aggregate 1,931,450 common shares at a
price of CAD$0.19 per share for gross proceeds of CAD$366,976 (USD equivalent $292,890), and an aggregate 3,118,618 common shares at
a price of CAD$0.21 per share for gross proceeds of CAD$654,910 (USD equivalent $516,735). Upon exercise, CAD$5,333 (USD equivalent $4,291)
previously recorded in equity reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2021, upon the exercise of options we issued an aggregate 2,000,000 common shares at a price of CAD$0.05
per share for gross proceeds of CAD$100,000 (USD equivalent $80,058), an aggregate 200,000 common shares at a price of CAD$0.11 per share
for gross proceeds of CAD$22,000 (USD equivalent $17,456), an aggregate 300,000 common shares at a price of CAD$0.12 per share for gross
proceeds of CAD$36,000 (USD equivalent $29,096), an aggregate 100,000 common shares at a price of CAD$0.13 per share for gross proceeds
of CAD$13,000 (USD equivalent $10,315), and an aggregate 30,000 common shares at a price of CAD$0.16 per share for gross proceeds of
CAD$4,800 (USD equivalent $3,809). Upon exercise, CAD$152,218 (USD equivalent $121,932) previously recorded in equity reserves was reclassified
to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by Sam Ataya,
a director and officer of our Company, is eligible to receive up to 5% of the issued and outstanding common shares of the Company as
at August 28, 2018 for up to $5 million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3,
2021, the Company issued 9,163,425 common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614)
as share issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2021, in connection with a conversion of $100,000 principal amount due under the June 2021 Convertible Debenture, the Company
issued a private investor a total of 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10,
2026, and 500,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 26, 2021, in connection with a non-brokered private placement, 1,375,499 units were issued to private investors at a price of
$0.55 per share for gross proceeds of $756,524. Each unit consists of one common share and one common share purchase warrant exercisable
into one common share at a price of $0.75 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 13, 2021, in connection with a conversion of $100,000 principal amount due under the June 2021 Convertible Debenture, the Company
issued to a private investor 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and
500,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 20, 2022, in connection with a conversion of $100,000 principal amount due under the June 2021 Convertible Debenture, the Company
issued to a private investor a 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026,
and 500,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended January 31, 2022, upon the exercise of common share purchase warrants the Company issued to private investors
an aggregate 15,159,448 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$2,880,295 (USD equivalent $2,279,136),
200,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$10,000 (USD equivalent $7,830), and 30,000 common shares
at a price of CAD$0.30 per share for gross proceeds of CAD$9,000 (USD equivalent $6,981). A total of 2,428,363 warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 10, 2022, in connection with a partial conversion of the June 2021 Convertible Debenture, the Company issued 1,000,000 units to
a private investor for a total of 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026,
and 500,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 14, 2022, we entered into and closed on the transaction set forth in the Securities Purchase Agreement (the &#8220;Securities Purchase
Agreement&#8221;) entered into with an investor (the &#8220;Purchaser&#8221;) for the sale of our convertible debenture in the principal
amount of $2,000,000 (the &#8220;April 2022 Convertible Debenture&#8221;) for a subscription amount of $2,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2022 Convertible Debenture bears interest at the rate of 15% per annum, matures on October 14, 2023 and is convertible (principal,
and interest upon receipt of TSXV approval) at any time after the issuance date and, upon receipt of TSX Venture Exchange approval,
into shares of our Common Stock at a conversion price equal to the greater of (i) $0.30 per share and (ii) the minimum conversion price
permitted by the TSX Venture Exchange at the time of conversion (should our Common Stock then be listed on such exchange), subject to
adjustment as provided therein (the &#8220;Conversion Price&#8221;). In addition, upon each conversion of the April 2022 Convertible
Debenture, the holder is entitled to receive a Warrant (the &#8220;2022 Warrants&#8221;) to purchase a number of shares of Common Stock
equal to 100% of the conversion shares being issued on such conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
event of default under the April 2022 Convertible Debenture, the interest rate will increase to the lesser of 20% per annum or the maximum
rate permitted under applicable law until paid and the following &#8220;Mandatory Default Amount&#8221; shall be paid by us, if demanded
by the Purchaser: the sum of (a) the greater of (i) the outstanding principal amount of the April 2022 Convertible Debenture divided
by the Conversion Price on the date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an
event of default) or otherwise due or (B) paid in full, whichever has a lower Conversion Price, multiplied by the VWAP on the date the
Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 125% of the outstanding
principal amount of the April 2022 Convertible Debenture plus (b) all other amounts, costs, expenses and liquidated damages due in respect
of the April 2022 Convertible Debenture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to certain covenants contained in the Securities Purchase Agreement, the terms of the April 2022 Convertible Debenture contain
certain negative covenants by us, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    than certain permitted indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed
    money of any kind, including, but not limited to, a guarantee, on or with respect to any of our property or assets now owned or hereafter
    acquired or any interest therein or any income or profits therefrom;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    than certain permitted liens, enter into, create, incur, assume or suffer to exist any liens of any kind, on or with respect to any
    of our property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amend
    our charter documents, including, without limitation, our certificate of incorporation and bylaws, in any manner that materially
    adversely affects any rights of the April 2022 Convertible Debenture Holder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">repay,
    repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of our Common Stock or common
    stock equivalents other than as to the Underlying Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">redeem,
    defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether
    by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any of our indebtedness
    (other than the April 2022 Convertible Debentures if on a pro-rata basis), whether by way of payment in respect of principal of (or
    premium, if any) or interest on, such indebtedness, in any case unless such indebtedness or interest is due and payable in accordance
    with the initial terms of such debt prior to any default thereunder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">declare
    or make any dividend or other distribution of our assets or rights to acquire our assets to holders of shares of our Common Stock,
    preferred stock, or any other equity security by way of return of capital or otherwise including, without limitation, any distribution
    of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
    scheme of arrangement or other similar transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sell
    or offer to sell any securities with non-fixed or floating price features, issue any Common Stock or common stock equivalents at
    a price lower than the conversion price herein then in effect, or issue any equity or debt instruments with anti-dilution provisions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delist
    from any exchange or market the Common Stock is traded upon at the time the April 2022 Convertible Debenture was issued (except or
    unless the Common Stock subsequently becomes traded on NASDAQ, in which case the common stock may be delisted from the TSX Venture
    Exchange); or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
    into any agreement with respect to any of the foregoing.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the date hereof until such time as the April 2022 Convertible Debenture or 2022 Warrants are no longer outstanding, we will not, without
either (i) the consent of the Purchasers, or (ii) (A) having prepaid the April 2022 Convertible Debenture pursuant to the terms thereof,
or (B) having first lowered the Conversion Price of the April 2022 Convertible Debenture to such lower price with having obtained the
necessary regulatory approval, issue any common stock or common stock equivalents with a conversion or exercise price lower than the
Conversion Price and exercise price then in effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event we issue or sell any common stock or common stock equivalents with terms that the purchaser then holding outstanding April
2022 Convertible Debenture (the &#8220;April 2022 Convertible Debenture Holder&#8221;) or the 2022 Warrants reasonably believes are more
favorable to such holder than are the terms of the April 2022 Convertible Debenture or the 2022 Warrants (the &#8220;MFN Securities&#8221;),
then upon notice to us by such holder within five trading days after notice to such holder by us, we will use commercially reasonable
efforts to obtain the approval of the TSX Venture Exchange and any additional required regulatory approval to amend the terms of the
April 2022 Convertible Debenture or the 2022 Warrants as required, as the case may be, so as to give such holder the benefit of such
more favorable terms or conditions. If we fail to obtain such regulatory approvals and the approval of the TSX Venture Exchange, then
absent such approval by us, is forbidden to issue the MFN Securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion price of the April 2022 Convertible Debenture is subject to proportional adjustment in the event of stock splits, stock dividends
and similar corporate events. In addition, if, at any time while the April 2022 Convertible Debenture is outstanding, the Company, directly
or indirectly, effect any merger or consolidation of the Company with or into another person or engage in a &#8220;Fundamental Transaction&#8221;
as defined in the April 2022 Convertible Debenture, the April 2022 Convertible Debenture Holder shall have the right to receive, for
each conversion share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction,
the number of shares of our common stock of the successor or acquiring corporation or us, if the Company is the surviving corporation,
and any additional consideration (the &#8220;Alternate Consideration&#8221;) receivable as a result of such Fundamental Transaction by
a holder of the number of shares of our common stock for which the April 2022 Convertible Debenture is convertible immediately prior
to such Fundamental Transaction. In addition, the Conversion Price will be subject to certain adjustments so that the economic value
of such shares and such conversion price are protected and which is reasonably satisfactory in form and substance to the April 2022 Convertible
Debenture Holder. Alternatively, the April 2022 Convertible Debenture Holder may demand that we redeem the April 2022 Convertible Debenture
at a rate equal to 125% of the principal and interest due thereon, to be paid in full contemporaneously with consummation of the Fundamental
Transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company granted the investors certain rights of first refusal on our future offerings for so long as the April 2022 Convertible Debenture
or the 2022 Warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2022 Convertible Debenture is not exercisable if the number of shares to be issued to the holder upon such exercise, together with
all other shares then owned by the holder and our affiliates, would result in the holder beneficially owning more than 9.99% of our outstanding
common stock. The holder may increase or decrease this ownership limitation to any percentage not exceeding 9.99% upon 61 days prior
written notice to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">2022
Warrants</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
each conversion of the April 2022 Convertible Debenture, the Company will issue to the holder of the April 2022 Convertible Debenture,
a Warrant to purchase a number of shares of our common stock equal to 100% of the conversion shares being issued on such conversion at
a per share exercise price of $0.40, subject to adjustment as provided for in the 2022 Warrants and discussed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders may exercise the 2022 Warrants on a cashless basis at any time that there is not an effective registration statement covering
the underlying shares of common stock and the volume weighted average price of our common stock is greater than the exercise price at
the time of exercise. The 2022 Warrants are not exercisable, however, if the number of shares to be issued to the holder upon such exercise,
together with all other shares then owned by the holder and our affiliates, would result in the holder beneficially owning more than
9.99% of our outstanding common stock. The holder may increase or decrease this ownership limitation to any percentage not exceeding
9.99% upon 61 days prior written notice to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price of the 2022 Warrants is subject to proportional adjustment in the event of stock splits, recapitalizations and similar
corporate events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Registration
Rights Agreement</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Registration Rights Agreement the Company entered into in connection with the Securities Purchase Agreement, the Company
agreed to file a registration statement with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) by May 14, 2022, covering
the public resale of the shares of common stock underlying the April 2022 Convertible Debenture, the convertible debentures issued to
the investor pursuant to a Securities Purchase Agreement dated June 10, 2021 (the &#8220;June 2021 Convertible Debenture&#8221;), upon
their conversion, the 2022 Warrants issuable upon conversion of the April 2022 Convertible Debenture and the warrants issued upon conversion
of the June 2021 Convertible Debenture (the &#8220;Underlying Shares&#8221;), all to the extent permissible under SEC rules, and to use
our best efforts to cause the registration statement to be declared effective on June 28, 2022 if the SEC does not review the registration
statement or by August 12, 2022 if the SEC reviews the registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company fails to file the registration statement or such registration statement is not declared effective within the time
periods noted above or such registration statement is not kept effective, the Company will be obligated to pay the holder of the debentures
a penalty in cash, in the amount of $20,000 on the date of such failure and on the 30<sup>th</sup> day of each month following such failure.
In addition, the Company has agreed to pay all expenses of the registration, other than underwriting commissions and discounts, and to
indemnify the holder of the securities to be registered against any claim that may arise under the Securities Act of 1933, as amended,
(the &#8220;Securities Act&#8221;) in connection with the filing of the registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 22, 2022, in connection with a conversion of CAD$100,000 principal amount and CAD$12,000 accrued interest due under the July 2021
Convertible Debenture, the Company issued to a private investor 933,333 common shares and 933,333 common share purchase warrants exercisable
at a price of CAD$0.20 for a period of two years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 27, 2022, in connection with a conversion of $200,000 principal amount due under the June 2021 Convertible Debenture, the Company
issued to a private investor 2,000,000 common shares, 1,000,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026,
and 1,000,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended April 30, 2022, upon the exercise of common share purchase warrants the Company issued to private investors an
aggregate 6,198,713 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$1,177,755 (USD equivalent $823,505), 2,082,025
common shares at a price of CAD$0.05 per share for gross proceeds of CAD$104,101 (USD equivalent $81,591), and 30,960 common shares at
a price of CAD$0.30 per share for gross proceeds of CAD$9,288 (USD equivalent $7,360). A total of 3,191,933 warrants and 40,000 broker
warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended April 30, 2022, upon the exercise of options we issued an aggregate 750,000 common shares at a price of CAD$0.05
per share for gross proceeds of CAD$37,500 (USD equivalent $29,715).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 9, 2022, in connection with a non-brokered private placement, 1,727,000 units were issued to private investors at a price of $0.25
per share for gross proceeds of $431,750. Each unit consists of one common share and one common share purchase warrant exercisable into
one common share at a price of $0.45 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Options: NewSection; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 9, 2022, upon the exercise of common share purchase warrants the Company issued to private investors an aggregate 242,700 common
shares at a price of CAD$0.19 per share for gross proceeds of CAD46,113 (USD equivalent $35,635) and 800,000 common shares at a price
of CAD$0.05 per share for gross proceeds of CAD$40,000 (USD equivalent $31,196). A total of 13,725 broker warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 11, 2022, upon the exercise of common share purchase warrants the Company issued to private investors an aggregate 290,110 common
shares at a price of CAD$0.19 per share for gross proceeds of CAD55,121 (USD equivalent $42,770).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
Flows</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Used in Operating Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities for the three months ended January 31, 2022 and January 31, 2021, and for the years ended October 31,
2021 and 2020, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years
    Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">January
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">October
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Cash Used in Operating Activities</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,798,902</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(990,364</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,367,567</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,270,534</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Flow from Investing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities for the three months ended January 31, 2022 and January 31, 2021, and for the years ended October 31,
2021 and 2020, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years
    Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">January
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">October
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Cash Provided by (Used in) Investing Activities</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(687,385</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(167,559</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,066,566</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,985</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Flow from Financing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in financing activities for the three months ended January 31, 2022 and January 31, 2021, and for the years ended October 31,
2021 and 2020, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years
    Ended</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">January
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">October
    31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    Cash Provided by Financing Activities</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,804,287</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,180,422</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,850,435</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,257,823</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Off-Balance
Sheet Arrangements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, we do not have any off-balance-sheet arrangements that have, or are reasonably likely to have, a current
or future effect on our results of operations or financial condition, including, and without limitation, such considerations as liquidity
and capital resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual
Obligations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of January 31, 2022, we have the following obligations to make future payments, representing contracts and other commitments that are
known and committed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="18" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Payments
    Due by Period</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Less
    than 1 Year</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
                                            &#8211; 3</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
                                            &#8211; 5</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">More
    than 5 Years</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease
    obligations &#8211; premises</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">732,391</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">319,987</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">372,861</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,543</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease
    obligations &#8211; machines</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31,699</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,742</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,765</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,192</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Debt
    and interest obligations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,521,350</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,521,350</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,293,310</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,867,949</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">383,626</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,735</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Real
Estate Option Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of August 4, 2021, we entered into a Real Estate Option Agreement (the &#8220;Option&#8221;) with Harrison County Community Improvement
Corporation, an unrelated party (the &#8220;Seller&#8221;), to purchase a parcel of land comprising approximately 122 acres in the Village
of Cadiz, Harrison County, Ohio (the &#8220;Property&#8221;). We are entitled to exercise the Option at any time up until its expiration
on August 3, 2023. The Option contains covenants, representations and warranties that are customary of real estate purchase and sale
agreements including, but not limited to, completion of title work and a survey of the Property, an environmental audit, an engineering
feasibility study of the Property, availability of certain utilities, obtaining permits, approval of the Option by our Board of Directors,
our exercise of the Option and obtaining certain state and local economic incentives and tax abatements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
with Related Parties</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deposits
held by related parties</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included
in our current assets are the following amounts due from related parties:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January
                                            31, 2022</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October
                                            31, 2021</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October
                                            31, 2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deposits
    held by a director and officer</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">524,881</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">291,481</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deposits
    held by an officer</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,860</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">194,981</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deposits
    held by related parties</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">565,741</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">486,462</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Due
to related parties</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included
in our current liabilities are the following amounts due to related parties:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January
                                            31, 2022</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October
                                            31, 2021</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October
                                            31, 2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Wages
    payable to directors and officers</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">357,500</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">357,500</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">161,922</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Benefits
    payable to directors and officers</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">581,854</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">539,209</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fees
    and expenses payable to related parties</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">151,261</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">127,878</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">682,068</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interests
    due to a director and officer</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,171</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,230</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    due to related parties</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,092,786</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,026,817</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">843,990</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Leases</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into a sublease agreement with a company controlled by Sam Ataya, a director and officer of our Company, for our Canadian
office at 580 Hornby Street, Suite 900, Vancouver, British Columbia, Canada, V6C 3B6. The lease had a two-year term from April 1, 2021
to March 31, 2023 and required a monthly payment of CAD$9,794 for a total of CAD$235,056.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Scope
of Work Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an agreement entered on August 29, 2018 and which was approved by the TSXV on September 12, 2018, a company controlled by Sam Ataya,
a director and officer of our Company, is eligible to receive up to 5% of the issued and outstanding common shares of the Company as
at August 28, 2018 for up to $5 million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3,
2021, the Company issued 9,163,425 common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614)
as share issue costs.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in or Adoption of Accounting Practices</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following GAAP standards have been recently issued by the accounting standards board. We are assessing the impact of these new standards
on future consolidated financial statements. We have elected to take advantage of the extended transition period allowed for emerging
growth companies for complying with new or revised accounting guidance as allowed by Section 107 of the JOBS Act and Section 7(a)(2)(B)
of the Securities Act. Pronouncements that are not applicable or where it has been determined do not have a significant impact on us
have been excluded herein.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02,
                                            Leases (Topic 842) (&#8220;ASU 2016-02&#8221;), which amended the FASB Accounting Standards
                                            Codification (&#8220;ASC&#8221;) by creating ASC 842 to replace ASC 840. ASU 2016-02 requires
                                            lessees to recognize a right-of-use asset and a lease liability on the balance sheet for
                                            substantially all leases. Leases are classified as either finance or operating, with classification
                                            affecting the pattern of expense recognition in the statement of income. In July 2018, the
                                            FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements (&#8220;ASU 2018-11&#8221;)
                                            to provide entities with relief from the costs of implementing certain aspects of the new
                                            leasing standard. In March 2019, the FASB issued ASU 2019-01, Leases (Topic 842): Codification
                                            Improvements (&#8220;ASU 2019-01&#8221;), which clarifies certain items regarding lessor
                                            accounting. It also clarifies the interim disclosure requirements during transition. These
                                            updates are effective for fiscal years beginning after December 15, 2018, and interim periods
                                            within those fiscal years, with early adoption permitted.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    November 1, 2019, the Company adopted ASC 842 retrospectively using the modified retrospective approach with no restatement of prior
    year amounts. Reclassifications and the adjustments arising from the new leasing rules are therefore recognized in the opening balance
    sheet on November 1, 2019. In the context of initial application, we used the following assumptions to evaluate the lease population:</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercised
    the option not to apply the new recognition requirements to short-term leases and to leases of low-value assets; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">made
    the election to not separate non-lease components from lease components and instead account for each lease component and any associated
    non-lease components as a single lease component.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
    842 applies to leases for the year ended October 31, 2020. Upon adoption, we recognized right-of-use assets and lease liabilities
    in relation to leases which had previously been classified as &#8216;operating leases&#8217; under the principles of ASC 840. These
    assets and liabilities were measured at the present value of the remaining lease payments, discounted using the lessee&#8217;s incremental
    borrowing rate as of November 1, 2019. The weighted-average incremental borrowing rate for lease liabilities initially recognized
    as of November 1, 2019 was 7%.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    were no onerous lease contracts that would have required an adjustment to the right-of-use assets at the date of initial application.
    In applying ASC 842 for the first time, we applied the following practical expedients permitted by the standard:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#9679;</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">use
    of a single discount rate to a portfolio of leases with reasonably similar characteristics;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#9679;</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reliance
    on previous assessments of whether leases are onerous immediately before the date of initial application;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#9679;</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">application
    of the short-term leases exemption to leases with a remaining lease term of less than 12 months as at the date of initial application;
    and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#9679;</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exclusion
    of initial direct costs from the measurement of the right-of-use asset at the date of initial application.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    elected not to reassess whether a contract is or contains a lease at the date of initial application. Instead, for contracts entered
    into before the transition date, the previous determinations pursuant to ASC 840 of whether a contract is a lease have been maintained.
    Additionally, we elected to not apply hindsight in determining a lease term of the ROU assets at the adoption date. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Based
on the foregoing, the impact of the change in accounting policy on November 1, 2019 is summarized below:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#9679;</i></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    recognized right-of-use assets of $83,549, and a lease liability of $83,549.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(ii)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on
    Financial Instruments (&#8220;ASU 2016-13&#8221;). ASU 2016-13 requires the measurement of current expected credit losses for financial
    assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Adoption
    of ASU 2016-13 will require financial institutions and other organizations to use forward-looking information to better formulate
    their credit loss estimates. In addition, the ASU amends the accounting for credit losses on available for sale debt securities and
    purchased financial assets with credit deterioration. In May 2019, the FASB issued ASU 2019-05, Financial Instruments &#8211; Credit
    Losses (Topic 326): <i>Targeted Transition Relief</i> (&#8220;ASU 2019-05&#8221;)<i>, </i>which provides transition relief to entities
    adopting ASU 2016-13. As smaller reporting companies as defined by the SEC, these updates are effective for fiscal years beginning
    after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. We are currently evaluating
    the effect of adoption of these updates on our financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 51; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(iii)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            January 2017, the FASB issued ASU 2017-04, Intangibles &#8211; Goodwill and Other (Topic
                                            350): Simplifying the Test for Goodwill Impairment&#8221; (&#8220;ASU 2017-04&#8221;), which
                                            simplifies the accounting for goodwill impairment. ASU 2017-04 requires entities to record
                                            an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over
                                            its fair value (Step 1 under the current impairment test). The standard eliminates Step 2
                                            from the current goodwill impairment test, which included determining the implied fair value
                                            of goodwill and comparing it with the carrying amount of that goodwill. As smaller reporting
                                            companies as defined by the SEC, ASU 2017-04 is effective for fiscal years beginning after
                                            December 15, 2022, and interim periods within those fiscal years, with early adoption permitted.
                                            We are currently evaluating the effect of adopting this ASU on our financial statements.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(iv)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            June 2018, the FASB issued ASU 2018-07, Compensation &#8211; Stock Compensation (Topic 718):
                                            Improvements to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-07), which aligns
                                            the measurement and classification guidance for share-based payments to nonemployees with
                                            that for employees, with certain exceptions. ASU 2018-07 expands the scope of Topic 718 to
                                            include share-based payments granted to non-employees in exchange for goods or services used
                                            or consumed in the entity&#8217;s own operations and supersedes the guidance in Subtopic
                                            505-50, Equity &#8211; Equity-Based Payments to Nonemployees. ASU 2018-07 retains the existing
                                            cost attribution guidance, which requires entities to recognize compensation cost for nonemployee
                                            awards in the same period and in the same manner (i.e. capitalize or expense) they would
                                            if they paid cash for the goods or services, but it moves the guidance to Topic 718. ASU
                                            2018-07 is effective for fiscal years beginning after December 15, 2018, and interim periods
                                            within those fiscal years, with early adoption permitted. Effective November 1, 2019, the
                                            Company adopted the new standard. There were no material impact or adjustment to its financial
                                            statements.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(v)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure
                                            Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement (&#8220;ASU
                                            2018-13&#8221;). ASU 2018-13 adds, modifies, and removes certain fair value measurement disclosure
                                            requirements. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019,
                                            and interim periods within those fiscal years, with early adoption permitted. Effective November
                                            1, 2020, the Company adopted the new standard. There were no material impact or adjustment
                                            to its financial statements.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(vi)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting
                                            for Income Taxes (&#8220;ASU 2019-12&#8221;), which is intended to simplify various aspects
                                            related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general
                                            principles in Topic 740 and also clarifies and amends existing guidance to improve consistent
                                            application. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020,
                                            and interim periods within those fiscal years, with early adoption permitted. Effective November
                                            1, 2021, the Company adopted the new standard. There was no material impact or adjustment
                                            to its financial statements.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(vii)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    January 2020, the FASB issued ASU 2020-01, Investments &#8211; Equity Securities (Topic 321), Investments &#8211; Equity Method and
    Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#8220;ASU 2020-01&#8221;), which is intended to clarify the
    interactions of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting
    in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is
    effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption
    permitted. Effective November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to its financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(viii)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    August 2020, the FASB issued ASU 2020-06, Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and
    Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;). ASU 2020-06 eliminates the
    beneficial conversion and cash conversion accounting models for convertible instruments and supersedes the respective guidance within
    ASC 470-20 and ASC 740-10-55-51, which will result in more instruments to be accounted for as a single instrument rather than having
    their proceeds allocated between liability and equity accounting units. As smaller reporting companies as defined by the United States
    Securities and Exchange Commission (the &#8220;SEC&#8221;), ASU 2020-06 is effective for fiscal years beginning after December 15,
    2023, and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect
    of adopting these updates on its financial statements.</span></td></tr>
  </table>
<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRITICAL
ACCOUNTING ESTIMATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of our consolidated financial statements requires management to make judgments, estimates and assumptions about the carrying
amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based
on historical experience and other factors that are considered relevant. Actual results may differ from these estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period
in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods, if the
revision affects both current and future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
judgments, estimates and assumptions that have the most significant effect on the amounts recognized in the financial statements are
described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Functional
Currency</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of each entity of the Company is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Functional
    Currency</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Corporation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States dollars</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Corp.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States dollars</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Canada Corporation</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian
    dollars (&#8220;CA$&#8221;)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended January 31, 2022, significant changes in economic facts and circumstances have occurred in our operations which
resulted in the change of its functional currency to the United States dollars from the Canadian dollars effective November 1, 2021.
For both monetary and non-monetary assets and liabilities, translated balances at the end of the prior period become the new accounting
basis. The rate on the date of change becomes the historical rate at which non-monetary assets and liabilities are translated in subsequent
years. There is no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded cumulative translation
adjustments are not reversed. Effects of change in functional currency included the reclassifications of convertible debentures and warrants
and broker warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Estimated
Useful Lives of Property Plant and Equipment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
of property, plant and equipment is dependent upon estimates of useful lives which are determined through the exercise of judgment. The
assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that consider factors such as economic
and market conditions and the useful lives of assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Estimated
Useful Lives of and Amortization of Intangible Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
of intangible assets is recorded over their estimated useful lives which do not exceed any contractual periods, if any. Intangible assets
that have indefinite useful lives are not subject to amortization and are tested annually for impairment, or more frequently if events
or changes in circumstances indicate that they might be impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consolidation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgment
is applied in assessing whether we exercise control and have significant influence over entities in which we directly or indirectly own
an interest. We have control when we have the power over the subsidiary, have exposure or rights to variable returns, and have the ability
to use our power to affect the returns. Significant influence is defined as the power to participate in the financial and operating decisions
of the subsidiaries. Where we are determined to have control, these entities are consolidated. Additionally, judgment is applied in determining
the effective date on which control was obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-Based
Payments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
of stock-based compensation and warrants requires management to make estimates regarding the inputs for option pricing models, such as
the expected life of the option, the volatility of our stock price, the vesting period of the option and the risk-free interest rate
are used. Actual results could differ from those estimates. The estimates are considered for each new grant of stock options or warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use the following policies to evaluate our leases:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining
a lease: At contract inception, we review the facts and circumstances of the arrangement to determine if the contract is or contains
a lease. We follow the guidance in ASU 2016-02, Leases (Topic 842), ASU 2018-11, Leases (Topic 842): Targeted Improvements, and ASU 2019-01,
Leases (Topic 842): Codification Improvements to evaluate if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    contract has an identified asset;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have the right to obtain substantially all economic benefits from the asset; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have the right to direct the use of the underlying asset.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
determining if a contract has an identified asset, we consider both explicit and implicit assets, and whether the vendor has the right
to substitute the asset. When determining if we have the right to direct the use of an underlying asset, we consider if we have the right
to direct how and for what purpose the asset is used throughout the period of use and if we control the decision-making rights over the
asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
rate: At commencement, lease-related assets and liabilities are measured at the present value of future lease payments over the lease
term using an incremental borrowing rate. As most of our leases do not provide an implicit rate, we exercise judgment in determining
the incremental borrowing rate based on information available at the time the lease commences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent
increases or escalation clauses: Certain leases contain scheduled rent increases or escalation clauses. We assess each contract individually
and apply appropriate payments based on the terms of the agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renewal,
purchase and termination options: Our lease terms may include options to extend or terminate the lease. We exercise judgment in determining
the term of these leases when extension or termination options are present and include such options in the calculation of the lease terms
when it is reasonably certain that we will exercise these options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognizing
leases: We do not recognize leases with a contractual term of less than 12 months or low value leases on our financial statements. Lease
payments are expensed on a straight-line basis over the lease terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Residual
value guarantees, restrictions or covenants: Our lease agreements do not contain residual value guarantees, restrictions or covenants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Estimates and Assumptions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
estimates and assumptions where there is potential risk of material adjustments to assets and liabilities in future accounting periods
include the recoverability of the carrying value of exploration and evaluation assets, fair value measurements for financial instruments,
the recoverability and measurement of deferred tax assets and liabilities and contingent liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Significant
Judgments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
most significant judgments, apart from those involving estimates, in applying accounting policies in the Company&#8217;s financial statements
include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    assessment of the Company&#8217;s ability to continue as a going concern and whether there are events or conditions that may give
    rise to substantial doubt;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    there are indicators of impairment of the Company&#8217;s exploration and evaluation assets and other non-current assets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    classification of financial instruments; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determination
    of functional currency.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
INSTRUMENTS AND FINANCIAL RISK MANAGEMENT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial instruments consist of cash and cash equivalents, amounts receivable, deposits held by related parties, accounts payable, due
to related parties, promissory note, convertible debenture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of financial instruments is the amount of consideration that would be agreed upon in an arm&#8217;s length transaction between
knowledgeable, willing parties who are under no compulsion to act. The fair value of current financial instruments approximates their
carrying values as long as they are short-term in nature or bear interest at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments recorded at fair value are classified using a fair value hierarchy that prioritizes inputs used in determining the fair value
and depending on the degree to which they are observable. The three levels of hierarchy are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Unadjusted quoted prices in active markets for identical assets or liabilities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Inputs other than quoted prices that are observable for the asset or liability, either directly (i.e. as prices) or indirectly
(i.e. from derived prices); and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Inputs for the asset or liability that are not based on observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, October 31, 2021 and October 31, 2020, the fair value of cash and cash equivalents held by us was based on Level
1 inputs of the fair value hierarchy. There were no transfers between the levels during the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
Risk Management</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has the overall responsibility for the establishment and oversight of our risk management framework. Our risk management
policies are established to identify and analyze the risks faced by the Company, to set appropriate risk limits and controls, and to
monitor risks and adherence to limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions
and in response to our activities. Management regularly monitors compliance with our risk management policies and procedures and reviews
the adequacy of the risk management framework in relation to the risks faced by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of operations, the Company is exposed to various risks such as interest rate, foreign exchange, commodity, credit,
and liquidity. To manage these risks, management determines what activities must be undertaken to minimize potential exposure to risks.
The objectives of the Company in managing risks are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintaining
    sound financial condition;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
    operations; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensuring
    liquidity to all operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to satisfy these objectives, the Company has adopted the following policies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepare
    budget documents at prevailing market rates to ensure clear corporate alignment to performance management and achievement of targets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize
    and observe the extent of operating risk within the business; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify
    the magnitude of the impact of market risk factors on the overall risk of the business and take advantage of natural risk reductions
    that arise from these relationships.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no changes in risks that have arisen or how the Company manages those risks during the three months ended January 31, 2022
and 2021 and the years ended October 31, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[i]
Interest rate risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Interest
rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in the market interest rates.
The Company is exposed to interest rate risk on its cash on deposits with banks and, from time to time, on its holdings of short-term
investments. As of January 31, 2022 and October 31, 2021, the Company had cash on deposits with banks of $772,522 and $462,360, respectively.
The Company had no short-term investment as at January 31, 2022 or October 31 2021. Given the level of cash and cash equivalents held
by the Company, fluctuations in the market interest rates had no significant impact on its interest income during the three months ended
January 31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[ii]
Foreign currency risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to foreign currency risk on fluctuations related to cash and cash equivalents, amounts receivable, accounts payable and accrued
liabilities, due from/to related parties, and convertible debentures that are denominated in Canadian dollars. We have not entered into
foreign exchange derivative contracts. A significant change in the currency exchange rates between the U.S. dollar relative to the Canadian
dollar could have a material effect on our balance sheet, results of operations, or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Based
on the Company net exposures as at January 31, 2022, assuming that all other variables remain constant, a 5% appreciation or deterioration
of the Canadian dollar against the U.S. dollar would result in an increase or decrease of $88,138 in the Company&#8217;s net income (loss)
and comprehensive income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[iii]
Commodity price risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of our magnesium production business and its exploration and evaluation assets are dependent on the price of magnesium and the
outlook for this mineral. Market prices for these metals historically have fluctuated widely and are affected by numerous factors outside
our control, including but not limited to, levels of worldwide production, short-term changes in supply and demand, industrial and retail
demand, as well as certain other factors related specifically to magnesium. If magnesium prices decline for a prolonged period below
the cost of production, it may not be economically feasible to continue towards production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 55; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[iv]
Credit risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
risk is the risk of loss if counterparties do not fulfill their contractual obligations and arises principally from trade receivables.
Our credit risk is primarily attributable to cash and cash equivalents, amounts receivable and deposits held by related parties. The
Company limits its exposure to credit risk on cash and cash equivalents as these financial instruments are held with major banks in Canada
and the United States. Amounts receivable consist primarily of goods and services tax due from the Federal Government of Canada and other
subsidy receivable. Management believes the credit risk concentration with respect to amounts receivable is remote. The carrying amount
of financial assets recorded in the financial statements, net of any allowances, represents our maximum exposure to credit risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[v]
Liquidity risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Liquidity
risk is the risk that the Company will not be able to meet its financial obligations as they come due. The Company&#8217;s exposure to
liquidity risk is dependent on its purchasing commitments and obligations and its ability to raise funds to meet commitments and sustain
operations. The Company manages liquidity risk by continuously monitoring its actual and forecasted working capital requirements to ensure
there is capital to meet short-term and long-term obligations. As of January 31, 2022 and October 31, 2021, we had working capital deficiency
of $10,900,774 and $9,657,316, respectively. As disclosed in <i>note 1 </i>of the Company&#8217;s financial statements, the ability of
the Company to continue as a going concern is dependent on many factors. The Company&#8217;s cash is primarily deposited in bank accounts
and held as deposits by certain related parties. The Company anticipates that its cash on hand and deposits, together with expected funds
raised from private placements and on exercises of common share purchase warrants and stock options, as well as debt financing, will
provide sufficient financial resources to carry out its operations through the next twelve months. However, additional funding will be
required. There can be no assurance that the Company will be able to raise the funds necessary to continue future operations. Liquidity
risk has been assessed as high.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sur_001"></span>MANAGEMENT</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Officers and Directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the individuals that are our directors and executive officers as of the date of this prospectus and their
respective positions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karim
    Alameddine</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    Secretary</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rabih
    Ataya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and Executive Vice President (&#8220;EVP&#8221;), Special Projects</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam
    Ataya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    Executive President and Chief Executive Officer (&#8220;CEO&#8221;)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrea
    Chan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Controller</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Ramsey Hamady</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer (&#8220;CFO&#8221;)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Lee</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    Executive Chairman and former President and CEO</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisa
    Maxwell</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Global Operations and Chief Operating Officer (&#8220;COO&#8221;)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Rutkowski</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVP,
    Enterprise Business and Defense</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    O&#8217;Rourke</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and President, US Operations</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Sauv&#233;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVP,
    Operations and Chief Technology Officer (&#8220;CTO&#8221;)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Thorlakson </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
and Executive Officer Biographies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Karim
Alameddine.</i></b> Mr. Alameddine joined Western Magnesium in 2019 as Assistant Corporate Secretary and now serves as our Corporate
Secretary. From November 2013 to October 2019, he worked with the Toronto-Dominion Bank (&#8220;TDB&#8221;), one of the largest multinational
banks in Canada. During his time with TDB he developed a thorough understanding of the regulatory standards which he utilized in his
day-to-day responsibilities throughout his various positions within the organization. Mr. Alameddine&#8217;s drive for professionalism
and passion for corporate services has created a unique opportunity for him with our company, where he serves shareholders in meeting
their needs while centering his focus on industry and regulatory proceedings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rabih
Ataya. </i></b>Mr. Rabih Ataya joined Western Magnesium as our Senior Vice President, Strategy in November 2019 and has been a member
of our board of directors since March 2020, and now serves as our Executive Vice President, Special Projects. He brings to us over 30
years of extensive operational experience in the automotive industry. From 2018 to March 2020, Mr. Ataya had taken a brief hiatus from
the industry. From 2010 to 2018, he was the General Manager of Alfardan Automobiles, LLC, from 2002 to 2010 he was the General Manager
of the Automotive Division of Mohammad Saleh &amp; Reza Yousuf Behbehani Company and from 1996 to 2002 he was the General Manager of
Mirage General Trading Establishment. He has led strategies into tactical initiatives that drove bottom line results. Mr. Ataya&#8217;s
extensive experience in the automotive industry includes the North American, European, and Middle Eastern markets. This has afforded
him opportunities to understand the industry throughout the supply chain process &#8211; by understanding the materials market, dealing
with the full range of original equipment manufacturers and finally expanding dealership business for high-end automobile makers. He
has developed, nurtured and maintained strong relationships in the global auto industry. Mr. Ataya received his Executive Master of Business
Administration from HEC Paris, France, one of the most recognized universities in the world, and an Innovative Management and Entrepreneurial
Leadership Certification from Babson College. In addition, Mr. Ataya holds a Bachelor of Engineering in Mechanical Engineering from American
University of Beirut, Lebanon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rabih
Ataya is the cousin of Sam Ataya, our Executive President and Chief Executive Office and member of the board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sam
Ataya. </i></b>Mr. Sam Ataya has been our Chief Executive Officer and a director since September 2018. He was appointed as our Executive
President in January 20202. Mr. Ataya has a record with key strengths in demonstrating &#8220;big picture&#8221; approaches toward project
management that require long term strategic planning and operational management. His ability to manage multi-faceted projects through
team leadership has led him through operational turnarounds, management changes and the ability to mobilize resources to achieve the
wanted results from strategic planning and analysis. From 2008 to 2018, Sam Ataya was the CEO of The Stirling Group of Vancouver, B.C.,
a &#8220;One Stop&#8221; consulting service focused on assisting Micro-Cap, Mid-Cap, and Large-Cap Companies in need of financial recapitalization.
The Stirling Group aids companies in strengthening their business models, investment proposals and helps source capital directly from
an established global funding network. From 1987 to 2008 he was the President of ASK Ventures, a venture capital firm. Sam Ataya studied
Business Administration at Langara College, Canada in 1990 and at the American University of London, England in 1992.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam
Ataya is the cousin of Rabih Ataya, our Executive Vice President, Special Projects and member of the board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Andrea
Chan. </i></b>Ms. Chan brings to our company extensive experience in accounting and corporate finance in various industries including
pharmaceuticals, technology and insurance with roles of increasing responsibility. Prior to joining our company in March 2021 as our
Chief Controller, Ms. Chan served from March 2016 to March 2021 as Interim Chief Financial Officer, Director, Finance and Administration
and Corporate Secretary at Pacgen Life Science Corporation, a TSXV listed company, where she oversaw and managed the accounting and corporate
regulatory functions of the company, and assisted the completion of various corporate transactions including an initial public offering,
private placement financings, acquisitions, financial restructuring and licensing transactions. Ms. Chan was also a senior consultant
at KeenVision Consulting Inc. from September 2014 to March 2021, where she provided consulting services to public and private companies
across different industries. Ms. Chan is a Chartered Professional Accountant, Certified General Accountant, and a Certified Public Accountant
designated in the State of Delaware. She graduated from the University of British Columbia with a Bachelor of Commerce Degree in Accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Robert
Ramsey Hamady. </i></b><span style="background-color: white">Mr. Hamady has been our Chief Financial Officer since March 7, 2022. Previously
since 2016, Mr. Hamady has been a managing director at Habboush Group, a private investment management firm focused on investing in and
operating special opportunities in energy, infrastructure, technology and real estate. From 2011 to 2016, Mr. Hamady was a founding partner
of Gulf Capital, an alternative credit fund anchored and backed by Abu Dhabi sovereign and quasi-sovereign funds focused on investing
in loans, mezzanine debt, and convertibles in healthcare, education, energy, retail, food and beverage, and other diversified industries.
From 2008 to 2011, Mr. Hamady was a Senior Vice President of Waha Capital where he was a member of the investment team that managed a
distressed debt portfolio and help the formation of joint ventures. From 1997 to 2008, Mr. Hamady held various roles engaged in investing
in asset back securities, special situations credit investments, leveraged buyouts, microfinance initiatives targeting poverty alleviation
in emerging markets and as an analyst for sovereign fixed income investments. Mr. Hamady holds a Bachelor of Science Degree in Finance
from Carnegie Mellon University.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Edward
Lee. </i></b>A longtime entrepreneur in private business in northern British Columbia, Mr. Lee has been a member of our board of directors
since March 2004. In addition, he served as our President from March 2013 to November 2019, as our Chief Executive Officer from March
2013 to September 2018 and as our Executive Chairman since 2019. Mr. Lee served on the Boards of American Manganese, Inc. from August
2011 to March 2013 and Goldrea Resources Corp. from November 2003 to April 2013. Previously, he was a Director and Executive Vice President
for Adanac Molybdenum Corp. from November 2006 to January 2009. Since 1989, Mr. Lee has been assisting public companies in capital formation
and strategic business development. He brings Western Magnesium invaluable strategic insight, industry expertise and proven leadership.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lisa
Maxwell. </i></b>Ms. Maxwell joined our company in August 2013 as Corporate Secretary and full time in April 2019 as Senior Vice President,
Corporate Development and now serves as our President, Global Operations and Chief Operating Officer. She brings with her over 25 years
of experience in project management and business development. In December 2010 she founded Sequoia Corporate Services Inc., a management
consulting firm where she provided project management, compliance, corporate governance, business development and regulatory compliance
services for public companies from December 2010 to April 2019. In 2000 she founded Maxwell &amp; Associates, where she provided project
management services for public, private and crown corporations in the areas of education, healthcare and transportation from 2000 until
2010. Ms. Maxwell studied International Business at Athabasca University, Alberta<b><i>, </i></b>Canada and Capilano University, North
Vancouver, British Columbia, Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Michael
Rutkowski. </i></b>Colonel Michael Rutkowski, (Retired), joined Western Magnesium on September 1, 2021 as the Executive Vice President
of Enterprise Business and Defense. Prior to joining the Western Magnesium team, Colonel Rutkowski was the Director for Strategic Initiatives
for B3 Group, an award-winning IT consulting firm specializing in digital services and innovative technology solutions in Herndon, Virginia
from April 2021 to September 2021. From March 2020 to April 2021, he was the Executive Vice President and Chief of Business Development
for MCI a global engagement and marketing agency that creates human-centric touchpoints that unleash the power of people to deliver innovation
and growth. From 2011 to March 2020 Colonel Rutkowski served in the United States Army in the Aviation Branch and achieved the rank of
Colonel. At the time of his retirement in March 2020, he was serving as the Senior Military Advisor to the Secretary of Veteran&#8217;s
Affairs (VA) where he worked in numerous leadership roles throughout the agency. He was appointed as Deputy Director for Electronic Healthcare
Records Management (EHRM) from April 2019 to November 2019 and helped oversee one of the largest information technology acquisition programs
ever in the federal government. Colonel Rutkowski served as a program manager for Air Traffic Control from June 2011 to June 2014 and
following that assignment he was a program manager in the Joint Office of the Pentagon (J8 - Capabilities and Acquisition Division) then
as the Chief of Staff for two J8 directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colonel
Rutkowski holds a BS in Business Management (1993) from Niagara University, an MBA with concentration in supply chain management (2005)
from Florida State University and an MS in National Security and Resource Strategy with concentration in Space Industry (2018) from the
Eisenhower War College - National Defense University in Washington D.C.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Peter
O&#8217;Rourke.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
O&#8217;Rourke serves as our President, US Operations. Prior to joining our company in November 2020 as a director and Senior Vice President,
Business Development and Government Affairs, Mr. O&#8217;Rourke was Managing Partner of TCI Partners LLC a multidisciplinary consultancy
based in Washington DC (December 2018-April 2021). Mr. O&#8217;Rourke was the acting Secretary of Veterans Affairs and Senior Advisor
to the Secretary of Veterans Affairs for the US government (May &#8211; December 2018). Between February and May 2018 he was the Chief
of Staff, Department of Veterans Affairs and led the Department&#8217;s staff and executive functions during a time of significant organizational
change. He began his service with the VA as Senior Advisor to the Secretary (January &#8211; April 2017) moving up to the position of
Executive Director for the Office of Accountability and Whistleblower Protection (May 2017 &#8211; February 2018) and then promoted to
VA Chief of Staff (February &#8211; May 2018). In these roles he organized the VA&#8217;s senior staff and spearheaded the implementation
of Presidential and Congressional intent to reset the definition of accountability in the civilian workforce and operationalized the
protection and support for government whistleblowers. Mr. O&#8217;Rourke was a self-employed government affairs consultant (September&#8212;December
2016). Between May 2015 and July 2016 he was the Principal of Calibre Systems, a company which led the development of transformational
plans for Veterans Affairs, the U.S. Department of Defense, and other government organizations. From January to April 2015 he worked
as a self-employed consultant. Between May and December 2014 Mr. O&#8217;Rourke served as a Senior Policy Advisor in the US House of
Representatives. From February to April 2014 he worked as a self-employed consultant. Between March 2012 and January 2014 he was the
Vice-President, Marketing &amp; Business Development with Blackland Aerospace where he created the worldwide marketing and business development
capabilities for the firm and its aerospace manufacturing facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
O&#8217;Rourke was the Executive Director for Strong America Now where he led development and daily operations for a non-profit focused
on generating support for government efficiency and cost savings using Lean Six Sigma methods from November 2010 to April 2012. Prior
to this he was the Director, Marketing &amp; Business Development for Accenture Federal Services from 2007 through 2009), in this capacity
he led development and execution of global strategic and operational marketing and business development activities for a new acquisition
(George Group Consulting, LP). campaigns and client teams to enable effective business development initiatives and between 2005 and 2007
he was a Senior Consultant for George Group Consulting LP where he coached, mentored and taught U.S. Department of Defense senior officers
and executives Lean Six Sigma methods, tools, and implementation strategies as a certified Lean Six Sigma Master Black Belt. Between
1998 and 2006, Mr. O&#8217;Rourke held multiple assignments worldwide as a high-performing expert in multiple supply chain and logistics
disciplines. Mr. O&#8217;Rourke completed undergraduate studies from 1995 until 1998. From 1990 &#8211; 1994 he was an Airman (Enlisted),
U.S. Navy, performing assignments worldwide as Plane Captain, Fighter Squadron 213, Miramar Naval Air Station, California. Mr. O&#8217;Rourke
holds a B.A. Political Science from the University of Tennessee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Paul
Sauv&#233;. </i></b>Mr. Sauv&#233; has been our Senior Vice President, Technology and Operations since March 2020 and now serves
as our Executive Vice President, Operations and Chief Technology Officer. He brings with him over 15 years of experience in the mining
industry including senior positions with Teck Resources as Senior Project Engineer and Metallurgist from June 2006 &#8211; March 2020.
Based on his strong chemical engineering background, he has had extensive experience with diversified metals &amp; mining companies,
gaining valuable know how in process development and optimization; fully integrated plant systems management; hydrometallurgical research
facility operation that involved testing for metal recovery; process engineering for full-scale studies and project execution; as well
as modeling commercial sized facilities for production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an innovative and versatile chemical/mine engineer, he has been recognized for his in-depth expertise in metallurgy &#8211; managing
a dynamic &amp; multifaceted hydrometallurgical research facility; shift metallurgist for an operating plant; flotation plant metallurgy;
metallurgist for multi-unit operation in a continuous pilot plant; and supervision of a hydrometallurgical research plant. In addition
to being a member of the Association of Professional Engineers and Geoscientists of British Columbia since June 2011, he comes with specialized
skills in lab and filed-testing protocols, METSIM (a general-purpose process simulation system designed to assist in performing mass
and energy balances of complex processes), Unisim (a modeling platform that helps engineers create steady-state and dynamic models for
plant design and performance monitoring), Visual Minteq (a chemical equilibrium software application) and WHMIS (workplace hazardous
materials information system). He holds a Bachelor of Applied Science/Chemical Engineering degree from Lakehead University (2011) and
a Diploma of Applied Science/Chemical Science Technology from BCIT (2006).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stephen
Thorlakson. </i></b>Mr. Thorlakson has been a member of our board of directors since December 2013. He brings a wealth of experience
in the construction project management and logistics industry, as well as extensive financial and business management expertise, having
worked more than three decades within the construction and financial services industry. In September 2019, Mr. Thorlakson became the
Vice-President of FloRite ESI and Klassic Oilfield Services Ltd., companies which service the oil and gas industry. In 2011, he founded
and became the President of Thorlakson Management Ltd., a construction management firm that specializes in quality control, safety and
site remediation where he has provided guidance, direction and hands-on management of major industrial and business development projects
for clients. Mr. Thorlakson continues to provide consulting services for Thorlakson Management Ltd. From June 2006 to November 2010,
he was the General Manager for Surerus Pipeline. From 1980 until 2006, Mr. Thorlakson was a self- employed chartered financial planner
in Fort St. John, British Columbia, a city for which he served as Mayor from 1990 through 2005 and Alderman from 1986 through 1990. He
began his professional career working at Toronto Dominion Bank as Branch Manager and Senior Assistant Manager of Commercial Credit from
September 1976 to September 1979.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jeff
Wilson. </i></b>Jeff Wilson, Ph.D., P.Geo, has been a member of our board of directors since August 2014. He has worked in mineral exploration,
consulting and market regulation for over 20 years. He has also worked as an independent consultant since 2013. From 2010 until 2013,
Dr. Wilson was the director of Geology at Tetra Tech WEI, Inc., a leading provider of consulting, engineering and technical services
focused on the worldwide water, environmental, energy, infrastructure and natural resource industries. From 2006 until 2010, Dr. Wilson
worked as a Listings Manager at the TSXV, where he was responsible for reviewing technical and financial submissions by publicly traded
resource companies. In addition, he has worked as a Project Geologist at Placer Dome Inc. from 2005 to 2006, Project Geologist for Fronteer
Development Group from 2004 to 2005, an independent consultant from 2001 to 2004, as a Senior Structural Geologist for AngloGold Ashanti
in Brazil from 2000 to 2001, an independent consultant in 1999, a Prestigious Geological Fellow at Rhodes University South Africa in
1998 and a Senior Geologist at Newcrest Mining in Indonesia in 1997. Dr. Wilson graduated with a Ph.D. in Geology from Kingston University,
England in 1996 and a Bachelor Degree in Geology from Glasgow University, Scotland in 1991.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Family
Relationships</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rabih
Ataya is the cousin of Sam Ataya, our Executive President and Chief Executive Office and member of the board of directors. Sam Ataya
is the cousin of Rabih Ataya, our Executive Vice President, Special Projects and member of the board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Officer
and Board Qualifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers and board of directors are well qualified as leaders. In their prior positions they have gained experience in core management
skills, such as strategic and financial planning, public company financial reporting, compliance, risk management, and leadership development.
Our officers and directors also have experience serving on boards of directors and board committees of other public companies and private
companies, and have an understanding of corporate governance practices and trends, which provides an understanding of different business
processes, challenges, and strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Number
and Terms of Office of Officers and Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is comprised of six directors. Each director is elected at our annual meeting of stockholders and holds office for
one year, or until his successor is elected and qualified. Our officers are elected by the board of directors and serve at the discretion
of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices
set forth in our bylaws as it deems appropriate. Our bylaws provide that our officers may consist of a Chief Executive Officer, President,
Chief Financial Officer, Vice Presidents, Secretary, Assistant Secretaries, Treasurer and such other offices as may be determined by
the board of directors.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
Committees</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have an audit committee, a compensation committee, and a corporate governance committee. The members of each are set out below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Member</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committee</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    Committee</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
    Governance Committee</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rabih
    Ataya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Lee</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
    <sup>(1)</sup></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Thorlakson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
    <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
    <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff
    Wilson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Denotes chairperson.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
brief description of each committee is set out below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Committee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee of our board of directors (the &#8220;Audit Committee&#8221;) is responsible for review of our interim and annual financial
statements. For the purposes of performing their duties, the members of the Audit Committee have the right at all times, to inspect all
of our books and financial records and any subsidiaries and to discuss with management and our independent auditors any accounts, records
and matters relating to our financial statements. The Audit Committee members meet periodically with management and annually with our
independent auditors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Composition
of the Audit Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, the following are the members of the Audit Committee:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 38%"><p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            of Member</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 36%; background-color: white; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent
    <sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 22%; background-color: white; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financially
    Literate <sup>(2)</sup></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rabih
    Ataya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Thorlakson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff
    Wilson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    member of the Audit Committee is independent if he or she has no direct or indirect &#8216;material relationship&#8217; with Western
    Magnesium. A material relationship is a relationship which could, in the view of our board of directors, reasonably interfere with
    the exercise of a member&#8217;s independent judgment. An executive officer, such as the President or Secretary, is deemed to have
    a material relationship with Western Magnesium.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    member of the Audit Committee is financially literate if he or she has the ability to read and understand a set of financial statements
    that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of
    the issues that can reasonably be expected to be raised by our financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relevant
Education and Experience</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
member of the Audit Committee has experience relevant to his or her responsibilities as an Audit Committee member. See &#8220;Management&#8221;
for a description of the education and experience of each Audit Committee member.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee Oversight</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
no time since the commencement of our most recently completed fiscal year was a recommendation of the Audit Committee to nominate or
compensate an external auditor not adopted by our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee&#8217;s Charter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted a written charter for the Audit Committee, which sets out the Audit Committee&#8217;s responsibilities
in detail. The Audit Committee has access to all books, records, facilities and personnel and may request any information about us as
it may deem appropriate. It will also have the authority to retain and compensate special legal, accounting, financial and other consultants
or advisors to advise the Audit Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
Committee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation committee of our board of directors (the &#8220;Compensation Committee&#8221;) has the responsibility of assisting our board
of directors in discharging its oversight responsibilities relating to the attraction, compensation, evaluation and retention of key
senior management employees, and in particular the Chief Executive Officer. In addition, the Compensation Committee is tasked with reviewing
our annual disclosure regarding executive compensation for inclusion where appropriate in our disclosure documents. The Compensation
Committee is also charged with annually reviewing the Western Magnesium Corporation 2021 Equity Incentive Plan (the &#8220;2021 Equity
Incentive Plan&#8221;) and proposing changes thereto, approving any awards of options under the 2021 Equity Incentive Plan and recommending
any other employee benefit plans, incentive awards and perquisites with respect to our executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Composition
of the Compensation Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, the following are the members of the Compensation Committee:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; background-color: white; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 49%"><p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            of Member</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent
    <sup>(1)</sup></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rabih
    Ataya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Thorlakson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff
    Wilson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    member of the Compensation Committee is independent if he or she has no direct or indirect &#8216;material relationship&#8217; with
    Western Magnesium. A material relationship is a relationship which could, in the view of our board of directors, reasonably interfere
    with the exercise of a member&#8217;s independent judgment. An executive officer, such as the President or Secretary, is deemed to
    have a material relationship with Western Magnesium.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee&#8217;s Charter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted a written charter for the Compensation Committee, which sets out the Compensation Committee&#8217;s responsibilities
in detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
additional details on the Compensation Committee, see &#8220;Executive Compensation&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
Governance Committee</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Governance committee of our board of directors (the &#8220;Corporate Governance Committee&#8221;) is responsible to develop
and monitor our approach to matters of governance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Composition
of the Corporate Governance Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, the following are the members of the Corporate Governance Committee:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; background-color: white; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 49%"><p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            of Member</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent
    <sup>(1)</sup></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Lee</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Thorlakson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff
    Wilson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    member of the Corporate Governance Committee is independent if he or she has no direct or indirect &#8216;material relationship&#8217;
    with Western Magnesium. A material relationship is a relationship which could, in the view of our board of directors, reasonably
    interfere with the exercise of a member&#8217;s independent judgment. An executive officer, such as the President or Secretary, is
    deemed to have a material relationship with Western Magnesium.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
Qualifications</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that each of the members of our board of directors has the experience, qualifications, attributes and skills that make him or
her suitable to serve as our director, in light of our highly regulated magnesium business and the complex nature of our operations.
See above under the heading &#8220;Management&#8221; for a description of the education and experience of each director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Rabih Ataya&#8217;s specific qualifications, experience, skills and expertise include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core
    business skills, including financial and strategic planning;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
    and financial reporting expertise; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    and management experience.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 61; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Sam Ataya&#8217;s specific qualifications, experience, skills and expertise include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core
    business skills, including financial and strategic planning;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
    and financial reporting expertise; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    and management experience.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Lee&#8217;s specific qualifications, experience, skills and expertise include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core
    business skills, including financial and strategic planning;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
    and financial reporting expertise; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    and management experience.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
O&#8217;Rourke&#8217;s specific qualifications, experience, skills and expertise include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core
    business skills, including financial and strategic planning;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finance
    and financial reporting expertise; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    and management experience.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Thorlakson&#8217;s specific qualifications, experience, skills and expertise include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core
    business skills, including financial and strategic planning;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    deep understanding of entrepreneurship and of the industry; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    and management experience.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Wilson&#8217;s specific qualifications, experience, skills and expertise include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core
    business skills, including financial and strategic planning;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    deep understanding of entrepreneurship and of the industry; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    and management experience.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe these qualifications bring a broad set of complementary experience to our board of directors&#8217; discharge of its responsibilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director
Independence</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this prospectus, the independence of our directors is determined under the corporate governance rules of the Nasdaq Stock
Market (&#8220;Nasdaq&#8221;). The independence rules of Nasdaq include a series of objective tests, including that an &#8220;independent&#8221;
person will not be employed by us and will not be engaged in various types of business dealings with us. In addition, our board of directors
is required to make a subjective determination as to each person that no material relationship exists with us either directly or as a
partner, shareholder or officer of an organization that has a relationship with us. It has been determined that two of our directors
are independent persons under the independence rules of Nasdaq: Jeff Wilson and Stephen Thorlakson.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nomination
of Directors</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is responsible for identifying individuals qualified to become new Board members and recommending to the Board new director nominees
for the next annual meeting of shareholders. New nominees must have a track record in general business management, special expertise
in an area of strategic interest to the Company, the ability to devote the required time, show support for the Company&#8217;s mission
and strategic objectives, and a willingness to serve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bylaws of the Company contain advance notice provisions, which include, among other things, a provision that requires advance notice
be given to the Company in circumstances where nominations of persons for election to the Board are made by shareholders.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
Leadership Structure and Board&#8217;s Role in Risk Oversight</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board is generally responsible for the oversight of corporate risk in its review and deliberations relating to our activities. Our principal
source of risk falls into two categories, financial and product commercialization. The audit committee oversees management of financial
risks; our board regularly reviews information regarding our cash position, liquidity and operations, as well as the risks associated
with each. The board regularly reviews plans, results and potential risks related to our business. The board is also expected to oversee
risk management as it relates to our compensation plans, policies and practices for all employees including executives and directors,
particularly whether our compensation programs may create incentives for our employees to take excessive or inappropriate risks which
could have a material adverse effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Code
of Ethics and Business Conduct</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a Code of Ethics and Business Conduct applicable to our directors, officers and employees. We previously filed a copy of
our Code of Ethics and Business Conduct as an exhibit to our Form 10-K for the period ended October 31, 2021. You will be able to review
this document by accessing our public filings at the SEC&#8217;s web site at <i>www.sec.gov</i>. In addition, a copy of the Code of Ethics
and Business Conduct will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain
provisions of our Code of Ethics and Business Conduct in a Current Report on Form 8-K. See &#8220;Where You Can Find Additional Information.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limitation
on Liability and Indemnification of Officers and Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;) empowers a Delaware corporation to indemnify any persons who are,
or are threatened to be made, parties to any threatened, pending, or completed legal action, suit, or proceeding, whether civil, criminal,
administrative, or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person
was an officer or director of such corporation, or is or was serving at the request of such corporation as a director, officer, employee,
or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#8217; fees), judgments, fines,
and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit, or proceeding, provided
that such officer or director acted in good faith and in a manner he reasonably believed to be in or not opposed to the corporation&#8217;s
best interests, and, for criminal proceedings, had no reasonable cause to believe his conduct was illegal. A Delaware corporation may
indemnify officers and directors in an action by or in the right of the corporation under the same conditions, except that no indemnification
is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation in the performance of his
duty. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation
must indemnify him against the expenses which such officer or director actually and reasonably incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws, as amended, provide that we will indemnify our directors and officers to the fullest extent permitted by Delaware law, except
that no indemnification will be provided to a director, officer, employee, or agent if the indemnification sought is in connection with
a proceeding initiated by such person without the authorization of our board of directors. The bylaws, as amended, also provide that
the right of directors and officers to indemnification will be a contract right and will not be exclusive of any other right now possessed
or hereafter acquired under any statute, provision of the certificate of incorporation, bylaw, agreement, vote of stockholders or disinterested
directors or otherwise. The bylaws, as amended, also permit us to secure insurance on behalf of any officer, director, employee, or other
agent for any liability arising out of his or her actions in such capacity, regardless of whether the bylaws, as amended, would permit
indemnification of any such liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Section 102(b)(7) of the DGCL, our certificate of incorporation provides that directors will not be personally liable
for monetary damages for breaches of their fiduciary duty as directors. The effect of this provision is to eliminate the personal liability
of directors for monetary damages or actions involving a breach of their fiduciary duty of care, including any actions involving gross
negligence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also maintain director and officer liability insurance to insure our directors and officers against the cost of defense, settlement or
payment of a judgment under specified circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action,
if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder&#8217;s investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced
officers and directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sur_002"></span>EXECUTIVE
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021
Summary Compensation Table</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes all compensation recorded by us in the past two fiscal years for:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.55in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    principal executive officer or other individual acting in a similar capacity during the fiscal year ended October 31, 2021,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    two most highly compensated executive officers, other than our principal executive officers, who were serving as executive officers
    at October 31, 2021, and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">up
    to two additional individuals for whom disclosure would have been provided but for the fact that the individual was not serving as
    an executive officer at October 31, 2021.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
definitional purposes, these individuals are sometimes referred to as the &#8220;named executive officers.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    and Principal Position</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
                                            Year ended October</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
                                            Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
                                            Awards <sup>(1)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity
                                            Incentive Plan Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-qualified
                                            Deferred Compensation Earnings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 28%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sam
    Ataya</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">360,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,570,452</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200,188</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,130,640</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    Executive President and CEO <sup>(2)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">360,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,150</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">70,288</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">89,160</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">556,598</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Edward
    Lee</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">420,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,053,221</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">251,023</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,724,244</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    Executive Chairman and former President and CEO <sup>(3)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">420,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,711</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">495,711</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lisa
    Maxwell</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">192,917</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,593,783</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">144,380</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,931,080</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Global Operations and COO <sup>(4)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">120,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,242</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,600</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">165,842</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Rabih
    Ataya</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">248,897</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,878</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">484,775</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and EVP, Special Projects <sup>(5)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">47,626</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">227,626</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paul
    Sauv&#233;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">186,812</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">484,200</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,701</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">773,713</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVP,
                                            Operations and CTO
                                            <sup>(6)</sup></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,154</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,373</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">132,527</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts reported in the Option Awards column reflects aggregate grant date fair value computed in accordance with ASC Topic 718,
    Compensation&#8212;Stock Compensation. These amounts reflect our calculation of the value of these awards at the grant date and do
    not necessarily correspond to the actual value that may ultimately be realized by the named executive officer. Assumptions used in
    the calculation of these amounts are included in Note <i>14</i> to our audited consolidated financial statements for the fiscal year
    ended October 31, 2021, which are included elsewhere in this registration statement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">The
2020 Option Award compensation includes the following:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 Option Award compensation for Sam Ataya reflects the issuance of 650,000 stock options granted on April 24, 2020, which entitles
the holder of each such stock option to purchase one share of our common stock at an exercise price of CAD$0.12 until April 23, 2025,
and vested in full on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 Option Award compensation for Edward Lee reflects the issuance of 700,000 stock options granted on April 24, 2020, which entitles
the holder of each such stock option to purchase one share of our common stock at an exercise price of CAD$0.12 until April 23, 2025,
and vested in full on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 Option Award compensation for Lisa Maxwell reflects the issuance of 400,000 stock options granted on April 24, 2020, which entitles
the holder of each such stock option to purchase one share of our common stock at an exercise price of CAD$0.12 until April 23, 2025,
and vested in full on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 Option Award compensation for Rabih Ataya reflects the issuance of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000
    stock options granted on November 4, 2019, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.15 until November 3, 2024; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000
    stock options granted on April 24, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.12 until April 23, 2025,</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stock options were fully vested on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 Option Award compensation for Paul Sauv&#233; reflects the issuance of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000
    stock options granted on March 27, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.11 until March 26, 2024; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000
    stock options granted on April 24, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.12 until April 23, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stock options were fully vested on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">The
2021 Option Award compensation includes the following:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Option Award compensation for Sam Ataya reflects the issuance of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,500,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2025; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stock options were fully vested on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Option Award compensation for Edward Lee reflects the issuance of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2025; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Option Award compensation for Lisa Maxwell reflects the issuance of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">750,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2022; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stock options were fully vested on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Option Award compensation for Rabih Ataya reflects the issuance of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2022; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stock options were fully vested on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2021 Option Award compensation for Paul Sauv&#233; reflects the issuance of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">750,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2022; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stock options were fully vested on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Ataya was appointed as our CEO and elected to our board of directors effective September 21, 2018. Mr. Ataya was appointed as our
    President effective January 31, 2020. The compensation disclosed for Mr. Ataya is for his position as our CEO and he was not separately
    compensated as a director. Mr. Ataya&#8217;s reported 2021 salary includes $90,000 accrued not yet paid. Mr. Ataya&#8217;s reported
    2021 All Other Compensation includes vacation and benefits of $166,486 accrued not yet paid and consulting fees of $35,772 paid to
    a company where Mr. Ataya is principal. Mr. Ataya&#8217;s reported 2020 salary includes $75,000 accrued not yet paid. Mr. Ataya&#8217;s
    reported 2020 All Other Compensation includes consulting fees of $89,160 paid to a company where Mr. Ataya is principal.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Lee was appointed as our Executive Chairman and CEO on March 24, 2013 and resigned as CEO on September 21, 2018. Mr. Lee was appointed
    as a director on March 29, 2004. The compensation disclosed for Mr. Lee is for his position as our Executive Chairman and he was
    not separately compensated as a director. Mr. Lee&#8217;s reported 2021 Salary includes $105,000 accrued not yet paid. Mr. Lee&#8217;s
    reported 2021 All Other Compensation includes vacation and benefits of $254,986 accrued not yet paid. Mr. Lee&#8217;s reported 2020
    Salary includes $87,500 accrued not yet paid.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Maxwell was appointed as SVP, Corporate Development on December 1, 2020 and promoted as EVP, Corporate Development effective July
    15, 2021 and as President, Global Operations and COO effective October 1, 2021. Ms. Maxwell&#8217;s reported 2021 All Other Compensation
    includes benefits of $48,325 accrued not yet paid. Ms. Maxwell&#8217;s reported 2020 All Other Compensation includes consulting fees
    of $2,600 paid to a company where Ms. Maxwell is principal.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Ataya was appointed as SVP, Strategy on November 1, 2019 and as a director on March 10, 2020. He was promoted as EVP, Special Projects
    effective October 1, 2021. The compensation disclosed for Mr. Ataya is for his position as our SVP, Strategy and subsequently EVP,
    Special Projects; he was not separately compensated as a director. Mr. Ataya&#8217;s reported 2021 All Other Compensation includes
    benefits of $29,954 accrued not yet paid.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Sauv&#233; was appointed as SVP, Technology &amp; Operations on March 23, 2020 and promoted as EVP, Operations and CTO effective
    October 1, 2021. Mr. Sauv&#233;&#8217;s reported 2021 All Other Compensation includes benefits of $12,075 accrued not yet paid.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
Employment Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have employment agreements with Edward Lee, Executive Chairman, Sam Ataya, Executive President and CEO, Lisa Maxwell, President, Global
Operations and COO, Rabih Ataya, EVP, Special Projects, and Paul Sauv&#233;, EVP, Operations and CTO under which compensation was provided
during the most recently completed financial year and/or interim period, or is payable in respect of services provided to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Edward
Lee</i>. </b>Executive Chairman, Edward Lee signed a contract on April 8, 2022 (the &#8220;Lee Contract&#8221;) with an indefinite term
that may be terminated by us at any time 30 days after written notice to Mr. Lee. Mr. Lee will be paid an annual base salary of USD$420,000
which will be subject to all required deductions. Mr. Lee shall have the opportunity to earn an annual discretionary bonus upon meeting
or exceeding our achievement of annual financial and operating targets and his performance targets. Mr. Lee will also be granted such
stock options as determined by the Board or a committee thereof in its sole discretion and be entitled to participate in our benefits
plans. During Mr. Lee&#8217;s employment and for a period of one year from the end of Mr. Lee&#8217;s employment (howsoever occasioned),
Mr. Lee shall not, directly or indirectly, whether as owner, shareholder (except to the extent of a less than 2% ownership interest of
the outstanding shares of a publicly held corporation), director, agent, officer, employee, consultant, independent contractor or in
any other capacity whatsoever of a corporation, partnership, proprietorship, be engaged in, compete with, be financially concerned or
interested with, or employed by any company carrying on the business of development or processing of magnesium anywhere in North or South
America or Europe. Upon the death or disability of Mr. Lee such that, in the view of our directors other than Mr. Lee, Mr. Lee is not
able to carry out his responsibilities, we may terminate Mr. Lee&#8217;s employment by providing Mr. Lee or his estate with pay and severance
pay, if applicable, in the amount of six (6) months&#8217; base salary payable monthly. In the event we terminate Mr. Lee&#8217;s employment
without cause within 12 months of a Change of Control (as defined below) or Mr. Lee terminates his employment for Good Reason (as defined
below) within 12 months of a Change of Control, Mr. Lee is entitled to receive from us a payment equal to the greater of: (i) a onetime
payment of USD$6 million, less applicable deductions and withholdings; and (ii) any minimum entitlements to written notice of termination,
payment in lieu of such notice, or a combination of written notice and payment in lieu of such notice, at our sole discretion, required
by the <i>Employment Standards Act </i>(British Columbia) (the &#8220;BCESA&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sam
Ataya</i>. </b>Executive President and CEO, Sam Ataya has signed a contract on April 8, 2022 (the &#8220;S. Ataya Contract&#8221;) with
an indefinite term that may be terminated by us at any time 30 days after written notice to Mr. Ataya. Mr. Ataya will be paid an annual
base salary of USD$360,000 which will be subject to all required deductions. Mr. Ataya shall have the opportunity to earn an annual discretionary
bonus upon meeting or exceeding our achievement of annual financial and operating targets and Mr. Ataya&#8217;s performance targets.
Mr. Ataya will also be granted such stock options as determined by the Board or a committee thereof in its sole discretion and be entitled
to participate in our benefits plans. During Mr. Ataya&#8217;s employment and for a period of one year from the end of Mr. Ataya&#8217;s
employment (howsoever occasioned), Mr. Ataya shall not, directly or indirectly, whether as owner, shareholder (except to the extent of
a less than 2% ownership interest of the outstanding shares of a publicly held corporation), director, agent, officer, employee, consultant,
independent contractor or in any other capacity whatsoever of a corporation, partnership, proprietorship, be engaged in, compete with,
be financially concerned or interested with, or employed by any company carrying on the business of development or processing of magnesium
anywhere in North or South America or Europe. Upon the death or disability of Mr. Ataya such that, in the view of our directors other
than Mr. Ataya, Mr. Ataya is not able to carry out his responsibilities, we may terminate Mr. Ataya&#8217;s employment by providing Mr.
Ataya or his estate with pay and severance pay, if applicable, in the amount of six (6) months&#8217; base salary payable monthly. In
the event we terminate Mr. Ataya&#8217;s employment without cause within 12 months of a Change of Control (as defined below) or Mr. Ataya
terminates his employment for Good Reason (as defined below) within 12 months of a Change of Control, Mr. Ataya is entitled to receive
from us a payment equal to the greater of: (i) a onetime payment of USD$5 million, less applicable deductions and withholdings; and (ii)
any minimum entitlements to written notice of termination, payment in lieu of such notice, or a combination of written notice and payment
in lieu of such notice, at our sole discretion, required by the BCESA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lisa
Maxwell</i>. </b>President, Global Operations and COO, Lisa Maxwell, has signed a contract on April 8, 2022 (the &#8220;Maxwell Contract&#8221;)
with an indefinite term that may be terminated by us at any time 30 days after written notice to Ms. Maxwell. Ms. Maxwell will be paid
an annual base salary of USD$250,000 which will be subject to all required deductions. Ms. Maxwell will also be granted such stock options
as determined by the Board or a committee thereof in its sole discretion and be entitled to participate in our benefits plans. During
Ms. Maxwell&#8217;s employment and for a period of one year from the end of her employment (howsoever occasioned), she shall not, directly
or indirectly, whether as owner, shareholder (except to the extent of a less than 2% ownership interest of the outstanding shares of
a publicly held corporation), director, agent, officer, employee, consultant, independent contractor or in any other capacity whatsoever
of a corporation, partnership, proprietorship, be engaged in, compete with, be financially concerned or interested with, or employed
by any company carrying on the business of development or processing of magnesium anywhere in North or South America or Europe. Upon
the death or disability diagnosed by a licensed physician of the Employee such that, in the view of the Company&#8217;s directors other
than the Employee, the Employee is not able to carry out his essential job functions, the Company may terminate the Employee&#8217;s
employment by providing the Employee or his estate with pay and severance pay, if applicable, in the amount of six (6) months&#8217;
Base Salary payable monthly, and conditioned on the effectiveness of a Release. In the event we terminate Ms. Maxwell&#8217;s employment
without cause within 12 months of a Change of Control (as defined below) or Ms. Maxwell terminates his employment for Good Reason within
12 months of a Change of Control, she is entitled to receive from us a payment equal to the greater of: (i) a onetime payment of USD$2
million, less applicable deductions and withholdings; and (ii) any minimum entitlements to written notice of termination, payment in
lieu of such notice, or a combination of written notice and payment in lieu of such notice, at our sole discretion, required by the BCESA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rabih
Ataya</i>. </b>EVP, Special Projects, Rabih Ataya, has signed a contract on November 1, 2019 (the &#8220;R. Ataya Contract&#8221;) and
will be paid an annual base salary of USD$180,000 which will be subject to all required deductions. Mr. Ataya shall have the opportunity
to earn an annual discretionary bonus upon meeting or exceeding our achievement of annual financial and operating targets and Mr. Ataya&#8217;s
performance targets. Mr. Ataya will also be granted such stock options as determined by the Board or a committee thereof in its sole
discretion and be entitled to participate in our benefits plans. During Mr. Ataya&#8217;s employment and for a period of one year from
the end of Mr. Ataya&#8217;s employment (howsoever occasioned), Mr. Ataya shall not, directly or indirectly, whether as owner, shareholder
(except to the extent of a less than 2% ownership interest of the outstanding shares of a publicly held corporation), director, agent,
officer, employee, consultant, independent contractor or in any other capacity whatsoever of a corporation, partnership, proprietorship,
be engaged in, compete with, be financially concerned or interested with, or employed by any company carrying on the business of development
or processing of magnesium anywhere in North or South America or Europe. Upon the death or disability of Mr. Ataya such that, in the
view of our directors other than Mr. Ataya, Mr. Ataya is not able to carry out his responsibilities, we may terminate Mr. Ataya&#8217;s
employment by providing him or his estate with pay and severance pay, if applicable, in the amount of six month&#8217;s base salary payable
monthly. In the event we terminate Mr. Ataya&#8217;s employment without cause within 12 months of a Change of Control or Mr. Ataya terminates
his employment for Good Reason within 12 months of a Change of Control, he is entitled to receive from us six month&#8217;s base salary
and any minimum entitlements to written notice of termination, payment in lieu of such notice, or a combination of written notice and
payment in lieu of such notice, at our sole discretion, required by the BCESA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Paul
Sauv&#233;</i>. </b>EVP, Operations and CTO, Paul Sauv&#233;, has signed a contract on March 23, 2020 (the &#8220;Sauv&#233; Contract&#8221;)
and will be paid an annual base salary of CAD$210,000 which will be subject to all required deductions. Mr. Sauv&#233;&#8217;s annual
base salary is increased to CAD$240,000 effective January 1, 2021 and to USD$240,000 effective September 1, 2021. Mr. Sauv&#233; shall
have the opportunity to earn an annual discretionary bonus upon meeting or exceeding our achievement of annual financial and operating
targets and Mr. Sauv&#233;&#8217;s performance targets. Mr. Sauv&#233; will also be granted such stock options as determined by the
Board or a committee thereof in its sole discretion and be entitled to participate in our benefits plans. During Mr. Sauv&#233;&#8217;s
employment and for a period of one year from the end of Mr. Sauv&#233;&#8217;s employment (howsoever occasioned), Mr. Sauv&#233;
shall not, directly or indirectly, whether as owner, shareholder (except to the extent of a less than 2% ownership interest of the outstanding
shares of a publicly held corporation), director, agent, officer, employee, consultant, independent contractor or in any other capacity
whatsoever of a corporation, partnership, proprietorship, be engaged in, compete with, be financially concerned or interested with, or
employed by any company carrying on the business of development or processing of magnesium anywhere in North or South America or Europe.
Upon the death or disability of Mr. Sauv&#233; such that, in the view of our directors other than Mr. Sauv&#233;, Mr. Sauv&#233;
is not able to carry out his responsibilities, we may terminate Mr. Sauv&#233;&#8217;s employment by providing Mr. Sauv&#233; or
his estate with pay and severance pay, if applicable, in the amount of one (1) month&#8217;s base salary payable monthly. In the event
we terminate Mr. Sauv&#233;&#8217;s employment without cause within 12 months of a Change of Control (as defined below) or Mr. Sauv&#233;
terminates his employment for Good Reason (as defined below) within 12 months of a Change of Control, Mr. Sauv&#233; is entitled to
receive from us one month&#8217;s base salary and any minimum entitlements to written notice of termination, payment in lieu of such
notice, or a combination of written notice and payment in lieu of such notice, at our sole discretion, required by the BCESA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Robert
Ramsey Hamady</i>. </b>Our CFO, Robert Ramsey Hamady signed an Executive Employment Agreement effective as of March 7, 2022 (the &#8220;Hamady
Agreement&#8221;) pursuant to which we agreed to pay him <span style="background-color: white">an annual base salary of USD$350,000.
The term of the agreement is for a period of three years and may be terminated by us for cause as defined in the agreement, without cause
effective 60 days after notice or for good reason by Mr. Hamady as defined in the agreement, which includes a &#8220;Change in Control.&#8221;
</span>Mr. Hamady is entitled to receive a USD$25,000 signing bonus on March 15, 2022 and will be eligible to earn an annual discretionary
bonus upon meeting or exceeding our achievement of annual financial and operating targets and Mr. Hamady&#8217;s performance targets
(&#8220;Bonus&#8221;). The amount of the Bonus, if any, and specific targets for the Bonus will be determined by us in our sole and absolute
discretion. Mr. Hamady was granted stock options to purchase 500,000 shares of our common stock. The stock options vest immediately and
are exercisable at a price of $0.40 per share for a period of five years from the date of grant. Mr. Hamady will be entitled to severance
in the amount of six (6) months of his then base salary if he is terminated without cause by us or he terminates the Hamady Agreement
for &#8220;Good Reason&#8221; as defined therein, payable in the form of a lump-sum payment. Mr. Hamady&#8217;s receipt of severance
is subject to his execution and non-revocation of a waiver and release agreement and his cooperation during the one year period following
his termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Change
of Control&#8221; is generally defined in the Lee Contract, S. Ataya Contract, Hamady Agreement, Maxwell Contract, R. Ataya Contract
and Sauv&#233; Contract (collectively, the &#8220;Management Contracts&#8221;) as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    acquisition, directly or indirectly, of voting our securities (including securities of the Company on which conversion will become
    voting securities) by any person or group of persons acting in concert such that such person or group of persons are able for the
    first time to affect materially the control of our company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    merger, amalgamation or other business combination of us with or into another entity, or any other corporate reorganization, if more
    than 50% of the combined voting power of the continuing or surviving entity&#8217;s securities outstanding immediately thereafter
    are owned by persons who were not our security holders immediately prior to such merger, amalgamation, business combination or reorganization;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exercise of the voting power of any of all of our securities so as to cause or result in the election of a majority of members of
    the Board who were not previously incumbent directors thereof;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    completion of a tender offer, an exchange offer, a take-over bid or any other offer or bid by an entity, person or group (other than
    with us or a wholly-owned subsidiary of ours) of more than 50% of our issued and outstanding voting securities; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sale, transfer or disposition by us of all or substantially all of our assets.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Good
Reason&#8221; is generally defined in the Management Contracts as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    material and detrimental change in the title, position, duties and responsibilities, authority or status of the executive with us;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    material breach by us of the employment agreement; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    material reduction of the executive&#8217;s base salary.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview
of Executive Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is authorized to review and approve annually all compensation decisions relating to our executive officers. In accordance
with reduced disclosure rules applicable to emerging growth companies as set forth in Item 402 of Regulation S-K, this section explains
how our compensation program is structured for its Chief Executive Officer and the other executive officers named in the 2021 Summary
Compensation Table (the &#8220;named executive officers&#8221; or &#8220;NEOs&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Governance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have created a Compensation Committee, the members of which are Stephen Thorlakson, Jeff Wilson and Rabih Ataya.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
tasks related to developing and monitoring our approach to the compensation of our NEOs and directors are performed initially by the
Compensation Committee and reviewed and approved by the members of the Board. The compensation of the NEOs, directors and our employees
or consultants is recommended and approved by the Board without reference to any specific formula or criteria. NEOs that are also directors
of our company are involved in discussions relating to compensation, and disclose their interest in and abstain from voting on compensation
decisions relating to them, as applicable, in accordance with the applicable corporate legislation. Our compensation program is intended
to attract, motivate, reward and retain the management talent needed to achieve our business objectives of improving overall corporate
performance and creating long term value for our shareholders. The compensation program is intended to reward executive officers on the
basis of individual performance and achievement of corporate objectives, including the advancement of our exploration and development
goals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current compensation program is comprised of three major components: base salary or fees, short-term incentives such as discretionary
bonuses and long-term incentives such as stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making compensation decisions, the Compensation Committee and the Board strive to find a balance between short-term and long-term compensation
and cash versus equity incentive compensation. Base salaries or fees and discretionary cash bonuses primarily reward recent performance
and incentive stock options encourage NEOs and directors to continue to deliver results over a longer period of time and serve as a retention
tool. The annual salary or fee for each NEO, as applicable, is recommended by the Compensation Committee and determined by the Board
based on the level of responsibility and experience of the individual, the relative importance of the position to us, the professional
qualifications of the individual and the performance of the individual over time. The NEOs&#8217; performances and salaries or fees are
to be reviewed periodically. Increases in salary or fees are to be evaluated on an individual basis and are performance and market-based.
The amount and award of cash bonuses to key executives and senior management is discretionary, depending on, among other factors, the
financial targeted goal, employee retention and advancement within our company. The Executive Chairman and CEO make the recommendation
which is then sent to the Board for their approval. A peer group is not used to determine compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pension
Plan Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have any pension, defined benefit, defined contribution or deferred compensation plans in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Long-Term
Equity Incentive Awards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
long-term component of compensation for executive officers, including the Named Executive Officers, will be based on equity awards issued
pursuant to the Western Magnesium Corporation 2021 Equity Incentive Plan (the &#8220;2021 Equity Incentive Plan&#8221;) that was approved
by our shareholders on June 11, 2021. The 2021 Equity Incentive Plan permits the grant of the following (collectively, the &#8220;Awards&#8221;):
(i) nonqualified stock options (&#8220;NQSOs&#8221;) and incentive stock options (&#8220;ISOs&#8221;) (collectively, &#8220;Options&#8221;);
(ii) stock appreciate rights (&#8220;SARs&#8221;); (iii) restricted stock (&#8220;Restricted Stock&#8221;) and restricted stock units
(&#8220;RSUs&#8221;); (iv) performance awards; (v) dividend equivalents; and (vi) other stock-based awards. This component of compensation
is intended to reinforce management&#8217;s commitment to long term improvements in our performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2021 Equity Incentive Plan is to enable us and certain of our subsidiaries to obtain and retain services of the eligible
participants, which is essential to our long-term success. The granting of Options and other Awards under the 2021 Equity Incentive Plan
is intended to promote our long-term financial interests and growth and the long-term financial interests and growth of our subsidiaries
by attracting and retaining management and other personnel and key service providers with the training, experience and ability to enable
them to make a substantial contribution to the success of our business. Moreover, the 2021 Equity Incentive Plan aims to align the interests
of eligible participants with those of our shareholders through opportunities for increased equity-based ownership in our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Outstanding
Equity Awards at 2021 Fiscal Year-End</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth outstanding equity awards for our named executive officers at fiscal 2021 year-end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Option
    Awards</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Name
    and Principal Position</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Number
    of<br />
 Securities<br />
 Underlying<br />
 Unexercised<br />
 Options &#8211;<br />
 Exercisable (#)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Number
    of<br />
 Securities<br />
 Underlying<br />
 Unexercised<br />
 Options &#8211;<br />
 Un-exercisable (#)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Equity
                                            Incentive<br />
 Plan Awards:<br />
 Number of<br />
 Securities<br />
 Underlying<br />
 Unexercised<br />
 Unearned<br />
 Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(#)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Option
    Exercise<br />
 Price (CAD$)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Option
    Expiration<br />
 Date</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Number
    of<br />
 Shares or Units<br />
 of Stock That<br />
 Have Not<br />
 Vested (#)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Market
    Value of<br />
 Shares or Units<br />
 of Stock That<br />
 Have Not<br />
 Vested ($)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Equity
    Incentive<br />
 Plan Awards:<br />
 Number of<br />
 Unearned<br />
 Shares, Units or<br />
 Other Rights<br />
 That Have Not<br />
 Vested (#)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 26%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Sam
    Ataya</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.05</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2023-12-03</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Director,</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2024-05-22</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Executive</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">650,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025-04-23</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">President</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025-12-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">and
    CEO</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2026-08-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Edward
    Lee</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">250,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.05</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022-03-27</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Director,</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">750,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.05</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2023-08-12</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Executive</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">850,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.05</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2023-12-03</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chairman
    and</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,300,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2024-05-22</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">former
    President</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">700,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025-04-23</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">and
    CEO</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025-12-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2026-08-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Lisa
    Maxwell</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">250,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.05</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022-03-27</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">President,
    Global</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">300,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.05</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2023-12-03</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Operations
    and</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2024-05-22</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">COO</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">400,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025-04-23</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">750,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022-12-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2026-08-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Rabih
    Ataya</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">250,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2024-05-22</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Director
    and EVP,</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">250,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.15</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2024-11-03</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Special
    Projects</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">200,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025-04-23</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022-12-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2026-08-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Paul
    Sauv&#233;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">100,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.11</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025-03-26</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">EVP,
    Operations</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">150,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2025-04-23</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">and
    CTO</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">750,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.13</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2022-12-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.70</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2026-08-30</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Retirement
Benefit Plans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any pension, defined benefit, defined contribution or deferred compensation plans in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Termination
and Change of Control Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described below, we do not have any contract, agreement, plan or arrangement that provides for payments to a named executive officer
at, following or in connection with a termination (whether voluntary, involuntary or constructive), resignation, retirement, a change
of control of our company or a change in a named executive officer&#8217;s responsibilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each of the foregoing agreements, the following table summarizes the estimated incremental payments that are triggered by, or result
from, change of control, severance, termination or constructive dismissal (assuming such events had occurred on or before October 31,
2021):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NEO
    or Director</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payout
    for Termination Without Cause by the Company / Change of Control <sup>(1)</sup> / Good Reason <sup>(2)</sup></b></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam
    Ataya, <i>Director, Executive President and CEO</i></span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rabih
    Ataya, <i>EVP, Special Projects</i></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">90,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisa
    Maxwell, <i>President, Global Operations and COO</i></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Lee, <i>Director and Executive Chairman</i></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,000,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Sauv&#233;, <i>EVP, Operations and CTO</i></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    by us without cause within 12 months of a Change of Control.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    by the Executive for Good Reason within 12 months of a Change of Control.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all compensation paid to or earned by each of our directors during fiscal year 2021, except for compensation
with respect to Messrs. Sam Ataya, Lee, Rabih Ataya, and O&#8217;Rourke. Information with respect to the compensation of these current
and former directors is included above in the &#8220;2021 Summary Compensation Table&#8221; except for O&#8217;Rourke. As our executive
officers, none of these directors (other than as described above) received any compensation for service as a director during fiscal year
2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fiscal
2021 Director Compensation Table</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
                                            Earned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            Cash <sup>(1)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            <sup>(2)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-qualified</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 37%; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Michael
                                            Pickholz</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Former
                                            Director <sup>(3)</sup></b></span></p></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">96,904</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">106,320</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">203,224</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stephen
                                            Thorlakson</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
                                            Director</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,291</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,291</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jeff
                                            Wilson</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
                                            Director</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">143,885</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">143,885</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    cash compensation during the fiscal year ended October 31, 2021.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 71; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts reported in the Stock Awards and the Option Awards columns reflect aggregate grant date fair value computed in accordance
    with ASC Topic 718, Compensation&#8212;Stock Compensation. These amounts reflect our calculation of the value of these awards at
    the grant date and do not necessarily correspond to the actual value that may ultimately be realized by the named executive officer.
    Assumptions used in the calculation of these amounts are included in Note <i>14</i> to our audited consolidated financial statements
    for the fiscal year ended October 31, 2021, which are included elsewhere in this registration statement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Pickholz was appointed as a director on October 18, 2018 and resigned on November 27, 2020. Mr. Pickholz&#8217;s reported All Other
    Compensation for 2021 was consulting fees for consulting services provided and he was not separately compensated as a director.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Authorized for Issuance under Equity Compensation Plans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth securities authorized for issuance under any equity compensation plans approved by our stockholders as well
as any equity compensation plans not approved by our stockholders as of October 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            be issued upon</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding
                                            options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrant
                                            and rights</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise
                                            price of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding
                                            options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants
                                            and rights</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining
                                            available</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            future issuance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>under
                                            equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>compensation
                                            plans</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Plan
    Category</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(#)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(CAD$)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(#)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 46%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity
    compensation plans approved by security holders</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,260,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.33</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,892,368</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Equity
    compensation plans not approved by security holders</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,260,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.33</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,892,368</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sur_003"></span>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT<sup></sup></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the beneficial ownership of our common stock as of May 16, 2022 for (i) each member of our board of directors,
(ii) each named executive officer, (iii) each person known to us to be the beneficial owner of more than 5% of our securities and (iv)
the members of our board of directors and our executive officers as a group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, the business address for each of the beneficial owners is c/o Western Magnesium Corporation, 8180 Greensboro Drive,
Suite 720, McLean, Virginia, United States 22102.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name,
    Position and Address of Beneficial Owner</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.
                                            of Shares of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
                                            Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficially
                                            Owned</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
                                            Stock<sup>(1)</sup></b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rabih
                                            Ataya <sup>(2)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
                                            and EVP, Special Projects</span></p></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,700,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sam
                                            Ataya <sup>(3)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
                                            Executive President and CEO</span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,082,655</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.54</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Edward
                                            Lee <sup>(4)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
                                            Executive Chairman and former President and CEO</span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,014,850</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.75</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lisa
                                            Maxwell <sup>(5)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
                                            Global Operations and COO</span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,609,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.27</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Robert
                                            Ramsey Hamady <sup>(6)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.11</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Peter
                                            O&#8217;Rourke <sup>(7)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
                                            and President, US Operations</span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,500,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.34</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paul
                                            Sauv&#233; <sup>(8)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVP,
                                            Operations and CTO</span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,040,837</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.46</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stephen
                                            Thorlakson <sup>(9)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,249,791</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.74</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jeff
                                            Wilson <sup>(10)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,650,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.38</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">All
    directors and executive officers as a group</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,347,133</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12.12</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Five
    Percent Shareholders:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpha
    Capital Anstalt <sup>(11)</sup></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,255,011</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.59</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    percentages in the table have been calculated on the basis of treating as outstanding for a particular person, all shares of our
    capital stock outstanding on May 16, 2022. On May 16, 2022, there were 437,926,611 shares of our common stock outstanding. To calculate
    a stockholder&#8217;s percentage of beneficial ownership, we include in the denominator the common stock outstanding and all shares
    of our common stock issuable to that person in the event of the exercise of outstanding options, warrants and other derivative securities
    owned by that person which are exercisable within 60 days of May 16, 2022. Common stock warrants and derivative securities held by
    other stockholders are disregarded in this calculation. Therefore, the denominator used in calculating beneficial ownership among
    our stockholders may differ. Unless we have indicated otherwise, each person named in the table has sole voting power and sole investment
    power for the shares listed opposite such person&#8217;s name.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) no shares of common stock, (ii) 450,000 options to purchase common stock at an exercise price of CAD$0.12 per
    share, (iii) 250,000 options to purchase common stock at an exercise price of CAD$0.15 per share, (iv) 500,000 options to purchase
    common stock at an exercise price of CAD$0.13 per share, and (v) 500,000 options to purchase common stock at an exercise of CAD$0.70
    per share. The stock options fully vested upon award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) 769,230 shares of common stock, (ii) 9,163,425 shares of common stock issued to a company where Mr. Ataya is principal,
    (iii) 3,000,000 options to purchase common stock at an exercise price of CAD$0.05 per share, (iv) 2,650,000 options to purchase common
    stock at an exercise price of CAD$0.12 per share, (v) 4,500,000 options to purchase common stock at an exercise price of CAD$0.13
    per share, and (vi) 5,000,000 options to purchase common stock at an exercise of CAD$0.70 per share. The stock options fully vested
    upon award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) 1,414,850 shares of common stock, (ii) 1,600,000 options to purchase common stock at an exercise price of CAD$0.05
    per share, (iii) 3,000,000 options to purchase common stock at an exercise price of CAD$0.12 per share, (iv) 5,000,000 options to
    purchase common stock at an exercise price of CAD$0.13 per share and (v) 6,000,000 options to purchase common stock at an exercise
    price of CAD$0.70 per share. The stock options fully vested upon award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) 159,000 shares of common stock, (ii) 300,000 options to purchase common stock at an exercise price of CAD$0.05
    per share, (iii) 900,000 options to purchase common stock at an exercise price of CAD$0.12 per share, (iv) 750,000 options to purchase
    common stock at an exercise price of CAD$0.13 per share, and (v) 3,500,000 options to purchase common stock at an exercise price
    of CAD$0.70 per share. The stock options fully vested upon award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) no shares of common stock, and (ii) 500,000 options to purchase common stock at an exercise price of CAD$0.40
    per share. The stock options fully vested upon award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) 500,000 shares of common stock, (ii) 500,000 options to purchase common stock at an exercise price of CAD$0.13
    per share, and (iii) 500,000 options to purchase common stock at an exercise price of CAD$0.70 per share. The stock options fully
    vested upon award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) 40,837 shares of common stock, (ii) 100,000 options to purchase common stock at an exercise price of CAD$0.11
    per share, (iii) 150,000 options to purchase common stock at an exercise price of CAD$0.15 per share, (iv) 750,000 options to purchase
    common stock at an exercise price of CAD$0.13 per share, and (v) 1,000,000 options to purchase common stock at an exercise price
    of CAD$0.70 per share. The stock options fully vested upon award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) 2,249,791 shares of common stock, (ii) 400,000 options to purchase common stock at an exercise price of CAD$0.12
    per share, (iii) 300,000 options to purchase common stock at an exercise price of CAD$0.13 per share, and (iv) 300,000 options to
    purchase common stock at an exercise price of CAD$0.70 per share. The stock options fully vested upon award.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) 550,000 shares of common stock, (ii) 250,000 options to purchase common stock at an exercise price of CAD$0.05
    per share, (iii) 350,000 options to purchase common stock at an exercise price of CAD$0.12 per share, (iv) 200,000 options to purchase
    common stock at an exercise price of CAD$0.13 per share, and (v) 300,000 options to purchase common stock at an exercise price of
    CAD$0.70 per share. The stock options fully vested upon award.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    the following: (i) 1,774,500 shares of common stock held and 9,000,000 shares of common stock issuable upon conversion of a 12% convertible
    note in the original principal amount of $1,500,000 issued on June 15, 2021 with a current principal balance of $900,000 plus
    accrued interest of $207,222 (the &#8220;June 2021 Convertible Debenture&#8221;), (ii) 3,000,000 Class A Warrants held and 5,536,110
    Class A Warrants issuable upon conversion of the June 2021 Convertible Debenture to purchase common stock at an exercise price
    of $0.13 until June 10, 2026, (iii) 3,000,000 Class B Warrants held and 5,536,110 Class B Warrants issuable upon conversion
    of the June 2021 Convertible Debenture to purchase common stock at an exercise price of $0.19 until June 10, 2026, (iv) 8,168,037
    shares of common stock issuable upon conversion of a 15% convertible note in the original principal amount of $2,000,000 plus
    accrued interest of $450,411 issued on April 14, 2022 (the &#8220;April 2022 Convertible Debenture&#8221;), and (v) 8,168,037
    warrants issuable upon conversion of the April 2022 Convertible Debenture to purchase common stock at an exercise price of $0.40
    for a period of five years after the date of issuance.&#160;&#160; The address for Alpha Capital Anstalt is Altenbach 8, FL-9490
    Vaduz, Liechtenstein. The Debentures and Warrants are subject to a beneficial ownership transaction which restrict Alpha Capital
    Anstalt&#8217;s ability to convert any portion of the Convertible Debentures or exercise the Warrants if it would result in Alpha
    Capital Anstalt owning in excess of 9.99% of the outstanding shares of the Company&#8217;s common stock.</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sur_004"></span>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the compensation arrangements, including employment, termination of employment and change in control arrangements and indemnification
arrangements, discussed in &#8220;Executive Compensation&#8221; above, the following is a description of each transaction since November
1, 2020 and each currently proposed transaction in which:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have been or will be a participant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed
    fiscal years; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    of our directors, executive officers or beneficial owners of more than 5% of our capital stock, or any immediate family member of,
    or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
parties include any person who is or was (since the beginning of the last fiscal year, even if such person does not presently serve in
that role) our executive officer or director, any shareholder owning more than 5% of any class of our voting securities or an immediate
family member of any such person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
potential related party transaction that requires approval will be reviewed and overseen by the Audit Committee, and the Audit Committee
will consider such factors as it deems appropriate to determine whether to approve, ratify or disapprove the related party transaction.
The Audit Committee may approve the related party transaction only if it determines in good faith that, under all of the circumstances,
the transaction is in the best interests of us and our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transactions
with Related Parties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(1)
Sam Ataya</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Ataya is a director, Executive President and Chief Executive Officer of the Company. Mr. Ataya is also principal of The Stirling Group
(&#8220;Stirling&#8221;). Stirling is a consulting company that provides us with management and operational services and has been involved
in facilitating payment of expenses related to the ongoing construction of our planned magnesium research and development pilot plant
and to obtain necessary permits and authorizations to construct and operate the facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ending October 31, 2021, we provided advances to Stirling on our behalf for anticipated future costs related to our planned
magnesium research and development pilot plant and other administrative expenses (the &#8220;Pilot Plant Advances&#8221;). During the
fiscal year ended October 31, 2021, we advanced Stirling the aggregate amount of $987,912, of which Stirling used $696,431 for costs
and expenses leaving a balance of $291,481 as of October 31, 2021. During the three months ended January 31, 2022, we advanced Stirling
the aggregate amount of $300,000 related to Pilot Plant Advances, of which Stirling used $79,793 for costs and expenses, including a
foreign exchange effect of $13,193, leaving a balance of $524,881 as of January 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into a sublease agreement with Stirling for our Canadian office at 580 Hornby Street, Suite 900, Vancouver, British
Columbia, Canada V6C 3B6. The lease had a two-year term from April 1, 2019 to March 31, 2021 and required a monthly payment of CAD$9,345
for a total of CAD$224,280. The sublease agreement has been renewed for another two-year term from April 1, 2021 to March 31, 2023 and
requires a monthly payment of CAD$9,794 for a total of CAD$235,056.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an agreement entered on August 29, 2018 between the Company and Stirling, and which was approved by the TSXV on September 12, 2018,
Stirling is eligible to receive up to 5% of the issued and outstanding common shares of the Company as at August 28, 2018 for up to $5
million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued 9,163,425
common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614) as share issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, the Company received an unsecured loan of CAD$150,000 (USD equivalent $112,895) from Mr. Ataya.
The loan bore interest at 18% and was due on demand. During the fiscal year ended October 31, 2020, the loan was increased by an additional
CAD$60,000 (USD equivalent $44,588) to CAD$210,000 (USD equivalent $157,483) and was due on September 24, 2021. During the fiscal year
ended October 31, 2021, we have repaid the entire principal balance and all interests accrued in the amount of CAD$26,724 (USD equivalent
$19,944).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(2)
Lisa Maxwell</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Maxwell is President, Global Operations and COO of the Company. Ms. Maxwell is also principal of Sequoia Corporate Services Inc. (&#8220;Sequoia&#8221;).
Sequoia is a consulting company that provides us with management and operational services and has been involved in facilitating payment
of expenses related to the ongoing construction of our planned magnesium research and development pilot plant and to obtain necessary
permits and authorizations to construct and operate the facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the current fiscal year ending October 31, 2021, we provided Pilot Plant Advances to Sequoia. During the fiscal year ended October 31,
2021, we advanced Sequoia the aggregate amount of $2,292,912, of which Sequoia used $2,097,931 of such advances for costs and expenses
leaving a balance of $194,981 as of October 31, 2021. During the three months ended January 31, 2022, we advanced Sequoia the aggregate
amount of $522,335 related to Pilot Plant Advances, of which Sequoia used $675,390 for costs and expenses, including a negative foreign
exchange effect of $1,066, leaving a balance of $40,860 as of January 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
Independence</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of director independence of our board members, see &#8220;Management &#8211; Director Independence&#8221; on page 59
of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sur_005"></span>DESCRIPTION
OF SECURITIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following is a description of our capital stock and the material provisions of our certificate of incorporation, our amended and restated
certificate of incorporation, bylaws (as amended) and other agreements to which we and our shareholders are parties, in each case as
of the date of this prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 1,000,000,000 shares of common stock, par value $0.001 per share. As of the date of this prospectus,
there were 437,926,611 shares of our common stock issued and outstanding held of record by 678 stockholders. &#160;&#160;At our June
11, 2021 annual and special meeting of shareholders, our shareholders approved a special resolution authorizing us to amend and restate
our Certificate of Incorporation, to include (a) an amendment for the purpose of authorizing up to 100,000,000 shares of undesignated
preferred stock, and (b) certain other corporate maintenance matters (the &#8220;Amended and Restated Certificate of Incorporation&#8221;).
We filed the Amended and Restated Certificate of Incorporation on May 13, 2022. Any designation of preferences and rights of the preferred
stock requires the TSXV&#8217;s approval. Following TSXV approval, our board of directors may from time to time authorize by resolution
the issuance of any or all shares of our common stock or preferred stock authorized in accordance with the terms and conditions set forth
in the amended and restated certificate of incorporation for such purposes, in such amounts, to such persons, corporations, or entities,
for such consideration and in the case of the preferred stock, in one or more series, all as our board of directors in its discretion
may determine and without any vote or other action by the stockholders, except as otherwise required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
description of the material terms and provisions of our certificate of incorporation affecting the rights of holders of our capital stock
is set forth below. The description is intended as a summary only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting</i>.
</b>The holders of our common stock are entitled to one vote for each outstanding share of common stock owned by that stockholder on
every matter properly submitted to the stockholders for their vote. Stockholders are not entitled to vote cumulatively for the election
of directors. Except for the election of directors, which are elected by a plurality vote, a majority vote of common stockholders is
generally required to take action under our certificate of incorporation and bylaws, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conversion,
Redemption and Preemptive Rights</i></b>. Holders of our common stock have no conversion, redemption, preemptive, subscription or similar
rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividend
Rights</i></b>. Subject to the rights of holders of preferred stock, holders of our common stock shall be entitled to receive such cash
dividends as may be declared thereon by our board of directors from time to time out of assets of funds of our company legally available
for the payment of dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred
Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Certificate of Incorporation
authorizes to issue up to 100,000,000 shares of preferred stock. Subject to TSXV approval, our board of directors
will have the authority to issue this preferred stock in one or more series and to fix the number of shares and the relative rights,
conversion rights, voting rights and terms of redemption (including sinking fund provisions) and liquidation preferences, without further
vote or action by the stockholders. If shares of preferred stock with voting rights are issued, such issuance could affect the voting
rights of the holders of our common stock by increasing the number of outstanding shares having voting rights, and by the creation of
class or series voting rights. If our board of directors authorized the issuance of shares of preferred stock with conversion rights,
the number of shares of common stock outstanding could potentially be increased by up to the authorized amount. Issuance of preferred
stock could, under certain circumstances, have the effect of delaying or preventing a change in control of our company and may adversely
affect the rights of the holders of our common stock. Also, preferred stock could have preferences over our common stock (and other series
of preferred stock) with respect to dividend and liquidation rights. We currently have no plans to issue any preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities between February 22, 2017 and May 10, 2017, we issued 13,051,460 warrants with an exercise
price of CAD$0.05 per share. These warrants are exercisable for a period of five years after the date of issuance. In connection with
this transaction, we issued 263,626 broker&#8217;s warrants with an exercise price of CAD$0.05 per share for a period of five years.
As of the date of this prospectus, 11,686,260 warrants were exercised and 1,365,200 warrants were expired unexercised, and 209,901 broker
warrants were exercised and 53,725 broker warrants were expired unexercised. The warrants were subject to an acceleration clause in the
years three, four and five whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require a holder
to exercise the warrants within 30 days should the closing price of our common stock exceeds the exercise price of the warrants by 25%
of more for at least ten consecutive trading days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities on August 15, 2017, we issued 1,570,000 warrants with an exercise price of CAD$0.05
per share. These warrants are exercisable for a period of five years after the date of issuance. As of the date of this prospectus, all
of these warrants were exercised. The warrants were subject to an acceleration clause in the years three, four and five whereby the Company
had the right, upon provision of thirty days&#8217; written notice, to require a holder to exercise the warrants within 30 days should
the closing price of our common stock exceeds CAD$0.0625 per share for at least ten consecutive trading days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities on January 20, 2020, we issued 3,643,791 warrants with an exercise price of CAD$0.21
per share. These warrants are exercisable for a period of one year after the date of issuance. Subsequent to October 31, 2020, we extended
the expiration date of the warrants to August 31, 2021. As of the date of this prospectus, 3,118,618 warrants were exercised and 525,173
warrants were expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities between November 20, 2020 and April 27, 2021, we issued 25,787,255 warrants with an
exercise price of CAD$0.19 per share. These warrants are exercisable for a period of one year after the date of issuance. As of the date
of this prospectus, 21,469,859 warrants were exercised and 4,317,396 warrants were expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities between May 28, 2021 and June 17, 2021, we issued 23,076,926 warrants with an exercise
price of CAD$0.19 per share. These warrants are exercisable for a period of one year after the date of issuance. As of the date of this
prospectus, 20,724,364 of these warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities on July 16, 2021, we issued 4,350,000 warrants with an exercise price of CAD$0.30 per
share. These warrants are exercisable for a period of one year after the date of issuance. As of the date of this prospectus, 4,289,040
of these warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities on August 11, 2021, we issued 3,827,601 warrants with an exercise price of CAD$0.65
(USD$0.52) per share. These warrants are exercisable for a period of eighteen months after the date of issuance. As of the date of this
prospectus, 3,827,601 of these warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities on November 26, 2021, we issued 1,375,499 warrants with an exercise price of $0.75
per share. These warrants are exercisable for a period of one year after the date of issuance. As of the date of this prospectus, 1,375,499
of these warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with partial conversions of the June 2021 Convertible Debenture between November 3, 2021 and April 27, 2022, we issued 3,000,000
Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 3,000,000 Class B Warrants exercisable at a price of $0.19
until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with conversion of the July 2021 Convertible Debenture on April 22, 2022, we issued 933,333 warrants with an exercise price
of CAD$0.20 per share. These warrants are exercisable for a period of two years after the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with a private offering of securities on May 9, 2022, we issued 1,727,000 warrants with an exercise price of $0.45 per share.
These warrants are exercisable for a period of one year after the date of issuance. As of the date of this prospectus, 1,727,000 of these
warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Provisions
of our Amended and Restated Certificate of Incorporation that May Have an Anti-Takeover Effect</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than our authorized but unissued common stock and &#8220;blank-check&#8221; preferred stock following the filing of the Amended and Restated
Certificate of Incorporation available for future issuance without stockholder approval, as described under &#8220;Common Stock&#8221;
and &#8220;Preferred Stock&#8221; above, our certificate of incorporation does not contain any provisions that may be deemed to have
an anti-takeover effect or may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider to be in
its best interests, including attempts that might result in a premium being paid over the market price for the shares held by stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Delaware
Takeover Statute</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 of the Delaware General Corporation Law prohibits a Delaware corporation that is a public company from engaging
in any &#8220;business combination&#8221; (as defined below) with any &#8220;interested stockholder&#8221; (defined generally as an entity
or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with
such entity or person) for a period of three years following the date that such stockholder became an interested stockholder, unless:
(1) prior to such date, our board of directors of the corporation approved either the business combination or the transaction that resulted
in the stockholder becoming an interested stockholder; (2) on consummation of the transaction that resulted in the stockholder becoming
an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time
the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned (x) by persons who
are directors and also officers and (y) by employee stock plans in which employee participants do not have the right to determine confidentially
whether shares held subject to the plan will be tendered in a tender or exchange offer; or (3) on or subsequent to such date, the business
combination is approved by our board of directors and authorized at an annual or special meeting of stockholders, and not by written
consent, by the affirmative vote of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
203 of the Delaware General Corporation Law defines &#8220;business combination&#8221; to include: (1) any merger or consolidation involving
the corporation and the interested stockholder; (2) any sale, transfer, pledge or other disposition of 10% or more of the assets of the
corporation involving the interested stockholder; (3) subject to certain exceptions, any transaction that results in the issuance or
transfer by the corporation of any stock of the corporation to the interested stockholder; (4) any transaction involving the corporation
that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by
the interested stockholder; or (5) the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges
or other financial benefits provided by or through the corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Potential
for Anti-Takeover Effects</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
certain provisions of Delaware law may have an anti-takeover effect, these provisions are intended to enhance the likelihood of continuity
and stability in the composition of our board of directors and in the policies formulated by the board, and to discourage certain types
of transactions that may involve an actual or threatened change of control. In that regard, these provisions are designed to reduce our
vulnerability to an unsolicited acquisition proposal. The provisions also are intended to discourage certain tactics that may be used
in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and,
as a consequence, they also may inhibit fluctuations in the market price of our common stock that could result from actual or rumored
takeover attempts. Such provisions also may have the effect of preventing changes in our management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Choice
of Forum</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws, as amended, provide that the Court of Chancery of the State of Delaware will be the exclusive forum for any derivative action
or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising
under the Delaware General Corporation Law, our certificate of incorporation or our bylaws, as amended; any action to interpret, apply,
enforce or determine the validity of our certificate of incorporation or our bylaws, as amended; and any action asserting a claim against
us that is governed by the internal affairs doctrine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
exclusive forum provisions may limit a stockholder&#8217;s ability to bring certain claims in a judicial forum that it finds favorable
for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors,
officers and other employees. Alternatively, if a court were to find either exclusive forum provision in our bylaws, as amended, to be
inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving such action in
other jurisdictions, all of which could have a material adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
exclusive forum provisions will not apply, however, to actions arising under the Securities Act or the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transfer
Agent and Registrar</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent for our shares of common stock is Odyssey Trust Company, United Kingdom Building, 409 Granville Street, Suite 350, Vancouver,
British Columbia, Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sur_006"></span>SELLING
SECURITYHOLDER</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholder may offer and sell, from time to time, any or all of the shares of our common stock underlying the Convertible
Debentures and Warrants and all the shares of our common stock registered for resale covered by this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
Securityholder is offering for resale the issuance of 19,240,256 shares of our common stock underlying the Convertible Debentures,
which entitle the holder to convert the principal and interest under the Convertible Debentures at a price of $0.10 per share for $900,000
principal amount convertible debentures and $0.30 per share for a $2,000,000 principal amount convertible debenture, (ii) the issuance
by the Company of an aggregate of 25,240,256 shares of our common stock underlying the Warrants, which entitle the holder to purchase
one share of our common stock at an exercise price of $0.13 per share for 8,536,110 warrants, $0.19 per share for 8,536,110
warrants and $0.40 per share for 8,168,037 warrants and 1,774,500 shares of Common Stock which we issued to the Selling Securityholder
upon the partial exercise of the Convertible Debentures, are being registered by the registration statement of which this prospectus
forms a part pursuant to registration rights granted to the Selling Securityholder in connection with the issuances of such Convertible
Debentures and Warrants. See the section entitled &#8220;Plan of Distribution&#8221; for further information regarding the Selling Securityholder&#8217;
method of distributing these securities. For purposes of this prospectus, we have assumed a conversion price of the Convertible Debentures
of $0.10 per share for principal amount $900,000 and $0.30 per share of our common stock for $2,000,000 principal amount. For purposes
of this prospectus, we have assumed an exercise price of the Warrants of $0.13 per share of our common stock for 8,536,110 warrants,
$0.19 per share of our common stock for 8,536,110 warrants and $0.40 per share of our common stock for 8,168,037 warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides, as of May 16, 2022, information regarding the beneficial ownership of our common stock, Warrants and Convertible
Debentures held by the Selling Securityholder, the securities that may be sold by the Selling Securityholder under this prospectus and
the number and percentage of securities that the Selling Securityholder will beneficially own after this offering. Applicable percentages
are based on 19,240,256 shares of our common stock underlying the Convertible Debentures, 25,240,256 shares of our common
stock underlying the Warrants as of May 16, 2022 and 1,774,500 shares of our Common Stock held which we issued to the Selling Securityholder
upon the partial exercise of the Convertible Debentures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholder is not making any representation that any shares of our common stock covered by this prospectus will be offered
for sale. Because the Selling Securityholder may dispose of all, none or some portion of their securities, no estimate can be given as
to the number of securities that will be beneficially owned by a Selling Securityholder upon termination of this offering. For purposes
of the table below, however, we have assumed that after termination of this offering none of the securities covered by this prospectus
will be beneficially owned by the Selling Securityholder and further assumed that the Selling Securityholder will not acquire beneficial
ownership of any additional securities during the offering. In addition, the Selling Securityholder may have sold, transferred or otherwise
disposed of, or may sell, transfer or otherwise dispose of, at any time and from time to time, our securities in transactions exempt
from the registration requirements of the Securities Act after the date on which the information in the table is presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may amend or supplement this prospectus from time to time in the future to update or change this Selling Securityholder list and the
securities that may be resold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the section entitled &#8220;Plan of Distribution&#8221; for further information regarding the stockholders&#8217; method of distributing
these shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares of Common Stock Beneficially Owned Prior to Offering</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Maximum
    Number of Common Stock to be Offered Pursuant to this</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares of Common Stock Beneficially Owned after Offering</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name
    of Selling Stockholder</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    (1)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Percent
    (2)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Prospectus
    (3)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Percent
    (2)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Alpha
    Capital Anstalt (4)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,255,011</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.59</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,255,011</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts and percentages of our common stock beneficially owned are determined in accordance with the SEC&#8217;s rules, pursuant
    to which a person is deemed to be a &#8220;beneficial owner&#8221; of a security if that person has or shares voting or investment
    power or has the right to acquire such power within 60 days through exercise of any option, warrant or other right. Securities that
    can be so acquired are deemed to be outstanding for purposes of computing such person&#8217;s ownership percentage, but not for purposes
    of computing any other person&#8217;s percentage. Under these rules, more than one person may be deemed beneficial owner of the same
    securities, and a person may be deemed to be a beneficial owner of securities as to which such person has no economic interest. Except
    as otherwise indicated in these footnotes, each of the beneficial owners has, to our knowledge, sole voting and investment power
    with respect to the indicated shares of our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on 437,926,611 shares of common stock issued and outstanding as of May 16, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    shares of our common stock shown in this column includes shares of our common stock that are offered for resale by the Selling Securityholder
    pursuant to this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares of our common stock beneficially owned by Alpha Capital Anstalt (&#8220;Alpha Capital&#8221;) includes (a) 1,774,500
    shares of our common stock held, (b) 19,240,256 shares of our common stock issuable upon conversion of Convertible Debentures
    held by Alpha Capital, which Convertible Debentures are subject to, as applicable, certain beneficial ownership limitations, which
    provide that a holder of such Convertible Debentures will not have the right to convert any portion thereof if such holder, together
    with its affiliates, would beneficially own in excess of 9.99%, of the number of shares of our common stock outstanding immediately
    after giving effect to such conversion, provided that upon at least 61 days&#8217; prior notice to us, such holder may increase or
    decrease such limitation, and (c) 25,240,256 shares of our common stock issuable upon exercise of the Warrants held by Alpha
    Capital, which Warrants are subject to, as applicable, certain beneficial ownership limitations, which provide that a holder of such
    warrants will not have the right to exercise any portion thereof if such holder, together with its affiliates, would beneficially
    own in excess of 9.99% of the number of shares of our common stock outstanding immediately after giving effect to such exercise,
    provided that upon at least 61 days&#8217; prior notice to us, such holder may increase or decrease such limitation. Alpha Capital
    is the record and beneficial owner of the securities set forth in the table. Konrad Ackerman, a Director of Alpha Capital has <span style="background-color: white">voting
    control and investment discretion over the securities reported herein that are held by</span> Alpha Capital. The address of Alpha
    Capital is <span style="background-color: white">Altenbach 8, FL-9490 Vaduz, Liechtenstein.</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sur_007"></span>PLAN
OF DISTRIBUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the shares of our common stock that may be issued upon conversion of the Convertible Debentures issued pursuant to the
2021 SPA and the 2022 SPA and upon exercise of the Warrants issued pursuant to the terms of the 2021 SPA and the 2022 SPA to permit the
resale of these shares of our common stock by the holders of such shares and Warrants from time to time after the date of this prospectus.
We will not receive any of the proceeds from the sale by the Selling Securityholder of the shares of our common stock. We will bear all
fees and expenses incident to our obligation to register the shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholder may sell all or a portion of the shares of our common stock it beneficially owns and offered hereby from time
to time directly or through one or more underwriters, broker-dealers or agents. If the shares of our common stock are sold through underwriters
or broker-dealers, the Selling Securityholder will be responsible for underwriting discounts or commissions or agent&#8217;s commissions.
The shares of our common stock may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the
sale, at varying prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions, which may
involve crosses or block transactions, pursuant to one or more of the following methods:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the over-the-counter market;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions otherwise than on these exchanges or systems or in the over-the-counter market;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing of options, whether such options are listed on an options exchange or otherwise;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as
    principal to facilitate the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">short
    sales effected after the effective date of this Registration Statement;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    pursuant to Rule 144;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers
    may agree with the selling securityholder to sell a specified number of such shares at a stipulated price per share;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Selling Securityholder effects such transactions by selling shares of our common stock to or through underwriters, broker-dealers
or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from
the Selling Securityholder or commissions from purchasers of the shares of our common stock for whom they may act as agent or to whom
they may sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be
in excess of those customary in the types of transactions involved). In connection with sales of the shares of our common stock or otherwise,
the Selling Securityholder may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares
of our common stock in the course of hedging in positions they assume. The Selling Securityholder may also sell shares of our common
stock short and deliver shares of our common stock covered by this prospectus to close out short positions and to return borrowed shares
in connection with such short sales. The Selling Securityholder may also loan or pledge shares of our common stock to broker-dealers
that in turn may sell such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholder may pledge or grant a security interest in some or all of the shares of our common stock, Convertible Debentures
or Warrants owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer
and sell the shares of our common stock from time to time pursuant to this prospectus or any amendment to this prospectus under Rule
424(b)(3) or other applicable provision of the Securities Act of 1933, as amended, amending, if necessary, the list of Selling Securityholder
to include the pledgee, transferee or other successors in interest as Selling Securityholder under this prospectus. The Selling Securityholder
also may transfer and donate the shares of our common stock in other circumstances in which case the transferees, donees, pledgees or
other successors in interest will be the selling beneficial owners for purposes of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholder and any broker-dealer participating in the distribution of the shares of our common stock may be deemed to be
&#8220;underwriters&#8221; within the meaning of the Securities Act, and any commission paid, or any discounts or concessions allowed
to, any such broker-dealer may be deemed to be underwriting commissions or discounts under the Securities Act. At the time a particular
offering of the shares of our common stock is made, a prospectus supplement, if required, will be distributed which will set forth the
aggregate amount of shares of our common stock being offered and the terms of the offering, including the name or names of any broker-dealers
or agents, any discounts, commissions and other terms constituting compensation from the Selling Securityholder and any discounts, commissions
or concessions allowed or re-allowed or paid to broker-dealers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the securities laws of some states, the shares of our common stock may be sold in such states only through registered or licensed brokers
or dealers. In addition, in some states the shares of our common stock may not be sold unless such shares have been registered or qualified
for sale in such state or an exemption from registration or qualification is available and is complied with.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that any selling stockholder will sell any or all of the shares of our common stock registered pursuant to the registration
statement, of which this prospectus forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholder and any other person participating in such distribution will be subject to applicable provisions of the Exchange
Act and the rules and regulations thereunder, including, without limitation, Regulation M of the Exchange Act, which may limit the timing
of purchases and sales of any of the shares of our common stock by the Selling Securityholder and any other participating person. Regulation
M may also restrict the ability of any person engaged in the distribution of the shares of our common stock to engage in market-making
activities with respect to the shares of our common stock. All of the foregoing may affect the marketability of the shares of our common
stock and the ability of any person or entity to engage in market-making activities with respect to the shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay all expenses of the registration of the shares of our common stock pursuant to the Registration Rights Agreement, estimated
to be $42,179 in total, including, without limitation, SEC filing fees and expenses of compliance with state securities or &#8220;blue
sky&#8221; laws; provided, however, that a selling stockholder will pay all underwriting discounts and selling commissions, if any. We
will indemnify the Selling Securityholder against liabilities, including some liabilities under the Securities Act, in accordance with
the Registration Rights Agreement, or the Selling Securityholder will be entitled to contribution. We may be indemnified by the Selling
Securityholder against civil liabilities, including liabilities under the Securities Act, that may arise from any written information
furnished to us by the selling stockholder specifically for use in this prospectus, in accordance with the Registration Rights Agreement,
or we may be entitled to contribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
sold under the registration statement, of which this prospectus forms a part, the shares of our common stock will be freely tradable
in the hands of persons other than our affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARES
ELIGIBLE FOR FUTURE SALE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict the effect, if any, that market sales of shares of our common stock or the availability of shares of our common stock
for sale will have on the market price of our common stock prevailing from time to time. Future sales of our common stock in the public
market, or the availability of such shares for sale in the public market, could adversely affect market prices prevailing from time to
time. The availability for sale of a substantial number of shares of our common stock acquired through the exercise of outstanding warrants
could materially adversely affect the market price of our common stock. In addition, sales of our common stock in the public market after
the restrictions lapse as described below, or the perception that those sales may occur, could cause the prevailing market price to decrease
or to be lower than it might be in the absence of those sales or perceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sale
of Restricted Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 16, 2022, there were 437,926,611 shares of common stock issued and outstanding. Of the approximately 437,926,611 shares of our
common stock outstanding as of May 16, 2022, approximately 302,627,434 shares are tradable without restriction. These remaining shares
are &#8220;restricted securities&#8221; within the meaning of Rule 144 under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rule
144</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 144, as currently in effect, a person (or persons whose shares are required to be aggregated), including a person
who may be deemed an &#8220;affiliate&#8221; of a company, who has beneficially owned restricted securities for at least six months may
sell, within any three-month period, a number of shares that does not exceed the greater of: (1) 1% of the then-outstanding shares of
common stock, or (2) if and when the common stock is listed on a national securities exchange, the average weekly trading volume of the
common stock during the four calendar weeks preceding the date on which notice of such sale was filed under Rule 144. Sales under Rule
144 are also subject to certain requirements as to the manner of sale, notice, and availability of current public information about our
company. A person who is not deemed to have been an affiliate of us at any time during the 90 days preceding a sale by such person, and
who has beneficially owned the restricted shares for at least one year, is entitled to sell such shares under Rule 144 without regard
to any of the restrictions described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot estimate the number of shares of our common stock that our existing stockholders will elect to sell under Rule 144.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent for our shares of common stock is Odyssey Trust Company, United Kingdom Building, 409 Granville Street, Suite 350, Vancouver,
British Columbia, Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sur_008"></span>MATERIAL
UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a discussion of the material U.S. federal income tax considerations generally applicable to the acquisition, ownership and
disposition of our common stock and warrants. This discussion is limited to certain U.S. federal income tax considerations to beneficial
owners of our securities who hold the securities as a capital asset within the meaning of Section 1221 of the U.S. Internal Revenue Code
of 1986, as amended (the &#8220;Code&#8221;). This discussion does not describe all of the tax consequences that may be relevant to you
in light of your particular circumstances, including the alternative minimum tax, the Medicare contribution tax on certain investment
income and the different consequences that may apply if you are subject to special rules that apply to certain types of investors, such
as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
    institutions or financial services entities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
    companies;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">governments
    or agencies or instrumentalities thereof;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
    investment companies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">real
    estate investment trusts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expatriates
    or former long-term residents of the United States;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that actually or constructively own five percent or more of our voting shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that acquired our securities pursuant to an exercise of employee share options, in connection with employee share incentive plans
    or otherwise as compensation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dealers
    or traders subject to a mark to market method of accounting with respect to the securities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    holding the securities as part of a &#8220;straddle,&#8221; hedge, constructive sale, conversion or other integrated or similar transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    holders (as defined below) whose functional currency is not the U.S. dollar;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
    or other pass through entities for U.S. federal income tax purposes; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax
    exempt entities.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a partnership for U.S. federal income tax purposes, the U.S. federal income tax treatment of your partners will generally depend
on the status of the partners and your activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion is based on the Code and administrative pronouncements, judicial decisions and final, temporary and proposed Treasury regulations
as of the date hereof, changes to any of which subsequent to the date of this prospectus may affect the tax consequences described herein.
This discussion does not address any aspect of state, local or non-U.S. taxation, or any U.S. tax law other than the U.S. federal income
tax (such as gift, estate or Medicare contribution taxes) or except as discussed below, any tax reporting obligations of a holder of
our securities. This discussion also assumes that any distribution made (or deemed made on our securities and any consideration received
(or deemed received) by a holder from the sale or other disposition of our securities will be in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not sought, and will not seek, a ruling from the Internal Revenue Service (the &#8220;IRS&#8221;) as to any U.S. federal income
tax consequence described herein. The IRS may disagree with the discussion herein, and its determination may be upheld by a court. Moreover,
there can be no assurance that future legislation, regulations, administrative rulings or court decisions will not adversely affect the
accuracy of the statements in this discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS
DISCUSSION IS ONLY A SUMMARY OF THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR SECURITIES.
EACH PROSPECTIVE INVESTOR IN OUR SECURITIES IS URGED TO CONSULT ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO
SUCH INVESTOR OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR SECURITIES, INCLUDING THE APPLICABILITY AND EFFECT OF ANY STATE, LOCAL,
AND NON-U.S. TAX LAWS, AS WELL AS U.S. FEDERAL TAX LAWS AND ANY APPLICABLE TAX TREATIES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Personal
Holding Company Status</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
could be subject to a second level of U.S. federal income tax on a portion of our income if we are determined to be a personal holding
company, or PHC, for U.S. federal income tax purposes. A U.S. corporation generally will be classified as a PHC for U.S. federal income
tax purposes in a given taxable year if (i) at any time during the last half of such taxable year, five or fewer individuals (without
regard to their citizenship or residency and including as individuals for this purpose certain entities such as certain tax-exempt organizations,
pension funds and charitable trusts) own or are deemed to own (pursuant to certain constructive ownership rules) more than 50% of the
stock of the corporation by value and (ii) at least 60% of the corporation&#8217;s adjusted ordinary gross income, as determined for
U.S. federal income tax purposes, for such taxable year consists of PHC income (which includes, among other things, dividends, interest,
certain royalties, annuities and, under certain circumstances, rents).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depending
on the date and size of our transactions, at least 60% of our adjusted ordinary gross income may consist of PHC income as discussed above.
In addition, depending on the concentration of our stock in the hands of individuals, including the members of our sponsor and certain
tax-exempt organizations, pension funds and charitable trusts, more than 50% of our stock may be owned or deemed owned (pursuant to the
constructive ownership rules) by such persons during the last half of a taxable year. Thus, no assurance can be given that we will not
become a PHC following this offering or in the future. If we are or were to become a PHC in a given taxable year, we would be subject
to an additional PHC tax, currently 20%, on our undistributed PHC income, which generally includes our taxable income, subject to certain
adjustments. The PHC requirements may apply to us in the taxable year of the offering and/or future taxable years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
Holders</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section applies to you if you are a &#8220;U.S. holder.&#8221; A U.S. holder is a beneficial owner of our securities who or that is,
for U.S. federal income tax purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the United States;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized in or under the laws of the
    United States, any state thereof or the District of Columbia;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust if (i) a court within the United States is able to exercise primary supervision over the administration of the trust and one
    or more U.S. persons have the authority to control all substantial decisions of the trust, or (ii) it has in effect a valid election
    to be treated as a U.S. person.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of Distributions.</i>&#8195;If we pay cash distributions to U.S. holders of shares of our common stock, such distributions generally will
be treated as a dividend for U.S. federal income tax purposes to the extent the distribution is paid out of our current or accumulated
earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of current and accumulated earnings
and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the U.S. holder&#8217;s
adjusted tax basis in our common stock. Any remaining excess will be treated as gain realized on the sale or other disposition of the
common stock and will be treated as described under &#8220;U.S. holders &#8212; Gain or Loss on Sale, Taxable Exchange or Other Taxable
Disposition of Our Securities&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
we pay to a U.S. holder that is a taxable corporation generally will qualify for the dividends received deduction if the requisite holding
period is satisfied. With certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment
interest deduction limitations), and provided certain holding period requirements are met, dividends we pay to a non-corporate U.S. holder
generally will constitute &#8220;qualified dividends&#8221; that will be subject to tax at the maximum tax rate accorded to long-term
capital gains.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gain
or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Our Securities.</i>&#8195;Upon a sale or other taxable disposition of
our securities which, in general, would include a redemption of common stock or warrants, a U.S. holder generally will recognize capital
gain or loss in an amount equal to the difference between the amount realized and the U.S. holder&#8217;s adjusted tax basis in such
securities. Any such capital gain or loss generally will be long-term capital gain or loss if the U.S. holder&#8217;s holding period
for the securities so disposed of exceeds one year. Long-term capital gains recognized by non-corporate U.S. holders will be eligible
to be taxed at reduced rates. The deductibility of capital losses is subject to various limitations that are not described herein because
a discussion of such limitations depends on each U.S. holder&#8217;s particular facts and circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the amount of gain or loss recognized by a U.S. holder is an amount equal to the difference between (i) the sum of the amount of cash
and the fair market value of any property received in such disposition and (ii) the U.S. holder&#8217;s adjusted tax basis in its securities
so disposed of. A U.S. holder&#8217;s adjusted tax basis in its common stock or warrants generally will equal the U.S. holder&#8217;s
acquisition cost less, in the case of a share of common stock, any prior distributions treated as a return of capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
or Lapse of a Warrant.</i>&#8195;Except as discussed below with respect to the cashless exercise of a warrant, a U.S. holder generally
will not recognize taxable gain or loss from the acquisition of common stock upon exercise of a warrant for cash. The U.S. holder&#8217;s
tax basis in the share of our common stock received upon exercise of the warrant generally will be an amount equal to the sum of the
U.S. holder&#8217;s initial investment in the warrant and the exercise price. It is unclear whether a U.S. holder&#8217;s holding period
for the shares of common stock received upon exercise of the warrants will commence on the date of exercise of the warrant or the day
following the date of exercise of the warrants; in either case, the holding period will not include the period during which the U.S.
holder held the warrants. If a warrant is allowed to lapse unexercised, a U.S. holder generally will recognize a capital loss equal to
such holder&#8217;s tax basis in the warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax consequences of a cashless exercise of a warrant are not clear under current tax law. A cashless exercise may be tax-free, either
because the exercise is not a realization event or because the exercise is treated as a recapitalization for U.S. federal income tax
purposes. In either tax-free situation, a U.S. holder&#8217;s basis in the common stock received would equal the holder&#8217;s basis
in the warrant. If the cashless exercise were treated as not being a realization event, it is unclear whether a U.S. holder&#8217;s holding
period for the shares of common stock would be treated as commencing on the date of exercise of the warrant or the day following the
date of exercise of the warrant. If the cashless exercise were treated as a recapitalization, the holding period of the common stock
would include the holding period of the warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is also possible that a cashless exercise could be treated in part as a taxable exchange in which gain or loss would be recognized. In
such event, a U.S. holder could be deemed to have surrendered warrants equal to the number of common shares having a value equal to the
exercise price for the total number of warrants to be exercised. The U.S. holder would recognize capital gain or loss in an amount equal
to the difference between the fair market value the warrants deemed surrendered and the U.S. holder&#8217;s tax basis in the warrants
deemed surrendered. In this case, a U.S. holder&#8217;s tax basis in the common stock received would equal the sum of the fair market
value of the warrants deemed surrendered and the U.S. holder&#8217;s tax basis in the warrants exercised. It is unclear whether a U.S.
holder&#8217;s holding period for the shares of common stock would commence on the date of exercise of the warrant or the day following
the date of exercise of the warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 83; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the absence of authority on the U.S. federal income tax treatment of a cashless exercise, there can be no assurance which, if any,
of the alternative tax consequences and holding periods described above would be adopted by the IRS or a court of law. Accordingly, U.S.
holders should consult their tax advisors regarding the tax consequences of a cashless exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Possible
Constructive Distributions.</i>&#8195;The terms of each warrant provide for an adjustment to the number of shares of common stock for
which the warrant may be exercised or to the exercise price of the warrant in certain events, as discussed in the section of this prospectus
captioned &#8220;Description of Securities &#8212; Warrants &#8212; Public Stockholders&#8217; Warrants.&#8221; An adjustment which has
the effect of preventing dilution generally is not taxable. The U.S. holders of the warrants would, however, be treated as receiving
a constructive distribution from us if, for example, the adjustment increases the warrant holders&#8217; proportionate interest in our
assets or earnings and profits (e.g., through an increase in the number of shares of common stock that would be obtained upon exercise)
as a result of a distribution of cash to the holders of shares of our common stock which is taxable to the U.S. holders of such shares
as described under &#8220;U.S. holders &#8212; Taxation of Distributions&#8221; above. For example, if the exercise price of the warrants
is decreased as a result of certain taxable dividends paid to holders of the common stock (as contemplated by the terms of the warrant
in certain circumstances), then the amount by which such exercise was decreased could be considered an increase in the warrant holder&#8217;s
proportionate interest in our assets or earnings and profits, which may result in a constructive distribution to holders of the warrants.
Such constructive distribution would be subject to tax as described under that section in the same manner as if the U.S. holders of the
warrants received a cash distribution from us equal to the fair market value of such increased interest. For certain information reporting
purposes, we are required to determine the date and amount of any such constructive distributions. Recently proposed Treasury regulations,
which we may rely on prior to the issuance of final regulations, specify how the date and amount of constructive distributions are determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Reporting and Backup Withholding.</i> In general, information reporting requirements may apply to dividends paid to a U.S. holder and
to the proceeds of the sale or other disposition of our securities, unless the U.S. holder is an exempt recipient. Backup withholding
may apply to such payments if the U.S. holder fails to provide a taxpayer identification number, a certification of exempt status or
has been notified by the IRS that it is subject to backup withholding (and such notification has not been withdrawn).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
amounts withheld under the backup withholding rules will be allowed as a refund or a credit against a U.S. holder&#8217;s U.S. federal
income tax liability provided the required information is timely furnished to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-U.S.
Holders</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section applies to you if you are a &#8220;Non-U.S. holder.&#8221; A Non-U.S. holder is a beneficial owner of our securities who or that
is, for U.S. federal income tax purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    non resident alien individual, other than certain former citizens and residents of the United States subject to U.S. tax as expatriates;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    foreign corporation; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate or trust that is not a U.S. holder;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">but
does not include an individual who is present in the United States for 183 days or more in the taxable year of disposition. If you are
such an individual, you should consult your tax advisor regarding the U.S. federal income tax consequences of the sale or other disposition
of a security.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of Distributions.</i>&#8195;In general, any distributions we make to a Non-U.S. holder of shares of our common stock, to the extent paid
out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles), will constitute dividends
for U.S. federal income tax purposes and, provided such dividends are not effectively connected with the Non-U.S. holder&#8217;s conduct
of a trade or business within the United States, we will be required to withhold tax from the gross amount of the dividend at a rate
of 30%, unless such Non-U.S. holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides
proper certification of its eligibility for such reduced rate (usually on an IRS Form W-8BEN or W-8BEN-E). Any distribution not constituting
a dividend will be treated first as reducing (but not below zero) the Non-U.S. holder&#8217;s adjusted tax basis in its shares of our
common stock and, to the extent such distribution exceeds the Non-U.S. holder&#8217;s adjusted tax basis, as gain realized from the sale
or other disposition of the common stock, which will be treated as described under &#8220;Non-U.S. holders &#8212; Gain on Sale, Taxable
Exchange or Other Taxable Disposition of Our Securities&#8221; below. In addition, if we determine that we are classified as a &#8220;United
States real property holding corporation&#8221; (see &#8220;Non-U.S. holders &#8212; Gain on Sale, Taxable Exchange or Other Taxable
Disposition of Our Securities&#8221; below), we will withhold 15% of any distribution that exceeds our current and accumulated earnings
and profits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
withholding tax does not apply to dividends paid to a Non-U.S. holder who provides a Form W-8ECI, certifying that the dividends are effectively
connected with the Non-U.S. holder&#8217;s conduct of a trade or business within the United States. Instead, the effectively connected
dividends will be subject to regular U.S. federal income tax as if the Non-U.S. holder were a U.S. resident, subject to an applicable
income tax treaty providing otherwise. A Non-U.S. corporation receiving effectively connected dividends may also be subject to an additional
&#8220;branch profits tax&#8221; imposed at a rate of 30% (or a lower treaty rate).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 84; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
of a Warrant.</i>&#8195;The U.S. federal income tax treatment of a Non-U.S. holder&#8217;s exercise of a warrant, or the lapse of a warrant
held by a Non-U.S. holder, generally will correspond to the U.S. federal income tax treatment of the exercise or lapse of a warrant by
a U.S. holder, as described under &#8220;U.S. holders &#8212; Exercise or Lapse of a Warrant&#8221; above, although to the extent a cashless
exercise results in a taxable exchange, the consequences would be similar to those described below in &#8220;Non-U.S. holders &#8212;
Gain on Sale, Taxable Exchange or Other Taxable Disposition of Our Securities.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gain
on Sale, Taxable Exchange or Other Taxable Disposition of Our Securities.</i>&#8195;A Non-U.S. holder generally will not be subject to
U.S. federal income or withholding tax in respect of gain recognized on a sale, taxable exchange or other taxable disposition of our
securities unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    gain is effectively connected with the conduct of a trade or business by the Non-U.S. holder within the United States (and, under
    certain income tax treaties, is attributable to a United States permanent establishment or fixed base maintained by the Non-U.S.
    holder); or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are or have been a &#8220;U.S. real property holding corporation&#8221; for U.S. federal income tax purposes at any time during the
    shorter of the five-year period ending on the date of disposition or the period that the Non-U.S. holder held our securities, and,
    in the case where shares of our common stock are regularly traded on an established securities market, the Non-U.S. holder has owned,
    directly or constructively, more than 5% of our common stock at any time within the shorter of the five-year period preceding the
    disposition or such Non-U.S. holder&#8217;s holding period for the shares of our common stock. There can be no assurance that our
    common stock will be treated as regularly traded on an established securities market for this purpose.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
an applicable treaty provides otherwise, gain described in the first bullet point above will be subject to tax at generally applicable
U.S. federal income tax rates as if the Non-U.S. holder were a U.S. resident. Any gains described in the first bullet point above of
a Non-U.S. holder that is a foreign corporation may also be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate (or
lower treaty rate).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the second bullet point above applies to a Non-U.S. holder, gain recognized by such holder on the sale, exchange or other disposition
of our securities will be subject to tax at generally applicable U.S. federal income tax rates. In addition, a buyer of our securities
from such holder may be required to withhold U.S. federal income tax at a rate of 15% of the amount realized upon such disposition. We
will be classified as a U.S. real property holding corporation if the fair market value of our &#8220;U.S. real property interests&#8221;
equals or exceeds 50% of the sum of the fair market value of our worldwide real property interests plus our other assets used or held
for use in a trade or business, as determined for U.S. federal income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Reporting and Backup Withholding</i>.&#8195;Information returns will be filed with the IRS in connection with payments of dividends and
the proceeds from a sale or other disposition of our securities. A Non-U.S. holder may have to comply with certification procedures to
establish that it is not a United States person in order to avoid information reporting and backup withholding requirements. The certification
procedures required to claim a reduced rate of withholding under a treaty will satisfy the certification requirements necessary to avoid
the backup withholding as well. The amount of any backup withholding from a payment to a Non-U.S. holder will be allowed as a credit
against such holder&#8217;s U.S. federal income tax liability and may entitle such holder to a refund, provided that the required information
is timely furnished to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>FATCA
Withholding Taxes.</i>&#8195;Provisions commonly referred to as &#8220;FATCA&#8221; impose withholding of 30% on payments of dividends
(including constructive dividends) on our securities, and, beginning January 1, 2019, sales or other disposition proceeds from our securities
to &#8220;foreign financial institutions&#8221; (which is broadly defined for this purpose and in general includes investment vehicles)
and certain other Non-U.S. entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership
by U.S. persons of interests in or accounts with those entities) have been satisfied, or an exemption applies (typically certified as
to by the delivery of a properly completed IRS Form W-8BEN-E). If FATCA withholding is imposed, a beneficial owner of the payment that
is not a foreign financial institution (or that is a foreign financial institution entitled to a reduced rate of withholding tax with
respect to such payment under an income tax treaty) generally may be entitled to a refund or credit of any amounts withheld by filing
a U.S. federal income tax return and providing certain other information to the IRS (which may entail significant administrative burden).
Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA
may be subject to different rules. Prospective investors should consult their tax advisers regarding the effects of FATCA on their investment
in our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sur_009"></span>LEGAL
MATTERS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities offered by this prospectus will be passed upon for us by Anthony L.G., PLLC, 625 N. Flagler Drive, Suite 600,
West Palm Beach, Florida 33401.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 85; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sur_010"></span>EXPERTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
balance sheets as of October 31, 2021 and October 31, 2020 and the related statement of operations, changes in stockholders&#8217; equity
and cash flows for the years ended October 31, 2021 and 2020 included in this prospectus have been audited by Dale Matheson Carr-Hilton
LaBonte LLP, independent registered public accounting firm, as indicated in their report (which report expresses an unqualified opinion
and includes an explanatory paragraph related to our ability to continue as a going concern) with respect thereto, and has been so included
in reliance upon the report of such firm given on their authority as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sur_011"></span>DISCLOSURE
OF COMMISSION&#8217;S POSITION ON INDEMNIFICATION FOR</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
ACT LIABILITIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors and officers are indemnified as provided by Delaware law, our certificate of incorporation and our bylaws. We have agreed to
indemnify each of our directors and certain officers against certain liabilities, including liabilities under the Securities Act. Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons
pursuant to the provisions described above, or otherwise, we have been advised that in the opinion of the SEC, such indemnification is
against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than our payment of expenses incurred or paid by our director, officer or controlling person in the successful
defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act
and will be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="sur_012"></span>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC the registration statement on Form S-1 under the Securities Act for the securities offered by this prospectus.
This prospectus, which is a part of the registration statement, does not contain all of the information in the registration statement
and the exhibits filed with it, portions of which have been omitted as permitted by SEC rules and regulations. For further information
concerning us and the securities offered by this prospectus, we refer to the registration statement and to the exhibits filed with it.
Statements contained in this prospectus as to the content of any contract or other document referred to are not necessarily complete.
In each instance, we refer you to the copy of the contracts and/or other documents filed as exhibits to the registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement on Form S-1, of which this prospectus forms a part, including exhibits, is available at the SEC&#8217;s website
at <i>http://www.sec.gov</i>. You may also read and copy any document we file with, or furnish to, the SEC at its public reference facilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    Reference Room Office</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    F Street, N.E.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Room
    1580</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
    D.C. 20549</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 31.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E.,
Room 1580, Washington, D.C. 20549. Callers in the United States can also call (202) 551-8090 for further information on the operations
of the public reference facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 86; Value: 45 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sur_013"></span>INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audited
    financial statements for the years ended October 31, 2021 and 2020</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.65in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#si_016">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F- 3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#j_001">Consolidated Balance Sheets as of October 31, 2021 and 2020 (Audited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-
    4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#j_002">Consolidated Statements of Loss and Comprehensive Loss for the years ended October 31, 2021 and 2020 (Audited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-
    5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#j_003">Consolidated Statements of Shareholders Deficit for the years ended October 31, 2021 and 2020 (Audited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-
    6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#j_004">Consolidated Statements of Cash Flows for the years ended October 31, 2021 and 2020 (Audited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-
    7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#j_005">Notes to Audited Consolidated Financial Statements for the years ended October 31, 2021 and 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-
    8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interim
    financial statements for the three months ended January 31, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">Consolidated Balance Sheets as of January 31, 2022 (Unaudited) and October 31, 2021 (Audited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-
    37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">Consolidated Statements of Loss and Comprehensive Loss for the three months ended January 31, 2022 and 2021 (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-
    38</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">Consolidated Statements of Shareholders Deficit for the three months ended January 31, 2022 and 2021 (Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-
    39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">Consolidated Statements of Cash Flows for the three months ended January 31, 2022 and 2021(Unaudited)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-
    40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ag_001">Notes to Unaudited Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-
    41</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 87; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="aud_05.jpg" alt="" style="height: 89px; width: 250px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WESTERN
MAGNESIUM CORPORATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
FINANCIAL STATEMENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Years Ended October 31, 2021 and 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed
in US Dollars)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="aud_001.jpg" alt="" style="height: 98px; width: 410px" /></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="si_016"></span>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the shareholders and the board of directors of Western Magnesium Corporation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Western Magnesium Corporation (the &#8220;Company&#8221;) as of October
31, 2021 and 2020, the related consolidated statements of loss and comprehensive loss, shareholders&#8217; deficit, and cash flows, for
the years then ended, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the
financial statements present fairly, in all material respects, the financial position of the Company as of October 31, 2021 and 2020,
and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted
in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
1 to the financial statements, the Company has not generated revenues since inception, has incurred losses in developing its business,
and further losses are anticipated. The Company requires additional funds to meet its obligations and the costs of its operations. These
factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in this regard
are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting in accordance with
the standards of the PCAOB. As part of our audits we are required to obtain an understanding of internal control over financial reporting
but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.
Accordingly, we express no such opinion in accordance with the standards of the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;DMCL&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DALE
MATHESON CARR-HILTON LABONTE LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHARTERED
PROFESSIONAL ACCOUNTANTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2013</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vancouver,
Canada</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
4, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="aud_002.jpg" alt="" style="height: 111px; width: 170px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WESTERN
MAGNESIUM CORPORATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="j_001"></span>Consolidated
Balance Sheets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at October 31, 2021 and 2020</span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expressed
in US Dollars</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_111_zvnAKBgquS5e" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20211031_z5VGTwUfUOuf" style="font-weight: bold; text-align: center">October 31, 2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20201031_zEtRWrA9ydl8" style="font-weight: bold; text-align: center">October 31, 2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB_zm1f5ndBrov3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">ASSETS</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsCurrentAbstract_i01B_zYaffM90BAwb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzfAc_zlVsjdn0cRE4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 50%; text-align: left">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 8%; text-align: center">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 16%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">462,360</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,571</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_i02I_maACzfAc_znliE0URMgd5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amounts receivable</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,485</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,579</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_i02I_maACzfAc_z3cDRGoDJ2ma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepayments</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,647</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,109</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DepositsAssetsCurrent_i02I_maACzfAc_z64bjBnThyg3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deposits held by related parties</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center">9[a]</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:DepositsAssetsCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0053">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsCurrent_i02TI_maCzL7x_mtACzfAc_zvIi4c4PpFXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current assets</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,233,954</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">159,259</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsNoncurrentAbstract_i01B_zVwO8m9zCuD" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non-current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maCzL7x_zKPBMICiDHOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Property, plant and equipment</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">5</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,574,704</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_maCzL7x_zTTS9vygWOkk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Right-of-use assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">6</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">598,575</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">373,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--MineralPropertiesNet_i02I_maCzL7x_z3IOfbHlqbqe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Mineral property costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">8</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ReclamationDepositsNonCurrent_i02I_maCzL7x_zxIsOAC6URp1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Reclamation deposits</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:ReclamationDepositsNonCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,826</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ReclamationDepositsNonCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--OtherDepositsNonCurrent_i02I_maCzL7x_ziIjDyUEYVz2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other deposits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OtherDepositsNonCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0074">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Assets_i01TI_mtCzL7x_zwidIO0iFAdb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,513,512</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">708,763</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zMaAFtCvzKX3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrentAbstract_i01B_zeN9PFC5taU6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzdMA_zGLNt21NZGE6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,989,316</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,169,817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DueToRelatedPartiesCurrent_i02I_maLCzdMA_zwhOBotE760l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Due to related parties</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">9[b]</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,026,817</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">843,990</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maLCzdMA_zCG0jMZnY737" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Lease obligations &#8211; current</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">7</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,045</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,709</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NotesPayableCurrent_i02I_maLCzdMA_zRxCMpkQeHfb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Promissory note</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">11</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0094">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,567</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--CurrentPortionProvisionForFlowThroughShareIssuances_i02I_maLCzdMA_zn02CpzZBmwj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Provision for flow through share issuances</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">12</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:CurrentPortionProvisionForFlowThroughShareIssuances" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">233,285</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:CurrentPortionProvisionForFlowThroughShareIssuances" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">216,924</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ConvertibleDebentureExcludingDerivativeLiabillityCurrent_i02I_maLCzdMA_zLzRzjPC1Ujc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Convertible debenture</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">13</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:ConvertibleDebentureExcludingDerivativeLiabillityCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ConvertibleDebentureExcludingDerivativeLiabillityCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">96,318</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ConvertibleDebentureDerivativeLiabilitiesCurrent_i02I_maLCzdMA_zQ3CiLKJvfSb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Convertible debenture &#8211; derivative liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">13</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:ConvertibleDebentureDerivativeLiabilitiesCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,700</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ConvertibleDebentureDerivativeLiabilitiesCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,123</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ConvertibleDebentureCurrent_i02I_maLCzdMA_zGzBCBpntsFb" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Convertible debenture</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:ConvertibleDebentureCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,807</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DerivativeLiabilityCurrent_i02I_maLCzdMA_zy7QrskETo4l" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Derivative liability</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesCurrent_i02TI_pp0p0_mtLCzdMA_maCz52o_zSc38JjrOfjf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current liabilities</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,891,270</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,551,448</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_zv2WMWxvlUQa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non-current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maCz52o_zlqMnIOlD7P6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Lease obligations &#8211; non-current</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">7</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">392,280</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">237,218</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--Liabilities_i01TI_mtCz52o_maCzmL2_zFyHY0Uc8QM6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,283,550</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,788,666</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockholdersEquityAbstract_i01B_zvBa3LjJbFp5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Shareholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Capital stock</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Authorized: <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pn9n9_c20211031_zgUVTPiw2BHk"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pn9n9_c20201031_zmFYTanDCus3"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="-9" scale="9" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="-9" scale="9" unitRef="Shares">1</ix:nonFraction></ix:nonFraction></span></span> billion common stock at par value of $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211031_zModUhDgyiji"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20201031_zye4q8pEqZti"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CommonStockValue_i02I_pp0p0_maCzTny_zHjssNvFawW7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Issued and paid: <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20211031_zevBtXOhqUe9"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211031_z1Yg3D3A8zCd"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">392,943,398</ix:nonFraction></ix:nonFraction></span></span> (2020 &#8211; <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20201031_ztNnB9W0M1bk"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20201031_z2DZ9R7e4elj"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">323,419,527</ix:nonFraction></ix:nonFraction></span></span>)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">14</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,842,167</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,322,022</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CommonStockValue_i02I_pp0p0_maCzTny_zuevCTjFZVke" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; padding-left: 10pt; text-align: left">Capital stock Authorized: 1 billion common stock at par value of $0.001 Issued and paid: 392,943,398 (2020 &#8211; 323,419,527)</td><td style="display: none; font-weight: bold">&#160;</td>
    <td style="display: none; font-weight: bold; text-align: center">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,842,167</ix:nonFraction></td><td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,322,022</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdditionalPaidInCapital_i02I_maCzTny_zJeDw4xU9YF1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid-in-capital</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">14</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,186,480</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,182,037</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CommonStockSharesSubscriptions_i02I_maCzTny_z0mAeYJy85k8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Obligations to issue shares</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">14</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">596,872</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maCzTny_zgxq73RXv4S5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,109</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">399,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzTny_zPcnFYfsfOG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,129,621</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,580,009</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquity_i02TI_mtCzTny_maCzmL2_zZB0FCzKsVwk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total shareholders&#8217; deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,770,038</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,079,903</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzmL2_z6v0YCNKKpw8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,513,512</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">708,763</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nature of operations and going concern <i>[note 1]</i></span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent liabilities and commitments <i>[note 10]</i></span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent events <i>[note 19]</i></span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WESTERN
MAGNESIUM CORPORATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="j_002"></span>Consolidated
Statements of Loss and Comprehensive Loss</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Years Ended October 31, 2021 and 2020</span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expressed
in US Dollars</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_113_zyWlmQ6urEBl" summary="xdx: Statement - Consolidated Statements of Loss and Comprehensive Income (Loss)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20201101__20211031_zqzeEBHhrdo5" style="font-weight: bold; text-align: right">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20191101__20201031_zPibqZZrzXv5" style="font-weight: bold; text-align: right">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostsAndExpensesAbstract_iB_zpvH1qQrGUD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Expenses (recoveries)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--BankCharges_i01_maCzRNE_zvg5Z3bw7OF5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 50%; text-align: left">Bank charges</td><td style="width: 2%">&#160;</td>
    <td style="width: 8%; text-align: center">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="MLYF:BankCharges" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,287</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="MLYF:BankCharges" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,764</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--BusinessDevelopment_i01_pp0p0_maCzRNE_zdCsPmZU6dEb" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Business development</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ComputerSystemAndSoftwareExpenses_i01_maCzRNE_zxhqlEOS8GT5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Computer system and software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ComputerSystemAndSoftwareExpenses" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94,426</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ComputerSystemAndSoftwareExpenses" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,230</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ManagementFeeExpense_i01_maCzRNE_zWl88EApG5d4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Consulting and management fees</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">9[d]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ManagementFeeExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">914,617</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ManagementFeeExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">598,574</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Depreciation_i01_maCzRNE_zQIAoQaqYGwf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5, 6</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">229,902</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">86,706</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DueDiligenceExpenses_i01_maCzRNE_zehqcqXcwoL5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Due diligence expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DueDiligenceExpenses" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,565</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DueDiligenceExpenses" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,776</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--EngineeringExpenses_i01_maCzRNE_zFz6oKVFormg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Engineering expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:EngineeringExpenses" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,706</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:EngineeringExpenses" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">569,145</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i01N_di_msCzRNE_zd8wpj16wdak" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Foreign exchange gain</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,054</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,685</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--AccretionExpense_i01_maCzRNE_zgU4oFEhkaz7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest and accretion</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,319</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,638</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--InvestorRelationsExpense_i01_maCzRNE_zdXv8lsfNh7k" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Investor relations</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:InvestorRelationsExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">280,249</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:InvestorRelationsExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">237,874</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LegalFees_i01_maCzRNE_zXlAXYXFRFqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Legal and professional fees</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">889,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,916</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzRNE_zTAGls9W6pWa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Office and general</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,348</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,553</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostMaintenance_i01_maCzRNE_z12xluHyICph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Property maintenance fees</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CostMaintenance" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,069</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CostMaintenance" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,098</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--FacilitiesAndRentExpenses_i01_maCzRNE_zReelQQlDwO7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Facilities and rent</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:FacilitiesAndRentExpenses" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">187,832</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:FacilitiesAndRentExpenses" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,304</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LaborAndRelatedExpense_i01_maCzRNE_zYJXFqHiKQ85" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Salaries and benefits</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">9[c]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,168,008</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,797,783</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensation_i01_maCzRNE_zqpcz2tF0in2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9[c], 14</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,051,124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">666,259</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ShareholderCommunicationsExpense_i01_maCzRNE_zZyL8oDjDYY6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Shareholder communications</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ShareholderCommunicationsExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,747</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ShareholderCommunicationsExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,554</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--SubsidiesAndRecoveries_i01N_di_msCzRNE_zX5XDOVh2vQf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Subsidies and recoveries</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:SubsidiesAndRecoveries" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,735</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0214">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--TransferAgentAndRegulatoryFees_i01_maCzRNE_zRax2chBHfGf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Transfer agent and regulatory fees</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:TransferAgentAndRegulatoryFees" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,098</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:TransferAgentAndRegulatoryFees" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,371</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TravelAndEntertainmentExpense_i01_maCzRNE_zkotPL914mLg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Travel expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:TravelAndEntertainmentExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">409,528</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:TravelAndEntertainmentExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,880</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CostsAndExpenses_i01T_mtCzRNE_msCzw51_zZrr7AWI7qy2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
    and Expenses</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,705,211</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,714,740</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zvtQbCV4gTsc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other items</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DerivativeGainLossOnDerivativeNet_i01_maCzH7H_zLohB8ztzsBl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of derivative liability</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,701,270</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,979</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--GainLossOnRecognitionOfDebtHostLiability_i01_maCzH7H_zh4iz8KXLJkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on recognition of debt host liability</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:GainLossOnRecognitionOfDebtHostLiability" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">140,943</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0232">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GainsLossesOnSalesOfAssets_i01_maCzH7H_ziCgriNRSfqa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Gain on sale of assets previously written off</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0234">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnSalesOfAssets" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,156</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--WriteoffOfEquipment_i01_maCzH7H_zRkN1NhlaUw1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Write-off of equipment</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center">5</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:WriteoffOfEquipment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,188</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0238">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzH7H_maCzw51_z4xskhBYaxF2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonoperating
    Income (Expense)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,844,401</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,135</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_iT_mtCzw51_maCzfVP_zqocUO6L0tLe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net loss for the year</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,549,612</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,672,605</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ComprehensiveIncomeNetOfTaxAbstract_iB_zHVHR4E6sugc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other comprehensive loss</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_i01_maCzfVP_zEuS72J110Ei" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">278,066</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">76,806</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ComprehensiveIncomeNetOfTax_i01T_mtCzfVP_zY0TqblrqFP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Comprehensive loss for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,827,678</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,749,411</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_z2qLX7S1pqLe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Basic and diluted loss per common share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.07</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zmlfck4SyPTl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Weighted average number of common shares outstanding &#8211; basic and diluted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">356,656,854</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">312,450,631</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WESTERN
MAGNESIUM CORPORATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="j_003"></span>Consolidated
Statements of Shareholders&#8217; Deficit</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Years Ended October 31, 2021 and 2020</span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expressed
in US Dollars</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_114_z0RZutzudyb9" summary="xdx: Statement - Consolidated Statements of Shareholders&apos; Deficit" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zgaACnXajw8f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zGGIdWaL3oVa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_custom--ObligationToIssueSharesMember_ztgCuuff1we1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zHRmV2MwI2d9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z5Wxzs6TzIf8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_zzfSnDsELCN" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>paid-in</b></span></p>
                                                                                                                                                                                                                                          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>capital</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Obligation</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">to issue</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">shares</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">other</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">comprehensive</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">income (loss)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">deficit</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Shareholders&#8217;</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">deficit</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_43F_c20191101__20201031_eus-gaap--StockholdersEquity_iS_zp62cqWFoMg4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 37%">Balance, October 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20191101__20201031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze28gFl8uVG5" title="Beginning balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">278,939,075</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,587,118</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,535,553</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,722</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">475,981</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-10-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,907,404</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,269,030</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zSOqDTtSGrP" style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left">Shares issued pursuant to <br />private placements [note 14[b]]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20191101__20201031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztrYJBJE25z2" title="Shares issued pursuant to private placements [note 14[b]], shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,719</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0271">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">39,722</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0273">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0274">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">376,997</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_z9EIC7vUgAaa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued on warrants exercised <i>[note 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20191101__20201031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTFq2BoE8LOa" title="Shares issued on warrants exercised [note 14[b]], shares" style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,336,661</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,313,284</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0280">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0281">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,313,284</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zmxCt3OohmY3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued on options exercised <i>[note 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20191101__20201031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z14e2NjkIO9d" title="Shares issued on options exercised [note 14[b]], shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,176</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,775</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0290">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0291">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0292">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,401</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zdZkDjpumWHd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares issued for convertible debenture <i>[notes 13[a] and 14[b]]</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Shares issued on options exercised, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_zcv5ql9YQls4" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares issued for convertible de<span style="font-family: Times New Roman, Times, Serif">benture <i>[notes
    13[a] and 14[b]], shares</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Shares issued on options exercised, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueIssuedForEquipment_zmuOgGZAP6Yd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued for equipment <i>[note 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Shares issued on options exercised, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodSharesIssuedForEquipment_zJ84IejBCYp8" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued for equipment [note 14[b]],
    shares</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Shares issued on options exercised, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueIssuedForCosts_zqik986ycUfl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issue costs <i>[note 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2019-11-012020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,275</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0326">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0327">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0328">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0329">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,275</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_z1LyrD1CXlvc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation <i>[note 14[d]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0332">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-11-012020-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">666,259</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0334">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0335">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0336">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">666,259</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_zzEHbaWkX2Vj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity component of convertible debenture <i>[note 13[b]]</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--ObligationToIssueShareSubscriptions_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share subscriptions <i>[note 14[f]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0346">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2019-11-012020-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">596,872</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0349">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">596,872</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zzymzuOmzlfd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign currency translation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0353">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0354">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0355">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2019-11-012020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">76,806</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0357">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">76,806</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0360">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0361">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0362">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0363">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,672,605</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,672,605</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_435_c20201101__20211031_eus-gaap--StockholdersEquity_iS_zbrt4nxxIwEh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; font-weight: bold">Balance, October 31, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zReqBliPIiKi" title="Beginning balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">323,419,527</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,322,022</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,182,037</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">596,872</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">399,175</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,580,009</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,079,903</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zdugXlnbkKxh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Shares issued pursuant to <br />private placements [note 14[b]]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVyYWOmGkNi" title="Shares issued pursuant to private placements [note 14[b]], shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,979,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,438,041</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">596,872</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0379">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0380">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,841,169</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_zxcmRGkpPDJf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued on warrants exercised <i>[note 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQmz82sKavvl" title="Shares issued on warrants exercised [note 14[b]], shares" style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,014,969</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">891,811</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,291</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0387">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0388">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">887,520</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zWbxxfMHb789" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued on options exercised <i>[note 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzcdFGSox9Ph" title="Shares issued on options exercised [note 14[b]], shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,630,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,666</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">121,932</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0396">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0397">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0398">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,734</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zbGn6ub4E5B5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued for convertible debenture <i>[notes 13[a] and 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRRlArHxzXaf" title="Shares issued for convertible debenture [notes 13[a] and 14[b]], shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,360,959</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,829</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0404">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0406">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0407">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,829</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueIssuedForEquipment_zlk57cQZFv9l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued for equipment <i>[note 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesIssuedForEquipment_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3TQsrGbEeP6" title="Shares issued for equipment [note 14[b]], shares" style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesIssuedForEquipment" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,538,461</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForEquipment" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">305,832</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0414">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0416">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForEquipment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">305,832</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuedForCosts_znelPCtdxK48" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issue costs <i>[note 14[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2020-11-012021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">541,034</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0424">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">541,034</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zI2UkJWTLYFj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation <i>[note 14[d]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0428">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,051,124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0430">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0431">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0432">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,051,124</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_z0ADiBAw8osd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity component of convertible debenture <i>[note 13[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-11-012021-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,542</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ObligationToIssueShareSubscriptions_zF39l2IfrgI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share subscriptions <i>[note 14[f]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0442">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0443">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2020-11-012021-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0445">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0446">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zz9D1TJsuuuk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign currency translation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0449">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0450">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0451">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">278,066</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0453">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">278,066</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zk6sBMyNkITi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0458">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0459">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,549,612</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,549,612</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43C_c20201101__20211031_eus-gaap--StockholdersEquity_iE_z9ZBOeEJfNHa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; font-weight: bold; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqCjR06Lk1n1" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">392,943,398</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,842,167</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,186,480</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,109</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,129,621</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,770,038</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WESTERN
MAGNESIUM CORPORATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="j_004"></span>Consolidated
Statements of Cash Flows</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Years Ended October 31, 2021 and 2020</span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expressed
in US Dollars</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_112_z4q1HF5KLXqi" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20201101__20211031_z8g9jxdFTBKi" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20191101__20201031_zgU0lm0uMKZb" style="font-weight: bold; text-align: center">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zgB3oYSJmxAg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_i01_maCzEO9_zmuVUgdsY69d" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss for the year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,549,612</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,672,605</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zyDek5h60lWk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Add (subtract) items not affecting cash:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--AccruedInterestAndAccretion_i02_maCzEO9_zsKSLqKKA3y8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued interest and accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:AccruedInterestAndAccretion" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,331</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:AccruedInterestAndAccretion" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,605</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AmortizationOfDebtDiscountPremium_i02_pp0p0_maCzEO9_zn9JNCHBUyuh" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amortization of debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DerivativeGainLossOnDerivativeNet_i02N_di_msCzEO9_zBbPZTYKRwri" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,701,270</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,979</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--GainLossOnRecognitionOfDebtHostLiability_i02N_di_msCzEO9_z2ifXBh5Vg9e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Loss on recognition of debt host liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:GainLossOnRecognitionOfDebtHostLiability" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">140,943</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DepreciationAndAmortization_i02_maCzEO9_zSie41BitWPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,148</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,871</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_maCzEO9_zj2Ijehe8WRi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation of right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,754</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,835</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ForeignCurrencyTransactionGainLossUnrealized_i02N_di_msCzEO9_zUKfeosWIu7b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Foreign exchange gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">198,371</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,080</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--GainsLossesOnSalesOfAssets_i02N_di_msCzEO9_ziynXH4qQ9R8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Gain on sale of exploration and evaluation assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0502">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnSalesOfAssets" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,156</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--InterestExpenseOnLeaseObligations_i02_maCzEO9_zyWA3UBciwCj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest expense on lease obligations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:InterestExpenseOnLeaseObligations" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,319</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:InterestExpenseOnLeaseObligations" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,033</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ShareBasedCompensation_i02_maCzEO9_zQ2X8Ob2XAof" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,051,124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">666,259</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--WriteoffOfEquipment_i02N_di_msCzEO9_z72VVoafaxX1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Write-off of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:WriteoffOfEquipment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,188</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0512">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zuP1BjCNfU95" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in non-cash working capital items relating to operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02N_di_msCzEO9_zxj2STJZfF1d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,283</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_di_msCzEO9_zhNS01Nry0R7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,703</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,317</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInDepositOtherAssets_i02N_di_msCzEO9_zMek2S5vNNQf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deposits held by related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDepositOtherAssets" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">478,902</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0524">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i02_maCzEO9_zip2bZwkkQG1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">719,906</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">510,773</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i02_maCzEO9_zreMRwGvXaMf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Due to related parties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,321</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,727</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzEO9_maCzhwB_zuUS0QA3sLga" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,367,567</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,270,534</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zS49lBV0hBW" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzaCa_zMkVDZkC6UNb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Purchase of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,056,566</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,172</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--PaymentsForOtherDeposits_i01N_di_msCzaCa_zuOcazPxxN1l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForOtherDeposits" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromSaleOfProductiveAssets_i01_maCzaCa_zxkjbAHnUQQd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Proceeds from sale of exploration and evaluation assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0544">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,157</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzaCa_maCzhwB_zRkbx4xPNafe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash provided by (used in) investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,066,566</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,985</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zE6DzeBL8352" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maCzyIt_zVJbGDZ0oXU5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of shares, net of share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,328,389</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,715,129</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromShareSubscriptions_i01_maCzyIt_zD9fHTNyobL4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from share subscriptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ProceedsFromShareSubscriptions" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ProceedsFromShareSubscriptions" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">557,150</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ProceedsFromConvertibleDebt_i01_maCzyIt_zsDZMeWS1F98" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from convertible debenture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,579,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,470</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RepaymentsOfDebt_i01N_di_msCzyIt_z3FrpkilxlC3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Payments of promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,761</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,478</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--RepaymentsOfLeaseObligations_i01N_di_msCzyIt_zEWWuGU53KQe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Payments of lease obligations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:RepaymentsOfLeaseObligations" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,562</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:RepaymentsOfLeaseObligations" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,448</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzyIt_maCzhwB_zUPt5ZaRjw2h" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash provided by financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,850,435</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,257,823</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCzhwB_zOck3voneZN6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Change in cash for the year</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,302</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,274</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zzkRhJIOFf7l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash, beginning of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,571</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,649</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_z1T2vWxRWZqa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Effect of foreign exchange on cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,487</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">352</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zjEdamlEp39g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents, end of the year</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">462,360</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,571</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zePmjGUjeskf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other non-cash transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssued1_i01_zYucNGV8ls42" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Shares issued for conversion of debt and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">468,661</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RightOfUseOfAssetAdditionByWayOfLeaseObligation_i01_zdiSZxwcHjL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">ROU asset addition by way of lease obligation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:RightOfUseOfAssetAdditionByWayOfLeaseObligation" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">351,886</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:RightOfUseOfAssetAdditionByWayOfLeaseObligation" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">437,812</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z93gKTf2G5l8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other cash flow disclosures:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--InterestPaidNet_i01_zhujqWWVJo5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Cash paid during the period for interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,204</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,199</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_041_c20201101__20211031_z1bruNx719nc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="j_005"></span>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:NatureOfOperations"><p id="xdx_800_eus-gaap--NatureOfOperations_zu6N0siIZZT2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 1pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 1pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 1pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_826_zKWJX5conCj6">NATURE
    OF OPERATIONS AND GOING CONCERN</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
Magnesium Corporation (the &#8220;Company&#8221;, or &#8220;WMC&#8221;) was incorporated under the laws of British Columbia on March
24, 1966. On May 14, 2019, the Company discontinued from the jurisdiction of the Business Corporations Act (British Columbia) and domesticated
under the General Corporation Law of the State of Delaware under the name &#8220;Western Magnesium Corporation&#8221;. The Company is
a reporting issuer in Canada and in the United States, listed for trading in Canada on the TSX Venture Exchange (the &#8220;TSX-V&#8221;)
under the symbol &#8220;WMG.V&#8221;, in the United States on the OTCQB tier of the OTC Markets (the &#8220;OTCQB&#8221;) under the symbol
&#8220;MLYF&#8221;, and in Germany on the Frankfurt Stock Exchange under the symbol &#8220;3WM&#8221;. The Company has developed proprietary
magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium metal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at October 31, 2021, the Company had an accumulated deficit of $<span id="xdx_90E_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20211031_ztjKuhWpJK27" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,129,621</ix:nonFraction></span> (October 31, 2020 &#8211; $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20201031_z3gmGGnhGoCk" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,580,009</ix:nonFraction></span>) and working capital
deficiency of $<span id="xdx_90D_ecustom--WorkingCapitalDeficit_iI_c20211031_zV7M2QK60nKc" title="Working capital deficit"><ix:nonFraction name="MLYF:WorkingCapitalDeficit" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,657,316</ix:nonFraction></span> (October 31, 2020 &#8211; $<span id="xdx_902_ecustom--WorkingCapitalDeficit_iI_c20201031_zIdmedXo97n5" title="Working capital deficit"><ix:nonFraction name="MLYF:WorkingCapitalDeficit" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,392,189</ix:nonFraction></span>). For the year ended October 31, 2021, the Company reported a comprehensive
loss of $<span id="xdx_902_eus-gaap--ComprehensiveIncomeNetOfTax_iN_di_c20201101__20211031_zLSYqZCQ8uP8" title="Comprehensive loss"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,827,678</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_90A_eus-gaap--ComprehensiveIncomeNetOfTax_iN_di_c20191101__20201031_zyKzxz4C4qS9" title="Comprehensive loss"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,749,411</ix:nonFraction></span>). The Company is considered to be in the development stage. It has not yet achieved profitable
operations and expects to incur further losses in the development of its business. The Company has financed its activities and operations
through equity issuances and debt financing and expects to continue to do so to the extent such instruments are issuable under terms
acceptable to the Company and until such time as its operations provide positive cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements (the &#8220;Financial Statements&#8221;) have been prepared under the assumption that the Company will
continue as a going concern. The going concern basis of presentation assumes that the Company will be able to meet its obligations and
continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in
the normal course of business. Management believes that the going concern assumption is appropriate for these Financial Statements based
on its continuing ability to raise financings through share and debt issuances. If future financing is unavailable or if for any reason
the Company is unable to continue as a going concern, it could impact the Company&#8217;s ability to realize its assets at their recognized
values and to meet its obligations in the ordinary course of business at the amounts stated in these Financial Statements. These Financial
Statements do not give effect to adjustments that would be necessary to the carrying values and classifications of assets and liabilities
should the Company be unable to continue as a going concern. If the going concern assumption is not used, the adjustments required to
report the Company&#8217;s assets and liabilities on a liquidation basis could be material to these Financial Statements. These factors
indicate the existence of a material uncertainty that cast substantial doubt on the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the World Health Organization declared COVID-19 a global pandemic. In order to combat the spread of COVID-19, governments
worldwide, including the Unites States and Canada, have enacted emergency measures including travel bans, legally enforced or self-imposed
quarantine periods, social distancing and business and organization closures. These measures have adversely affected workforces, economies,
and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant but could affect
the Company&#8217;s ability to raise financings in the future and restrict travel. Management continues to monitor the situation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:BasisOfAccounting"><p id="xdx_809_eus-gaap--BasisOfAccounting_zsMkNOFDKq1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_zuqnVdUVi0Za">BASIS
    OF PRESENTATION</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Financial Statements comprise the financial statements of Western Magnesium Corporation and its wholly owned subsidiaries, Western Magnesium
Canada Corporation, incorporated in British Columbia, Canada and Western Magnesium Corp., incorporated in the State of Nevada in the
United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
    standards</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying Financial Statements have been prepared by the Company in accordance with accounting principles generally accepted in the
United States of America (&#8220;US GAAP&#8221;) on the basis that the Company will continue as a going concern, which assumes that the
Company will be able to meet its obligations and continue its operations for the next year. Realization values may be substantially different
from carrying values as shown and these Financial Statements do not give effect to adjustments that would be necessary to the carrying
values and classification of assets and liabilities should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Financial Statements have been prepared on a historical cost basis except for financial instruments that have been measured at fair value.
In addition, these Financial Statements have been prepared using the accrual basis of accounting, except for cash flow information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Functional
    and presentation currency</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Financial Statements are presented in United States dollars (&#8220;US dollars&#8221; or &#8220;USD&#8221;), except where otherwise indicated.
The functional currency of each entity of the Company is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Functional
    Currency</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Corporation</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian
    dollars (&#8220;CA$&#8221;)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Canada Corporation</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian
    dollars</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Corp. </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States dollars </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounts of the Company, and those of its subsidiary Western Magnesium Canada Corporation, have been translated to US dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
    accounting estimates and judgments</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Estimates and Assumptions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of these Financial Statements in accordance with US GAAP requires the Company to make estimates and assumptions concerning
the future. Management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors,
including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted
for prospectively in the period in which the estimates are revised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
and assumptions where there is potential risk of material adjustments to assets and liabilities in future accounting periods include
the useful lives of property, plant and equipment, the recoverability of the carrying value of exploration and evaluation assets, fair
value measurements for financial instruments, discount rates for leases, the recoverability and measurement of deferred tax assets and
liabilities and contingent liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Judgments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of these Financial Statements in accordance with US GAAP requires the Company to make judgments, apart from those involving
estimates, in applying accounting policies. The most significant judgments in applying the Company&#8217;s Financial Statements include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    assessment of the Company&#8217;s ability to continue as a going concern and whether there are events or conditions that may give
    rise to substantial doubt;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    there are indicators of impairment of the Company&#8217;s exploration and evaluation assets and other non-current assets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    classification of financial instruments; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determination
    of functional currency.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1pt"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zA69Niv9DFE7" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_zH6KfoSMmugd">SIGNIFICANT
    ACCOUNTING POLICIES</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting policies set out below have been applied consistently to all periods presented in these Financial Statements by the Company
and its subsidiaries.</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_846_eus-gaap--ConsolidationPolicyTextBlock_zdGJmH3DxzC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[a]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zUk9pxdFphJ5">Principles
    of consolidation</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Financial Statements include the accounts of the Company and its wholly owned and controlled subsidiaries as described in <i>note 2</i>.
Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so
as to obtain benefits from its activities. The financial statements of the subsidiaries are included in these consolidated financial
statements from the date that control commences until the date that control ceases. All inter-company transactions and balances have
been eliminated upon consolidation.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zPS60Zi84nig" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zQ19g8KakOHg">Foreign
    currency</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each consolidated entity are measured using the currency of the primary economic environment
in which the entity operates (the &#8220;functional currency&#8221;). Foreign currency transactions are translated into the functional
currency using the prevailing exchange rates on the dates of transactions. Foreign exchange gains and losses resulting from the settlement
of such transactions and from the translation of monetary assets and liabilities not denominated in the functional currency of an entity
are recognized in the statements of loss and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities of the Company and its subsidiary with a functional currency in Canadian dollars are translated at the period end rates
of exchange, and the results of its operations are translated at average rates of exchange for the period. Equity transactions have been
translated using historical rates in effect on the date that each transaction occurred. The resulting translation adjustments are included
in accumulated other comprehensive income or loss as shareholders&#8217; equity or deficit. Additionally, foreign exchange gains and
losses related to certain intercompany loans that are permanent in nature are included in accumulated other comprehensive income or loss.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z7Zw232xfael" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zrifKw4oKnn8">Cash
    and cash equivalents</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include highly liquid financial instruments that are readily convertible into cash with original maturities of three
months or less.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zxUM8nANaVi8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[d]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zPNac5tjOXYf">Property,
    plant and equipment </span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
plant and equipment (&#8220;PP&amp;E&#8221;) is carried at cost, less accumulated depreciation and accumulated impairment losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of an item of PP&amp;E consists of the purchase price, any costs directly attributable to bringing the asset to the location and
condition necessary for its intended use and an initial estimate of the costs of dismantling and removing the item and restoring the
site on which it is located.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:ScheduleOfDepreciationRateTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfDepreciationRateTableTextBlock_zZAmal3bt6q4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is provided at rates calculated to write off the cost of PP&amp;E, less their estimated residual value. The depreciation rates and method
applicable to each category of property, plant and equipment are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zy6BdnS05Kf4" style="display: none">SCHEDULE
OF DEPRECIATION RATE</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rate</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    equipment</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--DepreciationRate_c20201101__20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zGgCMd5KOpu5" title="Depreciation rate"><ix:nonNumeric contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" name="MLYF:DepreciationRate">55%
    declining balance</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--DepreciationRate_c20201101__20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zZ4pp56WpSC8"><ix:nonNumeric contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" name="MLYF:DepreciationRate">20%
    declining balance</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant
    equipment</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--DepreciationRate_c20201101__20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zNkTiUXt1M07"><ix:nonNumeric contextRef="From2020-11-012021-10-31_us-gaap_EquipmentMember" name="MLYF:DepreciationRate">20%
    declining balance</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnace
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--DepreciationRate_c20201101__20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnaceMember_zLPlKfNP7Hmb"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_FurnaceMember" name="MLYF:DepreciationRate">To
    be determined</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvement</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--DepreciationRate_c20201101__20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zC6smGUaIA2l"><ix:nonNumeric contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" name="MLYF:DepreciationRate">Term
    of lease</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use
    assets</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--DepreciationRate_c20201101__20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RightOfUseAssetsMember_zUbfU4b8t4V8"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_RightOfUseAssetsMember" name="MLYF:DepreciationRate">Term
    of lease</ix:nonNumeric></span></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zQfWY4Qc1W7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
item of PP&amp;E is derecognized upon disposal or when no future economic benefits are expected to arise from the continued use of the
asset. Any gain or loss arising on disposal of the asset, determined as the difference between the net disposal proceeds and the carrying
amount of the asset, is recognized in profit or loss in the consolidated statements of loss and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
an item of PP&amp;E comprises major components with different useful lives, the components are accounted for as separate items. Expenditures
incurred to replace a component of an item of PP&amp;E that is accounted for separately, including major inspection and overhaul expenditures,
are capitalized.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:ReclamationDepositsPolicyTextBlock"><p id="xdx_84F_ecustom--ReclamationDepositsPolicyTextBlock_zKKcPyEysXMg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[e]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zkfFoQlM1wha">Reclamation
    deposits</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash deposits, as required by regulatory bodies, as assurance for the funding of decommissioning costs. These funds
are restricted to that purpose and are not available to the Company until the reclamation obligations have been fulfilled and are therefore
classified as long-term assets.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zglOajXIP7Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[f]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zqoERFXwLvxd">Research
    and development</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures
on research activities taken to develop a pyro metallurgical process to extract and recover magnesium metal from dolomite are expensed
as incurred. Development expenditures are expensed in the period incurred.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:MineralPropertyAcquisitionAndExplorationAssetsPolicyTextBlock"><p id="xdx_84A_ecustom--MineralPropertyAcquisitionAndExplorationAssetsPolicyTextBlock_zgYrF15cCm76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[g]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zjAp80iZpet">Mineral
    property acquisition and exploration assets</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs are capitalized when incurred. Acquisition costs include cash consideration and the fair market value of shares
issued on the acquisition of mineral property claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
related to the development of mineral reserves are capitalized when it has been determined an ore body can be economically developed.
The development stage begins when an ore body is determined to be economically recoverable based on proven and probable reserves and
appropriate permits are in place, and ends when the production stage or exploitation of reserves begins. Major mine development expenditures
are capitalized, including primary development costs such as costs of building access ways, tailings impoundment, development of water
supply and infrastructure developments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exploration
costs include those relating to activities carried out (a) in search of previously unidentified mineral deposits, or (b) at undeveloped
concessions. Pre-development activities involve costs incurred in the exploration stage that may ultimately benefit production that are
expensed due to the lack of evidence of economic development, which is necessary to demonstrate future recoverability of these expenses.
Secondary development costs are incurred for preparation of an ore body for production in a specific ore block or work area, providing
a relatively short-lived benefit only to the mine area they relate to, and not to the ore body as a whole. All exploration costs have
been expensed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
production has commenced, capitalized costs will be depleted using the units-of-production method over the estimated life of the proven
and probable reserves. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to the consolidated
statements of loss and comprehensive loss in that period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying cost of mineral properties is assessed for impairment whenever information or circumstances indicate the potential for impairment.
Such evaluations compare estimated future net cash flows with carrying costs and future obligations on an undiscounted basis. If it is
determined that the future undiscounted cash flows are less than the carrying value of the property, a write down to the estimated fair
value is charged to the consolidated statements of loss and comprehensive loss for the period. Where estimates of future net cash flows
are not available and where other conditions suggest impairment, management assesses if the carrying value can be recovered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
conducted an impairment test on its mineral properties for recoverability and impairment loss during the years ended October 31, 2021
and 2020 and determined that its mineral properties were not impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
significant development projects, interest is capitalized as part of the historical cost of developing and constructing assets in accordance
with ASC 835-20. Interest is capitalized until the asset is ready for service. Capitalized interest is determined by multiplying the
Company&#8217;s weighted-average borrowing cost on general debt by the average amount of qualifying costs incurred. Once an asset subject
to interest capitalization is completed and placed in service, the associated capitalized interest is expensed through depletion or impairment.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ImpairedFinancingReceivablePolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--ImpairedFinancingReceivablePolicyPolicyTextBlock_zLthDSwoFXo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[h]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zOt4dTWfurUd">Impairment
    of non-financial assets</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-financial
assets are evaluated at the end of each reporting period by management for indicators that carrying value is impaired and may not be
recoverable. When indicators of impairment are present, non-financial assets are tested for impairment as an individual asset, as part
of an asset group or at the reporting unit (&#8220;RU&#8221;) level. An asset group is the lowest level for which there are identifiable
cash flows (i.e. both cash inflows and cash outflows) that are largely independent of the net cash flows of other groups of assets. An
RU is an operating segment or one level below an operating segment if certain conditions are met. Impairment tests for non-financial
assets subject to depreciation or amortization are applied to individual assets if possible. If this is not possible, then these assets
are tested for impairment at the asset group level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
impairment loss is triggered for non-financial assets only if the asset&#8217;s, or asset group&#8217;s, carrying amount exceeds its
recoverable amount (i.e. the carrying amount is greater than the undiscounted cash flows of the asset or asset group). If the carrying
amount is not recoverable, then the impairment loss is the difference between the carrying amount of the asset (asset group) and the
fair value of the asset (asset group). An impairment loss for an asset group is allocated pro rata to the non-financial assets in the
asset group. Impairment losses are recognized in the consolidated statements of loss and comprehensive loss and are not reversed.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zhXNaLKjbjh7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[i]
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zZqQHfzWqE8a">Income
    taxes</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset and liability method. The asset and liability method provides that deferred tax assets
and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and
tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured
using the currently enacted tax rates. The Company records a valuation allowance to reduce deferred tax assets to the amount that is
believed more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted the provisions of FASB ASC 740 &#8220;Income Taxes&#8221; regarding accounting for uncertainty in income taxes. The
Company initially recognizes tax positions in the financial statements when it is more likely than not the position will be sustained
upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax benefit
that is greater than 50% likely of being realized upon ultimate settlement with the tax authority, assuming full knowledge of the position
and all relevant facts. Application requires numerous estimates based on available information. The Company considers many factors when
evaluating and estimating its tax positions and tax benefits, and its recognized tax positions and tax benefits may not accurately anticipate
actual outcomes. As additional information is obtained, there may be a need to periodically adjust the recognized tax positions and tax
benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
periodic adjustments may have a material impact on the consolidated statements of loss and comprehensive loss. When applicable, the Company
classifies penalties and interest associated with uncertain tax positions as a component of income tax expense in its consolidated statements
of loss and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_z56I6RHvHA27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[j]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zeoqmd2ktEvh">Loss
    per share</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share (&#8220;EPS&#8221;) is calculated by dividing profit or loss attributable to ordinary equity holders (numerator)
by the weighted average number of ordinary shares outstanding (denominator) during the period. The denominator is calculated by adjusting
the shares issued at the beginning of the period by the number of shares bought back during the period, multiplied by a time-weighting
factor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
EPS is calculated by adjusting the earnings and number of shares for the effects of dilutive options and other dilutive potential units.
The effects of anti-dilutive options and potential units are ignored in calculating diluted EPS. All options and potential units are
considered anti-dilutive when the Company is in a loss position.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_84C_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zqCJu2vNMRg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[k]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zBfkM4WiVTnd">Share-based
    payments</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has an equity-settled share purchase stock option plan that is described in <i>note 14</i>. Share-based payments to employees
are measured at the fair value of the instruments issued at the grant date using the Black-Scholes Option Pricing Model, and are expensed
over the vesting period, which is the period over which all of the specific vesting conditions are satisfied. For awards with graded
vesting, the fair value of each tranche is recognized over its respective vesting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock-based payments to non-employees is periodically re-measured until the counterparty performance is complete, and any
change therein is recognized over the vesting period of the award and in the same manner as if the Company had paid cash instead of paying
with or using equity-based instruments. The cost of the stock-based payments to non-employees that are fully vested and non-forfeitable
as at the grant date is measured and recognized at that date, unless there is a contractual term for services in which case such compensation
would be amortized over the contractual term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the granting of stock options to employees using the fair value method whereby all awards to employees will be recorded
at fair value on the date of the grant. The fair value of all stock options is expensed over their vesting period with a corresponding
increase to additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
costs for stock-based payments that do not include performance conditions are recognized on a straight-line basis. Compensation cost
associated with a share-based award having a performance condition is only recognized over the requisite service period if it is probable.
Share-based awards with a performance condition are accrued on an award by award basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
share-based compensation fair value is determined using an estimated forfeiture rate. Compensation ultimately recognized is revised in
subsequent periods to reflect final grant amounts. For employees and consultants who are working on specific capital projects, the share-based
compensation is allocated to projects under development. For the remainder of employees and consultants, the compensation is expensed.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:DecommissioningLiabilitiesPolicyTextBlock"><p id="xdx_845_ecustom--DecommissioningLiabilitiesPolicyTextBlock_zIxhlT3ioEUd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[l]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_z3EO8EuLpU7f">Decommissioning
    liabilities</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records a liability for the reclamation of its exploration and evaluation interests based on the best estimate of costs for site
closure and reclamation activities that the Company is legally or constructively required to remediate, and the liability is recognized
at the time the environmental disturbance occurs. The resulting costs are capitalized to the corresponding asset. The fair value of the
provision for closure and reclamation liabilities is estimated using expected cash flows, based on engineering and environmental reports
prepared by third party industry specialists, discounted at a pre-tax rate specific to the liability. The capitalized amount is amortized
on the same basis as the related asset. The liability is adjusted for accretion of the discounted obligation and any changes in the amount
or timing of the underlying future cash flows. Significant judgments and estimates are involved in forming expectations of the amount
and timing of future site closure and reclamation cash flows. Future restoration costs are reviewed annually and any changes in the estimate
are reflected in the present value of the provision at the reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:ShareCapitalPolicyTextBlock"><p id="xdx_84F_ecustom--ShareCapitalPolicyTextBlock_zjVmKfd51Uij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[m]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zIK6KcWXEErf">Share
    capital</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 14.35pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records proceeds from share issuances net of issuance costs. Shares issued for consideration other than cash are valued at the
quoted price on the date the shares are issued.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_844_eus-gaap--DerivativesPolicyTextBlock_z9bJVeV1E4Q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[n]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zmui1s5m5645">Financial
    instruments</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s classification of its financial instruments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset
    or Liability</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Held-for-trading</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    receivable</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to related parties</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    note and convertible debenture</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
    liability</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value through profit and loss (&#8220;FVTPL&#8221;)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value hierarchy under US GAAP is based on the following three levels of inputs, of which the first two are considered observable
and the last unobservable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1: Quoted prices (unadjusted) in active markets for identical assets or liabilities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2: Observable inputs other than Level I, quoted prices for similar assets or liabilities in active prices whose inputs are
observable or whose significant value drivers are observable; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3: Assets and liabilities whose significant value drivers are unobservable by little or no market activity and that are significant
to the fair value of the assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s derivative liability is based on Level 3 inputs in the ASC 820 fair value hierarchy. .</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative
Liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments and other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with ASC 815. The result of this accounting treatment is that the
fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair
value is recorded in the consolidated statements of loss and comprehensive loss. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value
of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current
or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Scholes Option Pricing Model to value derivative liabilities. This model uses Level 3 inputs in the fair value
hierarchy established by ASC 820 Fair Value Measurement.</span></p>

</ix:nonNumeric><p id="xdx_85F_zRsqFc0iJnBc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"><p id="xdx_80C_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_z0Y2eOlTY4Lb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82F_zkta08Je5lId">RECENT
                                            ACCOUNTING PRONOUNCEMENTS</span></b></span></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Accounting Standards Adopted During the Year</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value Measurements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2018-13, &#8220;Disclosure Framework&#8212;Changes
to the Disclosure Requirements for Fair Value Measurement&#8221; which adds the disclosure of the range and weighted average of significant
unobservable inputs used to develop Level 3 fair value measurements. Certain alternatives apply. Effective November 1, 2020, the Company
adopted the new standard. There was no material impact or adjustment to these Financial Statements.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Accounting Standards Not Yet Adopted</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no new accounting standards not yet adopted by the Company that are expected to have a significant impact on its Financial Statements.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zePU92K1TFYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_znGOVzyuj0Cd">PROPERTY,
    PLANT AND EQUIPMENT</span></span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJ0Yat2xbukl" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B1_zH6B1vRLykng" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--PropertyPlantAndEquipmentByTypeAxis_us-gaap--ComputerEquipmentMember_zXPrdRBSbHL7" style="font-weight: bold; text-align: center">Computer Equipment</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--PropertyPlantAndEquipmentByTypeAxis_us-gaap--FurnitureAndFixturesMember_zW266zqNYsZ4" style="font-weight: bold; text-align: center">Furniture</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--PropertyPlantAndEquipmentByTypeAxis_us-gaap--LeaseholdImprovementsMember_zBGifytTCX5e" style="font-weight: bold; text-align: center">Leasehold Improvement</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--PropertyPlantAndEquipmentByTypeAxis_custom--FurnaceAndPlantEquipmentMember_z5nNVWlKnTq5" style="font-weight: bold; text-align: center">Furnace &amp; Plant Equipment</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B6_zU4b2esPBw0b" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20191101__20201031_eus-gaap--PropertyPlantAndEquipmentGross_iS_zCULmps7jSX6" style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left">Balance, October 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,632</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,584</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,850</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,897</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,963</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentAdditions_zfha5JrRYxZb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2019-11-012020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,852</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2019-11-012020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,672</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2019-11-012020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,810</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2019-11-012020-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">838</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,172</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--PropertyPlantAndEquipmentForeignExchangeEffect_zb6oxi7qZ2G1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2019-11-012020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2019-11-012020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">340</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2019-11-012020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">50</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2019-11-012020-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">322</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">878</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20201101__20211031_eus-gaap--PropertyPlantAndEquipmentGross_iS_zUvT4fBF37Ae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,318</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,610</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,413</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,257</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20201101__20211031_eus-gaap--PropertyPlantAndEquipmentGross_iS_z4KCqX5esmik" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cost, Beginning Balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,318</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,610</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,413</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,257</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentAdditions_ziDu89gGuJQ8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,955</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,510</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,257</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,278,205</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,496,927</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--PropertyPlantAndEquipmentWriteOffOfEquipment_zOcqWt6B6Mpb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Write-off of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,245</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0696">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0697">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0698">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,245</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--PropertyPlantAndEquipmentForeignExchangeEffect_zavgwCuIRkJ9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,116</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,614</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,108</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,439</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20201101__20211031_eus-gaap--PropertyPlantAndEquipmentGross_iE_zTr1dJWJaylb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,629</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,542</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,481</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,344,726</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,647,378</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20201101__20211031_eus-gaap--PropertyPlantAndEquipmentGross_iE_zZW9Bu4UFpT2" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cost, Ending Balance</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,629</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,542</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,481</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,344,726</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,647,378</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Accumulated Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20191101__20201031_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_zIgffzI9hGXg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance, October 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2019-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,184</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2019-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,679</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2019-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,950</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0722">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,813</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DepreciationAndAmortization_zI8JlKXjik03" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-11-012020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,412</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-11-012020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-11-012020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,861</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0728">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,871</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1_zPp09Cy8nEPh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2019-11-012020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2019-11-012020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2019-11-012020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0734">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">137</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20201101__20211031_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_zfUpAyvM8m6d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,326</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,818</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0740">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,821</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201101__20211031_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_zjK2nwALgJIi" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Depreciation, Beginning Balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,326</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,818</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,821</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DepreciationAndAmortization_zlkInjwYp8B" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,907</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,443</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,971</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,148</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment_z7pt8NB54Px7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Write-off of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,057</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0756">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0757">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0758">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,057</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1_z3EgvonN8gT5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,294</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">745</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">502</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">221</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,762</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201101__20211031_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_zmwnRIr6VAYc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,821</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,514</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,147</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,192</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,674</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20201101__20211031_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_zrzddKm03pHg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Accumulated Depreciation, Ending Balance</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,821</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,514</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,147</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,192</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,674</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Net Book Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201031_eus-gaap--PropertyPlantAndEquipmentNet_iI_zsvCZOhplWBb" style="vertical-align: bottom; background-color: White">
    <td>Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,641</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,590</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,792</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,413</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_431_c20211031_eus-gaap--PropertyPlantAndEquipmentNet_iI_z32Get0FjPs5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,808</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,028</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,334</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,330,534</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,574,704</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20211031_eus-gaap--PropertyPlantAndEquipmentNet_iI_ztI3OwGdHd21" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Net Book Value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,808</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,028</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,334</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,330,534</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,574,704</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A0_zpeRcQXhhhk6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:RightOfUseAssetsDisclosureTextBlock"><p id="xdx_805_ecustom--RightOfUseAssetsDisclosureTextBlock_zKrZy3gmclfa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_zjlqrTQCYaj3">RIGHT-OF-USE
    ASSETS</span></span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">As
at October 31, 2021, the right-of-use assets are leases for the Company&#8217;s corporate offices in Vancouver, British Columbia and
McLean, Virginia, and its research and development pilot plant located in Burnaby, British Columbia. These leases terminate on March
31, 2023, February 28, 2025 and September 30, 2023, respectively. The lease for the Company&#8217;s office in Las Vegas, Nevada ended
on May 31, 2021. </span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:ScheduleOfRightOfUseAssetsTableTextBlock"><p id="xdx_892_ecustom--ScheduleOfRightOfUseAssetsTableTextBlock_z3hP7i5HFqx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"><span id="xdx_8BF_zYvbsqykycu9" style="display: none">SCHEDULE
OF RIGHT-OF-USE
    ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BE_us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis_custom--VancouverOfficeMember_zJVoEhllvtQ4" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B1_us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis_custom--VirginiaOfficeMember_zK7XEPtB47Rb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B6_us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis_custom--NevadaOfficeMember_z1UyhRExS2q6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B0_us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis_custom--PilotPlantMember_zkzUlMaU5iNc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B2_zs6iFEVC4j65" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Vancouver Office</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Virginia</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office</b></span></p></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Nevada Office</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Pilot Plant</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20191101__20201031_ecustom--OperatingLeaseRightOfUseAssetCost_iS_zP2Id9yEAxUi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance, October 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0801">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0802">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0803">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0805">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--RightOfUseAssetsInitialAdoptionOfAccountingStandardsUpdates_zvDMAGu0ZEn3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 35%; text-align: left">Initial adoption of ASU 2016-02</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:RightOfUseAssetsInitialAdoptionOfAccountingStandardsUpdates" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,418</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0808">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:RightOfUseAssetsInitialAdoptionOfAccountingStandardsUpdates" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,131</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0810">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:RightOfUseAssetsInitialAdoptionOfAccountingStandardsUpdates" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,549</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_zTrfEPnvxwk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0813">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0814">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0815">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,263</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,263</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset_zwXvqhRQF1Zh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">717</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">275</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,686</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,694</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetCost_iS_ziwy3yqlFmkf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,701</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0826">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,856</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,949</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">440,506</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetCost_iS_zqvVVbMz21g" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left">Operating lease right-of-use asset, cost, beginning balance</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,701</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0832">&#8211;</span></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,856</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,949</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">440,506</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_zRMy6wJBiMQ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">287,847</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0839">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0840">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">379,084</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset_zSX7UGQ8tRFb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,943</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,544</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,724</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,997</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,208</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetCost_iE_zM7q011Qdlmi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,881</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292,391</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,946</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">858,798</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_437_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetCost_iE_z6JdMSBfqc7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Operating lease right-of-use asset, cost, ending balance</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,881</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292,391</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,946</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">858,798</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Accumulated Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_435_c20191101__20201031_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iS_zqt0A4egGFIh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Balance, October 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0861">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0862">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0865">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_zH2sPsKk8qB1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,708</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0868">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,286</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,841</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,835</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation_zj7wpz5wwWAg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">434</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0874">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">148</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">684</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iS_zbKnlohHiDzl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,142</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0880">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,434</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,943</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,519</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iS_zF61HpjSeb2i" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; text-align: left">Operating lease right-of-use asset, accumulated depreciation, beginning balance</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,142</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0886">&#8211;</span></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,434</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,943</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,519</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_zE0QJGvGHSFj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,259</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,288</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,915</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,292</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,754</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation_zgQEwZOipA7c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,876</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,602</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,950</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iE_zzl1wj3dHUZa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,277</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,529</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,837</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,223</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iE_zpVQiDd1Dxsi" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Operating lease right-of-use asset, accumulated depreciation, ending balance</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,277</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,529</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,837</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,223</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Net Book Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_435_c20191101__20201031_eus-gaap--OperatingLeaseRightOfUseAsset_iE_zl0OPlnqMZCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,559</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0916">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,422</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">348,006</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">373,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20201101__20211031_eus-gaap--OperatingLeaseRightOfUseAsset_iE_zudFzacOEDXa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,604</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,862</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0923">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,109</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">598,575</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20201101__20211031_eus-gaap--OperatingLeaseRightOfUseAsset_iE_zE89LDVDFds7" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-weight: bold; padding-bottom: 2.5pt">Operating lease right-of-use asset</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,604</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,862</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0929">&#8211;</span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,109</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">598,575</ix:nonFraction></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zepP2jpKibX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zycjXTIM0tPf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_823_zJ4lFfxgiLbb">LEASE
    OBLIGATIONS</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">On
adoption of ASU 2016-02 on November 1, 2019, the Company recognized lease liabilities of $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20191102_zFHiA4MP3ul3" title="Lease liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-11-02" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,549</ix:nonFraction></span> which had previously been classified
as operating leases. The lease liabilities were measured at the present value of the remaining lease payments and discounted using the
lessee&#8217;s incremental borrowing rate of approximately <span id="xdx_902_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_c20191102_z3TEYrXQSZI4" title="Borrowing rate"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2019-11-02" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>%. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">During
the year ended October 31, 2020, the Company entered into a new operating lease with respect to its research and development pilot plant
located in Burnaby, British Columbia and recognized a lease liability of $<span id="xdx_904_eus-gaap--OperatingLeaseLiability_iI_c20201031__srt--StatementGeographicalAxis__custom--BritishColumbiaMember_z0jO5m7XCUj8"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_BritishColumbiaMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,263</ix:nonFraction></span>, which was measured by discounting lease payments using
an incremental borrowing rate of approximately <span id="xdx_903_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_c20201031__srt--StatementGeographicalAxis__custom--BritishColumbiaMember_ztvoQhK48udh"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2020-10-31_custom_BritishColumbiaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">During
the year ended October 31, 2021, the Company renewed its operating lease with respect to its corporate office in Vancouver, British Columbia
and recognized a lease liability of $<span id="xdx_90A_eus-gaap--OperatingLeaseLiability_iI_c20211031__srt--StatementGeographicalAxis__custom--BritishColumbiaMember_z17t1RrCUU99"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_BritishColumbiaMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,237</ix:nonFraction></span>, which was measured by discounting lease payments using an incremental borrowing rate of
approximately <span id="xdx_909_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_c20211031__srt--StatementGeographicalAxis__custom--BritishColumbiaMember_zY9V2iCBUXk"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2021-10-31_custom_BritishColumbiaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">During
the year ended October 31, 2021, the Company entered into a new operating lease with respect to its office in McLean,Virginia and recognized
a lease liability of $<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_c20211031__srt--StatementGeographicalAxis__custom--McLeanAndVirginiaMember_zSMmpilWGpL9"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_McLeanAndVirginiaMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,649</ix:nonFraction></span>, which was measured by discounting lease payments using an incremental borrowing rate of approximately
<span id="xdx_902_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_c20211031__srt--StatementGeographicalAxis__custom--McLeanAndVirginiaMember_zlmXyDVJwXe7"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2021-10-31_custom_McLeanAndVirginiaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>%.</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_890_eus-gaap--LeaseCostTableTextBlock_zREVEufV7cI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"><span id="xdx_8B5_zYK48EAcjGo2" style="display: none">SCHEDULE
OF OPERATING LEASE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BD_srt--StatementGeographicalAxis_custom--VancouverOfficeMember_zODO2NCFZMmg" style="font-weight: bold; text-align: center">Vancouver Office</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_4BD_srt--StatementGeographicalAxis_custom--VirginiaOfficeMember_zQTB8npb4aI6" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Virginia</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office</b></span></p></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BE_srt--StatementGeographicalAxis_custom--NevadaOfficeMember_zhYPoHa2iZ77" style="font-weight: bold; text-align: center">Nevada Office</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B1_srt--StatementGeographicalAxis_custom--PilotPlantMember_zs08FiY3xMab" style="font-weight: bold; text-align: center">Pilot Plant</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BE_zyx5na4nKTA" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_43D_c20191101__20201031_eus-gaap--OperatingLeaseLiability_iS_z0cnEAcrTzBh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Balance, October 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0948">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0949">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0951">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--OperatingLeaseInitialAdoption_zLZj9MzaeUxe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 35%; text-align: left">Initial adoption of ASU 2016-02</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseInitialAdoption" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember50338046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,418</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0954">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseInitialAdoption" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember50338078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,131</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0956">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseInitialAdoption" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,549</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--OperatingLeaseAdditions_z6ELbji2HMbh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0959">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0961">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember50338078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,263</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,263</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeasePayments_iN_di_zH5xiQjWq34h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember50338046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,627</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember50338078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,990</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember50338078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,831</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,448</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseExpense_zjjahilR4Ipl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember50338046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,477</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember50338078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,005</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember50338078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,551</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,033</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--OperatingLeaseForeignExchangeEffect_zieQAcmqhCLe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2019-11-012020-10-31_custom_VancouverOfficeMember50338046" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,145</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0978">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2019-11-012020-10-31_custom_NevadaOfficeMember50338078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,065</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2019-11-012020-10-31_custom_PilotPlantMember50338078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,610</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,530</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20201101__20211031_eus-gaap--OperatingLeaseLiability_iS_zyDgMyi4dPvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Balance, October 31, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember50338187" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,123</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">&#8211;</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember50338218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,211</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_PilotPlantMember50338234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">350,593</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">380,927</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--OperatingLeaseAdditions_z59gqg2fWZS9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,649</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0991">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">351,886</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeasePayments_iN_di_z6HdU2aFMq14" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,931</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,137</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,457</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,037</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,562</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseExpense_znptUhjtlLf1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,076</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">219</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,005</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--OperatingLeasePriorPeriodAdjustment_zWnQdCqJaAs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prior period adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1007">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1008">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,065</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1010">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,065</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--OperatingLeaseForeignExchangeEffect_zXhPcY9LQpti" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,099</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,081</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,548</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,820</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20201101__20211031_eus-gaap--OperatingLeaseLiability_iE_zInZB3G72zEl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember50338437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,604</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember50338453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,612</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1021">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_PilotPlantMember50338500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,109</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">584,325</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Which consist of:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43F_c20211031_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zL3jQngZyLwg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Current lease obligation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember50338437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,270</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember50338453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,328</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1027">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-10-31_custom_PilotPlantMember50338500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,447</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,045</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20211031_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zAt9u4blG1Yg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Non-current lease obligation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember50338437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,334</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember50338453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">246,284</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1033">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-10-31_custom_PilotPlantMember50338500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,662</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">392,280</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20201101__20211031_eus-gaap--OperatingLeaseLiability_iE_zrvE8M5xpoIe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance, October 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember50338437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,604</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember50338453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,612</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1039">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_PilotPlantMember50338500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,109</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">584,325</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zzC9yWt2Gep8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:MineralIndustriesDisclosuresTextBlock"><p id="xdx_800_eus-gaap--MineralIndustriesDisclosuresTextBlock_zlhk2jGJPDQ4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_823_zUyhwI7BMgfe">MINERAL PROPERTY COSTS</span></span></p>


<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:ScheduleOfMineralPropertyCostsTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfMineralPropertyCostsTableTextBlock_zn3x3iJWa7G3" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zh5CY7TP7TSj" style="display: none">SCHEDULE
OF MINERAL PROPERTY COSTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Beaverdell
    Property</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Silverado
    Property</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Tami Mosi
    <br />Property</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Balance, October
    31, 2019</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; font-weight: bold; text-align: right"><span id="xdx_907_eus-gaap--MineralPropertiesGross_iS_c20191101__20201031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_zybpfmby8Uza" title="Balance, beginning" style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2019-10-31_custom_BeaverdellPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; font-weight: bold; text-align: right"><span id="xdx_90D_eus-gaap--MineralPropertiesGross_iS_c20191101__20201031__srt--ProductOrServiceAxis__custom--SilveradoPropertyMember_zNeGQLKSCZF4" title="Balance, beginning" style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2019-10-31_custom_SilveradoPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; font-weight: normal; text-align: right"><span id="xdx_90E_eus-gaap--MineralPropertiesGross_iS_c20191101__20201031__srt--ProductOrServiceAxis__custom--TamiMosiPropertyMember_zbqkFjXbA245" title="Balance, beginning" style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2019-10-31_custom_TamiMosiPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,452</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 10%; font-weight: normal; text-align: right"><span id="xdx_900_eus-gaap--MineralPropertiesGross_iS_c20191101__20201031_zr7eFLCY98F1" title="Balance, beginning" style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,454</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Sale of mineral property</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--SaleOfMineralProperty_c20191101__20201031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_z9OoquMRJ89c" title="Sale of mineral property" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MLYF:SaleOfMineralProperty" contextRef="From2019-11-012020-10-31_custom_BeaverdellPropertyMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SaleOfMineralProperty_c20191101__20201031__srt--ProductOrServiceAxis__custom--SilveradoPropertyMember_zUYZTF37wLng" title="Sale of mineral property" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1057">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--SaleOfMineralProperty_c20191101__20201031__srt--ProductOrServiceAxis__custom--TamiMosiPropertyMember_z1RnH3qGRtN7" title="Sale of mineral property" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1059">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--SaleOfMineralProperty_c20191101__20201031_zFlTXYhMB827" title="Sale of mineral property" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="MLYF:SaleOfMineralProperty" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance,
    October 31, 2020 and 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;<span id="xdx_902_eus-gaap--MineralPropertiesGross_iS_c20201101__20211031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_zqNx9qQ5rumf" title="Balance, beginning"><span style="-sec-ix-hidden: xdx2ixbrl1063">&#8211;</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;<span><span id="xdx_907_eus-gaap--MineralPropertiesGross_iS_c20201101__20211031__srt--ProductOrServiceAxis__custom--SilveradoPropertyMember_znL7K52bVrr" title="Balance, ending"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2020-10-31_custom_SilveradoPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--MineralPropertiesGross_iS_c20201101__20211031__srt--ProductOrServiceAxis__custom--TamiMosiPropertyMember_zJCReBaPwB12" title="Balance, ending"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2020-10-31_custom_TamiMosiPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,452</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--MineralPropertiesGross_iS_c20201101__20211031_zDvrITrTpSRk" title="Balance, ending"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Sale of mineral property</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--SaleOfMineralProperty_c20201101__20211031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_z5IlXID4giU1" title="Sale of mineral property" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1071">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--SaleOfMineralProperty_c20201101__20211031__srt--ProductOrServiceAxis__custom--SilveradoPropertyMember_zC6x2ukUTns6" title="Sale of mineral property" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1073">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_ecustom--SaleOfMineralProperty_c20201101__20211031__srt--ProductOrServiceAxis__custom--TamiMosiPropertyMember_zJHMDio3ZfN6" title="Sale of mineral property" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1075">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--SaleOfMineralProperty_c20201101__20211031_zbT4c0mdiq4l" title="Sale of mineral property" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance,
    October 31, 2020 and 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;<span id="xdx_90F_eus-gaap--MineralPropertiesGross_iE_c20201101__20211031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_z8SkdqEEiWra" title="Balance, ending"><span style="-sec-ix-hidden: xdx2ixbrl1079">&#8211;</span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;<span><span id="xdx_903_eus-gaap--MineralPropertiesGross_iE_c20201101__20211031__srt--ProductOrServiceAxis__custom--SilveradoPropertyMember_zxLdl3OpULs9" title="Balance, ending"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2021-10-31_custom_SilveradoPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span title="Balance, ending" style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eus-gaap--MineralPropertiesGross_iE_c20201101__20211031__srt--ProductOrServiceAxis__custom--TamiMosiPropertyMember_zMybLuvdfSOa" title="Balance, ending"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2021-10-31_custom_TamiMosiPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,452</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--MineralPropertiesGross_iE_c20201101__20211031_zzwZE8thVFH1" title="Balance, ending"><ix:nonFraction name="us-gaap:MineralPropertiesGross" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AC_zDWTp4v3Hoaa" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[a]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beaverdell
    Property, Greenwood Mining Division, British Columbia, Canada</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Beaverdell property is located in British Columbia, and was <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_zMGUQ1zEEXgi" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-10-31_custom_BeaverdellPropertyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% owned by the Company until the year ended October 31, 2020. During the
year ended October 31, 2020, the Company sold its <span id="xdx_90D_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20191101__20201031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_zO1demde2ex1" title="Sale of stock ownership interest percentage"><ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="From2019-11-012020-10-31_custom_BeaverdellPropertyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% interest in and to the mineral property for aggregate proceeds of CA$<span id="xdx_90A_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_uCA_c20201101__20211031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_zJDFCdrXEUL5" title="Aggregate proceeds from sale of property amount"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_custom_BeaverdellPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">50,000</ix:nonFraction></span> (USD
equivalent $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_uUSD_c20201101__20211031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_zzRR4wKBpoQ" title="Aggregate proceeds from sale of property amount"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_custom_BeaverdellPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,157</ix:nonFraction></span>) to be paid in two equal tranches: (i) upon signing of the sale agreement (received); and (ii) on or before April
7, 2020 (received). As a result, the Company recognized a gain on sale of $<span id="xdx_907_eus-gaap--GainLossOnSaleOfPropertyPlantEquipment_c20200405__20200407__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_zhpU4GIpSe8j" title="Recognized gain on sale of property"><ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="From2020-04-052020-04-07_custom_BeaverdellPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,156</ix:nonFraction></span> during the year ended October 31, 2020. The carrying
value of the property was $<span id="xdx_903_eus-gaap--RetailLandSalesDepositMethodPropertyCarryingValue_iI_c20201031__srt--ProductOrServiceAxis__custom--BeaverdellPropertyMember_zp5qp5yikxog" title="Carrying value of property"><ix:nonFraction name="us-gaap:RetailLandSalesDepositMethodPropertyCarryingValue" contextRef="AsOf2020-10-31_custom_BeaverdellPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[b]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Silverado
    Property<span style="font-weight: normal">,</span> Nevada, United States</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Silverado property is located in the Pinto mining district of Nevada, consists of 3 patented mining claims totaling approximately 120
hectares, and is <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211031__srt--ProductOrServiceAxis__custom--SilveradoPropertyMember_zEnbsy1Ju3P9" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-10-31_custom_SilveradoPropertyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% owned by the Company. The carrying value of the property is $<span id="xdx_90E_eus-gaap--RetailLandSalesDepositMethodPropertyCarryingValue_iI_c20201031__srt--ProductOrServiceAxis__custom--SilveradoPropertyMember_zaE3VKncfNc2" title="Carrying value of property"><ix:nonFraction name="us-gaap:RetailLandSalesDepositMethodPropertyCarryingValue" contextRef="AsOf2020-10-31_custom_SilveradoPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[c]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tami
    Mosi Property, Nevada, United States</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company holds a <span id="xdx_90B_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20201101__20211031__srt--ProductOrServiceAxis__custom--TamiMosiPropertyMember_zSdOjpejznP7" title="Sale of stock ownership interest percentage"><ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="From2020-11-012021-10-31_custom_TamiMosiPropertyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% interest in 81 unpatented lode mining claims totaling approximately <span id="xdx_902_eus-gaap--AreaOfLand_iI_uAcre_c20211031__srt--ProductOrServiceAxis__custom--TamiMosiPropertyMember_z7gXtt2Wdjp3" title="Number of acres located"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2021-10-31_custom_TamiMosiPropertyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Acre">1,637</ix:nonFraction></span> acres located in White Pine County, Nevada
and four unpatented lode mining claims totaling approximately 10 acres located in the Moor Mining District, Elko County, Nevada. These
mining claims are subject to a <span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211031__srt--ProductOrServiceAxis__custom--TamiMosiPropertyMember_zJTjZWwnmfog" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-10-31_custom_TamiMosiPropertyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% net smelter royalty in favor of the prior owner of the claims.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zErucV4wf6f7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_ztaVy7U3E2I6">RELATED PARTY TRANSACTIONS</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deposits
    held by related parties</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2021, the Company provided related parties with advances that were held as deposits for anticipated future
costs related to the Company&#8217;s planned magnesium research and development pilot plant and other administrative expenses (the &#8220;Pilot
Plant Advances&#8221;). During the year ended October 31, 2021, the Company provided Pilot Plant Advances to a company controlled by
a director and officer in the aggregate amount of $<span id="xdx_90A_eus-gaap--DueFromOfficersOrStockholders_iI_c20211031_zoSjfCLweIUb" title="Director and officer aggregate amount"><ix:nonFraction name="us-gaap:DueFromOfficersOrStockholders" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">987,912</ix:nonFraction></span>, of which $<span id="xdx_90B_eus-gaap--CostsAndExpensesRelatedParty_c20201101__20211031_zjBQoNZadPEd" title="Costs and expenses related party"><ix:nonFraction name="us-gaap:CostsAndExpensesRelatedParty" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">696,431</ix:nonFraction></span> was used for costs and expenses leaving a balance of $<span id="xdx_90E_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20201101__20211031_zloxZaLCVd76" title="Related party transaction remaining balance"><ix:nonFraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">291,481</ix:nonFraction></span>
as of October 31, 2021. During the same period, the Company provided Pilot Plant Advances to a company controlled by an officer in the
aggregate amount of $<span id="xdx_909_eus-gaap--DueFromOfficersOrStockholders_iI_c20211031__srt--TitleOfIndividualAxis__srt--OfficerMember_ziXPPdZ2aQSk" title="Director and officer aggregate amount"><ix:nonFraction name="us-gaap:DueFromOfficersOrStockholders" contextRef="AsOf2021-10-31_srt_OfficerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,292,912</ix:nonFraction></span>, of which $<span id="xdx_90C_eus-gaap--CostsAndExpensesRelatedParty_c20201101__20211031__srt--TitleOfIndividualAxis__srt--OfficerMember_zn4t7IgdnSa7" title="Costs and expenses related party"><ix:nonFraction name="us-gaap:CostsAndExpensesRelatedParty" contextRef="From2020-11-012021-10-31_srt_OfficerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,097,931</ix:nonFraction></span> was used for costs and expenses leaving a balance of $<span id="xdx_90A_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20201101__20211031__srt--TitleOfIndividualAxis__srt--OfficerMember_zULHOqycLiK3" title="Related party transaction remaining balance"><ix:nonFraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="From2020-11-012021-10-31_srt_OfficerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,981</ix:nonFraction></span> as of October 31, 2021.
The aggregate deposits held by related parties were $<span id="xdx_90E_eus-gaap--RelatedPartyDepositLiabilities_iI_c20211031_zcIib7w044Fa" title="Deposit held related parties"><ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,462</ix:nonFraction></span> as of October 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Due
    to related parties</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at October 31, 2021, balances due to related parties totaled $<span id="xdx_90E_ecustom--DueToRelatedParties_iI_c20211031_zvYG3jbEXRrk" title="Due to related parties"><ix:nonFraction name="MLYF:DueToRelatedParties" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,026,817</ix:nonFraction></span> (October 31, 2020 &#8211; $<span id="xdx_90D_ecustom--DueToRelatedParties_iI_c20201031_zsufdjeivKVi" title="Due to related parties"><ix:nonFraction name="MLYF:DueToRelatedParties" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">843,990</ix:nonFraction></span>). All advances are unsecured,
non-interest bearing, and have no stated terms of repayment.</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_znQOYyXEd96d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zI25humGibdj" style="display: none">SCHEDULE
OF DUE TO RELATED PARTIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20211031_zbacH1JzaPIe" style="font-weight: bold; text-align: center">October 31, 2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20201031_ztwrBoDB5hs" style="font-weight: bold; text-align: center">October 31, 2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DirectorsAndOfficersWagesPayable_iI_maRPTDFzRvT_zz5vSCjv8nR5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Wages payable to directors and officers</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersWagesPayable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersWagesPayable" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,922</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DirectorsAndOfficersBenefitsPayable_iI_maRPTDFzRvT_zuCRo8oTkPzg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Benefits payable to directors and officers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersBenefitsPayable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">539,209</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1135">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DirectorsAndOfficersFeesAndExpensesPayable_iI_maRPTDFzRvT_zwcTIJjLi8sl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fees and expenses payable to directors and officers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersFeesAndExpensesPayable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersFeesAndExpensesPayable" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">682,068</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--InterestsDueToShareholder_iI_maRPTDFzRvT_ziWXPZBD3WH7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Interests due to a shareholder</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:InterestsDueToShareholder" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,230</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1141">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--RelatedPartyTransactionDueFromToRelatedPartyCurrent_iTI_mtRPTDFzRvT_z9JZq4WkHa3f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,026,817</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">843,990</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zx7gUm2YMpIf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
    management compensation</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at October 31, 2021, the Company had twelve executives including eight in senior management. Their aggregate annualized compensation
is approximately $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20201101__20211031_zdEQGaHZ9iH2" title="Key management compensation expenses"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.9</ix:nonFraction></span> million. During the year ended October 31, 2021, the Company incurred salaries, management and consulting fees
totaling $<span id="xdx_908_ecustom--SalariesManagementAndConsultingFees_c20201101__20211031_zW1wpKld2YA7" title="Salaries management and consulting fees"><ix:nonFraction name="MLYF:SalariesManagementAndConsultingFees" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,020,102</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_902_ecustom--SalariesManagementAndConsultingFees_c20191101__20201031_zlXoNCKvTlGg" title="Salaries management and consulting fees"><ix:nonFraction name="MLYF:SalariesManagementAndConsultingFees" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,785,032</ix:nonFraction></span>) to directors, officers and related companies with directors in common, and stock-based
compensation totaling $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20201101__20211031__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficersMember_ziiQtClwOSF9" title="Directors officers and related parties stock based compensation"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-11-012021-10-31_custom_DirectorsAndOfficersMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,248,013</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20191101__20201031__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficersMember_z277KkbV6Fs4"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-11-012020-10-31_custom_DirectorsAndOfficersMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,211</ix:nonFraction></span>) for options granted to directors and officers of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[d]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transactions
    with related parties</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2021, the Company incurred consulting fees of CA$<span id="xdx_908_eus-gaap--ProfessionalFees_uCA_c20201101__20211031_zOfiAvapfhM6" title="Consulting fees"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="CA">120,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_909_eus-gaap--ProfessionalFees_c20201101__20211031_zxpqDfyEXFT1" title="Consulting fees"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">95,390</ix:nonFraction></span>) to a member of senior management.
The Company also incurred consulting fees of CA$<span id="xdx_90E_eus-gaap--ProfessionalFees_uCA_c20191101__20201031_zIgXloCVxGd9" title="Consulting fees"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="CA">45,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_900_eus-gaap--ProfessionalFees_c20191101__20201031_zREnbB90Yq7" title="Consulting fees"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,771</ix:nonFraction></span>) to a company controlled by a director and officer, and
$<span id="xdx_90C_eus-gaap--DueToOfficersOrStockholdersCurrentAndNoncurrent_iI_c20211031_zBhn1oJqqYgj" title="Director and officer"><ix:nonFraction name="us-gaap:DueToOfficersOrStockholdersCurrentAndNoncurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></span> to a company controlled by a director and officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zvBbRf2hoOQg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_820_z90poAUSHSnh">CONTINGENT LIABILITIES AND COMMITMENTS</span></b></span></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contingent liabilities</b></span></td></tr></table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
On September 29, 2020, James Sever filed a Notice of Civil Claim against the Company in the Supreme Court of British Columbia (the &#8220;Sever
Claim&#8221;). The Sever Claim alleges that Mr. Sever had an employment and/or other similar contractual relationship with the Company,
and that the Company breached such contractual relationship by way of constructive dismissal or similar conduct. The Sever Claim seeks
damages in excess of $<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_c20200927__20200929__srt--RangeAxis__srt--MaximumMember_z9Mafhd2r9G2" title="Loss contingency damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-09-272020-09-29_srt_MaximumMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction></span> million, certain equity compensation, prejudgment garnishment, costs, interest and other non-monetary relief.
On July 27, 2021, the Company filed a response to the Sever Claim, which included the following pleadings: (a) that the Company was never
properly served with the Sever Claim; (b) that the Company had never had any form of employment, independent or consulting relationship
or agreement with Mr. Sever; (c) that the Company had no debts, liabilities or obligations to Mr. Sever; (d) that to the extent that
Mr. Sever had some form of employment, independent or consulting or similar relationship or agreement as alleged in the Sever Claim,
such contract or relationship, if one existed, was never with the Company and was with some other corporate entity. The Company intends
to vigorously defend against the Sever Claim, and believes that the Sever Claim is without merit. As the Company cannot predict the outcome
of the Sever Claim, no provision has been recognized as there is no present obligation and the probability of an outcome cannot be determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
On December 30, 2020, the Company entered into a settlement agreement with Frank Halliday, a former director and officer of the Company,
whereby the Company has agreed to pay Mr. Halliday termination pay in the amount of CA$<span id="xdx_901_eus-gaap--LossOnContractTermination_uCA_c20201229__20201230_zVLEttfg76Z9" title="Payment termination amount"><ix:nonFraction name="us-gaap:LossOnContractTermination" contextRef="From2020-12-292020-12-30" format="ixt:numdotdecimal" decimals="0" unitRef="CA">102,001</ix:nonFraction></span> (USD equivalent $<span id="xdx_904_eus-gaap--LossOnContractTermination_c20201229__20201230_zkhNrftErgj7" title="Payment termination amount"><ix:nonFraction name="us-gaap:LossOnContractTermination" contextRef="From2020-12-292020-12-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,588</ix:nonFraction></span>) via installment
payments commencing in January 2021 until October 2021. As at October 31, 2020, the Company had recorded a provision for the settlement
amount. As at October 31, 2021, the Company had paid the entire balance, reducing the provision to $nil.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iii]
On December 31, 2020, GEM Yield Bahamas Limited (&#8220;GEM&#8221;) served the Company with a Notice of Intention to Arbitrate (the &#8220;New
York Arbitration Notice&#8221;) before the American Arbitration Association in New York (the &#8220;GEM New York Arbitration&#8221;).
The New York Arbitration Notice alleges the Company breached a Share Subscription Agreement dated November 15, 2019 entered into between
the Company and GEM (the &#8220;GEM Agreement&#8221;), among other things, claiming damages of CA$<span id="xdx_904_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_uCA_c20201229__20201231_zpriUbls8I45" title="Loss contingency damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-12-292020-12-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="CA">4.2</ix:nonFraction></span> million (USD equivalent $<span id="xdx_90F_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_uUSD_c20201229__20201231_zfo3cRgJFTfe" title="Loss contingency damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-12-292020-12-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.4</ix:nonFraction></span> million).
On January 19, 2021, the Company filed a petition in the New York Supreme Court to stay the GEM New York Arbitration claiming the GEM
Agreement was not valid. On March 19, 2021, the Court in the New York State Action ruled that there was an arbitration clause in the
GEM Agreement but it was up to the arbitrator to determine if the arbitration clause was valid. Following this ruling, the New York State
Action was closed. In June 2021, GEM filed a Statement of Claim in the GEM New York Arbitration, and the Company filed a Statement of
Answer denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company
filed a Modified Statement of Defense and Counterclaims. The Company intends to vigorously defend itself in the GEM New York Arbitration
and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been
recognized in respect to the GEM New York Arbitration as there is no present obligation and the probability of an outcome cannot be determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iv]
On February 8, 2021, GEM instituted another arbitration against the Company before the International Centre for Dispute Resolution in
Montreal Canada (the &#8220;GEM Montreal Arbitration&#8221;) and joined GEM&#8217;s affiliate, GEM Global Yield LLC SCS (&#8220;GEM Global
Yield&#8221; together with GEM, the &#8220;GEM Parties&#8221;). The Statement of Claim filed by the GEM Parties alleges the Company breached
a Share Subscription Agreement dated November 15, 2019 and promissory note, among other things, claiming damages of approximately CA$<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_uCA_c20210206__20210208_zsu8kUsAz0xk" title="Loss contingency damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2021-02-062021-02-08" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="CA">4.9</ix:nonFraction></span>
million (USD equivalent $<span id="xdx_903_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_uUSD_c20210206__20210208_znpZ7ihIgZ2d" title="Loss contingency damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2021-02-062021-02-08" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.9</ix:nonFraction></span> million), in addition to costs and expenses, stemming from the Company&#8217;s alleged failure to issue
to GEM Global Yield warrants to purchase up to <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pn6n6_c20210208__srt--RangeAxis__srt--MaximumMember_zOxWGO6QBtul" title="Warrant to purchase connon stock shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-02-08_srt_MaximumMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="Shares">33</ix:nonFraction></span> million shares of the Company&#8217;s common stock. The Company filed a Statement of
Defense denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company
filed an Amended Statement of Defense and Cross-claim. The Company intends to vigorously defend itself in the GEM Montreal Arbitration
and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been
recognized in respect to the GEM Montreal Arbitration as there is no present obligation and the probability of an outcome cannot be determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[v]
On April 19, 2021, Lampert Advisors, LLC (&#8220;Lampert&#8221;) filed a Verified Complaint against the Company&#8217;s wholly owned
subsidiary Western Magnesium Corp., a Nevada corporation (&#8220;Western Magnesium &#8211; Nevada&#8221;) in the Supreme Court of the
State of New York, County of New York (the &#8220;Lampert Lawsuit&#8221;). The complaint filed in the Lampert Lawsuit alleges that Lampert
entered into an agreement with Western Magnesium &#8211; Nevada to provide various financial advisory services including acquisition
advisory services and act as an exclusive placement agent for a combination of debt and equity securities (the &#8220;Lampert Agreement&#8221;),
that it performed all services required under that agreement and that it is owed $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20210419__us-gaap--TypeOfArrangementAxis__custom--LampertAgreementMember_zs8FLxuTf32g" title="Debt instrument interest rate owned value"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-04-19_custom_LampertAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">367,227</ix:nonFraction></span> plus interest at the rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20210419__us-gaap--TypeOfArrangementAxis__custom--LampertAgreementMember_zcHieVllCXG7" title="Percentage of interest rate owned"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2021-04-19_custom_LampertAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>% from February
3, 2021 and that it has a right of first refusal to act as financial advisor in connection with any debt, equity or debt restructuring
assignments on terms, conditions and compensation customary for Lampert for a transaction of the type contemplated. Although Lampert
claims to have personally served Western Magnesium &#8211; Nevada, the Company never received the Summons and Complaint and therefore,
never submitted a response. On September 9, 2021, Lampert filed a Motion seeking the entry of a default judgment (the &#8220;Motion&#8221;).
The Company opposed the Motion and filed a cross-motion to compel Lampert to accept the Company&#8217;s answer. The Court granted the
Company&#8217;s cross-motion and denied Lampert&#8217;s Motion as moot. The Court scheduled a preliminary conference for the parties
on March 30, 2022. The Company intends to vigorously defend against the Lampert Lawsuit, and believes that the Lampert Lawsuit is without
merit. As the Company cannot predict the outcome of the Lampert Lawsuit, no provision has been recognized as there is no present obligation
and the probability of an outcome cannot be determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commitments</b></span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
On November 1, 2016, the Company signed a contract services agreement with Lodestar Management Group, LLC (&#8220;Lodestar&#8221;), a
US corporate logistics company. Lodestar provides advisory, consulting, negotiation and other management services relating to corporate
management, administrative and/or operational activities of the Company. The term of the contract was for one year and has been renewed
under the same terms on January 1, 2018 and 2019. The Company has agreed to compensate Lodestar in the amount of $<span id="xdx_909_eus-gaap--DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount_iI_c20161101_zuVB9vaWxqgh" title="Commitment of cash or arrangments amount"><ix:nonFraction name="us-gaap:DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount" contextRef="AsOf2016-11-01" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,800</ix:nonFraction></span> or CA$<span id="xdx_903_ecustom--CommitmentOfCashOrArrangmentsAmountCash_iI_uCA_c20161101_zE4ptCm3hrb6" title="Commitment of cash or arrangments amount cash"><ix:nonFraction name="MLYF:CommitmentOfCashOrArrangmentsAmountCash" contextRef="AsOf2016-11-01" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,500</ix:nonFraction></span> per
month by either cash or arrangement of the issuance of shares. The number of shares issued will be based on the share price on the day
of issuance that is not lower than the CA$<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20161101_zx2szt5NXB1l" title="Number of shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2016-11-01" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> per share minimum requirement and will not exceed $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_c20201101__20211031__srt--RangeAxis__srt--MaximumMember_zdY8BzzzFzS3" title="Issuance of share based minimum requirement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" contextRef="From2020-11-012021-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,800</ix:nonFraction></span> or CA$<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_uCA_c20201101__20211031__srt--RangeAxis__srt--MaximumMember_zpq2IZ6lJGNh" title="Issuance of share based minimum requirement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" contextRef="From2020-11-012021-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,500</ix:nonFraction></span> in value. The shares
will be issued on the last working day of each month for a period of twelve months. During the year ended October 31, 2021, the Company
paid $<span id="xdx_90F_eus-gaap--Cash_iI_c20211031_zWxhXoBxkivi" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,600</ix:nonFraction></span> in cash (2020 &#8211; $<span id="xdx_909_eus-gaap--Cash_iI_dxL_c20201031_zHLJc0zLKVrb" title="Cash::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1199">nil</span></span>) and did not issue any shares to Lodestar (2020 &#8211; nil). As at October 31, 2021, the outstanding
amounts payable to Lodestar was $<span id="xdx_902_eus-gaap--NotesPayable_iI_uUSD_c20211031_zmp4N93hzxwe" title="Outstanding amount payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,491</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
During the year ended October 31, 2020, the Company has entered into a lease agreement for its research and development pilot plant in
Burnaby, British Columbia with a lease term from October 1, 2020 to September 30, 2023 at a monthly rent of CA$<span id="xdx_90D_eus-gaap--SubleaseIncome_uCA_c20191101__20201031_zbDRqxy8geF1"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="CA">20,715</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(USD equivalent $<span id="xdx_905_eus-gaap--SubleaseIncome_uUSD_c20191101__20201031_zBiGY2WQGZE3"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,727</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).
In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its corporate office
in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 at a monthly rent of CA$<span id="xdx_90F_eus-gaap--SubleaseIncome_uCA_c20210601__20210630_zkEhLmX8rL5l"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2021-06-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="CA">9,794</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(USD equivalent $<span id="xdx_90D_eus-gaap--SubleaseIncome_uUSD_c20210601__20210630_zzpfGyBVqsAi"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2021-06-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,909</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).
In September 2021, the Company entered into a lease agreement for its office in McLean, Virginia with a lease term from September 14,
2021 to February 28, 2025 at a monthly rent of $<span id="xdx_90B_eus-gaap--SubleaseIncome_uUSD_c20210901__20210930__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_z3MxfxFzKIYg"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2021-09-012021-09-30_custom_LeaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,113</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company will be abated for the beginning five months and is entitled to a tenant allowance of $<span id="xdx_901_eus-gaap--PaymentsForProceedsFromTenantAllowance_c20201101__20211031_zwMQUXVfbdSg"><ix:nonFraction name="us-gaap:PaymentsForProceedsFromTenantAllowance" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,010</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[notes 6 and 7]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iii]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer is eligible to receive up to <span id="xdx_907_ecustom--PercentageOfIssuedAndOutstandingCommonShares_iI_pid_dp_uPure_c20180912_zuRPltPiKrad" title="Percentage of issued and outstanding common shares"><ix:nonFraction name="MLYF:PercentageOfIssuedAndOutstandingCommonShares" contextRef="AsOf2018-09-12" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $<span id="xdx_90D_eus-gaap--CommonStockValueOutstanding_iI_pn6n6_c20180828_z2gr43433rPk" title="Common stock outstanding"><ix:nonFraction name="us-gaap:CommonStockValueOutstanding" contextRef="AsOf2018-08-28" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">5</ix:nonFraction></span> million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
<span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20211103_zIXgdPmvHR3" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,163,425</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uCAPShares_c20211103_zGxKPNqaEywh" title="Common share price per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.65</ix:nonFraction></span> per share with a total fair value of CA$<span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_uCA_c20210311_zRlob6myXiOl" title="Fair value of equivalents"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-03-11" format="ixt:numdotdecimal" decimals="0" unitRef="CA">5,956,226</ix:nonFraction></span> (USD equivalent $<span id="xdx_906_eus-gaap--AssetsFairValueDisclosure_iI_uUSD_c20211103_z3S6N0c3ypdi" title="Fair value of equivalents"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,796,832</ix:nonFraction></span>) as share
issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:PromissoryNoteTextBlock"><p id="xdx_802_ecustom--PROMISSORYNOTETextBlock_zD7b22TlHThl" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_821_zm4wGrufWbbd">PROMISSORY NOTE</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2019, the Company received a loan of CA$<span id="xdx_90D_eus-gaap--PaymentsToFundLongtermLoansToRelatedParties_uCA_c20191001__20191031_zxhpvHqYmJth" title="Related party loan"><ix:nonFraction name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" contextRef="From2019-10-012019-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="CA">150,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_905_eus-gaap--PaymentsToFundLongtermLoansToRelatedParties_uUSD_c20191001__20191031_zX0FYNV1bDck" title="Related party loan"><ix:nonFraction name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" contextRef="From2019-10-012019-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,895</ix:nonFraction></span>) from a related party. The loan was
unsecured, bore interest at <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20191031_zYUWgsrV0fQ4" title="Percentage of unsecured loan interest"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>% and was due on demand. During the year ended October 31, 2020, the loan was increased by an additional
CA$<span id="xdx_905_ecustom--AdditionalIncreaseInPromissoryNoteLoan_uCA_c20201001__20201031__srt--RangeAxis__srt--MinimumMember_zxyorVvpPemb" title="Additional increase in promissory note loan"><ix:nonFraction name="MLYF:AdditionalIncreaseInPromissoryNoteLoan" contextRef="From2020-10-012020-10-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">60,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_90B_ecustom--AdditionalIncreaseInPromissoryNoteLoan_uUSD_c20201001__20201031__srt--RangeAxis__srt--MinimumMember_zpYaDKmBT4O5" title="Additional increase in promissory note loan"><ix:nonFraction name="MLYF:AdditionalIncreaseInPromissoryNoteLoan" contextRef="From2020-10-012020-10-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,588</ix:nonFraction></span>) to CA$<span id="xdx_90B_ecustom--AdditionalIncreaseInPromissoryNoteLoan_uCA_c20201001__20201031__srt--RangeAxis__srt--MaximumMember_z9ocTb2a51Sg" title="Additional increase in promissory note loan"><ix:nonFraction name="MLYF:AdditionalIncreaseInPromissoryNoteLoan" contextRef="From2020-10-012020-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">210,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_903_ecustom--AdditionalIncreaseInPromissoryNoteLoan_uUSD_c20201001__20201031__srt--RangeAxis__srt--MaximumMember_zpYcIlQq6VTc" title="Additional increase in promissory note loan"><ix:nonFraction name="MLYF:AdditionalIncreaseInPromissoryNoteLoan" contextRef="From2020-10-012020-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,483</ix:nonFraction></span>), and was due on September 24, 2021. During the year ended
October 31, 2021, the Company accrued interest expense of $<span id="xdx_908_eus-gaap--InterestAndDebtExpense_c20201101__20211031_zkH6E3PujaO9" title="Accrued interest promissory note"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,639</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_905_eus-gaap--InterestAndDebtExpense_c20191101__20201031_zRBUDVMvU4Ma" title="Accrued interest promissory note"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,655</ix:nonFraction></span>) and repaid the entire balance and interest totaling
$<span id="xdx_909_eus-gaap--RepaymentsOfDebt_uUSD_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zL82s5rZyI6i" title="Repayment of promissory note interest"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2020-11-012021-10-31_custom_PromissoryNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,761</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_904_eus-gaap--RepaymentsOfDebt_uUSD_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zOk9O1LsH7uk" title="Repayment of promissory note interest"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2019-11-012020-10-31_custom_PromissoryNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,066</ix:nonFraction></span>). As at October 31, 2021, the outstanding balance was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_dxL_c20211031__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zvHbe9gYWd3" title="Outstanding notes payable::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1245">nil</span></span> (October 31, 2020 &#8211; $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20201031__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zbaTi14VnKW1" title="Outstanding notes payable"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-10-31_custom_PromissoryNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,567</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:ProvisionForFlowThroughShareIssuancesTextBlock"><p id="xdx_809_ecustom--ProvisionForFlowThroughShareIssuancesTextBlock_zvCZLY6s8MG5" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_826_zjVxklk4LcVb">PROVISION FOR FLOW THROUGH SHARE ISSUANCES</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company has recorded a provision in the amount of $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20211031_zeaHsW6jDmZf" title="Provision for tax and related obligations"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">233,285</ix:nonFraction></span> (October 31, 2020 &#8211; $<span id="xdx_906_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20201031_zkqOiJmdkwq2" title="Provision for tax and related obligations"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">216,924</ix:nonFraction></span>) for tax and related obligations relating
to flow through share issuances from prior years. </span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_807_eus-gaap--DebtDisclosureTextBlock_zj6o9N5nFCck" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>CONVERTIBLE DEBENTURE</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>&#160;<span id="xdx_824_z3ImpRMs92ce" style="display: none">CONVERTIBLE
DEBENTURE AND DERIVATIVE LIABILITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[a]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2020 Convertible Debenture</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">On
July 27, 2020, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_uCA_c20200727__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zxzn5Ud19PZ6"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">150,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(USD equivalent $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20200727__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zoRXmM2VgAFb"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,124</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
the &#8220;July 2020 Convertible Debenture&#8221;). The note bears interest at <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200727__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zQoktqC6KUAh"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per annum and is due on the date that is one year following the closing date. The note is convertible into common shares of the Company
at the price which is the greater of CA$<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20200727__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zAAD0pjsDdL"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per common share and the market price on the
date of the conversion notice. Any accrued but unpaid interest will be payable on the earlier of the maturity date and the date of conversion
in cash or common shares. No finder&#8217;s fees were paid in connection with this private placement. On May 18, 2021, the Company issued
a total of <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_pid_c20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zLnw6VacSLXf"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,360,959</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares on the conversion of the July 2020
Convertible Debenture including conversion of accrued interest and <span id="xdx_905_eus-gaap--ConversionOfStockSharesIssued1_pid_c20210517__20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zAc5oxjYKha6"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2021-05-172021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">263,973</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares valued at $<span id="xdx_901_eus-gaap--CommonStockValue_iI_c20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zpsOAROMuXkk"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,286</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in transaction costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[b]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    2021 Convertible Debenture</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">On
July 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_uCA_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_ztyC3Ts6oI7a"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">100,000</ix:nonFraction></span>
(USD equivalent $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zQHLNLhUO9l6"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,542</ix:nonFraction></span>, the &#8220;July 2021 Convertible Debenture&#8221;) which it received on April 22, 2021. The note bears interest
at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zEd13ZmHZDB"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% per annum and is due on the date that is one year following the closing date. The note is convertible at a price of CA$<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_uCAPShares_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zlrLzxN10sdg" title="Conversion price per share"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></span> per
Unit, where each Unit is comprised of one common share and one common share purchase warrant exercisable at a price of CA$<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_uCAPShares_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zhGwDFxLufPi"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.20</ix:nonFraction></span> per common
share for a period of two years. Any accrued but unpaid interest will be payable on the earlier of the maturity date and the date of
conversion in cash or common shares. As at October 31, 2021, the Company incurred contractual interest of CA$<span id="xdx_903_eus-gaap--InterestExpense_uCA_c20211030__20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zVKl2flo1lOb" title="Interest expenses incurred"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-10-302021-10-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">7,299</ix:nonFraction></span> (USD equivalent $<span id="xdx_907_eus-gaap--InterestExpense_c20211030__20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z8hHoRMb7Ye5"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-10-302021-10-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,802</ix:nonFraction></span>).
The July 2021 Convertible Debenture has an <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateBasisForEffectiveRate_dp_c20210728__20210730__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zcwME84NW6lj"><ix:nonNumeric contextRef="From2021-07-282021-07-30_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" name="us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate">effective interest rate of 1,878%</ix:nonNumeric></span>. The Company has allocated the intrinsic value of the beneficial
conversion feature of the July 2021 Convertible Debenture capped at the face value of CA$<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_uCA_c20210725__20210730__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zX0OVjAjNWcc"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature" contextRef="From2021-07-252021-07-30_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">100,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20210725__20210730__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zoB7zgSSQdcj"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature" contextRef="From2021-07-252021-07-30_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,542</ix:nonFraction></span>) to equity reserves.
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[c]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    2021 Convertible Debenture</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_uCA_c20210615__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zAU0yCoFjuIb"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">1,500,000</ix:nonFraction></span>
(the &#8220;June 2021 Convertible Debenture&#8221;). The note bears interest at <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210615__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zmq7iildgAL3"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% per annum and matures on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20210610__20210615__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zoTzcYZFLARj" title="Maturity date of debt"><ix:nonNumeric contextRef="From2021-06-102021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">December 10, 2022</ix:nonNumeric></span>. The June
2021 Convertible Debenture is convertible into <span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_c20210610__20210615__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zoO4z9uJ9paj"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-102021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000,000</ix:nonFraction></span> units, where each unit consists of (i) one share of the Company&#8217; common
stock, (ii) <span id="xdx_90C_eus-gaap--DebtConversionDescription_c20201101__20211031_zFOhbSw6U9C9"><ix:nonNumeric contextRef="From2020-11-012021-10-31" name="us-gaap:DebtConversionDescription">one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until
June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price
of $0.19 until June 10, 2026 (collectively, the &#8220;Class A and B Warrants&#8221;). In addition, the conversion price for accrued
interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the offering of the June 2021 Convertible Debenture, the Company also entered into the June 10, 2021 Securities Purchase Agreement
(the &#8220;Securities Purchase Agreement&#8221;), whereby the Company agreed to use commercially reasonable efforts to file a registration
statement with the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) by August 14, 2021, covering the public resale
of the shares of common stock underlying such debenture and, upon its conversion, the Class A and B Warrants issuable upon such conversion
(the &#8220;Underlying Shares&#8221;), and to use its best efforts to cause the registration statement to be declared effective on October
13, 2021 <i>[note 19[vi]]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to certain covenants contained in the Securities Purchase Agreement, the terms of the June 2021 Convertible Debenture contain
certain negative covenants by the Company, including, among others, sell or offer to sell any securities with non-fixed or floating price
features, issue any common stock or common stock equivalents at a price lower than the Conversion Price herein then in effect, or issue
any equity or debt instruments with anti-dilution provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
                         MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
                         TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><span style="font-size: 10pt"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Expressed in US Dollars, except where otherwise indicated</span></td>
  <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company issues or sells any common stock or common stock equivalents with terms that the purchaser holding the outstanding
June 2021 Convertible Debenture (the &#8220;Convertible Debenture Holder&#8221;) or the Class A and B Warrants reasonably believes are
more favorable to such holder than the terms of the June 2021 Convertible Debenture or the Class A and B Warrants, then upon notice to
the Company by such holder within five trading days after notice to such holder by the Company, the Company will use commercially reasonable
efforts to obtain the approval of the TSX-V and any additional required regulatory approval to amend the terms of the June 2021 Convertible
Debenture or the Class A and B Warrants as required, as the case may be, so as to give such holder the benefit of such more favorable
terms or conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion price of the June 2021 Convertible Debenture and the exercise price of the Class A and B Warrants are subject to proportional
adjustment in the event of stock splits, stock dividends and similar corporate events, including merger or consolidation of the Company
or in a &#8220;Fundamental Transaction&#8221; as defined in the June 2021 Convertible Debenture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has granted the holders certain rights of first refusal on its future offerings for as long as the June 2021 Convertible Debenture
or the Class A and B Warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may prepay and satisfy the June 2021 Convertible Debenture so long as an event of default has not occurred, upon 20 days&#8217;
prior written notice received by the Company to the holder, by paying 125% of the amounts owed on the June 2021 Convertible Debenture,
including all principal, interest and other fees. The holder of this debenture may, however, convert all or a portion of the debenture
during the 20-day notice period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at October 31, 2021, the Company incurred contractual interest of $<span id="xdx_909_eus-gaap--InterestExpense_c20211030__20211031_zZlVb72leIx6"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-10-302021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,521</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to October 31, 2021, the Company issued an aggregate <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20211103__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpZktHoTB9sd" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></span> units on partial conversion of the June 2021 Convertible Debenture, for
a total of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20211103__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ1XXUnqC9N1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></span> common shares, <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211103__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zMyWETaPNtnf" title="Number of warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></span> Class A Warrants exercisable at a price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211103__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQsAM1VciSC9"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span> until June 10, 2026, and <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211103__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7uQZ063AdW7"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></span> Class
B Warrants exercisable at a price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211103__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzFLcLV1f1k1"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-11-03_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_SubsequentEventMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction></span> until June 10, 2026 <i>[note 19[iii]]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[d]
Debt Host Liability and Embedded Derivative Liability</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
July 2020 Convertible Debenture and the June 2021 Convertible Debenture were determined to be hybrid financial instruments comprised
of a debt host liability and an embedded derivative liability, as under the conversion feature the number of shares that will or may
be issued to settle the notes may vary. The Company uses the Black-Scholes Option Pricing Model based on different default risks and
assumptions. The debt host liability of the convertible note will be measured at amortized cost, with the embedded derivative liability
measured at fair value through profit and loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">On
issuance date of the July 2020 Convertible Debenture, the fair value of its debt host liability was determined to be $<span id="xdx_905_eus-gaap--DebtInstrumentFairValue_iI_c20211031_zZiUvDNcj7qg" title="Fair value of debt host liability"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,083</ix:nonFraction></span> and the
respective embedded derivative liability was valued at $<span id="xdx_90C_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20201101__20211031_zgXUyuBEcYm" title="Embedded derivative liability"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,041</ix:nonFraction></span>. Fair value adjustments were made to the embedded derivative liability
of the July 2020 Convertible Debenture on conversion date of May 18, 2021. As at October 31, 2021, the amortized cost of the July 2020
Convertible Debenture&#8217;s debt host liability was $<span id="xdx_904_eus-gaap--DebtInstrumentFairValue_iI_dxL_c20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zXZz19XffGvd" title="Convertible debenture&apos;s debt host liability::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1295">nil</span></span> (October 31, 2020 &#8211; $<span id="xdx_908_eus-gaap--DebtInstrumentFairValue_iI_c20201031__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zBB6c1SdXxN6" title="Convertible debenture&apos;s debt host liability"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2020-10-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">96,318</ix:nonFraction></span>) and the fair value of the embedded derivative
liability was $<span id="xdx_909_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_dxL_c20211031_zY4ZlGdCArgb" title="Fair value of embedded derivative liability::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1299">nil</span></span> (October 31, 2020 &#8211; $<span id="xdx_907_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20201031_zlLR4xumUrHg"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,123</ix:nonFraction></span>), resulting in a combined value of $<span id="xdx_909_eus-gaap--ConvertibleDebtCurrent_iI_dxL_c20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertiblesDebentureMember_zRVlY5c7vRnd" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1301">nil</span></span> (October 31, 2020 &#8211; $<span id="xdx_905_eus-gaap--ConvertibleDebtCurrent_iI_c20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertiblesDebentureMember_zB1wA8meYixd" title="Embedded derivative liability combined value"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertiblesDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,441</ix:nonFraction></span>). The
July 2020 Convertible Debenture had an effective interest rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20201031__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zIBN0HU1GzQa"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2020-10-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">37</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">On
issuance date of the June 2021 Convertible Debenture, the embedded derivative liability was valued at $<span id="xdx_90E_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zfUjLLEUFNA2"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,646,600</ix:nonFraction></span> which exceeded the
face value of the note itself of $<span id="xdx_90C_eus-gaap--DebtInstrumentFairValue_iI_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zk7TFwXAAuL7"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span>, the debt host liability was then assigned a face value of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zUESwijldaPi" title="Debt host liability share, face value"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1</ix:nonFraction></span>, with an immediate loss of
$<span id="xdx_90E_eus-gaap--DerivativeLossOnDerivative_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zzNK1592ucy9" title="Loss on recognition of debt liability"><ix:nonFraction name="us-gaap:DerivativeLossOnDerivative" contextRef="From2020-11-012021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,601</ix:nonFraction></span> on recognition of the debt host liability. As at October 31, 2021, the amortized cost of the June 2021 Convertible
Debenture&#8217;s debt host liability was $<span id="xdx_907_eus-gaap--DebtInstrumentFairValue_iI_dxL_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleDebentureMember_zEGA9dIeHbwb"><span style="-sec-ix-hidden: xdx2ixbrl1311">44</span></span> (October 31, 2020 &#8211; $<span id="xdx_906_eus-gaap--DebtInstrumentFairValue_iI_dxL_c20201031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleDebentureMember_zpEmKALvy0Ye" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1312">nil</span></span>) and the fair value of the embedded derivative
liability was $<span id="xdx_904_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_dxL_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zv7CNOtt8Irc"><span style="-sec-ix-hidden: xdx2ixbrl1313">7,449,700</span></span> (October 31, 2020 &#8211; $<span id="xdx_907_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_dxL_c20201031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zes2d1gojPvi" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1314">nil</span></span>), resulting in a combined value of $<span id="xdx_90A_eus-gaap--ConvertibleDebtCurrent_iI_dxL_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zvdgaaHxhKbd"><span style="-sec-ix-hidden: xdx2ixbrl1315">7,449,744</span></span> (October 31, 2020 &#8211;
$<span id="xdx_90D_eus-gaap--ConvertibleDebtCurrent_iI_dxL_c20201031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zhkLHp8yUVx4" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1316">nil</span></span>). The June 2021 Convertible Debenutre has an effective interest rate of <span id="xdx_901_ecustom--DebtInstrumentInterestRateEffectivePercentage1_iI_uPure_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zpmxH8E1h6I5" title="Convertible debenture effective interest rate"><ix:nonFraction name="MLYF:DebtInstrumentInterestRateEffectivePercentage1" contextRef="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1,448</ix:nonFraction></span>% </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
                         MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
                         TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><span style="font-size: 10pt"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Expressed in US Dollars, except where otherwise indicated</span></td>
  <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zJFXQn2gWAS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
inputs used in the Black-Scholes Option Pricing Model are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B1_zfaHqnbW1dl4" style="display: none">SCHEDULE
OF OPTION PRICING MODEL</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">October 31,</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">June 15,</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">July 27,</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-size: 10pt">Risk free rate of interest</span></td><td style="width: 2%; font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--OctoberThirtyOneTwentyThousandTwentyOneMember_zmX3HiWf2aoh" title="Risk free rate of interest" style="width: 14%; font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2020-11-012021-10-31_custom_OctoberThirtyOneTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.08</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">%</span></td><td style="width: 2%; font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JuneFifteenTwentyThousandTwentyOneMember_zgvObhjvCBS8" style="width: 14%; font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2020-11-012021-10-31_custom_JuneFifteenTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.31</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">%</span></td><td style="width: 2%; font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwentySevenTwentyThousandTwentyOneMember_z4015pTmAhHa" style="width: 14%; font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2020-11-012021-10-31_custom_JulyTwentySevenTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.26</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Expected life in years</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--OctoberThirtyOneTwentyThousandTwentyOneMember_zfAoFrKMdq21" title="Expected life in years"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OctoberThirtyOneTwentyThousandTwentyOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.11</ix:nonNumeric></span>
                                            years</span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JuneFifteenTwentyThousandTwentyOneMember_zAp0XyFq89Xb"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_JuneFifteenTwentyThousandTwentyOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.50</ix:nonNumeric></span>
                                            year</span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwentySevenTwentyThousandTwentyOneMember_zGOKrWE5oumh"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_JulyTwentySevenTwentyThousandTwentyOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">0.74</ix:nonNumeric></span>
                                            year</span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Conversion exercise price</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211031__us-gaap--DebtInstrumentAxis__custom--OctoberThirtyOneTwentyThousandTwentyOneMember_zhCorTNkk07b" title="Conversion exercise price" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-10-31_custom_OctoberThirtyOneTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneFifteenTwentyThousandTwentyOneMember_zs01b9Gogv9k" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-10-31_custom_JuneFifteenTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif">CA$<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_uCAPShares_c20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwentySevenTwentyThousandTwentyOneMember_zzt8yA7zZ1uh"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-10-31_custom_JulyTwentySevenTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction></span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Underlying share price of the Company</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif">CA$<span id="xdx_906_ecustom--UnderlyingSharePriceOfTheCompany_iI_uCAPShares_c20211031__us-gaap--DebtInstrumentAxis__custom--OctoberThirtyOneTwentyThousandTwentyOneMember_z1TVBsY5KVz2" title="Underlying share price of the Company"><ix:nonFraction name="MLYF:UnderlyingSharePriceOfTheCompany" contextRef="AsOf2021-10-31_custom_OctoberThirtyOneTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.73</ix:nonFraction></span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif">CA$<span id="xdx_907_ecustom--UnderlyingSharePriceOfTheCompany_iI_uCAPShares_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneFifteenTwentyThousandTwentyOneMember_zoq80O4IM492" title="Underlying share price of the Company"><ix:nonFraction name="MLYF:UnderlyingSharePriceOfTheCompany" contextRef="AsOf2021-10-31_custom_JuneFifteenTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.23</ix:nonFraction></span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; text-align: right"><span style="font: normal 10pt Times New Roman, Times, Serif">CA$<span id="xdx_907_ecustom--UnderlyingSharePriceOfTheCompany_iI_uCAPShares_c20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwentySevenTwentyThousandTwentyOneMember_zP4B8QYwflei" title="Underlying share price of the Company"><ix:nonFraction name="MLYF:UnderlyingSharePriceOfTheCompany" contextRef="AsOf2021-10-31_custom_JulyTwentySevenTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Expected volatility</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--OctoberThirtyOneTwentyThousandTwentyOneMember_zTE9OXHqyiJd" title="Expected volatility" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2020-11-012021-10-31_custom_OctoberThirtyOneTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">107.62</ix:nonFraction></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">%</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JuneFifteenTwentyThousandTwentyOneMember_z3jSTFetU4Tb" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2020-11-012021-10-31_custom_JuneFifteenTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">87.17</ix:nonFraction></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">%</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwentySevenTwentyThousandTwentyOneMember_zbfQibKvEWE" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2020-11-012021-10-31_custom_JulyTwentySevenTwentyThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82.54</ix:nonFraction></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Expected dividend rate</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dxL_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--OctoberThirtyOneTwentyThousandTwentyOneMember_zEsoS8Efer7f" title="Expected dividend rate::XDX::-" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1344"><span style="font: normal 10pt Times New Roman, Times, Serif">Nil</span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dxL_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JuneFifteenTwentyThousandTwentyOneMember_zEVsJjAFEPq" title="::XDX::-" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1345"><span style="font: normal 10pt Times New Roman, Times, Serif">Nil</span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dxL_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwentySevenTwentyThousandTwentyOneMember_zh4Krv47KIIl" title="::XDX::-" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1346"><span style="font: normal 10pt Times New Roman, Times, Serif">Nil</span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zYqFIHagLIVf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfDerivativeInstrumentsTextBlock_zzcxzvplHvK5" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zedgIhohElP1" style="display: none">SCHEDULE
OF DERIVATIVE INSTRUMENTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">July 2020 Convertible Debenture</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">June 2021 Convertible Debenture</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">July 2021 Convertible Debenture</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">Total</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">Debt Host Liability</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: left">Balance, October 31, 2019</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zZu50InNI5Ph" title="Balance, October 31, 2019" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1350">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConvertibleDebtCurrent_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zMa8rYG3lpyf" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1351">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConvertibleDebtCurrent_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zYzvYkgUfb78" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1352">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConvertibleDebtCurrent_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zyF8Xo28sYg5" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1353">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; font-weight: normal; text-align: left"><span style="font-size: 10pt">Value of debt host liability recognized</span></td><td style="width: 2%; font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98A_ecustom--ValueOfDebtHostLiabilityRecognized_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_ztmYqC8UKzY" title="Value of debt host liability recognized" style="width: 10%; font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,083</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 2%; font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_986_ecustom--ValueOfDebtHostLiabilityRecognized_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_znRBjKRBKkOc" style="width: 10%; font-weight: normal; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1356">&#8211;</span></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 2%; font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_989_ecustom--ValueOfDebtHostLiabilityRecognized_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zaqk0iqz8zn" title="Value of debt host liability recognized" style="width: 10%; font-weight: normal; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1358">&#8211;</span></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 2%; font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_980_ecustom--ValueOfDebtHostLiabilityRecognized_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_z12639LXlfa2" style="width: 10%; font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,083</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">Accretion and interest expense</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--AccretionExpense_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zkR8Xr2rwu4g" title="Accretion and interest expense" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,751</ix:nonFraction></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--AccretionExpense_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zOUfj3nUHco2" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1362">&#8211;</span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--AccretionExpense_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z3WSepeF9hQ8" title="Accretion and interest expense" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1364">&#8211;</span></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--AccretionExpense_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zI2VNnMsaivb" style="font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,751</ix:nonFraction></span></td><td style="font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Foreign currency translation</span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_z8RrwZa5DD4l" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zSCahlGyeIXi" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1368">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_984_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zi7E45KtAFYl" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1369">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_z1SzpvK7QdYd" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_i_pp0p0" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: left; padding-bottom: 1.5pt">Fair value of embedded derivative liability recognized</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DerivativeGainLossOnDerivativeNet_i_pp0p0" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: left; padding-bottom: 1.5pt">Fair value adjustment</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_zjJ7yrLstPs4" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: left; padding-bottom: 1.5pt">Conversion</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--EffectsOfChangeInFunctionalCurrency_zTEXbqAcVZ4b" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: left; padding-bottom: 1.5pt">Effects of change in functional currency</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">Balance, October 31, 2020</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--ConvertibleDebtCurrent_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zwfTUjxtWmAa" title="Balance, October 31, 2020" style="font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">96,318</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--ConvertibleDebtCurrent_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zImDWg4PIDl" style="font-weight: bold; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1377">&#8211;</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zi1dE9vwNUw5" style="font-weight: bold; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1378">&#8211;</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zNd34yHhjHnd" style="font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">96,318</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Value of debt host liability recognized</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_988_ecustom--ValueOfDebtHostLiabilityRecognized_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zR0vVv0yCgBc" title="Value of debt host liability recognized" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1381">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_ecustom--ValueOfDebtHostLiabilityRecognized_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zZVl0sswl8Aj" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98F_ecustom--ValueOfDebtHostLiabilityRecognized_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zopiFzs7a255" title="Value of debt host liability recognized" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1384">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_ecustom--ValueOfDebtHostLiabilityRecognized_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zYEZFpD545Qj" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Accretion and interest expense</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--AccretionExpense_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zpZWGkjQJQRl" title="Accretion and interest expense" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,587</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--AccretionExpense_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zKX0xZgP9Ex9" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--AccretionExpense_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zwTDxRITDe8h" title="Accretion and interest expense" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--AccretionExpense_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zsdYl6pdaRyg" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,693</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Conversion</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zlZLl3gsNJYi" title="Conversion" style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,560</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zXJS696baAt5" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1394">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zJAqd0pGyhJa" title="Conversion" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1396">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_znbjuYhvgvMd" style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,560</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Foreign currency translation</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zAQdyzHjK9wb" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,655</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zTpLLU4qsKDg" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1400">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zIzIwVqIImBe" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1402">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zxGt14XMLEja" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,655</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Balance, October 31, 2021</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--ConvertibleDebtCurrent_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zqKPVx17HBLa" title="Balance, October 31, 2021" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1405">&#8211;</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zkaF5DiyVTS8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--ConvertibleDebtCurrent_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zVVVZuQeYjef" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--ConvertibleDebtCurrent_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_ztx4RlPmkjL3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">Embedded Derivative Liability</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: left">Balance, October 31, 2019</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ConvertibleDebtCurrent_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zIskcBwHZrQ7" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1409">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ConvertibleDebtCurrent_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zeCeyMc4zjd6" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1410">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConvertibleDebtCurrent_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z24IgoCdMnw7" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1411">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConvertibleDebtCurrent_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zqXpbTwBpai8" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1412">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Fair value of embedded derivative liability recognized</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zSYIzGqoF5A3" title="Fair value of embedded derivative liability recognized" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,041</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zUk7uttFlngg" title="Fair value of embedded derivative liability recognized" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1416">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zX6OfrbxDMQc" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1417">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zB6iXrk2ySl1" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,041</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Fair value adjustment</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zHen3UI3zECd" title="Fair value adjustment" style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,979</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zABzS0MLOF5l" title="Fair value adjustment" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1422">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zoRPFdTIp5v3" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1423">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zmpW3mzNT594" style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,979</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Foreign currency translation</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zhTKTmyy2813" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zO8suPcgZjZd" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1428">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zMUjXvqPJNLc" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1429">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zAOO9Mw1DSNd" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2019-11-012020-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">Balance, October 31, 2020</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--ConvertibleDebtCurrent_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zSTUb2xBxaZb" style="font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,123</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zqGVrtryN7K" style="font-weight: bold; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432">&#8211;</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ConvertibleDebtCurrent_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zsyd4Ehdrlqa" style="font-weight: bold; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1433">&#8211;</span></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zGfhP1nAd4G6" style="font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,123</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Fair value of embedded derivative liability recognized</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_984_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zxA1brUnR1D8" title="Fair value of embedded derivative liability recognized" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1436">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zVMXQ1Q6tXce" title="Fair value of embedded derivative liability recognized" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,646,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z0wVaq77WT4d" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1439">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z9NTukgWucna" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,646,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Fair value adjustment</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--DerivativeGainLossOnDerivativeNet_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zSnN2DobUk79" title="Fair value adjustment" style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,058</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zcgXSPdzsgUd" title="Fair value adjustment" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,717,328</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--DerivativeGainLossOnDerivativeNet_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zX9P5TPoMPS" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1445">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z07RyIwWcEk6" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,701,270</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Conversion</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_z1tPvIFVQip6" title="Conversion" style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,247</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zxNMVo74mVfa" title="Conversion" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1450">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zhOa0aYHcvwl" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1451">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z1MsStkEFfj1" style="text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,247</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Foreign currency translation</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zN9Alv4bh3Vl" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,182</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z12fCnmcXlWe" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">85,772</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zmy88HxyRF33" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1456">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_984_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zkdtPtdZBWC9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">86,954</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Balance, October 31, 2021</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ConvertibleDebtCurrent_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zAxReqFTAoh5" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1458">&#8211;</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zbU9Frz40uU1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,700</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zXWiDnAik6Qh" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1460">&#8211;</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zErdCUhgnTqb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,700</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">Combined Value of Convertible Debenture</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; text-align: left">Balance, October 31, 2019</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConvertibleDebt_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zy3U0qtBv1Fc" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1462">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConvertibleDebt_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zytMaPBidhU1" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1463">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConvertibleDebt_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zjcftvJCRcpb" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1464">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td><td style="font-weight: normal">&#160;</td>
    <td style="font-weight: normal; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConvertibleDebt_iS_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember_zQ7Qq67OcGng" style="font-weight: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1465">&#8211;</span></td><td style="font-weight: normal; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">Conversion</span></td><td style="display: none"><span style="display: none; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--DebtConversionOriginalDebtAmount1_iN_di_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zHedZBDLX6Gf" title="Conversion" style="display: none; text-align: right"><span style="display: none; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1467">&#8211;</span></span></td><td style="display: none; text-align: left">&#160;</td><td style="display: none"><span style="display: none; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--DebtConversionOriginalDebtAmount1_iN_di_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zpyuCm5sidQc" title="Conversion" style="display: none; text-align: right"><span style="display: none; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">&#8211;</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--DebtConversionOriginalDebtAmount1_iN_di_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zlA1aLBav88c" style="display: none; text-align: right"><span style="display: none; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">&#8211;</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td id="xdx_98A_eus-gaap--DebtConversionOriginalDebtAmount1_iN_di_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember_zcqDejX3LzOd" style="display: none; text-align: right"><span style="display: none; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1471">&#8211;</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-size: 10pt"></span></td></tr>
  <tr id="xdx_40B_eus-gaap--AmortizationOfDebtDiscountPremium_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; text-align: left">Amortization</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Conversion" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Conversion" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Balance, October 31, 2020</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zHcEHHcto8zj" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,441</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--ConvertibleDebt_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zvxLkhMXIYxk" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1474">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zH8xmeVbN053" style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1475">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--ConvertibleDebt_iS_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember_z6foej4TJxEl" style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,441</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">Conversion</span></td><td style="display: none"><span style="display: none; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--DebtConversionOriginalDebtAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zqqOIna7POt2" style="display: none; text-align: right"><span style="display: none; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1477">&#8211;</span></span></td><td style="display: none; text-align: left">&#160;</td><td style="display: none"><span style="display: none; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--DebtConversionOriginalDebtAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zajE4lQ6Vfwj" style="display: none; text-align: right"><span style="display: none; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1478">&#8211;</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--DebtConversionOriginalDebtAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zKRrHgl6JIR3" style="display: none; text-align: right"><span style="display: none; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1479">&#8211;</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--DebtConversionOriginalDebtAmount1_iN_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember_z7za1nIglrYf" title="Conversion" style="display: none; text-align: right"><span style="display: none; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1481">&#8211;</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-size: 10pt"></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Balance, October 31, 2021</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ConvertibleDebt_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zleUlh1EVTQ8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">&#8211;</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--ConvertibleDebt_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zuEzROVMDlQ5" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,744</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--ConvertibleDebt_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zwHJXTUp4Mf1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--ConvertibleDebt_iE_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember_zJoncbI4eqf4" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,807</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"></p>


<ix:exclude><!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
                         MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
                         TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><span style="font-size: 10pt"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">Expressed in US Dollars, except where otherwise indicated</span></td>
  <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zemYwddRrpV4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_828_zrJfIsqDeRcf">SHARE CAPITAL</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized
    capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authorized share capital consists of <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211031_znUfkoRJiYdc" title="Common voting shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></span> common voting shares at par value of $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211031_zZbkqxhhi3Rg" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    shares issued</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fiscal
2020</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
On December 20, 2019, the Company exercised its right to call, subject to acceleration provisions, all outstanding common share purchase
warrants set to expire between May 7, 2020 and May 13, 2021. The expiry was amended to January 19, 2020. This expiry date was then extended
to <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20211031_zWEsOS8hVVf2" title="Warrants expire date"><ix:nonNumeric contextRef="AsOf2021-10-31" format="ixt:datemonthdayyearen" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">February 19, 2020</ix:nonNumeric></span>. As of February 19, 2020, any unexercised warrants were extinguished. In all, <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20200219_zsE1TBtewSlh" title="Common stock warrants exercised"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2020-02-19" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">35,472,661</ix:nonFraction></span> warrants at an average
price of CA$<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20200219_ztzGaxmNiCBe" title="Exercise of warrants price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-02-19" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></span> per common share were exercised and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20200218__20200219__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZh4w9VDxZAa" title="Common stock warrants expired unexercised"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2020-02-182020-02-19_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,794,484</ix:nonFraction></span> expired unexercised. A further <span id="xdx_904_ecustom--CommonStockWarrantsExercised_iI_pid_c20211031_zrHaZJmG8AQb" title="Common stock warrants exercised"><ix:nonFraction name="MLYF:CommonStockWarrantsExercised" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,864,000</ix:nonFraction></span> warrants were also exercised
during the year at CA$<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031_zNGGWeKAaOA8" title="Exercise of warrants price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> per common share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
On January 17, 2020, the Company closed a non-brokered private placement consisting of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200116__20200117__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zi5ozkbGjWV4" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-01-162020-01-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,792</ix:nonFraction></span> units at a price of CA$<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20200117__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zbiaoahDUTo2" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-01-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction></span> per unit
for gross proceeds of CA$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20200116__20200117__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zNPDsOBEFRq5" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-01-162020-01-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">546,569</ix:nonFraction></span> (USD equivalent $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20200116__20200117__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zr9b8tBwLXLa" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-01-162020-01-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,719</ix:nonFraction></span>), of which CA$<span id="xdx_902_eus-gaap--CommonStockSharesSubscriptions_iI_uCA_c20200117__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zLfCYVPhtgA2" title="Common stock subscriptions received"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-01-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">52,922</ix:nonFraction></span> (USD equivalent $<span id="xdx_906_eus-gaap--CommonStockSharesSubscriptions_iI_uUSD_c20200117__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zhHv67GZyMi5" title="Common stock subscriptions received"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-01-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,722</ix:nonFraction></span>) was recorded as advance share
subscriptions received prior to October 31, 2019. <span id="xdx_909_ecustom--IssuanceOfSharesDescription_c20200116__20200117__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zhhNzcYbng3i" title="Issuance of shares, description"><ix:nonNumeric contextRef="From2020-01-162020-01-17_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit consists of one common share and one common share purchase warrant exercisable
at a price of CA$0.21 per common share for a period of one year. The expiration date of these common share purchase warrants was subsequently
extended to August 31, 2021. These common share purchase warrants were subject to an expiry acceleration provision, upon thirty days&#8217;
written notice, should the price of the Company&#8217;s common shares exceed CA$0.30 for at least ten consecutive trading days.</ix:nonNumeric></span> The fair
value of the common shares was equal to the total proceeds raised and as a result, no amount was allocated to the fair value of the common
share purchase warrants. Finder&#8217;s fees of $<span id="xdx_90B_ecustom--FindersFeesPaid_iI_uUSD_c20200117__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zpsEmvc7Wm46" title="Finders fees paid"><ix:nonFraction name="MLYF:FindersFeesPaid" contextRef="AsOf2020-01-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,275</ix:nonFraction></span> were paid or accrued in connection with the placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iii]
On May 26, 2020, the Company issued a total of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20200525__20200526_zV8DGyGTvEN7" title="Common stock shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-05-252020-05-26" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> common shares on the exercise of stock options for gross proceeds of CA$<span id="xdx_90B_eus-gaap--ProceedsFromStockOptionsExercised_uCA_c20200525__20200526_zL5GRb5oNyci" title="Proceeds from stock options erercised"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-05-252020-05-26" format="ixt:numdotdecimal" decimals="0" unitRef="CA">37,000</ix:nonFraction></span>
(USD equivalent $<span id="xdx_90E_eus-gaap--ProceedsFromStockOptionsExercised_uUSD_c20200525__20200526_zJFDhKF6MAck" title="Proceeds from stock options erercised"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-05-252020-05-26" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,401</ix:nonFraction></span>) and re-classified $<span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_uUSD_c20200525__20200526_z9H9fEMl4PS3" title="Conversion of equity reserves to share capital amount"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2020-05-252020-05-26" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,775</ix:nonFraction></span> from equity reserves to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iv]
On September 10, 2020, the Company announced a non-brokered private placement of up to <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200909__20200910__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__srt--RangeAxis__srt--MaximumMember_zsOOlKOG8T4h" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-09-092020-09-10_custom_NonBrokeredPrivatePlacementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">53,846,154</ix:nonFraction></span> units at a price of CA$<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20200910__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zptmPetEWxV8" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-09-10_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit
to raise gross proceeds of up to CA$<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20200909__20200910__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__srt--RangeAxis__srt--MaximumMember_zrqNiNU4ErRh" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-09-092020-09-10_custom_NonBrokeredPrivatePlacementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">7,000,000</ix:nonFraction></span>. <span id="xdx_901_ecustom--IssuanceOfSharesDescription_c20200909__20200910__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zsaq3hwVxzR3" title="Issuance of shares, description"><ix:nonNumeric contextRef="From2020-09-092020-09-10_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit is comprised of one common share and one common share purchase warrant exercisable
at CA$0.19 per common share for a period of one year.</ix:nonNumeric></span> As at October 31, 2020, the Company had received advance share subscriptions of
CA$<span id="xdx_905_eus-gaap--CommonStockSharesSubscriptions_iI_uCA_c20201031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zDzdDSArs6D2" title="Common stock subscriptions received"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-10-31_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">747,392</ix:nonFraction></span> (USD equivalent $<span id="xdx_90E_eus-gaap--CommonStockSharesSubscriptions_iI_uUSD_c20201031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zU99l0eVL4fd" title="Common stock subscriptions received"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-10-31_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">596,872</ix:nonFraction></span>) <i>[note 14[f]]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fiscal
2021</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
In connection with the non-brokered private placement announced on September 10, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2020, the Company closed the first tranche of the non-brokered private placement, issuing <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201119__20201120__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zm7fsyyXG3Y7" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-11-192020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,599,171</ix:nonFraction></span> units at a price of
CA$<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20201120__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z3HBjV67o5Ng" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20201119__20201120__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zeaTQf0wZ9ab" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-192020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">727,892</ix:nonFraction></span> (USD equivalent $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20201119__20201120__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zqCzl50BXKKj" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-192020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">556,876</ix:nonFraction></span>), which had been received prior to October 31, 2020 and recorded
as an obligation to issue shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2021, the Company closed the second tranche of the non-brokered private placement, consisting of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210114__20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zKKYp5AsDot2" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-142021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,337,914</ix:nonFraction></span> units at a price
of CA$<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zjrx5F3XRqMg"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210114__20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zYKa8IsOmU0k"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-142021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">953,930</ix:nonFraction></span> (USD equivalent $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210114__20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zm0OylJxgZt3"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-142021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">749,435</ix:nonFraction></span>), of which $<span id="xdx_90D_eus-gaap--CommonStockSharesSubscriptions_iI_uUSD_c20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_z1HKDTP2rRPb" title="Common stock subscriptions received"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,996</ix:nonFraction></span> had been received prior to October 31,
2020 and recorded as an obligation to issue shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2021, the Company closed the third tranche of the non-brokered private placement consisting of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210128__20210129__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zYgTYrULugn6"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-282021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,382,303</ix:nonFraction></span> units at a price
of CA$<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210129__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zowlf8THWg6i"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210128__20210129__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zUOCQJNgw64c"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-282021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">699,699</ix:nonFraction></span> (USD equivalent $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210128__20210129__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_z0c24nVOpfhg"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-282021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">547,496</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 24, 2021, the Company closed the fourth tranche of the non-brokered private placement consisting of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210323__20210324__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_z3hvkoUNgUOi"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-03-232021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,172</ix:nonFraction></span> units at a price
of CA$<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210324__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zvMVNAkyyQ53"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210323__20210324__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zxZoX5lw9VH5"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-03-232021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">852,042</ix:nonFraction></span> (USD equivalent $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210323__20210324__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zkr9KWuBioB8"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-03-232021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">678,270</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 27, 2021, the Company closed the fifth and final tranche of the non-brokered private placement consisting of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210426__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_zxJJT6Hfx1ul"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">851,395</ix:nonFraction></span> units at a
price of CA$<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210424__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_zkjIa3rZVBwe"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-04-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210426__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_z03Y0i6SDRel"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">110,681</ix:nonFraction></span> (USD equivalent $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210426__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_zlmGE7LcMeC8"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,237</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
total, the Company issued an aggregate <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201119__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zlIFwJIY1Wnl"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-11-192021-04-27_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,724,955</ix:nonFraction></span> units at a price of CA$<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_z6bFOqQaSAhl"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-04-27_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for aggregate gross proceeds of CA$<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20201119__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zqKy7puOWSPh"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-192021-04-27_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">3,344,244</ix:nonFraction></span> (USD
equivalent $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20201119__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zXrukC84cysc"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-192021-04-27_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,621,314</ix:nonFraction></span>). <span id="xdx_903_ecustom--IssuanceOfSharesDescription_uCA_c20201119__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_z00kji9fMYN5"><ix:nonNumeric contextRef="From2020-11-192021-04-27_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire
a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche.</ix:nonNumeric></span> The
Company incurred aggregate share issue costs of $<span id="xdx_90B_eus-gaap--PaymentsOfStockIssuanceCosts_uUSD_c20210426__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_znOaMNgW9rYg" title="Shares issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">195,614</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
On May 5, 2021, the Company announced a non-brokered private placement priced at CA$<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210505__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zhoWxDncl3fe"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-05-05_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit to raise gross proceeds of up to CA$<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210504__20210505__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__srt--RangeAxis__srt--MaximumMember_zp7ReMLopf"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-05-042021-05-05_custom_NonBrokeredPrivatePlacementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">3,000,000</ix:nonFraction></span>.
On May 28, 2021, the Company closed the first tranche of the non-brokered private placement issuing <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210527__20210528__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_z1ymY2CxOxX5"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-05-272021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,223,420</ix:nonFraction></span> units at a price of CA$<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210528__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zQatRoIhNPBi"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span>
per unit for gross proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210527__20210528__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zOsYKvvWjQRa"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-05-272021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">679,044</ix:nonFraction></span> (USD equivalent $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210527__20210528__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zHRYI5q3kWNf"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-05-272021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">561,844</ix:nonFraction></span>). On June 17, 2021, the Company closed the second and final tranche
of the non-brokered private placement consisting of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTwoAndFinalMember_zRvJ2jLoFJMj"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,853,506</ix:nonFraction></span> units at a price of CA$<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTwoAndFinalMember_zctRrnRG2EZ"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTwoAndFinalMember_zh5IWKxxZsZf"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,320,956</ix:nonFraction></span>
(USD equivalent $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTwoAndFinalMember_zYR5byGldBsh"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,880,687</ix:nonFraction></span>). The Company issued total of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zn4BLrKDJBy7" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,076,926</ix:nonFraction></span> units at a price of CA$<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_zWpaaQof5DTk" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for total gross proceeds of
CA$<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_znz0O5URtPmj" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">3,000,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210529__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zuqQFtvC4gce" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-05-292021-06-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,442,531</ix:nonFraction></span>). <span id="xdx_902_ecustom--IssuanceOfSharesDescription_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zhHYzntMl148" title="Issuance of shares, description"><ix:nonNumeric contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit issued consists of one common share and one common share purchase warrant entitling
the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective
financing tranche.</ix:nonNumeric></span> The Company incurred aggregate share issue costs of $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_uUSD_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zZv3Q04lY8i3" title="Shares issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,336</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">[iii]
On May 18, 2021, the Company issued a total of <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pid_c20210518_zweOjh2BAuNb" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-05-18" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,360,959</ix:nonFraction></span> common shares on the conversion of the July 2020 Convertible Debenture including
accrued interest and <span id="xdx_906_eus-gaap--ConversionOfStockSharesIssued1_pid_c20210517__20210518_zaH4N81JKIA9" title="Convertiable common shares"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2021-05-172021-05-18" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">263,973</ix:nonFraction></span> common shares valued at $<span id="xdx_901_eus-gaap--ConversionOfStockAmountIssued1_c20211017__20211018_zEowTpnOSRNj" title="Conversion of stock value"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2021-10-172021-10-18" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,286</ix:nonFraction></span> in transaction costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iv]
On June 7, 2021, the Company issued <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20210607_z9BOXfvj4wUg" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-07" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,538,461</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210607__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0N1ZE0Xz9D3" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-06-07_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.24</ix:nonFraction></span> per share with a total fair value of CA$<span id="xdx_90B_eus-gaap--AssetsFairValueDisclosure_iI_uCA_c20210607_zf24EcJ7lVcf" title="Fair value of equipment"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-06-07" format="ixt:numdotdecimal" decimals="0" unitRef="CA">369,231</ix:nonFraction></span> (USD
equivalent $<span id="xdx_90B_eus-gaap--AssetsFairValueDisclosure_iI_c20210607_zWnkgF4zzz5g" title="Fair value of equipment"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-06-07" format="ixt:numdotdecimal" decimals="0" unitRef="USD">305,832</ix:nonFraction></span>) for equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[v]
On July 16, 2021, the Company closed a non-brokered private placement and issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210715__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zYuiZT4gIOy9"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-07-152021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,350,000</ix:nonFraction></span> units at a price of CA$<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zWPCD2sU6uk1"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.20</ix:nonFraction></span> per unit for gross
proceeds of CA$<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210715__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_z3Kyq2rKxDA7"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-07-152021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">870,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210715__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zRcHAF7c9xtj"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-07-152021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690,860</ix:nonFraction></span>). <span id="xdx_90D_ecustom--IssuanceOfSharesDescription_c20210715__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zl62ThqzBnp1"><ix:nonNumeric contextRef="From2021-07-152021-07-16_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit consists of one common share and one common share purchase warrant entitling
the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing.</ix:nonNumeric></span> The Company
incurred aggregate share issue costs of $<span id="xdx_90F_eus-gaap--PaymentsOfStockIssuanceCosts_uUSD_c20210715__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_z44yrazDYiv2"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-07-152021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,319</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[vi]
On August 11, 2021, the Company closed a non-brokered private placement and issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zmt37yTibC61" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,827,601</ix:nonFraction></span> units at a price of CA$<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_znZNGaLLhZVh" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.55</ix:nonFraction></span> (US$<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zgdwmIIaJSa4" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></span>) per
unit for gross proceeds of CA$<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zGHMH3PHZjj3" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,105,180</ix:nonFraction></span> (USD equivalent $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uUSD_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zstzCaBohDAe" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,683,336</ix:nonFraction></span>). <span id="xdx_901_ecustom--IssuanceOfSharesDescription_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zKDD45WZYjJ2" title="Issuance of shares, description"><ix:nonNumeric contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit consists of one common share and one common share purchase
warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 (US$0.52) for a period of eighteen months
from the date of closing.</ix:nonNumeric></span> The Company incurred aggregate share issue costs of $<span id="xdx_908_ecustom--SharesIssuanceCosts_uUSD_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_z8gDeDxBbkzd" title="Shares issuance costs"><ix:nonFraction name="MLYF:SharesIssuanceCosts" contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,479</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[vii]
During the year ended October 31, 2021, the Company issued a total of <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_c20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNBe3eF2KoY6" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-10-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,014,969</ix:nonFraction></span> common shares on the exercise of common share purchase
warrants at a price ranging from CA$<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBiRFSq8fesb" title="Exercise of warrants price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_srt_MinimumMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> to CA$<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9GCugncxSNd" title="Exercise of warrants price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_srt_MaximumMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.21</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfWarrants_uCA_c20201101__20211031_zgNmQRlIWS69" title="Proceeds from stock warrants erercised"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="CA">1,120,130</ix:nonFraction></span> (USD equivalent $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfWarrants_uUSD_c20201101__20211031_z27IT5q7mNpc" title="Proceeds from stock warrants erercised"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">887,520</ix:nonFraction></span>). A total of
<span id="xdx_903_ecustom--CommonStockWarrantsExpiredUnexercised_iI_pid_c20211031_zocmbPCgaPXf" title="Common stock warrants expired unexercised"><ix:nonFraction name="MLYF:CommonStockWarrantsExpiredUnexercised" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">525,173</ix:nonFraction></span> warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[viii]
During the year ended October 31, 2021, the Company issued a total of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSaHpz9RkRWl" title="Stock option shares issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,630,000</ix:nonFraction></span> common shares on the exercise of stock options at a price
ranging from CA$<span id="xdx_900_eus-gaap--StockOptionExercisePriceIncrease_pid_uCAPShares_c20201101__20211031__srt--RangeAxis__srt--MinimumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zogD5RKsFH7f" title="Exercise of options price per share"><ix:nonFraction name="us-gaap:StockOptionExercisePriceIncrease" contextRef="From2020-11-012021-10-31_srt_MinimumMember_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> to CA$<span id="xdx_905_eus-gaap--StockOptionExercisePriceIncrease_pid_uCAPShares_c20201101__20221031__srt--RangeAxis__srt--MaximumMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTuHJnQTkTI6" title="Exercise of options price per share"><ix:nonFraction name="us-gaap:StockOptionExercisePriceIncrease" contextRef="From2020-11-012022-10-31_srt_MaximumMember_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_904_eus-gaap--ProceedsFromStockOptionsExercised_uCA_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9PZMSBoclii" title="Proceeds from stock options erercised"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">175,800</ix:nonFraction></span> (USD equivalent $<span id="xdx_90B_eus-gaap--ProceedsFromStockOptionsExercised_uUSD_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zz2Q5CTc2bpe" title="Proceeds from stock options erercised"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,734</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ix]
With respect to the exercises of common share purchase warrants and options, the Company reclassified $<span id="xdx_906_eus-gaap--ProceedsFromOtherEquity_uUSD_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWVKuob6vLX5" title="Conversion of equity reserves to share capital amount"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2020-11-012021-10-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,291</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--ProceedsFromOtherEquity_uUSD_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZZUHYISKzg8" title="Conversion of equity reserves to share capital amount"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,932</ix:nonFraction></span>, respectively,
from equity reserves to share capital during the year ended October 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[x]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer is eligible to receive up to <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20180828__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember__srt--RangeAxis__srt--MaximumMember_zM6PHvJ7NKLe" title="Percentage of ownership of common stock"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2018-08-28_custom_DirectorAndOfficersMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $<span id="xdx_90D_eus-gaap--CommonStockValue_iI_pn6n6_c20180828__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember__srt--RangeAxis__srt--MaximumMember_zEcIYzsTQd6l" title="Issued and outstanding common shares value"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2018-08-28_custom_DirectorAndOfficersMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">5</ix:nonFraction></span> million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
<span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_pid_c20211103_zxMQTjmgSLga" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,163,425</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20211103__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9ryHdxFFYka" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-11-03_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.65</ix:nonFraction></span> per share with a total fair value of CA$<span id="xdx_904_eus-gaap--AssetsFairValueDisclosure_iI_uCA_c20211103_zz78LERTWVEf" title="Fair value of assets"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="0" unitRef="CA">5,956,226</ix:nonFraction></span> (USD equivalent $<span id="xdx_90F_eus-gaap--AssetsFairValueDisclosure_iI_uUSD_c20211103_zQwu1uIX248k" title="Fair value of assets"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,796,832</ix:nonFraction></span>) as share
issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common share purchase warrants</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.15pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zVVwGAVnZk3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the changes in the Company&#8217;s common share purchase warrants during the year ended October 31, 2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zJxO7Ym12Zb9" style="display: none">SUMMARY
OF CHANGES IN COMMON SHARE PURCHASE WARRANTS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Expiry Date</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                                                                                                                                                                                                                                                             (CA$)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Life</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">(Years)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October&#160;31,</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span>2020</p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October&#160;31,</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F48_zsa0Stro54Vk" style="width: 38%; text-align: left">August 31, 2021*</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_fKg_____zEwATDwJcZb4" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="Fact001670" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.21</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211031__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_fKg_____zV4JJG6MKGs7" title="::XDX::P0Y" style="width: 5%; text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl1671">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_fKg_____zBMj5tAm3TPa" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="Fact001672" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_fKg_____zD1z8OGZyeRa" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1673">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_fKg_____z1hMDmYVWkr2" style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="Fact001674" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,118,618</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_fKg_____zGsDBO44wcQe" style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="Fact001675" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">525,173</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_fKg_____z2SRrXBlGGH2" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1676">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">November 22, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_z8h1RtqVEh07" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_z4UaBBdc5Oxc" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.14</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zmbQ6uMCB9Cf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1679">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zoXJR6PNVgXa" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,599,171</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zxKTaVpRSX3h" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,439,150</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zKxTFSJRn8Ig" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1682">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zoGBQhv9AQ69" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,160,021</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">January 17, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zYNLBpGpUlx2" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zx3Xz8fVSv65" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.29</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zA9fZRIjJzhe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1686">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zQpNiBV2JvPa" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,337,914</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zMfVDpjU52n3" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">70,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zROrPrMM9oBg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1689">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zKVL4arrqzVb" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,267,914</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">January 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zqAzrpiPvLPj" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zmEuGuqT0ra2" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.33</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zUjcKgfERmZ3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1693">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zEXYtfam0Rbg" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,382,303</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zdobSPdOUiX3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1695">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zJlUY6bhDft9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1696">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zW3EXGv8fYv1" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,382,303</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">February 21, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zPxT67Y5kIMl" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zPK0F8R4Llfg" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.39</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_z2b0Bp5i2Mle" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,505,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zOLYMcKBGsrd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1701">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zgIiKa7Zp6r2" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1702">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zjOJzuQPrCr3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1703">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_z8T0Zw9JpXLg" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,505,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 24, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zfEJSVCHEPS1" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zFgzXsQjKwe5" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.48</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zMOqrCDRnnk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1707">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zhi9UF21mfnk" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,172</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zbl1fXoEqiL5" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">212,300</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zRWZorjJr5K4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1710">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zfB1PUPZ9Q28" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,341,872</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">March 27, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_z7nUji90Pfjl" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zijvBpFTbmDl" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.49</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zr13tdvlRXXk" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,482,025</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zIZEDY18vvDi" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1715">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zONGnSg8VqA4" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zuMjDsJcy1od" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1717">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zAJUogi27FJ" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">982,025</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">April 27, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_zCjsUmbytLA8" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_ztm0JPqsK5O9" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.57</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_zr4YZU4IzKhi" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1721">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_zVVdf1SDeKq5" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">851,395</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_zN2BuEWyXUbl" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_zW0rZNNC1xxf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1724">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_zYIChLaGvwxf" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">791,395</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">May 9, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zLAB4ZZXQ8Mi" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zAYppNrzKFB9" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.61</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zhlNakjJZ3Qg" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,368,626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zlYoaarmPfzl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1729">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zoQH7VIuc5q1" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">554,901</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zT6Tx6IizVF8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1731">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zhxZbCVx8cAb" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,813,725</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">May 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zaVBzIjHDlt5" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zt6IYM8LdOQ1" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.66</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_z6aiu9Ne2XJ9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1735">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zV6dlJscYVWb" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,223,420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zWeaoO7JJQ2b" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1737">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zMGI5GNVG6Q4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1738">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zbd02JOawNe9" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,223,420</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">June 17, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_z0lhoIm9Q7Ql" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zVr6NLWijWy2" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.71</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zLFDgOJPyj5i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1742">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zhDHalPsje02" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,853,506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zMWxteLgYg22" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zHSRY6UGi2Pj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1745">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zMRvK4gRflhd" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,703,506</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">July 18, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--JuneEighteenTwoThousandTwentyTwoMember_zuFtUXxF2PJ6" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.30</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--JuneEighteenTwoThousandTwentyTwoMember_zck6fDzZzcBd" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.79</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneEighteenTwoThousandTwentyTwoMember_zsGavH3bQdJd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1749">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneEighteenTwoThousandTwentyTwoMember_zr2zZNS2Jkfe" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneEighteenTwoThousandTwentyTwoMember_zcFOkiuFDxg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1751">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneEighteenTwoThousandTwentyTwoMember_zkk41N5JGCxc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1752">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--JuneEighteenTwoThousandTwentyTwoMember_zmDp0LaiB2ba" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JuneEighteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">August 14, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zkSdVdP7JuEl" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zj5FP2LMjUk3" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.87</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zDRs8LV2BN98" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,110,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_z5uTfvdYBePg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1757">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zWhEhfHp1aee" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">910,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zYhphW3pGo12" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1759">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_z0bx2bKL6gs7" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">February 13, 2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20211031__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_zCVkbynJGVA7" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.65</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211031__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_zvKak4XYXY7d" style="text-align: center"><ix:nonNumeric contextRef="AsOf2021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">1.37</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_zV38vRTr8nHh" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1763">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_zk0ZvOi1wesk" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,827,601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_zXuJF6QeRBje" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1765">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_zopuduhaHxxj" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1766">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_z2FhZ2egis24" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,827,601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20211031_zfhAZYAHZCwl" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,109,642</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20211031_z2yZf794fKsi" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,979,482</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20211031_zUFdc1qKSyB" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,014,969</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20211031_zp0V7yjxP5Af" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">525,173</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20211031_z1BKoZdiQbJh" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,548,982</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Weighted average exercise price</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20201101__20211031_zJI2SnplYRVk"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.11</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted_c20201101__20211031_zi64XaCknoF"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.23</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised_c20201101__20211031_zanrI5fBaljj"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.16</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled_c20201101__20211031_z8qLIVLBUp87"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.21</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20201101__20211031_zCIzkq8lg8He"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.22</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"><span id="xdx_F04_zWCljaizlr11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
  <td style="text-align: justify"><span id="xdx_F13_zxAhNw2VYS3i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001778" xml:lang="en-US">The Company received approval of the TSX-V on January 13, 2021
and amended the expiry date of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210113_zyQ19jD1dLEc" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQ0hBTkdFUyBJTiBDT01NT04gU0hBUkUgUFVSQ0hBU0UgV0FSUkFOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-01-13" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction>
</span></ix:footnote></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants, extending the expiry date from January
17, 2021 to August 31, 2021, subject to acceleration if the closing price of the Company&#8217;s shares exceeds CA$<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uCAPShares_c20210113_zlFid5OQKhDk" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQ0hBTkdFUyBJTiBDT01NT04gU0hBUkUgUFVSQ0hBU0UgV0FSUkFOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-01-13" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.30</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per common share for at least <span id="xdx_90C_ecustom--NumberOfMinimumConsecutiveTradingDays_iI_uDays_c20210113_zrnq6tDUAw9j" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQ0hBTkdFUyBJTiBDT01NT04gU0hBUkUgUFVSQ0hBU0UgV0FSUkFOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" title="Number of minimum consecutive trading days"><ix:nonFraction name="MLYF:NumberOfMinimumConsecutiveTradingDays" contextRef="AsOf2021-01-13" format="ixt:numdotdecimal" decimals="INF" unitRef="Days">10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consecutive trading days.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the changes in the Company&#8217;s common share purchase warrants during the year ended October 31, 2020 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Expiry Date</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price<br />
                                            (CA$)</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Average</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">Life</p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0">(Years)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October
31,</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span><b>2019</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October
31,</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span><b>2020</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left">January 17, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyOneMember_zOzFTA8EXg93" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.21</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20201031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyOneMember_zJSwqzak5nZi" title="::XDX::P0Y" style="width: 5%; text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl1784">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyOneMember_zjTAxwQCO7h6" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1785">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyOneMember_z8KoS34b6iP7" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyOneMember_zOQPmtgB6TXl" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1787">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyOneMember_zbz7Wo5Gy2a8" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1788">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyOneMember_z3fRzKc9qQBc" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_JanuarySeventeenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">February 21, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zlw88aFQx32h" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20201031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zlpxeK1GNoL5" style="text-align: center"><ix:nonNumeric contextRef="AsOf2020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">2.31</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zUdT2fdDV9qa" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,505,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zkbosElNQz1b" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1793">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_z8Msee3B36Pa" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1794">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zk8enDT6o6X9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1795">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zbanzlt5GYc5" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,505,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">March 27, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zlfbaZ4jBo7b" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20201031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_z9DHi6qdy7v9" style="text-align: center"><ix:nonNumeric contextRef="AsOf2020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">2.41</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zNB5bJNxSmnc" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,426,025</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zFqZth49Cdii" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1800">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zUwPs3zJDQk" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,944,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zBPaOh1vuao9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1802">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zl5wgi1pN3y3" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,482,025</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">May 9, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zoNQwuCemfbh" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20201031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zUMmZAlkMP0g" style="text-align: center"><ix:nonNumeric contextRef="AsOf2020-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">2.52</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_znhajn8CEFT9" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,088,626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zRYGm6Di0JAf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1807">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zQHIbjyeGqul" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,720,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zuIfAZJTcDF8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1809">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_z4PZmoYbUqNa" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,368,626</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">August 14, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_z0CniELjlvz" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20201031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_z5cFog7a9jO2" style="text-align: center"><ix:nonNumeric contextRef="AsOf2020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">2.79</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_z0r2GxTRnfBe" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,310,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zu00ij0vt4L9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1814">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zOeDY74rBjda" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zqBWWc4M7WLb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1816">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_z4R1kVUaxg9d" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,110,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_F45_zdSmz65i9jz" style="text-align: left">May 7, 2020*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--MaySevenTwoThousandTwentyMember_fKg_____zWGCwrTF3Zuj" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_MaySevenTwoThousandTwentyMember" id="Fact001818" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20201031__us-gaap--AwardDateAxis__custom--MaySevenTwoThousandTwentyMember_fKg_____zylUVpYdXf51" title="::XDX::P0Y" style="text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl1819">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MaySevenTwoThousandTwentyMember_fKg_____zjrQngufnpcc" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_MaySevenTwoThousandTwentyMember" id="Fact001820" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MaySevenTwoThousandTwentyMember_fKg_____z42ojU6I7gz8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1821">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MaySevenTwoThousandTwentyMember_fKg_____zhogtcmJSiG3" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_MaySevenTwoThousandTwentyMember" id="Fact001822" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MaySevenTwoThousandTwentyMember_fKg_____ze8ZzqhC8Q7b" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_MaySevenTwoThousandTwentyMember" id="Fact001823" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MaySevenTwoThousandTwentyMember_fKg_____zSQIYglMzCif" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1824">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F4C_zgwB7XzTdnck" style="text-align: left">October 4, 2020*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--OctoberFourTwoThousandTwentyMember_fKg_____zHnSOhApEvo5" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_OctoberFourTwoThousandTwentyMember" id="Fact001825" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20201031__us-gaap--AwardDateAxis__custom--OctoberFourTwoThousandTwentyMember_fKg_____z3auIrHuMuQk" title="::XDX::P0Y" style="text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl1826">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--OctoberFourTwoThousandTwentyMember_fKg_____zknAyPHRFm2l" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OctoberFourTwoThousandTwentyMember" id="Fact001827" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,016,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--OctoberFourTwoThousandTwentyMember_fKg_____zD9CK7VNa2Rg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1828">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--OctoberFourTwoThousandTwentyMember_fKg_____z3X7RQePBUnf" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_OctoberFourTwoThousandTwentyMember" id="Fact001829" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,425,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--OctoberFourTwoThousandTwentyMember_fKg_____zTRl0Herojzh" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_OctoberFourTwoThousandTwentyMember" id="Fact001830" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,591,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--OctoberFourTwoThousandTwentyMember_fKg_____zrxL1G1xO7nk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_F40_zSTKIQqaU3h5" style="text-align: left">November 30, 2020*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyMember_fKg_____zlcq04kvSZHf" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_NovemberThirtyTwoThousandTwentyMember" id="Fact001832" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20201031__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyMember_fKg_____zPjzT5NGmvag" title="::XDX::P0Y" style="text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl1833">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyMember_fKg_____zmE6LOowDCcb" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_NovemberThirtyTwoThousandTwentyMember" id="Fact001834" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,169,926</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyMember_fKg_____zhglry3hMrb3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1835">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyMember_fKg_____zyRnrsDvCUZ3" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_NovemberThirtyTwoThousandTwentyMember" id="Fact001836" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,091,383</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyMember_fKg_____znGUJmrJMM5g" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_NovemberThirtyTwoThousandTwentyMember" id="Fact001837" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,078,543</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyMember_fKg_____zQIcPn2VX4a9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1838">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F4A_z4zp0P3dWxig" style="text-align: left">January 23, 2021*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--JanuaryTwentyThreeTwoThousandTwentyOneMember_fKg_____z7i5E6AWJv52" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember" id="Fact001839" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20201031__us-gaap--AwardDateAxis__custom--JanuaryTwentyThreeTwoThousandTwentyOneMember_fKg_____z8c5TP5812nc" title="::XDX::P0Y" style="text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl1840">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuaryTwentyThreeTwoThousandTwentyOneMember_fKg_____zwIhYOVKsLjl" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember" id="Fact001841" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,388,435</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuaryTwentyThreeTwoThousandTwentyOneMember_fKg_____zKNhChy9XGU" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1842">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuaryTwentyThreeTwoThousandTwentyOneMember_fKg_____zeZRPh9SY7na" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember" id="Fact001843" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,409,160</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuaryTwentyThreeTwoThousandTwentyOneMember_fKg_____zsqJNJg2jzhl" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_JanuaryTwentyThreeTwoThousandTwentyOneMember" id="Fact001844" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,979,275</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--JanuaryTwentyThreeTwoThousandTwentyOneMember_fKg_____z4bNcLyJL6R" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1845">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_F49_zLkdDIB7s4Yi" style="text-align: left">March 29, 2021*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--MarchTwentyNineTwoThousandTwentyOneMember_fKg_____zdFqgM1MN6m8" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember" id="Fact001846" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20201031__us-gaap--AwardDateAxis__custom--MarchTwentyNineTwoThousandTwentyOneMember_fKg_____zHSnhg6SdNW" title="::XDX::P0Y" style="text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl1847">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentyNineTwoThousandTwentyOneMember_fKg_____z939OHYqJ3Ai" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember" id="Fact001848" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,188,046</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentyNineTwoThousandTwentyOneMember_fKg_____z89RXoJOBLne" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1849">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentyNineTwoThousandTwentyOneMember_fKg_____zcy0Q8t941g2" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember" id="Fact001850" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,496,710</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentyNineTwoThousandTwentyOneMember_fKg_____zd14y8BD5Za9" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_MarchTwentyNineTwoThousandTwentyOneMember" id="Fact001851" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,691,336</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MarchTwentyNineTwoThousandTwentyOneMember_fKg_____zakcxUVPqf5" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1852">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F4A_zWvYzELtnvx1" style="text-align: left; padding-bottom: 1.5pt">May 13, 2021*</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20201031__us-gaap--AwardDateAxis__custom--MayThirteenTwoThousandTwentyOneMember_fKg_____z9KBqbsFpfOd" title="Warrants exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-31_custom_MayThirteenTwoThousandTwentyOneMember" id="Fact001854" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20201031__us-gaap--AwardDateAxis__custom--MayThirteenTwoThousandTwentyOneMember_fKg_____zrtswJRW3Wre" title="Warrants weighted average life (Years)::XDX::P0Y" style="text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl1856">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayThirteenTwoThousandTwentyOneMember_fKg_____zma2eoIxAjkl" title="Warrants, Beginning balance" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31_custom_MayThirteenTwoThousandTwentyOneMember" id="Fact001858" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,404,738</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayThirteenTwoThousandTwentyOneMember_fKg_____zTytsQWDx2z6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1859">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayThirteenTwoThousandTwentyOneMember_fKg_____z2R7jdctIlr5" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31_custom_MayThirteenTwoThousandTwentyOneMember" id="Fact001860" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,050,408</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayThirteenTwoThousandTwentyOneMember_fKg_____zkpwsuxyANb6" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31_custom_MayThirteenTwoThousandTwentyOneMember" id="Fact001861" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,354,330</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardDateAxis__custom--MayThirteenTwoThousandTwentyOneMember_fKg_____zHeycjUqlmjk" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1862">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20191101__20201031_zSyIPUG3UkT1" title="Warrants, Beginning balance" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">71,596,996</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20191101__20201031_zgf2HBMS0ybk" title="Warrants, granted" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20191101__20201031_z5SqWRpP04l2" title="Warrants, exercised" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,336,661</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20191101__20201031_z045CwUT8qJk" title="Warrants, Expired/Cancelled" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,794,484</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20191101__20201031_z5cub0M8gAx8" title="Warrants, Ending balance" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,109,642</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Weighted average exercise price</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCAPShares_c20191101__20201031_zKy6PzZHowEi" title="Warrants, weighted average exercise price outstanding"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted_pid_uCAPShares_c20191101__20201031_zkZoHCxSIXfb" title="Warrants, weighted average exercise price granted"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.21</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised_pid_uCAPShares_c20191101__20201031_zZ324et4ySSg" title="Warrants, weighted average exercise price, exercised"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled_pid_uCAPShares_c20191101__20201031_z2gRxYrXP0w3" title="Warrants, weighted average exercise price expired cancelled"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCAPShares_c20191101__20201031_zc6vc0lxSS99" title="Warrants, weighted average exercise price outstanding"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.11</ix:nonFraction></span></b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"><span id="xdx_F0A_z4O1CZSxZM9f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
  <td style="text-align: justify"><span id="xdx_F11_zBsKp7EE6TV9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001883" xml:lang="en-US">On December 20, 2019, the Company exercised its right to call,
subject to acceleration provisions, all outstanding warrants set to expire between May 7, 2020 and May 13, 2021. The expiry was amended
to January 19, 2020. This expiry date was then extended to February 19, 2020. Any unexercised warrants were voided and of no value after
February 19, 2020.</ix:footnote></span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AF_zzPAZYD7YuM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[d]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock options</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted an incentive stock option plan, effective on August 8, 2017 and as amended on August 8, 2018, under the rules of
the TSX-V pursuant to which it is authorized to grant stock options to executive officers, directors, employees and consultants, enabling
them to acquire up to <span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentage_iI_dp_uPure_c20180808__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__srt--RangeAxis__srt--MaximumMember_zjS5Gt8vf8ee" title="Percentage of authorized grant stock options"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentage" contextRef="AsOf2018-08-08_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction>%</span> of the total shares outstanding of the Company (the &#8220;2017 Stock Option Plan&#8221;). Under the 2017 Stock
Option Plan, the option exercise price of any option granted shall not be less than the discounted market price of the Company&#8217;s
common shares. For the purposes of the 2017 Stock Option Plan, the discounted market price is calculated in accordance with the policies
of the TSX-V at the time of the grant of the options. <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_c20180807__20180808__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember_zgg5FKtnUTe7" title="Stock option granted terms"><ix:nonNumeric contextRef="From2018-08-072018-08-08_custom_TwoThousandSeventeenStockOptionPlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms">Stock options granted are subject to a maximum term of 5 years. All options granted
shall vest immediately, except for those options granted to persons performing investor relations activities for the Company.</ix:nonNumeric></span> Pursuant
to the policies of the TSX-V, shares issued upon the exercise of options are restricted from trading during the 4-month period subsequent
to the exercise of options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2021, the Company adopted the 2021 Equity Incentive Plan which replaces the 2017 Stock Option for providing stock-based compensation
to directors, officers, employees, consultants, and advisors of the Company and no further options will be granted under the 2017 Stock
Option Plan. Under the 2021 Equity Incentive Plan, the Company is authorized to issue up <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20210611__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zRltq9jySMkd" title="Number of shares authorized to issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2021-06-11_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,312,368</ix:nonFraction></span> shares of the Company. In addition,
any common shares reserved for issuance under the 2017 Stock Option Plan that are forfeited as a result of the expiration or termination
of any awards under that plan after the date of adoption of the 2021 Equity Incentive Plan will be added to the 2021 Equity Incentive
Plan. During the year ended October 31, 2021, <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20201101__20211031__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zc7lSzwZV5ai" title="Number of stock options forfeited"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2020-11-012021-10-31_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,730,000</ix:nonFraction></span> stock options forfeited under the 2017 Stock Option Plan were added to the 2021
Equity Incentive Plan. The 2021 Equity Incentive Plan provides for various equity-based and cash-based incentive awards, including incentive
stock options, non-statutory stock options, stock appreciation rights, restricted stock and restricted stock units, performance awards,
dividend equivalents and other equity-based or cash-based awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2020, the Company granted <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember_zvCaUvhJdc3k" title="Number of stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,600,000</ix:nonFraction></span> stock options pursuant to its 2017 Stock Option Plan to its directors,
officers, employees and consultants. These options are exercisable at a price ranging from CA$<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20201031__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__srt--RangeAxis__srt--MinimumMember_zmcd91mLXlo8" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.11</ix:nonFraction></span> to CA$<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20201031__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__srt--RangeAxis__srt--MaximumMember_zZGqzCsd5Gf8" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></span> per share for a period
of <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtxL_c20191101__20201031__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__srt--RangeAxis__srt--MinimumMember_zQsQuV5lipGg" title="Options exercisable period::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1899">two</span></span> to <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dc_c20191101__20201031__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__srt--RangeAxis__srt--MaximumMember_zAfx1uCI01ie" title="Options exercisable period"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MaximumMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">five years</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2020, the Company granted <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201229__20201230__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember_zIq1OJfVT8Ta" title="Number of stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-12-292020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,650,000</ix:nonFraction></span> stock options pursuant to its 2017 Stock Option Plan to its directors, officers, employees
and consultants at a price of CA$<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20201230__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember_zc94DOO0O0ik" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per share, of which <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20201230__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__us-gaap--AwardDateAxis__custom--ExercisableAtFiveYearsMember_zm9WpHJiDxB8" title="Number of stock options exercisable"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember_custom_ExercisableAtFiveYearsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></span> were exercisable for a period of five years and <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20201230__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__us-gaap--AwardDateAxis__custom--ExercisableAtTwoYearsMember_zhZMDQVSCgC8" title="Number of stock options exercisable"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember_custom_ExercisableAtTwoYearsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,150,000</ix:nonFraction></span> were exercisable
for a period of two years. However, these options exceeded the maximum allowed under the Company&#8217;s 2017 Stock Option Plan. On June
11, 2021, the Company received shareholders&#8217; approval to amend the Company&#8217;s 2017 Stock Option Plan to increase the number
of common shares reserved for issuance under such plan and rectified the grant of these options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 30, 2021, the Company granted <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210829__20210830__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zmH9Vi7HIUz4" title="Number of stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-08-292021-08-30_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,700,000</ix:nonFraction></span> incentive stock options pursuant to its 2021 Equity Incentive Plan to its directors,
officers, employees and consultants. These options are exercisable at a price of CA$<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20210830__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zbbgytANLMv2" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-08-30_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.70</ix:nonFraction></span> per share for a period of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pid_dc_c20210829__20210830__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z599Lc3rAuv9" title="Options exercisable period"><ix:nonNumeric contextRef="From2021-08-292021-08-30_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">five years</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2021, the Company granted <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210929__20211001__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zpCdcmhICvz8" title="Number of stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-09-292021-10-01_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></span> incentive stock options pursuant to its 2021 Equity Incentive Plan to its officer and
employee and consultants. These options are exercisable at a price of CA$<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20211001__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zALqV3fJvspb" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-10-01_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.50</ix:nonFraction></span> per share for a period of <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c20210929__20211001__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zTvd2k83Ceec" title="Options exercisable period"><ix:nonNumeric contextRef="From2021-09-292021-10-01_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">five years</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at October 31, 2021, the maximum number of common shares available under the 2021 Equity Incentive Plan was <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20211031__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zhU6HZWfTX29" title="Maximum number of shares available"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-10-31_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,042,368</ix:nonFraction></span>, of which <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20211031_zJINnXgyGUN8" title="Shares available for grant"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,892,368</ix:nonFraction></span>
remained available for grant thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2021, the Company recognized a net stock-based compensation totaling $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20201101__20211031_zpr4SiST9S9f" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,051,124</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20191101__20201031_zVzGFHqYJDkj"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">666,259</ix:nonFraction></span>) in
relation to the grant of its stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average grant date fair value of the stock options granted during the year ended October 31, 2021 was CA$<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_uCAPShares_c20201101__20211031__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zY3DzUXoQcNg" title="Weighted average grant date fair value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember50365765" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.36</ix:nonFraction></span> (2020 &#8211;
CA$<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_uCAPShares_c20191101__20201031__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zA0C4l7POpE8"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2019-11-012020-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.14</ix:nonFraction></span>) per option. Option pricing models require the use of highly subjective estimates and assumptions including expected stock price
volatility. Changes in the underlying assumptions can materially affect the fair value estimates. The fair value of stock options was
estimated on the measurement date using the Black-Scholes Option Pricing Model. The assumptions used to calculate the fair value were
as follows:</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zotDtI9IpOQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zmcEsU6E8DUd" style="display: none">SCHEDULE OF ASSUMPTIONS USED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Risk free rate of interest</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20201101__20211031_zoGP5fOuYCGa" title="Risk-free interest rates, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.20</ix:nonFraction></span>% &#8211; <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20201101__20211031_zH5fHrUbv4be" title="Risk-free interest rates, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.07</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20191101__20201031_zwcrV7f817j8" title="Risk-free interest rates, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.43</ix:nonFraction></span>% &#8211; <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20191101__20201031_zgfbnhGRMvge"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.51</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20201101__20211031__srt--RangeAxis__srt--MinimumMember_zYhdkRXMyv8f" title="Expected life of options"><ix:nonNumeric contextRef="From2020-11-012021-10-31_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2</ix:nonNumeric></span> to <span><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20201101__20211031__srt--RangeAxis__srt--MaximumMember_zGEKOcvtQE59"><ix:nonNumeric contextRef="From2020-11-012021-10-31_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric></span> years</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20191101__20201031_zKT5tvQo7C0e"><ix:nonNumeric contextRef="From2019-11-012020-10-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric></span> years</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise price of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uCAPShares_c20211031__srt--RangeAxis__srt--MinimumMember_zFnCSf3qezb6" title="Exercise price of options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2021-10-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> &#8211; CA$<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_dtY_uCAPShares_c20211031__srt--RangeAxis__srt--MaximumMember_zkPYcrvbRGLh"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2021-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.70</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uCAPShares_c20201031__srt--RangeAxis__srt--MinimumMember_zixAwJsSjwt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2020-10-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.11</ix:nonFraction></span> &#8211; CA$<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_dt_uCAPShares_c20201031__srt--RangeAxis__srt--MaximumMember_z6fwFVmGmFBb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2020-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected annualized volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20201101__20211031_zDaWglbT5Ei" title="Expected annualized volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">130.88</ix:nonFraction></span>% &#8211; <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20201101__20211031_zZuTmx452R5a" title="Expected annualized volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">140.05</ix:nonFraction></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20191101__20201031_zoRfqjZGY5lh" title="Expected annualized volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">120.13</ix:nonFraction></span>% &#8211; <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20191101__20201031_zrOXdYnmgcMc" title="Expected annualized volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">188.46</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Expected dividend rate</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dxL_uPure_c20201101__20211031_zJainiiF9Ca8" title="Expected dividend rate::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1959">Nil</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dxL_uPure_c20191101__20201031_zAOjtsvSk74h" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1960">Nil</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zHHY6yUppu5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" continuedAt="ConU001965-01" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_gL3SOSBCSOATT-TPWV_z7DNbVnlimp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the changes in the Company&#8217;s stock options during the year ended October 31, 2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zIobws5UZnGe" style="display: none">SCHEDULE
OF STOCK OPTIONS ACTIVITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Expiry Date</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price<br /> (CA$)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember_zWHsswwn7pG1" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">February 11, 2021</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><span id="xdx_903_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneMember_zy5pAKYeidwa" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><span title="Weighted Average Life (Years)">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneMember_zVJZUYyCWHD5" title="Beginning balance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneMember_zV6iZ2PAdOXi" title="Granted" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1973">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneMember_zyo7kxoDr8uj" title="Exercised" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1975">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneMember_z5c7PLXrOcY6" title="Expired/Cancelled" style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionOneMember_custom_FebruaryElevenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneMember_zgm5Ytxh70Uj" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1979">&#8211;</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneMember_zmNMTzrvtRLd" title="Options vested" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1981">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zq6yu8wWRFHk" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 16, 2021</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneMember_zD8HGIpRf077" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span title="Weighted Average Life (Years)">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneMember_zOo1eTs17e1c" title="Outstanding as at October 31, 2020"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneMember_zUaIdwAJaqF6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1988">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneMember_zk382t89I7mh" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionTwoMember_custom_AugustSixteenTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">600,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneMember_zCmrOPUqCGEc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1990">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneMember_zhGdlozqPI4g"><span style="-sec-ix-hidden: xdx2ixbrl1991">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneMember_zfHtECMF6qm4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1992">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zPRbqBD4CYT8" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionThreeMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 27, 2022</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zqleeISxavPd" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zWknDgxpr7n3" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">0.40</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zlgddlhsCQK8"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,750,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_z0BFPbnAGx05" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2000">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zEKtJQDNDsRa" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">250,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zW41qR3RclZb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2002">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zkSOyzfNN3Af"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zkZdBLjSecj7" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionThreeMember_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember_zbCHioYf0lWg" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionFourMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 26, 2022</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoMember_zfUY2FHuJyVj" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span title="Weighted Average Life (Years)">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoMember_zBueYMvMyXSh"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoMember_zSE8zqww67sb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2010">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoMember_zdYcrD0gqw87" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2011">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoMember_zAZpjV5DvPWc" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionFourMember_custom_AugustTwentySixTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoMember_zqBiF4Q2uTN5"><span style="-sec-ix-hidden: xdx2ixbrl2013">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoMember_zbsdSbaC4ULe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2014">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember_zTNYc8kVX8He" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionFiveMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 30, 2022</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_zrA2fr3jqm5h" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_zqyz4VgHyK4j" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.16</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_zwWvPHqdjkkj"><span style="-sec-ix-hidden: xdx2ixbrl2021">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_zh9j8sNbTOWg" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,150,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_z6tgS6Ek8OW9" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_zV7Q8nhMtCG9" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_zNYO4ixiylJh"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_z4HZHU3H52h7" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFiveMember_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,837,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember_zVFzmVHmH2Z" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionSixMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">April 19, 2023</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeMember_zorbfoU4p5oc" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span title="Weighted Average Life (Years)">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeMember_zMWA8hbfM1gi"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeMember_zetMW0tUy8Ok" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2032">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeMember_zK7yC8hO9Vr" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2033">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeMember_zHMpqrljXK0e" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionSixMember_custom_AprilNinteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeMember_zIBb2LFTMgXb"><span style="-sec-ix-hidden: xdx2ixbrl2035">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeMember_zZRpNSEvjSQc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2036">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember_zaqjSM1eQH9h" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionSevenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 12, 2023</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeMember_z4NsKb34Vyog" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeMember_zd5BvevJymjc" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.78</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeMember_zi3rbdEK36n9"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,120,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeMember_zkLY3Ooo7q3e" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2044">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeMember_zFKC6x1hjQWj" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">600,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeMember_zW7LH77CG0vj" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">230,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeMember_zyswX8z4ZUzf"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,290,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeMember_zV3kJ6Je79Vj" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionSevenMember_custom_AugustTwelveTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,290,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember_zI9lFyXkLt73" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionEightMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 3, 2023</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeMember_zDxFgaYLqC3j" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeMember_zHaVk9ywT0Wk" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.09</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeMember_zlErXpPOUAHc"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeMember_zEMmECTR1BQ6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2056">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeMember_zIsdYTyoWpp5" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">550,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeMember_z9zP1CwLhHOb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2058">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeMember_zELq2CgTf5N2"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeMember_zi5ylYeZYTVb" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionEightMember_custom_DecemberThreeTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember_z11cfHVuCV9l" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionNineMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">May 22, 2024</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourMember_zGoEBoMxyMn3" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourMember_z7TCGWBhItr3" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.56</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourMember_zgdSexGl5lz7"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,950,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourMember_z6gpVwwUhdc3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2068">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourMember_zhT1oNA4FSo4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2069">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourMember_ziHZffTf8Qmc" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourMember_zqYmtt6vHkD7"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,900,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourMember_zw3NWRsaJ6c9" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionNineMember_custom_MayTwentyTwoTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember_zF7ba3oUcOl8" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionTenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 3, 2024</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourMember_zNI4riCf3SN" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourMember_zH649NCaNnHj" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.01</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourMember_zPmLyA7Qij42"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourMember_zFhjT1pmAMSh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2080">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourMember_zdL9ybj9Ic0l" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2081">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourMember_zoRjWIf3TiGk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2082">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourMember_zCo3NAJrvW31"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourMember_zxm7UkEKvlwb" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTenMember_custom_NovemberThreeTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember_zgPXz4cYchq2" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionElevenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 24, 2024</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourMember_ztKCUZlerPEj" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourMember_zxVlhM4z1hl4" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.07</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourMember_zWe1iUMGo5Tb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourMember_zfn4bS9YI3vl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2092">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourMember_z7hMQFue7oDg" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">30,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourMember_z2BmMeob1R8b" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">550,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourMember_zNuQ3jlpwPe5"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourMember_zhFuif36BCYc" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionElevenMember_custom_NovemberTwentyFourTwoThousandTwentyFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember_zTOd3B9AO45c" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionTwelveMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 26, 2025</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveMember_zUdBj4uxqP8f" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.11</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveMember_zTDI5mMIQVpl" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.40</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveMember_zfyzxTykeoSg"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveMember_zTHA7hojjNQ8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2104">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveMember_zBdPpfZB10vb" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">200,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveMember_z2h7IZpdyU53" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2106">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveMember_z27cizneAc8c"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveMember_zr0KblrHeQW5" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTwelveMember_custom_MarchTwentySixTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember_zwkf5Mxz6z3" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionThirteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">April 23, 2025</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveMember_zeDmlM91zIA5" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveMember_z90y0Ak4uWwk" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.48</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveMember_zqJgtGnAaGPe"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveMember_zp2FDMyqQFh7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2116">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveMember_zYFPdryfo1vh" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">300,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveMember_zi1LDCZksOR8" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveMember_zQRIh6ljDO3"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveMember_zh6yI9TEEqq" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionThirteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember_z7Fu4SQgVW35" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionFourteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 30, 2025</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyFiveMember_zqRgMu0hB3Cl" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyFiveMember_zfROgFZD9hs5" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.17</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyFiveMember_zG8EAnd1Wmhb"><span style="-sec-ix-hidden: xdx2ixbrl2127">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyFiveMember_zVNRXpJJYPy1" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyFiveMember_zC1NViiFtnmh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2129">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyFiveMember_z9A7WDAFViYj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2130">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyFiveMember_zBc68b6QYqGf"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyFiveMember_zC0AjRIKF5X4" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFourteenMember_custom_DecemberThirtyTwoThousandTwentyFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember_zQh9JYJvipHg" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionFifteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 30, 2026</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember__us-gaap--AwardDateAxis__custom--AugustThirtyTwoThousandTwentySixMember_z974YBgfvLXd" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.70</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember__us-gaap--AwardDateAxis__custom--AugustThirtyTwoThousandTwentySixMember_zHQ1Ocofl8V4" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.83</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember__us-gaap--AwardDateAxis__custom--AugustThirtyTwoThousandTwentySixMember_zzdBVrRLmcZc"><span style="-sec-ix-hidden: xdx2ixbrl2139">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember__us-gaap--AwardDateAxis__custom--AugustThirtyTwoThousandTwentySixMember_zdLIYQrGPqc" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember__us-gaap--AwardDateAxis__custom--AugustThirtyTwoThousandTwentySixMember_zQk0bcvukzY6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2141">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember__us-gaap--AwardDateAxis__custom--AugustThirtyTwoThousandTwentySixMember_zvoiIT307979" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2142">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember__us-gaap--AwardDateAxis__custom--AugustThirtyTwoThousandTwentySixMember_zD3HRz6ctzFl"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,700,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionFifteenMember__us-gaap--AwardDateAxis__custom--AugustThirtyTwoThousandTwentySixMember_zfrdQaXuTN12" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFifteenMember_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,400,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember_zdgvRZrYQ3f8" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionSixteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">October 1, 2026</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharePrice_iI_uCAPShares_c20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentySixMember_zqs83Y2lQklh" title="Exercise Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.50</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentySixMember_z1acPm8Z4sk7" title="Weighted Average Life (Years)"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.92</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentySixMember_zOwr5NTdCeea"><span style="-sec-ix-hidden: xdx2ixbrl2151">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentySixMember_zGVki6NdSn74" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentySixMember_zt19CFcOCdIj" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2153">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentySixMember_zUZweBG4mRk2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2154">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentySixMember_zVYKa0zMJvKb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031__us-gaap--AwardTypeAxis__custom--OptionSixteenMember__us-gaap--AwardDateAxis__custom--OctoberOneTwoThousandTwentySixMember_z6Mj97exldFh" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionSixteenMember_custom_OctoberOneTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20211031_zqQuzqvUR9ek" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,420,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031_zYP8D7gID2R" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,800,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031_zk66a8IZhlhb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">2,630,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20211031_zW1mEZFYHWc2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,330,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20211031_zpAZaodr2irg"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">61,260,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211031_zfl7jhRNcZP3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,797,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average exercise price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_uCAPShares_c20201101__20211031_z5uHinTDY1nf" title="Weighted average exercise price, beginning balance" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.09</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_uCAPShares_c20201101__20211031_zRz0h8Y6ZU3b" title="Weighted average exercise price, granted" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.46</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_uCAPShares_c20201101__20211031_z8KQvPi1PtVa" title="Weighted average exercise price, exercised" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_uCAPShares_c20201101__20211031_zRH2KYkCABl" title="Weighted average exercise price, expired/cancelled" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.09</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_uCAPShares_c20201101__20211031_z9XxC47ZqdN9" title="Weighted average exercise price, ending balance" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.33</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_uCAPShares_c20201101__20211031_zZC2seKCO8Ik" title="Weighted average exercise price, vested" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.32</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20211031_zLLAbpCjjlga" title="Aggregate intrinsic value, outstanding" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,994,025</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20211031_zZaA4h4fkg1h" title="Aggregate intrinsic value, vested" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,908,026</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Weighted average remaining life</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031_zQm9GZrWTIlh" title="Weighted average remaining life, outstanding" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonNumeric contextRef="From2020-11-012021-10-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.46</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20201101__20211031_zmLkRwzvpEjk" title="Weighted average remaining life, vested" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonNumeric contextRef="From2020-11-012021-10-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">3.46</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_za1m0ZnO1Og4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"><p id="xdx_892_eus-gaap--ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_zpV5M8mabUWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the changes in the Company&#8217;s nonvested stock options during the year ended October 31, 2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zl4nftBwqpGi" style="display: none">SCHEDULE
OF NONVESTED STOCK OPTIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td id="xdx_488_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedExpirationDate_dd_zmUgrHzyxLE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Expiry Date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_481_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uCAPShares_zSVmMYQPTUX4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Per Share<br /> (CA$)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_zxgpbzAEi3Ib" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonvested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_pid_zpZJV4wma3G9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_489_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_pid_z3L6xYAjx9X3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_zRCvItXWnW65" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_481_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_z0hXtv6iKbwa" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonvested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_414_20201101__20211031__us-gaap--AwardTypeAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_zguo81miQlv7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 31%; text-align: left"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedExpirationDate">December 30, 2022</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-11-012021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--DecemberThirtyTwoThousandTwentyTwoMember_z6uaO41Md064" style="width: 6%; text-align: center"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm2">1.16</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2187">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">650,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2020-11-012021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">487,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2190">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-10-31_custom_DecemberThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_413_20201101__20211031__us-gaap--AwardTypeAxis__custom--AugustThirtyTwoThousandTwentySixMember_zaEiWuxEbJoe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt:datemonthdayyearen" name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedExpirationDate">August 30, 2026</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-11-012021-10-31_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.56</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm2_dtY_c20201101__20211031__us-gaap--AwardTypeAxis__custom--AugustThirtyTwoThousandTwentySixMember_zfZvAas9ijrc" style="text-align: center"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt-sec:duryear" name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm2">4.83</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2195">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2197">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2198">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-10-31_custom_AugustThirtyTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20201101__20211031_zBm3U0ZhzL6k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">950,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_c20201101__20211031_zmvwp6Sdsol1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">487,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20201101__20211031_zmcVNOEUhS3d" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2203">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20201101__20211031_z00FwfAQ5it" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">462,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                            average grant date fair value </b></span><b>&#8211; per option</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_uCAPShares_c20191101__20201031_z4mLzVtSoOy" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2205">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_uCAPShares_c20201101__20211031_zS6FH4Kx7yDd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.22</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_uCAPShares_c20201101__20211031_zjjnfOHmerJ3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_uCAPShares_c20201101__20211031_zZVmCVFsnsyb" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2208">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_uCAPShares_c20201101__20211031_z0GL4ZnGcJP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.39</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
                                            average grant date fair value </b></span><b>&#8211; total</b></p></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageGrantDateFairValue_iS_c20201101__20211031_zTNMp7LFmlK6" style="border-bottom: Black 2.5pt double; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2210">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsWeightedAverageGrantDateFairValue_c20201101__20211031_zxqfG2BVkXrh" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsWeightedAverageGrantDateFairValue" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">170,781</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValueTotal_c20201101__20211031_zGKXSTmIMzTf" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValueTotal" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,650</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValueTotal_c20201101__20211031_z8P1nxKYHdGb" style="border-bottom: Black 2.5pt double; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2213">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueTotal_iE_c20201101__20211031_zXqgOSyiPAv" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueTotal" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,131</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_z4Fy3AN7HGr3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C00_gL3SOSBCSOATT-TPWV_zvUrZWbiV2Mk"><ix:continuation continuedAt="ConU001965-02" id="ConU001965-01">A
summary of the changes in the Company&#8217;s stock options during the year ended October 31, 2020 are as follows:</ix:continuation></span></span></p>

<div id="xdx_C0F_gL3SOSBCSOATT-TPWV_zR3PYXE45JOb"><ix:continuation continuedAt="ConU001965-03" id="ConU001965-02"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Expiry Date</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price<br /> (CA$)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2019</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionOneMember_zfMpPmcr0Tli"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">May 31, 2020</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><span id="xdx_902_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--MayThirtyFirstTwoThousandTwentyMember_zWUJl52ouwNf"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.08</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><span title="::XDX::0">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--MayThirtyFirstTwoThousandTwentyMember_zFZMUDNvm7q5"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">400,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--MayThirtyFirstTwoThousandTwentyMember_zAl1EJrQLY5d" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2218">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--MayThirtyFirstTwoThousandTwentyMember_zxjdXLHv7hx3" style="width: 5%; text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionOneMember_custom_MayThirtyFirstTwoThousandTwentyMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">400,000</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--MayThirtyFirstTwoThousandTwentyMember_z5Nk8Ge0NMe4" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2220">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--MayThirtyFirstTwoThousandTwentyMember_z5O8V8rXOdsf"><span style="-sec-ix-hidden: xdx2ixbrl2221">&#8211;</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionOneMember__us-gaap--AwardDateAxis__custom--MayThirtyFirstTwoThousandTwentyMember_zYpZC6BAoGZ9" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2222">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zjXVbN7ctCg3"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">June 3, 2020</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--JuneThreeTwoThousandTwentyMember_zTpMYbZ5chi3"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span>&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--JuneThreeTwoThousandTwentyMember_zBjYO2fvOtDe"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">550,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--JuneThreeTwoThousandTwentyMember_zkxb0ASktPOg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2226">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--JuneThreeTwoThousandTwentyMember_z9YFFDdkU1b5" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2227">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--JuneThreeTwoThousandTwentyMember_zKZrSpBrkqwb" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionTwoMember_custom_JuneThreeTwoThousandTwentyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">550,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--JuneThreeTwoThousandTwentyMember_z7PY2pzfUJNi"><span style="-sec-ix-hidden: xdx2ixbrl2229">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionTwoMember__us-gaap--AwardDateAxis__custom--JuneThreeTwoThousandTwentyMember_z0Gyn64nsYMa" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2230">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zQMOfcymu7ma"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionThreeMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">February 11, 2021</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneOneMember_zpkLj2J2iDt6"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneOneMember_zSUYenlIjX5j"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">0.53</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneOneMember_zNuqJUopYde2"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,300,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneOneMember_zzowtaG6Y0rd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2235">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneOneMember_zWggVcM29l19" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2236">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneOneMember_zQVKP3EJkCy3" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneOneMember_zuLde9WUpV5g"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionThreeMember__us-gaap--AwardDateAxis__custom--FebruaryElevenTwoThousandTwentyOneOneMember_zeJxTPX5wnm9" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionThreeMember_custom_FebruaryElevenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourMember_zr3ylWBu7zfj"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionFourMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 16, 2021</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneOneMember_zPEVbS0Mba66"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtYxL_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneOneMember_zN2G4QojSwSg"><span style="-sec-ix-hidden: xdx2ixbrl2242">1.04</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneOneMember_zpZpmBQdyTV5"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneOneMember_zeKtqKDJqrxj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2244">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneOneMember_zMlsJV9nOXKh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2245">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneOneMember_zx9ofCwr68N5" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneOneMember_zHd2KgeE8Trl"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionFourMember__us-gaap--AwardDateAxis__custom--AugustSixteenTwoThousandTwentyOneOneMember_zCINjjhWKlZd" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFourMember_custom_AugustSixteenTwoThousandTwentyOneOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFiveMember_zAhTJ7czjwpa"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionFiveMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 27, 2022</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoOneMember_zDBVChg2uYD4"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoOneMember_zKwmmvvYyFPg"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.65</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoOneMember_zeJTPfJtyMEe"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoOneMember_zLCqjRYE1N64" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2253">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoOneMember_zNGkOgGyvZlh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2254">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoOneMember_z6qseFEKXmLj" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoOneMember_zaf4IAzqrCye"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,750,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionFiveMember__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoOneMember_zkOUx1LRTmgi" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFiveMember_custom_MarchTwentySevenTwoThousandTwentyTwoOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,750,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSixMember_zIgKGCU5kWr4"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionSixMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 26, 2022</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoOneMember_zcxGEXagHVbb"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span>&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoOneMember_zGCWNXVR0ke1"><span style="-sec-ix-hidden: xdx2ixbrl2260">&#8211;</span></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoOneMember_zfLPOXf6lxQk" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoOneMember_z4qeCQpeeJ5i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2262">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoOneMember_zGcfWzy4czYc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2263">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoOneMember_z4rm9qlgHsf8"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSixMember_custom_AugustTwentySixTwoThousandTwentyTwoOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionSixMember__us-gaap--AwardDateAxis__custom--AugustTwentySixTwoThousandTwentyTwoOneMember_zoyMB9gLPuEg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2265">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSevenMember_z4kJphapOiq"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionSevenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">April 19, 2023</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeOneMember_zeOeYaULTDK1"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeOneMember_zQl3d0ihT0Qg"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.72</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeOneMember_zpscpgzCVjfb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeOneMember_zyBEJR7XsHz5" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2270">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeOneMember_zmaChZVVvbL4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2271">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeOneMember_zkHwEj1KhSf3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2272">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeOneMember_zc8g2plljmTk"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionSevenMember__us-gaap--AwardDateAxis__custom--AprilNinteenTwoThousandTwentyThreeOneMember_zRXlgYKNJqN8" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSevenMember_custom_AprilNinteenTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionEightMember_z22ZgJa5UIOf"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionEightMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 12, 2023</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeOneMember_zWi9T3H1UmA6"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeOneMember_zbEYPL0HcIu7"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.03</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeOneMember_z7n968m2rYhc"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,780,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeOneMember_z4GA4v69mfk4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2279">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeOneMember_zC2KJj1hk9Q" style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2020-11-012021-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeOneMember_zaTd0ngV3lRg" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">560,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeOneMember_zdpYlVy9HWd7"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,120,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionEightMember__us-gaap--AwardDateAxis__custom--AugustTwelveTwoThousandTwentyThreeOneMember_zuUU9piuF7i" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionEightMember_custom_AugustTwelveTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,120,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionNineMember_zsCrRLvrBLK3"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionNineMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 3, 2023</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeOneMember_zbM41yGJR90d"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeOneMember_zdTB0GMIL8ij"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionTenMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.35</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeOneMember_zhkxnJa7vNSh"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,600,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeOneMember_zrsXoDXzi3x2" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2288">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeOneMember_zNovGx5YT135" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2289">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeOneMember_zEHjRf5iRSme" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,600,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeOneMember_zUnPsKFOCiDj"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionNineMember__us-gaap--AwardDateAxis__custom--DecemberThreeTwoThousandTwentyThreeOneMember_zJNr7lMDzYY2" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionNineMember_custom_DecemberThreeTwoThousandTwentyThreeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember_zHOhpeFUP6Ae"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionTenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">May 22, 2024</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourOneMember_zRXjt1l1oPd7"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourOneMember_zl4EyQKnV57k"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.81</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourOneMember_zoZus5uVY05l"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourOneMember_zJYc6g1phPff" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2297">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourOneMember_z8GwuBOPcmnb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2298">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourOneMember_zcjg0Ev7mMrc" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,050,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourOneMember_z4oHmI6wLncf"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,950,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionTenMember__us-gaap--AwardDateAxis__custom--MayTwentyTwoTwoThousandTwentyFourOneMember_zUGoRJueDbr7" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTenMember_custom_MayTwentyTwoTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,950,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionElevenMember_zfncl2WYZ99e"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionElevenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 3, 2024</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourOneMember_zxCQm3innVJk"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourOneMember_z0q4CmimgK3l"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.27</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourOneMember_z2E9Om35q8K8"><span style="-sec-ix-hidden: xdx2ixbrl2305">&#8211;</span></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourOneMember_zL7E2WFINoJa" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourOneMember_zYlRK2tfLdJg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2307">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourOneMember_zYfX8XuV4Xwb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2308">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourOneMember_zw0Doox2QIf"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionElevenMember__us-gaap--AwardDateAxis__custom--NovemberThreeTwoThousandTwentyFourOneMember_zeZTfYTUKjEg" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionElevenMember_custom_NovemberThreeTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember_z9Uz4R8XH9g1"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionTwelveMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 24, 2024</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourOneMember_zWvY2lWR15l8"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourOneMember_zsvxe2ISRHcf"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.32</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourOneMember_zcCZXwj2uQ62"><span style="-sec-ix-hidden: xdx2ixbrl2314">&#8211;</span></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourOneMember_zRkIq5W2kljg" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourOneMember_zBT7XmBAdgMa" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2316">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourOneMember_zKrwgLjpjMx8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2317">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourOneMember_z68f99clNqV6"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionTwelveMember__us-gaap--AwardDateAxis__custom--NovemberTwentyFourTwoThousandTwentyFourOneMember_zzGHUSGcb5Lh" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTwelveMember_custom_NovemberTwentyFourTwoThousandTwentyFourOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">775,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember_zKRaNnJhESba"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionThirteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 26, 2025</ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveOneMember_zfGoK2NM24lf"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.11</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveOneMember_zwKmCda5Xgc3"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.66</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveOneMember_zateW5UUT86"><span style="-sec-ix-hidden: xdx2ixbrl2323">&#8211;</span></span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveOneMember_z54x4FIbvPmc" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveOneMember_zPwYQnQtYBSh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2325">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveOneMember_zZL7TIiKOgpj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2326">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveOneMember_z4ToUjXQ6Fo1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionThirteenMember__us-gaap--AwardDateAxis__custom--MarchTwentySixTwoThousandTwentyFiveOneMember_z1REbDwsnb96" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionThirteenMember_custom_MarchTwentySixTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember_zuQVKqHzynYf"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionFourteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">April 23, 2025</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_902_eus-gaap--SharePrice_iI_uCAPShares_c20201031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveOneMember_zW6sJ74scb75"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveOneMember_zj04xOGjwLW7"><ix:nonNumeric contextRef="From2019-11-012020-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.73</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveOneMember_zJW4JULsHCq5"><span style="-sec-ix-hidden: xdx2ixbrl2332">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveOneMember_zZYnxA76I65k" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,200,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20211031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveOneMember_zF3SUTGzVd0l" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2334">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveOneMember_zBz80MEcSxM7" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveOneMember_z6whT4yTAQVi"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031__us-gaap--AwardTypeAxis__custom--OptionFourteenMember__us-gaap--AwardDateAxis__custom--AprilTwentyThreeTwoThousandTwentyFiveOneMember_zkiuxUapzHl5" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFourteenMember_custom_AprilTwentyThreeTwoThousandTwentyFiveOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,625,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20191101__20201031_zQbt0yV1DvMc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,630,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191101__20201031_zKO49NHAZa71" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,600,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20191101__20201031_zAEefe4vezU7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20191101__20201031_ziU2mWYSROB9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,310,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20191101__20201031_zcYVgnPSFndl"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,420,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201031_zIcBpObtta6i" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,420,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average exercise price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_uCAPShares_c20191101__20201031_zCRnJsRhEjG3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_uCAPShares_c20191101__20201031_zjABnEiRFP3c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_uCAPShares_c20191101__20201031_zr47E8vRAuU8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_uCAPShares_c20191101__20201031_zY3S0uLiQQM8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_uCAPShares_c20191101__20201031_z4kUh89hw3n3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.09</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_uCAPShares_c20191101__20201031_ztWF41pHDSnc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.09</ix:nonFraction></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20201031_zEOxIPSZTD11" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">801,922</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20201031_zGVe3bZrLaud" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">866,441</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Weighted average remaining life</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191101__20201031_zePJ5McSYw54" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonNumeric contextRef="From2019-11-012020-10-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.18</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20191101__20201031_z3oT1YF4uDG7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonNumeric contextRef="From2019-11-012020-10-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">3.18</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C08_gL3SOSBCSOATT-TPWV_zhGBVkPN6tx3"><ix:continuation id="ConU001965-03">&#160;</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
intrinsic value of options exercised during the year ended October 31, 2021 was $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20201101__20211031_zHZd92qSQ9di" title="Intrinsic value of options exercised"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">962,936</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20191101__20201031_zfIVyotjt3Xg" title="Intrinsic value of options exercised"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,533</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[e]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
    payments and other reserves</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
share-based payments and other reserves are used to recognize the fair value of stock options granted to executive officers, directors,
employees and consultants as part of their remuneration, as well as those of broker warrants issued in relation to the Company&#8217;s
financings. When stock options and broker warrants are subsequently exercised, the fair value of such stock options and broker warrants
in reserves is credited to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
share purchase warrants attached to units as part of a unit placement are assigned a $nil value. The residual method is used to calculate
the fair value of the warrant component of units issued, whereby the residual of the private placement proceeds less the fair value of
the share component is assigned as the fair value of the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has allocated the intrinsic value of the beneficial conversion feature of the July 2021 Convertible Debenture capped
at the face value of CA$<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_uCA_c20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zJa3zFTdBhth"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-10-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">100,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_uUSD_c20211031__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zSYNNvwRSrB5"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-10-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,542</ix:nonFraction></span>) to equity reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[f]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Obligations
    to issue shares</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at October 31, 2021, the Company received advance share subscriptions in the amount of $<span id="xdx_90B_eus-gaap--CommonStockSharesSubscriptions_iI_c20211031_zunAiQROiOW5"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></span> (October 31, 2020 &#8211; $<span id="xdx_906_eus-gaap--CommonStockSharesSubscriptions_iI_c20201031_z6dXPA2rfB7l"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">596,872</ix:nonFraction></span>) in
respect of a non-brokered private placement closed subsequent to the year <i>[note 19[iv]]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[g]</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dilutive
    common shares</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended October 31, 2021, potentially dilutive common shares relating to common share purchase warrants and options outstanding
totaling <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20201101__20211031_zTvDABWzoqB4"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">120,808,982</ix:nonFraction></span> (2020 &#8211; <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20191101__20201031_zurw2iaodWe5"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,529,642</ix:nonFraction></span>) were not included in the computation of loss per share as the effect would be anti-dilutive.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="MLYF:CapitalManagementTextBlock"><p id="xdx_80F_ecustom--CapitalManagementTextBlock_z5rrdAqsSKzb" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82E_zFWMZx6zHbp1">CAPITAL MANAGEMENT</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies the components of shareholders&#8217; equity as capital, which at October 31, 2021, was a deficiency of $<span id="xdx_906_eus-gaap--StockholdersEquity_iNI_di_c20211031_zmDtp5Ip51Jc" title="Stockholders deficit"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,770,038</ix:nonFraction></span>
(October 31, 2020 &#8211; $<span id="xdx_909_eus-gaap--StockholdersEquity_iNI_di_c20201031_zU39ieXvttof"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,079,903</ix:nonFraction></span>). When managing capital, the Company&#8217;s objective is to ensure the entity continues as a going
concern and advance stakeholders&#8217; interests. Management adjusts the capital structure as necessary in order to support its business
and technology development. The Company&#8217;s board of directors does not establish qualitative return on capital criteria for management,
but rather relies on the expertise of the Company&#8217;s management to sustain future development of the business. The Company focuses
on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and the development
of a full-scale commercial magnesium production facility. The Company is considered to be in the development stage and is dependent upon
external financing to fund its activities. In order to carry out its business development activities and pay for administrative costs,
the Company will spend its existing working capital and raise additional amounts as needed. Management reviews its capital management
approach on an ongoing basis and believes that this approach, given the relative size of the Company, is appropriate. There were no changes
in the Company&#8217;s approach to capital management during the period. The Company is not subject to any externally imposed capital
requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_801_eus-gaap--FairValueDisclosuresTextBlock_zjUah83CUoP9" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_zR0YfLq907Wd">FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zfsnsFmk1V1b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s classification of its financial instruments is as follows:</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_8BF_z7qNz3exl1eh" style="display: none">SCHEDULE OF CLASSIFICATION OF ITS FINANCIAL INSTRUMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Instruments</b></span></p></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.85pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Measurement</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.85pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method</b></span></p></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Associated
    Risk</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
    Value at</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October
    31, 2021</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FVTPL</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
    and currency</span></td>
    <td>&#160;</td>
    <td id="xdx_98E_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20211031_zMQKGeu3ATY8" title="Cash" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">462,360</ix:nonFraction></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    receivable</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
    and currency</span></td>
    <td>&#160;</td>
    <td id="xdx_98C_eus-gaap--ReceivablesFairValueDisclosure_iI_c20211031_zMNmfxDbgsKf" title="Amounts receivable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ReceivablesFairValueDisclosure" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,485</ix:nonFraction></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits
    held by related parties</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
    and currency</span></td>
    <td>&#160;</td>
    <td id="xdx_98C_eus-gaap--DepositsFairValueDisclosure_iI_c20211031_zG0rpTy86yNk" title="Deposits held by related parties" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepositsFairValueDisclosure" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,462</ix:nonFraction></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable and accrued liabilities </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency</span></td>
    <td>&#160;</td>
    <td id="xdx_985_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_c20211031_zUiSd2hdHqo9" title="Accounts payable and accrued liabilities" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,989,316</ix:nonFraction></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to related parties</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency</span></td>
    <td>&#160;</td>
    <td id="xdx_987_ecustom--DueToRelatedPartiesFairValueDisclosure_iI_c20211031_zCF8kCNtqnCd" title="Due to related parties" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MLYF:DueToRelatedPartiesFairValueDisclosure" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,026,817</ix:nonFraction></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    debenture</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortized
    cost</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency</span></td>
    <td>&#160;</td>
    <td id="xdx_98B_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20211031_z2n2HE6uC2g8" title="Convertible debenture" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107</ix:nonFraction></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    debenture - derivative liability</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FVTPL</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency</span></td>
    <td>&#160;</td>
    <td id="xdx_982_ecustom--ConvertibleDebentureDerivativeLiabilityFairValueDisclosure_iI_c20211031_zdcPZe9NE9C4" title="Convertible debenture and derivative liability" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="MLYF:ConvertibleDebentureDerivativeLiabilityFairValueDisclosure" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,700</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_za02IxVtMZa3" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[a]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of financial instruments is the amount of consideration that would be agreed upon in an arm&#8217;s length transaction between
knowledgeable, willing parties who are under no compulsion to act. The fair value of current financial instruments except derivative
liability approximates their carrying values as long as they are short-term in nature or bear interest at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[b]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    value hierarchy</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that are held at fair value are categorized based on a valuation hierarchy which is determined by the valuation methodology
utilized. The fair value hierarchy under US GAAP is based on the following three levels of inputs, of which the first two are considered
observable and the last unobservable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
1</b> &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
2</b> &#8211; Observable inputs other than Level 1, quoted prices for similar assets or liabilities in active prices whose inputs are
observable or whose significant value drivers are observable; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
3</b> &#8211; Assets and liabilities whose significant value drivers are unobservable by little or no market activity and that are significant
to the fair value of the assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents are valued using a market approach based upon unadjusted quoted prices for identical assets in an active market
obtained from securities exchanges. As at October 31, 2021, the fair value of cash and cash equivalents held by the Company was based
on Level 1 of the fair value hierarchy. There were no transfers between Levels 1 and 2 during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments and other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with ASC 815. The result of this accounting treatment is that the
fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair
value is recorded in the consolidated statements of loss and comprehensive loss. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value
of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current
or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Scholes Option Pricing Model to value derivative liabilities. This model uses Level 3 inputs in the fair value
hierarchy established by ASC 820 Fair Value Measurement. The inputs used in determining the fair value of the embedded derivative are
disclosed in <i>note 13[d]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[c]</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    risk management</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s board of directors has the overall responsibility for the establishment and oversight of the Company&#8217;s risk management
framework. The Company&#8217;s risk management policies are established to identify and analyze the risks faced by the Company, to set
appropriate risk limits and controls, and to monitor risks and adherence to limits. Risk management policies and systems are reviewed
regularly to reflect changes in market conditions and in response to the Company&#8217;s activities. Management regularly monitors compliance
with the Company&#8217;s risk management policies and procedures and reviews the adequacy of the risk management framework in relation
to the risks faced by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of operations, the Company is exposed to various risks such interest rate, foreign exchange, commodity, credit, and
liquidity. To manage these risks, management determines what activities must be undertaken to minimize potential exposure to risks. The
objectives of the Company in managing risks are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintaining
    sound financial condition:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
    operations; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensuring
    liquidity to all operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to satisfy these objectives, the Company has adopted the following policies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepare
    budget documents at prevailing market rates to ensure clear corporate alignment to performance management and achievement of targets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize
    and observe the extent of operating risk within the business; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify
    the magnitude of the impact of market risk factors on the overall risk of the business and take advantage of natural risk reductions
    that arise from these relationships.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>[i]</i></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>Interest
    rate risk</i></span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in the market interest rates.
The Company is exposed to interest rate risk on its cash on deposits with banks and, from time to time, on its holdings of short-term
investments. As of October 31, 2021, the Company had $<span id="xdx_902_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211031_zQyO0IrvBU8i" title="Cash"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">462,360</ix:nonFraction></span> (October 31, 2020 &#8722; $<span id="xdx_905_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20201031_zRBwWayUAMXd" title="Cash"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,571</ix:nonFraction></span>) of cash on deposits with banks. The
Company had <span id="xdx_907_eus-gaap--ShortTermInvestments_iI_do_c20211031_zsrjGCsRg8Pk" title="Short term investments"><span id="xdx_90D_eus-gaap--ShortTermInvestments_iI_do_c20201031_zWQMlGWjdvM1" title="Short term investments"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2021-10-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2020-10-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> short-term investment as at October 31, 2021 and October 31, 2020. Given the level of cash and cash equivalents held by
the Company, fluctuations in the market interest rates had no significant impact on its interest income during the year ended October
31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>[ii]</i></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>Foreign
    currency risk</i></span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is exposed to foreign currency risk on fluctuations related to cash, deposits held by related parties, accounts payable, due
to related parties and convertible debenture that are denominated in US dollars. The Company has not entered into foreign exchange derivative
contracts. A significant change in the currency exchange rates between the Canadian dollar relative to the US dollar could have a material
effect on the Company&#8217;s financial position, results of operations, or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Company net exposures as at October 31, 2021, assuming that all other variables remain constant, a <span id="xdx_900_ecustom--ForeignCurrencyRiskRate_pid_dp_uPure_c20201101__20211031_zzsSvrs5yY0a" title="Foreign currency risk rate">5%</span> appreciation or deterioration
of the Canadian dollar against the US dollar would result in an increase or decrease of $<span id="xdx_90F_ecustom--IncreaseDecreaseInForeignCurrencyTransactionAmount_c20201101__20211031_zWQyqaH1P3M8" title="Increase decrease in foreign currency transaction amount"><ix:nonFraction name="MLYF:IncreaseDecreaseInForeignCurrencyTransactionAmount" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,941</ix:nonFraction></span> in the Company&#8217;s net income (loss)
and comprehensive income (loss).</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zeyfsdhe4LZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-transform: uppercase"><span id="xdx_8B7_zQ2rADkJceo8" style="display: none">SCHEDULE OF FOREIGN CURRENCY
RISK</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">October 31, 2021</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: left">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetReportingCurrencyDenominatedValue_iI_c20211031__us-gaap--BalanceSheetLocationAxis__us-gaap--CashMember_z1wIvL76Cgi9" title="Assets" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:AssetReportingCurrencyDenominatedValue" contextRef="AsOf2021-10-31_us-gaap_CashMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">186,627</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deposits held by related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AssetReportingCurrencyDenominatedValue_iI_c20211031__us-gaap--BalanceSheetLocationAxis__custom--DepositsHeldByRelatedPartiesMember_z8QE3lqy4edd" title="Assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetReportingCurrencyDenominatedValue" contextRef="AsOf2021-10-31_custom_DepositsHeldByRelatedPartiesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,462</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LiabilityReportingCurrencyDenominatedValue_iNI_di_c20211031__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_zQkt7HtOl08" title="Liabilities" style="text-align: right">(<ix:nonFraction name="us-gaap:LiabilityReportingCurrencyDenominatedValue" contextRef="AsOf2021-10-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">773,011</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LiabilityReportingCurrencyDenominatedValue_iNI_di_c20211031__us-gaap--BalanceSheetLocationAxis__custom--DueToRelatedPartiesMember_zr7zBK9RMXsh" title="Liabilities" style="text-align: right">(<ix:nonFraction name="us-gaap:LiabilityReportingCurrencyDenominatedValue" contextRef="AsOf2021-10-31_custom_DueToRelatedPartiesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">467,500</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible debenture</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LiabilityReportingCurrencyDenominatedValue_iNI_di_c20211031__us-gaap--BalanceSheetLocationAxis__custom--ConvertibleDebentureMember_z1pmwZfxB9l4" title="Liabilities" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LiabilityReportingCurrencyDenominatedValue" contextRef="AsOf2021-10-31_custom_ConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_ecustom--AssetAndLiabilitiesReportingCurrencyDenominatedValue_iI_c20211031_z7kWRugZNm0c" title="Total" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="MLYF:AssetAndLiabilitiesReportingCurrencyDenominatedValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,067,422</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zx6gE6zgCzya" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>[iii]</i></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>Commodity
    price risk</i></span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of the Company&#8217;s magnesium production business and its exploration and evaluation assets are dependent on the price of magnesium
and the outlook for this mineral. Market prices for these metals historically have fluctuated widely and are affected by numerous factors
outside the Company&#8217;s control, including but not limited to, levels of worldwide production, short-term changes in supply and demand,
industrial and retail demand, as well as certain other factors related specifically to magnesium. If magnesium prices decline for a prolonged
period below the cost of production, it may not be economically feasible to continue towards production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>[iv]</i></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>Credit
    risk</i></span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
risk is the risk of loss if counterparties do not fulfill their contractual obligations and arises principally from trade receivables.
The Company&#8217;s credit risk is primarily attributable to cash, and deposits held by related parties. The Company limits its exposure
to credit risk on cash as these financial instruments are held with major Canadian and international banks. Amounts receivable consist
primarily of GST due from the Federal Government of Canada. Management believes the credit risk concentration with respect to amounts
receivable is remote. The carrying amount of financial assets recorded in the financial statements, net of any allowances, represents
the Company&#8217;s maximum exposure to credit risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>[v]</i></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>Liquidity
    risk</i></span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
risk is the risk that the Company will not be able to meet its financial obligations as they come due. The Company&#8217;s exposure to
liquidity risk is dependent on its purchasing commitments and obligations and its ability to raise funds to meet commitments and sustain
operations. The Company manages liquidity risk by continuously monitoring its actual and forecasted working capital requirements to ensure
there is capital to meet short-term and long-term obligations. As of October 31, 2021 and October 31, 2020, the Company had working capital
deficiency of $<span id="xdx_90B_ecustom--WorkingCapitalDeficit_iI_c20211031_z960RKazdmYc" title="Working capital deficit"><ix:nonFraction name="MLYF:WorkingCapitalDeficit" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,657,316</ix:nonFraction></span> and $<span id="xdx_904_ecustom--WorkingCapitalDeficit_iI_c20201031_zzJgIhsmFRe7" title="Working capital deficit"><ix:nonFraction name="MLYF:WorkingCapitalDeficit" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,392,189</ix:nonFraction></span>, respectively. As disclosed in <i>note 1 </i>of these Financial Statements, the ability of the
Company to continue as a going concern is dependent on many factors. The Company&#8217;s cash is primarily deposited in bank accounts
and held as deposits by certain related parties. The Company anticipates that its cash on hand and deposits, together with expected funds
raised from private placements and on exercises of common share purchase warrants and stock options, as well as debt financing, will
provide sufficient financial resources to carry out its operations through the next twelve months. However, additional funding will be
required. There can be no assurance that the Company will be able to raise the funds necessary to continue future operations. Liquidity
risk has been assessed as high.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_801_eus-gaap--SegmentReportingDisclosureTextBlock_z8G0PRbCCjug" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_zMjLwdF2u2c2">SEGMENTED INFORMATION</span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company focuses on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and
the development of a full-scale commercial magnesium production facility. The Company also owns mining claims for the exploration and
development of mineral property interests. Geographic information for the Company&#8217;s assets is as follows:</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z7XFaUR8ILtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none; text-align: justify"><span id="xdx_8B2_zQ0I3HIhtxYh" style="display: none">SCHEDULE
OF ASSETS INFORMATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">October 31, 2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">October 31, 2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Canada &#8211; property, plant and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211031__srt--StatementGeographicalAxis__country--CA_zenhG3vrOmYa" title="Property, plant and equipment" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_country_CA" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,546,383</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20201031__srt--StatementGeographicalAxis__country--CA_zIfs0D2pHuki" title="Property, plant and equipment" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_country_CA" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,436</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United States &#8211; property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211031__srt--StatementGeographicalAxis__country--US_zQQFzvdhdI23" title="Property, plant and equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,321</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20201031__srt--StatementGeographicalAxis__country--US_zGhqT8b0X5d9" title="Property, plant and equipment" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2428">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">United States &#8211; mineral property costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--MineralPropertiesNet_iI_c20211031__srt--StatementGeographicalAxis__country--US_zM1ExU4ilhR7" title="Assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2021-10-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--MineralPropertiesNet_iI_c20201031__srt--StatementGeographicalAxis__country--US_zJMGM5J60JQg" title="Mineral property costs" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2020-10-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset</span></td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_ecustom--PropertyPlantEquipmentsAndMineralPropertiesNet_iI_c20211031_zkvDNWmpXg35" title="Property, plant, equipment and mineral properties" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantEquipmentsAndMineralPropertiesNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,668,157</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_ecustom--PropertyPlantEquipmentsAndMineralPropertiesNet_iI_c20201031_zxA3Axekshj6" title="Property, plant, equipment and mineral properties" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantEquipmentsAndMineralPropertiesNet" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,889</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Canada &#8211; other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherAssets_iI_c20211031__srt--StatementGeographicalAxis__country--CA_z6viQmqZ0wph" title="Other assets" style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-10-31_country_CA" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,554,827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherAssets_iI_c20201031__srt--StatementGeographicalAxis__country--CA_zh7lXKpE0MIc" title="Other assets" style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2020-10-31_country_CA" format="ixt:numdotdecimal" decimals="0" unitRef="USD">533,815</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">United States &#8211; other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherAssets_iI_c20211031__srt--StatementGeographicalAxis__country--US_z1BGCFeqz1mi" title="Other assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-10-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,528</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherAssets_iI_c20201031__srt--StatementGeographicalAxis__country--US_zMzNGtoiACG7" title="Other assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2020-10-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,059</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OtherAssets_iI_c20211031_zOWAe6aa5nIc" title="Other assets" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,845,355</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherAssets_iI_c20201031_zJwy7PGtinq8" title="Other assets" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">535,874</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Assets_iI_c20211031_zqp69npvnzMd" title="Total Assets" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,513,512</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Assets_iI_c20201031_zWCf4Iz3Doaa" title="Total Assets" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">708,763</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zBpcD3YLo4a6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zOlB2pwV0KW8" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_829_zf7rDmv9rk8c">INCOME TAX</span></span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z0mNAb6Ynjfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
items resulting in the difference between the Company&#8217;s income tax rate and the federal statutory rate are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none; text-align: justify"><span id="xdx_8B6_zy0iXkXMdXi" style="display: none">SCHEDULE OF EFFECTIVE TAX RATES RECONCILIATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20201101__20211031_zJOvYcclomAf" style="font-weight: bold; text-align: right">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20191101__20201031_zLQNyWBBWhu9" style="font-weight: bold; text-align: right">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zwstuPZEdCa2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Loss for the year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,549,612</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,672,605</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Effective statutory rate</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20201101__20211031_zCuh97CWRH1a" title="Statutory rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33.02</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20191101__20201031_zRijRWvJCsT" title="Statutory rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">31.21</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zNQKVrgCsRf2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected income tax recovery at statutory rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,778,880</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,458,320</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxReconciliationDeductibleAndNondeductibleExpense_zxK4GZFy9OFe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net adjustment for deductible and non-deductible amounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:IncomeTaxReconciliationDeductibleAndNondeductibleExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,636,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:IncomeTaxReconciliationDeductibleAndNondeductibleExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,196</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IncomeTaxReconciliationOfForeignExchangeEffect_z51XmJYYMhk8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign exchange effect</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:IncomeTaxReconciliationOfForeignExchangeEffect" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,867</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:IncomeTaxReconciliationOfForeignExchangeEffect" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">175,597</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ztvpXK02sTF6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,152,485</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,383,721</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_zlYjU8jpdCwj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Deferred income tax provision (recovery)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2477">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2478">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zsuQJYmvM1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zps1GffFC1T4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s deferred tax assets and liabilities are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><span id="xdx_8BC_zQGxTUjsfdEi" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITY</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20211031_z5ffKYnYXdH1" style="font-weight: bold; text-align: right">2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20201031_zh1dqQVUKPag" style="font-weight: bold; text-align: right">2020</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_maDTALNzTUZ_zKZG9pZoCSYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Non-capital loss carry-forwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,340,578</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,600,561</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iNI_di_maDTALNzTUZ_zFvlgUvMIIse" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">159,673</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">123,561</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsLeaseLiability_iI_maDTALNzTUZ_zLgyjrX30LNa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DeferredTaxAssetsLeaseLiability" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,812</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DeferredTaxAssetsLeaseLiability" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,789</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsConvertibleDebenture_iI_maDTALNzTUZ_z0fBuD8fWyhd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible debenture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:DeferredTaxAssetsConvertibleDebenture" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">509,985</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2492">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsConvertibleDebentureAndDerivativeLiability_iI_maDTALNzTUZ_zJv02xBRcVS5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible debenture &#8211; derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DeferredTaxAssetsConvertibleDebentureAndDerivativeLiability" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,532,898</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2495">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DeferredTaxAssetsExplorationAndEvaluationAsset_iI_maDTALNzTUZ_zXKo3nu5qJ2i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exploration and evaluation asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DeferredTaxAssetsExplorationAndEvaluationAsset" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">359,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2498">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsShareIssueCost_iI_maDTALNzTUZ_zjf2ZV5IvDm2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Share issue costs</td><td>&#160;</td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2500">&#160;</span></td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DeferredTaxAssetsShareIssueCost" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,056</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNzTUZ_zVgk7LWWlfbh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,744,330</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,591,845</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNTI_di_mtDTALNzTUZ_zdkJ14HBArS2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Deferred income tax asset (liability)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2506">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2507">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zvRPElQayGrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_c20211031__srt--StatementGeographicalAxis__country--GB_zciObNEqBbul" title="Net operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-10-31_country_GB" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,439,000</ix:nonFraction></span> net operating losses in the US and $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20211030__srt--StatementGeographicalAxis__country--GB_z3ebSMIjz3I1" title="Net operating loss"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-10-30_country_GB" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,515,000</ix:nonFraction></span> in Canada that, under certain circumstances, can
be used to reduce the taxable income of future years. These losses expire at various dates through 2042.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN MAGNESIUM CORPORATION</b></span></p>
                         <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>For
the Years Ended October 31, 2021 and 2020</td>
  <td style="text-align: right; width: 40%"><img src="aud_004.jpg" alt="" style="height: 46px; width: 130px" /></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1.5pt solid">Expressed
in US Dollars, except where otherwise indicated</td>
  <td style="border-bottom: Black 1.5pt solid">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-11-012021-10-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_z8Piol2MqMld" style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82D_zm34PGRbGkk5">SUBSEQUENT EVENTS</span></span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
Subsequent to October 31, 2021, upon exercise of common share purchase warrants, the Company issued an aggregate <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Stock issued during period, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,159,448</ix:nonFraction></span> common shares
at a price CA$<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztX9kA0LiBpl" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-02-10_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_uCA_c20211101__20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqmECsxRUBxg" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">2,880,295</ix:nonFraction></span>, <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_pdd" title="Stock issued during period, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zH4ANjTerBI9" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> per share for gross proceeds
of CA$<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_uCA_c20211101__20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zHD6Rhw3XzH1" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">10,000</ix:nonFraction></span>, and <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_pdd" title="Stock issued during period, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,000</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_zdWPnfSDhWW6" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.30</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_uCA_c20211101__20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_zhjfjPYx6szj" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-02-10_us-gaap_SubsequentEventMember_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">9,000</ix:nonFraction></span>. A total of <span id="xdx_904_ecustom--ClassOfWarrantOrRightUnexercisedOfWarrantsOrRights1_c20220210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" title="Warrants unexercised"><ix:nonFraction name="MLYF:ClassOfWarrantOrRightUnexercisedOfWarrantsOrRights1" contextRef="AsOf2022-02-10_us-gaap_SubsequentEventMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,428,363</ix:nonFraction></span> warrants
expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer is eligible to receive up to <span id="xdx_904_ecustom--CommonStockIssuedAndOutstandingPercentage_iI_dp_c20180828__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkkxdRLkPTIj" title="Common stock issued and outstanding percentage"><ix:nonFraction name="MLYF:CommonStockIssuedAndOutstandingPercentage" contextRef="AsOf2018-08-28_custom_AgreementMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction>%</span> of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $<span id="xdx_902_eus-gaap--CommonStockValue_iI_pn6n6_c20180828__us-gaap--TypeOfArrangementAxis__custom--AgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember_zqlYv0b5qChk" title="Common stock value"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2018-08-28_custom_AgreementMember_us-gaap_CommonStockMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">5</ix:nonFraction></span> million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Stock issued during period, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012021-11-03_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,163,425</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzXkfRGskr3" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-11-03_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.65</ix:nonFraction></span> per share with a total fair value of CA$<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uCA_c20211101__20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCK8Kk7VZP24" title="Stock issued during period, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-012021-11-03_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">5,956,226</ix:nonFraction></span> (USD equivalent $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_uUSD_c20211101__20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZQL5vYLaqw6" title="Stock issued during period, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-012021-11-03_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,796,832</ix:nonFraction></span>) as share
issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iii]
On November 4, 2021, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20211101__20211104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebenturesMember_z45Lu3Re8Xpc" title="Stock issued during period, conversion units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2021-11-012021-11-04_us-gaap_SubsequentEventMember_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> units on partial conversion of the June 2021 Convertible Debenture, for a total of
<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20211101__20211104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zudDoeRaLCcb" title="Stock issued during period, conversion shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-11-012021-11-04_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> common shares, <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20211104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_pdd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-11-04_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> Class A Warrants exercisable at a price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_pdd" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-11-04_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span> until June 10, 2026, and <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20211104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_pdd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-11-04_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> Class B Warrants exercisable
at a price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_pdd" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-11-04_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction></span> until June 10, 2026. On December 13, 2021, the the Company issued a further <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20211212__20211213__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebenturesMember_zP313bJ16MY8"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2021-12-122021-12-13_us-gaap_SubsequentEventMember_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> units on partial conversion
of the June 2021 Convertible Debenture, for a total of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20211212__20211213__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbIl3LgQg8s5" title="Stock issued during period, conversion shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-12-122021-12-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> common shares, <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20211213__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_pdd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-12-13_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> Class A Warrants exercisable at a price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211213__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_pdd" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-13_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span>
until June 10, 2026, and <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20211213__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_pdd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-12-13_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> Class B Warrants exercisable at a price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20211213__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_pdd" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-13_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction></span> until June 10, 2026. On January 20, 2022, the the Company
issued a further <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220119__20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebenturesMember_zgEP7HIEzzUi"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-01-192022-01-20_us-gaap_SubsequentEventMember_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> units on partial conversion of the June 2021 Convertible Debenture, for a total of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20220119__20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEG3tkdvFfXc" title="Stock issued during period, conversion shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2022-01-192022-01-20_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> common shares,
<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_pdd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-20_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> Class A Warrants exercisable at a price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_pdd" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-20_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span> until June 10, 2026, and <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_pdd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-20_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> Class B Warrants exercisable at a price of
$<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zAsWzakVZx7d" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-20_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction></span> until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iv]
On November 26, 2021, the Company closed a non-brokered private placement and issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211125__20211126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Stock issued during period, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-252021-11-26_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,375,499</ix:nonFraction></span> units at a price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_c20211126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-11-26_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.55</ix:nonFraction></span> per unit for
gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20211125__20211126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-11-252021-11-26_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">756,524</ix:nonFraction></span>. Each unit consists of one common share and one common share purchase warrant entitling the holder thereof
to acquire a further common share at a price of $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20211126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ziCUr0fwqNZ" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-11-26_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction></span> for a period of one year from the date of closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[v]
On December 3, 2021, the Company granted <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20211202__20211203__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_pdd" title="Incentive stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-12-022021-12-03_us-gaap_SubsequentEventMember_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></span> incentive stock options pursuant to its 2021 Equity Incentive Plan to an employee. These
options are exercisable at a price of CA$<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_uCAPShares_c20211203__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zymPi7IanK1a" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-12-03_us-gaap_SubsequentEventMember_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.58</ix:nonFraction></span> per share for a period of <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dt_c20211202__20211203__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zQmb0LkxhZD1" title="Options exercisable term"><ix:nonNumeric contextRef="From2021-12-022021-12-03_us-gaap_SubsequentEventMember_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">five years</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[vi]
On December 13, 2021, the Company&#8217;s Form 10 Registration Statement filed with the US SEC was declared effective, and the Company
will be subject to the reporting requirements of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;).</span></p>

</ix:nonNumeric><p id="xdx_810_zfW8t99ooMTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
MAGNESIUM CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>Unaudited
Interim Condensed Consolidated Balance Sheets</b></span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_111_zJjIKvH1Cxj1" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20220131_zb2o9KHUyxe" style="font-weight: bold; text-align: center">January 31, 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20211031_zv3hpdOlIQya" style="font-weight: bold; text-align: center">October 31, 2021</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB_zNZDpWshmB1i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrentAbstract_i01B_zzkqKPpjk1Pa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCz4HB_maACzU8d_zK02SJ4FkPHe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; padding-left: 10pt">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 12%; text-align: center">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 16%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,522</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">462,360</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccountsReceivableNetCurrent_i02I_maCz4HB_maACzU8d_zGFfFyLOttmd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Amounts receivable</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">235,821</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,485</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PrepaidExpenseCurrent_i02I_maCz4HB_maACzU8d_zJVgwBd7gWX4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Prepayments</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,872</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DepositsAssetsCurrent_i02I_maCz4HB_maACzU8d_z7fOU6SKyUH4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Deposits held by related parties</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">8[a]</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:DepositsAssetsCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">565,741</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepositsAssetsCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_i02TI_mtACzU8d_maAzi7Q_zOjpyc2LwF3g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current assets</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,701,956</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,233,954</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsNoncurrentAbstract_i01B_zTcUpfHz8pJf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non-current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maCzKw1_maAzi7Q_z12Pnocif5Bc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Property, plant and equipment</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">4</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,159,244</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,574,704</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_maCzKw1_maAzi7Q_zEeUhFoxZFj8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Right-of-use assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">5</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">533,093</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">598,575</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--MineralPropertiesNet_i02I_maCzKw1_maAzi7Q_zgQ7SLW2lLrd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Mineral property costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">7</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--ReclamationDepositsNonCurrent_i02I_maCzKw1_maAzi7Q_zlQZap0INOk2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Reclamation deposits</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:ReclamationDepositsNonCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,752</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ReclamationDepositsNonCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,826</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--OtherDepositsNonCurrent_i02I_maCzKw1_maAzi7Q_zAzIvGucfc0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other deposits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OtherDepositsNonCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OtherDepositsNonCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Assets_i01TI_mtAzi7Q_zjem9jR24358" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL ASSETS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,500,498</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,513,512</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zaPoq2VptR5a" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrentAbstract_i01B_zFStqDij5SB7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maCz9qc_maLCz4vK_zPQBYwsA8qEl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,552,509</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,989,316</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DueToRelatedPartiesCurrent_i02I_maCz9qc_maLCz4vK_zycFRmxYSL29" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Due to related parties</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">8[b]</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,092,786</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,026,817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maLCzdMA_maLCz4vK_zUpkwoxvLwub" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Lease obligations &#8211; current</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">6</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,309</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,045</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--CurrentPortionProvisionForFlowThroughShareIssuances_i02I_maCz9qc_maLCz4vK_z38d0JC0Dbmb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Provision for flow through share issuances</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">11</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:CurrentPortionProvisionForFlowThroughShareIssuances" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227,140</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:CurrentPortionProvisionForFlowThroughShareIssuances" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">233,285</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ConvertibleDebentureCurrent_i02I_maCz9qc_maLCz4vK_zfLKtXqJRhK7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Convertible debenture</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">12</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:ConvertibleDebentureCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">221,599</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ConvertibleDebentureCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,807</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DerivativeLiabilityCurrent_i02I_maLCz4vK_zAKQ05qS5Uc2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Derivative liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">12[e]</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:DerivativeLiabilityCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,288,387</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2659">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrent_i02TI_pp0p0_mtLCz4vK_maLzVsy_zLX6u6TGXVbl" style="vertical-align: bottom; background-color: White">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Current liabilities</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,602,730</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,891,270</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_zRmDMT3Sx0w9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maCz52o_maLzVsy_zf26dvAHs1vf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Lease obligations &#8211; non-current</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">6</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">320,045</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">392,280</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--Liabilities_i01TI_mtLzVsy_maLASEzwD7_zYpMBhLvGQwj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,922,775</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,283,550</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockholdersEquityAbstract_i01B_zi1DazowxiLh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Shareholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockValue_i02I_pp0p0_maCzTny_maSEz7ab_zVLD0sgTbNr5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Capital stock Authorized: <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pn9n9_c20220131_z2cocNXNXFu4" title="Common stock, shares authorized"><span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pn9n9_c20211031_zD1wxlfOdpyh" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="-9" scale="9" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="-9" scale="9" unitRef="Shares">1</ix:nonFraction></ix:nonFraction></span></span> billion common stock at par value of $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220131_z0SJTbkgtaTj" title="Common stock, par value"><span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211031_zHfs5KJt4sh3" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> Issued and paid: <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_c20220131_zWcXjCQVWfX2" title="Common stock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20220131_zCB78qqjTSt" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">421,871,770</ix:nonFraction></ix:nonFraction></span></span> (2021 &#8211; <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20211031_zJVwnW5wdx6b" title="Common stock, shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20211031_zu0Ia7ZW87x1" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">392,943,398</ix:nonFraction></ix:nonFraction></span></span>)</td><td><b>&#160;</b></td>
    <td style="text-align: center"><b>13</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><b><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,637,228</ix:nonFraction></b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,842,167</ix:nonFraction> </td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_maCzXDE_maSEz7ab_zSL4djzXbiB1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Additional paid-in-capital</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">13</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,684,015</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,186,480</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CommonStockSharesSubscriptions_i02I_maCzXDE_maSEz7ab_z2irlt9F1Xhe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Obligations to issue shares</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">13</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,741</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maCzXDE_maSEz7ab_zPT9z7G3O861" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">285,889</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,109</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzXDE_maSEz7ab_z6UqyFK2mLd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt">Deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">67,076,150</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,129,621</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquity_i02TI_mtSEz7ab_maLASEzwD7_zyucozUp4jzi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total shareholders&#8217; deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,422,277</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,770,038</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzwD7_zAfyDlOWLIhf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,500,498</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,513,512</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nature of operations and going concern
<i>[note 1]</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent liabilities and commitments
<i>[note 9]</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent events <i>[note 17]</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
MAGNESIUM CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>Unaudited
Interim Condensed Consolidated Statements of Loss and Comprehensive Income</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_113_zzutPm3ph7pg" summary="xdx: Statement - Consolidated Statements of Loss and Comprehensive Income (Loss)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20211101__20220131_zZ77TjDrmMI5" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20201101__20210131_zF4Ww61p100d" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended January 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CostsAndExpensesAbstract_iB_zEjlAyS0doO6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Expenses (recoveries)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--BankCharges_i01_maCzfEG_maCAEz21H_zULHUhjbeNzf" style="vertical-align: bottom; background-color: White">
    <td style="width: 54%; text-align: left; padding-left: 10pt">Bank charges</td><td style="width: 2%">&#160;</td>
    <td style="width: 12%; text-align: center">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MLYF:BankCharges" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,264</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="MLYF:BankCharges" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,562</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--BusinessDevelopment_i01_maCAEz21H_zupnkXDiTUyd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Business development</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessDevelopment" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,552</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2720">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ComputerSystemAndSoftwareExpenses_i01_maCzfEG_maCAEz21H_zsqb9smEmA9e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Computer system and software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ComputerSystemAndSoftwareExpenses" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,651</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ComputerSystemAndSoftwareExpenses" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,089</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ManagementFeeExpense_i01_maCzfEG_maCAEz21H_zBxZNipbToB2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Consulting and management fees</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">8[d]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ManagementFeeExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">197,927</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ManagementFeeExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,101</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Depreciation_i01_maCzfEG_maCAEz21H_zz2u0Qwfsxhf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Depreciation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">4, 5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,340</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,326</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--EngineeringExpenses_i01_maCzRNE_maCAEz21H_zgUTF0GAO4Gj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Engineering expenses (recoveries)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:EngineeringExpenses" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,373</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:EngineeringExpenses" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">63,612</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i01N_di_msCzRNE_msCAEz21H_zUBJJa1X5Zcg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Foreign exchange loss</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">167,474</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">49,920</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AccretionExpense_i01_maCzfEG_maCAEz21H_zg3MzGReTpaa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Interest and accretion</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">12</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">322,280</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,574</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--InvestorRelationsExpense_i01_maCzfEG_maCAEz21H_zQSgEKJ7P0S" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Investor relations</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:InvestorRelationsExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,378</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:InvestorRelationsExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,876</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LegalFees_i01_maCzfEG_maCAEz21H_zNRCATGM65I7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Legal and professional fees</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">606,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,744</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzfEG_maCAEz21H_zPLILguE6DA7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Office and general</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,080</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,454</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--FacilitiesAndRentExpenses_i01_maCzfEG_maCAEz21H_zzY7q0yhSVBi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Facilities and rent</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:FacilitiesAndRentExpenses" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,669</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:FacilitiesAndRentExpenses" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,085</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LaborAndRelatedExpense_i01_maCzfEG_maCAEz21H_zqOQRclTcgFg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Salaries and benefits</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">8[c]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">995,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,648</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ShareBasedCompensation_i01_maCzfEG_maCAEz21H_zwLvzLqD6pGb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Stock-based compensation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">13[d]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,575</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,048,990</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ShareholderCommunicationsExpense_i01_maCzfEG_maCAEz21H_zHy6qQux0iv2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Shareholder communications</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ShareholderCommunicationsExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,201</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2759">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--SubsidiesAndRecoveries_i01N_di_msCzfEG_msCAEz21H_zC5BJqGT6LMh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Subsidies and recoveries</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:SubsidiesAndRecoveries" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,102</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2762">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--TransferAgentAndRegulatoryFees_i01_maCzfEG_maCAEz21H_zjnN80r8eCyg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Transfer agent and regulatory fees</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:TransferAgentAndRegulatoryFees" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,017</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:TransferAgentAndRegulatoryFees" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,883</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TravelAndEntertainmentExpense_i01_maCzfEG_maCAEz21H_z0hulAqgY8m3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Travel expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:TravelAndEntertainmentExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,116</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:TravelAndEntertainmentExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">836</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CostsAndExpenses_i01T_mtCAEz21H_msNILzeDv_zIQZvqM5yyG6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
    and Expenses</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,045,185</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,108,476</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zRQIGoXYxWD5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other items</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DerivativeGainLossOnDerivativeNet_i01_maCz9pw_maNIEzlUy_zdNJgwj5YO2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Change in fair value of derivative liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">12</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,559,791</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,534</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--GainLossOnRecognitionOfDebtHostLiability_i01_maCz9pw_maNIEzlUy_zHstE0bRQrW9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Loss on recognition of debt host liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">12</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:GainLossOnRecognitionOfDebtHostLiability" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">341,553</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2780">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpense_i01T_mtNIEzlUy_maNILzeDv_zKNlm5uKc41e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonoperating
    Income (Expense)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,901,344</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,534</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_iT_mtNILzeDv_maCINOTzkSX_zPodoCSGPkI8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net loss for the period</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,946,529</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,123,010</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ComprehensiveIncomeNetOfTaxAbstract_iB_zS4hTP6roLma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other comprehensive gain (loss)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_i01_maCINOTzkSX_z6xFkJmt7AK6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">164,780</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,762</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ComprehensiveIncomeNetOfTax_i01T_mtCINOTzkSX_zEwpN80wFST8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Comprehensive loss for the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,781,749</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,210,772</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_zaYL7kQd3Rj3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Basic and diluted loss per common share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.04</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z3L2gdHwl405" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Weighted average number of common shares outstanding &#8211; basic and diluted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">410,834,167</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">329,203,182</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
MAGNESIUM CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>Unaudited
Interim Condensed Consolidated Statements of Shareholders&#8217; Deficit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_114_zCL5mRM3aH31" summary="xdx: Statement - Consolidated Statements of Shareholders&apos; Deficit" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z8C2N5YB1GZ2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zHXfHUQGrZX8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_custom--ObligationToIssueSharesMember_zJkIBsr4B5F" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zzjsN9PNnmGi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z41cMpJtpphf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_z0RVxptp4Lw9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common shares</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>paid-in capital</b></span></p></td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Obligation to issue shares</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated other comprehensive income (loss)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated deficit</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Shareholders&#8217; deficit</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_43C_c20201101__20210131_eus-gaap--StockholdersEquity_iS_z8aMI65zK0td" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; font-weight: bold">Balance, October 31, 2020</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20201101__20210131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmBhVkA8Pywi" title="Beginning balance, shares" style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">323,419,527</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,322,022</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,182,037</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">596,872</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">399,175</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,580,009</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 5%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,079,903</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zD9hshjyv0c2" style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left">Shares issued pursuant to <br />private placements [note 13[b]]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201101__20210131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIVKCXqyvdn5" title="Shares issued pursuant to private placements, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-11-012021-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,319,388</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,853,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2813">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-01-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">596,872</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2815">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2816">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,256,934</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_z3og8OVVrFqa" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-style: italic; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued on warrants exercised <i style="display: none">[notes 12[e] and 13[b]]</i></span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Shares issued pursuant to private placements, shares" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_zn2d9ibaE6F4" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-style: italic; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
issued on warrants exercised, shares</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Shares issued pursuant to private placements, shares" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zZQUiikCzQtj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-style: italic; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued for convertible debenture <i style="display: none">[notes 12[c] and 13[b]]</i></span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Shares issued pursuant to private placements, shares" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_zV6JMMzijeck" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-style: italic; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
issued for convertible debenture, shares</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Shares issued pursuant to private placements, shares" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--SharesIssuedForFindersFeesValue_zL7Wri3zjdR4" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-style: italic; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued for finder&#8217;s fees <i style="display: none">[note 13[b]]</i></span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Shares issued pursuant to private placements, shares" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--SharesIssuedForFindersFeesShares_zh8UFtxXNB13" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-style: italic; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
issued for finder&#8217;s fees, shares</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Shares issued pursuant to private placements, shares" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuedForCosts_zUn8JxrmKytb" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-style: italic; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issue costs <i style="display: none">[note 13[b]]</i></span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td title="Shares issued pursuant to private placements, shares" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zmCdZxeRky2e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation <i>[note 13[d]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2870">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-01-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,048,990</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2872">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2873">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2874">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,048,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--EffectsOfChangeInFunctionalCurrencyOnConvertibleDebentures_zf8AMpoDQH67" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Effects of change in functional currency on convertible debentures <i style="display: none">[notes 12[d]]</i></span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--EffectsOfChangeInFunctionalCurrencyOnBrokerWarrants_zuXJKjsFtSW9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Effects of change in functional currency on broker warrants <i style="display: none">[notes 12[e]]</i></span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--ObligationToIssueShareSubscriptions_zHKPjqm01cB5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Share subscriptions <i style="display: none">[note 13[f]]</i></span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zFrwhRkHuFza" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign currency translation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2898">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2899">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2900">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,762</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2902">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,762</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zrxSqf1ZtQ8e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss for the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2905">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2906">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2907">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2908">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-01-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,123,010</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,123,010</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20201101__20210131_eus-gaap--StockholdersEquity_iE_zlVlbRi4yVxc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20201101__20210131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zepCKuZGZ9Sd" title="Ending balance, shares" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">341,738,915</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,175,828</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-01-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,231,027</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2914">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">311,413</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-01-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,703,019</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,984,751</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20211101__20220131_eus-gaap--StockholdersEquity_iS_zqiDF2dx0Uha" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance, October 31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoOwcHQHNnG3" title="Beginning balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">392,943,398</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,842,167</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,186,480</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,109</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,129,621</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,770,038</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zONPGlFmnVHa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Shares issued pursuant to <br />private placements [note 13[b]]</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcnESQ3sWyVi" title="Shares issued pursuant to private placements, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,375,499</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">756,524</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2931">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">209,827</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2933">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2934">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,697</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_zWwIvvhynyo2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued on warrants exercised <i>[notes 12[e] and 13[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMYd8fFxTgWi" title="Shares issued on warrants exercised, shares" style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,389,448</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,774,998</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2940">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2941">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2942">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2943">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,774,998</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zBddB6KC6xMf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued for convertible debenture <i>[notes 12[c] and 13[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmJj1K7OSFO6" title="Shares issued for convertible debenture, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2949">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2950">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2951">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2952">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--SharesIssuedForFindersFeesValue_zEi2Gsy18Wr9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued for finder&#8217;s fees <i>[note 13[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--SharesIssuedForFindersFeesShares_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfbshDEQJY72" title="Shares issued for finder&apos;s fees shares" style="text-align: right"><ix:nonFraction name="MLYF:SharesIssuedForFindersFeesShares" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,163,425</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2957">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2958">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2959">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2960">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2961">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2962">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuedForCosts_z3WfOasxK6ta" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issue costs <i>[note 13[b]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,461</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2967">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2968">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2969">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2970">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:StockIssuedDuringPeriodValueIssuedForCosts" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,461</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zx782aY800il" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation <i>[note 13[d]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2973">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,575</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2975">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2976">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2977">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,575</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--EffectsOfChangeInFunctionalCurrencyOnConvertibleDebentures_zsvVpSWQqAHb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effects of change in functional currency on convertible debentures <i>[notes 12[d]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2980">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnConvertibleDebentures" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,370,159</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2982">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2983">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2984">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnConvertibleDebentures" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,370,159</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--EffectsOfChangeInFunctionalCurrencyOnBrokerWarrants_z9U5lNwsErb6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effects of change in functional currency on broker warrants <i>[notes 12[e]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2987">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnBrokerWarrants" contextRef="From2021-11-012022-01-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,198</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2989">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2990">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2991">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrencyOnBrokerWarrants" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,198</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_ecustom--ObligationToIssueShareSubscriptions_zQssbr9yZAW2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share subscriptions <i>[note 13[f]]</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2994">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2995">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2021-11-012022-01-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,741</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2997">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2998">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ObligationToIssueShareSubscriptions" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,741</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zAUV8FaLdi12" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign currency translation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3001">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3002">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3003">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2021-11-012022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">164,780</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3005">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">164,780</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zG2KAFcaPl6e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss for the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3008">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3009">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3010">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3011">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-11-012022-01-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,946,529</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,946,529</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_437_c20211101__20220131_eus-gaap--StockholdersEquity_iE_zaQZD1M6eFtf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmKFrj2E8dpc" title="Ending balance, shares" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">421,871,770</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,637,228</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-01-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,684,015</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-01-31_custom_ObligationToIssueSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,741</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-01-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">285,889</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-01-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">67,076,150</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,422,277</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
MAGNESIUM CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>Unaudited
Interim Condensed Consolidated Statements of Cash Flows</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_112_zSfqEAuDwUVi" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20211101__20220131_z3bkw0kgdwM2" style="font-weight: bold; text-align: center">2022</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20201101__20210131_zbYzSNWFXol9" style="font-weight: bold; text-align: center">2021</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended January 31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2022</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2021</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zdzUqAm1jRf2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_i01_maCzEO9_maNCPBUzKrE_zjKVe5VlpAdh" style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Net loss for the period</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,946,529</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,123,010</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zaVHcYbHAGe2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Add (subtract) items not affecting cash:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--AccruedInterestAndAccretion_i02_maCzHg9_maNCPBUzKrE_zSY8bkC61hl1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued interest and accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:AccruedInterestAndAccretion" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,773</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:AccruedInterestAndAccretion" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,803</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AmortizationOfDebtDiscountPremium_i02_maNCPBUzKrE_zXKS0zUwHaGg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amortization of debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,034</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3037">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DerivativeGainLossOnDerivativeNet_i02N_di_msCzHg9_msNCPBUzKrE_zsfzyy4RWuUb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,559,791</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,534</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--GainLossOnRecognitionOfDebtHostLiability_i02N_di_msCzHg9_msNCPBUzKrE_zZnZocUup4i6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on recognition of debt host liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:GainLossOnRecognitionOfDebtHostLiability" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">341,553</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3043">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i02_maCzHg9_maNCPBUzKrE_z1JIFKwgobje" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,434</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,039</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_maCzHg9_maNCPBUzKrE_zvGGec7Dx9Sg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation of right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,906</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,287</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ForeignCurrencyTransactionGainLossUnrealized_i02N_di_msCzEO9_msNCPBUzKrE_zKkNfX4x8w4g" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Foreign exchange loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">153,408</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,213</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--InterestExpenseOnLeaseObligations_i02_maCzHg9_maNCPBUzKrE_zgDiWW8cs4H6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest expense on lease obligations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:InterestExpenseOnLeaseObligations" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,240</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:InterestExpenseOnLeaseObligations" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,700</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensation_i02_maCzHg9_maNCPBUzKrE_zGrdVLG7pGfh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,575</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,048,990</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zGrFY7qzCpj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in non-cash working capital items relating to operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02N_di_msCzHg9_msNCPBUzKrE_z1Y1ujfMlxx9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Amounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">88,738</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,694</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_di_msCzHg9_msNCPBUzKrE_zfcjO3kZDm72" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Prepayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,266</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,380</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDepositOtherAssets_i02N_di_msCzHg9_msNCPBUzKrE_zEk1mQVcNQ6e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deposits held by related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDepositOtherAssets" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,521</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3070">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i02_maCzHg9_maNCPBUzKrE_zUmufCGaisz1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">619,673</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,196</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i02_maCzHg9_maNCPBUzKrE_zWimqB5d3kIe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Due to related parties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,233</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">958</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzKrE_maCCERCz6tw_zCdqtWYgy581" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,798,902</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">990,364</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zgDkmuQwyOad" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCznoU_msNCPBUzHnW_zeBuZ64g8Fsl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Purchase of property, plant and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">687,385</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,559</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzHnW_maCCERCz6tw_zczIRbIDeol6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash used in investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">687,385</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">167,559</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zrIzvBkPgtPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maCzn59_zpjgHSuVRtmg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of shares, net of share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,804,182</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,256,934</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromShareSubscriptions_i01_maCzn59_z7NyljHxFFZf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from share subscriptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:ProceedsFromShareSubscriptions" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,741</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3097">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RepaymentsOfDebt_i01N_di_msCzn59_z58gNNzX7cC4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Payments of promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3099">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,202</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--RepaymentsOfLeaseObligations_i01N_di_msCzn59_zVyWOEG08Wy9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Payments of lease obligations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:RepaymentsOfLeaseObligations" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,636</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:RepaymentsOfLeaseObligations" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,310</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzn59_maCzVhU_maCCERCz6tw_zS7tgZFBW2s5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash provided by financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,804,287</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,180,422</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCCERCz6tw_zNun1u5MFkpc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Change in cash for the period</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">318,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,499</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zsxsV9c19i81" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Cash, beginning of the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">462,360</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,571</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_zXXs9lWbRWY9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Effect of foreign exchange on cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,838</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,320</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zPLP532MEZLh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cash, end of the period</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,522</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,390</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_04D_c20211101__20220131_zseGZs42qZyj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
MAGNESIUM CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ag_001"></span><span id="a_007"></span>Notes
to Unaudited Interim Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:NatureOfOperations"><p id="xdx_80F_eus-gaap--NatureOfOperations_zUbstPxjROk3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span id="xdx_821_zGSrCLwHAA3f">NATURE OF OPERATIONS AND GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
Magnesium Corporation (the &#8220;Company&#8221;, or &#8220;WMC&#8221;) was incorporated under the laws of British Columbia on March
24, 1966. On May 14, 2019, the Company discontinued from the jurisdiction of the Business Corporations Act (British Columbia) and domesticated
under the General Corporation Law of the State of Delaware under the name &#8220;Western Magnesium Corporation&#8221;. The Company is
a reporting issuer in Canada and in the United States, listed for trading in Canada on the TSX Venture Exchange (the &#8220;TSX-V&#8221;)
under the symbol &#8220;WMG.V&#8221;, in the United States on the OTCQB tier of the OTC Markets (the &#8220;OTCQB&#8221;) under the symbol
&#8220;MLYF&#8221;, and in Germany on the Frankfurt Stock Exchange under the symbol &#8220;3WM&#8221;. The Company has developed proprietary
magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium metal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, the Company had an accumulated deficit of $<span id="xdx_903_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220131_z6ZWilqcsCE7"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">67,076,150</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(October 31, 2021 &#8211; $<span id="xdx_908_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211031_zYRmsT3JyeXe"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">52,129,621</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
and working capital deficiency of $<span id="xdx_902_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20220131_zmdOQOpB5A4a"><ix:nonFraction name="MLYF:WorkingCapitalDeficit" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,900,774</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(October 31, 2021 &#8211; $<span id="xdx_90A_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20211031_zSYB84tL6R3l"><ix:nonFraction name="MLYF:WorkingCapitalDeficit" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,657,316</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).
For the three months ended January 31, 2022, the Company reported a comprehensive loss of $<span id="xdx_902_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pp0p0_c20211101__20220131_zr7qNMQxZFp4"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,781,749</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2021 &#8211; $<span id="xdx_906_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pp0p0_c20201101__20210131_zmoGEo26qs54"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,210,772</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).
The Company is considered to be in the development stage. It has not yet achieved profitable operations and expects to incur further
losses in the development of its business. The Company has financed its activities and operations through equity issuances and debt financing
and expects to continue to do so to the extent such instruments are issuable under terms acceptable to the Company and until such time
as its operations provide positive cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated interim financial statements (the &#8220;Interim Financial Statements&#8221;) have been prepared under
the assumption that the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will
be able to meet its obligations and continue its operations for the foreseeable future and be able to realize its assets and discharge
its liabilities and commitments in the normal course of business. Management believes that the going concern assumption is appropriate
for these Interim Financial Statements based on its continuing ability to raise financings through share and debt issuances. If future
financing is unavailable or if for any reason the Company is unable to continue as a going concern, it could impact the Company&#8217;s
ability to realize its assets at their recognized values and to meet its obligations in the ordinary course of business at the amounts
stated in these Interim Financial Statements. These Interim Financial Statements do not give effect to adjustments that would be necessary
to the carrying values and classifications of assets and liabilities should the Company be unable to continue as a going concern. If
the going concern assumption is not used, the adjustments required to report the Company&#8217;s assets and liabilities on a liquidation
basis could be material to these Interim Financial Statements. These factors indicate the existence of a material uncertainty that cast
substantial doubt on the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the World Health Organization declared COVID-19 a global pandemic. In order to combat the spread of COVID-19, governments
worldwide, including the Unites States and Canada, have enacted emergency measures including travel bans, legally enforced or self-imposed
quarantine periods, social distancing and business and organization closures. These measures have adversely affected workforces, economies,
and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant but could affect
the Company&#8217;s ability to raise financings in the future and restrict travel. Management continues to monitor the situation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:BasisOfAccounting"><p id="xdx_807_eus-gaap--BasisOfAccounting_zM0XFBYygprc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_821_zONFpXeSZjI3">BASIS OF PRESENTATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Interim Financial Statements comprise the financial statements of Western Magnesium Corporation and its wholly owned subsidiaries, Western
Magnesium Corp., incorporated in Nevada, United States and Western Magnesium Canada Corporation, incorporated in British Columbia, Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]
Accounting standards</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying Interim Financial Statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America (&#8220;US GAAP&#8221;) on the basis that the Company will continue as a going concern, which assumes
that the Company will be able to meet its obligations and continue its operations for the next year. Realization values may be substantially
different from carrying values as shown and these Financial Statements do not give effect to adjustments that would be necessary to the
carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Interim Financial Statements have been prepared on a historical cost basis except for financial instruments that have been measured at
fair value. In addition, these Interim Financial Statements have been prepared using the accrual basis of accounting, except for cash
flow information. They do not include all the information required for full annual financial statements, and should be read in conjunction
with the Company&#8217;s audited consolidated financial statements and the notes thereto for the year ended October 31, 2021 (the &#8220;Fiscal
2021 Financial Statements&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]
Functional and presentation currency</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
Interim Financial Statements are presented in United States dollars (&#8220;US dollars&#8221; or &#8220;US$&#8221;), except where otherwise
indicated. The functional currency of each entity of the Company is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Functional
    Currency</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Corporation</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States dollars </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Corp.</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    States dollars</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Western
    Magnesium Canada Corporation</span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian
    dollars (&#8220;CA$&#8221;)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended January 31, 2022, significant changes in economic facts and circumstances have occurred in Western Magnesium Corporation&#8217;s
operations which resulted in the change of its functional currency to the United States dollars from the Canadian dollars effective November
1, 2021. For both monetary and non-monetary assets and liabilities, translated balances at the end of the prior period become the new
accounting basis. The rate on the date of change becomes the historical rate at which non-monetary assets and liabilities are translated
in subsequent years. There is no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded cumulative
translation adjustments are not reversed. Effects of change in functional currency included the reclassifications of convertible debentures
and warrants and broker warrants <i>[notes 12[d] and [e]]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounts of the Company&#8217;s subsidiary Western Magnesium Canada Corporation have been translated to United States dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]
Critical accounting estimates and judgments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Estimates and Assumptions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of these Interim Financial Statements in accordance with US GAAP requires the Company to make estimates and assumptions concerning
the future. Management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors,
including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted
for prospectively in the period in which the estimates are revised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
and assumptions where there is potential risk of material adjustments to assets and liabilities in future accounting periods include
the useful lives of property, plant and equipment, recoverability of the carrying value of exploration and evaluation assets, fair value
measurements for financial instruments, discount rates for leases, recoverability and measurement of deferred tax assets and liabilities,
and contingent liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant
Judgments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of these Interim Financial Statements in accordance with US GAAP requires the Company to make judgments, apart from those
involving estimates, in applying accounting policies. The most significant judgments in applying the Company&#8217;s Interim Financial
Statements include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    assessment of the Company&#8217;s ability to continue as a going concern and whether there are events or conditions that may give
    rise to substantial doubt;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    there are indicators of impairment of the Company&#8217;s exploration and evaluation assets and other non-current assets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    classification of financial instruments; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determination
    of functional currency.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"><p id="xdx_801_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_zNSaklZMewwa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_825_zjZbWRRcN9n3">RECENT ACCOUNTING PRONOUNCEMENTS</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Accounting Standards Adopted During the Periods</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;),
which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general
principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for
fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Effective
November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to these Interim Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU 2020-01, Investments &#8211; Equity Securities (Topic 321), Investments &#8211; Equity Method and Joint
Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#8220;ASU 2020-01&#8221;), which is intended to clarify the interactions
of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic
323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is effective for
fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Effective
November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to these Interim Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Accounting Standards Not Yet Adopted</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
&#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;). ASU 2020-06 eliminates the beneficial conversion
and cash conversion accounting models for convertible instruments and supersedes the respective guidance within ASC 470-20 and ASC 740-10-55-51,
which will result in more instruments to be accounted for as a single instrument rather than having their proceeds allocated between
liability and equity accounting units. As smaller reporting companies as defined by the United States Securities and Exchange Commission
(the &#8220;SEC&#8221;), ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those
fiscal years, with early adoption permitted. The Company is currently evaluating the effect of adopting these updates on its financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zJYMK7RUMrY" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82B_zfHowx19ivk6">PROPERTY, PLANT AND EQUIPMENT</span></b></span></p>



<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_892_eus-gaap--PropertyPlantAndEquipmentTextBlock_zKnUgrTO2EBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B2_zxU4uWfrgev1" style="display: none">SCHEDULE
OF PROPERTY, PLANT AND EQUIPMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--PropertyPlantAndEquipmentByTypeAxis_us-gaap--ComputerEquipmentMember_zYjeHQc3Nxn" style="font-weight: bold; text-align: center">Computer Equipment</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--PropertyPlantAndEquipmentByTypeAxis_us-gaap--FurnitureAndFixturesMember_ze3WuvQ3nQ61" style="font-weight: bold; text-align: center">Furniture</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--PropertyPlantAndEquipmentByTypeAxis_us-gaap--LeaseholdImprovementsMember_zdzyNJvnRyJl" style="font-weight: bold; text-align: center">Leasehold Improvement</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--PropertyPlantAndEquipmentByTypeAxis_custom--FurnaceAndPlantEquipmentMember_zoMXsxjncZNl" style="font-weight: bold; text-align: center">Furnace &amp; Plant Equipment</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BE_us-gaap--PropertyPlantAndEquipmentByTypeAxis_us-gaap--VehiclesMember_zkOlBT3eM5W1" style="font-weight: bold; text-align: center">Vehicle</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BE_zPpdkS6NEP65" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_437_c20201101__20211031_eus-gaap--PropertyPlantAndEquipmentGross_iS_zaJ9WnY7Nlyc" style="vertical-align: bottom; background-color: White">
    <td style="width: 40%">Balance, October 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,318</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,916</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,610</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,413</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3140">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,257</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentAdditions_zw6mneXz6YB8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,955</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,510</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,257</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,278,205</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3147">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,496,927</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PropertyPlantAndEquipmentWriteOffOfEquipment_ze0hAf4wWGwl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Write-off of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,245</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3151">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3152">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3153">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3154">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentWriteOffOfEquipment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,245</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_ecustom--PropertyPlantAndEquipmentForeignExchangeEffect_zuhaOGrGRX6k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,116</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,614</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,108</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3161">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,439</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20211101__20220131_eus-gaap--PropertyPlantAndEquipmentGross_iS_zEiNVGlxHape" style="vertical-align: bottom; background-color: White">
    <td>Balance, October 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,629</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,481</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,344,726</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3168">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,647,378</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20211101__20220131_eus-gaap--PropertyPlantAndEquipmentGross_iS_zMMrFQEmVZti" style="display: none; vertical-align: bottom; background-color: White">
    <td>Cost, Beginning Balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,629</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,481</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,344,726</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3175">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,647,378</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentAdditions_z8RIgZgLYtV" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3178">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2021-11-012022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,171</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2021-11-012022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,932</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2021-11-012022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">634,067</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2021-11-012022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,215</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentAdditions" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">687,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--PropertyPlantAndEquipmentForeignExchangeEffect_zPdQfCSJ9gDl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3185">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2021-11-012022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">230</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2021-11-012022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,611</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2021-11-012022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">49,144</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2021-11-012022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">136</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:PropertyPlantAndEquipmentForeignExchangeEffect" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">53,121</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_436_c20211101__20220131_eus-gaap--PropertyPlantAndEquipmentGross_iE_z7J6c3VKiDFc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,629</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,483</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,802</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,929,649</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,079</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,281,642</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20211101__20220131_eus-gaap--PropertyPlantAndEquipmentGross_iE_z7Gd5dbM66Gg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost, Ending Balance</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,629</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,483</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,802</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,929,649</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,079</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,281,642</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Accumulated Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201101__20211031_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_zRX9VysvrEH1" style="vertical-align: bottom; background-color: White">
    <td>Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,326</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,818</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3209">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3210">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,821</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DepreciationAndAmortization_ztDvEB4mRA5c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,907</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,443</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,971</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3217">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,148</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment_zGoCDjCCuVpl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Write-off of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,057</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3221">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3222">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3223">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3224">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationWriteOffOfEquipmentPropertyPlantAndEquipment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,057</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1_zzniVLjSf3j9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,294</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">745</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">502</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">221</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3231">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,762</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_435_c20211101__20220131_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_zMxE88Zp6o4e" style="vertical-align: bottom; background-color: White">
    <td>Balance, October 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,821</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,514</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,147</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,192</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3238">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,674</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20211101__20220131_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_zbJj2gS3kWvk" style="display: none; vertical-align: bottom; background-color: White">
    <td>Accumulated Depreciation, Beginning Balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,821</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,514</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,147</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,192</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3245">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,674</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DepreciationAndAmortization_zRXWUV40Z5ng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-11-012022-01-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,794</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-11-012022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-11-012022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,656</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-11-012022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-11-012022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">730</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,434</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1_zjgYyQbKMw0g" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3255">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2021-11-012022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">35</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2021-11-012022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">230</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2021-11-012022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">442</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2021-11-012022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:AccumulatedDepreciationDepletionAndAmortizationForeignExchangeEffectPropertyPlantAndEquipment1" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">710</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20211101__20220131_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_zFNBawrGGT76" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,615</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,359</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,573</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,124</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">727</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,398</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_439_c20211101__20220131_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_zi92O8gEMlCk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Accumulated Depreciation, Ending Balance</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,615</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,359</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,573</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,124</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">727</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,398</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Net Book Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_c20201031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,641</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20201031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,590</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20201031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,792</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20201031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnaceAndPlantEquipmentMember_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,413</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20201031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" title="Net Book Value" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3284">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_c20201031_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">79,436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, October 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,808</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,028</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_c20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,334</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnaceAndPlantEquipmentMember_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,330,534</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_c20211031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" title="Net Book Value" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3296">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20211031_pp0p0" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,574,704</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">73,014</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,124</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">139,229</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnaceAndPlantEquipmentMember_pp0p0" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31_custom_FurnaceAndPlantEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,881,525</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,352</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220131_pp0p0" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,159,244</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zmH5SGWFkrfl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="MLYF:RightOfUseAssetsDisclosureTextBlock"><p id="xdx_801_ecustom--RightOfUseAssetsDisclosureTextBlock_z3LDmD4gMNPl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
<span id="xdx_821_zk3tJregpKU5">RIGHT-OF-USE ASSETS</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, the right-of-use assets are leases for the Company&#8217;s corporate offices in Vancouver, British Columbia and
McLean, Virginia, and its research and development pilot plant located in Burnaby, British Columbia. These leases terminate on March
31, 2023, February 28, 2025 and September 30, 2023, respectively. The lease for the Company&#8217;s office in Las Vegas, Nevada ended
on May 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="MLYF:ScheduleOfRightOfUseAssetsTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfRightOfUseAssetsTableTextBlock_z2GOHR6OYj5i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zunzxytVBKDf" style="display: none">SCHEDULE
OF RIGHT-OF-USE ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BE_us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis_custom--VancouverOfficeMember_zrTz0ao8iH6c" style="font-weight: bold; text-align: center">Vancouver Office</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis_custom--VirginiaOfficeMember_zRBOljiqnZV5" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Virginia</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office</b></span></p></td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis_custom--NevadaOfficeMember_z87j21lEP9ze" style="font-weight: bold; text-align: center">Nevada Office</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis_custom--PilotPlantMember_zzP2C3aZ6Xjj" style="font-weight: bold; text-align: center">Pilot Plant</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B2_zia0ZAof1KDj" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetCost_iS_z7MnsVh1cZ53" style="vertical-align: bottom; background-color: White">
    <td style="width: 35%">Balance, October 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,701</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3317">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,856</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,949</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">440,506</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_z6FXJ5FpOql" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">287,847</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3324">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3325">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">379,084</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset_zT7wprmcLhE4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,943</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,544</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,724</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,997</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,208</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20211101__20220131_ecustom--OperatingLeaseRightOfUseAssetCost_iS_z6QYhwRlTitl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, October 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,881</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292,391</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,946</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">858,798</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20211101__20220131_ecustom--OperatingLeaseRightOfUseAssetCost_iS_z36HVIfHEs9d" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none">Cost, beginning balance</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,881</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292,391</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">384,946</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">858,798</ix:nonFraction></td><td style="display: none; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset_zIoXWWdN4OGa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3346">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3347">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3348">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2021-11-012022-01-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,139</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAsset" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,139</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_433_c20211101__20220131_ecustom--OperatingLeaseRightOfUseAssetCost_iE_zFy4cgI6Pq27" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,881</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292,391</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,807</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">848,659</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20211101__20220131_ecustom--OperatingLeaseRightOfUseAssetCost_iE_zV73j2scBSXl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; font-weight: bold; padding-bottom: 1.5pt">Cost, ending balance</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,881</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292,391</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,807</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetCost" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">848,659</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Accumulated Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_437_c20201101__20211031_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iS_z5T2835m2HBj" style="vertical-align: bottom; background-color: White">
    <td>Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,142</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3365">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,434</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,943</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,519</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_zSRtUJO4X3tc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,259</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,288</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,915</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,292</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,754</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation_zws4Z03bPdU1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,876</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,602</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,950</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20211101__20220131_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iS_zhyKdpT9dDti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, October 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,277</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,529</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,837</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,223</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20211101__20220131_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iS_zOZXB1RhKl6k" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accumulated depreciation, beginning balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,277</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,529</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,837</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,223</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_zyUetwz0rVU7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-11-012022-01-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-11-012022-01-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3396">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-11-012022-01-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,950</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,906</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation_zspx7rvjwFta" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3400">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3401">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3402">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2021-11-012022-01-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,563</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:ForeignExchangeEffectOnOperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,563</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20211101__20220131_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iE_zlwK9s8jaRah" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,298</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,464</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,224</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">315,566</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20211101__20220131_ecustom--OperatingLeaseRightOfUseAssetAccumulatedDepreciation_iE_zsf6Lmvqhfv7" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Accumulated depreciation, ending balance</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,298</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,464</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,580</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,224</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseRightOfUseAssetAccumulatedDepreciation" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">315,566</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Net Book Value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20201031__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VancouverOfficeMember_zf2fRa9Q1BQ6" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,559</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20201031__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VirginiaOfficeMember_zLO3UBvynRcl" title="Net Book Value" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3420">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20201031__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--NevadaOfficeMember_zgzrVjpaxrP8" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,422</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20201031__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--PilotPlantMember_z8TuTlALmMdl" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">348,006</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20201031_zGy9ZR2RuPK6" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">373,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Balance, October 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20211031__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VancouverOfficeMember_zB99BuIgrqK9" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,604</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20211031__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VirginiaOfficeMember_z9KJD4zQJ77e" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,862</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20211031__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--NevadaOfficeMember_zuBFUaogrP31" title="Net Book Value" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3432">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20211031__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--PilotPlantMember_z9dOK8vd2tS5" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,109</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20211031_zcyiAGWUyCp6" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">598,575</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220131__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VancouverOfficeMember_z9LZJ2orNid9" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,583</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220131__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VirginiaOfficeMember_zmw5axcExP85" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">259,927</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220131__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--NevadaOfficeMember_zAaduLUGKEi8" title="Net Book Value" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3442">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220131__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--PilotPlantMember_zG8WAHBoBBq9" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-01-31_custom_PilotPlantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,583</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220131_zLrv8JDqyAUi" title="Net Book Value" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">533,093</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AC_zUuU33dWI3wd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_zgrWqRRByghc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_zuexlysU0gMh">LEASE OBLIGATIONS</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
adoption of ASU 2016-02 on November 1, 2019, the Company recognized lease liabilities of $<span id="xdx_905_eus-gaap--OperatingLeaseLiability_iI_c20191102_zpyJ7AOOemr5" title="Operating Lease, Liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-11-02" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,549</ix:nonFraction></span> which had previously been classified
as operating leases. The lease liabilities were measured at the present value of the remaining lease payments and discounted using the
lessee&#8217;s incremental borrowing rate of approximately <span id="xdx_900_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_uPure_c20191102_zFaMisPr0B0h" title="Lessee, Operating Lease, Discount Rate"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2019-11-02" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2020, the Company entered into a new operating lease with respect to its research and development pilot plant
located in Burnaby, British Columbia and recognized a lease liability of $<span id="xdx_904_eus-gaap--OperatingLeaseLiability_iI_c20201031__srt--StatementGeographicalAxis__custom--BritishColumbiaMember_z8PlZ1FyBPf1" title="Operating Lease, Liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_BritishColumbiaMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,263</ix:nonFraction></span>, which was measured by discounting lease payments using
an incremental borrowing rate of approximately <span id="xdx_905_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_uPure_c20201031__srt--StatementGeographicalAxis__custom--BritishColumbiaMember_z1KfJWXwRbr8" title="Lessee, Operating Lease, Discount Rate"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2020-10-31_custom_BritishColumbiaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2021, the Company renewed its operating lease with respect to its corporate office in Vancouver, British Columbia
and recognized a lease liability of $<span id="xdx_90B_eus-gaap--OperatingLeaseLiability_iI_c20211031__srt--StatementGeographicalAxis__custom--BritishColumbiaMember_zLOImygzCS08" title="Operating Lease, Liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_BritishColumbiaMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,237</ix:nonFraction></span>, which was measured by discounting lease payments using an incremental borrowing rate of
approximately <span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_uPure_c20211031__srt--StatementGeographicalAxis__custom--BritishColumbiaMember_zeaPEDik9fVf" title="Lessee, Operating Lease, Discount Rate"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2021-10-31_custom_BritishColumbiaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2021, the Company entered into a new operating lease with respect to its office in McLean, Virginia and recognized
a lease liability of $<span id="xdx_906_eus-gaap--OperatingLeaseLiability_iI_c20211031__srt--StatementGeographicalAxis__custom--McLeanAndVirginiaMember_ziUwcUAXHNPi" title="Operating Lease, Liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_McLeanAndVirginiaMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,649</ix:nonFraction></span>, which was measured by discounting lease payments using an incremental borrowing rate of approximately
<span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDiscountRate_iI_pid_dp_uPure_c20211031__srt--StatementGeographicalAxis__custom--McLeanAndVirginiaMember_zUd1vL8lCB1b" title="Lessee, Operating Lease, Discount Rate"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseDiscountRate" contextRef="AsOf2021-10-31_custom_McLeanAndVirginiaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_892_eus-gaap--LeaseCostTableTextBlock_zAdrN8m9cnDe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zefxzke4dr99" style="display: none">SCHEDULE
OF OPERATING LEASE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BF_srt--StatementGeographicalAxis_custom--VancouverOfficeMember_zjU2fY7TLf8e" style="font-weight: bold; text-align: center">Vancouver Office</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_4B1_srt--StatementGeographicalAxis_custom--VirginiaOfficeMember_zcXnIhORyba8" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Virginia</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office</b></span></p></td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B0_srt--StatementGeographicalAxis_custom--NevadaOfficeMember_zu6j1Fg7oShi" style="font-weight: bold; text-align: center">Nevada Office</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B5_srt--StatementGeographicalAxis_custom--PilotPlantMember_zMerfwmreCkj" style="font-weight: bold; text-align: center">Pilot Plant</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B4_zYlhUtFSwaq3" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_430_c20201101__20211031_eus-gaap--OperatingLeaseLiability_iS_zsfhxWnqqBe8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font-weight: bold">Balance, October 31, 2020</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_VancouverOfficeMember50338187" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,123</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3469">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_NevadaOfficeMember50338218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,211</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31_custom_PilotPlantMember50338234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">350,593</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">380,927</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--OperatingLeaseAdditions_zH7PK0NdTxn" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,649</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3476">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3477">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseAdditions" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">351,886</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeasePayments_iN_di_zE8CpkVZgile" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,931</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,137</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,457</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,037</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,562</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseExpense_z7tug7mwPSq5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,076</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">219</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,005</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--OperatingLeasePriorPeriodAdjustment_zh9DN4H5Z2R8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Prior period adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3492">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3493">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,065</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3495">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="MLYF:OperatingLeasePriorPeriodAdjustment" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,065</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--OperatingLeaseForeignExchangeEffect_z67rWGC6MhUj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_VancouverOfficeMember50338265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,099</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_VirginiaOfficeMember50338281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,081</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_NevadaOfficeMember50338296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31_custom_PilotPlantMember50338312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,548</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,820</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20211101__20220131_eus-gaap--OperatingLeaseLiability_iS_zOQOQBMiiOR6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance, October 31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember50338437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,604</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember50338453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,612</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3506">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_PilotPlantMember50338500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,109</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">584,325</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20211101__20220131_eus-gaap--OperatingLeaseLiability_iS_zxkwPjBst2Oj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; font-weight: bold">Operating lease liability, beginning balance</td><td style="display: none; font-weight: bold">&#160;</td>
    <td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_VancouverOfficeMember50338437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,604</ix:nonFraction></td><td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_VirginiaOfficeMember50338453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,612</ix:nonFraction></td><td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3512">&#8211;</span></td><td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31_custom_PilotPlantMember50338500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,109</ix:nonFraction></td><td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold">&#160;</td>
    <td style="display: none; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">584,325</ix:nonFraction></td><td style="display: none; font-weight: bold; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeasePayments_iN_di_z7ceQ1yKCoOb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-11-012022-01-31_custom_VancouverOfficeMember50338640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,097</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3517">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3518">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-11-012022-01-31_custom_PilotPlantMember50338718" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,538</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,635</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseExpense_zyZzi2Yv1mJl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-11-012022-01-31_custom_VancouverOfficeMember50338640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,076</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-11-012022-01-31_custom_VirginiaOfficeMember50338671" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,575</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3524">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-11-012022-01-31_custom_PilotPlantMember50338718" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,589</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,240</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--OperatingLeaseForeignExchangeEffect_zqdG0TbM8huc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3528">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3529">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3530">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2021-11-012022-01-31_custom_PilotPlantMember50338718" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,576</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:OperatingLeaseForeignExchangeEffect" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,576</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43C_c20211101__20220131_eus-gaap--OperatingLeaseLiability_iE_zrPCg1NoAQv9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember50338781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,583</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember50338796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,187</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3536">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_PilotPlantMember50338828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,584</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">540,354</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20211101__20220131_eus-gaap--OperatingLeaseLiability_iE_zdNqxVj6f3W4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; font-weight: bold; padding-bottom: 1.5pt">Operating lease liability, ending balance</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember50338781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,583</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember50338796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,187</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3542">&#8211;</span></td><td style="display: none; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_PilotPlantMember50338828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,584</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">540,354</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Which consist of:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20220131_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zU9wVWZssOM" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Current lease obligation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember50338781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,548</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember50338796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,823</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3548">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-01-31_custom_PilotPlantMember50338828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,938</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,309</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20220131_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_z67S1oEsgJla" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Non-current lease obligation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember50338781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,035</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember50338796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">222,364</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3554">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-01-31_custom_PilotPlantMember50338828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,646</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">320,045</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43F_c20211101__20220131_eus-gaap--OperatingLeaseLiability_iE_zjqnquBOZbHi" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember50338781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,583</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember50338796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,187</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3560">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_PilotPlantMember50338828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,584</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">540,354</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_439_c20211101__20220131_eus-gaap--OperatingLeaseLiability_iE_zyhN3aJx1572" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-weight: bold; padding-bottom: 1.5pt">Operating lease liability, ending balance</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_VancouverOfficeMember50338781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,583</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_VirginiaOfficeMember50338796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,187</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3566">&#8211;</span></td><td style="display: none; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31_custom_PilotPlantMember50338828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,584</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">540,354</ix:nonFraction></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_znP3wcrZ0lFg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:MineralIndustriesDisclosuresTextBlock"><p id="xdx_803_eus-gaap--MineralIndustriesDisclosuresTextBlock_zTS9EN9TOwMd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zJc0r0RGvkB3">MINERAL PROPERTY COSTS</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, the Company had the following mining claims:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]
Silverado Property</b>, <b>Nevada, United States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Silverado property is located in the Pinto mining district of Nevada, consists of 3 patented mining claims totaling approximately <span id="xdx_901_eus-gaap--AreaOfLand_iI_uHectares_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SilveradoPropertyMember_zDRvCCuHqBzk" title="Area of land"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2022-01-31_custom_SilveradoPropertyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Hectares">120</ix:nonFraction></span>
hectares, and is <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SilveradoPropertyMember_zwwvOmoSviP3" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-01-31_custom_SilveradoPropertyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% owned by the Company. The carrying value of the property is $<span id="xdx_904_eus-gaap--MineralPropertiesNet_iI_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SilveradoPropertyMember_zFfsZ7GrQ3G3" title="Mineral properties, net"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2022-01-31_custom_SilveradoPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]
Tami Mosi Property, Nevada, United States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company holds a <span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TamiMosiPropertyMember__srt--StatementGeographicalAxis__custom--WhitePineCountyMember_zjB62iQkJmeb" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-01-31_custom_TamiMosiPropertyMember_custom_WhitePineCountyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% interest in 81 unpatented lode mining claims totaling approximately <span id="xdx_902_eus-gaap--AreaOfLand_iI_uAcre_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TamiMosiPropertyMember__srt--StatementGeographicalAxis__custom--WhitePineCountyMember_ziaHSm4i0sYa"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2022-01-31_custom_TamiMosiPropertyMember_custom_WhitePineCountyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Acre">1,637</ix:nonFraction></span> acres located in White Pine County, Nevada
and four unpatented lode mining claims totaling approximately <span id="xdx_90C_eus-gaap--AreaOfLand_iI_uAcre_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TamiMosiPropertyMember__srt--StatementGeographicalAxis__custom--MoorMiningDistrictMember_zfkwevknr1q3" title="Area of land"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2022-01-31_custom_TamiMosiPropertyMember_custom_MoorMiningDistrictMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Acre">10</ix:nonFraction></span> acres located in the Moor Mining District, Elko County, Nevada. These
mining claims are subject to a <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TamiMosiPropertyMember__srt--StatementGeographicalAxis__custom--MoorMiningDistrictMember_zjsNTgDTwDkj" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-01-31_custom_TamiMosiPropertyMember_custom_MoorMiningDistrictMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% net smelter royalty in favor of the prior owner of the claims. The carrying value of the property is
$<span id="xdx_90A_eus-gaap--MineralPropertiesNet_iI_c20220131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TamiMosiPropertyMember_zjBtOw057Pef" title="Mineral properties, net"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2022-01-31_custom_TamiMosiPropertyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,452</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zqOjrNrV0AV" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_z055UhGwH9Nh">RELATED PARTY TRANSACTIONS</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]
Deposits held by related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provided related parties with advances that were held as deposits for anticipated future costs related to the Company&#8217;s
planned magnesium research and development pilot plant and other administrative expenses (the &#8220;Pilot Plant Advances&#8221;). As
at January 31, 2022, the Company had the following deposits held by related parties:</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="MLYF:ScheduleOfDepositsHeldByRelatedPartyTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfDepositsHeldByRelatedPartyTableTextBlock_zd9dNsww7TIl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8B8_zlk5XwDgNeH7" style="display: none">SCHEDULE
OF DEPOSITS HELD BY RELATED PARTY</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--RelatedPartyTransactionAxis_custom--RelatedPartyAMember_znCWB6He82x3" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related Party </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A
                                            <sup id="xdx_F52_zMWVrMczRvUd">[i]</sup></b></span></p></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--RelatedPartyTransactionAxis_custom--RelatedPartyBMember_z4NuWZXHPpxe" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related Party </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B <sup id="xdx_F57_zaKfH7SaDNae">[ii]</sup></b></span></p></td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BA_zPyufsZUXlFf" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_43B_c20201101__20211031_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_iS_zYifAo7zaBY" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance, October 31, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3591">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3592">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3593">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProceedsFromRelatedPartyDebt_zt9RAw6MlHB7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 46%">Advances</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-11-012021-10-31_custom_RelatedPartyAMember" id="Fact003595" format="ixt:numdotdecimal" decimals="0" unitRef="USD">987,912</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-11-012021-10-31_custom_RelatedPartyBMember" id="Fact003596" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,292,912</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,280,824</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RelatedPartyCosts_iN_di_zSPhT4mfJ8Z7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Costs and expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RelatedPartyCosts" contextRef="From2020-11-012021-10-31_custom_RelatedPartyAMember" id="Fact003599" format="ixt:numdotdecimal" decimals="0" unitRef="USD">696,431</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RelatedPartyCosts" contextRef="From2020-11-012021-10-31_custom_RelatedPartyBMember" id="Fact003600" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,097,931</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RelatedPartyCosts" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,794,362</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_433_c20211101__20220131_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_iS_zR3EpJzhjnW9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance, October 31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2021-10-31_custom_RelatedPartyAMember" id="Fact003603" format="ixt:numdotdecimal" decimals="0" unitRef="USD">291,481</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2021-10-31_custom_RelatedPartyBMember" id="Fact003604" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,981</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,462</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromRelatedPartyDebt_zgLLOGP7Jtw7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Advances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-11-012022-01-31_custom_RelatedPartyAMember" id="Fact003607" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-11-012022-01-31_custom_RelatedPartyBMember" id="Fact003608" format="ixt:numdotdecimal" decimals="0" unitRef="USD">522,335</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">822,335</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RelatedPartyCosts_iN_di_zNyMCZPFseM2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Costs and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RelatedPartyCosts" contextRef="From2021-11-012022-01-31_custom_RelatedPartyAMember" id="Fact003611" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,793</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RelatedPartyCosts" contextRef="From2021-11-012022-01-31_custom_RelatedPartyBMember" id="Fact003612" format="ixt:numdotdecimal" decimals="0" unitRef="USD">675,390</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RelatedPartyCosts" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">755,183</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_ecustom--RelatedPartyTransactionForeignExchangeEffect_ztmRyHCyFZ19" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign exchange effect</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:RelatedPartyTransactionForeignExchangeEffect" contextRef="From2021-11-012022-01-31_custom_RelatedPartyAMember" id="Fact003615" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,193</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="MLYF:RelatedPartyTransactionForeignExchangeEffect" contextRef="From2021-11-012022-01-31_custom_RelatedPartyBMember" id="Fact003616" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,066</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:RelatedPartyTransactionForeignExchangeEffect" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,127</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20211101__20220131_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_iE_zcNyLIFJbHv9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2022-01-31_custom_RelatedPartyAMember" id="Fact003619" format="ixt:numdotdecimal" decimals="0" unitRef="USD">524,881</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2022-01-31_custom_RelatedPartyBMember" id="Fact003620" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,860</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">565,741</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.15pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i id="xdx_F05_zmUUBQ4q02w6">[i]</i></span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i id="xdx_F19_zgjIHLt1tAqa"><ix:footnote id="Footnote003622" xml:lang="en-US">Related Party A is a company controlled by a director and
officer.</ix:footnote></i></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.15pc"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i id="xdx_F0A_zD5W9m1atDth">[ii]</i></span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i id="xdx_F1F_zJDFuIQsfhpk"><ix:footnote id="Footnote003623" xml:lang="en-US">Related Party B is a company controlled by an officer.</ix:footnote></i></span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A4_zTcmeYAL4dbj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]
Due to related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, balances due to related parties totaled $<span id="xdx_90D_ecustom--DueToRelatedParties_iI_c20220131_zqqUQPXeg4H6" title="Due to related parties"><ix:nonFraction name="MLYF:DueToRelatedParties" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,092,786</ix:nonFraction></span> (October 31, 2021 &#8211; $<span id="xdx_906_ecustom--DueToRelatedParties_iI_c20211031_zmrqZU5yOoLi" title="Due to related parties"><ix:nonFraction name="MLYF:DueToRelatedParties" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,026,817</ix:nonFraction></span>). All advances are unsecured,
non-interest bearing, and have no stated terms of repayment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zEbYploJFqE7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zUgw36yxqUn5" style="display: none">SCHEDULE
OF DUE TO RELATED PARTIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20220131_zRxxYU2eDm13" style="font-weight: bold; text-align: center">January 31, 2022</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20211031_z7JDNaiMUhv8" style="font-weight: bold; text-align: center">October 31, 2021</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DirectorsAndOfficersWagesPayable_iI_maRPTDFzRvT_zhKCEJu7IEnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Wages payable to directors and officers</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersWagesPayable" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersWagesPayable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DirectorsAndOfficersBenefitsPayable_iI_maRPTDFzRvT_zwyLOdqkKdgj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Benefits payable to directors and officers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersBenefitsPayable" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">581,854</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersBenefitsPayable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">539,209</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DirectorsAndOfficersFeesAndExpensesPayable_iI_maRPTDFzRvT_z0M16pJRGELa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fees and expenses payable to directors and officers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersFeesAndExpensesPayable" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">151,261</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="MLYF:DirectorsAndOfficersFeesAndExpensesPayable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,878</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--InterestsDueToShareholder_iI_maRPTDFzRvT_z7wiYHwBBU9i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Interests due to a shareholder</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:InterestsDueToShareholder" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,171</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:InterestsDueToShareholder" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,230</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RelatedPartyTransactionDueFromToRelatedPartyCurrent_iTI_mtRPTDFzRvT_zNQhrvj0Dh93" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,092,786</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyTransactionDueFromToRelatedPartyCurrent" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,026,817</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zosjfIlNMTR6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]
Key management compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, the Company had twelve executives including eight in senior management. Their aggregate annualized compensation
is approximately $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20211101__20220131_zptpMOEcbhT7" title="Share-based payment arrangement, expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.9</ix:nonFraction></span> million. During the three months ended January 31, 2022, the Company incurred salaries, benefits, and consulting
fees totaling $<span id="xdx_90F_ecustom--SalariesManagementAndConsultingFees_c20211101__20220131_z1by7w9mu9Hc" title="Salaries management and consulting fees"><ix:nonFraction name="MLYF:SalariesManagementAndConsultingFees" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">747,589</ix:nonFraction></span> to directors and officers of the Company. There were no stock options granted to directors or officers of the
Company during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[d]
Transactions with related parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
During the three months ended January 31, 2022, the Company incurred consulting fees of CA$<span id="xdx_90F_eus-gaap--ProfessionalFees_uCA_c20211101__20220131_zai1gwwRHe5j" title="Consulting fees"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="CA">30,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_904_eus-gaap--ProfessionalFees_uUSD_c20211101__20220131_zFf8n1f9wICl" title="Consulting fees"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,587</ix:nonFraction></span>) to a member
of senior management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its corporate office
in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 at a monthly rent of CA$<span id="xdx_90E_eus-gaap--PaymentsForRent_uCA_c20210601__20210630_zgt4koJh6QQd" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2021-06-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="CA">9,794</ix:nonFraction></span> (USD equivalent $<span id="xdx_902_eus-gaap--PaymentsForRent_uUSD_c20210601__20210630_zzjJldJ08Uj8" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2021-06-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,700</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iii]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer is eligible to receive up to <span id="xdx_903_ecustom--CommonStockPercentage_pid_dp_uPure_c20180908__20180912__srt--TitleOfIndividualAxis__custom--DirectorAndrOfficerMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyAgreementMember_zlfc2p92okZj" title="Equity method investment, ownership percentage"><ix:nonFraction name="MLYF:CommonStockPercentage" contextRef="From2018-09-082018-09-12_custom_DirectorAndrOfficerMember_custom_RelatedPartyAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20180822__20180828__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyAgreementMember__srt--TitleOfIndividualAxis__custom--DirectorAndrOfficerMember_zmEQYCjgtQgj" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2018-08-222018-08-28_custom_RelatedPartyAgreementMember_custom_DirectorAndrOfficerMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">5</ix:nonFraction></span> million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20211030__20211103__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyAgreementMember_zyJo76b23tQb" title="Number of common stock issued, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-10-302021-11-03_custom_RelatedPartyAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,163,425</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20211103__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyAgreementMember_zh9dhaRoauk3" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-11-03_custom_RelatedPartyAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.65</ix:nonFraction></span> per share with a total fair value of CA$<span id="xdx_90D_ecustom--FairValueOfShareIssue_iI_uCA_c20211103_zKs7sH0R5c0b" title="Fair value of share issue"><ix:nonFraction name="MLYF:FairValueOfShareIssue" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="0" unitRef="CA">5,956,226</ix:nonFraction></span> (USD equivalent $<span id="xdx_909_ecustom--FairValueOfShareIssue_iI_uUSD_c20211103_zjnr7SSi0Odi" title="Fair value of share issue"><ix:nonFraction name="MLYF:FairValueOfShareIssue" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,796,832</ix:nonFraction></span>) as share
issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zUo2I2Ym39w9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zSAgb90Rpty6">CONTINGENT LIABILITIES AND COMMITMENTS</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]
Contingent liabilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
On September 29, 2020, James Sever filed a Notice of Civil Claim against the Company in the Supreme Court of British Columbia (the &#8220;Sever
Claim&#8221;). The Sever Claim alleges that Mr. Sever had an employment and/or other similar contractual relationship with the Company,
and that the Company breached such contractual relationship by way of constructive dismissal or similar conduct. The Sever Claim seeks
damages in excess of $<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_c20200927__20200929__srt--RangeAxis__srt--MaximumMember_zihVU8WhUmpf" title="Loss contingency, damages sought, value"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-09-272020-09-29_srt_MaximumMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction></span> million, certain equity compensation, prejudgment garnishment, costs, interest and other non-monetary relief.
On July 27, 2021, the Company filed a response to the Sever Claim, which included the following pleadings: (a) that the Company was never
properly served with the Sever Claim; (b) that the Company had never had any form of employment, independent or consulting relationship
or agreement with Mr. Sever; (c) that the Company had no debts, liabilities or obligations to Mr. Sever; (d) that to the extent that
Mr. Sever had some form of employment, independent or consulting or similar relationship or agreement as alleged in the Sever Claim,
such contract or relationship, if one existed, was never with the Company and was with some other corporate entity. The Company intends
to vigorously defend against the Sever Claim, and believes that the Sever Claim is without merit. As the Company cannot predict the outcome
of the Sever Claim, no provision has been recognized as there is no present obligation and the probability of an outcome cannot be determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
On December 31, 2020, GEM Yield Bahamas Limited (&#8220;GEM&#8221;) served the Company with a Notice of Intention to Arbitrate (the &#8220;New
York Arbitration Notice&#8221;) before the American Arbitration Association in New York (the &#8220;GEM New York Arbitration&#8221;).
The New York Arbitration Notice alleges the Company breached a Share Subscription Agreement dated November 15, 2019 entered into between
the Company and GEM (the &#8220;GEM Agreement&#8221;), among other things, claiming damages of CA$<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_uCA_c20201229__20201231_zZEo1lnPRNRe" title="Loss contingency damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-12-292020-12-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="CA">4.2</ix:nonFraction></span> million (USD equivalent $<span id="xdx_904_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_c20201229__20201231_zT84UHmwXNdl" title="Loss contingency, damages sought, value"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2020-12-292020-12-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.4</ix:nonFraction></span> million).
On January 19, 2021, the Company filed a petition in the New York Supreme Court to stay the GEM New York Arbitration claiming the GEM
Agreement was not valid. On March 19, 2021, the Court in the New York State Action ruled that there was an arbitration clause in the
GEM Agreement but it was up to the arbitrator to determine if the arbitration clause was valid. Following this ruling, the New York State
Action was closed. In June 2021, GEM filed a Statement of Claim in the GEM New York Arbitration, and the Company filed a Statement of
Answer denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company
filed a Modified Statement of Defense and Counterclaims. The Company intends to vigorously defend itself in the GEM New York Arbitration
and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been
recognized in respect to the GEM New York Arbitration as there is no present obligation and the probability of an outcome cannot be determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iii]
On February 8, 2021, GEM instituted another arbitration against the Company before the International Centre for Dispute Resolution in
Montreal Canada (the &#8220;GEM Montreal Arbitration&#8221;) and joined GEM&#8217;s affiliate, GEM Global Yield LLC SCS (&#8220;GEM Global
Yield&#8221; together with GEM, the &#8220;GEM Parties&#8221;). The Statement of Claim filed by the GEM Parties alleges the Company breached
a Share Subscription Agreement dated November 15, 2019 and promissory note, among other things, claiming damages of approximately CA$<span id="xdx_902_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_uCA_c20210206__20210208_zM23fHBukJJg" title="Loss contingency, damages sought, value"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2021-02-062021-02-08" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="CA">4.9</ix:nonFraction></span>
million (USD equivalent $<span id="xdx_905_eus-gaap--LossContingencyDamagesSoughtValue_pn5n6_c20210206__20210208_ziFeCrqoiRA9" title="Loss contingency, damages sought, value"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2021-02-062021-02-08" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.9</ix:nonFraction></span> million), in addition to costs and expenses, stemming from the Company&#8217;s alleged failure to issue
to GEM Global Yield warrants to purchase up to <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pn6n6_c20210208__srt--RangeAxis__srt--MaximumMember_zOcl9GkITut6" title="Purchase of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-02-08_srt_MaximumMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="Shares">33</ix:nonFraction></span> million shares of the Company&#8217;s common stock. The Company filed a Statement of
Defense denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company
filed an Amended Statement of Defense and Cross-claim. The Company intends to vigorously defend itself in the GEM Montreal Arbitration
and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been
recognized in respect to the GEM Montreal Arbitration as there is no present obligation and the probability of an outcome cannot be determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iv]
On April 19, 2021, Lampert Advisors, LLC (&#8220;Lampert&#8221;) filed a Verified Complaint against the Company&#8217;s wholly owned
subsidiary Western Magnesium Corp., a Nevada corporation (&#8220;Western Magnesium &#8211; Nevada&#8221;) in the Supreme Court of the
State of New York, County of New York (the &#8220;Lampert Lawsuit&#8221;). The complaint filed in the Lampert Lawsuit alleges that Lampert
entered into an agreement with Western Magnesium &#8211; Nevada to provide various financial advisory services including acquisition
advisory services and act as an exclusive placement agent for a combination of debt and equity securities (the &#8220;Lampert Agreement&#8221;),
that it performed all services required under that agreement and that it is owed $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20210419__us-gaap--TypeOfArrangementAxis__custom--LampertAgreementMember_zbKvzXUQrKy1" title="Debt instrument, face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-04-19_custom_LampertAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">367,227</ix:nonFraction></span> plus interest at the rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20210419__us-gaap--TypeOfArrangementAxis__custom--LampertAgreementMember_zhVICdJaMtoe" title="Percentage of interest rate owned"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2021-04-19_custom_LampertAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>% from February
3, 2021 and that it has a right of first refusal to act as financial advisor in connection with any debt, equity or debt restructuring
assignments on terms, conditions and compensation customary for Lampert for a transaction of the type contemplated. Although Lampert
claims to have personally served Western Magnesium &#8211; Nevada, the Company never received the Summons and Complaint and therefore,
never submitted a response. On September 9, 2021, Lampert filed a Motion seeking the entry of a default judgment (the &#8220;Motion&#8221;).
The Company opposed the Motion and filed a cross-motion to compel Lampert to accept the Company&#8217;s answer. The Court granted the
Company&#8217;s cross-motion and denied Lampert&#8217;s Motion as moot. The Court scheduled a preliminary conference for the parties
on March 30, 2022. The Company intends to vigorously defend against the Lampert Lawsuit, and believes that the Lampert Lawsuit is without
merit. As the Company cannot predict the outcome of the Lampert Lawsuit, no provision has been recognized as there is no present obligation
and the probability of an outcome cannot be determined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]
Commitments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
On November 1, 2016, the Company signed a contract services agreement with Lodestar Management Group, LLC (&#8220;Lodestar&#8221;), a
US corporate logistics company. Lodestar provides advisory, consulting, negotiation and other management services relating to corporate
management, administrative and/or operational activities of the Company. The term of the contract was for one year and has been renewed
under the same terms on January 1, 2018 and 2019. The Company has agreed to compensate Lodestar in the amount of $<span id="xdx_90C_eus-gaap--DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount_iI_c20161101_zLT74mhXoVMl" title="Commitment of cash or arrangments amount"><ix:nonFraction name="us-gaap:DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount" contextRef="AsOf2016-11-01" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,800</ix:nonFraction></span> or CA$<span id="xdx_900_eus-gaap--DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount_iI_uCA_c20161101_z0KxYWMtLPu2" title="Commitment of cash or arrangments amount"><ix:nonFraction name="us-gaap:DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount" contextRef="AsOf2016-11-01" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,500</ix:nonFraction></span> per
month by either cash or arrangement of the issuance of shares. The number of shares issued will be based on the share price on the day
of issuance that is not lower than the CA$<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20161101_znh4XDrwQJCd" title="Number of shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2016-11-01" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> per share minimum requirement and will not exceed $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_c20211101__20220131__srt--RangeAxis__srt--MaximumMember_zXUvVmWO1CJj" title="Issuance of share based minimum requirement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" contextRef="From2021-11-012022-01-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,800</ix:nonFraction></span> or CA$<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_uCA_c20211101__20220131__srt--RangeAxis__srt--MaximumMember_zXCPfq4GA294" title="Issuance of share based minimum requirement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" contextRef="From2021-11-012022-01-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,500</ix:nonFraction></span> in value. The shares
will be issued on the last working day of each month for a period of twelve months. During the three months ended January 31, 2022, the
Company did not make any cash payment (2021 &#8211; $<span id="xdx_902_eus-gaap--Cash_iI_dxL_c20220131_zsns6aiRV5Sc" title="Cash::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3698">nil</span></span>) or issue any shares (2021 &#8211; <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_dxL_c20211101__20220131_zSNZcK03XAp8" title="Number of shares issued::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3700">nil</span></span>) to Lodestar. As at January 31, 2022,
the outstanding amounts payable to Lodestar was $<span id="xdx_90F_eus-gaap--NotesPayable_iI_uUSD_c20220131_zIZ0hQ19Ivnj" title="Outstanding amounts payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,491</ix:nonFraction></span> (October 31, 2021 &#8211; $<span id="xdx_900_eus-gaap--NotesPayable_iI_uUSD_c20211031_zfA6M1jJsmX2" title="Outstanding amounts payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,491</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
During the year ended October 31, 2020, the Company has entered into a lease agreement for its research and development pilot plant in
Burnaby, British Columbia with a lease term from October 1, 2020 to September 30, 2023 at a monthly rent of CA$<span id="xdx_902_eus-gaap--SubleaseIncome_uCA_c20191101__20201031_z6uS3udFDWBe" title="Sublease income"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="CA">20,715</ix:nonFraction></span> (USD equivalent
$<span id="xdx_90B_eus-gaap--SubleaseIncome_uUSD_c20191101__20201031_zqqMXpiNXxG1" title="Sublease income"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,727</ix:nonFraction></span>). In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its corporate
office in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 at a monthly rent of CA$<span id="xdx_901_eus-gaap--SubleaseIncome_uCA_c20210601__20210630_zSczyPOwXhT7" title="Sublease income"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2021-06-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="CA">9,794</ix:nonFraction></span> (USD equivalent
$<span id="xdx_903_eus-gaap--SubleaseIncome_uUSD_c20210601__20210630_zfg4XTlgP0rk" title="Sublease income"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2021-06-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,909</ix:nonFraction></span>). In September 2021, the Company entered into a lease agreement for its office in McLean, Virginia with a lease term from September
14, 2021 to February 28, 2025 at a monthly rent of $<span id="xdx_908_eus-gaap--SubleaseIncome_uUSD_c20210901__20210930__us-gaap--TypeOfArrangementAxis__custom--LeaseAgreementMember_zyBrjVgifpB4" title="Sublease income"><ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2021-09-012021-09-30_custom_LeaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,113</ix:nonFraction></span>. The Company will be abated for the beginning five months and is entitled to
a tenant allowance of $<span id="xdx_905_eus-gaap--PaymentsForProceedsFromTenantAllowance_c20211101__20220131_zp9qNNYbHnzf" title="Payments for tenant allowance"><ix:nonFraction name="us-gaap:PaymentsForProceedsFromTenantAllowance" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,010</ix:nonFraction></span> <i>[notes 5 and 6]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="MLYF:PromissoryNoteTextBlock"><p id="xdx_808_ecustom--PromissoryNoteTextBlock_zQ4xmyb2nU93" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_z2pOi7OjPsp6">PROMISSORY NOTE</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended October 31, 2019, the Company received a loan of CA$<span id="xdx_907_eus-gaap--PaymentsToFundLongtermLoansToRelatedParties_uCA_c20181101__20191031_zzG17pTuJJd5" title="Related party loan"><ix:nonFraction name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" contextRef="From2018-11-012019-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="CA">150,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_907_eus-gaap--PaymentsToFundLongtermLoansToRelatedParties_uUSD_c20181101__20191031_znwQku7ZNdfg" title="Related party loan"><ix:nonFraction name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" contextRef="From2018-11-012019-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,895</ix:nonFraction></span>) from a related party. The loan was
unsecured, bore interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20191031_zRltblDLF3P2" title="Percentage of unsecured loan interest"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2019-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>% and was due on demand. During the year ended October 31, 2020, the loan was increased by an additional
CA$<span id="xdx_900_ecustom--AdditionalIncreaseInPromissoryNoteLoan_uCA_c20191101__20201031__srt--RangeAxis__srt--MinimumMember_zTHjg6nPIsif" title="Additional increase in promissory note loan"><ix:nonFraction name="MLYF:AdditionalIncreaseInPromissoryNoteLoan" contextRef="From2019-11-012020-10-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">60,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_903_ecustom--AdditionalIncreaseInPromissoryNoteLoan_uUSD_c20191101__20201031__srt--RangeAxis__srt--MinimumMember_z5aa4oPuP019" title="Additional increase in promissory note loan"><ix:nonFraction name="MLYF:AdditionalIncreaseInPromissoryNoteLoan" contextRef="From2019-11-012020-10-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,588</ix:nonFraction></span>) to CA$<span id="xdx_90E_ecustom--AdditionalIncreaseInPromissoryNoteLoan_uCA_c20191101__20201031__srt--RangeAxis__srt--MaximumMember_zhO8M6UjQZI8" title="Additional increase in promissory note loan"><ix:nonFraction name="MLYF:AdditionalIncreaseInPromissoryNoteLoan" contextRef="From2019-11-012020-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">210,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_90F_ecustom--AdditionalIncreaseInPromissoryNoteLoan_uUSD_c20191101__20201031__srt--RangeAxis__srt--MaximumMember_zcNVGhvFBBhd" title="Additional increase in promissory note loan"><ix:nonFraction name="MLYF:AdditionalIncreaseInPromissoryNoteLoan" contextRef="From2019-11-012020-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,483</ix:nonFraction></span>), and was due on September 24, 2021. During the year ended
October 31, 2021, the Company accrued interest expense of $<span id="xdx_90E_eus-gaap--InterestAndDebtExpense_c20201101__20211031_zal1gzWV7DD4" title="Interest and Debt Expense"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,639</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_907_eus-gaap--InterestAndDebtExpense_c20191101__20201031_zagOFV1qjC76" title="Interest and debt expense"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2019-11-012020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,655</ix:nonFraction></span>) and repaid the entire balance and interest totaling
$<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_uUSD_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zxYrVzQidZW8" title="Repayments of debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2020-11-012021-10-31_custom_PromissoryNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,761</ix:nonFraction></span> (2020 &#8211; $<span id="xdx_901_eus-gaap--RepaymentsOfDebt_uUSD_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zLgcOL3ZtAtl" title="Repayments of debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2019-11-012020-10-31_custom_PromissoryNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,066</ix:nonFraction></span>).</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="MLYF:ProvisionForFlowThroughShareIssuancesTextBlock"><p id="xdx_80E_ecustom--ProvisionForFlowThroughShareIssuancesTextBlock_zBqQfqrTNCub" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_z1zuFgSEkBwh">PROVISION FOR FLOW THROUGH SHARE ISSUANCES</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has recorded a provision in the amount of $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20220131_ztymdp8iB6ff" title="Provision for tax and related obligations"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227,140</ix:nonFraction></span> (October 31, 2021 &#8211; $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_pp0p0_c20211031_zuw0OX1hWh4c" title="Provision for tax and related obligations"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">233,285</ix:nonFraction></span>) for tax and related obligations relating
to flow through share issuances from prior years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80F_eus-gaap--DebtDisclosureTextBlock_zIASQKmZv1oh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zNibPNLtEUfk">CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]
July 2020 Convertible Debenture</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2020, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_uCA_c20200727__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zS7rKIPdOhy4" title="Debt, principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">150,000</ix:nonFraction></span>
(USD equivalent $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20200727__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_z9yZIiyCWrm1" title="Debt, principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,124</ix:nonFraction></span>, the &#8220;July 2020 Convertible Debenture&#8221;). The note bears interest at <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200727__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zPN3Wrzh5qJk" title="Debt instrument, interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% per annum and is due on
the date that is one year following the closing date. The note is convertible into common shares of the Company at the price which is
the greater of CA$<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20200727__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_ze7XtMeva3hb" title="Debt, face value"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-07-27_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction></span> per common share and the market price on the date of the conversion notice. Any accrued but unpaid interest will
be payable on the earlier of the maturity date and the date of conversion in cash or common shares. No finder&#8217;s fees were paid
in connection with this private placement. On May 18, 2021, the Company issued a total of <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zF45bcj8pNK6" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,360,959</ix:nonFraction></span> common shares on the conversion of
the July 2020 Convertible Debenture including conversion of accrued interest and <span id="xdx_908_eus-gaap--ConversionOfStockSharesIssued1_c20210517__20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zobReHlIKy17" title="Conversion of stock, shares issued"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2021-05-172021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">263,973</ix:nonFraction></span> common shares valued at $<span id="xdx_909_eus-gaap--CommonStockValue_iI_c20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zFmsvyopGaBi" title="Common stock, value issued"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,286</ix:nonFraction></span> in transaction
costs. The July 2020 Convertible Debenture had an effective interest rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200731__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_z7RfU7jwBig4" title="Interest rate percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-07-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">37</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]
July 2021 Convertible Debenture</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_uCA_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zheA7CvKTf2h" title="Debt instrument, principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">100,000</ix:nonFraction></span>
(USD equivalent $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zwvkvNDq4bhd" title="Debt instrument, principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,542</ix:nonFraction></span>, the &#8220;July 2021 Convertible Debenture&#8221;) which it received on April 22, 2021. The note bears interest
at <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z5UMEA3OPLvi" title="Debt instrument,  interest rate percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% per annum and is due on the date that is one year following the closing date. The note is convertible at a price of CA$<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_uCAPShares_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zkOQS5aFtg3d" title="Debt instrument, conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></span> per
Unit, where each Unit is comprised of one common share and one common share purchase warrant exercisable at a price of CA$<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20210715__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zaMwSdQdUqd" title="Warrant exerciable price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-07-15_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.20</ix:nonFraction></span> per common
share for a period of two years. Any accrued but unpaid interest will be payable on the earlier of the maturity date and the date of
conversion in cash or common shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, the Company incurred contractual interest of CA$<span id="xdx_908_ecustom--ContractualInterest_uCA_c20220128__20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zGHmf6HZo8jg" title="Contractual interest"><ix:nonFraction name="MLYF:ContractualInterest" contextRef="From2022-01-282022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">9,337</ix:nonFraction></span> (USD equivalent $<span id="xdx_90B_ecustom--ContractualInterest_c20220128__20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zPb0oxpV1I19" title="Contractual interest"><ix:nonFraction name="MLYF:ContractualInterest" contextRef="From2022-01-282022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,375</ix:nonFraction></span>) [2021 &#8211; CA$<span id="xdx_90F_ecustom--ContractualInterest_uCA_c20210128__20210131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zf3124h09dSh" title="Contractual interest"><ix:nonFraction name="MLYF:ContractualInterest" contextRef="From2021-01-282021-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">7,299</ix:nonFraction></span> (USD equivalent
$<span id="xdx_905_ecustom--ContractualInterest_c20210128__20210131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zqeBLyOIJsDg" title="Contractual interest"><ix:nonFraction name="MLYF:ContractualInterest" contextRef="From2021-01-282021-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,802</ix:nonFraction></span>)]. The July 2021 Convertible Debenture has an <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateBasisForEffectiveRate_dp_c20210701__20210731__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zEA6UBNLfwWj" title="Debt instrument, interest rate description"><ix:nonNumeric contextRef="From2021-07-012021-07-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" name="us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate">effective interest rate of 608.98%</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]
June 2021 Convertible Debenture</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_uCA_c20210615__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zcY9aFxXyr8" title="Debt, principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">1,500,000</ix:nonFraction></span>
(the &#8220;June 2021 Convertible Debenture&#8221;). The note bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210615__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zP9DhbSLSX75" title="Debt instrument, interest rate percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% per annum and matures on <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20210610__20210615__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zeWXmSpOoKI6" title="Debt instrument maturity date"><ix:nonNumeric contextRef="From2021-06-102021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">December 10, 2022</ix:nonNumeric></span>. The June
2021 Convertible Debenture is convertible into <span id="xdx_90F_eus-gaap--ConversionOfStockSharesConverted1_c20210610__20210615__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zms1WaQDGc27" title="Conversion of convertiable debenture"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-06-102021-06-15_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000,000</ix:nonFraction></span> units, where each unit consists of <span id="xdx_900_eus-gaap--DebtConversionDescription_c20211101__20220131_z37tzEsPJ0y2" title="Debt conversion, description"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" name="us-gaap:DebtConversionDescription">(i) one share of the Company&#8217; common
stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until
June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price
of $0.19 until June 10, 2026 (collectively, the &#8220;Class A and B Warrants&#8221;). In addition, the conversion price for accrued
interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the offering of the June 2021 Convertible Debenture, the Company also entered into the June 10, 2021 Securities Purchase Agreement
(the &#8220;Securities Purchase Agreement&#8221;), whereby the Company agreed to use commercially reasonable efforts to file a registration
statement with the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) by August 14, 2021, covering the public resale
of the shares of common stock underlying such debenture and, upon its conversion, the Class A and B Warrants issuable upon such conversion
(the &#8220;Underlying Shares&#8221;), and to use its best efforts to cause the registration statement to be declared effective on October
13, 2021. On December 13, 2021, the Company&#8217;s Form 10 Registration Statement filed with the SEC was declared effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to certain covenants contained in the Securities Purchase Agreement, the terms of the June 2021 Convertible Debenture contain
certain negative covenants by the Company, including, among others, sell or offer to sell any securities with non-fixed or floating price
features, issue any common stock or common stock equivalents at a price lower than the Conversion Price herein then in effect, or issue
any equity or debt instruments with anti-dilution provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company issues or sells any common stock or common stock equivalents with terms that the purchaser holding the outstanding
June 2021 Convertible Debenture (the &#8220;Convertible Debenture Holder&#8221;) or the Class A and B Warrants reasonably believes are
more favorable to such holder than the terms of the June 2021 Convertible Debenture or the Class A and B Warrants, then upon notice to
the Company by such holder within five trading days after notice to such holder by the Company, the Company will use commercially reasonable
efforts to obtain the approval of the TSX-V and any additional required regulatory approval to amend the terms of the June 2021 Convertible
Debenture or the Class A and B Warrants as required, as the case may be, so as to give such holder the benefit of such more favorable
terms or conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conversion price of the June 2021 Convertible Debenture and the exercise price of the Class A and B Warrants are subject to proportional
adjustment in the event of stock splits, stock dividends and similar corporate events, including merger or consolidation of the Company
or in a &#8220;Fundamental Transaction&#8221; as defined in the June 2021 Convertible Debenture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has granted the holders certain rights of first refusal on its future offerings for as long as the June 2021 Convertible Debenture
or the Class A and B Warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may prepay and satisfy the June 2021 Convertible Debenture so long as an event of default has not occurred, upon 20 days&#8217;
prior written notice received by the Company to the holder, by paying 125% of the amounts owed on the June 2021 Convertible Debenture,
including all principal, interest and other fees. The holder of this debenture may, however, convert all or a portion of the debenture
during the 20-day notice period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended January 31, 2022, the Company issued an aggregate <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_ziF51MdCGQ0e" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></span> units on partial conversion of the June 2021 Convertible
Debenture, for a total of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3hpVdfVF2x6" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-012022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></span> common shares, <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zyKlivqr2mE9" title="Number of warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></span> Class A Warrants exercisable at a price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRwMHoVgLbm1" title="Warrants exerciable price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span> until June 10, 2026, and
<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ztsvid10aIgh" title="Number of warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></span> Class B Warrants exercisable at a price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zaWmuSPhPy5c" title="Warrants exerciable price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction></span> until June 10, 2026 <i>[note 13[b]]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, the Company incurred contractual interest of $<span id="xdx_905_ecustom--ContractualInterest_c20220128__20220131_zOGp9Aj3RRte" title="Contractual interest"><ix:nonFraction name="MLYF:ContractualInterest" contextRef="From2022-01-282022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,808</ix:nonFraction></span> (2021 &#8211; $<span id="xdx_903_ecustom--ContractualInterest_c20210128__20210131_zeKIbA9iXKri" title="Contractual interest"><ix:nonFraction name="MLYF:ContractualInterest" contextRef="From2021-01-282021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,521</ix:nonFraction></span>). The June 2021 Convertible Debenture
has an <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateBasisForEffectiveRate_dp_c20210128__20210131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zHerGo8S2WD1" title="Debt instrument interest rate description"><ix:nonNumeric contextRef="From2021-01-282021-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" name="us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate">effective interest rate of 1,348%</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[d]
Debt Host Liability and Embedded Derivative Liability</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the Company&#8217;s convertible debentures were determined to be hybrid financial instruments comprised of a debt host liability and
an embedded derivative liability, as under the conversion feature the number of shares that will or may be issued to settle the notes
may vary. The Company uses the Black-Scholes Option Pricing Model based on different default risks and assumptions. The debt host liability
of the convertible note will be measured at amortized cost, with the embedded derivative liability measured at fair value through profit
and loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
issuance date of the July 2020 Convertible Debenture, the fair value of its debt host liability was determined to be $<span id="xdx_90F_eus-gaap--DebtInstrumentFairValue_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zxxJEemTzaO3" title="Convertible debenture&apos;s debt host liability"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2022-01-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,083</ix:nonFraction></span> and the
respective embedded derivative liability was valued at $<span id="xdx_908_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zEmNdx2StsSf" title="Embedded derivative liability"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2021-11-012022-01-31_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,041</ix:nonFraction></span>. Fair value adjustments were made to the embedded derivative liability
of the July 2020 Convertible Debenture on conversion date of May 18, 2021, resulting in a value of $nil.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">On
issuance date of the June 2021 Convertible Debenture, it was determined to be a hybrid financial instrument comprised of a debt host
liability and an embedded derivative liability. The embedded derivative liability was valued at $<span id="xdx_904_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zlvMbw3ZOAcc" title="Embedded derivative liability"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2021-11-012022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,646,600</ix:nonFraction></span> which exceeded the face value
of the note itself of $<span id="xdx_90A_eus-gaap--DebtInstrumentFairValue_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zc3dFnTmRvxc" title="Debt instrument, fair value"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span>, the debt host liability was then assigned a face value of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zzRmhZOWsPvl" title="Debt host liability share, face value"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1</ix:nonFraction></span>, with an immediate loss of $<span id="xdx_909_eus-gaap--DerivativeLossOnDerivative_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zY3ujGUvLn8h" title="Loss on recognition of debt liability"><ix:nonFraction name="us-gaap:DerivativeLossOnDerivative" contextRef="From2021-11-012022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,601</ix:nonFraction></span> on
recognition of the debt host liability. As at October 31, 2021, its combined value was $<span id="xdx_906_eus-gaap--ConvertibleDebtCurrent_iI_c20211031__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z3F86BA8oL" title="Convertible debt combined value"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,449,744</ix:nonFraction></span>. On November 1, 2021, the Company&#8217;s
functional currency change resulted in the reclassification of the June 2021 Convertible Debenture from a hybrid financial instrument
accounted for in accordance with ASU 815-15 to a convertible debt instrument with a beneficial conversion feature accounted for in accordance
with ASU 470-20. The value of the embedded derivative liability was reclassified to additional paid-in capital and continues to amortize
the debt discount as interest costs over the period from the issuance date to the stated maturity date using the effective interest method.
During the three months ended January 31, 2022, the Company recorded interest expense on debt discount of $<span id="xdx_908_eus-gaap--AmortizationOfDebtDiscountPremium_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zvbwmTTMZHie" title="Amortization of debt discount premium"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-11-012022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,034</ix:nonFraction></span> which includes the
full amortization of the portions of the debt which were converted in the period. As at January 31, 2022, the debt discount had a carrying
value of $<span id="xdx_90F_ecustom--DebtDiscountCarryValue_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zxBhlmf9I1Kg" title="Debt discount carry value"><ix:nonFraction name="MLYF:DebtDiscountCarryValue" contextRef="From2021-11-012022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,199,966</ix:nonFraction></span>. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">On
issuance date of the July 2021 Convertible Debenture, it was determined to be a convertible debt instrument with a beneficial conversion
feature accounted for in accordance with ASU 470-20. The Company allocated the intrinsic value of the beneficial conversion feature of
the July 2021 Convertible Debenture capped at the face value of CA$<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_uCA_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zlNqM8o53hqk" title="Convertible debenture face value" style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature" contextRef="From2021-11-012022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">100,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zplnlkh46EOh" title="Convertible debenture face value"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature" contextRef="From2021-11-012022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,542</ix:nonFraction></span>) to additional paid-in capital. On
November 1, 2021, the Company&#8217;s functional currency change resulted in the reclassification of the July 2021 Convertible Debenture
to a hybrid financial instrument accounted for in accordance with ASU 815-15. The embedded derivative liability was valued at CA$<span id="xdx_90E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_uCA_c20220131__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zkmRRenRr7Xc"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2022-01-31_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">529,400</ix:nonFraction></span>
(USD equivalent $<span id="xdx_902_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zaJpIO4e5X79"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">421,095</ix:nonFraction></span>), the previous beneficial conversion feature was reversed out of additional paid-in capital, and a loss of CA$<span id="xdx_909_eus-gaap--AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_uCA_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z5bMANLnnbg2" title="Beneficial conversion feature additional paid-in capital and loss"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2021-11-012022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">429,400</ix:nonFraction></span>
(USD equivalent $<span id="xdx_905_eus-gaap--AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zslJLza3j9f5" title="Beneficial conversion feature additional paid-in capital and loss"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="From2021-11-012022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">341,553</ix:nonFraction></span>) was recognized in the statement of loss and comprehensive loss. As at January 31, 2022, the amortized cost
of the July 2021 Convertible Debenture&#8217;s debt host liability was CA$<span id="xdx_90A_eus-gaap--DebtInstrumentFairValue_iI_uCA_c20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleDebentureMember_zOEbqkm0K7d4"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">11,780</ix:nonFraction></span> (USD equivalent $<span id="xdx_90E_eus-gaap--DebtInstrumentFairValue_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleDebentureMember_z0QmI5lzmxI9"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,262</ix:nonFraction></span>) and the fair value of the embedded
derivative liability was CA$<span id="xdx_907_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_uCA_c20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleDebentureMember_z46z4MIwpeg2"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">269,300</ix:nonFraction></span> (USD equivalent $<span id="xdx_90F_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleDebentureMember_zokBuAiAPqVb" title="Fair value of embedded derivate liability"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,730</ix:nonFraction></span>), with a combined value of CA$<span id="xdx_903_eus-gaap--ConvertibleDebtCurrent_iI_uCA_c20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleDebentureMember_z3eScoofWEge" title="Convertible debt combined value"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">281,080</ix:nonFraction></span> (USD equivalent $<span id="xdx_902_eus-gaap--ConvertibleDebtCurrent_iI_c20220131__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleDebentureMember_zV7cUcocR7Z8" title="Convertible debt combined value"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember_custom_ConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,992</ix:nonFraction></span>). </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zE9iapVPiyx2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inputs used in the Black-Scholes Option Pricing Model are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;<span style="display: none"><span id="xdx_8B1_zEXPwMmX96qh">SCHEDULE
OF OPTION PRICING MODEL</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20220122__20220131_zh6PDXPBWNId" style="white-space: nowrap; font-weight: bold; text-align: center">January 31,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20211022__20211102_zCHP80zQ8Rr5" style="white-space: nowrap; font-weight: bold; text-align: center">November 1,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20211028__20211031_zSamBfyCFUVb" style="white-space: nowrap; font-weight: bold; text-align: center">October 31,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20210610__20210615_z246Q29vnWIb" style="font-weight: bold; text-align: center">June 15,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20200722__20200727_zud4YU7eV5c3" style="font-weight: bold; text-align: center">July 27,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_zm0pMs9s5OV" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Risk free rate of interest</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-222022-01-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.51</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-10-222021-11-02" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.07</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-10-282021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.08</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-06-102021-06-15" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.31</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2020-07-222020-07-27" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.26</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220122__20220131_zRiuTjhZ0hS6" title="Expected life in years"><ix:nonNumeric contextRef="From2022-01-222022-01-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">0.45</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20211022__20211102_zCiBXy2R4xv1" title="Expected life in years"><ix:nonNumeric contextRef="From2021-10-222021-11-02" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">0.70</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210922__20211031_zF5r5QtyR4Rh" title="Expected life in years"><ix:nonNumeric contextRef="From2021-09-222021-10-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.11</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210610__20210615_zGeyltZwUjK8" title="Expected life in years"><ix:nonNumeric contextRef="From2021-06-102021-06-15" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.50</ix:nonNumeric></span> year</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200722__20200727_znO7m3uIRhml" title="Expected life in years"><ix:nonNumeric contextRef="From2020-07-222020-07-27" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">0.74</ix:nonNumeric></span> year</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Conversion exercise price</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iE_uCAPShares_c20220122__20220131_z8gidPNYt1Gk" title="Conversion exercise price" style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iE_uCAPShares_c20211022__20211102_zo7bcWEN2c0a" title="Conversion exercise price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-11-02" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iE_c20210922__20211031_zkZRBbOnQ3va" title="Conversion exercise price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iE_c20210610__20210615_z9gP1CVxR167" title="Conversion exercise price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-06-15" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iE_uCAPShares_c20200722__20200727_zfgHhqrWLTzg" title="Conversion exercise price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2020-07-27" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Underlying share price of the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_906_ecustom--UnderlyingSharePriceOfTheCompany_iE_uCAPShares_c20220122__20220131_zDiLR1QbGo21" title="Underlying share price of the Company"><ix:nonFraction name="MLYF:UnderlyingSharePriceOfTheCompany" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.44</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_908_ecustom--UnderlyingSharePriceOfTheCompany_iE_uCAPShares_c20211022__20211102_zpQLR8Zbt49g" title="Underlying share price of the Company"><ix:nonFraction name="MLYF:UnderlyingSharePriceOfTheCompany" contextRef="AsOf2021-11-02" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.75</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_ecustom--UnderlyingSharePriceOfTheCompany_iE_c20210922__20211031_ztXCmjllDZQe" title="Underlying share price of the Company"><ix:nonFraction name="MLYF:UnderlyingSharePriceOfTheCompany" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.59</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_ecustom--UnderlyingSharePriceOfTheCompany_iE_c20210610__20210615_ztSAzf2iFNn3" title="Underlying share price of the Company"><ix:nonFraction name="MLYF:UnderlyingSharePriceOfTheCompany" contextRef="AsOf2021-06-15" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_900_ecustom--UnderlyingSharePriceOfTheCompany_iE_uCAPShares_c20200722__20200727_zR89fAzEmpoa" title="Underlying share price of the Company"><ix:nonFraction name="MLYF:UnderlyingSharePriceOfTheCompany" contextRef="AsOf2020-07-27" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_z6BJoPuqEpke" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-222022-01-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">109.11</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-10-222021-11-02" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">124.34</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-10-282021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">107.62</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-06-102021-06-15" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">87.17</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2020-07-222020-07-27" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82.54</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividend rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dxL_c20220122__20220131_z1b0k2v9DVJb" title="Expected dividend rate::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3895">Nil</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dxL_c20211022__20211102_zHZHbXThCvm2" title="Expected dividend rate::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3897">Nil</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dxL_c20210922__20211031_zfG1Fk4PBA1b" title="Expected dividend rate::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3899">Nil</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dxL_c20210610__20210615_zmHBNXtVEZpk" title="Expected dividend rate::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3901">Nil</span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dxL_c20200722__20200727_zgvDOz0OWYle" title="Expected dividend rate::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl3903">Nil</span></span></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zcCAq4dAI2oh" style="display: none; margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfDerivativeInstrumentsTextBlock_zskNJ4mvIPF3" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BF_z0n6spNVxHYe">SCHEDULE
OF DERIVATIVE INSTRUMENTS</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">July 2020 Convertible Debenture</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 2021 Convertible Debenture</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">July 2021 Convertible Debenture</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Debt Host Liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%">Balance, October 31, 2020</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_z3gIkwppsYG" title="Balance, beginning" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">96,318</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z4mXLyOTbDBh" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3908">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zhw3jXu2Yro1" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3909">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_z58tgkNmLnI1" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">96,318</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Value of debt host liability recognized</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ValueOfDebtHostLiabilityRecognized_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_pp0p0" title="Value of debt host liability recognized" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3912">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ValueOfDebtHostLiabilityRecognized_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z22DqAaPwEfe" style="text-align: right"><ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--ValueOfDebtHostLiabilityRecognized_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z1gh27XEJT1i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3914">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ValueOfDebtHostLiabilityRecognized_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zI0Btk9gc3u4" style="text-align: right"><ix:nonFraction name="MLYF:ValueOfDebtHostLiabilityRecognized" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accretion and interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AccretionExpense_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_pp0p0" title="Accretion and interest expense" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,587</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccretionExpense_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z3cWOfadIS8e" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccretionExpense_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z7QzyDHOA1o3" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AccretionExpense_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zLOjkhWQcJu7" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,693</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zTQuklKhYYpb" title="Conversion" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,560</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zmlAyXJBHSS8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3923">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zoTwPgEIEeoa" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3924">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zYu8ITqxiqRd" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,560</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_pp0p0" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,655</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zQc5Hwg2xQ3g" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3928">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_ztlpySLx6sD6" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3929">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_z4lME3lhCOAd" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,655</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance, October 31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zSDSsCFI4Xo4" title="Balance, beginning" style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3932">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z3O75ulmd4X4" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">44</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z2LZyWC8Y7G4" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_z4BEGw5OY8C1" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Effects of change in functional currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zaUgNZN7l3Ti" title="Effects of change in functional currency" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3937">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zqiS06YXNtK3" style="text-align: right"><ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zNjvlGnBSbd4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3939">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_z91Dts3n7rud" style="text-align: right"><ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accretion and interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AccretionExpense_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_z7r8xxBOaZU8" title="Accretion and interest expense" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3942">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccretionExpense_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zppjMtr1Gjvf" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">529</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccretionExpense_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zaY9skrKjMTg" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,244</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccretionExpense_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zMKvmOhUbFXi" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,773</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zS22ugFLM4nc" title="Conversion" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3947">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z0lkmgKe4Zs4" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">300,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z1mPAOJhMqLc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3949">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zzAceOoBuwG" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">300,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zbzCRrD3pEU4" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3952">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z1hOwN8Sa3s9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3953">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zxicDut3itrc" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">45</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_znaW4TqICJlb" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-012022-01-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">45</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zKgHjpIbTo4b" title="Balance, ending" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3957">&#8211;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zVmovj6SN2fg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_DebtHostLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,200,573</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_z3JUnltqwSM9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_DebtHostLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,262</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtHostLiabilityMember_zv5SDV5M6dIb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_DebtHostLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,209,835</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Embedded Derivative Liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zZfi0oXSMhnl" title="Balance, beginning" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,123</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z0VJcHIaXJSc" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3963">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zwdX4SkmXeE3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3964">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zouvUidfdw6h" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,123</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Fair value of embedded derivative liability recognized</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zqwh3Cp97mPi" title="Fair value of embedded derivative liability recognized" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3967">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z5OKEkFXPy9g" style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,646,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zJqtgDU1p9rf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3969">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zIrBeNA3Ko6h" style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,646,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fair value adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zNjRpgPoEPX2" title="Fair value adjustment" style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">16,058</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zTDyh2CIf9C" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,717,328</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zrjp3Xm6sAOk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3974">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zDo3cI4ERly2" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,701,270</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Conversion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_z7n31KF2qhkc" title="Conversion" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,247</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zK1yoS0WXCJi" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3978">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zqYwV4AzFJy3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3979">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DebtConversionConvertedInstrumentAmount1_iN_pp0p0_di_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zlY8D6AAUXM1" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,247</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_pp0p0" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,182</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zxyKzrAqEZ76" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">85,772</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zBimhws8nIM5" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3984">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zLOTFYyyxLA9" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2020-11-012021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">86,954</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance, October 31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zHj4eCky0fdl" title="Balance, beginning" style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3987">&#8211;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zTYBNr6G2DD7" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,449,700</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zFBxAhDIwLKe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3989">&#8211;</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConvertibleDebtCurrent_iS_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zEZYaJr5rJI6" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,449,700</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Effects of change in functional currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zDJsOE4JD1w6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3991">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_znti1Hk3Lqbc" style="text-align: right">(<ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,449,700</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zBwO8AiIqkA" style="text-align: right"><ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">421,094</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zr8PVUNbaVTk" style="text-align: right">(<ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,028,606</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Fair value adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zJJgkRk25JZc" title="Fair value adjustment" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3996">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zc9TmI7YvOt" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3997">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zjJX7Sv41uTa" style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">205,450</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zgcAAoUK9eul" style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">205,450</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zpINtYoPJmN5" title="Foreign currency translation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4001">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zKG1rxW1jDdd" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4002">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zak3bUa5Poyl" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,914</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zs68igDk5K4j" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextRef="From2021-11-012022-01-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,914</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zw8kDJFRo5e5" title="Balance, ending" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4006">&#8211;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zTmRPeODzJL3" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4007">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zPN7y6u3XK48" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_EmbeddedDerivativeLiabilityMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">211,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zieCbjyb337d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">211,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Debt Discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, October 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConvertibleDebt_iNS_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zCkdMsD9p2J2" title="Balance, beginning" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4011">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iNS_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zNf2AjlE4PMh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4012">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConvertibleDebt_iNS_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zSWP18x7wKw9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4013">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConvertibleDebt_iNS_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_z3LDWhKLlzX5" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4014">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Effects of change in functional currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zu5db6nSXE81" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4015">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zyc2tRjrQ9ah" style="text-align: right">(<ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zuweN4bj374e" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4017">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--EffectsOfChangeInFunctionalCurrency_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_zLbkLVS7sRR6" style="text-align: right">(<ix:nonFraction name="MLYF:EffectsOfChangeInFunctionalCurrency" contextRef="From2021-11-012022-01-31_custom_DebtDiscountMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,500,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zfndtcsiaJ0h" title="Amortization" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4020">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z6B9JGdQsbDl" title="Amortization" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-11-012022-01-31_custom_DebtDiscountMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">300,034</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zTNyfk0F8oub" title="Amortization" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4024">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_zDjTgh7Olnkf" title="Amortization" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-11-012022-01-31_custom_DebtDiscountMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">300,034</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConvertibleDebt_iNE_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zhCA2L5BI5W" title="Balance, ending" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4028">&#8211;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ConvertibleDebt_iNE_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zJTiUaVKyNDa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2022-01-31_custom_DebtDiscountMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,199,966</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConvertibleDebt_iNE_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zyHCyeoSa6Ah" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4030">&#8211;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConvertibleDebt_iNE_pp0p0_di_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_ztoTx8mIjEZk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2022-01-31_custom_DebtDiscountMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,199,966</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Combined Value of Convertible Debenture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, October 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zmyFTdwkxBda" title="Balance, ending" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,441</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_z5T8xGWIep1c" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4034">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zKim4gubOKba" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4035">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20191101__20201031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember_z5HZ7UdNSq8i" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2020-10-31_custom_CombinedValueOfConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,441</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Balance, October 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zfJ6I5dedTr3" title="Balance, ending" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4038">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zr0bjGMCnTC2" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,449,744</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zlBsmPDcHXFa" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20201101__20211031__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember_zcJnKEi7rM19" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2021-10-31_custom_CombinedValueOfConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,449,807</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, January 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211130__20220131__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zudahgfqMoce" title="Balance, ending" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4043">&#8211;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebentureMember_zbzY6ZlMMQC4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JuneTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">607</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember__us-gaap--FinancialInstrumentAxis__custom--JulyTwoThousandTwentyOneConvertibleDebentureMember_zrYwINMI2yqc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_CombinedValueOfConvertibleDebentureMember_custom_JulyTwoThousandTwentyOneConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">220,992</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConvertibleDebtCurrent_iE_pp0p0_c20211101__20220131__us-gaap--DebtInstrumentAxis__custom--CombinedValueOfConvertibleDebentureMember_zIjHUdGFwgA3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-01-31_custom_CombinedValueOfConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">221,599</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_znQgSocChsQi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[e]
Derivative Liability &#8211; Warrants and Broker Warrants</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2021, the Company&#8217;s functional currency change resulted in the reclassification of its outstanding warrants and broker
warrants denominated in the Canadian dollars as derivative liabilities measured at fair value through profit and loss. The previous
value of outstanding broker warrants was reversed out of additional paid-in capital, and the derivative liability of warrants
and broker warrants were valued at $<span id="xdx_907_eus-gaap--DerivativeLiabilities_iI_c20211102__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zoS0WlKHUlI6"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-11-02_custom_WarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,956,177</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_902_eus-gaap--DerivativeLiabilities_iI_c20211102__us-gaap--ClassOfWarrantOrRightAxis__custom--BrokerWarrantsMember_zGmP0Xhuce0e"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-11-02_custom_BrokerWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,811</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively. During the three months ended January 31, 2022, upon exercise of common share purchase warrants, a value of $<span id="xdx_901_ecustom--ExerciseOfCommonSharePurchaseWarrants_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zLmckJvEXk94" title="Exercise of common share purchase warrants"><ix:nonFraction name="MLYF:ExerciseOfCommonSharePurchaseWarrants" contextRef="From2021-11-012022-01-31_custom_WarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,481,052</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was reclassified from derivative liability
to share capital. As at January 31, 2022, the derivative liability of warrants and broker warrants were valued at $<span id="xdx_901_eus-gaap--DerivativeLiabilities_iI_c20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsMember_zCnlz3MAsEQc"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2022-01-31_custom_WarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,246,718</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90B_eus-gaap--DerivativeLiabilities_iI_c20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--BrokerWarrantsMember_z1PQHwPchYPe"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2022-01-31_custom_BrokerWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,670</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, resulting in a net loss in the quarter of $<span id="xdx_90A_eus-gaap--DerivativeLossOnDerivative_c20211101__20220131_zHuE1vNxWa78" title="Derivative, loss on derivative"><ix:nonFraction name="us-gaap:DerivativeLossOnDerivative" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,765,241</ix:nonFraction></span>.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
The Company uses the Black-Scholes Option Pricing Model based on default risks and assumptions as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zjZvGL5FpSZ4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82B_zTDouHnuaX47">SHARE CAPITAL</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]
Authorized capital</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authorized share capital consists of <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20220131_znet4y1GW3Ne" title="Common voting shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000,000</ix:nonFraction></span> common voting shares at par value of $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220131_zdqRVNWlpa1d" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]
Common shares issued</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fiscal
2021</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
In connection with the non-brokered private placement announced on September 10, 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2020, the Company closed the first tranche of the non-brokered private placement, issuing <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201119__20201120__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_ziV8pybTG3wj" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-11-192020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,599,171</ix:nonFraction></span> units at a price of
CA$<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20201120__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zhRnxKhSFlwl" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20201119__20201120__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_znHXvDo6gDu2" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-192020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">727,892</ix:nonFraction></span> (USD equivalent $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20201119__20201120__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zz58umhEfn67"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-192020-11-20_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">556,876</ix:nonFraction></span>), which had been received prior to October 31, 2020 and recorded
as an obligation to issue shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2021, the Company closed the second tranche of the non-brokered private placement, consisting of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210114__20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zJmzlEaph1Lh"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-142021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,337,914</ix:nonFraction></span> units at a price
of CA$<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zOqZC3suawu3"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210114__20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zBfb7vvm7Xi2"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-142021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">953,930</ix:nonFraction></span> (USD equivalent $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210114__20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_z99gpADytCf"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-142021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">749,435</ix:nonFraction></span>), of which $<span id="xdx_906_eus-gaap--CommonStockSharesSubscriptions_iI_c20210115__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zUAL5jk78b4h"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-01-15_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,996</ix:nonFraction></span> had been received prior to October 31,
2020 and recorded as an obligation to issue shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2021, the Company closed the third tranche of the non-brokered private placement consisting of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210128__20210129__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zd6Dq4JleAXc" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-282021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,382,303</ix:nonFraction></span> units at a price
of CA$<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210129__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zaVrBdbbnYHd" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210128__20210129__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zmrdOZeSYFdh" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-282021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">699,699</ix:nonFraction></span> (USD equivalent $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210128__20210129__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_z0rt6GUEEKKi"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-282021-01-29_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">547,496</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 24, 2021, the Company closed the fourth tranche of the non-brokered private placement consisting of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210323__20210324__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zFxMWIJ50cH5" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-03-232021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,172</ix:nonFraction></span> units at a price
of CA$<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210324__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zjlLp7hYPGF5" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210323__20210324__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_znFl6wt0ywdc" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-03-232021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">852,042</ix:nonFraction></span> (USD equivalent $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210323__20210324__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zHk5z5mhBLMd"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-03-232021-03-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFourMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">678,270</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 27, 2021, the Company closed the fifth and final tranche of the non-brokered private placement consisting of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210426__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_zsycVpwL4Mie" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">851,395</ix:nonFraction></span> units at a
price of CA$<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210424__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_zNQkcNqyF9qj" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-04-24_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210426__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_zr3Po3Gm4Eu1" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">110,681</ix:nonFraction></span> (USD equivalent $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210426__20210427__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveAndFinalMember_zLMl0MLHtk6d" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-04-262021-04-27_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheFiveAndFinalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,237</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
total, the Company issued an aggregate <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zsr3QXloicMk" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,724,955</ix:nonFraction></span> units at a price of CA$<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zMIPerByMCee" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-10-31_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for aggregate gross proceeds of CA$<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zQwyIbaO4pea" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">3,344,244</ix:nonFraction></span> (USD
equivalent $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zM6QGrci4Zf9" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,621,314</ix:nonFraction></span>). <span id="xdx_906_ecustom--IssuanceOfSharesDescription_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zxFzGCROHg0g"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire
a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche</ix:nonNumeric></span>. The
Company incurred aggregate share issue costs of $<span id="xdx_90E_eus-gaap--PaymentsOfStockIssuanceCosts_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zbdUQokwcdTa"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">195,614</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
On May 5, 2021, the Company announced a non-brokered private placement priced at CA$<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20210505__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_z83by36CN60j" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-05-05_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit to raise gross proceeds of up to CA$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210504__20210505__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__srt--RangeAxis__srt--MaximumMember_zEYYTte4fWm9" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-05-042021-05-05_custom_NonBrokeredPrivatePlacementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,000,000</ix:nonFraction></span>.
On May 28, 2021, the Company closed the first tranche of the non-brokered private placement issuing <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210527__20210528__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zvD8u7KQrT1c" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-05-272021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,223,420</ix:nonFraction></span> units at a price of CA$<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210528__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_ztaRZD4tXH8h" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span>
per unit for gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210527__20210528__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zgs2hiu1B6gg" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-05-272021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">679,044</ix:nonFraction></span> (USD equivalent $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210527__20210528__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zKil9uaeut9c"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-05-272021-05-28_custom_NonBrokeredPrivatePlacementMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">561,844</ix:nonFraction></span>). On June 17, 2021, the Company closed the second and final tranche
of the non-brokered private placement consisting of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTwoAndFinalMember_z7uLe8Yy6kF9" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,853,506</ix:nonFraction></span> units at a price of CA$<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTwoAndFinalMember_zLF76u2m7Es6" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for gross proceeds of CA$<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTwoAndFinalMember_zk56CTU7Btuj" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,320,956</ix:nonFraction></span>
(USD equivalent $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210616__20210617__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTwoAndFinalMember_zeYIcfPm3fk"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-06-162021-06-17_custom_NonBrokeredPrivatePlacementMember_custom_ShareBasedCompensationAwardTrancheTwoAndFinalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,880,687</ix:nonFraction></span>). The Company issued total of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementOneMember_zEs7XiDUKPEa" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,076,926</ix:nonFraction></span> units at a price of CA$<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementOneMember_z5yF3rVv1zZ2" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-10-31_custom_NonBrokeredPrivatePlacementOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per unit for total gross proceeds of
CA$<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_uCA_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementOneMember_zVBHWqtdcWa9" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">3,000,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementOneMember_zdvO6XRSqBn7" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,442,531</ix:nonFraction></span>). <span id="xdx_904_ecustom--IssuanceOfSharesDescription_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementOneMember_zdKPWa1TudGh" title="Issuance of shares, description"><ix:nonNumeric contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementOneMember" name="MLYF:IssuanceOfSharesDescription">Each unit issued consists of one common share and one common share purchase warrant entitling
the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective
financing tranche</ix:nonNumeric></span>. The Company incurred aggregate share issue costs of $<span id="xdx_90F_eus-gaap--PaymentsOfStockIssuanceCosts_c20201101__20211031__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementOneMember_zZoyc7xt20sk" title="Shares issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-11-012021-10-31_custom_NonBrokeredPrivatePlacementOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,336</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iii]
On May 18, 2021, the Company issued a total of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210517__20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zHjbCRq3Wali" title="Common stock shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-05-172021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,360,959</ix:nonFraction></span> common shares on the conversion of the July 2020 Convertible Debenture including
accrued interest and <span id="xdx_90D_eus-gaap--ConversionOfStockSharesIssued1_c20210517__20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zTaF5oZIS7V2" title="Convertiable common shares"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2021-05-172021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">263,973</ix:nonFraction></span> common shares valued at $<span id="xdx_900_eus-gaap--ConversionOfStockAmountIssued1_pp0p0_c20210517__20210518__us-gaap--DebtInstrumentAxis__custom--JulyTwoThousandTwentyConvertibleDebentureMember_zdVsq7F9Ww47" title="Conversion of stock value"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2021-05-172021-05-18_custom_JulyTwoThousandTwentyConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,286</ix:nonFraction></span> in transaction costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iv]
On June 7, 2021, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210606__20210607__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zVxW82fEZFtc"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-06-062021-06-07_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,538,461</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20210607__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z1XiQYEtXPug"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-06-07_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.24</ix:nonFraction></span> per share with a total fair value of CA$<span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_uCA_c20210607__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zpWYa3mDnvbg" title="Fair value of assets"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-06-07_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">369,231</ix:nonFraction></span> (USD
equivalent $<span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210607__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zhEdI6slNfPa" title="Fair value of assets"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-06-07_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">305,832</ix:nonFraction></span>) for equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[v]
On July 16, 2021, the Company closed a non-brokered private placement and issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210714__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zfBHuq5uXNj7" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-07-142021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,350,000</ix:nonFraction></span> units at a price of CA$<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zBMaPf01Q0t4" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.20</ix:nonFraction></span> per unit for gross
proceeds of CA$<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_uCA_c20210714__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zzSXSwPopylc" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-07-142021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">870,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_c20210714__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_z8JA8w2olKB2" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-07-142021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">690,860</ix:nonFraction></span>). <span id="xdx_90A_ecustom--IssuanceOfSharesDescription_c20210714__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zqxjCEl0UFPd" title="Issuance of shares, description"><ix:nonNumeric contextRef="From2021-07-142021-07-16_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit consists of one common share and one common share purchase warrant entitling
the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing</ix:nonNumeric></span>. The Company
incurred aggregate share issue costs of $<span id="xdx_901_eus-gaap--PaymentsOfStockIssuanceCosts_pp0p0_c20210714__20210716__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zZbVP91BNj6k" title="Shares issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-07-142021-07-16_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,319</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[vi]
On August 11, 2021, the Company closed a non-brokered private placement and issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zsGLQJUfiya4" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,827,601</ix:nonFraction></span> units at a price of CA$<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zoOulZqVyj6h" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.55</ix:nonFraction></span> (US$<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zs4hXhzL0Pzb" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></span>) per
unit for gross proceeds of CA$<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_uCA_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_z2eDB4tCfcD3" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">2,105,180</ix:nonFraction></span> (USD equivalent $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zn3KChh2cptd" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,683,336</ix:nonFraction></span>). <span id="xdx_901_ecustom--IssuanceOfSharesDescription_c20211101__20220131__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zsNfXSL3Mm57" title="Issuance of shares, description"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_NonBrokeredPrivatePlacementMember" name="MLYF:IssuanceOfSharesDescription">Each unit consists of one common share and one common share purchase
warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 (US$0.52) for a period of eighteen months
from the date of closing</ix:nonNumeric></span>. The Company incurred aggregate share issue costs of $<span id="xdx_903_eus-gaap--PaymentsOfStockIssuanceCosts_c20210810__20210811__us-gaap--SubsidiarySaleOfStockAxis__custom--NonBrokeredPrivatePlacementMember_zpVbwrAjr5R1" title="Shares issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-08-102021-08-11_custom_NonBrokeredPrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,923</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[vii]
During the year ended October 31, 2021, the Company issued a total of <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHf3wRorvrE7" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-10-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,014,969</ix:nonFraction></span> common shares on the exercise of common share purchase
warrants at a price ranging from CA$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_uCAPShares_c20211031__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zh82UpsbsUNl" title="Exercise of warrants price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_srt_MinimumMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> to CA$<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_uCAPShares_c20211031__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z44UzAHTDLEk" title="Exercise of warrants price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-10-31_srt_MaximumMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.21</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_904_eus-gaap--ProceedsFromWarrantExercises_pp0p0_uCA_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4GGoFZGlQ12" title="Proceeds from stock warrants erercised"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2020-11-012021-10-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">1,120,130</ix:nonFraction></span> (USD equivalent $<span id="xdx_90F_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVsjxL39C1K2" title="Proceeds from stock warrants erercised"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2020-11-012021-10-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">887,520</ix:nonFraction></span>). A total of
<span id="xdx_90A_ecustom--CommonStockWarrantsExpiredUnexercised_iI_pid_c20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5UCouv7hiz1" title="Common stock warrants expired unexercised"><ix:nonFraction name="MLYF:CommonStockWarrantsExpiredUnexercised" contextRef="AsOf2021-10-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">525,173</ix:nonFraction></span> warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[viii]
During the year ended October 31, 2021, the Company issued a total of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBAzh0XPGmHk" title="Number of stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,630,000</ix:nonFraction></span> common shares on the exercise of stock options at a price
ranging from CA$<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_z2QlLaMcpfKh" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-10-31_us-gaap_StockOptionMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> to CA$<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_z2NCMjCe9IPf" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-10-31_us-gaap_StockOptionMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_90F_eus-gaap--ProceedsFromStockOptionsExercised_pp0p0_uCA_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9gdUUdtndif" title="Proceeds from stock options erercised"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">175,800</ix:nonFraction></span> (USD equivalent $<span id="xdx_90D_eus-gaap--ProceedsFromStockOptionsExercised_pp0p0_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zpKEA46ZHPr5" title="Proceeds from stock options erercised"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,734</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ix]
With respect to the exercises of common share purchase warrants and options, the Company reclassified $<span id="xdx_903_eus-gaap--ProceedsFromOtherEquity_c20201101__20211031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVPc3LusbDW9"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2020-11-012021-10-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,291</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVyymFsDWH0i"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,932</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, from additional paid-in capital to share capital during the year ended October 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fiscal
2022</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[i]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer was eligible to receive up to 5% of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $<span id="xdx_903_eus-gaap--CommonStockValue_iI_pn6n6_c20180829__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember__srt--RangeAxis__srt--MaximumMember_zax3ZdVtnqj6"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2018-08-29_custom_DirectorAndOfficersMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">5</ix:nonFraction></span> million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
<span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_c20211103_z7O9M3lZfoB1" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,163,425</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pid_uCAPShares_c20211103_zPtpbDLMHbo6" title="Common shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.65</ix:nonFraction></span> per share with a total fair value of CA$<span id="xdx_907_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_uCA_c20211103_z0JF4Jp79mCi" title="Fair value of assets"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">5,956,226</ix:nonFraction></span> (USD equivalent $<span id="xdx_90B_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211103_zR11OWNRbPg3" title="Fair value of assets"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-11-03" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,796,832</ix:nonFraction></span>) as share
issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ii]
On November 4, 2021, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20211101__20211104__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebenturesMember_zu5h73jkTVqj"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2021-11-012021-11-04_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units on partial conversion of the June 2021
Convertible Debenture, for a total of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20211101__20211104__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMzVWV6MCErg"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-11-012021-11-04_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares, <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211104__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_znxLDELA9Tdc"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-11-04_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A Warrants exercisable at a price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211104__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_zckailVwIPy9"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-11-04_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">until June 10, 2026, and <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211104__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zZYqeXT9rP7d"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-11-04_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class B Warrants exercisable at a price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211104__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zK6nXGHs9hje"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-11-04_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">until June 10, 2026. On December 13, 2021, the
Company issued a further <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20211212__20211213__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebenturesMember_zi0OQkfetec"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2021-12-122021-12-13_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units on partial conversion of the June 2021
Convertible Debenture, for a total of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20211212__20211213__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6VyY2Lb0YT8"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-12-122021-12-13_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares, <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211213__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_zVMygqA0bsK3"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-12-13_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A Warrants exercisable at a price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211213__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_zJQkfeQMe7c2"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-13_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">until June 10, 2026, and <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211213__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zFAjdqofOxb"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-12-13_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class B Warrants exercisable at a price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211213__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zycxEypvS0Z3"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-13_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">until June 10, 2026. On January 20, 2022, the
Company issued a further <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220119__20220120__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebenturesMember_zCPNbOYYboM1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-01-192022-01-20_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units on partial conversion of the June 2021
Convertible Debenture, for a total of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20220119__20220120__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwmlIrvLWnia"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2022-01-192022-01-20_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares, <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220120__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zdQpSyKWtW8b"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-20_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A Warrants exercisable at a price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220120__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_zaxD4jEwrv6"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-20_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">until June 10, 2026, and <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220120__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zsKvXxJ04jKh"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-20_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class B Warrants exercisable at a price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220120__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_ziXxSupUWrMd"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-20_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">until June 10, 2026. The Company incurred aggregate
share issue costs of $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20220119__20220120__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zDuatfIVPVA"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2022-01-192022-01-20_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,361</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iii]
On November 26, 2021, the Company closed a non-brokered private placement and issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211125__20211126__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zaSSVpZEkWw1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-11-252021-11-26_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,375,499</ix:nonFraction></span> units at a price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20211126__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zejPGOgcQgqg"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-11-26_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.55</ix:nonFraction></span> per unit for
gross proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20211125__20211126__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zUvbxqIMSf2f"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-11-252021-11-26_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">756,524</ix:nonFraction></span>. Each unit consists of one common share and one common share purchase warrant entitling the holder thereof
to acquire a further common share at a price of $<span id="xdx_90F_eus-gaap--SharePrice_iI_c20211126__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zoAnN9QvUzXf"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-11-26_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction></span> for a period of one year from the date of closing. The Company incurred aggregate
share issue costs of $<span id="xdx_908_eus-gaap--PaymentsOfStockIssuanceCosts_c20211125__20211126__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zmvOF3iDqbQe"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-11-252021-11-26_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,656</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[iv]
During the three months ended January 31, 2022, upon exercise of common share purchase warrants, the Company issued an aggregate <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zgTLrbMAoFe2" title="Shares purchase of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-31_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,159,448</ix:nonFraction></span>
common shares at a price CA$<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zDSU5Hr0vPxj"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-01-31_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_uCA_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zSrYVmApotE6"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-01-31_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,880,295</ix:nonFraction></span> (USD equivalent $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zH3s4dUw9Sua"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-01-31_custom_CommonStockOneMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,279,136</ix:nonFraction></span>), <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_zyUFJaOOjLR5"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-31_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span> common shares at a
price of CA$<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_zJqgv5LgP7N6"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-01-31_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_uCA_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_zn6oQcSvYBj9"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-01-31_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">10,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_z1QNzFAn0iGc"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-01-31_custom_CommonStockTwoMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,830</ix:nonFraction></span>), and <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockThreeMember_zQaaXnqC1Cgc"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-31_custom_CommonStockThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,000</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockThreeMember_zDpSGcYpOu39"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-01-31_custom_CommonStockThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.30</ix:nonFraction></span> per
share for gross proceeds of CA$<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_uCA_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockThreeMember_zvPj7jRwOxZc"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-01-31_custom_CommonStockThreeMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">9,000</ix:nonFraction></span> (USD equivalent $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__custom--CommonStockThreeMember_zyZAVbRtHv5g"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-01-31_custom_CommonStockThreeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,981</ix:nonFraction></span>). The Company issued a total of <span id="xdx_90F_ecustom--ClassOfWarrantOrRightUnexercisedOfWarrantsOrRights1_iI_c20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zr8H5ZWxEbbd"><ix:nonFraction name="MLYF:ClassOfWarrantOrRightUnexercisedOfWarrantsOrRights1" contextRef="AsOf2022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,389,448</ix:nonFraction></span> common shares for gross proceeds
of CA$<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_uCA_c20211130__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjd88TaTY699"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-302022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,899,295</ix:nonFraction></span> (USD equivalent $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmqMgN5EDB2h"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-11-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,293,946</ix:nonFraction></span>). A total of <span id="xdx_900_ecustom--ClassOfWarrantOrRightUnexercisedOfWarrantsOrRights1_iI_c20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zti3aiiCMpid"><ix:nonFraction name="MLYF:ClassOfWarrantOrRightUnexercisedOfWarrantsOrRights1" contextRef="AsOf2022-01-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,428,363</ix:nonFraction></span> warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]
Common share purchase warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zEZDy9i2Js" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the changes in the Company&#8217;s common share purchase warrants during the three months ended January 31, 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zmOSTarJddgi" style="display: none">SUMMARY
OF CHANGES IN COMMON SHARE PURCHASE WARRANTS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td>
    <td id="xdx_48A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_ze3m7Fwq81bc" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Expiry Date</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price<br /> ($)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_487_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_zgqnvgEq2ds3" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_zomh37xKIBdh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_488_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_zELqisQ2TcZ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_zjM3fyEwHTj6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_zGxysPvZ2bC1" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Expiry Date</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price<br /> ($)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_414_20211101__20220131__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zD53nBztjGx6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 5%">&#160;</td>
    <td style="width: 46%"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 22, 2021</ix:nonNumeric></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zaPIrIdRKuW1" title="Exercise price" style="font: 10pt Times New Roman, Times, Serif"><span title="Class of Warrant or Right, Exercise Price of Warrants or Rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,160,021</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4251">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,080,573</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">79,448</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4254">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20211101__20220131__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zaEpz3H0Ko3h" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">January 17, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zg5J8ujGg94h" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,267,914</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4259">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,959,396</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,308,518</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4262">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_416_20211101__20220131__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zhxyKtkq3Aw3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">January 31, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zO2b4IQemwWl" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,382,303</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4267">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,341,906</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,040,397</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4270">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41A_20211101__20220131__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zgYVzmf9lDs5" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">February 21, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zWsKfAKGEk4" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zfQ0O43bl854" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.06</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,505,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4275">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4276">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4277">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,505,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_413_20211101__20220131__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zpGXmZI5ieZ9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 24, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_z7OmIbeyxcCh" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--MarchTwentyFourTwoThousandTwentyTwoMember_zCjhsIkPax96" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.14</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,341,872</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4284">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">570,046</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4286">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_MarchTwentyFourTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,771,826</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41B_20211101__20220131__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zt8MYi6kHOg2" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 27, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zvit3DJdW3z4" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zEB7lJ1nov63" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.15</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">982,025</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4293">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4294">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4295">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">982,025</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_416_20211101__20220131__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_z8XTGKLTZvIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">April 27, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_z7NLfj8wOrH1" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--AprilTwentySevenTwoThousandTwentyTwoMember_zHsU6d1Iu1q2" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.24</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">791,395</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4302">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4304">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_AprilTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">741,395</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41E_20211101__20220131__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zuSY2ys0Dogk" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">May 9, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zsNMrS2M3GO6" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_ztiLnPIVwKtb" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.27</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,813,725</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4311">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4312">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4313">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,813,725</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_411_20211101__20220131__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zeqKwtbOKyQh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">May 30, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zvw4VXvO4ANg" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--MayThirtyTwoThousandTwentyTwoMember_zMtsaMfNI1Gb" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.33</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,223,420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4320">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,527</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4322">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_MayThirtyTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,175,893</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_412_20211101__20220131__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zy0ivyoynHCc" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">June 17, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zl2XBaaJXQz2" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--JuneSeventeenTwoThousandTwentyTwoMember_zH1vSZFCgns9" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.38</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,703,506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4329">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">110,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4331">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_JuneSeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,593,506</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_416_20211101__20220131__us-gaap--AwardDateAxis__custom--JulyEighteenTwoThousandTwentyTwoMember_z3kTrMxNVglg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">July 18, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--JulyEighteenTwoThousandTwentyTwoMember_zB5l6gKWvXn3" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.30</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--JulyEighteenTwoThousandTwentyTwoMember_zWDHxeTZUwO" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.46</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_JulyEighteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4338">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4340">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_JulyEighteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,320,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_412_20211101__20220131__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zVuDOypbbrg5" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 14, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zX47Q8QFWaI1" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_z01c2bGh3qsi" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.53</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4347">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4349">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4350">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41D_20211101__20220131__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_zvOnLSYUedl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">February 13, 2023</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCAPShares_c20220131__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_z17aVrZBnbp5" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.65</ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--FebruarythirteenTwoThousandTwentyThreeMember_zRyacUgrUhy7" style="padding-bottom: 1.5pt; text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">1.04</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,827,601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4356">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4357">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4358">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_FebruarythirteenTwoThousandTwentyThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,827,601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Subtotal</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_zQ2Z9ynmwuMf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_PurchaseWarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,548,982</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_zKBsjqrDWej9" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4364">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_zbWh3SJalKd2" title="Exercised" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,389,448</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_zQOGVFxu3zZb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,428,363</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_zzMDdHx88AG5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_PurchaseWarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">41,731,171</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average exercise price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_uCAPShares_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_zMRNQ1S8Jlwg" title="Weighted average exercise price, beginning"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-10-31_custom_PurchaseWarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.22</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted_pid_uCAPShares_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_zeTQrq2KDMmd" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4371">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised_uCAPShares_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_zTkzbO1jmt26" title="Weighted average exercise price, exercised"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled_uCAPShares_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_z2nu01gkYVEa" title="Weighted average exercise price, expired/cancelled"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCAPShares_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantOneMember_ztf6zqD4P086" title="Weighted average exercise price, ending"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-01-31_custom_PurchaseWarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.23</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41C_20211101__20220131__us-gaap--AwardDateAxis__custom--NovemberTwentySevenTwoThousandTwentyTwoMember_zNzd8tXfFvgc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 27, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220131__us-gaap--AwardDateAxis__custom--NovemberTwentySevenTwoThousandTwentyTwoMember_zfBAwkD3ZPab" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--NovemberTwentySevenTwoThousandTwentyTwoMember_zvfCWS0opRQi" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.82</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4379">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,375,499</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4381">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4382">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_NovemberTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,375,499</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_411_20211101__20220131__us-gaap--AwardDateAxis__custom--JuneTenTwoThousandTwentySixMember_z81SpSxUr9nf" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">June 10, 2026</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220131__us-gaap--AwardDateAxis__custom--JuneTenTwoThousandTwentySixMember_zSDend4O3tx5" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_JuneTenTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--JuneTenTwoThousandTwentySixMember_zUyQPZP6iHn9" style="text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_JuneTenTwoThousandTwentySixMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">4.36</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4388">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4390">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4391">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_JuneTenTwoThousandTwentySixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_410_20211101__20220131__us-gaap--AwardDateAxis__custom--JuneTenTwoThousandTwentySixOneMember_zK5mcdIh1YL1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">June 10, 2026</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220131__us-gaap--AwardDateAxis__custom--JuneTenTwoThousandTwentySixOneMember_zdwHElNb5rOd" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_JuneTenTwoThousandTwentySixOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220131__us-gaap--AwardDateAxis__custom--JuneTenTwoThousandTwentySixOneMember_zZ9rwnfvJZC" style="padding-bottom: 1.5pt; text-align: right"><ix:nonNumeric contextRef="AsOf2022-01-31_custom_JuneTenTwoThousandTwentySixOneMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">4.36</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4397">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_JuneTenTwoThousandTwentySixOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4399">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4400">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_JuneTenTwoThousandTwentySixOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Subtotal</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_zS6oyfv7yHsh" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4405">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_z5R0w95OdFgc" title="Granted" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,375,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_zpf1y00BtOTi" title="Exercised" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4409">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_zpjRO677Fp84" title="Expired/Cancelled" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4411">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_zqEPkjNwbLn8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_PurchaseWarrantTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,375,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average exercise price</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_zkQ5l0aI24i6" title="Weighted average exercise price, beginning" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4414">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$<span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_z77XPWDnLWsl" title="Weighted average exercise price, granted"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_z5EA48D6XGP7" title="Weighted average exercise price, exercised" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4418">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zN6mps3Ba8Zf" title="Weighted average exercise price, expired/cancelled" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4420">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$<span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantTwoMember_zD2FEPlZZ0k" title="Weighted average exercise price, ending"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-01-31_custom_PurchaseWarrantTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zz4U5rtvCmm2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-10-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,548,982</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zd4T9ZHe2Y7c" title="Granted" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,375,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zfifMmOHiLMg" title="Exercised" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,389,448</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zvQN72qZHIt" title="Expired/Cancelled" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-11-012022-01-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,428,363</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20211101__20220131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_z7hrG371PULh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-01-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">46,106,670</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the changes in the Company&#8217;s common share purchase warrants during the three months ended January 31, 2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Expiry Date</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uCAPShares_zuyWvxnHDAQ5" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Exercise Price</b><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>($)</b></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_zrWlq0xcjaT5" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_zm6oYCt2jw5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_z4MHh4MPzOHc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_ztI776xPxzlc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/ Cancelled</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_z5IHDBCnr7bi" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Expiry Date</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price<br /> ($)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_410_20201101__20210131__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_zaDeKESZEqya" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 5%">&#160;</td>
    <td style="width: 46%"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20210131__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_znzhlpxLwtNj" title="Expiry Date"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 31, 2021</ix:nonNumeric></ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif"></span></td><td id="xdx_F20_zARZtMXFkFW1" style="width: 1%">*</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_uCAPShares_c20210131__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_fKg_____zCm9Unp42Dka" title="Class of Warrant or Right, Exercise Price of Warrants or Rights"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" id="Fact004446" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.21</ix:nonFraction></ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210131__us-gaap--AwardDateAxis__custom--AugustThirtyOneTwoThousandTwentyOneMember_zEoMybmI4tF9" style="width: 4%; text-align: right"><ix:nonNumeric contextRef="AsOf2021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.58</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction></ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl4433"><span style="-sec-ix-hidden: xdx2ixbrl4439">&#160;</span></span></td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4434"><span style="-sec-ix-hidden: xdx2ixbrl4440">&#8211;</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4435"><span style="-sec-ix-hidden: xdx2ixbrl4441">&#8211;</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_AugustThirtyOneTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction></ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20201101__20210131__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_z0wdnOXcDcob" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20210131__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zS852O4JonAe"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 22, 2021</ix:nonNumeric></ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210131__us-gaap--AwardDateAxis__custom--NovemberTwentyTwoTwoThousandTwentyOneMember_zVXGYNe7Wu4" style="text-align: right"><ix:nonNumeric contextRef="AsOf2021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.80</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4449"><span style="-sec-ix-hidden: xdx2ixbrl4455">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,599,171</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4451"><span style="-sec-ix-hidden: xdx2ixbrl4457">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4452"><span style="-sec-ix-hidden: xdx2ixbrl4458">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_NovemberTwentyTwoTwoThousandTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,599,171</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_415_20201101__20210131__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zEB0JX9FCxOi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20210131__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zEi61ALzbYi9"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">January 17, 2022</ix:nonNumeric></ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210131__us-gaap--AwardDateAxis__custom--JanuarySeventeenTwoThousandTwentyTwoMember_zNSkwK8Qlvdg" style="text-align: right"><ix:nonNumeric contextRef="AsOf2021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.96</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4463"><span style="-sec-ix-hidden: xdx2ixbrl4469">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,337,914</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4465"><span style="-sec-ix-hidden: xdx2ixbrl4471">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4466"><span style="-sec-ix-hidden: xdx2ixbrl4472">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_JanuarySeventeenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,337,914</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41E_20201101__20210131__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_z7GVGPD5Sib" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20210131__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zA3g60drkZXh"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">January 31, 2022</ix:nonNumeric></ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210131__us-gaap--AwardDateAxis__custom--JanuaryThirtyOneTwoThousandTwentyTwoMember_zdiEnKCw1sH5" style="text-align: right"><ix:nonNumeric contextRef="AsOf2021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">0.99</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4477"><span style="-sec-ix-hidden: xdx2ixbrl4483">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,382,303</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4479"><span style="-sec-ix-hidden: xdx2ixbrl4485">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4480"><span style="-sec-ix-hidden: xdx2ixbrl4486">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_JanuaryThirtyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,382,303</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41E_20201101__20210131__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zkD2i3eCV4Oe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20210131__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zlZ3vGCdtBU2"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">February 21, 2022</ix:nonNumeric></ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210131__us-gaap--AwardDateAxis__custom--FebruaryTwentyOneTwoThousandTwentyTwoMember_zsBt9j9ndvZk" style="text-align: right"><ix:nonNumeric contextRef="AsOf2021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">1.06</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,505,200</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4492"><span style="-sec-ix-hidden: xdx2ixbrl4498">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4493"><span style="-sec-ix-hidden: xdx2ixbrl4499">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4494"><span style="-sec-ix-hidden: xdx2ixbrl4500">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_FebruaryTwentyOneTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,505,200</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41B_20201101__20210131__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_z13pY2EPWUw3" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20210131__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zM8Em7TJuHV4"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 27, 2022</ix:nonNumeric></ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210131__us-gaap--AwardDateAxis__custom--MarchTwentySevenTwoThousandTwentyTwoMember_zsxmO3H58jQe" style="text-align: right"><ix:nonNumeric contextRef="AsOf2021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">1.15</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,482,025</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4506"><span style="-sec-ix-hidden: xdx2ixbrl4512">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4507"><span style="-sec-ix-hidden: xdx2ixbrl4513">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4508"><span style="-sec-ix-hidden: xdx2ixbrl4514">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_MarchTwentySevenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,482,025</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41A_20201101__20210131__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zodR62U800h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20210131__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_z4sY2bqSqffe"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">May 9, 2022</ix:nonNumeric></ix:nonNumeric></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210131__us-gaap--AwardDateAxis__custom--MayNineTwoThousandTwentyTwoMember_zs68TVoansA" style="text-align: right"><ix:nonNumeric contextRef="AsOf2021-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">1.27</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,368,626</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4520"><span style="-sec-ix-hidden: xdx2ixbrl4526">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4521"><span style="-sec-ix-hidden: xdx2ixbrl4527">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4522"><span style="-sec-ix-hidden: xdx2ixbrl4528">&#8211;</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_MayNineTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,368,626</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41A_20201101__20210131__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zqeoWnINh9Ze" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20201101__20210131__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_zegngmHoc0N2"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 14, 2022</ix:nonNumeric></ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210131__us-gaap--AwardDateAxis__custom--AugustFourteenTwoThousandTwentyTwoMember_z5BP6uazAxV3" title="Weighted average life (years)" style="padding-bottom: 1.5pt; text-align: right"><ix:nonNumeric contextRef="AsOf2021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">1.53</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,110,000</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4534"><span style="-sec-ix-hidden: xdx2ixbrl4540">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4535"><span style="-sec-ix-hidden: xdx2ixbrl4541">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4536"><span style="-sec-ix-hidden: xdx2ixbrl4542">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_AugustFourteenTwoThousandTwentyTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,110,000</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zXreClRuaiZ4" title="Beinning balance" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2020-10-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,109,642</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zUMvj7WLOZ5a" title="Granted" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-11-012021-01-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,319,388</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_ztmMWCepMIY6" title="Exercised" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4552">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zXrghKLyTus9" title="Expired/Cancelled" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4554">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zUK3xQRqamQc" title="Ending balance" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-01-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,429,030</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average exercise price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCAPShares_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_za5E419bss1h" title="Weighted average exercise price, beginning"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-10-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.11</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted_pid_uCAPShares_c20201101__20211031__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zE9x5km7H2Q5" title="Weighted average exercise price, granted"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted" contextRef="From2020-11-012021-10-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised_pid_uCAPShares_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zPIR8UV9XQGd" title="Weighted average exercise price, exercised" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4562">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExpiredCancelled_pid_uCAPShares_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zN8Gvvxgq90d" title="Weighted average exercise price, expired/cancelled" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4564">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCAPShares_c20201101__20210131__us-gaap--ClassOfWarrantOrRightAxis__custom--PurchaseWarrantMember_zk9aU0C36hxi" title="Weighted average exercise price, ending"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-01-31_custom_PurchaseWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.15pc"><span id="xdx_F0F_z2CUs02mT737" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
  <td style="text-align: center"><span id="xdx_F11_zHsmSOWjnLml" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote004567" xml:lang="en-US">The Company received approval of the TSX-V on January 13, 2021
and amended the expiry date of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210113_zH87X6nfoFK6" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQ0hBTkdFUyBJTiBDT01NT04gU0hBUkUgUFVSQ0hBU0UgV0FSUkFOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-01-13" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,643,791</ix:nonFraction></span> warrants, <span id="xdx_909_ecustom--WarrantsAndRightsOutstandingMaturityDateDescription_pid_c20210112__20210113_z3f9yWx5n4If" title="Maturity date, description" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQ0hBTkdFUyBJTiBDT01NT04gU0hBUkUgUFVSQ0hBU0UgV0FSUkFOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonNumeric contextRef="From2021-01-122021-01-13" name="MLYF:WarrantsAndRightsOutstandingMaturityDateDescription">extending the expiry date from January 17, 2021 to August 31, 2021</ix:nonNumeric></span>, subject to acceleration if the closing price of the Company&#8217;s shares exceeds CA$<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uCAPShares_c20210113_zzENe52AxzEf" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQ0hBTkdFUyBJTiBDT01NT04gU0hBUkUgUFVSQ0hBU0UgV0FSUkFOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-01-13" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.30</ix:nonFraction></span> per common share for at least <span id="xdx_90C_ecustom--NumberOfMinimumConsecutiveTradingDays_iI_uDays_c20210113_zyPxhG5lRxtg" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNVTU1BUlkgT0YgQ0hBTkdFUyBJTiBDT01NT04gU0hBUkUgUFVSQ0hBU0UgV0FSUkFOVFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="MLYF:NumberOfMinimumConsecutiveTradingDays" contextRef="AsOf2021-01-13" format="ixt:numdotdecimal" decimals="INF" unitRef="Days">10</ix:nonFraction></span> consecutive trading days.</ix:footnote></span></td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AC_zoSf3Xm84AR5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[d]
Stock options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted an incentive stock option plan, effective on August 8, 2017 and as amended on August 8, 2018, under the rules of
the TSX-V pursuant to which it is authorized to grant stock options to executive officers, directors, employees and consultants, enabling
them to acquire up to <span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentage_iI_pid_dp_uPure_c20180808__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__srt--RangeAxis__srt--MaximumMember_zYUkcA5gXV16" title="Percentage of authorized grant stock options"><ix:nonFraction name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentage" contextRef="AsOf2018-08-08_custom_TwoThousandSeventeenStockOptionPlanMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% of the total shares outstanding of the Company (the &#8220;2017 Stock Option Plan&#8221;). Under the 2017 Stock
Option Plan, the option exercise price of any option granted shall not be less than the discounted market price of the Company&#8217;s
common shares. For the purposes of the 2017 Stock Option Plan, the discounted market price is calculated in accordance with the policies
of the TSX-V at the time of the grant of the options. <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_c20211101__20220131__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember_zaB5uUUg7lW2" title="Stock option granted terms"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_TwoThousandSeventeenStockOptionPlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms">Stock options granted are subject to a maximum term of 5 years. All options granted
shall vest immediately, except for those options granted to persons performing investor relations activities for the Company</ix:nonNumeric></span>. Pursuant
to the policies of the TSX-V, shares issued upon the exercise of options are restricted from trading during the 4-month period subsequent
to the exercise of options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2021, the Company adopted the 2021 Equity Incentive Plan which replaces the 2017 Stock Option for providing stock-based compensation
to directors, officers, employees, consultants, and advisors of the Company and no further options will be granted under the 2017 Stock
Option Plan. Under the 2021 Equity Incentive Plan, the Company is authorized to issue up <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20210611__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_pdd" title="Number of shares authorized to issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2021-06-11_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,312,368</ix:nonFraction></span> shares of the Company. In addition,
any common shares reserved for issuance under the 2017 Stock Option Plan that are forfeited as a result of the expiration or termination
of any awards under that plan after the date of adoption of the 2021 Equity Incentive Plan will be added to the 2021 Equity Incentive
Plan. As of January 31, 2022, <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20220131__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zoMqhoYPwxi5"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2022-01-31_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,730,000</ix:nonFraction></span> stock options forfeited under the 2017 Stock Option Plan were added to the 2021 Equity Incentive
Plan (October 31, 2021 &#8211; <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_uShares_c20201101__20211031__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zP2XpjKnme03" title="Number of stock options forfeited"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2020-11-012021-10-31_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,730,000</ix:nonFraction></span>). The 2021 Equity Incentive Plan provides for various equity-based and cash-based incentive
awards, including incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock and restricted stock
units, performance awards, dividend equivalents and other equity-based or cash-based awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2020, the Company granted <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201229__20201230__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember_zGNnJjdoyH1k" title="Number of stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-12-292020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,650,000</ix:nonFraction></span> stock options pursuant to its 2017 Stock Option Plan to its directors, officers, employees
and consultants at a price of CA$<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_uCAPShares_c20201230__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember_zKI2d6bZYWzg" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> per share, of which <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20201230__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__us-gaap--AwardDateAxis__custom--ExercisableAtFiveYearsMember_zsQkzzTqDesi" title="Number of stock options exercisable"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember_custom_ExercisableAtFiveYearsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></span> were exercisable for a period of five years and <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20201230__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockOptionPlanMember__us-gaap--AwardDateAxis__custom--ExercisableAtTwoYearsMember_zZp3pU8BNoek" title="Number of stock options exercisable"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-12-30_custom_TwoThousandSeventeenStockOptionPlanMember_custom_ExercisableAtTwoYearsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,150,000</ix:nonFraction></span> were exercisable
for a period of two years. However, these options exceeded the maximum allowed under the Company&#8217;s 2017 Stock Option Plan. On June
11, 2021, the Company received shareholders&#8217; approval to amend the Company&#8217;s 2017 Stock Option Plan to increase the number
of common shares reserved for issuance under such plan and rectified the grant of these options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 30, 2021, the Company granted <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210829__20210830__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zCF3EC6jASR9" title="Number of stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-08-292021-08-30_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,700,000</ix:nonFraction></span> incentive stock options pursuant to its 2021 Equity Incentive Plan to its directors,
officers, employees and consultants. These options are exercisable at a price of CA$<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20210830__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zliKiQKQ7Hn"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-08-30_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.70</ix:nonFraction></span> per share for a period of <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_pid_dc_c20210829__20210830__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zPudVJXwXvAa"><ix:nonNumeric contextRef="From2021-08-292021-08-30_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">five years</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2021, the Company granted <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210929__20211001__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z8b9vRjCDHl" title="Number of stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-09-292021-10-01_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></span> incentive stock options pursuant to its 2021 Equity Incentive Plan to its officer and
employee and consultants. These options are exercisable at a price of CA$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_uCAPShares_c20211001__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zcsRn7FhOCIk" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-10-01_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.50</ix:nonFraction></span> per share for a period of <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dc_c20210929__20211001__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z7fcUxBZWO9g" title="Options exercisable period"><ix:nonNumeric contextRef="From2021-09-292021-10-01_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">five years</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 3, 2021, the Company granted <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20211202__20211203__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z0YXhCA3kNF3"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-12-022021-12-03_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></span> incentive stock options pursuant to its 2021 Equity Incentive Plan to an employee. These
options are exercisable at a price of CA$<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_uCAPShares_c20211203__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zsPUu8GdkxM5"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-12-03_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.58</ix:nonFraction></span> per share for a period of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dc_c20211202__20211203__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zXJAWevhBhl6"><ix:nonNumeric contextRef="From2021-12-022021-12-03_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">five years</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, the maximum number of common shares available under the 2021 Equity Incentive Plan was <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220131__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zMMaclQ8zAG4"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2022-01-31_custom_TwoThousandTwentyOneEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,042,368</ix:nonFraction></span>, of which <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220131_zDPgb9BNm6N2"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,642,368</ix:nonFraction></span>
remained available for grant thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months January 31, 2022, the Company recognized a stock-based compensation totaling $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20211101__20220131_zUOHwqIySId2"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,575</ix:nonFraction></span> (2021 &#8211; $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20201101__20210131_z6NzSoevqODj"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,048,990</ix:nonFraction></span>) in relation
to the grant of its stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
weighted average grant date fair value of the stock options granted during the three months ended January 31, 2022 was CA$<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_uCAPShares_c20211101__20220131__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zbOsMllYFQb6"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-11-012022-01-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.50</ix:nonFraction></span> (2021
&#8211; CA$<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_uCAPShares_c20201101__20211031__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zUPMALeAPXh"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-11-012021-10-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.09</ix:nonFraction></span>) per option. Option pricing models require the use of highly subjective estimates and assumptions including expected
stock price volatility. Changes in the underlying assumptions can materially affect the fair value estimates. The fair value of stock
options was estimated on the measurement date using the Black-Scholes Option Pricing Model. The assumptions used to calculate the fair
value were as follows:</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zEGVbXU7ukd3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zvUXMNWdV9N9" style="display: none">SCHEDULE
OF ASSUMPTIONS USED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Risk free rate of interest</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20211101__20220131_zHUoasZttaH8" title="Risk free rate of interest"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.34</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20201101__20211031_zrUZsTsQLjg9" title="Risk free rate of interest, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.20</ix:nonFraction></span>% &#8211; <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20201101__20211031_z4vHGpPPthA3" title="Risk free rate of interest, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.07</ix:nonFraction></span>%</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20211101__20220131_zc0E6ZKqfxv8" title="Expected life of options"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20201101__20211031__srt--RangeAxis__srt--MinimumMember_z45S8Ry8ysRd" title="Expected life of options"><ix:nonNumeric contextRef="From2020-11-012021-10-31_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2</ix:nonNumeric></span> to <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20201101__20211031__srt--RangeAxis__srt--MaximumMember_z3JktQ8YYAy1" title="Expected life of options"><ix:nonNumeric contextRef="From2020-11-012021-10-31_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercise price of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uCAPShares_c20220131_zXahoxGtSrZ" title="Exercise price of options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.58</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA$<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uCAPShares_c20211031__srt--RangeAxis__srt--MinimumMember_zpsfQyR07H72" title="Exercise price of options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2021-10-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span> &#8211; CA$<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_dtY_uCAPShares_c20211031__srt--RangeAxis__srt--MaximumMember_zMsHzNp6Bgfi" title="Exercise price of options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2021-10-31_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.70</ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected annualized volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20211101__20220131_zrODzBbT2EAc" title="Expected annualized volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">136.08</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20201101__20211031_zlyHgad3em33" title="Expected annualized volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">130.88</ix:nonFraction></span>% &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20201101__20211031_zcVIStuRta65" title="Expected annualized volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">140.05</ix:nonFraction></span>%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Expected dividend rate</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dxL_uPure_c20211101__20220131_zbjEm7jBAa75" title="Expected dividend rate::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl4636">Nil</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dxL_uPure_c20201101__20211031_zbTkuijAWrV9" title="Expected dividend rate::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl4638">Nil</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_z7opcGVA1Ss5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" continuedAt="ConU004643-01" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_gL3SOSBCSOATT-ZHYZW_zpksZ3zuRKxl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the changes in the Company&#8217;s stock options during the three months ended January 31, 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8BC_zPl5C2ayKgaa" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF STOCK OPTIONS ACTIVITY</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td id="xdx_485_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_zK1rXp0Hmq45" style="border-bottom: Black 1.5pt solid; font-weight: bold">Expiry Date</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48F_eus-gaap--SharePrice_iE_pid_uCAPShares_zlrXi4aBM9n3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price<br /> (CA$)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_zKxrqU2K5xj6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_482_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_z8ICMICez0C8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_483_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_zCGfHZl1vq26" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_zYPiVTpMSXgj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_zTBcAzYnyOI" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_zrOqc1G7vf3a" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_415_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionOneMember_zc92RoFk7OB6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 7%">&#160;</td>
    <td style="width: 37%"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 27, 2022</ix:nonNumeric></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionOneMember_zrzj5tsqj5lf" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">0.15</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4647">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4648">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,250,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,250,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_415_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zjlaY7DN0x08" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 30, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zbD5dl4Xc5ok" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">0.91</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4657">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4658">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4659">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41D_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zn9OZvlXr948" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionThreeMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 12, 2023</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zTWoErN645P4" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionThreeMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.53</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,290,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4667">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4668">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,540,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,540,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_413_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionFourMember_z2UnVx2EdB05" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionFourMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 3, 2023</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionFourMember_zeZz6uY1liff" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionFourMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.84</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4677">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4678">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,950,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,950,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_413_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionFiveMember_zLV9IPMcc8lj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionFiveMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">May 22, 2024</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionFiveMember_zzckxyzxC4R1" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionFiveMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.31</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4687">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4688">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-012022-01-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,400,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,400,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionSixMember_zaeeHUMEwguc" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionSixMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 3, 2024</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionSixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionSixMember_zeqru1fUVSP8" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionSixMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.76</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionSixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4697">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4698">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4699">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionSixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionSixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41A_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionSevenMember_zryTdlggDdsk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionSevenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 24, 2024</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionSevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionSevenMember_z4rnX9reYaz5" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionSevenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.82</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionSevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4707">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4708">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4709">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionSevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionSevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_411_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionEightMember_zezgsH6tHOvf" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionEightMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 26, 2025</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionEightMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionEightMember_zPX29BQ92OQ2" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionEightMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.15</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionEightMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4717">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4718">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4719">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionEightMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionEightMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_410_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionNineMember_zwRZLU0Ggvbe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionNineMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">April 23, 2025</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionNineMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionNineMember_zxz36q0fgAVd" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionNineMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.23</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionNineMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4727">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4728">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4729">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionNineMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionNineMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_413_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionTenMember_zvwSEiQtnqn4" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionTenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 30, 2025</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionTenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionTenMember_z5JLiKEM1Nw6" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionTenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.92</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4737">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4738">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4739">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionTenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionTenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionElevenMember_z75rKMONq0Oi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionElevenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 30, 2026</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionElevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionElevenMember_zA8H1WdoebRg" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionElevenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.58</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionElevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4747">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4748">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4749">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionElevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionElevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,475,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionTwelveMember_zoYEpqW7TLbl" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionTwelveMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">October 1, 2026</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionTwelveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionTwelveMember_z7jR1jsR1Kyi" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionTwelveMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.67</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31_custom_OptionTwelveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4757">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4758">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4759">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionTwelveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionTwelveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_411_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionThirteenMember_z7uhYtzOi5Jc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionThirteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 3, 2026</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2022-01-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.58</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionThirteenMember_zK67wmOcUHo1" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionThirteenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.84</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4766">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-012022-01-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4768">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4769">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20211101__20220131_zfBXMFvo1hA2" title="Total outstanding, beginning balance" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">61,260,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20211101__20220131_zeCu9Q1DAT3j" title="Total granted" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20211101__20220131_z9TMjcN1Yf2j" title="Total exercised" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4779">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20211101__20220131_zRCtsh7zOpG7" title="Total exprired, cancelled" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20211101__20220131_zZAUJfNi1S05" title="Total outstanding, ending balance" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,510,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20211101__20220131_ztXRHkflBQPd" title="Total vested" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,285,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average exercise price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_uCAPShares_c20211101__20220131_zC6dtQuwvoQ" title="Weighted average exercise price, beginning balance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.33</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_uCAPShares_c20211101__20220131_zG7cEowenvH4" title="Weighted average exercise price, granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.58</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_uCAPShares_c20211101__20220131_zNfO5NcvGDZ7" title="Weighted average exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl4791">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_uCAPShares_c20211101__20220131_zIc2oWLgsnce" title="Weighted average exercise price, expired/cancelled"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_uCAPShares_c20220131_zNONMKTSRfD1" title="Weighted average exercise price, ending balance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.34</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_uCAPShares_c20211101__20220131_zaKuKLIA7pwk" title="Weighted average exercise price, vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.33</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20211101__20220131_zzKXXibfNf55" title="Aggregate intrinsic value, outstanding" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,994,025</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20211101__20220131_za2J4vpRhEak" title="Aggregate intrinsic value, outstanding" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,886,548</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_c20211101__20220131_z6gXzlogtRld" title="Aggregate intrinsic value, vested" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2022-01-31" format="ixt:numdotdecimalin" decimals="0" unitRef="USD">4,93,542</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average remaining life</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20211101__20220131_zxaxATkpHywe" title="Weighted average remaining life, outstanding"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt-sec:duryear" name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">3.46</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131_zEQz3NaMvIS2" title="Weighted average remaining life, outstanding"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.27</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20211101__20220131_zq8J9mywMcR1" title="Weighted average remaining life, vested"><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">3.26</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zcEwFYWRcd59" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"><p id="xdx_898_eus-gaap--ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_zSeZJcqYLro5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the changes in the Company&#8217;s nonvested stock options during the year ended January 31, 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zch4OTOSV0y6" style="display: none">SCHEDULE
OF NONVESTED STOCK OPTIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td id="xdx_483_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedExpirationDate_dd_zpm1SplEMBE" style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiry Date</b></span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uCAPShares_z4kr7ntfUd82" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Per Share<br />
(CA$)</b></span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Life (Years)</b></span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_zDLO9HNZwMja" style="border-bottom: Black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Nonvested</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>as at</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>October&#160;31,</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2021</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_pid_z8MI86c0ktLh" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted</b></span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_489_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_pid_zAla72n6l9La" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_pid_di_zMkvxS3ooUNh" style="border-bottom: Black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Expired/</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Cancelled</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_z2qoP2CIcoog" style="border-bottom: Black 1.5pt solid; white-space: nowrap">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Nonvested</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>as at</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>January&#160;31,</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2022</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_411_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionOneMember_znoW8i7MxEE5" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 5%">&#160;</td>
    <td style="width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionOneMember" format="ixt:datemonthdayyearen" name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedExpirationDate">December 30, 2022</ix:nonNumeric></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-11-012022-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.07</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionOneMember_zP9JqV0vtnfa" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionOneMember" format="ixt-sec:duryear" name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm2">1.16</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-10-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,500</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4815">&#8211;</span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2021-11-012022-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">162,500</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4817">&#8211;</span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4818">&#8211;</span></span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr id="xdx_412_20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zV9lBMNGDetl" style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" format="ixt:datemonthdayyearen" name="MLYF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedExpirationDate">August 30, 2026</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.56</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm2_dtY_c20211101__20220131__us-gaap--AwardTypeAxis__custom--OptionTwoMember_z76pxrMfAqxg" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" format="ixt-sec:duryear" name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm2">4.83</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-10-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4824">&#8211;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2021-11-012022-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">75,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4826">&#8211;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20211101__20220131_zp0ha7YsUou8" title="Total nonvested, beginning balance" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">462,500</ix:nonFraction></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_c20211101__20220131_zmTuA4tYnqmj" title="Total nonvested, granted" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4833">&#8211;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1_c20211101__20220131_zEE8WTYrl5e6" title="Total nonvested, vested" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(<ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares1" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">237,500</ix:nonFraction></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20211101__20220131_zDfOMqsdF0wg" title="Total nonvested, expired, cancelled" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4837">&#8211;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20211101__20220131_zXS8N8T33OWh" title="Total nonvested, ending balance" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Weighted average grant date fair value &#8211; per option</b></p></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_uCAPShares_c20211101__20220131_zMU4lUEuzPt5" title="Weighted average grant date fair value per option, beginning balance"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.39</ix:nonFraction></span></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_uCAPShares_c20211101__20220131_zxnqLGEjZeZ6" title="Weighted average grant date fair value per option, granted"><span style="-sec-ix-hidden: xdx2ixbrl4843">&#8211;</span></span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_uCAPShares_c20211101__20220131_z8A9xIpYObt8" title="Weighted average grant date fair value per option, vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.22</ix:nonFraction></span></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_uCAPShares_c20211101__20220131_zmXa43WPWtnl" title="Weighted average grant date fair value per option, expired, cancelled"><span style="-sec-ix-hidden: xdx2ixbrl4847">&#8211;</span></span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_uCAPShares_c20211101__20220131_zcKVUJGW7NLf" title="Weighted average grant date fair value per option, ending balance"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.56</ix:nonFraction></span></b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Weighted average grant date fair value &#8211; total</b></p></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageGrantDateFairValue_iS_c20211101__20220131_zjKMITvsogG2" title="Weighted average grant date fair value total, beginning balance" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageGrantDateFairValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,131</ix:nonFraction></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsWeightedAverageGrantDateFairValue_c20211101__20220131_zuhMcwdtebli" title="Weighted average grant date fair value total, granted" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4853">&#8211;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValueTotal_c20211101__20220131_z38UwlZrW5Ga" title="Weighted average grant date fair value total, vested" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValueTotal" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,571</ix:nonFraction></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValueTotal_c20211101__20220131_zvQqlV1bh5i7" title="Weighted average grant date fair value total, expired, cancelled" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl4857">&#8211;</span></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueTotal_iE_c20211101__20220131_zberdGXOMs55" title="Weighted average grant date fair value total, ending balance" style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonFraction name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueTotal" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,764</ix:nonFraction></b></span></td>
    <td>&#160;</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A3_zsgWBNQBCD7e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0B_gL3SOSBCSOATT-ZHYZW_zkoUbeMqtDqk"><ix:continuation continuedAt="ConU004643-02" id="ConU004643-01">A
summary of the changes in the Company&#8217;s stock options during the three months ended January 31, 2021 are as follows:</ix:continuation></span></span></p>

<div id="xdx_C0F_gL3SOSBCSOATT-ZHYZW_zHe1TLHWgwC"><ix:continuation continuedAt="ConU004643-03" id="ConU004643-02"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_133_zIDPkb9m2LSh" summary="xdx: Disclosure - SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td id="xdx_482_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_z1p5xqDv46V5" style="border-bottom: Black 1.5pt solid; font-weight: bold">Expiry Date</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--SharePrice_iE_pid_uCAPShares_zYUGlZui7fT4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price<br /> (CA$)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_481_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_zDDvdD71upR4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_482_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_z5v03taWM8e7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_483_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_zACSlf743aSb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_488_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_zhptTmjvZRJ2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expired/</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cancelled</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_481_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_zwPf0DlwvYw4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_484_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_zcEqmOOlMIjg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_413_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionOneMember_zpzBjpJOh0t2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 9%">&#160;</td>
    <td style="width: 35%"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionOneMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">February 11, 2021</ix:nonNumeric></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionOneMember_zOcT6p8YAve3" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionOneMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">0.03</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4863">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4864">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4865">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_41C_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zxH9TyA1vztd" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionTwoMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 16, 2021</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zalS0vcFc8Xj" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionTwoMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">0.54</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4873">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4874">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4875">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_412_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zn9R5WicXLnh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionThreeMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 27, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zxHaOQDd0Nek" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionThreeMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.15</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,750,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4883">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4884">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4885">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,750,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionThreeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,750,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41D_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionFourMember_zLlek4q8c4z8" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionFourMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 26, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4893">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4894">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionFourMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4896">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4897">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionFiveMember_zXUrxBYO8cP8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionFiveMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 30, 2022</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionFiveMember_zNomk4bRE5G2" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionFiveMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.91</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4900">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,150,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4902">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4903">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,150,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionFiveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_410_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionSixMember_zAA3h5QFIDrl" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionSixMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">April 19, 2023</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionSixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionSixMember_zjuEEtteu692" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionSixMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.21</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4911">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4912">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4913">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionSixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionSixMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_410_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionSevenMember_zMJMArK3Piha" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionSevenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">August 12, 2023</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionSevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionSevenMember_zy4U5NYZ3cI9" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionSevenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.53</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionSevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,120,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4921">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4922">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4923">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionSevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,120,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionSevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,120,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41D_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionEightMember_zg5kE36zXKBc" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionEightMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 3, 2023</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionEightMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionEightMember_zHDL1xEPxXU1" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionEightMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.84</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionEightMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4931">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4932">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4933">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionEightMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionEightMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41E_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionNineMember_zxGxGeKA5W65" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionNineMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">May 22, 2024</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionNineMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionNineMember_zJOTSGgZ3yYk" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionNineMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.31</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionNineMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,950,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4941">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4942">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4943">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionNineMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,950,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionNineMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,950,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionTenMember_zB4xySF4tldk" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionTenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 3, 2024</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionTenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.15</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionTenMember_zB2jogirsGgg" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionTenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.76</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4951">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4952">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4953">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionTenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionTenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_410_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionElevenMember_z0GwXWrLa0fa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionElevenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">November 24, 2024</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionElevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionElevenMember_zriEiZ3Qtuhh" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionElevenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.82</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionElevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4961">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4962">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4963">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionElevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionElevenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_416_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionTwelveMember_zFKsj87q0hU7" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionTwelveMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">March 26, 2025</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionTwelveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionTwelveMember_zzCmAZ6tSTx5" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionTwelveMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.15</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionTwelveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4971">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4972">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4973">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionTwelveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionTwelveMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41B_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionThirteenMember_z4qN9niBpnLl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionThirteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">April 23, 2025</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionThirteenMember_zSCss0lpMNI6" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionThirteenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.23</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4981">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4982">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionThirteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,512,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41F_20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionFourteenMember_ztbKkg1O22Yj" style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionFourteenMember" format="ixt:datemonthdayyearen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">December 30, 2025</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2021-01-31_custom_OptionFourteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131__us-gaap--AwardTypeAxis__custom--OptionFourteenMember_zOgF55eiH2zg" title="Weighted average life (years)"><ix:nonNumeric contextRef="From2020-11-012021-01-31_custom_OptionFourteenMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.92</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4990">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31_custom_OptionFourteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4992">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4993">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionFourteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31_custom_OptionFourteenMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20201101__20210131_zBiq5mjYw6m8" title="Total outstanding, beginning balance" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,420,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20201101__20210131_zeWVo9ypkKS" title="Total granted" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,650,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercised1_c20201101__20210131_zWYxf7QkyGkh" title="Total exercised" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5003">&#8211;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20201101__20210131_zzgiwDSg8Lrj" title="Total exprired, cancelled" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20201101__20210131_z2Y610pJKUBd" title="Total outstanding, ending balance" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">43,270,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20201130__20210131_zkg75umg4yN" title="Total vested" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,432,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average exercise price</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_uCAPShares_c20201101__20210131_z2IXoEpZukAf" title="Weighted average exercise price, beginning balance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.09</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_uCAPShares_c20201101__20210131_z26ZPPvH4mVf" title="Weighted average exercise price, granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_uCAPShares_c20201101__20210131_zNF3slNNP1Vh" title="Weighted average exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl5015">&#8211;</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_uCAPShares_c20201101__20210131_zd1Y5AU87328" title="Weighted average exercise price, expired/cancelled"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2020-11-012021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.13</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_uCAPShares_c20201101__20210131_zsjvtrzXrDlh" title="Weighted average exercise price, ending balance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.10</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CA$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_uCAPShares_c20201101__20210131_zHWbYGsqYnG2" title="Weighted average exercise price, vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.10</ix:nonFraction></span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Aggregate intrinsic value</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20201101__20210131_zVkiKoBVrPe7" title="Aggregate intrinsic value, outstanding" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">801,922</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20201101__20210131_zVBOyCYTfoU" title="Aggregate intrinsic value, outstanding" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">743,918</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_c20201101__20210131_zhLcrilPQWV2" title="Aggregate intrinsic value, vested" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">801,892</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">Weighted average remaining life</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20201101__20210131_zzZGpTwLXZrj" title="Weighted average remaining life, outstanding"><ix:nonNumeric contextRef="From2020-11-012021-01-31" format="ixt-sec:duryear" name="MLYF:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">3.18</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20201101__20210131_zbrFQhXfvG01" title="Weighted average remaining life, outstanding"><ix:nonNumeric contextRef="From2020-11-012021-01-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.23</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20201101__20210131_zq468aNVFFWh" title="Weighted average remaining life, vested"><ix:nonNumeric contextRef="From2020-11-012021-01-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">3.24</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C0E_gL3SOSBCSOATT-ZHYZW_z59p8FCrszWa"><ix:continuation id="ConU004643-03">&#160;</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
intrinsic value of options exercised during the three months ended January 31, 2022 was $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dxL_c20211101__20220131_z6kkmXzcwgt1" title="Intrinsic value of options exercised::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl5035">nil</span></span> (2021 &#8211; $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dxL_c20201101__20210131_ziHhqBr9emH7" title="Intrinsic value of options exercised::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl5037">nil</span></span>) as no options were exercised
during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[e]
Share-based payments and other reserves</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
share-based payments and other reserves are used to recognize the fair value of stock options granted to directors, officers, employees
and consultants as part of their remuneration, as well as those of broker warrants issued in relation to the Company&#8217;s financings.
When stock options and broker warrants are subsequently exercised, the fair value of such stock options and broker warrants in additional
paid-in capital is credited to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
share purchase warrants attached to units as part of a unit placement were assigned a $nil value. The residual method is used to calculate
the fair value of the warrant component of units issued, whereby the residual of the private placement proceeds less the fair value of
the share component is assigned as the fair value of the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2021, the Company&#8217;s functional currency change resulted in the reclassification of its outstanding warrants and broker
warrants denominated in the Canadian dollars as derivative liabilities. The previous value of outstanding broker warrants was
reversed out of additional paid-in capital. On November 1, 2021, the Company&#8217;s functional currency change resulted in the
reclassification of the June 2021 Convertible Debenture from a hybrid financial instrument to a convertible debt instrument with a beneficial
conversion feature. The value of the embedded derivative liability was reclassified to additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[f]
Obligations to issue shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, the Company received advance share subscriptions in the amount of $<span id="xdx_907_eus-gaap--CommonStockSharesSubscriptions_iI_c20220131_zpN8xI99p2D7" title="Common stock shares subscriptions"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,741</ix:nonFraction></span> (October 31, 2021 &#8211; $<span id="xdx_905_eus-gaap--CommonStockSharesSubscriptions_iI_c20211031_zDUhywl6qWf8" title="Common stock shares subscriptions"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,827</ix:nonFraction></span>) in
respect of warrants exercised subsequent to the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[g]
Dilutive common shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at January 31, 2022, potentially dilutive common shares relating to common share purchase warrants and options outstanding totaling <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20211101__20220131_zavt6kaCzDp6" title="Antidilutive securities excluded from computation of earnings per share amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">105,616,670</ix:nonFraction></span>
(October 31, 2021 &#8211; <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20201101__20211031_zbXx5HyBHNj6" title="Antidilutive securities excluded from computation of earnings per share amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-11-012021-10-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">120,808,982</ix:nonFraction></span>) were not included in the computation of loss per share as the effect would be anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 146; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="MLYF:CapitalManagementTextBlock"><p id="xdx_80D_ecustom--CapitalManagementTextBlock_zUQvvyWdivd3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zEkTUejICQQl">CAPITAL MANAGEMENT</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies the components of shareholders&#8217; equity as capital, which at January 31, 2022, was a deficiency of $<span id="xdx_90F_eus-gaap--StockholdersEquity_iNI_di_c20220131_zxQLd2GAUK0g" title="Stockholders deficit"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,422,277</ix:nonFraction></span>
(October 31, 2021 &#8211; $<span id="xdx_906_eus-gaap--StockholdersEquity_iNI_di_c20211031_za5uNcd7FYJ4" title="Stockholders equity"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,770,038</ix:nonFraction></span>). When managing capital, the Company&#8217;s objective is to ensure the entity continues as a going
concern and advance stakeholders&#8217; interests. Management adjusts the capital structure as necessary in order to support its business
and technology development. The Company&#8217;s board of directors does not establish qualitative return on capital criteria for management,
but rather relies on the expertise of the Company&#8217;s management to sustain future development of the business. The Company focuses
on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and the development
of a full-scale commercial magnesium production facility. The Company is considered to be in the development stage and is dependent upon
external financing to fund its activities. In order to carry out its business development activities and pay for administrative costs,
the Company will spend its existing working capital and raise additional amounts as needed. Management reviews its capital management
approach on an ongoing basis and believes that this approach, given the relative size of the Company, is appropriate. There were no changes
in the Company&#8217;s approach to capital management during the period. The Company is not subject to any externally imposed capital
requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_800_eus-gaap--FairValueDisclosuresTextBlock_z66HHkbiahli" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_826_zzZcdGFTXMk2">FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><p id="xdx_89D_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zcddnqKSIwqe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s classification of its financial instruments is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<span id="xdx_8BA_zXvuVSWsnb79" style="display: none">SCHEDULE
OF CLASSIFICATION OF ITS FINANCIAL INSTRUMENTS</span></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Instruments</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Measurement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Associated Risk</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 8.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value at</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.05in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>January 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 8.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 16%; text-align: center">FVTPL</td><td style="width: 2%">&#160;</td>
    <td style="width: 20%; text-align: center">Credit and currency</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20220131_zqXdIRslpgf3" title="Cash" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,522</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amounts receivable</td><td>&#160;</td>
    <td style="text-align: center">Amortized cost</td><td>&#160;</td>
    <td style="text-align: center">Credit and currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ReceivablesFairValueDisclosure_iI_c20220131_z5FkFWlG9dlh" title="Amounts receivable" style="text-align: right"><ix:nonFraction name="us-gaap:ReceivablesFairValueDisclosure" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">235,821</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deposits held by related parties</td><td>&#160;</td>
    <td style="text-align: center">Amortized cost</td><td>&#160;</td>
    <td style="text-align: center">Credit and currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DepositsFairValueDisclosure_iI_c20220131_zOGyFb7e66td" title="Deposits held by related parties" style="text-align: right"><ix:nonFraction name="us-gaap:DepositsFairValueDisclosure" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">565,741</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: center">Amortized cost</td><td>&#160;</td>
    <td style="text-align: center">Currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_c20220131_zWaEbczrwbp1" title="Accounts payable and accrued liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,552,509</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Due to related parties</td><td>&#160;</td>
    <td style="text-align: center">Amortized cost</td><td>&#160;</td>
    <td style="text-align: center">Currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--DueToRelatedPartiesFairValueDisclosure_iI_c20220131_zNS0y4JQcW1c" title="Due to related parties" style="text-align: right"><ix:nonFraction name="MLYF:DueToRelatedPartiesFairValueDisclosure" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,092,786</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible debenture</td><td>&#160;</td>
    <td style="text-align: center">Amortized cost <br /> and FVTPL</td><td>&#160;</td>
    <td style="text-align: center">Currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20220131_zQdQK4u8Hvml" title="Convertible debenture" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">221,599</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Derivative liability &#8211; warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">FVTPL</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">Currency</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--DerivativeLiabilityWarrants_iI_c20220131_ztC4hf2nXfme" title="Derivative liability warrants" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="MLYF:DerivativeLiabilityWarrants" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,288,387</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_ziB2qiDIyqPd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[a]
Fair value</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of financial instruments is the amount of consideration that would be agreed upon in an arm&#8217;s length transaction between
knowledgeable, willing parties who are under no compulsion to act. The fair value of current financial instruments except derivative
liability approximates their carrying values as long as they are short-term in nature or bear interest at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 147; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[b]
Fair value hierarchy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that are held at fair value are categorized based on a valuation hierarchy which is determined by the valuation methodology
utilized. The fair value hierarchy under US GAAP is based on the following three levels of inputs, of which the first two are considered
observable and the last unobservable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
1</b> &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
2</b> &#8211; Observable inputs other than Level 1, quoted prices for similar assets or liabilities in active prices whose inputs are
observable or whose significant value drivers are observable; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
3</b> &#8211; Assets and liabilities whose significant value drivers are unobservable by little or no market activity and that are significant
to the fair value of the assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents are valued using a market approach based upon unadjusted quoted prices for identical assets in an active market
obtained from securities exchanges. As at January 31, 2022, the fair value of cash and cash equivalents held by the Company was based
on Level 1 of the fair value hierarchy. There were no transfers between Levels 1 and 2 during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments and other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with ASC 815. The result of this accounting treatment is that the
fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair
value is recorded in the consolidated statements of loss and comprehensive loss. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value
of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current
or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Scholes Option Pricing Model to value derivative liabilities. This model uses Level 3 inputs in the fair value
hierarchy established by ASC 820 Fair Value Measurement. The inputs used in determining the fair value of the embedded derivative are
disclosed in <i>note 12[d]</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[c]
Financial risk management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s board of directors has the overall responsibility for the establishment and oversight of the Company&#8217;s risk management
framework. The Company&#8217;s risk management policies are established to identify and analyze the risks faced by the Company, to set
appropriate risk limits and controls, and to monitor risks and adherence to limits. Risk management policies and systems are reviewed
regularly to reflect changes in market conditions and in response to the Company&#8217;s activities. Management regularly monitors compliance
with the Company&#8217;s risk management policies and procedures and reviews the adequacy of the risk management framework in relation
to the risks faced by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of operations, the Company is exposed to various risks such interest rate, foreign exchange, commodity, credit, and
liquidity. To manage these risks, management determines what activities must be undertaken to minimize potential exposure to risks. The
objectives of the Company in managing risks are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintaining
                                            sound financial condition:</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
                                            operations; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensuring
                                            liquidity to all operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to satisfy these objectives, the Company has adopted the following policies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepare
                                            budget documents at prevailing market rates to ensure clear corporate alignment to performance
                                            management and achievement of targets;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9679;</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize
                                            and observe the extent of operating risk within the business; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9679;</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify
                                            the magnitude of the impact of market risk factors on the overall risk of the business and
                                            take advantage of natural risk reductions that arise from these relationships.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[i]
Interest rate risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in the market interest rates.
The Company is exposed to interest rate risk on its cash on deposits with banks and, from time to time, on its holdings of short-term
investments. As of January 31, 2022, the Company had $<span id="xdx_907_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220131_zcEzq05OWjh7" title="Cash"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,522</ix:nonFraction></span> (October 31, 2021 &#8722; $<span id="xdx_907_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20211031_zk1YAABdP1N" title="Cash"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">462,360</ix:nonFraction></span>) of cash on deposits with banks. The
Company had <span id="xdx_90C_eus-gaap--ShortTermInvestments_iI_do_c20220131_zKWSgB0SILMh" title="Short term investments"><span id="xdx_90C_eus-gaap--ShortTermInvestments_iI_do_c20211031_zTgH8DXCDCu3" title="Short term investments"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2022-01-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2021-10-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> short-term investment as at January 31, 2022 and October 31, 2021. Given the level of cash and cash equivalents held by
the Company, fluctuations in the market interest rates had no significant impact on its interest income for the three months ended January
31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[ii]
Foreign currency risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is exposed to foreign currency risk on fluctuations related to cash, amounts receivable, accounts payable, due to related parties
and convertible debenture that are denominated in Canadian dollars. The Company has not entered into foreign exchange derivative contracts.
A significant change in the currency exchange rates between the US dollar relative to the Canadian dollar could have a material effect
on the Company&#8217;s financial position, results of operations, or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the Company net exposures as at January 31, 2022, assuming that all other variables remain constant, a <span id="xdx_906_ecustom--ForeignCurrencyRiskRate_pid_dp_uPure_c20201101__20211031_zCU49URXEVq7" title="Foreign currency risk rate">5</span>% appreciation or deterioration
of the Canadian dollar against the US dollar would result in an increase or decrease of $<span id="xdx_902_ecustom--IncreaseDecreaseInForeignCurrencyTransactionAmount_c20211101__20220131_zC8pKHUy5aJ9" title="Increase decrease in foreign currency transaction amount"><ix:nonFraction name="MLYF:IncreaseDecreaseInForeignCurrencyTransactionAmount" contextRef="From2021-11-01to2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">88,138</ix:nonFraction></span> in the Company&#8217;s net income (loss)
and comprehensive income (loss).</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zVa9hiKkaDD4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zh88mf48fNRj" style="display: none">SCHEDULE
OF FOREIGN CURRENCY RISK</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">January 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">CA$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AssetReportingCurrencyDenominatedValue_iI_uCA_c20220131__us-gaap--BalanceSheetLocationAxis__us-gaap--CashMember_zAC7RIiHLKK" title="Assets" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AssetReportingCurrencyDenominatedValue" contextRef="AsOf2022-01-31_us-gaap_CashMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">498,538</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AssetReportingCurrencyDenominatedValue_iI_uCA_c20220131__us-gaap--BalanceSheetLocationAxis__custom--AmountsReceivableMember_zK9uvwuxK2Nh" title="Assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetReportingCurrencyDenominatedValue" contextRef="AsOf2022-01-31_custom_AmountsReceivableMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">299,940</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LiabilityReportingCurrencyDenominatedValue_iNI_di_uCA_c20220131__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_zthy7WIKqGDi" title="Liabilities" style="text-align: right">(<ix:nonFraction name="us-gaap:LiabilityReportingCurrencyDenominatedValue" contextRef="AsOf2022-01-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">2,210,900</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LiabilityReportingCurrencyDenominatedValue_iNI_di_uCA_c20220131__us-gaap--BalanceSheetLocationAxis__custom--DueToRelatedPartiesMember_znOLHouLxzwa" title="Liabilities" style="text-align: right">(<ix:nonFraction name="us-gaap:LiabilityReportingCurrencyDenominatedValue" contextRef="AsOf2022-01-31_custom_DueToRelatedPartiesMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">729,621</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Convertible debenture</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LiabilityReportingCurrencyDenominatedValue_iNI_di_uCA_c20220131__us-gaap--BalanceSheetLocationAxis__custom--ConvertibleDebentureMember_zi4dp1ziNk48" title="Liabilities" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LiabilityReportingCurrencyDenominatedValue" contextRef="AsOf2022-01-31_custom_ConvertibleDebentureMember" format="ixt:numdotdecimal" decimals="0" unitRef="CA">100,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_ecustom--AssetAndLiabilitiesReportingCurrencyDenominatedValue_iI_uCA_c20220131_zliOmPtXj9F6" title="Total" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="MLYF:AssetAndLiabilitiesReportingCurrencyDenominatedValue" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="CA">2,242,043</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zmjAlYLiWUzl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[iii]
Commodity price risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of the Company&#8217;s magnesium production business and its exploration and evaluation assets are dependent on the price of magnesium
and the outlook for this mineral. Market prices for these metals historically have fluctuated widely and are affected by numerous factors
outside the Company&#8217;s control, including but not limited to, levels of worldwide production, short-term changes in supply and demand,
industrial and retail demand, as well as certain other factors related specifically to magnesium. If magnesium prices decline for a prolonged
period below the cost of production, it may not be economically feasible to continue towards production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[iv]
Credit risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
risk is the risk of loss if counterparties do not fulfill their contractual obligations and arises principally from trade receivables.
The Company&#8217;s credit risk is primarily attributable to cash, and deposits held by related parties. The Company limits its exposure
to credit risk on cash as these financial instruments are held with major Canadian and international banks. Amounts receivable consist
primarily of GST due from the Federal Government of Canada. Management believes the credit risk concentration with respect to amounts
receivable is remote. The carrying amount of financial assets recorded in the financial statements, net of any allowances, represents
the Company&#8217;s maximum exposure to credit risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>[v]
Liquidity risk</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
risk is the risk that the Company will not be able to meet its financial obligations as they come due. The Company&#8217;s exposure to
liquidity risk is dependent on its purchasing commitments and obligations and its ability to raise funds to meet commitments and sustain
operations. The Company manages liquidity risk by continuously monitoring its actual and forecasted working capital requirements to ensure
there is capital to meet short-term and long-term obligations. As of January 31, 2022 and October 31, 2021, the Company had working capital
deficiency of $<span id="xdx_900_ecustom--WorkingCapitalDeficit_iI_c20220131_zxxe6hGdWlA9" title="Working capital deficit"><ix:nonFraction name="MLYF:WorkingCapitalDeficit" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,900,774</ix:nonFraction></span> and $<span id="xdx_905_ecustom--WorkingCapitalDeficit_iI_c20211031_zQIEnZg7DEfa" title="Working capital deficit"><ix:nonFraction name="MLYF:WorkingCapitalDeficit" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,657,316</ix:nonFraction></span>, respectively. As disclosed in <i>note 1 </i>of these Interim Financial Statements, the ability
of the Company to continue as a going concern is dependent on many factors. The Company&#8217;s cash is primarily deposited in bank accounts
and held as deposits by certain related parties. The Company anticipates that its cash on hand and deposits, together with expected funds
raised from private placements and on exercises of common share purchase warrants and stock options, as well as debt financing, will
provide sufficient financial resources to carry out its operations through the next twelve months. However, additional funding will be
required. There can be no assurance that the Company will be able to raise the funds necessary to continue future operations. Liquidity
risk has been assessed as high.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_804_eus-gaap--SegmentReportingDisclosureTextBlock_ztfHkSwUKXk8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zXpUF3LGX311">SEGMENTED INFORMATION</span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company focuses on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and
the development of a full-scale commercial magnesium production facility. The Company also owns mining claims for the exploration and
development of mineral property interests. Geographic information for the Company&#8217;s assets is as follows:</span></p>

<ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zcyAMsgZMfr1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_z9iUbGLZ6Iij" style="display: none">SCHEDULE
OF ASSETS INFORMATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">January 31, 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">October 31, 2021</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Canada &#8211; property, plant and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20220131__srt--StatementGeographicalAxis__country--CA_zWWIiIKYp8m2" title="Property, plant and equipment" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31_country_CA" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,128,142</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211031__srt--StatementGeographicalAxis__country--CA_z8m9QP5MAGP7" title="Property, plant and equipment" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_country_CA" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,546,383</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United States &#8211; property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20220131__srt--StatementGeographicalAxis__country--US_zCx2GoCXgiX5" title="Property, plant and equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-01-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20211031__srt--StatementGeographicalAxis__country--US_zOyxlnCuJ5bj" title="Property, plant and equipment" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-10-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,321</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">United States &#8211; mineral property costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--MineralPropertiesNet_iI_c20220131__srt--StatementGeographicalAxis__country--US_zGTZUfFPTWvf" title="Property, plant, equipment and mineral properties" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2022-01-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--MineralPropertiesNet_iI_c20211031__srt--StatementGeographicalAxis__country--US_zpabAki1gry2" title="Property, plant, equipment and mineral properties" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:MineralPropertiesNet" contextRef="AsOf2021-10-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,453</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_ecustom--PropertyPlantEquipmentsAndMineralPropertiesNet_iI_c20220131_zfMmDi8ijZ36" title="Assets" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantEquipmentsAndMineralPropertiesNet" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,252,696</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_ecustom--PropertyPlantEquipmentsAndMineralPropertiesNet_iI_c20211031_zf76YOK9ATb2" title="Assets" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="MLYF:PropertyPlantEquipmentsAndMineralPropertiesNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,668,157</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Canada &#8211; other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherAssets_iI_c20220131__srt--StatementGeographicalAxis__country--CA_z9xGqmz5w5E9" title="Other assets" style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-01-31_country_CA" format="ixt:numdotdecimal" decimals="0" unitRef="USD">838,067</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherAssets_iI_c20211031__srt--StatementGeographicalAxis__country--CA_zJwj96PO5Lyi" title="Other assets" style="text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-10-31_country_CA" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,554,827</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">United States &#8211; other assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OtherAssets_iI_c20220131__srt--StatementGeographicalAxis__country--US_z7gehtjn0mB6" title="Other assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-01-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,409,734</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--OtherAssets_iI_c20211031__srt--StatementGeographicalAxis__country--US_zzXIxQM4s1qh" title="Other assets" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-10-31_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,528</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherAssets_iI_c20220131_zrCiOEE8GdKg" title="Other assets" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,247,801</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherAssets_iI_c20211031_z9ndceX05TK5" title="Other assets" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,845,355</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Assets_iI_c20220131_zt2mtxhs76Z8" title="Total Assets" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,500,498</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Assets_iI_c20211031_zihph9zNkoq8" title="Total Assets" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,513,512</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zuc1t9e6oPG7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-11-01to2022-01-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zFIsPVY6l1Rf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.
<span id="xdx_826_zEMSBmBr6gEc">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 10, 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220308__20220310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--JuneTwoThousandTwentyOneConvertibleDebenturesMember_z7scGnN6nQT4" title="Stock issued during period, conversion units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-03-082022-03-10_us-gaap_SubsequentEventMember_custom_JuneTwoThousandTwentyOneConvertibleDebenturesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> units on partial conversion of the June 2021 Convertible Debenture, for a total of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20220308__20220310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zw9jF1iLIXGf" title="Stock issued during period, conversion shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2022-03-082022-03-10_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span>
common shares, <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_zVdkSJImRCIk" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-03-10_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> Class A Warrants exercisable at a price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassAWarrantsMember_zDuSpRTl1jr3" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-03-10_us-gaap_SubsequentEventMember_custom_ClassAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span> until June 10, 2026, and <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zoM1BGzOO7bc" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-03-10_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> Class B Warrants exercisable
at a price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__custom--ClassBWarrantsMember_zsdYemORPbsa" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-03-10_us-gaap_SubsequentEventMember_custom_ClassBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.19</ix:nonFraction></span> until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to January 31, 2022, upon exercise of common share purchase warrants, the Company issued an aggregate <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220201__20220315__us-gaap--StatementEquityComponentsAxis__custom--CommonStockPurchaseWarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8sz8MZEXgkh" title="Stock issued during period, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-02-012022-03-15_custom_CommonStockPurchaseWarrantMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,793,657</ix:nonFraction></span> common shares at a price
CA$<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20220315__us-gaap--StatementEquityComponentsAxis__custom--CommonStockPurchaseWarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z99hBqQBA38l" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-03-15_custom_CommonStockPurchaseWarrantMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.19</ix:nonFraction></span> per share for gross proceeds of CA$<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_uCA_c20220201__20220315__us-gaap--StatementEquityComponentsAxis__custom--CommonStockPurchaseWarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFD5f4oWBR9j" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-02-012022-03-15_custom_CommonStockPurchaseWarrantMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">340,795</ix:nonFraction></span>, and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220201__20220315__us-gaap--StatementEquityComponentsAxis__custom--CommonStockPurchaseWarrantOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIRIT8Ib8QGf" title="Stock issued during period, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-02-012022-03-15_custom_CommonStockPurchaseWarrantOneMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,082,025</ix:nonFraction></span> common shares at a price of CA$<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_uCAPShares_c20220315__us-gaap--StatementEquityComponentsAxis__custom--CommonStockPurchaseWarrantOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zebBFeEKkiVl" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-03-15_custom_CommonStockPurchaseWarrantOneMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.05</ix:nonFraction></span> per share for gross proceeds of
CA$<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_uCA_c20220201__20220315__us-gaap--StatementEquityComponentsAxis__custom--CommonStockPurchaseWarrantOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z05tnuuvZrn" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-02-012022-03-15_custom_CommonStockPurchaseWarrantOneMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="CA">54,101</ix:nonFraction></span>. A total of <span id="xdx_907_ecustom--CommonStockWarrantsExpiredUnexercised_iI_c20220315__us-gaap--StatementEquityComponentsAxis__custom--CommonStockPurchaseWarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXx9FaDA0Zg6" title="Common stock warrants expired unexercised"><ix:nonFraction name="MLYF:CommonStockWarrantsExpiredUnexercised" contextRef="AsOf2022-03-15_custom_CommonStockPurchaseWarrantMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,305,200</ix:nonFraction></span> warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to January 31, 2022, the Company announced the appointment of a new Chief Financial Officer of the Company and the grant of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220201__20220315__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVVFf1UDVn8j" title="Incentive stock options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-02-012022-03-15_custom_TwoThousandTwentyOneEquityIncentivePlanMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> incentive
stock options pursuant to its 2021 Equity Incentive Plan exercisable at a price of CA$<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_uCAPShares_c20220315__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNSIX761Low7" title="Options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2022-03-15_custom_TwoThousandTwentyOneEquityIncentivePlanMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="CAPShares">0.40</ix:nonFraction></span> per share for a period of <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dt_c20220201__20220315__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ze32Xo9EcWF6" title="Options exercisable term"><ix:nonNumeric contextRef="From2022-02-012022-03-15_custom_TwoThousandTwentyOneEquityIncentivePlanMember_us-gaap_SubsequentEventMember" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">five years</ix:nonNumeric></span>.</span></p>

</ix:nonNumeric><p id="xdx_811_zOsmCpkoiHff" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="forms-1_002.jpg" alt="" style="height: 99px; width: 300px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WESTERN
MAGNESIUM CORPORATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,240,256
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of Common Stock Underlying Convertible Debentures</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,240,256
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of Common Stock Underlying Warrants</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,774,500
Shares of Common Stock for Resale by Selling Securityholder</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PROSPECTUS</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>__________,
</b>2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
and including [&#9679;], 2022 (the 40th day after the date of this offering), all dealers effecting transactions in these securities,
whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer&#8217;s obligation
to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 152 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
II</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION
NOT REQUIRED IN PROSPECTUS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 13.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Expenses of Issuance and Distribution</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the costs and expenses payable by us in connection with the issuance and distribution of the securities being
registered hereunder. No expenses will be borne by the Selling Stockholder. All of the amounts shown are estimates, except for the SEC
registration fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Type</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">SEC
    registration Fee</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">929</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Legal
    fees and expenses*</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounting
    fees and expenses*</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Printing
    expenses*</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Miscellaneous
    expense*</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">750</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    expenses*</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,179</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 14.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification of Directors and Officers.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation provides that all of our directors, officers, employees and agents shall be entitled to be indemnified by
us to the fullest extent permitted by the Delaware General Corporation Law (the &#8220;DGCL&#8221;). Section 145 of the DGCL concerning
indemnification of officers, directors, employees and agents is set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145. Indemnification of officers, directors, employees and agents; insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened,
    pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by
    or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the
    corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation,
    partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts
    paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person
    acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation,
    and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful.
    The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or
    its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person
    reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or
    proceeding, had reasonable cause to believe that the person&#8217;s conduct was unlawful.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened,
    pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact
    that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
    as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses
    (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of
    such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the
    best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to
    which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery
    or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability
    but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which
    the Court of Chancery or such other court shall deem proper.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense
    of any action, suit or proceeding referred to in subsections (a) and (b) of this section, or in defense of any claim, issue or matter
    therein, such person shall be indemnified against expenses (including attorneys&#8217; fees) actually and reasonably incurred by
    such person in connection therewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    indemnification under subsections (a) and (b) of this section (unless ordered by a court) shall be made by the corporation only as
    authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or
    agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a) and
    (b) of this section. Such determination shall be made, with respect to a person who is a director or officer at the time of such
    determination, (1) by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than
    a quorum, or (2) by a committee of such directors designated by majority vote of such directors, even though less than a quorum,
    or (3) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (4)
    by the stockholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 153; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
    (including attorneys&#8217; fees) incurred by an officer or director in defending any civil, criminal, administrative or investigative
    action, suit or proceeding may be paid by the corporation in advance of the final disposition of such action, suit or proceeding
    upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined
    that such person is not entitled to be indemnified by the corporation as authorized in this section. Such expenses (including attorneys&#8217;
    fees) incurred by former officers and directors or other employees and agents may be so paid upon such terms and conditions, if any,
    as the corporation deems appropriate.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this section shall not
    be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any
    bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#8217;s official
    capacity and as to action in another capacity while holding such office. A right to indemnification or to advancement of expenses
    arising under a provision of the certificate of incorporation or a bylaw shall not be eliminated or impaired by an amendment to such
    provision after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative
    action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the
    time of such act or omission explicitly authorizes such elimination or impairment after such action or omission has occurred.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee
    or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of
    another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and
    incurred by such person in any such capacity, or arising out of such person&#8217;s status as such, whether or not the corporation
    would have the power to indemnify such person against such liability under this section.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    purposes of this section, references to &#8220;the corporation&#8221; shall include, in addition to the resulting corporation, any
    constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate
    existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that
    any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request
    of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust
    or other enterprise, shall stand in the same position under this section with respect to the resulting or surviving corporation as
    such person would have with respect to such constituent corporation if its separate existence had continued.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    purposes of this section, references to &#8220;other enterprises&#8221; shall include employee benefit plans; references to &#8220;fines&#8221;
    shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to &#8220;serving at
    the request of the corporation&#8221; shall include any service as a director, officer, employee or agent of the corporation which
    imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its
    participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the
    interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed
    to the best interests of the corporation&#8221; as referred to in this section.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    indemnification and advancement of expenses provided by, or granted pursuant to, this section shall, unless otherwise provided when
    authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the
    benefit of the heirs, executors and administrators of such a person.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Court of Chancery is hereby vested with exclusive jurisdiction to hear and determine all actions for advancement of expenses or indemnification
    brought under this section or under any by law, agreement, vote of stockholders or disinterested directors, or otherwise. The Court
    of Chancery may summarily determine a corporation&#8217;s obligation to advance expenses (including attorneys&#8217; fees).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation also permits us to maintain insurance on behalf of any officer, director or employee for any liability arising
out of his or her actions, regardless of whether Delaware law would permit such indemnification. We have purchased a policy of directors&#8217;
and officers&#8217; liability insurance that insures our officers and directors against the cost of defense, settlement or payment of
a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action,
if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder&#8217;s investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 154; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
repeal or amendment of provisions of our certificate of incorporation affecting indemnification rights, whether by our board of directors,
stockholders or by changes in applicable law, or the adoption of any other provisions inconsistent therewith, will (unless otherwise
required by law) be prospective only, except to the extent such amendment or change in law permits us to provide broader indemnification
rights on a retroactive basis, and will not in any way diminish or adversely affect any right or protection existing thereunder with
respect to any act or omission occurring prior to such repeal or amendment or adoption of such inconsistent provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registrant also intends to enter into indemnification agreements with its future directors and executive officers. The registrant has
purchased directors&#8217; and officers&#8217; liability insurance. The registrant believes that this insurance is necessary to attract
and retain qualified directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons
pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment of expenses incurred or paid by a director, officer or controlling person in a successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, we will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to the court of
appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act
and will be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 15.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent Sales of Unregistered Securities.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of transactions by us since November 1, 2018 involving unregistered issuances of our common equity securities.
Included are new issues, securities issued in exchange for property, services or other securities, securities issued upon conversion
from our other share classes and new securities resulting from the modification of outstanding securities. We issued all of the securities
listed below pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), or Regulation D or Regulation S promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">During
the Fiscal Year ended October 31, 2019</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 30, 2018, in connection with a non-brokered private placement, 7,699,760 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$384,988 (USD equivalent $289,443). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 145,960 shares of common stock were issued to agents at a price of CAD$0.05 for a
fair value of CAD$7,298 (USD equivalent $5,487). Finder&#8217;s fees of $18,097 were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 23, 2019, in connection with a non-brokered private placement, 6,348,435 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$317,422 (USD equivalent $237,805). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 597,001 shares of common stock at a price of CAD$0.05 for a fair value of CAD$29,850
(USD equivalent $22,363) and 40,000 broker&#8217;s warrants exercisable at a price of CAD$0.08 per share for a period of two years were
issued to agents. Finder&#8217;s fees of $5,530 were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 29, 2019, in connection with a non-brokered private placement, 11,750,464 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$587,523 (USD equivalent $439,664). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 218,287 shares of common stock were issued to agents at a price of CAD$0.05 for a
fair value of CAD$10,914 (USD equivalent $8,168). Finder&#8217;s fees of $28,262 were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 155; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 13, 2019, in connection with a non-brokered private placement, 34,712,595 units were issued to private investors at a price of CAD$0.05
per share for gross proceeds of CAD$1,735,630 (USD equivalent $1,289,053). Each unit consists of one common share and one common share
purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were subject
to an acceleration clause whereby the Company had the right, upon provision of thirty days&#8217; written notice, to require a holder
to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive trading
days. Finder&#8217;s fees of $94,216 were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 6, 2019, 328,571 shares of common stock were issued to a non-arm&#8217;s length party for settlement of debt at a price of
CAD$0.175 per share for a fair value of CAD$57,500 (USD equivalent $43,647).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, an aggregate of 3,455,235 shares of common stock were issued to private investors upon the exercise
of warrants at a price of CAD$0.05 per share for gross proceeds of CAD$172,762 (USD equivalent $131,071).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, an aggregate of 11,600,109 shares of common stock were issued to private investors upon the exercise
of warrants at a price of CAD$0.08 per share for gross proceeds of CAD$928,009 (USD equivalent $706,111).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, an aggregate of 1,100,000 shares of common stock were issued to certain officers and consultants
upon the exercise of options at a price CAD$0.05 per share for gross proceeds of CAD$55,000 (USD equivalent $41,553). Upon exercise,
CAD$36,750 (USD equivalent $27,723) previously recorded in reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, in consideration of services provided to the Company, an aggregate of 150,000 shares of common
stock were issued to a service provider at a price of CAD$0.05 per share for a fair value of CAD$7,500 (USD equivalent 5,668).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">During
the Fiscal Year ended October 31, 2020</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 20, 2019, the Company exercised its right to call all outstanding common share purchase warrants set to expire between May 7,
2020 and May 13, 2021 to expiry on January 19, 2020, and then extended the expiration date to February 19, 2020. Any unexercised warrants
were voided and of no value after February 19, 2020. From November 13, 2019 through March 11, 2020, an aggregate of 32,472,661shares
of common stock were issued to private investors upon the exercise of warrants at a price of CAD$0.08 per share for gross proceeds of
CAD$2,597,813 (USD equivalent $1,969,797), an aggregate of 3,000,000 shares of common stock were issued to private investors upon the
exercise of warrants at a price of CAD$0.07 per share for gross proceeds of CAD$210,000 (USD equivalent $158,718), and a further 4,864,000
shares of common stock were issued to private investors upon the exercise of warrants at a price of CAD$0.05 per share for gross proceeds
of CAD$243,200 (USD equivalent $184,769). 24,794,484 warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2020, in connection with a non-brokered private placement, 3,643,791 units were issued to private investors at a price of
CAD$0.15 per share for gross proceeds of CAD$546,569 (USD equivalent $416,719). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.21 per share for a period of one year. Subsequent to October
31, 2020, we extended the expiration date of the warrants to August 31, 2021. The warrants were subject to an acceleration clause whereby
the Company had the right, upon provision of thirty days&#8217; written notice, to require a holder to exercise the warrants should the
closing price of our common stock exceeds CAD$0.30 per share for at least ten consecutive trading days. Finder&#8217;s fees of $41,275
were paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2020, 100,000 shares of common stock were issued to a consultant upon the exercise of options at a price CAD$0.05 per share for
gross proceeds of CAD$5,000 (USD equivalent 3,568).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2020, 400,000 shares of common stock were issued to a consultant upon the exercise of options at a price CAD$0.08 per share for
gross proceeds of CAD$32,000 (USD equivalent $22,833). Upon exercise, CAD$27,715 (USD equivalent $19,775) previously recorded in equity
reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">During
the Fiscal Year ended October 31, 2021</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 20, 2020, in connection with a non-brokered private placement, 5,599,171 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$727,892 (USD equivalent $556,876). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2021, in connection with a non-brokered private placement, 7,337,914 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$953,930 (USD equivalent $749,435). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 156; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2021, in connection with a non-brokered private placement, 5,382,303 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$699,699 (USD equivalent $547,496). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 24, 2021, in connection with a non-brokered private placement, 6,554,172 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$852,042 (USD equivalent $678,270). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 27, 2021, in connection with a non-brokered private placement, 851,395 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$110,681 (USD equivalent $89,237). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2021, in connection with the conversion of the July 2020 Convertible Debenture including accrued interest and transaction costs,
a total of 1,360,959 common shares were issued to private investors with a value of $162,829.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 28, 2021, in connection with a non-brokered private placement, 5,223,420 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$679,044 (USD equivalent $561,844). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 7, 2021, in consideration of equipment, 1,538,461 common shares were issued to Industrial Surplus Supplies Ltd. at a price of CAD$0.24
per share for a fair value of CAD$369,231 (USD equivalent $305,832).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2021, in connection with a non-brokered private placement, 17,853,506 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$2,320,956 (USD equivalent $1,880,687). Each unit consists of one common share and one common share
purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 16, 2021, in connection with a non-brokered private placement, 4,350,000 units were issued to private investors at a price of CAD$0.20
per share for gross proceeds of CAD$870,000 (USD equivalent $690,860). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.30 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 11, 2021, in connection with a non-brokered private placement, 3,827,601 units were issued to private investors at a price of
CAD$0.55 (USD$0.44) per share for gross proceeds of CAD$2,105,180 (USD equivalent $1,683,336). Each unit consists of one common share
and one common share purchase warrant exercisable into one common share at a price of CAD$0.65 (USD$0.52) per share for a period of eighteen
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2021, the Company issued to private investors upon the exercise of common share purchase warrants an
aggregate 1,964,901 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$98,245 (USD equivalent $77,896), an aggregate
1,931,450 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$366,976 (USD equivalent $292,890), and an aggregate
3,118,618 common shares at a price of CAD$0.21 per share for gross proceeds of CAD$654,910 (USD equivalent $516,735). Upon exercise,
CAD$5,333 (USD equivalent $4,291) previously recorded in equity reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2021, the Company issued to certain directors, officers, employees and consultants upon the exercise
of options an aggregate 2,000,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$100,000 (USD equivalent $80,058),
an aggregate 200,000 common shares at a price of CAD$0.11 per share for gross proceeds of CAD$22,000 (USD equivalent $17,456), an aggregate
300,000 common shares at a price of CAD$0.12 per share for gross proceeds of CAD$36,000 (USD equivalent $29,096), an aggregate 100,000
common shares at a price of CAD$0.13 per share for gross proceeds of CAD$13,000 (USD equivalent $10,315), and an aggregate 30,000 common
shares at a price of CAD$0.16 per share for gross proceeds of CAD$4,800 (USD equivalent $3,809). Upon exercise, CAD$152,218 (USD equivalent
$121,932) previously recorded in equity reserves was reclassified to share capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">During
the three months ended January 31, 2022</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an agreement entered on August 29, 2018 and which was approved by the TSXV on September 12, 2018, a company controlled by Sam Ataya,
a director and officer of our Company, is eligible to receive up to 5% of the issued and outstanding common shares of the Company as
at August 28, 2018 for up to $5 million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3,
2021, the Company issued 9,163,425 common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614)
as share issue costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 157; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2021, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling Securityholder
1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable
at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 26, 2021, in connection with a non-brokered private placement, 1,375,499 units were issued to private investors at a price of
$0.55 per unit for gross proceeds of $756,524. Each unit consists of one common share and one common share purchase warrant exercisable
into one common share at a price of $0.75 per share for a period of one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 13, 2021, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling
Securityholder 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class
B Warrants exercisable at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 20, 2022, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling Securityholder
1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable
at a price of $0.19 until June 10, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended January 31, 2022, upon the exercise of common share purchase warrants the Company issued to private investors
an aggregate 15,159,448 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$2,880,295 (USD equivalent $2,279,136),
200,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$10,000 (USD equivalent $7,830), and 30,000 common shares
at a price of CAD$0.30 per share for gross proceeds of CAD$9,000 (USD equivalent $6,981). A total of 2,428,363 warrants expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Debt
Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, we received an unsecured loan of CAD$150,000 (USD equivalent $112,895) from a director and officer.
The loan bore interest at 18% and was due on demand. During the fiscal year ended October 31, 2020, the loan was increased by an additional
CAD$60,000 (USD equivalent $44,588), to CAD$210,000 (USD equivalent $157,483), and was due on September 24, 2021. During the fiscal year
ended October 31, 2021, we have made repayments of the entire balance of principal and all interests accrued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2020, we issued to a private investor a CAD$150,000 (USD equivalent $112,124, the &#8220;July 2020 Convertible Debenture&#8221;)
principal amount 12% convertible debenture convertible at the option of the holder to our common stock at the greater of CAD$0.15 per
share and the market price on the date of the conversion notice. Any accrued but unpaid interest will be payable on the earlier of the
maturity date and the date of conversion in cash or shares of our common stock. The net proceeds from this transaction were used to fund
working capital and general corporate purposes. On May 18, 2021, 1,360,959 shares of common stock were issued in connection with the
conversion of the July 2020 Convertible Debenture including conversion of accrued interest and 263,973 common shares valued at $26,286
in transaction costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2021, we issued an unsecured convertible note in the principal amount of $1,500,000 (the &#8220;June 2021 Convertible Debenture&#8221;).
The June 2021 Convertible Debenture bears interest at 12% per annum and matures on December 10, 2022. The June 2021 Convertible Debenture
is convertible into 15,000,000 units, where each unit consists of (i) one share of our common stock, (ii) one-half of one Class A common
stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one
Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively,
the &#8220;Class A and B Warrants&#8221;). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii)
the minimum conversion price permitted by the TSXV at the time of conversion (should our common stock then be listed on such exchange).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 15, 2021, we issued to a private investor a CAD$100,000 (USD equivalent $79,542, the &#8220;July 2021 Convertible Debenture&#8221;)
principal amount 12% convertible debenture convertible at the option of the holder to common shares at a price of CAD$0.12 per share
and common share purchase warrants exercisable at a price of CAD$0.20 per share for a period of two years. Any accrued but unpaid interest
will be payable on the earlier of the maturity date and the date of conversion in cash or common shares. The net proceeds from this transaction
were used to fund working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Issuances</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2018, 9,600,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and
consultants as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.05 per share. These options
vested immediately on the grant date and expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 158; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2019, 10,000,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.12 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended October 31, 2019, we extended the expiration date of 400,000 options from May 9, 2019 to May 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2019, 700,000 options to purchase shares of our common stock were granted to certain officer, employee and consultant as
additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.15 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 25, 2019, 900,000 options to purchase shares of our common stock were granted to certain employees and consultants as additional
compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.16 per share. 400,000 options vested immediately on
the grant date and 500,000 options vest 25% every three-month period. These options expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2020, 300,000 options to purchase shares of our common stock were granted to an officer as additional compensation pursuant
to our 2017 Stock Option Plan at an exercise price of CAD$0.11 per share. These options vested immediately on the grant date and expire
5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 24, 2020, 4,200,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.12 per share. 3,750,000 options vested
immediately on the grant date and 450,000 options vest 25% every three-month period. These options expire five years after the grant
date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 26, 2020, 500,000 options to purchase shares of our common stock were granted to certain consultant as additional compensation
pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.13 per share. These options vest 25% every three-month period and
expire 2 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2020, 15,650,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and
consultants as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.13 per share. 15,000,000
options vested immediately on the grant date and 650,000 options vest 25% every three-month period. 9,500,000 of these options expire
five years after the grant date and 6,150,000 of these options expire two years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 30, 2021, 21,700,000 options to purchase common shares were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2021 Equity Incentive Plan at an exercise price of CAD$0.70 per share. 21,400,000 options
vested immediately on the grant date and 300,000 options vest 25% every three-month period. These options expire 5 years after the grant
date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2021, 1,450,000 options to purchase common shares were granted to certain officer, employee and consultants as additional
compensation pursuant to our 2021 Equity Incentive Plan at an exercise price of CAD$0.50 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 3, 2021, 250,000 options to purchase common shares were granted to an employee as additional compensation pursuant to our 2021
Equity Incentive Plan at an exercise price of CAD$0.58 per share. These options vested immediately on the grant date and expire 5 years
after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits and Financial Statement Schedules</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exhibits.
    </i>The list of exhibits preceding the signature page of this registration statement is incorporated herein by reference.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
    Statements.</i> See page F-1 for an index to the financial statements and schedules included in the registration statement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 17.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undertakings</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act &#8220;may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that
a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 159; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
    415 Offering. The undersigned registrant hereby undertakes:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
    if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set
    forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any material information with respect to the plan of distribution not previously disclosed in the registration statement
    or any material change to such information in the registration statement;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
    to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
    be deemed to be the initial bona fide offering thereof.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned Registrant hereby undertakes that it will:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    determining any liability under the Securities Act of 1933, treat the information omitted from the form of prospectus filed as part
    of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant under Rule
    424(b)(1), or (4) or 497(h) under the Securities Act of 1933 as part of this registration statement as of the time the Commission
    declared it effective.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    determining any liability under the Securities Act of 1933, treat each post-effective amendment that contains a form of prospectus
    as a new registration statement for the securities offered in the registration statement, and that offering of the securities at
    that time as the initial bona fide offering of those securities.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
for the purpose of determining liability under the Securities Act of 1933 to any purchaser, if the registrant is subject to Rule 430C,
each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements
relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration
statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into
the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of
sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part
of the registration statement or made in any such document immediately prior to such date of first use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 160; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
INDEX</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(i)(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex3-1_i.htm" style="-sec-extract: exhibit">Certificate of Domestication of Nevada Clean Magnesium Inc. and Certificate of Incorporation of Western Magnesium Corporation dated as of May 9, 2019 (incorporated by reference to Exhibit 3.1(i) to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(i)(b)*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-1_ib.htm">Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware on May 13, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex3-1ii.htm" style="-sec-extract: exhibit">Bylaws, as amended on April 22, 2021 (incorporated by reference to Exhibit 3.1(ii) to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315222004597/ex3-1_iii.htm" style="-sec-extract: exhibit">Amendment No. 2 to Bylaws of Western Magnesium Corporation effective November 17, 2021 (incorporated by reference to Exhibit 3.1(iii) to the Company&#8217;s Annual Report on Form 10-K filed on February 15, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex4-2.htm" style="-sec-extract: exhibit">Form of Representative&#8217;s Warrant (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2&#94;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221025232/ex4-1.htm" style="-sec-extract: exhibit">Convertible Debenture Due December 10, 2022, Principal Amount $1,500,000 issued on June 10, 2021 (incorporated by reference to Exhibit 4.2(ii) to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221027356/ex4-3.htm" style="-sec-extract: exhibit">12% Convertible Note, Principal Amount CDN$100,000 issued on July 15, 2021 (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315222010564/ex4-1.htm" style="-sec-extract: exhibit">Form of Convertible Debenture due October 14, 2023, Principal Amount $2,000,000 issued on April 14, 2022 (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on April 20, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Opinion of Anthony L.G., PLLC.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-1.htm" style="-sec-extract: exhibit">Form of Incentive Stock Option Agreement (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-2.htm" style="-sec-extract: exhibit">2017 Stock Option Plan, adopted on August 8, 2017 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-3.htm" style="-sec-extract: exhibit">Executive Employment Agreement between James Sever and Western Magnesium Corporation (formerly, Nevada Clean Magnesium Inc.) dated April 30, 2019 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-4.htm" style="-sec-extract: exhibit">Executive Employment Agreement between Edward Lee and Western Magnesium Corporation (formerly, Nevada Clean Magnesium Inc.) dated as of May 3, 2019 (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-5.htm" style="-sec-extract: exhibit">Executive Employment Agreement between Sam Ataya and Western Magnesium Corporation (formerly, Nevada Clean Magnesium Inc.) dated as of May 3, 2019 (incorporated by reference to Exhibit 10.5 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-6.htm" style="-sec-extract: exhibit">Letter Agreement regarding Short Term Promissory Note in favor of Sam Ataya dated September 24, 2019 (incorporated by reference to Exhibit 10.6 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-7.htm" style="-sec-extract: exhibit">Executive Employment Agreement between Rabih Ataya and Western Magnesium Canada Corporation dated as of November 1, 2019 (incorporated by reference to Exhibit 10.7 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-8.htm" style="-sec-extract: exhibit">Share Subscription Agreement between Western Magnesium Corporation, GEM Yield Bahamas Limited, GEM Global Yield LLC SCS and the Share Lenders dated November 2019 (incorporated by reference to Exhibit 10.8 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-9.htm" style="-sec-extract: exhibit">Executive Employment Agreement between Paul Sauv&#233; and Western Magnesium Canada Corporation dated as of March 23, 2020 (incorporated by reference to Exhibit 10.9 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-10.htm" style="-sec-extract: exhibit">Employment Agreement between Karim Alameddine and Western Magnesium Canada Corporation dated as of April 28, 2020 (incorporated by reference to Exhibit 10.10 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-11.htm" style="-sec-extract: exhibit">Amendment to Short-Term Promissory Note issued by Western Magnesium Corporation in favor of Sam Ataya dated April 30, 2020 (incorporated by reference to Exhibit 10.11 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-12.htm" style="-sec-extract: exhibit">Executive Employment Agreement between Lisa Maxwell and Western Magnesium Canada Corporation dated as of December 1, 2020 (incorporated by reference to Exhibit 10.12 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-13.htm" style="-sec-extract: exhibit">Employee Agreement between Andrea Chan and Western Magnesium Canada Corporation dated as of March 15, 2021 (incorporated by reference to Exhibit 10.13 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-14.htm" style="-sec-extract: exhibit">Form of Private Placement Subscription Agreement (Units) (incorporated by reference to Exhibit 10.14 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-15.htm" style="-sec-extract: exhibit">Form of Private Placement Subscription Agreement (Convertible Notes) (incorporated by reference to Exhibit 10.15 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 161; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16&#94;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-16.htm" style="-sec-extract: exhibit">Securities Purchase Agreement between Western Magnesium Corporation and an investor dated June 10, 2021 (incorporated by reference to Exhibit 10.16 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex10-17.htm" style="-sec-extract: exhibit">2021 Equity Incentive Plan, adopted on June 11, 2021 (incorporated by reference to Exhibit 10.17 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221025232/ex10-18.htm" style="-sec-extract: exhibit">Employment Agreement between Western Magnesium Corporation and Michael E. Rutkowski dated August 16, 2021 (incorporated by reference to Exhibit 10.18 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,19&#94;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221027356/ex10-19.htm" style="-sec-extract: exhibit">Unit 102 &#8211; 5140 North Fraser Way, Burnaby, BC Lease between Valens Holdings Inc. and Western Magnesium Canada Corporation dated August 1, 2020 (incorporated by reference to Exhibit 10.19 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221027356/ex10-20.htm" style="-sec-extract: exhibit">Real Estate Option Agreement between Western Magnesium Corporation and Harrison County Community Improvement Corporation effective as of August 4, 2021 (incorporated by reference to Exhibit 10.20 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21&#94;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221027356/ex10-21.htm" style="-sec-extract: exhibit">Internally Heated Lab Furnace Fabrication Agreement between Industrial Surplus Ltd. and Western Magnesium Corp. dated July 24, 2020 (incorporated by reference to Exhibit 10.21 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315222006301/ex10-1.htm" style="-sec-extract: exhibit">Executive Employment Agreement between Western Magnesium Corporation and Robert Ramsey Hamady effective as of March 7, 2022 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 8, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23&#94;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315222010564/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement between Western Magnesium Corporation and an investor dated April 14, 2022 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 20, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315222010564/ex10-2.htm" style="-sec-extract: exhibit">Form of 2022 Warrant (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on April 20, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25&#94;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315222010564/ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement between Western Magnesium Corporation and an investor dated April 14, 2022 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on April 20, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26*&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-26.htm">Executive
    Employment Agreement between Western Magnesium Canada Corporation and Edward Lee effective as of April 8, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27*&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-27.htm">Executive
    Employment Agreement between Western Magnesium Corporation and Sam Ataya effective as of April 8, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28*&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-28.htm">Executive
    Employment Agreement between Western Magnesium Canada Corporation and Lisa Maxwell effective as of April 8, 2022.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315222004597/ex14-1.htm" style="-sec-extract: exhibit">Code of Ethics (incorporate by reference to Exhibit 14.1 to the Company&#8217;s Form 10-K filed on February 15, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1801762/000149315221018835/ex21-1.htm" style="-sec-extract: exhibit">List of Subsidiaries (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Registration Statement on Form 10 (File No. 000-56323)).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of Dale Matheson Carr-Hilton Labonte LLP.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Consent of Anthony L.G., PLLC (included in Exhibit 5.1).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">Power of Attorney (included on the signature page).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex107.htm">Filing fee table.</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#94;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Certain
    confidential information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively
    harmful if publicly disclosed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    management contracts and compensation plans and arrangements</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 162; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of McLean, State of Virginia, on May 24,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WESTERN
    MAGNESIUM CORPORATION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Sam Ataya&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam
    Ataya</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></p></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="a_001"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">POWER
OF ATTORNEY</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Sam Ataya as his or her true and lawful
attorneys-in-fact and agents, each with the full power of substitution, for him or her in his or her name, place or stead, in any and
all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to sign any
registration statement for the same offering covered by this Registration Statement that is to be effective upon filing pursuant to Rule
462(b) promulgated under the Securities Act of 1933, as amended, and all post-effective amendments thereto, and to file the same, with
exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact
and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the
premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that said attorneys-in-fact
and agents, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities held
on May 24, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Sam Ataya</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, Executive Director and Executive </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2022 </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam
    Ataya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    (Principal Executive Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Robert Ramsey Hamady</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer (Principal Financial and Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Ramsey Hamady</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Rabih Ataya</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and Executive Vice President, Special Projects</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rabih
    Ataya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Edward Lee</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and Executive Chairman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Lee</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Peter O&#8217;Rourke</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and President, U.S. Operations</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    O&#8217;Rourke</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Stephen Thorlakson</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Thorlakson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jeff Wilson</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2022 </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 163; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
































</body>
</html>
[{"type": "S-1", "sequence": "1", "filename": "forms-1.htm", "secsgml_size_bytes": 5055507}]
{"company-data": {"conformed-name": "Western Magnesium Corp.", "cik": "0001801762", "assigned-sic": "1000", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1031"}, "filing-values": {"form-type": "S-1", "act": "33", "file-number": "333-265189", "film-number": "22958303"}, "business-address": {"street1": "8180 GREENSBORO DRIVE", "street2": "SUITE 720", "city": "MCLEAN,", "state": "VA", "zip": "22012", "phone": "604-423-2709"}, "mail-address": {"street1": "8180 GREENSBORO DRIVE", "street2": "SUITE 720", "city": "MCLEAN,", "state": "VA", "zip": "22012"}, "former-company": {"former-conformed-name": "Western Magnesium Corp", "date-changed": "20200130"}}
As
filed with the Securities and Exchange Commission on May [●], 2022
Registration
No. 333-
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
S-1
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF 1933
WESTERN
MAGNESIUM CORPORATION
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
3339
61-1934413
(State
    or Other Jurisdiction of
(Primary
    Standard Industrial
(I.R.S.
    Employer
Incorporation
    or Organization)
Classification
    Code Number)
Identification
    Number)
8180
Greensboro Drive
,
Suite 720
McLean
,
Virginia
22102
Telephone:
(571)
378-0762
(Address,
including zip code, and telephone number, including area code, of registrant's principal executive offices)
The
Corporation Trust Company
Corporation
Trust Center
1209
Orange Street
Wilmington
,
Delaware
19801
Telephone:
(302)
658-7581
(Name,
address, including zip code, and telephone number, including area code, of agent for service)
Copies
to:
Laura
Anthony, Esq.
Craig
D. Linder, Esq.
Anthony L.G., PLLC
625 N. Flagler Drive, Suite 600
West Palm Beach, Florida 33401
Telephone: (561) 514-0936
Approximate
date of commencement of proposed sale to the public:
As soon as practicable after the effective date of this registration statement.
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box: ☒
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer,"
"smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large
    accelerated filer ☐
Accelerated
    filer ☐
Non-Accelerated
    filer
☒
Smaller
    reporting company
☒
Emerging
    growth company
☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
☐
The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date
as the commission, acting pursuant to section 8(a) may determine.
The
information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities,
and it is not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted.
PRELIMINARY
    PROSPECTUS
SUBJECT
    TO COMPLETION
DATED
    MAY [●], 2022
WESTERN
MAGNESIUM CORPORATION
19,240,256
Shares of Common Stock Underlying Convertible Debentures
25,240,256
Shares of Common Stock Underlying Warrants
1,774,500
Shares of Common Stock for Resale by Selling Securityholder
This
prospectus relates to the issuance by us of up to 19,240,256 shares of our common stock, par value $0.001 per share ("common
stock") upon the conversion of the outstanding principal amount and accrued interest thereon of certain convertible debentures
("Convertible Debentures") held by the selling securityholder named in this prospectus or their permitted transferees ("Selling
Securityholder"), which entitle them to convert into our common stock at the conversion rate of $0.10 per share for $900,000
principal amount convertible debenture and $0.30 per share for a $2,000,000 principal amount convertible debenture. For purposes of this
prospectus, we have assumed a conversion prices of $0.10 per share and $0.30 per share of Common Stock.
In
addition, this prospectus relates to the issuance by us of up to 25,240,256 shares of our common stock upon the exercise of 25,240,256
warrants ("Warrants") issuable by us upon conversion of the Convertible Debentures, which we are obligated to issue in
connection with the conversion of the Convertible Debentures, which will entitle them to purchase our common stock at an exercise prices
of $0.13 per share for 8,536,110 warrants, $0.19 per share for 8,536,110 warrants and $0.40 per share for 8,168,037
warrants. For purposes of this prospectus, we have assumed exercise prices of $0.13, $0.19 and $0.40 per share of Common Stock.
Furthermore,
this prospectus relates to the resale from time to time by Selling Securityholder of 1,774,500 shares of Common Stock which we issued
to the Selling Securityholder upon the partial exercise of the Convertible Debentures.
The
Selling Securityholder will sell its shares registered for resale in this prospectus at fixed prices, at prevailing market prices at
the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale or at negotiated
prices.
We
will not receive any of the proceeds from the sale of the securities owned by the Selling Securityholder. We will not receive any proceeds
from the conversion of the Convertible Debentures, but will receive the proceeds of any cash exercise of the Warrants. See "Use
of Proceeds" beginning on page 19 of this prospectus. We will bear all costs, expenses and fees in connection with the registration
of these securities, including with regard to compliance with state securities or "blue sky" laws. The Selling Securityholder
will bear all commissions and discounts, if any, attributable to their sale of securities. See "Plan of Distribution" beginning
on page 76 of this prospectus.
Our
common stock is currently quoted on the OTC Market Group, Inc.'s OTCQB tier under the symbol "MLYF." On May 18,
2022, the last reported sale price of our common stock was $0.255.
Our
principal executive offices are located at 8180 Greensboro Drive, Suite 720, McLean, Virginia 22102.
Investing
in our common stock involves a high degree of risk. See "Risk Factors" beginning on page
9
of this prospectus.
Neither
the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of these
securities or passed on the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
The
date of this prospectus is ____________, 2022.
TABLE
OF CONTENTS
Page
CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS
1
CAUTIONARY
    NOTE REGARDING MINERALIZED MATERIAL
1
INDUSTRY
    AND MARKET DATA
1
TRADEMARKS
    AND COPYRIGHTS
1
CURRENCY
1
PROSPECTUS
    SUMMARY
2
THE
    OFFERING
8
SELECTED
    HISTORICAL CONSOLIDATED FINANCIAL DATA
9
RISK
    FACTORS
9
USE
    OF PROCEEDS
19
CAPITALIZATION
19
DETERMINATION
    OF OFFERING PRICE
20
DIVIDEND
    POLICY
20
MARKET
    PRICE FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
20
DESCRIPTION
    OF BUSINESS
28
MANAGEMENT'S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
33
MANAGEMENT
53
EXECUTIVE
    COMPENSATION
61
SECURITY
    OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
69
CERTAIN
    RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
71
DESCRIPTION
    OF SECURITIES
72
SELLING
    SECURITYHOLDER
75
PLAN
    OF DISTRIBUTION
76
MATERIAL
    UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
78
LEGAL
    MATTERS
82
EXPERTS
83
DISCLOSURE
    OF COMMISSION'S POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES
83
WHERE
    YOU CAN FIND ADDITIONAL INFORMATION
83
INDEX
    TO FINANCIAL STATEMENTS
F-1
No
dealer, salesperson or other individual has been authorized to give any information or to make any representation other than those contained
in this prospectus in connection with the offer made by this prospectus and, if given or made, such information or representations must
not be relied upon as having been authorized by us or the selling stockholder. This prospectus does not constitute an offer to sell or
a solicitation of an offer to buy any securities in any jurisdiction in which such an offer or solicitation is not authorized or in which
the person making such offer or solicitation is not qualified to do so, or to any person to whom it is unlawful to make such offer or
solicitation. Neither the delivery of this prospectus nor any sale made hereunder shall, under any circumstances, create any implication
that there has been no change in our affairs or that information contained herein is correct as of any time subsequent to the date hereof.
For
investors outside the United States: We have not, and the selling stockholder has not, done anything that would permit this offering
or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United
States. Persons outside the United States who come into possession of this prospectus must inform themselves, and observe any restrictions
relating to, the offering of the shares of our common stock and the distribution of this prospectus outside the United States.
i
Cautionary
Note Regarding Forward-Looking Statements
This
prospectus contains forward-looking statements. Specifically, forward-looking statements may include statements relating to:
●
our
    future financial performance;
●
changes
    in the market for our products and services;
●
our
    expansion plans and opportunities; and
●
other
    statements preceded by, followed by or that include the words "estimate," "plan," "project,"
    "forecast," "intend," "expect," "anticipate," "believe," "seek,"
    "target" or similar expressions.
These
forward-looking statements are based on information available as of the date of this prospectus and current expectations, forecasts and
assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied
upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements
to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise,
except as may be required under applicable securities laws.
As
a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from
those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:
●
Our
    losses and inability to provide assurance as to when or if we will become profitable and generate cash in our operating activities;
●
Our
    need for substantial additional financing to operate our business and difficulties we may face acquiring additional financing on
    terms acceptable to us or at all;
●
Our
    significant indebtedness and significant restrictions on our operations;
●
Our
    inability to implement our plans to construct and operate our planned magnesium research and development pilot plant and obtain necessary
    permits and authorizations to construct and operate the facility;
●
The
    dilutive effect of additional issuances of our common stock, or securities convertible into our common stock;
●
Our
    ability to raise further working capital as a result of a decline in the price of our common stock could affect our ability to continue
    operations;
●
Our
    increased costs as a result of being a public company in Canada and the United States; and
●
other
    risks and uncertainties indicated in this prospectus, including those under "Risk Factors."
CAUTIONARY
NOTE REGARDING MINERALIZED MATERIAL
"Mineralized
material" as used in this prospectus, although permissible under the United States Securities and Exchange Commission's ("SEC")
Industry Guide 7, does not indicate "reserves" by SEC standards. We cannot be certain that any mineralized materials will
ever be converted into SEC Industry Guide 7-compliant "reserves." Investors are cautioned not to assume that all or any part
of the disclosed mineralized material estimates will ever be confirmed or converted into reserves or that mineralized material can be
economically or legally extracted.
INDUSTRY
AND MARKET DATA
We
are responsible for the disclosure in this prospectus. However, this prospectus includes industry data that we obtained from internal
surveys, market research, publicly available information and industry publications. The market research, publicly available information
and industry publications that we use generally state that the information contained therein has been obtained from sources believed
to be reliable. The information therein represents the most recently available data from the relevant sources and publications and we
believe remains reliable. We did not fund and are not otherwise affiliated with any of the sources cited in this prospectus. Forward-looking
information obtained from these sources is subject to the same qualifications and additional uncertainties regarding the other forward-looking
statements in this prospectus.
TRADEMARKS
AND COPYRIGHTS
We
own or have rights to trademarks or trade names that we use in connection with the operation of our business, including our corporate
name, logo and website names. In addition, we own or have the rights to copyrights, trade secrets and other proprietary rights that protect
the pilot magnesium production facility we are developing and the formulations for our planned magnesium production. This prospectus
may also contain trademarks, service marks and trade names of other companies, which are the property of their respective owners. Our
use or display of third parties' trademarks, service marks, trade names or products in this prospectus is not intended to, and
should not be read to, imply a relationship with or endorsement or sponsorship of us. Solely for convenience, some of the copyrights,
trade names and trademarks referred to in this prospectus are listed without their ©, ® and ™ symbols, but we will assert,
to the fullest extent under applicable law, our rights to our copyrights, trade names and trademarks. All other trademarks are the property
of their respective owners.
CURRENCY
Unless
otherwise indicated, all references to "$" or "US$" in this registration statement refer to United States dollars,
and all references to "CAD$" refer to Canadian dollars.
1
PROSPECTUS
SUMMARY
This
summary highlights certain information about us, this offering, and selected information contained in this prospectus. This summary is
not complete and does not contain all of the information that you should consider before deciding whether to invest in our common stock.
For a more complete understanding of the Company and this offering, we encourage you to read and consider the more detailed information
in this prospectus, including "Risk Factors" and the financial statements and related notes. Unless the context otherwise
requires, "we," "us," "our," or "the Company" refers to "Western Magnesium Corporation,"
a Delaware corporation, and its consolidated subsidiaries.
Unless
otherwise indicated, all references to "$" or "US$" in this prospectus refer to United States dollars, and all
references to "CAD$" refer to Canadian dollars.
Our
Company
We
are a reporting issuer in Canada listed for trading on the TSX Venture Exchange (the "TSXV") under the symbol "
WMG
".
Our common stock is also traded in the United States on the OTCQB tier of the OTC Markets (the "OTCQB") under the symbol
"
MLYF
" and in Germany on the Frankfurt Stock Exchange under the symbol "
3WM
".
We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production of magnesium at a research and development pilot plant
in metropolitan Vancouver, British Columbia, Canada. We have commenced testing at this facility in the last calendar quarter of 2021
with full pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete.
Our proprietary technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor
and energy costs while generating minimal waste and toxic by-products.
In
addition, we own a 100% interest in 81 unpatented lode mining claims totaling approximately 1,673 acres (the "Tami Mosi Mining
Claim"), four unpatented lode mining claims totaling approximately 10 acres located in the Moor Mining District in Elco County,
Nevada and a 100% interest in three patented mining claims located in the Pinto mining district of Nevada totaling approximately 296
acres (the "Silverado Mining Claim"). We do not plan on commencing extraction of minerals at this time from any mining claims
we hold because we have identified alternative sources of supply of dolomite and ferrosilicon, the primary raw materials used to produce
pure magnesium. We may in the future, however, commence extraction of minerals from the Tami Mosi Mining Claim if we are unable to purchase
raw materials from the alternative sources we have identified at commercially reasonable rates. In addition, we do not consider our mining
claims to be material to our business or financial condition.
Corporate
History
We
were incorporated under the Company Act (British Columbia) on March 24, 1966 as "Ft. Lauderdale Resources Inc." We changed
our name to Amcorp Industries Inc. on July 20, 1990, to Molycor Gold Corporation on May 17, 1996, to Nevada Clean Magnesium Inc. on April
16, 2012 and to Western Magnesium Corporation on May 14, 2019. On May 14, 2019, we discontinued from the jurisdiction of the Business
Corporations Act (British Columbia) and domesticated under the General Corporation Law of the State of Delaware under the name "Western
Magnesium Corporation." In connection with the name change, we also changed our stock symbol to "WMG" on the TSXV.
We have two wholly-owned subsidiaries: Western Magnesium Corp., incorporated in the State of Nevada in the United States which owns our
mining claim in the Schell Creek Range located southeast of Ely, Nevada and manages the Company's Nevada properties; and Western
Magnesium Canada Corp., incorporated on May 3, 2019 in British Columbia, Canada which manages our Canadian operations.
General
Development of Our Business
In
2006, we acquired the Silverado Mining Claim. During the year ended October 31, 2013, an impairment was recorded on this claim for $412,793
reducing its book value to $1.
In
2009, we acquired 27 mining claims totaling approximately 1,744 acres on property located southeast of Beaverdell, British Columbia (the
"Beaverdell Mining Claim"). During the year ended October 31, 2013, an impairment was recorded on this claim for $335,133
reducing its book value to $1. During the year ended October 31, 2020, we sold our interest in the Beaverdell Mining Claim for $50,000
and recognized a gain on sale of $37,156.
On
October 9, 2006, we acquired the Tami Mosi Mining Claim. On May 1, 2009, an Initial Resource Estimate was completed by Norm Tribe &
Associates, Ltd. On June 11, 2010, a Phase 1 Process Development Study for Exploitation of the Tami Mosi Mining Claim was completed by
Haze Research, Inc. On August 3, 2011, an updated resource estimate was completed by Tetra Tech, Inc. ("Tetra Tech"), on
September 15, 2011 a Preliminary Economic Assessment and Technical Report of the Tami-Mosi Magnesium Project was completed by Tetra Tech
and amended on July 4, 2014.
2
On
April 4, 2017, we completed construction of a bench scale test furnace that employed our proprietary continuous silicothermic process
and in October 2017, we successfully completed furnace preparations - a major milestone in the testing of our bench scale pilot furnace.
In
November 2017, we completed "proof of concept" in the production of magnesium metal from our bench scale test furnace. The
metal produced was a result from a partial test charge being conducted in order to identify any operational deficiencies in the furnace
prior to a full charge test of dolime material.
In
January 2018, we received a final assay report assessing the purity of the raw magnesium metal produced from our bench scale pilot furnace
test program. In accordance with ASTM International standard ASTM E1479-16, the testing was analyzed via inductively coupled plasma (ICP).
This unrefined magnesium metal was found to have a very good metal purity capable of producing ASTM B92 grade metal with minimal treatment.
No impurities were found which would impact food grade applications.
In
July 2018, we entered into an agreement with Industrial Surplus Ltd. ("ISL") to build a silicothermic reduction furnace based
on our bench scale test furnace.
In
December 2018, our technical team produced a magnesium ingot from dolomite obtained from the Tami Mosi Mining Claim. This accomplishment
completed the proof-of-concept stage allowing us to develop a pilot magnesium furnace based on the bench scale furnace.
Our
Business
We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production at a research and development pilot plant in Metropolitan
Vancouver, British Columbia, Canada. We have commenced test production at this facility in the last calendar quarter of 2021 with full
pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete. Our proprietary
technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor and energy costs
while generating minimal toxic by-products.
Plan
of Operations
In
order to complete construction and commencing testing at our planned research and development pilot plant, the following are the key
milestones that we expect to achieve over the next 12 months following the date of this prospectus:
●
Complete
    construction of the plant;
●
Commission
    the plant and complete final training of operations staff;
●
Commence
    metal production under various scenarios to ensure sufficient data is collected;
●
Begin
    the request for proposal process for commercial engineering, procurement and construction management ("EPCM") firm;
●
Select
    EPCM firm;
●
Review
    all pilot data with chosen EPCM firm and validate proposed required operational scenarios; and
●
Begin
    geotechnical assessments of proposed full-scale magnesium production facility in Harrison County, Ohio.
We
estimate that the costs to complete this work will be approximately $8,000,000. We have commenced testing in the pilot reactor in the
last calendar quarter of 2021 with full pilot facility operations expected to commence in the second calendar quarter of 2022 after all
safety testing is complete.
Following
completion of our magnesium research and development pilot plant, we intend to construct a full-scale magnesium production facility with
expected capacity to produce 100,000 metric tons per year that will be scalable for greater production levels located on 122 acre property
located in Harrison County, Ohio. The proposed plant will be adjacent to the future home of a modern mixed fuels power plant which is
expected to provide power to our planned magnesium production plant. The proposed Harrison County, Ohio location is close to a dolomite
supply and has an infrastructure of rail and highway that is capable of transporting our magnesium finished product to industries across
the United States. Our plans will require a significant amount of additional capital. See "Management's Discussion and Analysis
of Financial Condition and Results of Operations – Liquidity and Capital Resources." We have no current plans to extract
minerals from any of our mining claims. See "Description of Business – Properties."
3
Magnesium
and Its Production
Magnesium
is the lightest of all commonly used structural metal, following steel and aluminum. It is the lightest and strongest of the structural
metals, it is one fourth the weight of steel, two fifths the weight of titanium and two thirds the weight of aluminum. Magnesium has
multiple industrial and consumer applications. Magnesium ingots are a prime raw material input for the production of titanium and aluminum
alloys and magnesium alloys. Magnesium powder and granules are used to remove sulfur in the production of steel. Due to their unique
light weight and high strength properties, magnesium alloys are used in a variety of aircraft and automobile parts, as well as in electronic
equipment such as computers, cameras and cellular phones.
Most
magnesium produced globally comes from natural minerals such as dolomite and magnesite in the form of magnesium carbonate. It can also
be found in seawater and in salt lakes brines or underground mineral salt deposits. Magnesium can be produced through several different
methods including the electrolytic process or thermal-reduction as practiced in the most commonly used Pidgeon process.
The
electrolytic process involves the electrolysis of molten magnesium chloride which produces molten magnesium and chlorine. The metal is
cast into ingots for further processing as needed and the chlorine by-product may be sold for use in the production of polymers such
as polyvinyl chloride pipe (PVC).
In
the thermal-reduction method calcined magnesium containing ores (magnesite and dolomite) are broken down into fine powder and mixed with
reducing agents and catalyst agent. The mixture is heated in a vacuum chamber producing magnesium vapors which later condense into crystals.
The crystals are then melted, refined and poured into ingots for further processing.
The
Pidgeon process, using ferrosilicon as a catalyst, is most commonly used for production of magnesium as its operation is relatively easy
and has a low capital cost. The traditional process using horizontal retorts is high in energy consumption and has low productivity.
Intellectual
Property—Patents, Trademarks
We
regularly seek to protect our intellectual property rights in connection with our production process and methods. We rely on non-disclosure/confidentiality
agreements and segregate development and engineering duties among certain members of our development team to protect our intellectual
property rights. To the extent we describe or disclose our proprietary production techniques, we redact or request redaction of such
information prior to public disclosure. Despite these measures, we may be unable to detect the unauthorized use of, or take appropriate
steps to enforce our intellectual property rights. Effective trade secret protection may not be available in every country in which we
offer or intend to produce magnesium or offer our products for sale to the same extent as in the United States. Failure to adequately
protect our intellectual property could impair our ability to compete effectively. Further, enforcing our intellectual property rights
could result in the expenditure of significant financial and managerial resources and may not prove successful. Although we intend to
protect our rights vigorously, there can be no assurance that these measures will be successful. See "Risk Factors" with
respect to intellectual property.
We
own the website domain
www.westernmagnesium.com
and
www.westmagcorp.com
and social media accounts across certain major
platforms.
We
do not have any patents or trademarks nor have we filed any patent or trademark applications in the United States or Canada.
Employees
As
of April 30, 2022, we had 31 employees. We consider our relations with our employees to be good.
COVID-19
In
December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely
concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections
have been reported globally. In March 2020, the World Health Organization declared COVID-19 a global pandemic. In order to combat the
spread of COVID-19, governments worldwide, including the Unites States and Canada, have enacted emergency measures including travel bans,
legally enforced or self-imposed quarantine periods, social distancing and business and organization closures. These measures have adversely
affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on us has not been significant
but could affect our ability to raise financings in the future and restrict travel. Management continues to monitor the situation.
4
Selling
Stockholder
June
2021 Securities Purchase Agreement and 12% Convertible Debenture
On
June 10, 2021, we entered into a securities purchase agreement (the "2021 SPA") with Alpha Capital Anstalt (the "Selling
Securityholder"), pursuant to which we issued a 12% convertible debenture (the "2021 Debenture") with a maturity date
of December 10, 2022, in the principal sum of $1,500,000. Pursuant to the terms of the 2021 Debenture, we agreed to pay to the Selling
Securityholder interest on the principal balance at the rate of 12% per annum. We intend to use the proceeds for working capital. The
Selling Securityholder may convert the principal amount of the 2021 Debenture and, upon receipt of TSXV approval, accrued interest
into our common stock (subject to the beneficial ownership limitation of 9.99% in the 2021 Debenture; provided however, that the
limitation on conversion may be waived by the Selling Securityholder upon, at the election of the Selling Securityholder, not less than
61 days' prior notice to us) at any time at a conversion price equal to $0.10 per share (the "2021 Conversion Price"),
as the same may be adjusted as provided in the 2021 Debenture. In addition, upon each conversion of the 2021 Debenture, the Selling Securityholder
is entitled to receive (i) Class A Warrants exercisable into 50% of the conversion shares being issued on such conversion at an exercise
price of $0.13 (the "Class A Warrants"); and (ii) Class B Warrants exercisable into 50% of the conversion shares being issued
on such conversion at an exercise price of $0.19 per share (the "Class B Warrants," together with the Class A Warrants, the
"2021 Warrants"). The 2021 Warrants may be exercised until June 10, 2026.
The
2021 Debenture may be prepaid by the Company so long as an event of default has not occurred, upon 20 days' prior written notice
received by the holder, by paying 125% of the amounts owed on the 2021 Debenture, including all principal, interest and other fees. The
holder of this debenture may, however, convert all or a portion of the debenture during the 20-day notice period.
In
event of default under the 2021 Debenture, the interest rate shall increase to the lesser of 20% per annum or the maximum rate permitted
under applicable law until paid and the following "Mandatory Default Amount" shall be paid by us, if demanded by the Purchaser:
the sum of (a) the greater of (i) the outstanding principal amount of the 2021 Debenture divided by the 2021 Conversion Price on the
date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an event of default) or otherwise
due or (B) paid in full, whichever has a lower 2021 Conversion Price, multiplied by the VWAP on the date the Mandatory Default Amount
is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 125% of the outstanding principal amount of the 2021
Debenture plus (b) all other amounts, costs, expenses and liquidated damages due in respect of the 2021 Debenture.
Pursuant
to the terms of the 2021 SPA, we agreed to use commercially reasonable efforts to file with the SEC a registration statement covering
the resale of all shares issued or issuable upon conversion of the 2021 Debenture and upon exercise of the 2021 Warrants. We agreed to
file the registration statement with the SEC within 60 days following June 10, 2021 and to have the registration statement declared effective
by the SEC within 120 days following June 10, 2021. In addition, pursuant to the 2021 SPA, we agreed to give the Selling Securityholder
certain piggy-back registration rights if we do not have an effective registration statement covering the shares issuable upon conversion
of the 2021 Debenture and the 2021 Warrants and we propose to file any registration statement under the Securities Act with respect to
our common stock.
April
2022 Securities Purchase Agreement and 15% Convertible Debenture
On
April 14, 2022, we entered into a securities purchase agreement (the "2022 SPA") with the Selling Securityholder, pursuant
to which we issued a 15% convertible debenture (the "2022 Debenture") with a maturity date of October 14, 2023, in the principal
sum of $2,000,000. Pursuant to the terms of the 2022 Debenture, we agreed to pay to the Selling Securityholder interest on the principal
balance at the rate of 15% per annum. We intend to use the proceeds for working capital. The Selling Securityholder may convert the principal
amount of the 2022 Debenture and, upon receipt of TSXV approval, accrued interest **into our common stock (subject to the
beneficial ownership limitation of 9.99% in the 2022 Debenture; provided however, that the limitation on conversion may be waived by
the Selling Securityholder upon, at the election of the Selling Securityholder, not less than 61 days' prior notice to us) at any
time at a conversion price equal to $0.30 per share (the "2022 Conversion Price"), as the same may be adjusted as provided
in the 2022 Debenture. In addition, upon each conversion of the 2022 Debenture, the Selling Securityholder is entitled to receive a warrant
(the "2022 Warrants") to purchase a number of shares of our common stock equal to 100% of the conversion shares being issued
on such conversion. The 2022 Warrants may be exercised for a period of five years after the date of issuance at an exercise price of
$0.40 per share, subject to adjustment as provided in the 2022 Warrants.
The
2022 Debenture may not prepaid prior to maturity and contains customary events of default relating to, among other things, payment defaults,
breach of representations and warranties, and breach of provisions of the 2022 Debenture or the 2022 SPA.
In
event of default under the 2022 Debenture, the interest rate shall increase to the lesser of 20% per annum or the maximum rate permitted
under applicable law until paid and the following "Mandatory Default Amount" shall be paid by us, if demanded by the Purchaser:
the sum of (a) the greater of (i) the outstanding principal amount of the 2022 Debenture divided by the 2022 Conversion Price on the
date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an event of default) or otherwise
due or (B) paid in full, whichever has a lower 2021 Conversion Price, multiplied by the VWAP on the date the Mandatory Default Amount
is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 125% of the outstanding principal amount of the 2022
Debenture plus (b) all other amounts, costs, expenses and liquidated damages due in respect of the 2022 Debenture.
5
Pursuant
to the terms of the 2022 SPA, on April 14, 2022, we also entered into a registration rights agreement, dated April 14, 2022, by and between
us and the Selling Securityholder (the "Registration Rights Agreement"). Pursuant to the terms of the Registration Rights
Agreement, we agreed to prepare and file with the SEC a registration statement covering the resale of all shares issued or issuable upon
conversion of the 2022 Debenture, upon exercise of the 2022 Warrants, upon conversion of the 2021 Debenture and upon exercise of the
2021 Warrants. We agreed to file the registration statement with the SEC within 30 days following April 14, 2022 and to use our best
efforts to have the registration statement declared effective by the SEC within 60 days following April 14, 2022 if the SEC does not
review it or by August 12, 2022 if the SEC reviews it. In the event we fail to file the registration statement or such registration statement
is not declared effective within the time periods noted above or such registration statement is not kept effective while any of the securities
registered pursuant to such registration statement, we will be obligated to pay the holder of the debentures a penalty in cash, in the
amount of $20,000 on the date of such failure and on the 30th day of each month following such failure. The Registration Rights Agreement
contains customary indemnification provisions.
The
2021 Debenture and the 2022 Debenture are collectively referred to hereinafter as the "Convertible Debentures". The 2021
Warrants and the 2022 Warrants are collectively referred to hereinafter as the "Warrants".
Recent
Developments
For
a detailed description of recent developments of the Company, see "Description of Business – General Development of Our Business"
on page 28 of this prospectus.
Summary
Risk Factors
Our
business is subject to numerous risks and uncertainties, including those in the section entitled "Risk Factors" and elsewhere
in this prospectus. These risks include, but are not limited to, the following:
●
Our
    losses and inability to provide assurance as to when or if we will become profitable and generate cash in our operating activities.
●
Our
    need for substantial additional financing to operate our business and difficulties we may face acquiring additional financing on
    terms acceptable to us or at all.
●
Our
    significant indebtedness and significant restrictions on our operations.
●
Our
    inability to implement our plans to construct and operate our planned magnesium research and development pilot plant and obtain necessary
    permits and authorizations to construct and operate the facility.
●
Risks
    related to health, safety and environmental laws, regulations and other requirements in Canada and the United States that may expose
    us to substantial claims, costs, and liabilities.
●
The
    impact of global climate change on our ability to conduct future operations.
●
Our
    lack of a diversified portfolio of assets.
●
Risks
    related to our information technology systems, and potential cyber-attacks and security and privacy breaches.
●
Risks
    related to our insurance coverage and uninsurable risks.
●
Our
    dependence on key inputs, suppliers, and skilled labor for the production of magnesium.
●
Our
    inability to attract and retain key personnel.
●
Growth-related
    risks, including capacity constraints and pressure on our internal systems and controls.
●
The
    adverse consequences of litigation we are currently involved in and litigation we may face from time to time.
●
Risk
    related to the protection of our intellectual and our exposure to infringement or misappropriation claims by third parties.
●
Risks
    related to competition.
●
Risks
    related to our lack of internal controls over financial reporting and their effectiveness.
●
Risks
    related to elimination of monetary liability against our directors, officers, and employees under Delaware law and the existence
    of indemnification rights for our obligations to our directors, officers, and employees.
6
●
Difficulty
    in enforcing judgments and effecting service of process on directors and officers that are not citizens of the United States.
●
The
    lack of a guarantee on a return on our common stock.
●
The
    dilutive effect of additional issuances of our common stock, or securities convertible into our common stock.
●
The
    adverse effect on the market price of our common stock related to sales of substantial amounts of our common stock or shares issuable
    upon conversion of our convertible debt securities.
●
The
    volatility of the market price for our common stock.
●
Our
    ability to raise further working capital as a result of a decline in the price of our common stock could affect our ability to continue
    operations.
●
Our
    stock price and trading volume could decline if securities or industry analysts do not publish or cease publishing research or reports
    or publish misleading, inaccurate or unfavorable research about us, our business or our market.
●
An
    investor may face liquidity risks with an investment in our common stock.
●
Risks
    related to a lack of dividend payments by us on our common stock and, consequently, the ability of investors to achieve a return
    on their investment.
●
Our
    increased costs as a result of being a public company in Canada and the United States.
In
addition, our management has concluded that our historical recurring losses from operations and negative cash flows from operations as
well as our dependence on securing private equity and other financings raise substantial doubt about our ability to continue as a going
concern and our auditor has included an explanatory paragraph relating to our ability to continue as a going concern in its audit reports
for the fiscal years ended October 31, 2021 and 2020.
Corporate
Information
Our
principal executive offices are located at 8180 Greensboro Drive, Suite 720, McLean, Virginia 22102, and our telephone number at that
location is (571) 378-0762. The address of our website is www.westernmagnesium.com. The inclusion of our website address in this prospectus
does not include or incorporate by reference the information on our website into this prospectus.
The
name of the Company, our logos and other trade names, trademarks or service marks appearing in this prospectus are the property of our
company. Trade names, trademarks and service marks of other organizations appearing in this prospectus are the property of their respective
holders.
7
THE
OFFERING
19,240,256
Shares of Common Stock Underlying Convertible
Debentures
25,240,256
Shares of Common Stock Underlying Warrants
1,774,500
Shares of Common Stock for Resale by Selling Securityholder
We
are registering (i) the issuance by us of up to 19,240,256 shares of our Common Stock which may be issued upon the conversion
of the Convertible Debentures held by the Selling Securityholder, (ii) the issuance by us of up to 25,240,256 shares of our Common
Stock which may be issued upon the exercise of the warrants held by the Selling Securityholder or which may be issued to the Selling
Securityholder in connection with the conversion of such Convertible Debentures and (iii) 1,774,500 shares of our Common Stock which
we issued to the Selling Securityholder upon the partial exercise of the Convertible Debentures.
Issuance
of Shares Underlying the Warrants and Convertible Debentures
Shares
    to be Issued upon Exercise of Warrants and Conversion of Convertible Debentures
44,480,511
shares of Common Stock underlying the Warrants
    and Convertible Debentures.
Shares
    held by Selling Securityholder
1,774,500
Shares
    Outstanding Prior to Exercise of Warrants and Conversion of Convertible Debentures
437,926,611
    shares of Common Stock as of May 16, 2022.
Shares
    to be Outstanding Assuming Exercise of All Warrants and Conversion of the Entire Principal and Interest of Convertible Debentures
482,407,122
shares of Common Stock.
Terms
    of Convertible Debentures
2021
                                            Debenture.
The per share conversion price into which the principal amount and accrued
                                            interest upon receipt of TSXV approval (including any default interest) under
                                            the 2021 Debenture shall be convertible into shares of Common Stock hereunder is $0.10 per
                                            share.
2022
    Debenture.
The per share conversion price into which the principal amount and accrued interest upon receipt of
    TSXV approval (including any default interest) under the 2022 Debenture shall be convertible into shares of Common Stock hereunder
    is $0.30 per share.
Terms
    of Warrants
2021
                                            Warrants
. Each Class A Warrant entitles the holder to purchase one share of our Common
                                            Stock at an exercise price of $0.13 per share and each Class B Warrant entitles the holder
                                            to purchase one share of our Common Stock at an exercise price of $0.19 per share. Each 2021
                                            Warrant may be exercised at any time commencing on the date of issuance until June 10, 2026.
2022
    Warrants
. Each 2022 Warrant entitles the holder to purchase one share of our Common Stock at an exercise price of $0.40 per
    share. Each 2022 Warrant may be exercised at any time commencing on the date of issuance until the fifth anniversary following the
    date of issuance.
Provisions
    Common to the Class A Warrants, the Class B Warrants and the 2022 Warrants
. In the event that there is no effective registration
    statement registering the shares underlying the warrants, then the warrants may be exercised by means of a "cashless exercise"
    at the holder's option, such that the holder may use the appreciated value of the warrants (the difference between the market
    price of the underlying shares of common stock and the exercise price of the underlying warrants) to exercise the warrants without
    the payment of any cash.
8
Use
    of Proceeds
We
    expect to receive approximately $5,998,770 in gross proceeds assuming the cash exercise of all of the warrants being registered
    hereby at the applicable exercise price stated above. However, the warrants may be exercised on a cashless basis, in which case we
    would not expect to receive any gross proceeds from the cash exercise of the warrants. We intend to use any net proceeds from the
    cash exercise of the warrants for working capital and general corporate purposes. We will not receive any of the proceeds from the
    conversion of the 2021 Debenture or the 2022 Debenture into shares of our Common Stock.
Trading
    Market
The
    Company's Common Stock is currently quoted on the OTCQB under the symbol "MLYF."
SELECTED
HISTORICAL CONSOLIDATED FINANCIAL DATA
The
following table presents our selected historical consolidated financial data for the periods indicated. The selected historical consolidated
financial data for the years ended October 31, 2021 and 2020 and the balance sheet data as of October 31, 2021 and 2020 are derived from
the audited financial statements. The summary historical consolidated financial data for the three months ended January 31, 2022 and
2021 and the balance sheet data as of January 31, 2022 and 2021 are derived from our unaudited financial statements.
Historical
results are included for illustrative and informational purposes only and are not necessarily indicative of results we expect in future
periods, and results of interim periods are not necessarily indicative of results for the entire year. The data presented below should
be read in conjunction with, and are qualified in their entirety by reference to, "Management's Discussion and Analysis of
Financial Condition and Results of Operations"
and our consolidated financial statements
and the notes thereto included elsewhere in this prospectus.
Three
    Months Ended
Years
    Ended
January
    31,
October
    31,
2022
2021
2021
2020
$
$
$
$
Total
    Expenses
(3,045,185
)
(2,108,476
)
(17,705,211
)
(4,714,740
)
Other
    Income (Expense)
(11,901,344
)
(14,534
)
(5,844,401
)
42,135
Net
    Loss
(14,946,529
)
(2,123,010
)
(23,549,612
)
(4,672,605
)
Loss Per Share
(0.04
)
(0.01
)
(0.07
)
(0.01
)
Total
    Assets
5,500,498
900,088
4,513,512
708,763
Current
    Liabilities
12,602,730
2,638,085
10,891,270
2,551,448
Long-Term
    Liabilities
320,045
246,754
392,280
237,218
RISK
FACTORS
The
following are certain factors relating to our business. These risks and uncertainties are not the only ones we face. Additional risks
and uncertainties not presently known to us or currently deemed immaterial by us, may also impair our operations. If any such risks actually
occur, our shareholders could lose all or part of their investment and its business, financial condition, liquidity, results of operations
and prospects could be materially adversely affected and its ability to implement its growth plans could be adversely affected. Our shareholders
should evaluate carefully the following risk factors associated with the shares of common stock.
Risks
Related to our Business and Operations
Although
our financial statements have been prepared on a going concern basis, we must raise additional capital to fund our operations in order
to continue as a going concern.
Dale
Matheson Carr-Hilton Labonte LLP, our independent registered public accounting firm for the fiscal year ended October 31, 2021, has included
an explanatory paragraph in their opinion that accompanies our audited consolidated financial statements as of and for the year ended
October 31, 2021, indicating that we have
not generated revenues since inception, have incurred
losses in developing our business, anticipate further losses and we require additional funds to meet our obligations and the costs of
our operations. These factors raise substantial doubt about our ability to continue as a going concern.
If we are unable to improve
our liquidity position, we may not be able to continue as a going concern. The accompanying consolidated financial statements do not
include any adjustments that might result if we are unable to continue as a going concern and, therefore, be required to realize our
assets and discharge our liabilities other than in the normal course of business. In addition, trading in our common stock is subject
to the "Penny Stock" rules adopted by the SEC which regulate broker-dealer practices in connection with Penny Stocks quoted
on the OTC Markets is often thin and characterized by wide fluctuations in trading prices. Consequently, these factors could make it
difficult for investors to sell their shares and cause them to suffer the loss of all or a substantial portion of their investment.
9
We
anticipate that our principal sources of liquidity will only be sufficient to fund our activities over the next twelve months. In order
to have sufficient cash to fund our operations after this time period, we will need to raise additional equity or debt capital in order
to continue as a going concern and we cannot provide any assurance that we will be successful in doing so.
We
incurred net losses in the three months ended January 31, 2022 and fiscal years 2021 and 2020 with net cash used in operating activities
and cannot provide assurance as to when or if we will become profitable and generate cash in our operating activities.
We
incurred net losses of $23,549,612 and $4,672,605 and net cash used in operating activities of $6,367,567 and $3,270,534 for the fiscal
years ended October 31, 2021 and 2020, respectively. In addition, we incurred net losses of $14,946,529 and $2,123,010 and net cash used
in operating activities of $1,798,902 and $990,364 for the three months ended January 31, 2022 and 2021, respectively. As of January
31, 2022, we had an aggregate accumulated deficit of $67,076,150. Such losses have historically required us to seek additional funding
through the issuance of debt or equity securities. In addition, we have historically experienced and may prospectively experience fluctuations
in our quarterly earnings due to the nature of our business. Our long-term success is dependent upon among other things, completion of
an operational magnesium production facility and generating revenue from sales of magnesium to reduce our cash needs, and there is no
assurance that we will be able to achieve sales of magnesium.
We
anticipate requiring substantial additional financing to operate our business and we may face difficulties acquiring additional financing
on terms acceptable to us or at all.
We
will need additional capital in the approximate amount of $8,000,000 to complete the buildout of our planned research and development
pilot magnesium production plant and ultimately a full-scale production facility as well as sustain our operations and will need to seek
further financing. If we fail to raise additional capital, as needed, our ability to implement these plans will be compromised. To date,
our operations and production plant development have been funded from the proceeds of debt and equity financings. We expect to require
substantial additional capital in the future primarily to fund working capital requirements of our business, including operational expenses,
planned capital expenditures for our research and development pilot plant and ultimately a full-scale production facility and debt service.
Even
if we obtain financing for our near-term operations and capital expenditures, we expect that we will require additional capital thereafter.
Our capital needs will depend on numerous factors including: (i) the costs and timing of completion of construction of a full- scale
magnesium production facility; (ii) achieving magnesium sales; (iii) the level of our investment in research and development; and (iv)
the amount of our capital expenditures.
If
we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership held by our existing
shareholders will be reduced and our shareholders may experience significant dilution. In addition, new securities may contain rights,
preferences, or privileges that are senior to those of existing securities. If we raise additional capital by incurring debt, this will
result in increased interest expense. If we raise additional funds through the issuance of equity securities, market fluctuations in
the price of our securities could limit our ability to obtain equity financing.
No
assurance can be given that any additional financing will be available to us, or if available, will be on terms favorable to us. If we
are unable to raise capital when needed, our business, financial condition and results of operations would be materially adversely affected,
and we could be forced to reduce or discontinue our operations.
We
have significant indebtedness under our debt obligations, which also include significant restrictions on our operations.
The
significant level of indebtedness represented by the Convertible Debentures could have important consequences to our shareholders due
to the following potential factors: (i) difficulty in satisfying obligations and covenants with respect to indebtedness; (ii) limitations
on the ability to obtain additional financing to fund future working capital, capital expenditures or other general corporate requirements
and increased cost of any additional borrowing; (iii) a requirement to pay the full principal amount plus accrued interest upon maturity
on December 10, 2022 with respect to the 2021 Debenture and October 14, 2023 with respect to the 2022 Debenture, thereby reducing the
amount of cash available for working capital, capital expenditures, acquisitions and other general corporate purposes; and (iv) placing
us at a disadvantage compared to our less leveraged competitors.
Our
ability to repay the principal and accrued interest upon maturity, or to refinance, our indebtedness will depend on our stock price and
our ability to raise additional equity and/or indebtedness and future cash flow, which is subject to our completion of a full-scale magnesium
production facility, future sales of magnesium, prevailing economic conditions, prevailing interest rate levels, and financial, competitive,
business and other factors, many of which are beyond our control.
10
The
Convertible Debentures contain numerous restrictive covenants that limit our discretion with respect to certain business matters, including
our ability to incur additional indebtedness, to create liens or other encumbrances, to sell additional securities and to merge or consolidate
with another entity or to make certain restricted payments, including declaring or paying dividends or other distributions. Our failure
to comply with our obligations under the Convertible Debentures could result in a default, which, if not waived, could permit acceleration
of the Convertible Debentures. If the Convertible Debentures were to be accelerated, there can be no assurance that our assets would
be sufficient to repay in full that indebtedness.
The
2021 Debenture will need to be repaid, renewed, refinanced or converted no later than December 10, 2022 and the 2022 Debenture will need
to be repaid, renewed, refinanced or converted no later than October 14, 2023. Although we believe that we can negotiate an extension
or renewal of the Convertible Debentures or obtain replacement financing, if necessary, prior to the maturity of each of the Convertible
Debentures, there can be no assurance that the maturity date under either of the Convertible Debentures will be extended or renewed or
that future borrowings will be available to us, or available on acceptable terms, in an amount sufficient to meet our financing requirements
at their respective maturity dates. If such an extension or renewal or future borrowings were not available, or not available on acceptable
terms, in each case, as necessary at the applicable time, it would have a material adverse impact on our business and financial condition.
We
may be subject to risks associated with increased liabilities and the ability to meet our debt obligations.
We
have incurred substantial liabilities, in addition to the Convertible Debentures, to invest in the businesses of our subsidiaries. These
liabilities have increased the risk of an investment in our common stock because the liabilities increase our need for capital to pay
them. Our ability to pay our accounts payable and other liabilities and comply with the terms and conditions of our Convertible Debentures
will depend upon our future performance and will be subject to financial, business and other factors affecting our business and operations,
including general economic conditions. There are no assurances that we will be able to pay all of our liabilities as they become due.
If
we fail to implement our development plans, our financial condition and results of operations could be materially and adversely affected.
A
fundamental part of our strategy is to construct and operate a research and development pilot magnesium production facility using a continuous
silicothermic reactor system technology we have developed. Although we have already commenced production for the purposes of testing
and certification in the last calendar quarter of 2021 and have raised approximately $15,989,098 in fiscal 2021 and through the date
of this prospectus, we will need additional financing to implement our development strategy to construct a full-scale magnesium production
facility. We may not have access to the funding required for this plan on acceptable terms. Our development plans may also suffer significant
delays as a result of a variety of factors, such as legal and regulatory requirements, either of which could prevent us from completing
our plans as currently expected. In addition, even if we can implement our strategy, development in the magnesium market, increased sales
to various industries, including the automobile industry may not materialize to the extent we expect, or at all, resulting in unutilized
magnesium production capacity. Any failure to successfully implement our business strategy, including for any of the above reasons, could
materially and adversely affect our financial condition and results of operations. We may, in addition, decide to alter or discontinue
certain aspects of our business strategy at any time.
We
may not be able to obtain necessary permits and authorizations.
We
may not be able to obtain the necessary licenses, permits, certificates, or authorizations to operate our planned research and development
pilot magnesium production facility in Metropolitan Vancouver, British Columbia, Canada and commence mining activities on our Tami Mosi
Mining Claim, or may only be able to do so at great cost. In addition, we may not be able to comply fully with the wide variety of laws
and regulations applicable to magnesium production and mineral mining. Failure to comply with or to obtain the necessary licenses, permits,
certificates, or authorizations could result in a delay in our ability to operate our planned research and development pilot magnesium
production facility, which could have a material adverse effect on our business, financial condition or results of operations.
We
are subject to a broad range of health, safety and environmental laws, regulations and other requirements in Canada and the U.S. that
may expose us to substantial claims, costs, and liabilities.
Magnesium
production and mining is subject to numerous complex and stringent federal, state, and local laws, regulations, policies, and other requirements,
including those related to health, safety, environmental, and waste management and disposal matters, which may expose us to substantial
claims, costs, and liabilities. We may be subject to fines, penalties and other damages, such as natural resource damages and the costs
associated with the investigation and cleanup of soil, surface water, groundwater, and other media under laws such as CERCLA (commonly
known as Superfund) or similar U.S. and foreign regulations. These laws, regulations, policies, and other requirements could change or
be applied or interpreted in ways that could (i) require us to enjoin, curtail, development of our planned research and development pilot
magnesium production facility and mining operations in Nevada, including the implementation of corrective measures, the installation
of additional equipment, or the undertaking of other remedial actions, or (ii) subject us to enforcement risk or impose on or require
us to incur additional capital expenditures, compliance or other costs, fines, or penalties, any of which could adversely affect our
results of operations, cash flows and financial condition, and the trading price of our common stock.
11
Once
we commence magnesium production at our planned research and development pilot facility in Canada, the costs of complying with such laws,
regulations, policies and other requirements, including participation in assessments, remediation activities, and cleanups of sites,
as well as internal voluntary programs, are expected to be significant for the foreseeable future.
In
addition, because environmental laws, regulations, policies and other requirements are constantly evolving, we expect to incur costs
to maintain compliance and such costs could increase materially and prove to be more limiting and costly than we anticipate. Evolving
standards and expectations can result in increased litigation and/or increased costs, all of which can have a material and adverse effect
on our business operations, expected revenues and cash flows. Future compliance with environmental, health and safety legislation and
other regulatory requirements or expectations may prove to be more limiting and costly than we anticipate and may disrupt our plans for
development of a magnesium production facility.
Global
climate change is an international concern and could impact our ability to conduct future operations
.
Global
climate change is an international issue and receives an enormous amount of publicity. We would expect that the imposition of international
treaties or federal, state or local laws or regulations pertaining to mandatory reductions in energy consumption or emissions of greenhouse
gases could affect the feasibility of our magnesium production and increase our operating costs.
Additionally,
legislation and increased regulation regarding climate change could impose significant costs on us and/or our suppliers, including costs
related to increased energy requirements, capital equipment, environmental monitoring and reporting and/or other costs to comply with
such regulations. Any adopted future climate change regulations could also negatively impact our ability to compete with companies situated
in areas not subject to such regulations. Given the political significance and uncertainty around the impact of climate change and how
it should be dealt with, we cannot predict how legislation and regulation will affect our financial condition, operating performance
or ability to compete.
We
will not have a highly diversified portfolio of assets.
We
have invested in and plan to operate solely within the magnesium industry. Thus, an investment in our company will provide limited diversity
as to asset type. Additionally, the assets to be held by us will be geographically concentrated as we intend to operate a single magnesium
production facility in the United States. This lack of diversification could increase the risk associated with the revenue stream we
expect to receive from the production and sale of magnesium and, as a result, could have a material adverse effect on our business, financial
condition or results of operations.
We
face risks related to our information technology systems, and potential cyber-attacks and security and privacy breaches.
Our
use of technology is critical in our continued operations. We are susceptible to operational, financial and information security risks
resulting from cyber-attacks and/or technological malfunctions. Successful cyber-attacks and/or technological malfunctions affecting
us, or our service providers can result in, among other things, financial losses, the inability to operate our planned magnesium production
facility, the unauthorized release of customer information or confidential information and reputational risk. We have not experienced
any material losses to date relating to cybersecurity attacks, other information breaches or technological malfunctions. However, there
can be no assurance that we will not incur such losses in the future. As cybersecurity threats continue to evolve, we may be required
to use additional resources to continue to modify or enhance protective measures or to investigate security vulnerabilities.
We
may store and collect personal information about future customers and will be responsible for protecting that information from privacy
breaches that may occur through procedural or process failure, information technology malfunction or deliberate unauthorized intrusions.
Any such theft or privacy breach would have a material adverse effect on our business, prospects, revenue, results of operation and financial
condition. We are subject to laws, rules and regulations in the United States and other jurisdictions relating to the collection, processing,
storage, transfer and use of personal data. Our ability to execute transactions and to possess and use personal information and data
in conducting our business subjects us to legislative and regulatory burdens that may require us to notify regulators and customers,
employees and other individuals of a data security breach. Evolving compliance and operational requirements under the privacy laws, rules
and regulations of jurisdictions in which we operate impose significant costs that are likely to increase over time. In addition, non-compliance
could result in proceedings against us by governmental entities and/or significant fines, could negatively impact our reputation and
may otherwise adversely impact our business, financial condition and operating results.
We
face risks related to our insurance coverage and uninsurable risks.
Our
business is subject to a number of risks and hazards generally, including adverse environmental conditions, accidents, fires, labor disputes
and changes in the regulatory environment. Such occurrences could result in damage to assets, personal injury or death, environmental
damage, delays in operations, monetary losses and possible legal liability.
12
Although
we intend to continue to maintain insurance to protect against certain risks in such amounts as we consider to be reasonable, our insurance
will not cover all the potential risks associated with our operations. We may also be unable to maintain insurance to cover these risks
at economically feasible premiums. Insurance coverage may not continue to be available or may not be adequate to cover any resulting
liability. Moreover, insurance against risks such as environmental pollution or other hazards encountered in our operations is not generally
available on acceptable terms. We might also become subject to liability for pollution or other hazards which we may not be insured against
or which we may elect not to insure against because of premium costs or other reasons. Losses from these events may cause us to incur
significant costs that could have a material adverse effect upon our financial performance and results of operations.
We
are dependent on key inputs, suppliers and skilled labor for the production of magnesium.
The
production of magnesium is dependent on a number of key inputs and their related costs, including raw materials and supplies related
to smelting operations, as well as electricity and other local utilities. Any significant interruption or negative change in the availability
or economics of the supply chain for key inputs, such as dolomite, could materially impact our business, financial condition, results
of operations or prospects. Some of these inputs may only be available from a single supplier or a limited group of suppliers. If a sole
source supplier was to go out of business, we might be unable to find a replacement for such source in a timely manner, or at all. If
a sole source supplier were to be acquired by a competitor, that competitor may elect not to sell to us in the future. Any inability
to secure required supplies and services, or to do so on appropriate terms, could have a materially adverse impact on our business, prospects,
revenue, results of operation and financial condition. We plan to purchase key inputs on a purchase order basis from suppliers at market
prices based on its production requirements and anticipated demand. We believe that we will have access to a sufficient supply of the
key inputs for the foreseeable future.
Our
planned magnesium production operations are expected to consume considerable energy, which makes us vulnerable to rising energy costs.
Accordingly, rising or volatile energy costs may adversely affect our business and our ability to operate profitably.
The
ability to compete and grow will be dependent on us having access, at a reasonable cost and in a timely manner, to skilled labor, equipment,
parts and components. No assurances can be given that we will be successful in maintaining our required supply of skilled labor, equipment,
parts and components. This could have a material effect on our financial results.
Our
inability to attract and retain key personnel could materially adversely affect our business.
Our
success is dependent upon the ability, expertise, judgment, discretion and good faith of our senior management and key personnel. We
compete with other companies both within and outside the magnesium industry to recruit and retain competent employees. If we cannot maintain
qualified employees to meet the needs of our anticipated growth, our business and financial condition could be materially adversely affected.
We
may be subject to growth-related risks.
We
may be subject to growth-related risks, including capacity constraints and pressure on our internal systems and controls. Our ability
to manage growth effectively will require us to implement and improve our operational and financial systems and to expand, train and
manage our employee base. Our inability to deal with this growth may have a material adverse effect on our business, prospects, revenue,
results of operation and financial condition.
We
are currently involved in litigation, and there may be additional litigation in which we will be involved in the future.
We
are currently involved in litigation. An adverse decision in the litigation could have a material adverse effect on our business, financial
condition or results of operations. Furthermore, even if we are successful in the litigation, we will likely incur substantial legal
fees in asserting our claims against the respondents and in defending against the counterclaims and, thus, these legal fees could have
a material adverse effect on our anticipated business, financial condition or results of operations.
We
may become party to litigation from time to time in the ordinary course of business which could adversely affect our business. Should
any litigation in which we become involved be determined against us such a decision could materially adversely affect our ability to
continue operating and the market price for our common stock and could use significant resources.
13
Our
intellectual property may be difficult to protect.
We
rely upon certain proprietary intellectual property, including but not limited to proprietary processes as it relates to magnesium production.
Our success will depend, in part, on our ability to maintain and enhance protection over our intellectual property, know-how and other
proprietary information. We enter into confidentiality or non-disclosure agreements with our corporate partners, employees, consultants,
outside scientific collaborators, developers, and other advisors. These agreements generally require that the receiving party keep confidential
and not disclose to third-parties confidential information developed by the receiving party or made known to the receiving party by us
during the course of the receiving party's relationship with us. These agreements also generally provide that inventions conceived
by the receiving party in the course of rendering services to us will be our exclusive property, and we enter into assignment agreements
to perfect our rights. These confidentiality, inventions, and assignment agreements may be breached and may not effectively assign rights
to proprietary information to us. In addition, our proprietary information could be independently discovered by competitors, in which
case we may not be able to prevent the use of such proprietary information by our competitors. The enforcement of a claim alleging that
a party illegally obtained and was using our proprietary information could be difficult, expensive, and time consuming and the outcome
would be unpredictable. In addition, courts outside the United States may be less willing to protect such proprietary information. The
failure to obtain or maintain meaningful intellectual property protection could adversely affect our ability to compete with other magnesium
producers.
Our
failure to adequately maintain and enhance protection over our proprietary information could have a material adverse effect on our business,
financial condition or results of operations.
We
may be exposed to infringement or misappropriation claims by third parties, which, if determined adversely to us, could subject us to
significant liabilities and other costs.
Our
success depends on our ability to use and develop new production technologies without infringing the intellectual property rights of
third parties. We cannot assure that third parties will not assert intellectual property claims against us. If third parties assert copyright
or patent infringement or violation of other intellectual property rights against us, we will be required to defend our self in litigation
or administrative proceedings, which can be both costly and time consuming and may significantly divert the efforts and resources of
management personnel. An adverse determination in any such litigation or proceedings to which we may become a party could subject us
to significant liability to third parties, require us to seek licenses from third parties, require us to pay ongoing royalties or subject
us to injunctions that may prohibit the development and operation of our planned magnesium production facility.
We
expect to face significant competition, which may have an adverse effect on expected revenues.
We
expect to compete with a variety of both U.S. and non-U.S. magnesium producers as well as with producers of other materials, such as
aluminum alloy, steel, titanium, plastics, composites, ceramics, and glass, among others. Use of such materials could reduce the demand
for magnesium products, which may reduce our expected revenues once we complete construction of our planned full-scale magnesium production
facility. Factors affecting our ability to compete include increased competition from overseas producers, our competitors' pricing
strategies, the introduction or advancement of new technologies and equipment by our competitors or our customers, changes in our customers'
strategy or material requirements, and our ability to achieve cost-efficiency of our planned facility. See "Description of Business
– Competitive Conditions and Our Position".
We
are subject to taxation both in Canada and the United States.
We
are treated as a Canadian resident company (as defined in the Income Tax Act (Canada) (the "
Tax Act
")) subject to
Canadian income taxes. We are also treated as a U.S. corporation subject to U.S. federal income tax pursuant to Section 7874 of the Code
and are subject to U.S. federal income tax on our worldwide income. As a result, we are subject to taxation both in Canada and the United
States, which could have a material adverse effect on our financial condition and results of operations.
It
is unlikely that we will pay any dividends on our common stock in the foreseeable future. However, dividends received by shareholders
who are residents of Canada for purposes of the Tax Act will be subject to U.S. withholding tax. Any such dividends may not qualify for
a reduced rate of withholding tax under the Canada-United States tax treaty. In addition, a foreign tax credit or a deduction in respect
of foreign taxes may not be available.
Dividends
received by U.S. shareholders will not be subject to U.S. withholding tax but will be subject to Canadian withholding tax. Dividends
paid by us will be characterized as U.S. source income for purposes of the foreign tax credit rules under the Code. Accordingly, U.S.
shareholders generally will not be able to claim a credit for any Canadian tax withheld unless, depending on the circumstances, they
have an excess foreign tax credit limitation due to other foreign source income that is subject to a low or zero rate of foreign tax.
Dividends
received by shareholders that are neither Canadian nor U.S. shareholders will be subject to U.S. withholding tax and will also be subject
to Canadian withholding tax. These dividends may not qualify for a reduced rate of U.S. withholding tax under any income tax treaty otherwise
applicable to our shareholders, subject to examination of the relevant treaty.
Because
our common stock is treated as shares of a U.S. domestic corporation, the U.S. gift, estate and generation-skipping transfer tax rules
generally apply to a non-U.S. shareholder of our common stock.
Each
shareholder should seek tax advice, based on such shareholder's particular circumstances, from an independent tax advisor.
14
Our
internal controls over financial reporting may not be effective, and our independent auditors may not be able to certify as to their
effectiveness, which could have a material and adverse effect on our business.
We
are subject to various Canadian and U.S. reporting and other regulatory requirements. We have incurred and will continue to incur expenses
and, to a lesser extent, diversion of our management's time in our efforts to comply with Section 404 of the Sarbanes-Oxley Act
and applicable Canadian securities laws regarding internal controls over financial reporting. Effective internal controls over financial
reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures,
are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation
could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of
the Sarbanes-Oxley Act and applicable Canadian securities laws, or the subsequent testing by our independent registered public accounting
firm when required, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses
or that may require prospective or retrospective changes to our consolidated financial statements or identify other areas for further
attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information,
which could have a negative effect on the trading price of our common stock.
The
elimination of monetary liability against our directors, officers, and employees under Delaware law and the existence of indemnification
rights for our obligations to our directors, officers, and employees may result in substantial expenditures by us and may discourage
lawsuits against our directors, officers, and employees.
Our
bylaws, as amended, contain a provision permitting us to eliminate the personal liability of our directors to us and our shareholders
for damages incurred as a director or officer to the extent provided by Delaware law. We may also have contractual indemnification obligations
under any future employment agreements with our officers or agreements entered into with our directors. The foregoing indemnification
obligations could result in us incurring substantial expenditures to cover the cost of settlement or damage awards against directors
and officers, which we may be unable to recoup. These provisions and the resulting costs may also discourage us from bringing a lawsuit
against directors and officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative litigation
by our shareholders against our directors and officers even though such actions, if successful, might otherwise benefit us and our shareholders.
An
exclusive forum provision in our bylaws, as amended, and Delaware law may limit a stockholder's ability to bring claims in a judicial
forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits.
Our
bylaws, as amended, provide that the Court of Chancery of the State of Delaware will be the exclusive forum for any derivative action
or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising
under the Delaware General Corporation Law, our certificate of incorporation or our bylaws, as amended; any action to interpret, apply,
enforce or determine the validity of our certificate of incorporation or our bylaws, as amended; and any action asserting a claim against
us that is governed by the internal affairs doctrine.
This
exclusive forum provision may limit a stockholder's ability to bring certain claims in a judicial forum that it finds favorable
for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors,
officers and other employees. Alternatively, if a court were to find either exclusive forum provision in our bylaws, as amended, to be
inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving such action in
other jurisdictions, all of which could have a material adverse effect on our business, financial condition, and results of operations.
This
exclusive forum provision will not apply, however, to actions arising under the Securities Act or the Exchange Act.
There
may be difficulty in enforcing judgments and effecting service of process on directors and officers that are not citizens of the United
States.
Certain
of our directors and officers reside outside of the United States and some or all of the assets of such persons are located outside of
the United States. Therefore, it may not be possible for shareholders to collect or to enforce judgments or liabilities against them
under U.S. securities laws. Moreover, it may not be possible for shareholders to effect service of process within the United States upon
such persons.
Generally,
original actions to enforce liabilities under U.S. federal securities laws may not be brought in a Canadian court. Such actions must
be brought in a court in the United States with applicable jurisdiction. Persons obtaining judgments against us in United States courts,
including judgments obtained under U.S. federal securities laws, will then be required to bring an application in a Canadian court to
enforce such judgments in Canada.
15
Risks
Related to our Securities
A
return on our common stock is not guaranteed.
There
is no guarantee that our common stock will earn any positive return in the short term or long term. A holding of our common stock is
speculative and involves a high degree of risk and should be undertaken only by holders whose financial resources are sufficient to enable
them to assume such risks and who have no need for immediate liquidity in their investment. A holding of our common stock is appropriate
only for holders who have the capacity to absorb a loss of some or all of their holdings.
Additional
issuances of our common stock, or securities convertible into our common stock, may result in dilution.
We
may issue additional equity or convertible debt securities in the future, which may dilute our existing shareholder's holdings.
Our certificate of incorporation permits the issuance of 1,000,000,000 shares of common stock and our Amended and Restated Certificate
of Incorporation permits the issuance of 100,000,000 shares of undesignated preferred stock, and existing shareholders will have no pre-emptive
rights in connection with such further issuances. Our board of directors has discretion to determine the price and the terms of further
issuances, and such terms could include rights, preferences and privileges superior to those existing holders of our common stock. Moreover,
additional shares of our common stock will be issued by us on the conversion of the Convertible Debentures in accordance with its terms.
To the extent holders of our options or other convertible securities convert or exercise their securities and sell our common stock they
receive, the trading price of our common stock may decrease due to the additional amount of common stock available in the market. Further,
we may issue additional shares of our common stock in connection with strategic acquisitions. We cannot predict the size or nature of
future issuances or the effect that future issuances and sales of our common stock (or securities convertible into our common stock)
will have on the market price of our common stock. Issuances of a substantial number of additional shares of our common stock, or the
perception that such issuances could occur, may adversely affect prevailing market prices for our common stock. With any additional issuance
of our common stock or preferred stock, investors will suffer dilution to their voting power and economic interest in our company.
Sales
of substantial amounts of our common stock may have an adverse effect on their market price.
Sales
of a substantial number of shares of our common stock in the public market could occur at any time either by existing holders of our
common stock, by the holder of the Convertible Debentures that is convertible into our common stock and the holders of warrants that
may be exercised to acquire our common stock. These sales, or the market perception that the holders of a large number of shares of our
common stock, Convertible Debentures or warrants intend to sell shares of our common stock, could reduce the market price of our common
stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of our securities.
Future
sales of common stock by management and other stockholders may have an adverse effect on the then prevailing market price of our common
stock.
In
the event a public market for our common stock is sustained in the future, sales of our common stock may be made by holders of our public
float or by holders of restricted securities in compliance with the provisions of Rule 144 of the Securities Act of 1933. In general,
under Rule 144, a non-affiliated person who has satisfied a six-month holding period in a fully reporting company under the Securities
Exchange Act of 1934, as amended, may, sell their restricted common stock without volume limitation, so long as the issuer is current
with all reports under the Exchange Act in order for there to be adequate common public information. Affiliated persons may also sell
their common shares held for at least six months, but affiliated persons will be required to meet certain other requirements, including
manner of sale, notice requirements and volume limitations. Non-affiliated persons who hold their common shares for at least one year
will be able to sell their common stock without the need for there to be current public information in the hands of the public. Future
sales of shares of our public float or by restricted common stock made in compliance with Rule 144 may have an adverse effect on the
then prevailing market price, if any, of our common stock.
The
market price for our common stock may be volatile.
The
market price for securities of early-stage magnesium companies generally are likely to be volatile. In addition, the market price for
our common stock has been and may be subject to wide fluctuations in response to numerous factors beyond our control, including, but
not limited to:
●
actual
    or anticipated fluctuations in our quarterly results of operations;
●
recommendations
    by securities research analysts;
●
changes
    in the economic performance or market valuations of companies in the industry in which we operate;
●
addition
    or departure of our executive officers and other key personnel;
16
●
registration
    of shares of our common stock issuable upon conversion of the Convertible Debentures or exercise of the Warrants;
●
sales
    or perceived sales of additional shares of our common stock;
●
operating
    and financial performance that varies from the expectations of management, securities analysts and investors;
●
regulatory
    changes affecting our industry generally and our business and operations both domestically and abroad;
●
announcements
    of developments and other material events by us or our competitors;
●
fluctuations
    in the costs of vital production materials and energy;
●
changes
    in global financial markets, global economies and general market conditions, such as interest rates and price volatility of competitive
    products;
●
significant
    acquisitions or business combinations, strategic partnerships, joint ventures or capital commitments by or involving us or our competitors;
●
operating
    and share price performance of other companies that investors deem comparable to us or from a lack of market comparable companies;
    and
●
news
    reports relating to trends, concerns, technological or competitive developments, regulatory changes and other related issues in our
    industry or target markets.
Financial
markets have at times historically experienced significant price and volume fluctuations that: (i) have particularly affected the market
prices of equity securities of companies and (ii) have often been unrelated to the operating performance, underlying asset values or
prospects of such companies. Accordingly, the market price of our common stock from time to time may decline even if our operating results,
underlying asset values or prospects have not changed. Additionally, these factors, as well as other related factors, may cause decreases
in asset values that may result in impairment losses to us. There can be no assurance that further fluctuations in price and volume of
equity securities will not occur. If increased levels of volatility and market turmoil continue, our operations could be adversely impacted,
and the trading price of our common stock may be materially adversely affected.
Our
common stock is or may become subject to the "penny stock" rules of the SEC and the trading market in the securities is limited,
which makes transactions in the stock cumbersome and may reduce the value of an investment in the stock.
Rule
15g-9 under the Exchange Act establishes the definition of a "penny stock," for the purposes relevant to us, as any equity
security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain
exceptions. For any transaction involving a penny stock, unless exempt, the rules require: (a) that a broker or dealer approve a person's
account for transactions in penny stocks; and (b) the broker or dealer receive from the investor a written agreement to the transaction,
setting forth the identity and quantity of the penny stock to be purchased.
In
order to approve a person's account for transactions in penny stocks, the broker or dealer must: (a) obtain financial information
and investment experience objectives of the person and (b) make a reasonable determination that the transactions in penny stocks are
suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the
risks of transactions in penny stocks.
The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to
the penny stock market, which, in highlight form: (a) sets forth the basis on which the broker or dealer made the suitability determination;
and (b) confirms that the broker or dealer received a signed, written agreement from the investor prior to the transaction. Generally,
brokers may be less willing to execute transactions in securities subject to the "penny stock" rules. If our common stock
is or becomes subject to the "penny stock" rules, it may be more difficult for investors to dispose of our common stock and
cause a decline in the market value of our common stock.
Disclosure
also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions
payable to both the broker or dealer and the registered representative, current quotations for the securities and the rights and remedies
available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent
price information for the penny stock held in the account and information on the limited market in penny stocks.
17
A
decline in the price of our common stock could affect our ability to raise further working capital and adversely impact our ability to
continue operations.
A
prolonged decline in the price of our common stock could result in a reduction in the liquidity of our common stock and a reduction in
our ability to raise capital. Because all of our operations have been and will be financed through the sale of convertible debt and equity
securities, a decline in the price of our common stock could be especially detrimental to our liquidity and our operations. Such reductions
may force us to reallocate funds from other planned uses and may have a material adverse effect on our business plan and operations,
including our ability to commence production of magnesium at our research and development pilot plant and ultimately at a full-scale
production plant. If the price of our common stock declines, there can be no assurance that we will be able to raise additional capital
or generate funds from operations sufficient to meet our obligations. If we are unable to raise sufficient capital in the future, we
may not be able to have the resources to continue our plans to develop a full-scale magnesium production plant.
If
securities or industry analysts do not publish or cease publishing research or reports or publish misleading, inaccurate or unfavorable
research about us, our business or our market, our stock price and trading volume could decline.
The
trading market for our common stock will be influenced by the research and reports that securities or industry analysts publish about
us, our business, our market or our competitors. If no or few securities or industry analysts cover us, the trading price and volume
of our common stock would likely be negatively impacted. If one or more of the analysts who covers us downgrades our shares or publishes
inaccurate or unfavorable research about our business, or provides more favorable relative recommendations about our competitors, our
stock price would likely decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly,
demand for our common stock could decrease, which could cause our stock price or trading volume to decline.
An
investor may face liquidity risks with an investment in our common stock.
Our
common stock currently trades on the TSXV in Canada and is quoted on the OTCQB in the United States. We cannot predict at what prices
our common stock will continue to trade, and there is no assurance that an active trading market will be sustained. Our common stock
does not currently trade on any U.S. national securities exchange. In the event our common stock begins trading on any U.S. national
securities exchange, we cannot predict at what prices it will trade and there is no assurance that an active trading market will develop
or be sustained. There is a material liquidity risk associated with an investment in our common stock.
Trading
in securities quoted on the OTC Markets is often thin and characterized by wide fluctuations in trading prices, due to many factors,
some of which may have little to do with our operations or business prospects. This volatility could depress the market price of our
common stock for reasons unrelated to operating performance. Moreover, the OTC Markets is not a U.S. national securities exchange, and
trading of securities on the OTC Markets is often more sporadic than the trading of securities listed on a U.S. national securities exchange
like the Nasdaq or the NYSE. These factors may result in investors having difficulty reselling our common stock on the OTC Markets.
We
do not intend to pay dividends on our common stock and, consequently, the ability of investors to achieve a return on their investment
will depend on appreciation in the price of our common stock.
We
have never declared or paid any cash dividend on our common stock and do not currently intend to do so in the foreseeable future. We
currently anticipate that we will retain future earnings, if materialized, for the development, operation and expansion of our business
and do not anticipate declaring or paying any cash dividends in the foreseeable future. Therefore, the success of an investment in our
common stock will depend upon any future appreciation in its value. There is no guarantee that our common stock will appreciate in value
or even maintain the price at which it was purchased.
General
Risks
We
may be negatively impacted by challenging global economic conditions.
Our
business, financial condition, results of operations and cash flow may be negatively impacted by challenging global economic conditions.
A
global economic slowdown would cause disruptions and extreme volatility in global financial markets, increased rates of default and bankruptcy
and declining consumer and business confidence, including as a result of COVID-19, which can lead to decreased levels of consumer spending.
These macroeconomic developments could negatively impact our business, which depends on the general economic environment and levels of
consumer spending. As a result, we may not be able to attract customers once we begin magnesium production, or we may be forced to reduce
the price of our products. We are unable to predict the likelihood of the occurrence, duration or severity of such disruptions in the
credit and financial markets or adverse global economic conditions. Any general or market-specific economic downturn could have a material
adverse effect on our business, financial condition, results of operations and cash flow.
18
We
are subject to increased costs as a result of being a public company in Canada and the United States.
As
a public company in Canada and the United States, we are subject to the reporting requirements, rules and regulations under the applicable
Canadian and American securities laws and rules of stock exchanges on which our securities may be listed. There are increased costs associated
with legal, accounting and other expenses related to such regulatory compliance. Securities legislation and the rules and policies of
the TSXV require listed companies to, among other things, adopt corporate governance and related practices, and to continuously prepare
and disclose material information, all of which add to a company's legal and financial compliance costs. We may also elect to devote
greater resources than we otherwise would have on communication and other activities typically considered important by publicly traded
companies.
We
are eligible to be treated as an "emerging growth company" as defined in the JOBS Act, and we cannot be certain if the reduced
disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.
We
are an "emerging growth company." as defined in the JOBS Act. For as long as we continue to be an emerging growth company,
we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies, including (1) not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act of 2002, (2) reduced disclosure obligations regarding executive compensation in this registration statement and periodic reports
and proxy statements, and (3) exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder
approval of any golden parachute payments not previously approved. We could be an emerging growth company for up to five years, although
circumstances could cause us to lose that status earlier, including if the market value of our common stock held by non-affiliates exceeds
$700 million as of July 31, 2022, or if we have total annual gross revenue of $1.07 billion or more during any fiscal year before that
time, in which case we would no longer be an emerging growth company as of the following October 31. Additionally, if we issue more than
$1.0 billion in non-convertible debt during any three-year period before July 31, 2022, we would cease to be an emerging growth company
immediately. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some
investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and the
stock price may be more volatile.
Under
the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards
apply to private companies. We have elected to take advantage of the extended transition period allowed for emerging growth companies
for complying with new or revised accounting guidance as allowed by Section 107 of the JOBS Act and Section 7(a)(2)(B) of the Securities
Act.
USE
OF PROCEEDS
All
of the shares of Common Stock offered by the Selling Securityholder pursuant to this prospectus will be sold by the Selling Securityholder
for its own account. We will not receive any of the proceeds from these sales. We will not receive any proceeds from the conversion of
the Convertible Debentures, but we will receive up to an aggregate of approximately $5,998,770 from the exercise of Warrants,
assuming the exercise in full of all of the Warrants for cash. We expect to use the net proceeds from the exercise of the Warrants for
general corporate purposes.
CAPITALIZATION
The
following table sets forth our cash and amounts held by related parties and capitalization as of January 31, 2022 on an actual basis.
This
table should be read in conjunction with the information contained in this prospectus, including "Management's Discussion
and Analysis of Financial Condition and Results of Operations" and our financial statements and the related notes thereto appearing
elsewhere in this prospectus.
As
    of
January 31, 2022
Actual
Cash
    and amounts held by related parties
$
1,338,263
Current
    portion of convertible note payable
221,599
Long-term
    convertible notes payable
–
Shareholders'
    deficit:
Common
    stock – $0.001 par value; 1,000,000,000 shares authorized; 421,871,770 shares issued and outstanding on an actual basis
36,637,228
Additional
    paid-in capital
22,684,015
Obligations
    to issue shares
46,741
Accumulated
    other comprehensive income
285,889
Accumulated
    deficit
(67,076,150
)
Total
    shareholders' deficit
(7,422,277
)
Total
    capitalization
$
(7,200,678
)
19
DETERMINATION
OF OFFERING PRICE
Resale
of Common Stock by Selling Securityholders
Our
Common Stock is quoted on the OTCQB under the symbol "MLYF." The shares registered for resale in this prospectus being offered
by the Selling Securityholders will be sold at fixed prices, at prevailing market prices at the time of sale, at prices related to the
prevailing market price, at varying prices determined at the time of sale or at negotiated prices.
Issuance
of Shares of Common Stock Underlying Convertible Debentures
The
price of the shares of Common Stock underlying the Convertible Debentures is determined by reference to the conversion price in each
of the respective Convertible Debentures, such that the principal amount and accrued interest upon receipt of TSXV approval
(including any default interest) under each of the Convertible Debentures shall be convertible into shares of Common Stock at a rate
of $0.10 per share and $0.30 per share, respectively.
Issuance
of Shares of Common Stock Underlying Warrants
The
price of the shares of Common Stock underlying the Warrants is determined by reference to the exercise price of the Warrants, such that
each warrant entitles the holder to purchase one share of our Common Stock at per share exercise prices of $0.13, $0.19 and $0.40, respectively.
DIVIDEND
POLICY
We
have not paid any cash dividends on our common stock and do not currently anticipate paying cash dividends in the foreseeable future.
The agreements into which we may enter in the future, including indebtedness, may impose limitations on our ability to pay dividends
or make other distributions on our capital stock. Payment of future dividends on our common stock, if any, will be at the discretion
of our board of directors and will depend on, among other things, our results of operations, cash requirements and surplus, financial
condition, contractual restrictions and other factors that our board of directors may deem relevant. We intend to retain future earnings,
if any, for reinvestment in the development and expansion of our business.
MARKET
PRICE FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
Market
Information
Our
common stock is traded in the United States on the OTCQB tier of the OTC Markets (the "OTCQB") under the symbol "
MLYF
".
The OTC Market is a network of security dealers who buy and sell stock. The dealers are connected by a computer network that provides
information on current "bids" and "asks", as well as volume information. We are also a reporting issuer in Canada
and our common stock is listed for trading on the TSX Venture Exchange (the "TSXV") under the symbol "
WMG
".
20
Trading
                                            Price and Volume
The
following table sets forth trading information for our common stock for the periods indicated, as quoted on the OTCQB.
(1)
These
quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.
Low
    Trading Price
High
    Trading Price
Period
($)
($)
First
    Quarter (January 31, 2022)
0.2604
0.6320
Year
    Ended October 31, 2021
Fourth
    Quarter (October 31, 2021)
0.2410
0.7625
Third
    Quarter (July 31, 2021)
0.0850
0.2661
Second
    Quarter (April 30, 2021)
0.0811
0.1400
First
    Quarter (January 31, 2021)
0.0769
0.1500
Year
    Ended October 31, 2020
Fourth
    Quarter (October 31, 2020)
0.0810
0.1153
Third
    Quarter (July 31, 2020)
0.0761
0.1200
Second
    Quarter (April 30, 2020)
0.0680
0.1279
First
    Quarter (January 31, 2020)
0.0794
0.1740
Notes:
(1)
Source:
    Yahoo Finance.
The
following table sets forth trading information for our common stock for the periods indicated, as quoted on the TSXV.
Low
    Trading Price
High
    Trading Price
Period
(CAD$)
(CAD$)
First
    Quarter (January 31, 2022)
0.21
0.77
Year
    Ended October 31, 2021
Fourth
    Quarter (October 31, 2021)
0.355
0.960
Third
    Quarter (July 31, 2021)
0.105
0.330
Second
    Quarter (April 30, 2021)
0.105
0.175
First
    Quarter (January 31, 2021)
0.100
0.180
Year
    Ended October 31, 2020
Fourth
    Quarter (October 31, 2020)
0.115
0.150
Third
    Quarter (July 31, 2020)
0.105
0.170
Second
    Quarter (April 30, 2020)
0.085
0.175
First
    Quarter (January 31, 2020)
0.105
0.230
Notes:
(1)
Source:
    Yahoo Finance.
Holders
of Common Stock
As
of May 16, 2022 there were approximately 678 record holders of our common stock. The number of record holders does not include beneficial
owners of common stock whose shares are held in the names of banks, brokers, nominees or other fiduciaries.
We
have not paid any cash dividends on our common stock and do not currently anticipate paying cash dividends in the foreseeable future.
We intend to retain future earnings, if any, for reinvestment in the development and expansion of our business.
Equity
Compensation Plans
2017
Stock Option Plan
Our
shareholders and board of directors approved a stock option plan effective on August 8, 2017 (the "2017 Stock Option Plan")
which consisted of a fixed number stock option plan reserving for issuance pursuant to the exercise of stock options a maximum of 35,219,701
shares of our common stock. At our shareholder meeting on August 8, 2018, our shareholders approved an increase in the number of shares
of common stock reserved for issuance under the 2017 Stock Option Plan to 36,643,701 (the "2017 Stock Option Plan Limit").
21
The
purpose of the 2017 Stock Option Plan is to attract and retain employees, officers, directors, consultants and management company employees
to motivate them to advance our interests by affording them the opportunity to acquire an equity interest in our company through stock
options. The 2017 Stock Option Plan was expected to benefit our shareholders by enabling us to attract and retain personnel of the highest
caliber by offering to them an opportunity to share in any increase in the value of our common stock to which they have contributed.
Under
the 2017 Stock Option Plan, the option exercise price must not be less than the last closing price of our common stock before the issuance
of the required news release disclosing the grant of stock options (subject to the exceptions prescribed by the TSXV, less the applicable
discount permitted by the policies of the TSXV). A stock option granted under the 2017 Stock Option Plan must, unless sooner terminated,
expire on a date to be determined by our board of directors which cannot exceed ten years from the date the stock option is granted.
The
number of shares of our common stock reserved for issuance to any one optionee pursuant to stock options granted under the 2017 Stock
Option Plan, together with any shares of our common stock reserved for issuance pursuant to stock options granted to that optionee during
the previous 12 months must not exceed 5% of the issued and outstanding common stock at the time of granting of the stock options, provided
that the aggregate number of stock options granted to each of the following categories of optionee: (a) each individual consultant; and
(b) persons performing investor relations activities on our behalf, must not exceed 2% of the outstanding Shares at the time of grant
unless the TSXV permits otherwise.
Subject
to the discretion of our board of directors to apply vesting to the grant of any stock option, the stock options granted to an optionee
under the 2017 Stock Option Plan will fully vest on the date of grant of such stock options. In accordance with the policies of the TSXV,
and subject to the TSXV's approval to the contrary, stock options granted to consultants performing investor relations activities
must vest (and not otherwise be exercisable) in stages over a minimum of 12 months with no more than ¼ of the stock options vesting
in any three-month period.
If
an optionee dies prior to the expiry of the optionee's stock option, the optionee's heirs, administrators or legal representatives
may, by the earlier of: (a) one year from the date of the optionee's death (or such lesser period as may be specified by our board
of directors at the time of granting the stock option); and (b) the expiry date of the stock option; exercise any portion of such stock
option. If an optionee ceases to be a director, officer, employee or consultant for any reason other than death, then such optionee's
stock option will terminate within a reasonable period to be determined by our board of directors commencing on the effective date the
optionee ceases to be employed by or provide services to us (but only to the extent that such stock option has vested on or before the
date the optionee ceased to be so employed or provide services to us) as provided for in the written option agreement between us and
the optionee. The maximum exercise period upon such cessation is six months unless the optionee has entered into a valid employment or
consulting agreement that provides for a longer exercise period, but in no case will the exercise period in such cessation be greater
than one year unless prior TSXV approval has been given.
Subsequent
to August 8, 2018 and up to June 11, 2021, we granted additional stock options and there were 42,170,000 stock options issued and outstanding,
which was in excess of the 2017 Stock Option Plan Limit. Under TSXV policies, at our annual shareholders' meeting on June 11, 2021
(the "2021 Annual Meeting"), we obtained (a) shareholder approval for the increase in the number of shares of our common
stock reserved for issuance under the 2017 Stock Option Plan to 42,370,000 shares of our common stock (the "Increased Stock Option
Limit"); and (b) Disinterested Shareholder Approval for the grant of 6,626,299 stock options on December 30, 2020 that resulted
in the 2017 Stock Option Plan Limit being exceeded (the "Excess Stock Option Grant"). "Disinterested Shareholder Approval"
means approval by a majority of the votes cast by all our shareholders at a duly constituted shareholders' meeting, excluding votes
attached to common stock beneficially owned by insiders that received the Excess Stock Option Grants. Edward Lee, our Executive Chairman,
was granted 5,000,000 stock options on December 30, 2020, and Sam Ataya, our Executive President and CEO, was granted 4,500,000 stock
options on December 30, 2020. These options have an exercise price of CAD$0.13 and expire on December 30, 2025.
Following
the shareholder approval of the Increased Stock Option Limit, the Excess Stock Option Grant and the 2021 Equity Incentive Plan discussed
below, we do not intend to grant additional stock options under the 2017 Stock Option Plan. Any shares of our common stock reserved for
issuance under the 2017 Stock Option Plan that are forfeited as a result of the expiration or termination of any awards under that plan
after the date of adoption of the 2021 Equity Incentive Plan will, however, be added to the 2021 Equity Incentive Plan.
2021
Equity Incentive Plan
Our
shareholders and our board of directors approved the 2021 Equity Incentive Plan effective June 11, 2021 and to reserve for the grant
of awards under that plan up to 27,312,368 shares of our common stock. We are awaiting the TSXV's approval of the 2021 Equity Incentive
Plan prior to it becoming effective.  The granting of awards under the 2021 Equity Incentive Plan is intended to attract and retain
the highly qualified employees essential for the execution of our business strategy. We believe the 2021 Equity Incentive Plan will (i)
attract and retain key personnel, and (ii) provide a means whereby our directors, officers, employees, consultants, and advisors and
our subsidiaries can acquire and maintain an equity interest in our company, or be paid incentive compensation, including incentive compensation
measure by reference to the value of our common stock, thereby strengthening their commitment to our welfare and aligning their interests
with those of our stockholders. Eligible participants under the 2021 Equity Incentive Plan include employees, directors and independent
contractors (except those performing services in connection with the offer or sale of our securities in a capital raising transaction,
or promoting or maintaining a market for our securities) of our company or our subsidiaries will be eligible to receive awards under
the 2021 Equity Incentive Plan. The 2021 Equity Incentive Plan will be administered by our board of directors or such other committee
appointed by our board of directors (the "Administrator").
22
The
2021 Equity Incentive Plan provides for various equity-based and cash-based incentive awards, including incentive stock options ("ISOs"),
non-statutory stock options ("NSOs"), stock appreciation rights ("SARs"), restricted stock and restricted stock
units ("RSUs"), performance units and shares and other equity-based or cash-based awards.
The
Administrator or its permitted delegates has the power and discretionary authority to determine the amount, terms and conditions of the
2021 Equity Incentive Plan awards, including, without limitation, (i) the exercise price of any stock options or stock appreciation rights,
(ii) the method of payment for shares purchased pursuant to any award, (iii) the method for satisfying any tax withholding obligation
arising in connection with any award, including by net exercise or the withholding or delivery of shares, (iv) the timing, terms and
conditions of the exercisability, vesting or payout of any award or any shares acquired pursuant thereto, (v) the performance criteria,
if any, applicable to any award and the extent to which such performance criteria have been attained, (vi) the time of the expiration
of any award, (vii) the effect of the participant's termination of service on any of the foregoing, and (viii) all other terms,
conditions and restrictions applicable to any award or shares acquired pursuant thereto as our board of directors shall consider to be
appropriate and not inconsistent with the terms of the 2021 Equity Incentive Plan. A non-employee director may not be granted 2021 Equity
Incentive Plan awards that exceed in the aggregate $300,000 in any calendar year. The foregoing limit does not apply to any award made
pursuant to any election by the director to receive an award in lieu of all or a portion of annual and committee retainers and meeting
fees.
The
following table sets forth securities authorized for issuance under the 2017 Stock Option Plan and the 2021 Equity Incentive Plan as
of January 31, 2022 and compensation plans not approved by our shareholders.
Number
                                            of securities
to
                                            be issued upon
exercise
                                            of
outstanding
                                            options,
warrant
                                            and rights
Weighted-average
exercise
                                            price of
outstanding
                                            options,
warrants
                                            and rights
Number
                                            of securities
remaining
                                            available
for
                                            future issuance
under
                                            equity
compensation
                                            plans
Plan
    Category
(#)
(CAD$)
(#)
Equity
    compensation plans approved by security holders
59,510,000
0.34
7,642,368
Equity
    compensation plans not approved by security holders
–
–
–
Total
59,510,000
0.34
7,642,368
The
following information represents securities sold by us within the past three years through January 31, 2022 which were not registered
under the Securities Act. Included are new issues, securities issued in exchange for property, services or other securities, securities
issued upon conversion from our other share classes and new securities resulting from the modification of outstanding securities. We
sold all of the securities listed below pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act,
or Regulation D or Regulation S promulgated thereunder.
Historical
Common Equity Transactions
The
following is a summary of transactions by us since November 1, 2018 involving unregistered issuances of our common equity securities.
Included are new issues, securities issued in exchange for property, services or other securities, securities issued upon conversion
from our other share classes and new securities resulting from the modification of outstanding securities. We sold all of the securities
listed below pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities
Act"), or Regulation D or Regulation S promulgated thereunder.
23
Common
Stock
During
the Fiscal Year ended October 31, 2019
On
November 30, 2018, in connection with a non-brokered private placement, 7,699,760 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$384,988 (USD equivalent $289,443). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days' written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 145,960 shares of common stock were issued to agents at a price of CAD$0.05 for a
fair value of CAD$7,298 (USD equivalent $5,487). Finder's fees of $18,097 were paid in cash.
On
January 23, 2019, in connection with a non-brokered private placement, 6,348,435 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$317,422 (USD equivalent $237,805). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days' written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 597,001 shares of common stock at a price of CAD$0.05 for a fair value of CAD$29,850
(USD equivalent $22,363) and 40,000 broker's warrants exercisable at a price of CAD$0.08 per share for a period of two years were
issued to agents. Finder's fees of $5,530 were paid in cash.
On
March 29, 2019, in connection with a non-brokered private placement, 11,750,464 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$587,523 (USD equivalent $439,664). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days' written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 218,287 shares of common stock were issued to agents at a price of CAD$0.05 for a
fair value of CAD$10,914 (USD equivalent $8,168). Finder's fees of $28,262 were paid in cash.
On
May 13, 2019, in connection with a non-brokered private placement, 34,712,595 units were issued to private investors at a price of CAD$0.05
per share for gross proceeds of CAD$1,735,630 (USD equivalent $1,289,053). Each unit consists of one common share and one common share
purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were subject
to an acceleration clause whereby the Company had the right, upon provision of thirty days' written notice, to require a holder
to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive trading
days. Finder's fees of $94,216 were paid in cash.
On
September 6, 2019, 328,571 shares of common stock were issued to a non-arm's length party for settlement of debt at a price of
CAD$0.175 per share for a fair value of CAD$57,500 (USD equivalent $43,647).
During
the fiscal year ended October 31, 2019, an aggregate of 3,455,235 shares of common stock were issued to private investors upon the exercise
of warrants at a price of CAD$0.05 per share for gross proceeds of CAD$172,762 (USD equivalent $131,071).
During
the fiscal year ended October 31, 2019, an aggregate of 11,600,109 shares of common stock were issued to private investors upon the exercise
of warrants at a price of CAD$0.08 per share for gross proceeds of CAD$928,009 (USD equivalent $706,111).
During
the fiscal year ended October 31, 2019, an aggregate of 1,100,000 shares of common stock were issued to certain officers and consultants
upon the exercise of options at a price CAD$0.05 per share for gross proceeds of CAD$55,000 (USD equivalent $41,553). Upon exercise,
CAD$36,750 (USD equivalent $27,723) previously recorded in reserves was reclassified to share capital.
During
the fiscal year ended October 31, 2019, in consideration of services provided to the Company, an aggregate of 150,000 shares of common
stock were issued to a service provider at a price of CAD$0.05 per share for a fair value of CAD$7,500 (USD equivalent 5,668).
During
the Fiscal Year ended October 31, 2020
On
December 20, 2019, the Company exercised its right to call all outstanding common share purchase warrants set to expire between May 7,
2020 and May 13, 2021 to expiry on January 19, 2020, and then extended the expiration date to February 19, 2020. Any unexercised warrants
were voided and of no value after February 19, 2020. From November 13, 2019 through March 11, 2020, an aggregate of 32,472,661shares
of common stock were issued to private investors upon the exercise of warrants at a price of CAD$0.08 per share for gross proceeds of
CAD$2,597,813 (USD equivalent $1,969,797), an aggregate of 3,000,000 shares of common stock were issued to private investors upon the
exercise of warrants at a price of CAD$0.07 per share for gross proceeds of CAD$210,000 (USD equivalent $158,718), and a further 4,864,000
shares of common stock were issued to private investors upon the exercise of warrants at a price of CAD$0.05 per share for gross proceeds
of CAD$243,200 (USD equivalent $184,769). 24,794,484 warrants expired unexercised.
24
On
January 17, 2020, in connection with a non-brokered private placement, 3,643,791 units were issued to private investors at a price of
CAD$0.15 per share for gross proceeds of CAD$546,569 (USD equivalent $416,719). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.21 per share for a period of one year. Subsequent to October
31, 2020, we extended the expiration date of the warrants to August 31, 2021. The warrants were subject to an acceleration clause whereby
the Company had the right, upon provision of thirty days' written notice, to require a holder to exercise the warrants should the
closing price of our common stock exceeds CAD$0.30 per share for at least ten consecutive trading days. Finder's fees of $41,275
were paid in cash.
On
May 26, 2020, 100,000 shares of common stock were issued to a consultant upon the exercise of options at a price CAD$0.05 per share for
gross proceeds of CAD$5,000 (USD equivalent 3,568).
On
May 26, 2020, 400,000 shares of common stock were issued to a consultant upon the exercise of options at a price CAD$0.08 per share for
gross proceeds of CAD$32,000 (USD equivalent $22,833). Upon exercise, CAD$27,715 (USD equivalent $19,775) previously recorded in equity
reserves was reclassified to share capital.
During
the Fiscal Year ended October 31, 2021
On
November 20, 2020, in connection with a non-brokered private placement, 5,599,171 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$727,892 (USD equivalent $556,876). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
January 15, 2021, in connection with a non-brokered private placement, 7,337,914 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$953,930 (USD equivalent $749,435). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
January 29, 2021, in connection with a non-brokered private placement, 5,382,303 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$699,699 (USD equivalent $547,496). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
March 24, 2021, in connection with a non-brokered private placement, 6,554,172 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$852,042 (USD equivalent $678,270). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
April 27, 2021, in connection with a non-brokered private placement, 851,395 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$110,681 (USD equivalent $89,237). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
May 18, 2021, in connection with the conversion of the July 2020 Convertible Debenture including accrued interest and transaction costs,
a total of 1,360,959 common shares were issued to private investors with a value of $162,829.
On
May 28, 2021, in connection with a non-brokered private placement, 5,223,420 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$679,044 (USD equivalent $561,844). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
June 7, 2021, in consideration of equipment, 1,538,461 common shares were issued to Industrial Surplus Supplies Ltd. at a price of CAD$0.24
per share for a fair value of CAD$369,231 (USD equivalent $305,832).
On
June 17, 2021, in connection with a non-brokered private placement, 17,853,506 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$2,320,956 (USD equivalent $1,880,687). Each unit consists of one common share and one common share
purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
July 16, 2021, in connection with a non-brokered private placement, 4,350,000 units were issued to private investors at a price of CAD$0.20
per share for gross proceeds of CAD$870,000 (USD equivalent $690,860). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.30 per share for a period of one year.
On
August 11, 2021, in connection with a non-brokered private placement, 3,827,601 units were issued to private investors at a price of
CAD$0.55 (USD$0.44) per share for gross proceeds of CAD$2,105,180 (USD equivalent $1,683,336). Each unit consists of one common share
and one common share purchase warrant exercisable into one common share at a price of CAD$0.65 (USD$0.52) per share for a period of eighteen
months.
During
the fiscal year ended October 31, 2021, the Company issued to private investors upon the exercise of common share purchase warrants an
aggregate 1,964,901 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$98,245 (USD equivalent $77,896), an aggregate
1,931,450 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$366,976 (USD equivalent $292,890), and an aggregate
3,118,618 common shares at a price of CAD$0.21 per share for gross proceeds of CAD$654,910 (USD equivalent $516,735). Upon exercise,
CAD$5,333 (USD equivalent $4,291) previously recorded in equity reserves was reclassified to share capital.
25
During
the fiscal year ended October 31, 2021, the Company issued to certain directors, officers, employees and consultants upon the exercise
of options an aggregate 2,000,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$100,000 (USD equivalent $80,058),
an aggregate 200,000 common shares at a price of CAD$0.11 per share for gross proceeds of CAD$22,000 (USD equivalent $17,456), an aggregate
300,000 common shares at a price of CAD$0.12 per share for gross proceeds of CAD$36,000 (USD equivalent $29,096), an aggregate 100,000
common shares at a price of CAD$0.13 per share for gross proceeds of CAD$13,000 (USD equivalent $10,315), and an aggregate 30,000 common
shares at a price of CAD$0.16 per share for gross proceeds of CAD$4,800 (USD equivalent $3,809). Upon exercise, CAD$152,218 (USD equivalent
$121,932) previously recorded in equity reserves was reclassified to share capital.
During
the three months ended January 31, 2022
Pursuant
to an agreement entered on August 29, 2018 and which was approved by the TSXV on September 12, 2018, a company controlled by Sam Ataya,
a director and officer of our Company, is eligible to receive up to 5% of the issued and outstanding common shares of the Company as
at August 28, 2018 for up to $5 million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3,
2021, the Company issued 9,163,425 common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614)
as share issue costs.
On
November 4, 2021, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling Securityholder
1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable
at a price of $0.19 until June 10, 2026.
On
November 26, 2021, in connection with a non-brokered private placement, 1,375,499 units were issued to private investors at a price of
$0.55 per unit for gross proceeds of $756,524. Each unit consists of one common share and one common share purchase warrant exercisable
into one common share at a price of $0.75 per share for a period of one year.
On
December 13, 2021, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling
Securityholder 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class
B Warrants exercisable at a price of $0.19 until June 10, 2026.
On
January 20, 2022, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling Securityholder
1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable
at a price of $0.19 until June 10, 2026.
During
the three months ended January 31, 2022, upon the exercise of common share purchase warrants the Company issued to private investors
an aggregate 15,159,448 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$2,880,295 (USD equivalent $2,279,136),
200,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$10,000 (USD equivalent $7,830), and 30,000 common shares
at a price of CAD$0.30 per share for gross proceeds of CAD$9,000 (USD equivalent $6,981). A total of 2,428,363 warrants expired unexercised.
Debt
Securities
During
the fiscal year ended October 31, 2019, we received an unsecured loan of CAD$150,000 (USD equivalent $112,895) from a director and officer.
The loan bore interest at 18% and was due on demand. During the fiscal year ended October 31, 2020, the loan was increased by an additional
CAD$60,000 (USD equivalent $44,588), to CAD$210,000 (USD equivalent $157,483), and was due on September 24, 2021. During the fiscal year
ended October 31, 2021, we have made repayments of the entire balance of principal and all interests accrued.
On
July 27, 2020, we issued to a private investor a CAD$150,000 (USD equivalent $112,124, the "July 2020 Convertible Debenture")
principal amount 12% convertible debenture convertible at the option of the holder to our common stock at the greater of CAD$0.15 per
share and the market price on the date of the conversion notice. Any accrued but unpaid interest will be payable on the earlier of the
maturity date and the date of conversion in cash or shares of our common stock. The net proceeds from this transaction were used to fund
working capital and general corporate purposes. On May 18, 2021, 1,360,959 shares of common stock were issued in connection with the
conversion of the July 2020 Convertible Debenture including conversion of accrued interest and 263,973 common shares valued at $26,286
in transaction costs.
On
June 15, 2021, we issued an unsecured convertible note in the principal amount of $1,500,000 (the "June 2021 Convertible Debenture").
The June 2021 Convertible Debenture bears interest at 12% per annum and matures on December 10, 2022. The June 2021 Convertible Debenture
is convertible into 15,000,000 units, where each unit consists of (i) one share of our common stock, (ii) one-half of one Class A common
stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one
Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively,
the "Class A and B Warrants"). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii)
the minimum conversion price permitted by the TSXV at the time of conversion (should our common stock then be listed on such exchange).
Upon TSXV approval, accrued interest on the June 2021 Convertible Debenture is convertible into our common stock on the same terms
as the principal amount of such debtenture.
26
On
July 15, 2021, we issued to a private investor a CAD$100,000 (USD equivalent $79,542, the "July 2021 Convertible Debenture")
principal amount 12% convertible debenture convertible at the option of the holder to common shares at a price of CAD$0.12 per share
and common share purchase warrants exercisable at a price of CAD$0.20 per share for a period of two years. Any accrued but unpaid interest
will be payable on the earlier of the maturity date and the date of conversion in cash or common shares. The net proceeds from this transaction
were used to fund working capital and general corporate purposes.
Other
Issuances
On
December 5, 2018, 9,600,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and
consultants as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.05 per share. These options
vested immediately on the grant date and expire 5 years after the grant date.
On
May 23, 2019, 10,000,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.12 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.
During
the fiscal year ended October 31, 2019, we extended the expiration date of 400,000 options from May 9, 2019 to May 31, 2020.
On
November 4, 2019, 700,000 options to purchase shares of our common stock were granted to certain officer, employee and consultant as
additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.15 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.
On
November 25, 2019, 900,000 options to purchase shares of our common stock were granted to certain employees and consultants as additional
compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.16 per share. 400,000 options vested immediately on
the grant date and 500,000 options vest 25% every three-month period. These options expire 5 years after the grant date.
On
March 27, 2020, 300,000 options to purchase shares of our common stock were granted to an officer as additional compensation pursuant
to our 2017 Stock Option Plan at an exercise price of CAD$0.11 per share. These options vested immediately on the grant date and expire
5 years after the grant date.
On
April 24, 2020, 4,200,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.12 per share. 3,750,000 options vested
immediately on the grant date and 450,000 options vest 25% every three-month period. These options expire five years after the grant
date.
On
August 26, 2020, 500,000 options to purchase shares of our common stock were granted to certain consultant as additional compensation
pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.13 per share. These options vest 25% every three-month period and
expire 2 years after the grant date.
On
December 30, 2020, 15,650,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and
consultants as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.13 per share. 15,000,000
options vested immediately on the grant date and 650,000 options vest 25% every three-month period. 9,500,000 of these options expire
five years after the grant date and 6,150,000 of these options expire two years after the grant date.
On
August 30, 2021, 21,700,000 options to purchase common shares were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2021 Equity Incentive Plan at an exercise price of CAD$0.70 per share. 21,400,000 options
vested immediately on the grant date and 300,000 options vest 25% every three-month period. These options expire 5 years after the grant
date.
On
October 1, 2021, 1,450,000 options to purchase common shares were granted to certain officer, employee and consultants as additional
compensation pursuant to our 2021 Equity Incentive Plan at an exercise price of CAD$0.50 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.
On
December 3, 2021, 250,000 options to purchase common shares were granted to an employee as additional compensation pursuant to our 2021
Equity Incentive Plan at an exercise price of CAD$0.58 per share. These options vested immediately on the grant date and expire 5 years
after the grant date.
27
DESCRIPTION
OF BUSINESS
Unless
the context otherwise requires, "we," "us," "our," or "the Company" refers to "Western
Magnesium Corporation," a Delaware corporation, and its consolidated subsidiaries.
Unless
otherwise indicated, all references to "$" or "US$" in this prospectus refer to United States dollars, and all
references to "CAD$" refer to Canadian dollars.
Background
We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production of magnesium at a research and development pilot plant
in metropolitan Vancouver, British Columbia, Canada. We have commenced testing at this facility in the last calendar quarter of 2021
with full pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete.
Our proprietary technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor
and energy costs while generating minimal waste and toxic by-products.
In
addition, we own a 100% interest in 81 unpatented lode mining claims totaling approximately 1,673 acres (the "Tami Mosi Mining
Claim"), four unpatented lode mining claims totaling approximately 10 acres located in the Moor Mining District in Elco County,
Nevada and a 100% interest in three patented mining claims located in the Pinto mining district of Nevada totaling approximately 296
acres (the "Silverado Mining Claim"). We do not plan on commencing extraction of minerals at this time from any mining claims
we hold because we have identified alternative sources of supply of dolomite and ferrosilicon, the primary raw materials used to produce
pure magnesium. We may in the future, however, commence extraction of minerals from the Tami Mosi Mining Claim if we are unable to purchase
raw materials from the alternative sources we have identified at commercially reasonable rates. In addition, we do not consider our mining
claims to be material to our business or financial condition. See "Description of Business – Properties."
Corporate
History
We
were incorporated under the Company Act (British Columbia) on March 24, 1966 as "Ft. Lauderdale Resources Inc." We changed
our name to Amcorp Industries Inc. on July 20, 1990, to Molycor Gold Corporation on May 17, 1996, to Nevada Clean Magnesium Inc. on April
16, 2012 and to Western Magnesium Corporation on May 14, 2019. On May 14, 2019, we discontinued from the jurisdiction of the Business
Corporations Act (British Columbia) and domesticated under the General Corporation Law of the State of Delaware under the name "Western
Magnesium Corporation." In connection with the name change, we also changed our stock symbol to "WMG" on the TSX Venture
Exchange. The Company has two wholly-owned subsidiaries: Western Magnesium Corp., incorporated in the State of Nevada in the United States
which owns our mining claim in the Schell Creek Range located southeast of Ely, Nevada and manages the Company's Nevada properties;
and Western Magnesium Canada Corp., incorporated on May 3, 2019 in British Columbia, Canada which manages our Canadian operations.
General
Development of Our Business
In
2006, we acquired the Silverado Mining Claim. During the year ended October 31, 2013, an impairment was recorded on this claim for $412,793
reducing its book value to $1.
In
2009, we acquired 27 mining claims totaling approximately 1,744 acres on property located southeast of Beaverdell, British Columbia (the
"Beaverdell Mining Claim"). During the year ended October 31, 2013, an impairment was recorded on this claim for $335,133
reducing its book value to $1. During the year ended October 31, 2020, we sold our interest in the Beaverdell Mining Claim for $50,000
and recognized a gain on sale of $37,156.
On
October 9, 2006, we acquired the Tami Mosi Mining Claim. On May 1, 2009, an Initial Resource Estimate was completed by Norm Tribe &
Associates, Ltd. On June 11, 2010, a Phase 1 Process Development Study for Exploitation of the Tami Mosi Mining Claim was completed by
Haze Research, Inc. On August 3, 2011, an updated resource estimate was completed by Tetra Tech, Inc. ("Tetra Tech"), on
September 15, 2011 a Preliminary Economic Assessment and Technical Report of the Tami-Mosi Magnesium Project was completed by Tetra Tech
and amended on July 4, 2014.
28
On
April 4, 2017, we completed construction of a bench scale test furnace that employed our proprietary continuous silicothermic process
and in October 2017, we successfully completed furnace preparations - a major milestone in the testing of our bench scale pilot furnace.
In
November 2017, we completed "proof of concept" in the production of magnesium metal from our bench scale test furnace. The
metal produced was a result from a partial test charge being conducted in order to identify any operational deficiencies in the furnace
prior to a full charge test of dolime material.
In
January 2018, we received a final assay report assessing the purity of the raw magnesium metal produced from our bench scale pilot furnace
test program. In accordance with ASTM International standard ASTM E1479-16, the testing was analyzed via inductively coupled plasma (ICP).
This unrefined magnesium metal was found to have a very good metal purity capable of producing ASTM B92 grade metal with minimal treatment.
No impurities were found which would impact food grade applications.
In
July 2018, we entered into an agreement with Industrial Surplus Ltd. ("ISL") to build a silicothermic reduction furnace based
on our bench scale test furnace.
In
December 2018, our technical team produced a magnesium ingot from dolomite obtained from the Tami Mosi Mining Claim. This accomplishment
completed the proof of concept stage allowing us to develop a pilot magnesium furnace based on the bench scale furnace.
Our
Business
We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production at a research and development pilot plant in Metropolitan
Vancouver, British Columbia, Canada. We have commenced test production at this facility in the last calendar quarter of 2021 with full
pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete. Our proprietary
technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor and energy costs
while generating minimal toxic by-products.
Plan
of Operations
In
order to complete construction and commencing testing at our planned research and development pilot plant, the following are the key
milestones that expect to achieve over the next 12 months following the date of this prospectus:
●
Complete
    construction of the plant;
●
Commission
    the plant and complete final training of operations staff;
●
Commence
    metal production under various scenarios to ensure sufficient data is collected;
●
Begin
    the request for proposal process for commercial engineering, procurement and construction management ("EPCM") firm;
●
Select
    EPCM firm;
●
Review
    all pilot data with chosen EPCM firm and validate proposed required operational scenarios; and
●
Begin
    geotechnical assessments of proposed full-scale magnesium production facility in Harrison County, Ohio.
We
estimate that the costs to complete this work will be approximately $8,000,000. We have commenced testing in the pilot reactor by the
end of 2021 with full pilot facility operations expected to commence in the first calendar quarter of 2022 after all safety testing is
complete.
Following
completion of our magnesium research and development pilot plant, we intend to construct a full-scale magnesium production facility with
expected capacity to produce 100,000 metric tons per year that will be scalable for greater production levels located on 122 acre property
located in Harrison County, Ohio. The proposed plant will be adjacent to the future home of a modern mixed fuels power plant which is
expected to provide power to our planned magnesium production plant. The proposed Harrison County, Ohio location is close to a dolomite
supply and has an infrastructure of rail and highway that is capable of transporting our magnesium finished product to industries across
the United States. Our plans will require a significant amount of additional capital. See "Management's Discussion and Analysis
of Financial Condition and Results of Operations – Liquidity and Capital Resources." We have no current plans to extract
minerals from any of our mining claims. See "Description of Business – Properties."
Magnesium
and Its Production
Magnesium
is the lightest of all commonly used structural metal, following steel and aluminum. It is the lightest and strongest of the structural
metals, it is one fourth the weight of steel, two fifths the weight of titanium and two thirds the weight of aluminum. Magnesium has
multiple industrial and consumer applications. Magnesium ingots are a prime raw material input for the production of titanium and aluminum
alloys and magnesium alloys. Magnesium powder and granules are used to remove sulfur in the production of steel. Due to their unique
light weight and high strength properties, magnesium alloys are used in a variety of aircraft and automobile parts, as well as in electronic
equipment such as computers, cameras and cellular phones.
29
Most
magnesium produced globally comes from natural minerals such as dolomite and magnesite in the form of magnesium carbonate. It can also
be found in seawater and in salt lakes brines or underground mineral salt deposits. Magnesium can be produced through several different
methods including the electrolytic process or thermal-reduction as practiced in the most commonly used Pidgeon process.
The
electrolytic process involves the electrolysis of molten magnesium chloride which produces molten magnesium and chlorine. The metal is
cast into ingots for further processing as needed and the chlorine by product may be sold for use in the production of polymers such
as polyvinyl chloride pipe (PVC).
In
the thermal-reduction method calcined magnesium containing ores (magnesite and dolomite) are broken down into fine powder and mixed with
reducing agents and catalyst agent. The mixture is heated in a vacuum chamber producing magnesium vapors which later condense into crystals.
The crystals are then melted, refined and poured into ingots for further processing.
The
Pidgeon process, using ferrosilicon as s catalyst, is most commonly used for production of magnesium as its operation is relatively easy
and has a low capital cost. The traditional process using horizontal retorts is high in energy consumption and has low productivity.
Dependence
on Customers, Principal Products or Services
Since
we have not commenced production of magnesium and have no revenues, we are currently not dependent on any customers. In addition, we
do not anticipate producing any significant quantities of magnesium until we launch a full-scale production facility following the launch
and testing of our magnesium research and development pilot facility.
Competitive
Conditions and Our Position
Magnesium
production is highly competitive and is dominated by several large producers in China, the United States, Israel, Brazil, Russia, Kazakhstan
and Turkey. Once we commence magnesium, we will compete with existing producers that may have greater resources, access to public equity
markets, more experienced management or may be more mature as a business. Production costs associated with the energy needed to fuel
the magnesium refinery and raw material costs are a significant challenge facing all producers. We believe that the more energy efficient
proprietary silicothermic magnesium production technology we are developing will enable us to be competitive with other magnesium producers
who use the less energy efficient electrolytic process or thermal-reduction as practiced in the most commonly used Pidgeon process that
consumes significantly greater resources. Further, we believe we face competition from manufacturers of other products, such as aluminum
alloys, steel, titanium, plastics, composites, ceramics, and glass, among others. Product quality, price and availability are important
differentiating factors. See "Risk Factors." We expect to face significant competition, which may have an adverse effect
on expected revenues.
Sources
and Availability of Materials
As
discussed above, we are currently in the final stages of developing a research and development pilot magnesium production facility and
consequently have no current need to obtain dolomite and ferrosilicon, the primary raw materials used to produce pure magnesium. The
production of magnesium products is dependent, however, on a number of key inputs and their related costs, including raw materials and
supplies related to production, as well as electricity and other local utilities. Dolomite and ferrosilicon are in abundant supply in
Canada, where our research and development pilot plant is being constructed, and the United States, where we intend to construct our
full-scale production facility. Once we commence commercial production of magnesium, any significant interruption or negative change
in the availability or economics of the supply chain for key inputs, such as the raw material cost of dolomite and ferrosilicon, could,
however, materially impact our business, financial condition, results of operations or prospects. We intend to purchase dolomite and
ferrosilicon on a purchase order basis from local suppliers at market prices based on our production requirements. In addition, we believe
there will be adequate availability of electricity needed to power our magnesium furnace and operate our production facility. Consequently,
our management believes that we will have access to a sufficient supply of the key inputs for the foreseeable future.
Intellectual
Property—Patents, Trademarks
We
regularly seek to protect our intellectual property rights in connection with our production process and methods. We rely on non-disclosure/confidentiality
agreements and segregate development and engineering duties among certain members of our development team to protect our intellectual
property rights. To the extent we describe or disclose our proprietary production techniques, we redact or request redaction of such
information prior to public disclosure. Despite these measures, we may be unable to detect the unauthorized use of, or take appropriate
steps to enforce our intellectual property rights. Effective trade secret protection may not be available in every country in which we
offer or intend to produce magnesium or offer our products for sale to the same extent as in the United States. Failure to adequately
protect our intellectual property could impair our ability to compete effectively. Further, enforcing our intellectual property rights
could result in the expenditure of significant financial and managerial resources and may not prove successful. Although we intend to
protect our rights vigorously, there can be no assurance that these measures will be successful. See "Risk Factors" with
respect to intellectual property.
30
We
own the website domain
www.westernmagnesium.com
and
www.westmagcorp.com
and social media accounts across certain major
platforms.
We
do not have any patents or trademarks nor have we filed any patent or trademark applications in the United States or Canada.
Regulation
of Magnesium Production and Mining, Environmental Compliance
Our
pilot magnesium production facility that we are currently developing in Metropolitan Vancouver, British Columbia, Canada, will require
local governmental approval before pilot operations can commence. We have applied for a business license, building permit, and all sub
trade permits, which all have been issued along with a conditional business license. This license allows us to currently operate our
Vancouver facility until we receive a final license which we expect to be issued in the first half of 2022 following a final inspection
of the facility. A final inspection has been delayed due to a backlog in the permitting process due to COVID-19. Once operational, we
will be subject to compliance with various types of government laws and regulations which often provide discretion to government authorities
and could be interpreted, applied, or modified in ways to make our operations or compliance activities more costly. These laws and regulations
include those relating to health and safety (WorkSafe BC, ASME, OSHA) (including those promulgated in response to the ongoing COVID-19
pandemic), competition, data privacy and security and environmental compliance.
Once
we commence pilot magnesium production in Canada and mining in the U.S., we will be subject to extensive provincial environmental laws
and regulations, including those relating to the release or discharge of materials into the air, water and soil, waste management, pollution
prevention measures, the generation, storage, handling, use, transportation and disposal of hazardous materials, the exposure of persons
to hazardous materials, and greenhouse gas emissions. Since our planned pilot magnesium production facility is not currently operational,
we have not incurred any material costs for compliance with environmental laws.
We
believe our planned operations in Canada and the holding of mining claims in the U.S. comply with the current environmental protection
requirements. We are not subject to any admonition, penalty, investigations or inquiries imposed by the environmental regulators in Canada
and the U.S., nor are we subject to any claims or legal proceedings to which we are named as a defendant for violation of any environmental
laws and regulations.
Employees
As
of April 30, 2022, we had 31 employees. We consider our relations with our employees to be good.
Legal
Proceedings
As
of the date of this prospectus, to our knowledge, there are no legal proceedings or regulatory actions material to us to which we are
a party, or have been a party to, or of which any of our property is or was the subject matter of, and no such proceedings or actions
are known by us to be contemplated except as provided below:
James
Sever Claim
. On September 29, 2020, James Sever filed a Notice of Civil Claim against us in the Supreme Court of British Columbia
(Court File No. S-209728) (the "Sever Claim"). The Sever Claim alleges that Mr. Sever had an employment and/or other similar
contractual relationship with us, and that we breached such contractual relationship by way of constructive dismissal or similar conduct.
The Sever Claim seeks damages in excess of $2,500,000, certain equity compensation, prejudgment garnishment, costs, interest and other
non-monetary relief. On July 27, 2021, we filed a response to the Sever Claim, which included the following pleadings: (a) that we were
never properly served with the Sever Claim; (b) that we have never had any form of employment, independent or consulting relationship
or agreement with Mr. Sever; (c) that we had no debts, liabilities or obligations to Mr. Sever; (d) that to the extent that Mr. Sever
had some form of employment, independent or consulting or similar relationship or agreement as alleged in the Sever Claim (the existence
of which we denied) such contract or relationship, if one existed, was never with us and was with some other corporate entity and, furthermore:
(i)
any such contract or relationship would be governed by laws of the United States;
(ii)
all, many or some of the claims in the Sever Claim would be barred by the British Columbia
Limitation Act
to the extent British
Columbia law applies;
(iii)
any such contract or relationship did not exist as alleged in the Sever Claim;
31
(iv)
Mr. Sever was not terminated or constructively dismissed and, instead, Mr. Sever never provided any services under any such contract
or relationship because Mr. Sever abandoned or resigned from, and/or failed to fulfil any of his obligations under, any and all contracts
and relationships; and/or
(v)
Mr. Sever failed to mitigate or alternatively has mitigated.
We
intend to vigorously defend against the Sever Claim, and we believe that the Sever Claim is without merit. We cannot predict the outcome
of the claim, however.
GEM
Yield Bahamas Limited Arbitration
.
On December 31, 2020, GEM Yield Bahamas Limited ("GEM") served us with a Notice
of Intention to Arbitrate (the "New York Arbitration Notice") before the American Arbitration Association in New York, New
York (Case No. 01-21-0004-2162) (the "GEM New York Arbitration"). The New York Arbitration Notice alleges we breached a Share
Subscription Agreement dated November 15, 2019 entered into between us and GEM (the "GEM Agreement"), among other things,
claiming damages of CAD$4.2 million (USD equivalent $3.3 million). On January 19, 2021, we filed a petition in the New York Supreme Court
(Index No. 650401/2021 (the "New York State Action") to stay the GEM New York Arbitration claiming the GEM Agreement was
not valid. The Court in the New York State Action ruled on March 19, 2021 that there is an arbitration clause in the GEM Agreement but
it is up the arbitrator in the GEM New York Arbitration to determine if the arbitration clause is valid. Following this ruling, the New
York State Action was closed. GEM filed a Statement of Claim in the GEM New York Arbitration on June 9, 2021 and on June 25, 2021, we
filed a Statement of Answer denying the existence of any binding agreement between us and GEM, among other defenses. In January 2022,
we filed a Modified Statement of Defense and Counterclaims. Furthermore, we intend to vigorously defend ourselves and believe the allegations
against us in the GEM New York Arbitration lack merit. We cannot predict the outcome of this arbitration proceeding, however.
There
have been no substantive motions or pleadings in the GEM New York Arbitration aside from the Statement of Claim and Statement of Answer
discussed above.
GEM
Yield Bahamas Limited and GEM Global Yield LLC SCS Arbitration
.
On or about February 8, 2021, GEM instituted another arbitration
against us before the International Centre for Dispute Resolution in Montreal Canada (Case No. 01-21-0001-1245) (the "GEM Montreal
Arbitration") and joined, GEM's affiliate, GEM Global Yield LLC SCS ("GEM Global Yield" together with GEM, the
"GEM Parties"). Similar to the allegations in the GEM New York Arbitration, the Statement of Claim filed by the GEM Parties
alleges we breached a Share Subscription Agreement dated November 15, 2019 and promissory note, among other things, claiming damages
of CAD$4.9 million (USD equivalent $3.8 million), in addition to costs and expenses stemming from our alleged failure to issue to GEM
Global Yield warrants to purchase up to 33,000,000 shares of our common stock. We filed a Statement of Defense, denying the existence
of any binding agreement between us and GEM, among other defenses. In January 2022, we filed an Amended Statement of Defense and Cross-claim.
We intend to vigorously defend ourselves in the GEM Montreal Arbitration and believe the allegations against us in this arbitration proceeding
lack merit. We cannot predict, however, the outcome of this arbitration proceeding.
There
have been no substantive motions or pleadings or rulings aside from the Statement of Claim and Statement of Answer.
Lampert
Advisors, LLC Claim
. On April 19, 2021, Lampert Advisors, LLC ("Lampert") filed a Verified Complaint against our
wholly owned subsidiary Western Magnesium Corporation, a Nevada corporation ("Western Magnesium – Nevada") in the Supreme
Court of the State of New York, County of New York (Index No. 652738/2021) (the "Lampert Lawsuit"). The complaint filed in
the Lampert Lawsuit alleges that Lampert entered into an agreement with Western Magnesium – Nevada to provide various financial
advisory services including acquisition advisory services and act as an exclusive placement agent for a debt and equity securities (the
"Lampert Agreement"), that it performed all services required under that agreement and such services were received and accepted
by our subsidiary, that it is owed $367,227.32 plus interest at the rate of 9% from February 3, 2021 and that it has a right of first
refusal to act as financial advisor in connection with any debt, equity or debt restructuring assignments on terms, conditions and compensation
customary for Lampert for a transaction of the type contemplated. Although Lampert claims to have personally served Western Magnesium
– Nevada, the company never received the Summons and Complaint and therefore, never submitted a response.
On
September 9, 2021, Lampert filed a Motion seeking the entry of a default judgment (the "Motion") alleging that Western Magnesium
– Nevada failed to file an answer or motion with respect to the complaint in this lawsuit within the time period provided under
the civil rules of procedure. We opposed Lambert's motion for entry of a default judgment and filed a cross-motion to compel Lampert
to accept our answer. The Court granted our cross-motion seeking to compel Lampert to accept our answer and denied Lampert's Motion
seeking the entry of a default judgment as moot. The Court scheduled a preliminary conference for the parties on March 30, 2022.
We
intend to vigorously defend ourselves and believe the allegations against us in the Lampert Lawsuit lack merit. We cannot predict the
outcome of this lawsuit, however.
32
Litigation
Assessment
We
have evaluated the foregoing claims to assess the likelihood of any unfavorable outcome and to estimate, if possible, the amount of potential
loss as it relates to the litigation discussed above. Based on this assessment and estimate, which includes an understanding of our intention
to vigorously defend the claims against us, we believe that the claims of any of the plaintiffs lack merit, however, and we cannot predict
the likelihood of any recoveries by any of the plaintiffs against us. This assessment and estimate is based on the information available
to management as of the date of this prospectus and involves a significant amount of management judgment, including the inherent difficulty
associated with assessing litigation matters in their early stages. As a result, the actual outcome or loss may differ materially from
those envisioned by the current assessment and estimate. Our failure to successfully defend or settle these claims could have a material
adverse effect on our financial condition, revenue and profitability and could cause the market value of our common stock to decline.
Properties
The
following tables set forth our principal physical properties as of the date of this prospectus, unless otherwise indicated.
Corporate
    Properties
Type
Location
Leased
    / Owned
Office
8180
    Greensboro Drive, Suite 720, McLean, Virginia
Leased
Office
580
    Hornby Street, Suite 900, Vancouver, British Columbia, Canada
Leased
Production
    Properties
Type
Description/Location
Leased
    / Owned
Mining
    Claim
Tami
    Mosi Magnesium Claim, Ely, Nevada
Leased
Mining
    Claim
Silverado
    Property, Pinto Mining District, Nevada
Leased
Research
    and Development Pilot Production Facility
5140
    North Fraser Way, Unit 102, Burnaby, British Columbia, Canada
Leased
Tami
Mosi Mining Claim
. We hold a 100% interest in 81 unpatented lode mining claims issued by the U.S. Bureau of Land Management totaling
approximately 1,637 acres located in White Pine County, Nevada (the "Tami Mosi Mining Claim") and four unpatented lode mining
claims totaling approximately 10 acres located in the Moor Mining District, Elco County, Nevada. These mining claims are subject to a
2% net smelter royalty in favor of the prior owner of the claims.
The
Tami Mosi Mining Claim are located in the Duck Creek Range, a mountain range located in central Nevada. The area is underlain by more
than 10,900 feet of mineral fragments and carbonate rocks, including a geological formation known as the Devonian Guilmette Formation.
Bands of dolomite altered from the limestone are characteristic within this formation.
Silverado
Mining Claim
. We hold a 100% interest in three patented mining claims located in the Pinto mining district of Nevada totaling
approximately 296 acres. This claim has been impaired to $1.
Mining
Plans
. We do not plan on commencing extraction of minerals from any mining claims we hold at this time. In addition, we do not
consider our mining claims to be material to our business or financial condition.
Research
and Development Pilot Production Facility
. In October 2020, we leased a 12,493 square foot facility in Burnaby, British Columbia,
Canada for a term of three years with a first right of offer to lease the premises beyond the expiration of the term if the landlord's
other tenant does not require the premises for the expansion of its business operations at the expiration of the term. We have commenced
construction of a research and development pilot plant at this facility which is in the Vancouver metropolitan area and is located near
major transportation routes and the Vancouver International Airport.
MANAGEMENT'S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This
management discussion and analysis ("MD&A") of the financial condition and results of operations of Western Magnesium
Corporation (the "Company," "Western Magnesium," "our" or "we") is for the three months
ended January 31, 2022 and 2021 and for the years ended October 31, 2021 and 2020. It is supplemental to, and should be read in conjunction
with, our interim condensed consolidated financial statements for the three months ended January 31, 2022 and 2021 and our consolidated
financial statements for the years ended October 31, 2021 and 2020 and the accompanying notes for each respective period. Our financial
statements are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").
Financial information presented in this MD&A is presented in United States dollars ("$" or "US$"), unless
otherwise indicated.
33
The
information about us provided in this MD&A, including information incorporated by reference, may contain "forward-looking statements"
and certain "forward-looking information" as defined under applicable United States securities laws and Canadian securities
laws. All statements, other than statements of historical fact, made by us that address activities, events or developments that we expect
or anticipate will or may occur in the future are forward-looking statements, including, but not limited to, statements preceded by,
followed by or that include words such as "may", "will", "would", "could", "should",
"believes", "estimates", "projects", "potential", "expects", "plans",
"intends", "anticipates", "targeted", "continues", "forecasts", "designed",
"goal", or the negative of those words or other similar or comparable words and includes, among others, information regarding:
our ability to become profitable and generate cash in our operating activities; our need for substantial additional financing to operate
our business and difficulties we may face acquiring additional financing on terms acceptable to us or at all; our significant indebtedness
and significant restrictions on our operations; our ability to construct and operate our planned a magnesium research and development
pilot plant and obtain necessary permits and authorizations to construct and operate the facility; the impact of global climate change
on our ability to conduct future operations.; our lack of a diversified portfolio of assets; our dependence on key inputs, suppliers
and skilled labor for the production of magnesium.; our ability to attract and retain key personnel; growth-related risks, including
capacity constraints and pressure on our internal systems and controls; the adverse consequences of litigation we are currently involved
in and litigation we may face from time to time; risk related to the protection of our intellectual and our exposure to infringement
or misappropriation claims by third parties; risks related to competition; risks related to our lack of internal controls over financial
reporting and their effectiveness; increased costs we are subject to as a result of being a public company in Canada and the United States;
and other events or conditions that may occur in the future.
Forward-looking
statements may relate to future financial conditions, results of operations, plans, objectives, performance or business developments.
These statements speak only as at the date they are made and are based on information currently available and on the then current expectations
of the party making the statement and assumptions concerning future events, which are subject to a number of known and unknown risks,
uncertainties and other factors that may cause actual results, performance or achievements to be materially different from that which
was expressed or implied by such forward-looking statements, including, but not limited to, risks and uncertainties described in "Risk
Factors."
Although
we believe that the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should
not be placed on the forward-looking statements, because no assurance can be given that they will prove to be correct. Since forward-looking
statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results
could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to
the risks described in "Risk Factors."
Consequently,
all forward-looking statements made in this MD&A and other documents, as applicable, are qualified by such cautionary statements,
and there can be no assurance that the anticipated results or developments will actually be realized or, even if realized, that they
will have the expected consequences to or effects on us. The cautionary statements contained or referred to in this section should be
considered in connection with any subsequent written or oral forward-looking statements that we and/or persons acting on its behalf may
issue. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise, other than as required under securities legislation.
Overview
of the Business
We
have developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium
metal. We are in the final stages of construction and commencing test production of magnesium at a research and development pilot plant
in metropolitan Vancouver, British Columbia, Canada. We have commenced test production at this facility in the last calendar quarter
of 2021 with full pilot facility operations expected to commence in the second calendar quarter of 2022 after all safety testing is complete.
Our proprietary technology utilizes a continuous silicothermic process that is expected to produce high grade magnesium with low labor
and energy costs while generating minimal waste and toxic by-products.
In
addition, we own a 100% interest in 81 unpatented lode mining claims totaling approximately 1,673 acres (the "Tami Mosi Mining
Claim"), four unpatented lode mining claims totaling approximately 10 acres located in the Moor Mining District in Elco County,
Nevada and a 100% interest in three patented mining claims located in the Pinto mining district of Nevada totaling approximately 296
acres (the "Silverado Mining Claim"). We do not plan on commencing extraction of minerals at this time from any mining claims
we hold because we have identified alternative sources of supply of dolomite and ferrosilicon, the primary raw materials used to produce
pure magnesium. We may in the future, however, commence extraction of minerals from the Tami Mosi Mining Claim if we are unable to purchase
raw materials from the alternative sources we have identified at commercially reasonable rates. In addition, we do not consider our mining
claims to be material to our business or financial condition. See "Description of Business – Properties."
Selected
Financial Information
The
following is selected financial data derived from our consolidated financial statements for the three months ended January 31, 2022 and
2021 and for the years ended October 31, 2021 and 2020.
34
The
selected consolidated financial information set out below may not be indicative of our future performance:
Three
    Months Ended
Years
    Ended
January
    31,
October
    31,
2022
2021
2021
2020
$
$
$
$
Total
    Expenses
(3,045,185
)
(2,108,476
)
(17,705,211
)
(4,714,740
)
Other
    Income (Expense)
(11,901,344
)
(14,534
)
(5,844,401
)
42,135
Net
    Loss
(14,946,529
)
(2,123,010
)
(23,549,612
)
(4,672,605
)
Loss Per Share
(0.04
)
(0.01
)
(0.07
)
(0.01
)
Total
    Assets
5,500,498
900,088
4,513,512
708,763
Current
    Liabilities
12,602,730
2,638,085
10,891,270
2,551,448
Long-Term
    Liabilities
320,045
246,754
392,280
237,218
Three
months ended January 31, 2022 Compared to three months ended January 31, 2021
Total
Expenses
Total
expenses were $3,045,185 for the three months ended January 31, 2022 ("First Quarter 2022"), as compared to $2,108,476 for
the three months ended January 31, 2021 ("First Quarter 2021"). The increase of $936,709 in operating expenditures was due
primarily to increases in legal and professional fees, interest and accretion and salaries and benefits, partly offset by a decrease
in stock-based compensation. The variance was primarily comprised of:
Legal
and professional fees (First Quarter 2022 – $606,848; First Quarter 2021 – $23,744; Variance – $583,104)
The
Company incurred legal and professional fees of $606,848 during the first quarter of Fiscal 2022, as compared to $23,744 during the first
quarter of Fiscal 2021. The increase of $583,104 in legal and professional fees was attributable to litigations discussed elsewhere in
this Quarterly Report on Form 10-Q, the Company's registration of its Common Stock with the US Securities and Exchange Commission
and other securities related matters, the setup of the new headquarter and management team in McLean, Virginia close to the Washington
DC metropolitan area, as well as for other general and corporate objectives during the first quarter of Fiscal 2022.
Interest
and accretion (First Quarter 2022 – $322,280; First Quarter 2021 – $18,574; Variance – $303,706)
The
Company incurred interest and accretion of $322,280 during the first quarter of Fiscal 2022, as compared to $18,574 during the first
quarter of Fiscal 2021. On November 1, 2021, the Company's functional currency change resulted in the reclassification of the June
2021 Convertible Debenture from a hybrid financial instrument to a convertible debt instrument with a beneficial conversion feature.
The Company allocated the intrinsic value of the beneficial conversion feature of the June 2021 Convertible Debenture capped at the face
value of $1,500,000 to additional paid-in capital, and recognized a debt discount of the same amount to be amortized as interest costs
over the period from issuance date to maturity date using the effective interest method. The increase of $303,706 in interest and accretion
during the first quarter of Fiscal 2022 was attributable to the interest costs of $300,034 from amortizing the debt discount on partial
conversion of the June 2021 Convertible Debenture during the period.
Salaries
and benefits (First Quarter 2022
–
$995,542; First Quarter 2021
–
$735,648; Variance
–
$259,894)
The
Company incurred salaries and benefits of $995,542 during the first quarter of Fiscal 2022, as compared to $735,648 during the first
quarter of Fiscal 2021, representing an increase of $259,894. This was due mainly to increased personnel headcount as the Company set
up its new headquarter and management team in McLean, Virginia close to the Washington DC metropolitan area and its continued effort
in the buildout of its research and development pilot plant. As at January 31, 2022, the Company had 30 employees including 12 executives.
While at January 31, 2021, the Company had 23 employees including 7 executives. Certain senior management members' salaries were
also adjusted to be in line with industry standards.
Engineering
expenses [First Quarter 2022
–
$118,373; First Quarter 2021
– (
$63,612); Variance
–
$181,985]
Engineering
expenses were $118,373 for the first quarter of Fiscal 2022 as the Company has completed the initial design and modeling of the magnesium
pilot plant and advanced into the final stage of the buildout of the pilot plant facility. While for the first quarter of Fiscal 2021,
the Company recorded a net recovery of $63,612 in engineering expenses due to a reclassification of certain expenses as capital assets.
This resulted in a variance of $181,985 between the two periods.
Consultant
and management fees (First Quarter 2022
–
$197,927; First Quarter 2021
–
$67,101; Variance
–
$130,826)
Consulting
and management fees were $197,927 in the first quarter of Fiscal 2022, as compared to $67,101 in the first quarter of Fiscal 2021. The
increase of $130,826 was a result of the Company advancing as a reporting issuer in the US and preparing for listing on other exchanges,
ramping up its operations towards the buildout of its research and development pilot plant facility, and commencing business development
activities in its new headquarter in McLean, Virginia close to the Washington DC metropolitan area.
35
Stock-based
compensation [First Quarter 2022 – $131,575; First Quarter 2021 – $1,048,990; Variance – ($917,415)]
During
first quarter of Fiscal 2022, the Company recorded stock-based compensation of $131,575 upon the grant of 250,000 stock options to an
employee. While during the first quarter of Fiscal 2021, the Company recorded stock-based compensation of $1,048,990 for the 15,650,000
stock options granted to directors, officers, employees and consultants. This resulted in a non-cash variance of $917,415. The adoption
of our 2021 Equity Incentive Plan which was approved by our shareholders during Fiscal 2021 is intended to promote our long-term financial
interests and growth by attracting and retaining management and other personnel and key service providers with the training, experience
and ability to enable them to make a substantial contribution to the success of our business. Moreover, our 2021 Equity Incentive Plan
aims to align the interests of eligible participants with those of our shareholders through opportunities for increased equity-based
ownership in our company.
Other
Items
Total
other loss was $11,901,344 for the first quarter of Fiscal 2022, as compared to $14,534 for the first quarter of Fiscal 2021. The variance
of $11,886,810 in other items was non-cash and was due to the reclassification of warrants and broker warrants as derivative liability
and the accounting treatment of its convertible debentures resulted from the Company's functional currency change. The variance
was comprised of:
Change
in fair value of derivative liability [First Quarter 2022 – ($11,559,791); First Quarter 2021 – ($14,534); Variance –
($11,545,257)]
On
November 1, 2021, the Company's functional currency change resulted in the reclassification of its outstanding warrants and broker
warrants denominated in the Canadian dollars as derivative liabilities measured at fair value through profit and loss at the end of each
reporting period. For the first quarter of Fiscal 2022, the Company recognized a non-cash loss of $11,765,241 on reclassification and
re-measurement of its derivative liability of warrants and broker warrants.
The
Company's functional currency change also resulted in the reclassification of the July 2021 Convertible Debenture from a convertible
debt instrument with a beneficial conversion feature to a hybrid financial instrument comprised of a debt host liability and an embedded
derivative liability. The debt host liability of the convertible note will be amortized at cost, with the embedded derivative liability
measured at fair value through profit and loss at the end of each reporting period. For the first quarter of Fiscal 2022, the Company
recognized a non-cash gain of $205,450 on re-measurement of its July 2021 Convertible Debenture. While for the first quarter of Fiscal
2021, the Company recognized a non-cash loss $14,534 on re-measurement of its July 2020 Convertible Debenture. This resulted in a variance
of $219,984 between the two periods.
Loss
on recognition of debt host liability [First Quarter 2022 – ($341,553); First Quarter 2021 – $Nil; Variance – ($341,553)]
On
November 1, 2021, the Company's functional currency change resulted in the reclassification of the July 2021 Convertible Debenture
from a convertible debt instrument with a beneficial conversion feature to a hybrid financial instrument. The embedded derivative liability
was valued at CA$529,400 (USD equivalent $421,095) which exceeded the face value of the note itself of CA$100,000 (USD equivalent $79,542),
the debt host liability was then assigned a face value of $1, with an immediate loss of CA$429,400 (USD equivalent $341,553) on recognition
of the debt host liability.
Net
Loss
As
a result of the foregoing, net loss for the three months ended January 31, 2022 and 2021 was $14,946,529 and $2,123,010, respectively.
Drivers
of Results of Operations
Total
Expenses
Total
expenses consist of general and administrative, research and development, stock-based compensation and depreciation.
General
and administrative expenses primarily include salaries and benefits, consulting, management, legal and professional fees, travel expenses,
investor relations, shareholder communications, regulatory fees, facilities and rent, computer system and software, and office and other
general and administrative expenses.
36
Research
and development expenses include engineering expenses which are in relation to the design and modeling of the magnesium pilot plant facility
and the magnesium furnace reactor, as well as the commercialization of our technology, and due diligence expenses which pertain to those
incurred in the potential acquisition of a smelter site for magnesium metal production.
Stock-based
compensation on stock options issued to directors, officers and employees is measured at the fair value on the date of grant and expensed
over the vesting period. For stock options issued to consultants, the fair value is periodically re-measured until the counterparty performance
is complete.
Depreciation
includes recognition of depreciation of property, plant and equipment and right-of-use assets over their depreciable lives.
Year
Ended October 31, 2021 Compared to Year Ended October 31, 2020
Total
Expenses
Total
expenses were $17,705,211 for the twelve months ended October 31, 2021 ("Fiscal 2021"), as compared to $4,714,740 for the
preceding year ended October 31, 2020 ("Fiscal 2020"). The increase of $12,990,471 in operating expenditures was due primarily
to a significant increase in stock-based compensation, a non-cash item, during the current fiscal. The variance was primarily comprised
of:
Stock-based
compensation (2021 – $11,051,124; 2020 – $666,259; Variance – $10,384,865)
During
Fiscal 2021, the Company recorded stock-based compensation of $11,051,124 upon the grant of 38,800,000 stock options to directors, officers,
employees and consultants. While during Fiscal 2020, the Company recorded stock-based compensation of $666,259 for the 6,700,000 stock
options granted. This resulted in a non-cash variance of $10,384,865. The adoption of our 2021 Equity Incentive Plan which was approved
by our shareholders during Fiscal 2021 is intended to promote our long-term financial interests and growth by attracting and retaining
management and other personnel and key service providers with the training, experience and ability to enable them to make a substantial
contribution to the success of our business. Moreover, our 2021 Equity Incentive Plan aims to align the interests of eligible participants
with those of our shareholders through opportunities for increased equity-based ownership in our company.
Salaries
and benefits (2021
–
$3,168,008; 2020
–
$1,797,783; Variance
–
$1,370,225)
The
Company incurred salaries and benefits of $3,168,008 during Fiscal 2021, as compared to $1,797,783 during Fiscal 2020, representing an
increase of $1,370,225. This was due mainly to increased personnel headcount as the Company continued to ramp up its operations as it
moves towards the buildout of its research and development pilot plant facility as well as setting up a new corporate office in McLean
in Virginia. As at October 31, 2021, the Company had 19 full-time employees including 6 executives. While at October 31, 2020, the Company
had 10 full-time employees including 7 executives. Certain senior management members' salaries were also adjusted during Fiscal
2021 to be in line with industry standards.
Legal
and professional fees (2021 – $889,175; 2020 – $138,916; Variance – $750,259)
The
Company incurred legal and professional fees of $889,175 during Fiscal 2021, as compared to $138,916 during Fiscal 2020. The increase
of $750,259 in legal and professional fees was attributable to litigations discussed elsewhere in this Annual Report, transaction costs
related to the June 2021 Convertible Debenture, and the Company's registration of its Common Stock with the Securities and Exchange
Commission, site plant selection purposes and other general and corporate objectives during Fiscal 2021.
Consultant
and management fees (2021
–
$914,617; 2020
–
$598,574; Variance
–
$316,043)
Consulting
and management fees were $914,617 in Fiscal 2021, as compared to $598,574 in Fiscal 2020. The increase of $316,043 was a result of the
Company ramping up its operations towards the buildout of its research and development pilot plant facility, commencement of business
development activities in its new corporate office in McLean in Virginia, as well as for advancing the Company as a reporting issuer
in the US and preparing for listing on other exchanges.
Travel
expenses (2021 – $409,528; 2020 – $104,880; Variance – $304,648)
Travel
expenses were $409,528 for Fiscal 2021 and $104,880 for Fiscal 2020, representing an increase of $304,648. As economies began to reopen
and recover from the COVID-19 pandemic, the Company continued to ramp up its operations and travelling activities for financing and site
plant selection purposes.
37
Engineering
expenses [2020
–
$105,706; 2019
–
$569,145; Variance
–
($463,439)]
Engineering
expenses were $105,706 for Fiscal 2021 and $569,145 for Fiscal 2020. The decrease of $463,439 was as a result of the Company having completed
the initial design and modeling of the magnesium pilot plant and advancing into the final stage of the buildout of the pilot plant facility
during Fiscal 2021.
Other
Items
Total
other loss was $5,844,401 for Fiscal 2021, and total other gain was $42,135 for Fiscal 2020. The variance of $5,886,536 in other items
was due primarily from the accounting treatment of its convertible debentures, partly offset by a gain on the sale of its exploration
and evaluation assets previously written off of $37,156. The variance was primarily comprised of:
Change
in fair value of derivative liability [2021 – ($5,701,270); 2020 – $4,979; Variance – ($5,706,249)]
The
Company's July 2020 Convertible Debenture and June 2021 Convertible Debenture were determined to be hybrid financial instruments
comprised of a debt host liability and an embedded derivative liability. The debt host liability of the convertible note will be amortized
at cost, with the embedded derivative liability measured at fair value through profit and loss at the end of each reporting period. For
Fiscal 2021, the Company recognized a non-cash gain of $16,058 and a non-cash loss of $5,717,328 on re-measurement of its July 2020 Convertible
Debenture and June 2021 Convertible Debenture, respectively. This resulted in an aggregate non-cash loss of $5,701,270 for Fiscal 2021,
compared to a non-cash gain of $4,979 on re-measurement of its July 2020 Convertible Debenture in Fiscal 2020.
Loss
on recognition of debt host liability [2021 – ($140,943); 2020 – $Nil; Variance – ($140,943)]
On
issuance date of the June 2021 Convertible Debenture, its embedded derivative liability was valued at $1,646,600 which exceeded the face
value of the note itself of $1,500,000, the debt host liability was then assigned a face value of $1, with an immediate loss of $146,601
on recognition of the debt host liability in Fiscal 2021, in addition to foreign exchange effect of $5,658.
Net
Loss
As
a result of the foregoing, net loss for the twelve months ended October 31, 2021 and 2020 was $23,549,612 and $4,672,605, respectively.
Drivers
of Results of Operations
Total
Expenses
Total
expenses consist of general and administrative, research and development, stock-based compensation and depreciation.
General
and administrative expenses primarily include salaries and benefits, consulting, management, legal and professional fees, travel expenses,
investor relations, shareholder communications, regulatory fees, facilities and rent, computer system and software, and office and other
general and administrative expenses.
Research
and development expenses include engineering expenses which are in relation to the design and modeling of the magnesium pilot plant facility
and the magnesium furnace reactor, as well as the commercialization of our technology, and due diligence expenses which pertain to those
incurred in the potential acquisition of a smelter site for magnesium metal production.
Stock-based
compensation on stock options issued to directors, officers and employees is measured at the fair value on the date of grant and expensed
over the vesting period. For stock options issued to consultants, the fair value is periodically re-measured until the counterparty performance
is complete.
Depreciation
includes recognition of depreciation of property, plant and equipment and right-of-use assets over their depreciable lives.
Working
Capital
The
calculation of Working Capital provides additional information and is not defined under GAAP. We define Working Capital as current assets
less current liabilities. This measure should not be considered in isolation or as a substitute for any standardized measure under GAAP.
This information is intended to provide investors with information about our liquidity.
Other
companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.
38
Liquidity
and Capital Resources
As
of January 31, 2022 and October 31, 2021, we had total current liabilities of $12,602,730 and $10,891,270, respectively, and current
assets of $1,701,956 and $1,233,954, respectively, to meet our current obligations. As of January 31, 2022, we had working capital deficiency
of $10,900,774, a decrease of working capital of $1,243,458 as compared to October 31, 2021, driven primarily by non-cash items including
the reclassification of warrants and broker warrants as derivative liabilities resulted from the Company's functional currency
change, partly offset by a decrease in derivative liabilities due to reclassifications of convertible debentures also resulted from the
Company's functional currency change.
On
November 1, 2021, the Company's functional currency change resulted in the reclassification of its outstanding warrants and broker
warrants denominated in the Canadian dollars as derivative liabilities measured at fair value through profit and loss at the end of each
reporting period. As at January 31, 2022, the derivative liability of warrants and broker warrants were valued at $8,246,718 and $41,670,
respectively.
On
November 1, 2021, the Company's functional currency change resulted in the reclassification of the June 2021 Convertible Debenture
from a hybrid financial instrument accounted for in accordance with ASU 815-15 to a convertible debt instrument with a beneficial conversion
feature accounted for in accordance with ASU 470-20. The value of the embedded derivative liability of $7,449,700 was reclassified to
additional paid-in capital. The Company's functional currency change also resulted in the reclassification of the July 2021 Convertible
Debenture from a convertible debt instrument with a beneficial conversion feature accounted for in accordance with ASU 470-20 to a hybrid
financial instrument accounted for in accordance with ASU 815-15. As at January 31, 2022, the amortized cost of the July 2021 Convertible
Debenture's debt host liability was CAD$11,780 (USD equivalent $9,262) and the fair value of the embedded derivative liability
was CAD$269,300 (USD equivalent $211,730), with a combined value of CAD$281,080 (USD equivalent $220,992).
We
have a history of operating losses. We have not yet achieved profitable operations and expect to incur further losses. We have funded
our operations primarily from equity and debt financing. As of January 31, 2022, cash generated from financing activities was not sufficient
to fund operations and, in particular, to fund our growth strategy in the short-term or long-term. As a result, we raised additional
funds from equity and debt financing transactions in 2022, 2021 and 2020 as discussed below under "Recent Financing Transactions."
The primary need for liquidity is to fund working capital requirements of the business, including operational expenses, develop and construct
our planned research and development pilot magnesium production facility and the capital expenditures associated with that project. The
primary source of liquidity has primarily been private financing transactions. The ability to fund operations, to make planned capital
expenditures, to execute on the development and operation of our planned research and development pilot facility, to develop a full-scale
commercial magnesium production facility and to make scheduled debt and rent payments and to repay or refinance indebtedness depends
on our ability to raise funds from debt and/or equity financing which is subject to prevailing economic conditions and financial, business
and other factors, some of which are beyond our control. There can be no assurance that additional financing will be available to us
when needed or, if available, that it can be obtained on commercially reasonable terms.
As
of January 31, 2022, there have not been any meaningful impact or disruptions to our operations as a result of the COVID-19 pandemic.
We continue to assess the impact of COVID-19 on an ongoing basis.
Recent
Financing Transactions
During
the year ended October 31, 2019, we received an unsecured loan of CAD$150,000 (USD equivalent $112,895) from a director and officer.
The loan bore interest at 18% and was due on demand. During the year ended October 31, 2020, the loan was increased by an additional
CAD$60,000 (USD equivalent $44,588), to CAD$210,000 (USD equivalent $157,483) and was due on September 24, 2021. During the fiscal year
ended October 31, 2021, we have made repayments of the entire balance of principal and all interest accrued.
On
December 20, 2019, we exercised our right and called all outstanding common share purchase warrants set to expire between May 7, 2020
and May 13, 2021 to expiry on January 19, 2020, and then extended the expiration date to February 19, 2020. Any unexercised warrants
were voided and of no value after February 19, 2020. In all, a total of 40,336,661 warrants were exercised for gross proceeds of CAD$3,050,668
(USD equivalent $2,313,284).
On
January 17, 2020, we completed a non-brokered private placement consisting of 3,643,791 units at a price of CAD$0.15 per unit for gross
proceeds of CAD$546,569 (USD equivalent $416,719). Each unit consists of one share of our common stock and one common share purchase
warrant exercisable at a price of CAD$0.21 per share for a period of one year from the date of issuance. Subsequent to October 31, 2020,
we extended the expiration date of the warrants to August 31, 2021. The common share purchase warrants were subject to an expiry acceleration
provision, upon thirty days' written notice, should the price of our common stock exceed CAD$0.30 for at least ten consecutive
trading days. Finder's fees of $41,275 were paid in connection with this offering.
On
July 27, 2020, we closed a non-brokered private placement of an unsecured convertible note in the principal amount of CAD$150,000 (USD
equivalent $112,124, the "July 2020 Convertible Debenture"). The note bears interest at 12% per annum, and any accrued but
unpaid interest, matures on the date that is one year following the closing date. Each July 2020 Convertible Debenture may be convertible
into our common stock at the prevailing market price and any accrued but unpaid interest thereon will be convertible into our common
stock at a price which is the greater of (i) CAD$0.15 or (ii) the Market Price (as defined in the policies of the TSXV) on the date of
a conversion notice. No finder's fees were paid in connection with this offering.
39
On
September 10, 2020, we announced a non-brokered private placement of up to 53,846,154 units priced at CAD$0.13 per unit (the "Unit")
for an aggregate offering of up to CAD$7,000,000 (USD$ 5,318,600) (the "September 2020 Private Placement"). Each Unit is
comprised of one share of our common stock and one common share purchase warrant exercisable at CAD$0.19 per share for a period of one
year from the date of issuance. On November 20, 2020, we closed the first tranche of the September 2020 Private Placement of 5,599,171
Units for gross proceeds of CAD$727,892 (USD equivalent $556,876). On January 15, 2021, we closed the second tranche of the September
2020 Private Placement consisting of 7,337,914 Units for gross proceeds of CAD$953,930 (USD equivalent $749,435). On January 29, 2021,
we closed the third tranche of the September 2020 Private Placement consisting of 5,382,303 Units for gross proceeds of CAD$699,699 (USD
equivalent $547,496). On March 24, 2021, we closed the fourth tranche of this offering and issued 6,554,172 Units for gross proceeds
of CAD$852,042 (USD equivalent $678,270). On April 27, 2021, we closed the fifth and final tranche of this offering and issued 851,395
Units for gross proceeds of CAD$110,681 (USD equivalent $89,237). We closed an aggregate 25,724,955 Units for aggregate gross proceeds
of CAD$3,344,244 (USD equivalent $2,621,314) and incurred aggregate share issue costs of $195,614 in connection to this offering.
On
May 5, 2021, we announced a non-brokered private placement priced at CAD$0.13 per unit (the "Unit") to raise gross proceeds
of up to CAD$3,000,000 (the "May 2021 Private Placement"). Each Unit in this offering consists of one share of our common
stock and one common share purchase warrant exercisable at a price of CAD$0.19 per share for a period of one year from the date of issuance.
On May 28, 2021, we closed the first tranche of the May 2021 Private Placement issuing 5,223,420 Units for gross proceeds of CAD$679,044
(USD equivalent $561,844). On June 17, 2021, we closed the second and final tranche of this offering consisting of 17,853,506 Units for
gross proceeds of CAD$2,320,956 (USD equivalent $1,880,687). We closed at the maximum offering and issued an aggregate 23,076,926 Units
for aggregate gross proceeds of CAD$3,000,000 (USD equivalent $2,442,531). We incurred aggregate share issue costs of $154,336 in connection
with this offering.
On
May 18, 2021, we issued 1,360,959 shares of common stock on the conversion of the July 2020 Convertible Debenture including conversion
of accrued interest and 263,973 common shares valued at $26,286 in transaction costs.
On
June 7, 2021, we received final approval from the TSXV for an agreement with Industrial Surplus Supplies Ltd. ("ISL"), pursuant
to which ISL will build a prototype internally heated testing lab furnace for the testing of a magnesium production process. We issued
1,538,461 shares of common stock at a price of CAD$0.24 per share with a total fair value of CAD$369,231 (USD equivalent $305,832) for
equipment.
On
June 15, 2021, we closed a non-brokered private placement of an unsecured convertible note in the principal amount of $1,500,000 (the
"June 2021 Convertible Debenture"). The June 2021 Convertible Debenture bears interest at 12% per annum and matures on December
10, 2022. The principal amount of the June 2021 Convertible Debenture is convertible into 15,000,000 units, where each unit consists
of (i) one share of our common stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable
at a price of $0.13 until June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being
exercisable at a price of $0.19 until June 10, 2026 (collectively, the "Class A and B Warrants"). In addition, the conversion
price for accrued interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSXV at the time of conversion
(should our common stock then be listed on such exchange).
Under
the terms of the June 10, 2021 Securities Purchase Agreement we entered into as part of the offering of the June 2021 Convertible Debenture
(the "Securities Purchase Agreement"), we agreed to use commercially reasonable efforts to file a registration statement
with the Securities and Exchange Commission by August 14, 2021, covering the public resale of the shares of common stock underlying such
debenture and, upon its conversion, the Class A and Class B Warrants issuable upon such conversion (the "Underlying Shares"),
and to use our best efforts to cause the registration statement to be declared effective on October 13, 2021. In addition, we agreed
to provide the holder to the June 2021 Convertible Debenture certain piggy-back registration rights if we do not have an effective registration
statement covering the Underlying Shares and we propose to file any registration statement under the Securities Act with respect to our
common stock. We will pay all costs associated with the registration statements, other than underwriting commissions and discounts. On
December 13, 2021, our Form 10 Registration Statement filed with the SEC was declared effective.
In
addition to certain covenants contained in the Securities Purchase Agreement, the terms of the June 2021 Convertible Debenture contain
certain negative covenants by us, including:
●
other
    than certain permitted indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed
    money of any kind, including, but not limited to, a guarantee, on or with respect to any of our property or assets now owned or hereafter
    acquired or any interest therein or any income or profits therefrom;
40
●
other
    than certain permitted liens, enter into, create, incur, assume or suffer to exist any liens of any kind, on or with respect to any
    of our property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;
●
amend
    our charter documents, including, without limitation, our certificate of incorporation and bylaws, in any manner that materially
    adversely affects any rights of the Convertible Debenture Holder (notwithstanding the foregoing, we are entitled to proceed with
    the amendments to the charter documents as set out in our proxy materials for our shareholder meeting to be held in 2021);
●
repay,
    repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of our common stock or common
    stock equivalents other than as to the Underlying Shares;
●
redeem,
    defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether
    by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any of our indebtedness
    (other than the Convertible Debentures if on a pro-rata basis), whether by way of payment in respect of principal of (or premium,
    if any) or interest on, such indebtedness, in any case unless such indebtedness or interest is due and payable in accordance with
    the initial terms of such debt prior to any default thereunder;
●
declare
    or make any dividend or other distribution of our assets or rights to acquire our assets to holders of shares of our common stock,
    preferred stock, or any other equity security by way of return of capital or otherwise including, without limitation, any distribution
    of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
    scheme of arrangement or other similar transaction;
●
sell
    or offer to sell any securities with non-fixed or floating price features, issue any common stock or common stock equivalents at
    a price lower than the conversion price herein then in effect, or issue any equity or debt instruments with anti-dilution provisions;
    or
●
enter
    into any agreement with respect to any of the foregoing.
In
the event we issue or sell any common stock or common stock equivalents with terms that the purchaser then holding outstanding June 2021
Convertible Debenture (the "Convertible Debenture Holder") or the Class A and B Warrants reasonably believes are more favorable
to such holder than are the terms of the June 2021 Convertible Debenture or the Class A and B Warrants (the "MFN Securities"),
then upon notice to us by such holder within five trading days after notice to such holder by us, we will use commercially reasonable
efforts to obtain the approval of the TSXV and any additional required regulatory approval to amend the terms of the June 2021 Convertible
Debenture or the Class A and B Warrants as required, as the case may be, so as to give such holder the benefit of such more favorable
terms or conditions. If we fail to obtain such regulatory approvals and the approval of the TSXV, then absent such approval we are forbidden
to issue the MFN Securities.
The
conversion price of the June 2021 Convertible Debenture is subject to proportional adjustment in the event of stock splits, stock dividends
and similar corporate events.
In
addition, if, at any time while the June 2021 Convertible Debenture is outstanding, we, directly or indirectly, effect any merger or
consolidation of our company with or into another person or engage in a "Fundamental Transaction" as defined in the June
2021 Convertible Debenture, the Convertible Debenture Holder shall have the right to receive, for each Conversion Share that would have
been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, the number of shares of our common
stock of the successor or acquiring corporation or us, if we are the surviving corporation, and any additional consideration (the "Alternate
Consideration") receivable as a result of such Fundamental Transaction by a holder of the number of shares of our common stock
for which the June 2021 Convertible Debenture is convertible immediately prior to such Fundamental Transaction. In addition, the Conversion
Price will be subject to certain adjustments so that the economic value of such shares and such conversion price are protected and which
is reasonably satisfactory in form and substance to the Convertible Debenture Holder. Alternatively, the Convertible Debenture Holder
may demand that we redeem the June 2021 Convertible Debenture at a rate equal to 125% of the principal and interest due thereon, to be
paid in full contemporaneously with consummation of the Fundamental Transaction.
We
granted the investor certain rights of first refusal on our future offerings for so long as the June 2021 Convertible Debenture or the
Class A and B Warrants are outstanding.
We
may prepay and satisfy the June 2021 Convertible Debenture so long as an event of default has not occurred, upon 20 days' prior
written notice received by us to the holder, by paying 125% of the amounts owed on the June 2021 Convertible Debenture, including all
principal, interest and other fees. The holder of this debenture may, however, convert all or a portion of the debenture during the 20
day notice period.
41
The
June 2021 Convertible Debenture is not exercisable if the number of shares to be issued to the holder upon such exercise, together with
all other shares then owned by the holder and our affiliates, would result in the holder beneficially owning more than 9.99% of our outstanding
common stock. The holder may increase or decrease this ownership limitation to any percentage not exceeding 9.99% upon 61 days prior
written notice to us.
Class
A and Class B Warrants
Upon
conversion of the June 2021 Convertible Debenture, we will issue the Class A and B Warrants. The holders may exercise the Class A and
B Warrants on a cashless basis at any time that there is not an effective registration statement covering the underlying shares of common
stock and the volume weighted average price of our common stock is greater than the exercise price at the time of exercise. The Class
A and Class B Warrants are not exercisable, however, if the number of shares to be issued to the holder upon such exercise, together
with all other shares then owned by the holder and our affiliates, would result in the holder beneficially owning more than 9.99% of
our outstanding common stock. The holder may increase or decrease this ownership limitation to any percentage not exceeding 9.99% upon
61 days prior written notice to us.
The
exercise price of the Class A and Class B Warrants is subject to proportional adjustment in the event of stock splits, recapitalizations
and similar corporate events. In addition, the exercise price are each subject to adjustment if we issue or sell shares of our common
stock for a consideration per share less than the exercise price then in effect, or issue options, warrants or other securities convertible
or exchange for shares of our common stock at an exercise price less than the exercise price then in effect. If any of these events should
occur, the exercise price each will be reduced to the lowest price at which these securities were issued or are exercisable.
In
addition, if, at any time while the Class A and Class B Warrants are outstanding, we engage in a Fundamental Transaction, the exercise
price thereof is subject to adjustment similar to the adjustment as provided for in the June 2021 Convertible Debenture. In addition,
we may not enter into a Fundamental Transaction unless the holders of our common stock receive securities of an entity that is listed
on a stock exchange in Canada or the United States, or cash, equal to the Black Scholes value of the remaining unexercised portion of
the Class A and Class B Warrants on the date of the consummation of such Fundamental Transaction.
On
July 15, 2021, we closed a non-brokered private placement of an unsecured convertible note in the principal amount of CAD$100,000 (USD
equivalent $79,542, the "July 2021 Convertible Debenture"). The note bears interest at 12% per annum and is due on the date
that is one year following the closing date. The note is convertible into common shares of the Company at the price of CAD$0.12 per share
and will have warrants exercisable for a price of CAD$0.20 for a period of two years. Any accrued but unpaid interest will be payable
on the earlier of the maturity date and the date of conversion in cash or common shares. No finder's fees were paid in connection
with this offering.
On
July 16, 2021, we closed a non-brokered private placement and issued 4,350,000 units at a price of CAD$0.20 per unit (the "Unit")
for gross proceeds of CAD$870,000 (USD equivalent $690,860, the "July 2021 Private Placement"). Each Unit in this offering
consists of one share of our common stock and one common share purchase warrant exercisable at a price of CAD$0.30 per share for a period
of one year from the date of issuance. We incurred aggregate share issue costs of $48,319 in connection with this offering.
On
August 11, 2021, we closed a non-brokered private placement and issued 3,827,601 units at a price of CAD$0.55 (USD$0.44) per unit (the
"Unit") for gross proceeds of CAD$2,105,180 (USD equivalent $1,683,336, the "August 2021 Private Placement").
Each Unit in this offering consists of one share of our common stock and one common share purchase warrant exercisable at a price of
CAD$0.65 (USD$0.52) per share for a period of eighteen months from the date of issuance.
During
the fiscal year ended October 31, 2021, upon the exercise of common share purchase warrants we issued an aggregate 1,964,901 common shares
at a price of CAD$0.05 per share for gross proceeds of CAD$98,245 (USD equivalent $77,896), an aggregate 1,931,450 common shares at a
price of CAD$0.19 per share for gross proceeds of CAD$366,976 (USD equivalent $292,890), and an aggregate 3,118,618 common shares at
a price of CAD$0.21 per share for gross proceeds of CAD$654,910 (USD equivalent $516,735). Upon exercise, CAD$5,333 (USD equivalent $4,291)
previously recorded in equity reserves was reclassified to share capital.
During
the fiscal year ended October 31, 2021, upon the exercise of options we issued an aggregate 2,000,000 common shares at a price of CAD$0.05
per share for gross proceeds of CAD$100,000 (USD equivalent $80,058), an aggregate 200,000 common shares at a price of CAD$0.11 per share
for gross proceeds of CAD$22,000 (USD equivalent $17,456), an aggregate 300,000 common shares at a price of CAD$0.12 per share for gross
proceeds of CAD$36,000 (USD equivalent $29,096), an aggregate 100,000 common shares at a price of CAD$0.13 per share for gross proceeds
of CAD$13,000 (USD equivalent $10,315), and an aggregate 30,000 common shares at a price of CAD$0.16 per share for gross proceeds of
CAD$4,800 (USD equivalent $3,809). Upon exercise, CAD$152,218 (USD equivalent $121,932) previously recorded in equity reserves was reclassified
to share capital.
42
Pursuant
to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by Sam Ataya,
a director and officer of our Company, is eligible to receive up to 5% of the issued and outstanding common shares of the Company as
at August 28, 2018 for up to $5 million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3,
2021, the Company issued 9,163,425 common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614)
as share issue costs.
On
November 4, 2021, in connection with a conversion of $100,000 principal amount due under the June 2021 Convertible Debenture, the Company
issued a private investor a total of 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10,
2026, and 500,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.
On
November 26, 2021, in connection with a non-brokered private placement, 1,375,499 units were issued to private investors at a price of
$0.55 per share for gross proceeds of $756,524. Each unit consists of one common share and one common share purchase warrant exercisable
into one common share at a price of $0.75 per share for a period of one year.
On
December 13, 2021, in connection with a conversion of $100,000 principal amount due under the June 2021 Convertible Debenture, the Company
issued to a private investor 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and
500,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.
On
January 20, 2022, in connection with a conversion of $100,000 principal amount due under the June 2021 Convertible Debenture, the Company
issued to a private investor a 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026,
and 500,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.
During
the three months ended January 31, 2022, upon the exercise of common share purchase warrants the Company issued to private investors
an aggregate 15,159,448 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$2,880,295 (USD equivalent $2,279,136),
200,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$10,000 (USD equivalent $7,830), and 30,000 common shares
at a price of CAD$0.30 per share for gross proceeds of CAD$9,000 (USD equivalent $6,981). A total of 2,428,363 warrants expired unexercised.
On
March 10, 2022, in connection with a partial conversion of the June 2021 Convertible Debenture, the Company issued 1,000,000 units to
a private investor for a total of 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026,
and 500,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.
On
April 14, 2022, we entered into and closed on the transaction set forth in the Securities Purchase Agreement (the "Securities Purchase
Agreement") entered into with an investor (the "Purchaser") for the sale of our convertible debenture in the principal
amount of $2,000,000 (the "April 2022 Convertible Debenture") for a subscription amount of $2,000,000.
The
April 2022 Convertible Debenture bears interest at the rate of 15% per annum, matures on October 14, 2023 and is convertible (principal,
and interest upon receipt of TSXV approval) at any time after the issuance date and, upon receipt of TSX Venture Exchange approval,
into shares of our Common Stock at a conversion price equal to the greater of (i) $0.30 per share and (ii) the minimum conversion price
permitted by the TSX Venture Exchange at the time of conversion (should our Common Stock then be listed on such exchange), subject to
adjustment as provided therein (the "Conversion Price"). In addition, upon each conversion of the April 2022 Convertible
Debenture, the holder is entitled to receive a Warrant (the "2022 Warrants") to purchase a number of shares of Common Stock
equal to 100% of the conversion shares being issued on such conversion.
In
event of default under the April 2022 Convertible Debenture, the interest rate will increase to the lesser of 20% per annum or the maximum
rate permitted under applicable law until paid and the following "Mandatory Default Amount" shall be paid by us, if demanded
by the Purchaser: the sum of (a) the greater of (i) the outstanding principal amount of the April 2022 Convertible Debenture divided
by the Conversion Price on the date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an
event of default) or otherwise due or (B) paid in full, whichever has a lower Conversion Price, multiplied by the VWAP on the date the
Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 125% of the outstanding
principal amount of the April 2022 Convertible Debenture plus (b) all other amounts, costs, expenses and liquidated damages due in respect
of the April 2022 Convertible Debenture.
In
addition to certain covenants contained in the Securities Purchase Agreement, the terms of the April 2022 Convertible Debenture contain
certain negative covenants by us, including:
●
other
    than certain permitted indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed
    money of any kind, including, but not limited to, a guarantee, on or with respect to any of our property or assets now owned or hereafter
    acquired or any interest therein or any income or profits therefrom;
●
other
    than certain permitted liens, enter into, create, incur, assume or suffer to exist any liens of any kind, on or with respect to any
    of our property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;
43
●
amend
    our charter documents, including, without limitation, our certificate of incorporation and bylaws, in any manner that materially
    adversely affects any rights of the April 2022 Convertible Debenture Holder;
●
repay,
    repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of our Common Stock or common
    stock equivalents other than as to the Underlying Shares;
●
redeem,
    defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether
    by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any of our indebtedness
    (other than the April 2022 Convertible Debentures if on a pro-rata basis), whether by way of payment in respect of principal of (or
    premium, if any) or interest on, such indebtedness, in any case unless such indebtedness or interest is due and payable in accordance
    with the initial terms of such debt prior to any default thereunder;
●
declare
    or make any dividend or other distribution of our assets or rights to acquire our assets to holders of shares of our Common Stock,
    preferred stock, or any other equity security by way of return of capital or otherwise including, without limitation, any distribution
    of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
    scheme of arrangement or other similar transaction;
●
sell
    or offer to sell any securities with non-fixed or floating price features, issue any Common Stock or common stock equivalents at
    a price lower than the conversion price herein then in effect, or issue any equity or debt instruments with anti-dilution provisions;
●
delist
    from any exchange or market the Common Stock is traded upon at the time the April 2022 Convertible Debenture was issued (except or
    unless the Common Stock subsequently becomes traded on NASDAQ, in which case the common stock may be delisted from the TSX Venture
    Exchange); or
●
enter
    into any agreement with respect to any of the foregoing.
From
the date hereof until such time as the April 2022 Convertible Debenture or 2022 Warrants are no longer outstanding, we will not, without
either (i) the consent of the Purchasers, or (ii) (A) having prepaid the April 2022 Convertible Debenture pursuant to the terms thereof,
or (B) having first lowered the Conversion Price of the April 2022 Convertible Debenture to such lower price with having obtained the
necessary regulatory approval, issue any common stock or common stock equivalents with a conversion or exercise price lower than the
Conversion Price and exercise price then in effect.
In
the event we issue or sell any common stock or common stock equivalents with terms that the purchaser then holding outstanding April
2022 Convertible Debenture (the "April 2022 Convertible Debenture Holder") or the 2022 Warrants reasonably believes are more
favorable to such holder than are the terms of the April 2022 Convertible Debenture or the 2022 Warrants (the "MFN Securities"),
then upon notice to us by such holder within five trading days after notice to such holder by us, we will use commercially reasonable
efforts to obtain the approval of the TSX Venture Exchange and any additional required regulatory approval to amend the terms of the
April 2022 Convertible Debenture or the 2022 Warrants as required, as the case may be, so as to give such holder the benefit of such
more favorable terms or conditions. If we fail to obtain such regulatory approvals and the approval of the TSX Venture Exchange, then
absent such approval by us, is forbidden to issue the MFN Securities.
The
conversion price of the April 2022 Convertible Debenture is subject to proportional adjustment in the event of stock splits, stock dividends
and similar corporate events. In addition, if, at any time while the April 2022 Convertible Debenture is outstanding, the Company, directly
or indirectly, effect any merger or consolidation of the Company with or into another person or engage in a "Fundamental Transaction"
as defined in the April 2022 Convertible Debenture, the April 2022 Convertible Debenture Holder shall have the right to receive, for
each conversion share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction,
the number of shares of our common stock of the successor or acquiring corporation or us, if the Company is the surviving corporation,
and any additional consideration (the "Alternate Consideration") receivable as a result of such Fundamental Transaction by
a holder of the number of shares of our common stock for which the April 2022 Convertible Debenture is convertible immediately prior
to such Fundamental Transaction. In addition, the Conversion Price will be subject to certain adjustments so that the economic value
of such shares and such conversion price are protected and which is reasonably satisfactory in form and substance to the April 2022 Convertible
Debenture Holder. Alternatively, the April 2022 Convertible Debenture Holder may demand that we redeem the April 2022 Convertible Debenture
at a rate equal to 125% of the principal and interest due thereon, to be paid in full contemporaneously with consummation of the Fundamental
Transaction.
The
Company granted the investors certain rights of first refusal on our future offerings for so long as the April 2022 Convertible Debenture
or the 2022 Warrants are outstanding.
The
April 2022 Convertible Debenture is not exercisable if the number of shares to be issued to the holder upon such exercise, together with
all other shares then owned by the holder and our affiliates, would result in the holder beneficially owning more than 9.99% of our outstanding
common stock. The holder may increase or decrease this ownership limitation to any percentage not exceeding 9.99% upon 61 days prior
written notice to us.
44
2022
Warrants
Upon
each conversion of the April 2022 Convertible Debenture, the Company will issue to the holder of the April 2022 Convertible Debenture,
a Warrant to purchase a number of shares of our common stock equal to 100% of the conversion shares being issued on such conversion at
a per share exercise price of $0.40, subject to adjustment as provided for in the 2022 Warrants and discussed below.
The
holders may exercise the 2022 Warrants on a cashless basis at any time that there is not an effective registration statement covering
the underlying shares of common stock and the volume weighted average price of our common stock is greater than the exercise price at
the time of exercise. The 2022 Warrants are not exercisable, however, if the number of shares to be issued to the holder upon such exercise,
together with all other shares then owned by the holder and our affiliates, would result in the holder beneficially owning more than
9.99% of our outstanding common stock. The holder may increase or decrease this ownership limitation to any percentage not exceeding
9.99% upon 61 days prior written notice to us.
The
exercise price of the 2022 Warrants is subject to proportional adjustment in the event of stock splits, recapitalizations and similar
corporate events.
Registration
Rights Agreement
Under
the terms of the Registration Rights Agreement the Company entered into in connection with the Securities Purchase Agreement, the Company
agreed to file a registration statement with the U.S. Securities and Exchange Commission (the "SEC") by May 14, 2022, covering
the public resale of the shares of common stock underlying the April 2022 Convertible Debenture, the convertible debentures issued to
the investor pursuant to a Securities Purchase Agreement dated June 10, 2021 (the "June 2021 Convertible Debenture"), upon
their conversion, the 2022 Warrants issuable upon conversion of the April 2022 Convertible Debenture and the warrants issued upon conversion
of the June 2021 Convertible Debenture (the "Underlying Shares"), all to the extent permissible under SEC rules, and to use
our best efforts to cause the registration statement to be declared effective on June 28, 2022 if the SEC does not review the registration
statement or by August 12, 2022 if the SEC reviews the registration statement.
In
the event the Company fails to file the registration statement or such registration statement is not declared effective within the time
periods noted above or such registration statement is not kept effective, the Company will be obligated to pay the holder of the debentures
a penalty in cash, in the amount of $20,000 on the date of such failure and on the 30
th
day of each month following such failure.
In addition, the Company has agreed to pay all expenses of the registration, other than underwriting commissions and discounts, and to
indemnify the holder of the securities to be registered against any claim that may arise under the Securities Act of 1933, as amended,
(the "Securities Act") in connection with the filing of the registration statement.
On
April 22, 2022, in connection with a conversion of CAD$100,000 principal amount and CAD$12,000 accrued interest due under the July 2021
Convertible Debenture, the Company issued to a private investor 933,333 common shares and 933,333 common share purchase warrants exercisable
at a price of CAD$0.20 for a period of two years.
On
April 27, 2022, in connection with a conversion of $200,000 principal amount due under the June 2021 Convertible Debenture, the Company
issued to a private investor 2,000,000 common shares, 1,000,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026,
and 1,000,000 Class B Warrants exercisable at a price of $0.19 until June 10, 2026.
During
the three months ended April 30, 2022, upon the exercise of common share purchase warrants the Company issued to private investors an
aggregate 6,198,713 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$1,177,755 (USD equivalent $823,505), 2,082,025
common shares at a price of CAD$0.05 per share for gross proceeds of CAD$104,101 (USD equivalent $81,591), and 30,960 common shares at
a price of CAD$0.30 per share for gross proceeds of CAD$9,288 (USD equivalent $7,360). A total of 3,191,933 warrants and 40,000 broker
warrants expired unexercised.
During
the three months ended April 30, 2022, upon the exercise of options we issued an aggregate 750,000 common shares at a price of CAD$0.05
per share for gross proceeds of CAD$37,500 (USD equivalent $29,715).
On
May 9, 2022, in connection with a non-brokered private placement, 1,727,000 units were issued to private investors at a price of $0.25
per share for gross proceeds of $431,750. Each unit consists of one common share and one common share purchase warrant exercisable into
one common share at a price of $0.45 per share for a period of one year.
45
On
May 9, 2022, upon the exercise of common share purchase warrants the Company issued to private investors an aggregate 242,700 common
shares at a price of CAD$0.19 per share for gross proceeds of CAD46,113 (USD equivalent $35,635) and 800,000 common shares at a price
of CAD$0.05 per share for gross proceeds of CAD$40,000 (USD equivalent $31,196). A total of 13,725 broker warrants expired unexercised.
On
May 11, 2022, upon the exercise of common share purchase warrants the Company issued to private investors an aggregate 290,110 common
shares at a price of CAD$0.19 per share for gross proceeds of CAD55,121 (USD equivalent $42,770).
Cash
Flows
Cash
Used in Operating Activities
Net
cash used in operating activities for the three months ended January 31, 2022 and January 31, 2021, and for the years ended October 31,
2021 and 2020, were as follows:
Three
    Months Ended
Years
    Ended
January
    31,
October
    31,
2022
2021
2021
2020
$
$
$
$
Net
    Cash Used in Operating Activities
(1,798,902
)
(990,364
)
(6,367,567
)
(3,270,534
)
Cash
Flow from Investing Activities
Net
cash used in investing activities for the three months ended January 31, 2022 and January 31, 2021, and for the years ended October 31,
2021 and 2020, were as follows:
Three
    Months Ended
Years
    Ended
January
    31,
October
    31,
2022
2021
2021
2020
$
$
$
$
Net
    Cash Provided by (Used in) Investing Activities
(687,385
)
(167,559
)
(2,066,566
)
18,985
Cash
Flow from Financing Activities
Net
cash used in financing activities for the three months ended January 31, 2022 and January 31, 2021, and for the years ended October 31,
2021 and 2020, were as follows:
Three
    Months Ended
Years
    Ended
January
    31,
October
    31,
2022
2021
2021
2020
$
$
$
$
Net
    Cash Provided by Financing Activities
2,804,287
1,180,422
8,850,435
3,257,823
Off-Balance
Sheet Arrangements
As
of the date of this prospectus, we do not have any off-balance-sheet arrangements that have, or are reasonably likely to have, a current
or future effect on our results of operations or financial condition, including, and without limitation, such considerations as liquidity
and capital resources.
Contractual
Obligations
As
of January 31, 2022, we have the following obligations to make future payments, representing contracts and other commitments that are
known and committed.
Payments
    Due by Period
Total
Less
    than 1 Year
1
                                            – 3
Years
3
                                            – 5
Years
More
    than 5 Years
$
$
$
$
$
Lease
    obligations – premises
732,391
319,987
372,861
39,543
–
Lease
    obligations – machines
31,699
18,742
10,765
2,192
–
Debt
    and interest obligations
1,521,350
1,521,350
–
–
–
Total
2,293,310
1,867,949
383,626
41,735
–
46
Real
Estate Option Agreement
Effective
as of August 4, 2021, we entered into a Real Estate Option Agreement (the "Option") with Harrison County Community Improvement
Corporation, an unrelated party (the "Seller"), to purchase a parcel of land comprising approximately 122 acres in the Village
of Cadiz, Harrison County, Ohio (the "Property"). We are entitled to exercise the Option at any time up until its expiration
on August 3, 2023. The Option contains covenants, representations and warranties that are customary of real estate purchase and sale
agreements including, but not limited to, completion of title work and a survey of the Property, an environmental audit, an engineering
feasibility study of the Property, availability of certain utilities, obtaining permits, approval of the Option by our Board of Directors,
our exercise of the Option and obtaining certain state and local economic incentives and tax abatements.
Transactions
with Related Parties
Deposits
held by related parties
Included
in our current assets are the following amounts due from related parties:
As
                                            of
January
                                            31, 2022
As
                                            of
October
                                            31, 2021
As
                                            of
October
                                            31, 2020
$
$
$
Deposits
    held by a director and officer
524,881
291,481
–
Deposits
    held by an officer
40,860
194,981
–
Deposits
    held by related parties
565,741
486,462
–
Due
to related parties
Included
in our current liabilities are the following amounts due to related parties:
As
                                            of
January
                                            31, 2022
As
                                            of
October
                                            31, 2021
As
                                            of
October
                                            31, 2020
$
$
$
Wages
    payable to directors and officers
357,500
357,500
161,922
Benefits
    payable to directors and officers
581,854
539,209
–
Fees
    and expenses payable to related parties
151,261
127,878
682,068
Interests
    due to a director and officer
2,171
2,230
–
Total
    due to related parties
1,092,786
1,026,817
843,990
Leases
We
have entered into a sublease agreement with a company controlled by Sam Ataya, a director and officer of our Company, for our Canadian
office at 580 Hornby Street, Suite 900, Vancouver, British Columbia, Canada, V6C 3B6. The lease had a two-year term from April 1, 2021
to March 31, 2023 and required a monthly payment of CAD$9,794 for a total of CAD$235,056.
Scope
of Work Agreement
Pursuant
to an agreement entered on August 29, 2018 and which was approved by the TSXV on September 12, 2018, a company controlled by Sam Ataya,
a director and officer of our Company, is eligible to receive up to 5% of the issued and outstanding common shares of the Company as
at August 28, 2018 for up to $5 million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3,
2021, the Company issued 9,163,425 common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614)
as share issue costs.
47
Changes
                                            in or Adoption of Accounting Practices
The
following GAAP standards have been recently issued by the accounting standards board. We are assessing the impact of these new standards
on future consolidated financial statements. We have elected to take advantage of the extended transition period allowed for emerging
growth companies for complying with new or revised accounting guidance as allowed by Section 107 of the JOBS Act and Section 7(a)(2)(B)
of the Securities Act. Pronouncements that are not applicable or where it has been determined do not have a significant impact on us
have been excluded herein.
(i)
In
                                            February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02,
                                            Leases (Topic 842) ("ASU 2016-02"), which amended the FASB Accounting Standards
                                            Codification ("ASC") by creating ASC 842 to replace ASC 840. ASU 2016-02 requires
                                            lessees to recognize a right-of-use asset and a lease liability on the balance sheet for
                                            substantially all leases. Leases are classified as either finance or operating, with classification
                                            affecting the pattern of expense recognition in the statement of income. In July 2018, the
                                            FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements ("ASU 2018-11")
                                            to provide entities with relief from the costs of implementing certain aspects of the new
                                            leasing standard. In March 2019, the FASB issued ASU 2019-01, Leases (Topic 842): Codification
                                            Improvements ("ASU 2019-01"), which clarifies certain items regarding lessor
                                            accounting. It also clarifies the interim disclosure requirements during transition. These
                                            updates are effective for fiscal years beginning after December 15, 2018, and interim periods
                                            within those fiscal years, with early adoption permitted.
Effective
    November 1, 2019, the Company adopted ASC 842 retrospectively using the modified retrospective approach with no restatement of prior
    year amounts. Reclassifications and the adjustments arising from the new leasing rules are therefore recognized in the opening balance
    sheet on November 1, 2019. In the context of initial application, we used the following assumptions to evaluate the lease population:
●
exercised
    the option not to apply the new recognition requirements to short-term leases and to leases of low-value assets; and
●
made
    the election to not separate non-lease components from lease components and instead account for each lease component and any associated
    non-lease components as a single lease component.
ASC
    842 applies to leases for the year ended October 31, 2020. Upon adoption, we recognized right-of-use assets and lease liabilities
    in relation to leases which had previously been classified as 'operating leases' under the principles of ASC 840. These
    assets and liabilities were measured at the present value of the remaining lease payments, discounted using the lessee's incremental
    borrowing rate as of November 1, 2019. The weighted-average incremental borrowing rate for lease liabilities initially recognized
    as of November 1, 2019 was 7%.
There
    were no onerous lease contracts that would have required an adjustment to the right-of-use assets at the date of initial application.
    In applying ASC 842 for the first time, we applied the following practical expedients permitted by the standard:
●
use
    of a single discount rate to a portfolio of leases with reasonably similar characteristics;
●
reliance
    on previous assessments of whether leases are onerous immediately before the date of initial application;
●
application
    of the short-term leases exemption to leases with a remaining lease term of less than 12 months as at the date of initial application;
    and
●
exclusion
    of initial direct costs from the measurement of the right-of-use asset at the date of initial application.
We
    elected not to reassess whether a contract is or contains a lease at the date of initial application. Instead, for contracts entered
    into before the transition date, the previous determinations pursuant to ASC 840 of whether a contract is a lease have been maintained.
    Additionally, we elected to not apply hindsight in determining a lease term of the ROU assets at the adoption date.
Based
on the foregoing, the impact of the change in accounting policy on November 1, 2019 is summarized below:
●
we
    recognized right-of-use assets of $83,549, and a lease liability of $83,549.
(ii)
In
    June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on
    Financial Instruments ("ASU 2016-13"). ASU 2016-13 requires the measurement of current expected credit losses for financial
    assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Adoption
    of ASU 2016-13 will require financial institutions and other organizations to use forward-looking information to better formulate
    their credit loss estimates. In addition, the ASU amends the accounting for credit losses on available for sale debt securities and
    purchased financial assets with credit deterioration. In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit
    Losses (Topic 326):
Targeted Transition Relief
("ASU 2019-05")
,
which provides transition relief to entities
    adopting ASU 2016-13. As smaller reporting companies as defined by the SEC, these updates are effective for fiscal years beginning
    after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. We are currently evaluating
    the effect of adoption of these updates on our financial statements.
48
(iii)
In
                                            January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other (Topic
                                            350): Simplifying the Test for Goodwill Impairment" ("ASU 2017-04"), which
                                            simplifies the accounting for goodwill impairment. ASU 2017-04 requires entities to record
                                            an impairment charge based on the excess of a reporting unit's carrying amount over
                                            its fair value (Step 1 under the current impairment test). The standard eliminates Step 2
                                            from the current goodwill impairment test, which included determining the implied fair value
                                            of goodwill and comparing it with the carrying amount of that goodwill. As smaller reporting
                                            companies as defined by the SEC, ASU 2017-04 is effective for fiscal years beginning after
                                            December 15, 2022, and interim periods within those fiscal years, with early adoption permitted.
                                            We are currently evaluating the effect of adopting this ASU on our financial statements.
(iv)
In
                                            June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718):
                                            Improvements to Nonemployee Share-Based Payment Accounting ("ASU 2018-07), which aligns
                                            the measurement and classification guidance for share-based payments to nonemployees with
                                            that for employees, with certain exceptions. ASU 2018-07 expands the scope of Topic 718 to
                                            include share-based payments granted to non-employees in exchange for goods or services used
                                            or consumed in the entity's own operations and supersedes the guidance in Subtopic
                                            505-50, Equity – Equity-Based Payments to Nonemployees. ASU 2018-07 retains the existing
                                            cost attribution guidance, which requires entities to recognize compensation cost for nonemployee
                                            awards in the same period and in the same manner (i.e. capitalize or expense) they would
                                            if they paid cash for the goods or services, but it moves the guidance to Topic 718. ASU
                                            2018-07 is effective for fiscal years beginning after December 15, 2018, and interim periods
                                            within those fiscal years, with early adoption permitted. Effective November 1, 2019, the
                                            Company adopted the new standard. There were no material impact or adjustment to its financial
                                            statements.
(v)
In
                                            August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure
                                            Framework – Changes to the Disclosure Requirements for Fair Value Measurement ("ASU
                                            2018-13"). ASU 2018-13 adds, modifies, and removes certain fair value measurement disclosure
                                            requirements. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019,
                                            and interim periods within those fiscal years, with early adoption permitted. Effective November
                                            1, 2020, the Company adopted the new standard. There were no material impact or adjustment
                                            to its financial statements.
(vi)
In
                                            December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting
                                            for Income Taxes ("ASU 2019-12"), which is intended to simplify various aspects
                                            related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general
                                            principles in Topic 740 and also clarifies and amends existing guidance to improve consistent
                                            application. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020,
                                            and interim periods within those fiscal years, with early adoption permitted. Effective November
                                            1, 2021, the Company adopted the new standard. There was no material impact or adjustment
                                            to its financial statements.
(vii)
In
    January 2020, the FASB issued ASU 2020-01, Investments – Equity Securities (Topic 321), Investments – Equity Method and
    Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) ("ASU 2020-01"), which is intended to clarify the
    interactions of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting
    in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is
    effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption
    permitted. Effective November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to its financial
    statements.
(viii)
In
    August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and
    Hedging – Contracts in Entity's Own Equity (Subtopic 815-40) ("ASU 2020-06"). ASU 2020-06 eliminates the
    beneficial conversion and cash conversion accounting models for convertible instruments and supersedes the respective guidance within
    ASC 470-20 and ASC 740-10-55-51, which will result in more instruments to be accounted for as a single instrument rather than having
    their proceeds allocated between liability and equity accounting units. As smaller reporting companies as defined by the United States
    Securities and Exchange Commission (the "SEC"), ASU 2020-06 is effective for fiscal years beginning after December 15,
    2023, and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect
    of adopting these updates on its financial statements.
CRITICAL
ACCOUNTING ESTIMATES
The
preparation of our consolidated financial statements requires management to make judgments, estimates and assumptions about the carrying
amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based
on historical experience and other factors that are considered relevant. Actual results may differ from these estimates.
The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period
in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods, if the
revision affects both current and future periods.
49
Significant
judgments, estimates and assumptions that have the most significant effect on the amounts recognized in the financial statements are
described below.
Functional
Currency
The
functional currency of each entity of the Company is as follows:
Entity
Functional
    Currency
Western
    Magnesium Corporation
United
    States dollars
Western
    Magnesium Corp.
United
    States dollars
Western
    Magnesium Canada Corporation
Canadian
    dollars ("CA$")
During
the three months ended January 31, 2022, significant changes in economic facts and circumstances have occurred in our operations which
resulted in the change of its functional currency to the United States dollars from the Canadian dollars effective November 1, 2021.
For both monetary and non-monetary assets and liabilities, translated balances at the end of the prior period become the new accounting
basis. The rate on the date of change becomes the historical rate at which non-monetary assets and liabilities are translated in subsequent
years. There is no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded cumulative translation
adjustments are not reversed. Effects of change in functional currency included the reclassifications of convertible debentures and warrants
and broker warrants.
Estimated
Useful Lives of Property Plant and Equipment
Depreciation
of property, plant and equipment is dependent upon estimates of useful lives which are determined through the exercise of judgment. The
assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that consider factors such as economic
and market conditions and the useful lives of assets.
Estimated
Useful Lives of and Amortization of Intangible Assets
Amortization
of intangible assets is recorded over their estimated useful lives which do not exceed any contractual periods, if any. Intangible assets
that have indefinite useful lives are not subject to amortization and are tested annually for impairment, or more frequently if events
or changes in circumstances indicate that they might be impaired.
Consolidation
Judgment
is applied in assessing whether we exercise control and have significant influence over entities in which we directly or indirectly own
an interest. We have control when we have the power over the subsidiary, have exposure or rights to variable returns, and have the ability
to use our power to affect the returns. Significant influence is defined as the power to participate in the financial and operating decisions
of the subsidiaries. Where we are determined to have control, these entities are consolidated. Additionally, judgment is applied in determining
the effective date on which control was obtained.
Stock-Based
Payments
Valuation
of stock-based compensation and warrants requires management to make estimates regarding the inputs for option pricing models, such as
the expected life of the option, the volatility of our stock price, the vesting period of the option and the risk-free interest rate
are used. Actual results could differ from those estimates. The estimates are considered for each new grant of stock options or warrants.
Leases
We
use the following policies to evaluate our leases:
Determining
a lease: At contract inception, we review the facts and circumstances of the arrangement to determine if the contract is or contains
a lease. We follow the guidance in ASU 2016-02, Leases (Topic 842), ASU 2018-11, Leases (Topic 842): Targeted Improvements, and ASU 2019-01,
Leases (Topic 842): Codification Improvements to evaluate if:
●
the
    contract has an identified asset;
●
we
    have the right to obtain substantially all economic benefits from the asset; and
●
we
    have the right to direct the use of the underlying asset.
50
When
determining if a contract has an identified asset, we consider both explicit and implicit assets, and whether the vendor has the right
to substitute the asset. When determining if we have the right to direct the use of an underlying asset, we consider if we have the right
to direct how and for what purpose the asset is used throughout the period of use and if we control the decision-making rights over the
asset.
Discount
rate: At commencement, lease-related assets and liabilities are measured at the present value of future lease payments over the lease
term using an incremental borrowing rate. As most of our leases do not provide an implicit rate, we exercise judgment in determining
the incremental borrowing rate based on information available at the time the lease commences.
Rent
increases or escalation clauses: Certain leases contain scheduled rent increases or escalation clauses. We assess each contract individually
and apply appropriate payments based on the terms of the agreement.
Renewal,
purchase and termination options: Our lease terms may include options to extend or terminate the lease. We exercise judgment in determining
the term of these leases when extension or termination options are present and include such options in the calculation of the lease terms
when it is reasonably certain that we will exercise these options.
Recognizing
leases: We do not recognize leases with a contractual term of less than 12 months or low value leases on our financial statements. Lease
payments are expensed on a straight-line basis over the lease terms.
Residual
value guarantees, restrictions or covenants: Our lease agreements do not contain residual value guarantees, restrictions or covenants.
Other
Estimates and Assumptions
Other
estimates and assumptions where there is potential risk of material adjustments to assets and liabilities in future accounting periods
include the recoverability of the carrying value of exploration and evaluation assets, fair value measurements for financial instruments,
the recoverability and measurement of deferred tax assets and liabilities and contingent liabilities.
Significant
Judgments
The
most significant judgments, apart from those involving estimates, in applying accounting policies in the Company's financial statements
include:
-
the
    assessment of the Company's ability to continue as a going concern and whether there are events or conditions that may give
    rise to substantial doubt;
-
whether
    there are indicators of impairment of the Company's exploration and evaluation assets and other non-current assets;
-
the
    classification of financial instruments; and
-
determination
    of functional currency.
FINANCIAL
INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
Our
financial instruments consist of cash and cash equivalents, amounts receivable, deposits held by related parties, accounts payable, due
to related parties, promissory note, convertible debenture.
The
fair value of financial instruments is the amount of consideration that would be agreed upon in an arm's length transaction between
knowledgeable, willing parties who are under no compulsion to act. The fair value of current financial instruments approximates their
carrying values as long as they are short-term in nature or bear interest at market rates.
Financial
instruments recorded at fair value are classified using a fair value hierarchy that prioritizes inputs used in determining the fair value
and depending on the degree to which they are observable. The three levels of hierarchy are:
Level
1 — Unadjusted quoted prices in active markets for identical assets or liabilities;
Level
2 — Inputs other than quoted prices that are observable for the asset or liability, either directly (i.e. as prices) or indirectly
(i.e. from derived prices); and
Level
3 — Inputs for the asset or liability that are not based on observable market data.
As
at January 31, 2022, October 31, 2021 and October 31, 2020, the fair value of cash and cash equivalents held by us was based on Level
1 inputs of the fair value hierarchy. There were no transfers between the levels during the reporting periods.
51
Financial
Risk Management
Our
board of directors has the overall responsibility for the establishment and oversight of our risk management framework. Our risk management
policies are established to identify and analyze the risks faced by the Company, to set appropriate risk limits and controls, and to
monitor risks and adherence to limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions
and in response to our activities. Management regularly monitors compliance with our risk management policies and procedures and reviews
the adequacy of the risk management framework in relation to the risks faced by the Company.
In
the normal course of operations, the Company is exposed to various risks such as interest rate, foreign exchange, commodity, credit,
and liquidity. To manage these risks, management determines what activities must be undertaken to minimize potential exposure to risks.
The objectives of the Company in managing risks are as follows:
●
Maintaining
    sound financial condition;
●
Financing
    operations; and
●
Ensuring
    liquidity to all operations.
In
order to satisfy these objectives, the Company has adopted the following policies:
●
Prepare
    budget documents at prevailing market rates to ensure clear corporate alignment to performance management and achievement of targets;
●
Recognize
    and observe the extent of operating risk within the business; and
●
Identify
    the magnitude of the impact of market risk factors on the overall risk of the business and take advantage of natural risk reductions
    that arise from these relationships.
There
have been no changes in risks that have arisen or how the Company manages those risks during the three months ended January 31, 2022
and 2021 and the years ended October 31, 2021 and 2020.
[i]
Interest rate risk
Interest
rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in the market interest rates.
The Company is exposed to interest rate risk on its cash on deposits with banks and, from time to time, on its holdings of short-term
investments. As of January 31, 2022 and October 31, 2021, the Company had cash on deposits with banks of $772,522 and $462,360, respectively.
The Company had no short-term investment as at January 31, 2022 or October 31 2021. Given the level of cash and cash equivalents held
by the Company, fluctuations in the market interest rates had no significant impact on its interest income during the three months ended
January 31, 2022 and 2021.
[ii]
Foreign currency risk
We
are exposed to foreign currency risk on fluctuations related to cash and cash equivalents, amounts receivable, accounts payable and accrued
liabilities, due from/to related parties, and convertible debentures that are denominated in Canadian dollars. We have not entered into
foreign exchange derivative contracts. A significant change in the currency exchange rates between the U.S. dollar relative to the Canadian
dollar could have a material effect on our balance sheet, results of operations, or cash flows.
Based
on the Company net exposures as at January 31, 2022, assuming that all other variables remain constant, a 5% appreciation or deterioration
of the Canadian dollar against the U.S. dollar would result in an increase or decrease of $88,138 in the Company's net income (loss)
and comprehensive income (loss).
[iii]
Commodity price risk
The
value of our magnesium production business and its exploration and evaluation assets are dependent on the price of magnesium and the
outlook for this mineral. Market prices for these metals historically have fluctuated widely and are affected by numerous factors outside
our control, including but not limited to, levels of worldwide production, short-term changes in supply and demand, industrial and retail
demand, as well as certain other factors related specifically to magnesium. If magnesium prices decline for a prolonged period below
the cost of production, it may not be economically feasible to continue towards production.
52
[iv]
Credit risk
Credit
risk is the risk of loss if counterparties do not fulfill their contractual obligations and arises principally from trade receivables.
Our credit risk is primarily attributable to cash and cash equivalents, amounts receivable and deposits held by related parties. The
Company limits its exposure to credit risk on cash and cash equivalents as these financial instruments are held with major banks in Canada
and the United States. Amounts receivable consist primarily of goods and services tax due from the Federal Government of Canada and other
subsidy receivable. Management believes the credit risk concentration with respect to amounts receivable is remote. The carrying amount
of financial assets recorded in the financial statements, net of any allowances, represents our maximum exposure to credit risk.
[v]
Liquidity risk
Liquidity
risk is the risk that the Company will not be able to meet its financial obligations as they come due. The Company's exposure to
liquidity risk is dependent on its purchasing commitments and obligations and its ability to raise funds to meet commitments and sustain
operations. The Company manages liquidity risk by continuously monitoring its actual and forecasted working capital requirements to ensure
there is capital to meet short-term and long-term obligations. As of January 31, 2022 and October 31, 2021, we had working capital deficiency
of $10,900,774 and $9,657,316, respectively. As disclosed in
note 1
of the Company's financial statements, the ability of
the Company to continue as a going concern is dependent on many factors. The Company's cash is primarily deposited in bank accounts
and held as deposits by certain related parties. The Company anticipates that its cash on hand and deposits, together with expected funds
raised from private placements and on exercises of common share purchase warrants and stock options, as well as debt financing, will
provide sufficient financial resources to carry out its operations through the next twelve months. However, additional funding will be
required. There can be no assurance that the Company will be able to raise the funds necessary to continue future operations. Liquidity
risk has been assessed as high.
MANAGEMENT
Executive
Officers and Directors
The
following table sets forth the individuals that are our directors and executive officers as of the date of this prospectus and their
respective positions.
Name
Age
Position
Karim
    Alameddine
28
Corporate
    Secretary
Rabih
    Ataya
62
Director
    and Executive Vice President ("EVP"), Special Projects
Sam
    Ataya
53
Director,
    Executive President and Chief Executive Officer ("CEO")
Andrea
    Chan
43
Chief
    Controller
Robert
    Ramsey Hamady
47
Chief
    Financial Officer ("CFO")
Edward
    Lee
60
Director,
    Executive Chairman and former President and CEO
Lisa
    Maxwell
55
President,
    Global Operations and Chief Operating Officer ("COO")
Michael
    Rutkowski
51
EVP,
    Enterprise Business and Defense
Peter
    O'Rourke
49
Director
    and President, US Operations
Paul
    Sauvé
35
EVP,
    Operations and Chief Technology Officer ("CTO")
Stephen
    Thorlakson
72
Director
Jeff
Wilson
52
Director
Director
and Executive Officer Biographies
Karim
Alameddine.
Mr. Alameddine joined Western Magnesium in 2019 as Assistant Corporate Secretary and now serves as our Corporate
Secretary. From November 2013 to October 2019, he worked with the Toronto-Dominion Bank ("TDB"), one of the largest multinational
banks in Canada. During his time with TDB he developed a thorough understanding of the regulatory standards which he utilized in his
day-to-day responsibilities throughout his various positions within the organization. Mr. Alameddine's drive for professionalism
and passion for corporate services has created a unique opportunity for him with our company, where he serves shareholders in meeting
their needs while centering his focus on industry and regulatory proceedings.
Rabih
Ataya.
Mr. Rabih Ataya joined Western Magnesium as our Senior Vice President, Strategy in November 2019 and has been a member
of our board of directors since March 2020, and now serves as our Executive Vice President, Special Projects. He brings to us over 30
years of extensive operational experience in the automotive industry. From 2018 to March 2020, Mr. Ataya had taken a brief hiatus from
the industry. From 2010 to 2018, he was the General Manager of Alfardan Automobiles, LLC, from 2002 to 2010 he was the General Manager
of the Automotive Division of Mohammad Saleh & Reza Yousuf Behbehani Company and from 1996 to 2002 he was the General Manager of
Mirage General Trading Establishment. He has led strategies into tactical initiatives that drove bottom line results. Mr. Ataya's
extensive experience in the automotive industry includes the North American, European, and Middle Eastern markets. This has afforded
him opportunities to understand the industry throughout the supply chain process – by understanding the materials market, dealing
with the full range of original equipment manufacturers and finally expanding dealership business for high-end automobile makers. He
has developed, nurtured and maintained strong relationships in the global auto industry. Mr. Ataya received his Executive Master of Business
Administration from HEC Paris, France, one of the most recognized universities in the world, and an Innovative Management and Entrepreneurial
Leadership Certification from Babson College. In addition, Mr. Ataya holds a Bachelor of Engineering in Mechanical Engineering from American
University of Beirut, Lebanon.
53
Rabih
Ataya is the cousin of Sam Ataya, our Executive President and Chief Executive Office and member of the board of directors.
Sam
Ataya.
Mr. Sam Ataya has been our Chief Executive Officer and a director since September 2018. He was appointed as our Executive
President in January 20202. Mr. Ataya has a record with key strengths in demonstrating "big picture" approaches toward project
management that require long term strategic planning and operational management. His ability to manage multi-faceted projects through
team leadership has led him through operational turnarounds, management changes and the ability to mobilize resources to achieve the
wanted results from strategic planning and analysis. From 2008 to 2018, Sam Ataya was the CEO of The Stirling Group of Vancouver, B.C.,
a "One Stop" consulting service focused on assisting Micro-Cap, Mid-Cap, and Large-Cap Companies in need of financial recapitalization.
The Stirling Group aids companies in strengthening their business models, investment proposals and helps source capital directly from
an established global funding network. From 1987 to 2008 he was the President of ASK Ventures, a venture capital firm. Sam Ataya studied
Business Administration at Langara College, Canada in 1990 and at the American University of London, England in 1992.
Sam
Ataya is the cousin of Rabih Ataya, our Executive Vice President, Special Projects and member of the board of directors.
Andrea
Chan.
Ms. Chan brings to our company extensive experience in accounting and corporate finance in various industries including
pharmaceuticals, technology and insurance with roles of increasing responsibility. Prior to joining our company in March 2021 as our
Chief Controller, Ms. Chan served from March 2016 to March 2021 as Interim Chief Financial Officer, Director, Finance and Administration
and Corporate Secretary at Pacgen Life Science Corporation, a TSXV listed company, where she oversaw and managed the accounting and corporate
regulatory functions of the company, and assisted the completion of various corporate transactions including an initial public offering,
private placement financings, acquisitions, financial restructuring and licensing transactions. Ms. Chan was also a senior consultant
at KeenVision Consulting Inc. from September 2014 to March 2021, where she provided consulting services to public and private companies
across different industries. Ms. Chan is a Chartered Professional Accountant, Certified General Accountant, and a Certified Public Accountant
designated in the State of Delaware. She graduated from the University of British Columbia with a Bachelor of Commerce Degree in Accounting.
Robert
Ramsey Hamady.
Mr. Hamady has been our Chief Financial Officer since March 7, 2022. Previously
since 2016, Mr. Hamady has been a managing director at Habboush Group, a private investment management firm focused on investing in and
operating special opportunities in energy, infrastructure, technology and real estate. From 2011 to 2016, Mr. Hamady was a founding partner
of Gulf Capital, an alternative credit fund anchored and backed by Abu Dhabi sovereign and quasi-sovereign funds focused on investing
in loans, mezzanine debt, and convertibles in healthcare, education, energy, retail, food and beverage, and other diversified industries.
From 2008 to 2011, Mr. Hamady was a Senior Vice President of Waha Capital where he was a member of the investment team that managed a
distressed debt portfolio and help the formation of joint ventures. From 1997 to 2008, Mr. Hamady held various roles engaged in investing
in asset back securities, special situations credit investments, leveraged buyouts, microfinance initiatives targeting poverty alleviation
in emerging markets and as an analyst for sovereign fixed income investments. Mr. Hamady holds a Bachelor of Science Degree in Finance
from Carnegie Mellon University.
Edward
Lee.
A longtime entrepreneur in private business in northern British Columbia, Mr. Lee has been a member of our board of directors
since March 2004. In addition, he served as our President from March 2013 to November 2019, as our Chief Executive Officer from March
2013 to September 2018 and as our Executive Chairman since 2019. Mr. Lee served on the Boards of American Manganese, Inc. from August
2011 to March 2013 and Goldrea Resources Corp. from November 2003 to April 2013. Previously, he was a Director and Executive Vice President
for Adanac Molybdenum Corp. from November 2006 to January 2009. Since 1989, Mr. Lee has been assisting public companies in capital formation
and strategic business development. He brings Western Magnesium invaluable strategic insight, industry expertise and proven leadership.
Lisa
Maxwell.
Ms. Maxwell joined our company in August 2013 as Corporate Secretary and full time in April 2019 as Senior Vice President,
Corporate Development and now serves as our President, Global Operations and Chief Operating Officer. She brings with her over 25 years
of experience in project management and business development. In December 2010 she founded Sequoia Corporate Services Inc., a management
consulting firm where she provided project management, compliance, corporate governance, business development and regulatory compliance
services for public companies from December 2010 to April 2019. In 2000 she founded Maxwell & Associates, where she provided project
management services for public, private and crown corporations in the areas of education, healthcare and transportation from 2000 until
2010. Ms. Maxwell studied International Business at Athabasca University, Alberta
,
Canada and Capilano University, North
Vancouver, British Columbia, Canada.
54
Michael
Rutkowski.
Colonel Michael Rutkowski, (Retired), joined Western Magnesium on September 1, 2021 as the Executive Vice President
of Enterprise Business and Defense. Prior to joining the Western Magnesium team, Colonel Rutkowski was the Director for Strategic Initiatives
for B3 Group, an award-winning IT consulting firm specializing in digital services and innovative technology solutions in Herndon, Virginia
from April 2021 to September 2021. From March 2020 to April 2021, he was the Executive Vice President and Chief of Business Development
for MCI a global engagement and marketing agency that creates human-centric touchpoints that unleash the power of people to deliver innovation
and growth. From 2011 to March 2020 Colonel Rutkowski served in the United States Army in the Aviation Branch and achieved the rank of
Colonel. At the time of his retirement in March 2020, he was serving as the Senior Military Advisor to the Secretary of Veteran's
Affairs (VA) where he worked in numerous leadership roles throughout the agency. He was appointed as Deputy Director for Electronic Healthcare
Records Management (EHRM) from April 2019 to November 2019 and helped oversee one of the largest information technology acquisition programs
ever in the federal government. Colonel Rutkowski served as a program manager for Air Traffic Control from June 2011 to June 2014 and
following that assignment he was a program manager in the Joint Office of the Pentagon (J8 - Capabilities and Acquisition Division) then
as the Chief of Staff for two J8 directors.
Colonel
Rutkowski holds a BS in Business Management (1993) from Niagara University, an MBA with concentration in supply chain management (2005)
from Florida State University and an MS in National Security and Resource Strategy with concentration in Space Industry (2018) from the
Eisenhower War College - National Defense University in Washington D.C.
Peter
O'Rourke.
Mr.
O'Rourke serves as our President, US Operations. Prior to joining our company in November 2020 as a director and Senior Vice President,
Business Development and Government Affairs, Mr. O'Rourke was Managing Partner of TCI Partners LLC a multidisciplinary consultancy
based in Washington DC (December 2018-April 2021). Mr. O'Rourke was the acting Secretary of Veterans Affairs and Senior Advisor
to the Secretary of Veterans Affairs for the US government (May – December 2018). Between February and May 2018 he was the Chief
of Staff, Department of Veterans Affairs and led the Department's staff and executive functions during a time of significant organizational
change. He began his service with the VA as Senior Advisor to the Secretary (January – April 2017) moving up to the position of
Executive Director for the Office of Accountability and Whistleblower Protection (May 2017 – February 2018) and then promoted to
VA Chief of Staff (February – May 2018). In these roles he organized the VA's senior staff and spearheaded the implementation
of Presidential and Congressional intent to reset the definition of accountability in the civilian workforce and operationalized the
protection and support for government whistleblowers. Mr. O'Rourke was a self-employed government affairs consultant (September—December
2016). Between May 2015 and July 2016 he was the Principal of Calibre Systems, a company which led the development of transformational
plans for Veterans Affairs, the U.S. Department of Defense, and other government organizations. From January to April 2015 he worked
as a self-employed consultant. Between May and December 2014 Mr. O'Rourke served as a Senior Policy Advisor in the US House of
Representatives. From February to April 2014 he worked as a self-employed consultant. Between March 2012 and January 2014 he was the
Vice-President, Marketing & Business Development with Blackland Aerospace where he created the worldwide marketing and business development
capabilities for the firm and its aerospace manufacturing facilities.
Mr.
O'Rourke was the Executive Director for Strong America Now where he led development and daily operations for a non-profit focused
on generating support for government efficiency and cost savings using Lean Six Sigma methods from November 2010 to April 2012. Prior
to this he was the Director, Marketing & Business Development for Accenture Federal Services from 2007 through 2009), in this capacity
he led development and execution of global strategic and operational marketing and business development activities for a new acquisition
(George Group Consulting, LP). campaigns and client teams to enable effective business development initiatives and between 2005 and 2007
he was a Senior Consultant for George Group Consulting LP where he coached, mentored and taught U.S. Department of Defense senior officers
and executives Lean Six Sigma methods, tools, and implementation strategies as a certified Lean Six Sigma Master Black Belt. Between
1998 and 2006, Mr. O'Rourke held multiple assignments worldwide as a high-performing expert in multiple supply chain and logistics
disciplines. Mr. O'Rourke completed undergraduate studies from 1995 until 1998. From 1990 – 1994 he was an Airman (Enlisted),
U.S. Navy, performing assignments worldwide as Plane Captain, Fighter Squadron 213, Miramar Naval Air Station, California. Mr. O'Rourke
holds a B.A. Political Science from the University of Tennessee.
Paul
Sauvé.
Mr. Sauvé has been our Senior Vice President, Technology and Operations since March 2020 and now serves
as our Executive Vice President, Operations and Chief Technology Officer. He brings with him over 15 years of experience in the mining
industry including senior positions with Teck Resources as Senior Project Engineer and Metallurgist from June 2006 – March 2020.
Based on his strong chemical engineering background, he has had extensive experience with diversified metals & mining companies,
gaining valuable know how in process development and optimization; fully integrated plant systems management; hydrometallurgical research
facility operation that involved testing for metal recovery; process engineering for full-scale studies and project execution; as well
as modeling commercial sized facilities for production.
55
As
an innovative and versatile chemical/mine engineer, he has been recognized for his in-depth expertise in metallurgy – managing
a dynamic & multifaceted hydrometallurgical research facility; shift metallurgist for an operating plant; flotation plant metallurgy;
metallurgist for multi-unit operation in a continuous pilot plant; and supervision of a hydrometallurgical research plant. In addition
to being a member of the Association of Professional Engineers and Geoscientists of British Columbia since June 2011, he comes with specialized
skills in lab and filed-testing protocols, METSIM (a general-purpose process simulation system designed to assist in performing mass
and energy balances of complex processes), Unisim (a modeling platform that helps engineers create steady-state and dynamic models for
plant design and performance monitoring), Visual Minteq (a chemical equilibrium software application) and WHMIS (workplace hazardous
materials information system). He holds a Bachelor of Applied Science/Chemical Engineering degree from Lakehead University (2011) and
a Diploma of Applied Science/Chemical Science Technology from BCIT (2006).
Stephen
Thorlakson.
Mr. Thorlakson has been a member of our board of directors since December 2013. He brings a wealth of experience
in the construction project management and logistics industry, as well as extensive financial and business management expertise, having
worked more than three decades within the construction and financial services industry. In September 2019, Mr. Thorlakson became the
Vice-President of FloRite ESI and Klassic Oilfield Services Ltd., companies which service the oil and gas industry. In 2011, he founded
and became the President of Thorlakson Management Ltd., a construction management firm that specializes in quality control, safety and
site remediation where he has provided guidance, direction and hands-on management of major industrial and business development projects
for clients. Mr. Thorlakson continues to provide consulting services for Thorlakson Management Ltd. From June 2006 to November 2010,
he was the General Manager for Surerus Pipeline. From 1980 until 2006, Mr. Thorlakson was a self- employed chartered financial planner
in Fort St. John, British Columbia, a city for which he served as Mayor from 1990 through 2005 and Alderman from 1986 through 1990. He
began his professional career working at Toronto Dominion Bank as Branch Manager and Senior Assistant Manager of Commercial Credit from
September 1976 to September 1979.
Jeff
Wilson.
Jeff Wilson, Ph.D., P.Geo, has been a member of our board of directors since August 2014. He has worked in mineral exploration,
consulting and market regulation for over 20 years. He has also worked as an independent consultant since 2013. From 2010 until 2013,
Dr. Wilson was the director of Geology at Tetra Tech WEI, Inc., a leading provider of consulting, engineering and technical services
focused on the worldwide water, environmental, energy, infrastructure and natural resource industries. From 2006 until 2010, Dr. Wilson
worked as a Listings Manager at the TSXV, where he was responsible for reviewing technical and financial submissions by publicly traded
resource companies. In addition, he has worked as a Project Geologist at Placer Dome Inc. from 2005 to 2006, Project Geologist for Fronteer
Development Group from 2004 to 2005, an independent consultant from 2001 to 2004, as a Senior Structural Geologist for AngloGold Ashanti
in Brazil from 2000 to 2001, an independent consultant in 1999, a Prestigious Geological Fellow at Rhodes University South Africa in
1998 and a Senior Geologist at Newcrest Mining in Indonesia in 1997. Dr. Wilson graduated with a Ph.D. in Geology from Kingston University,
England in 1996 and a Bachelor Degree in Geology from Glasgow University, Scotland in 1991.
Family
Relationships
Rabih
Ataya is the cousin of Sam Ataya, our Executive President and Chief Executive Office and member of the board of directors. Sam Ataya
is the cousin of Rabih Ataya, our Executive Vice President, Special Projects and member of the board of directors.
Officer
and Board Qualifications
Our
officers and board of directors are well qualified as leaders. In their prior positions they have gained experience in core management
skills, such as strategic and financial planning, public company financial reporting, compliance, risk management, and leadership development.
Our officers and directors also have experience serving on boards of directors and board committees of other public companies and private
companies, and have an understanding of corporate governance practices and trends, which provides an understanding of different business
processes, challenges, and strategies.
Number
and Terms of Office of Officers and Directors
Our
board of directors is comprised of six directors. Each director is elected at our annual meeting of stockholders and holds office for
one year, or until his successor is elected and qualified. Our officers are elected by the board of directors and serve at the discretion
of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices
set forth in our bylaws as it deems appropriate. Our bylaws provide that our officers may consist of a Chief Executive Officer, President,
Chief Financial Officer, Vice Presidents, Secretary, Assistant Secretaries, Treasurer and such other offices as may be determined by
the board of directors.
56
Board
Committees
We
currently have an audit committee, a compensation committee, and a corporate governance committee. The members of each are set out below.
Name
    of Member
Audit
Committee
Compensation
    Committee
Corporate
    Governance Committee
Rabih
    Ataya
X
X
Edward
    Lee
X
(1)
Stephen
    Thorlakson
X
(1)
X
(1)
X
Jeff
    Wilson
X
X
X
(1)
Denotes chairperson.
A
brief description of each committee is set out below.
Audit
Committee
The
audit committee of our board of directors (the "Audit Committee") is responsible for review of our interim and annual financial
statements. For the purposes of performing their duties, the members of the Audit Committee have the right at all times, to inspect all
of our books and financial records and any subsidiaries and to discuss with management and our independent auditors any accounts, records
and matters relating to our financial statements. The Audit Committee members meet periodically with management and annually with our
independent auditors.
Composition
of the Audit Committee
As
of the date of this prospectus, the following are the members of the Audit Committee:
Name
                                            of Member
Independent
(1)
Financially
    Literate
(2)
Rabih
    Ataya
No
Yes
Stephen
    Thorlakson
Yes
Yes
Jeff
    Wilson
Yes
Yes
Notes:
(1)
A
    member of the Audit Committee is independent if he or she has no direct or indirect 'material relationship' with Western
    Magnesium. A material relationship is a relationship which could, in the view of our board of directors, reasonably interfere with
    the exercise of a member's independent judgment. An executive officer, such as the President or Secretary, is deemed to have
    a material relationship with Western Magnesium.
(2)
A
    member of the Audit Committee is financially literate if he or she has the ability to read and understand a set of financial statements
    that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of
    the issues that can reasonably be expected to be raised by our financial statements.
Relevant
Education and Experience
Each
member of the Audit Committee has experience relevant to his or her responsibilities as an Audit Committee member. See "Management"
for a description of the education and experience of each Audit Committee member.
Audit
Committee Oversight
At
no time since the commencement of our most recently completed fiscal year was a recommendation of the Audit Committee to nominate or
compensate an external auditor not adopted by our board of directors.
Audit
Committee's Charter
Our
board of directors has adopted a written charter for the Audit Committee, which sets out the Audit Committee's responsibilities
in detail. The Audit Committee has access to all books, records, facilities and personnel and may request any information about us as
it may deem appropriate. It will also have the authority to retain and compensate special legal, accounting, financial and other consultants
or advisors to advise the Audit Committee.
Compensation
Committee
The
compensation committee of our board of directors (the "Compensation Committee") has the responsibility of assisting our board
of directors in discharging its oversight responsibilities relating to the attraction, compensation, evaluation and retention of key
senior management employees, and in particular the Chief Executive Officer. In addition, the Compensation Committee is tasked with reviewing
our annual disclosure regarding executive compensation for inclusion where appropriate in our disclosure documents. The Compensation
Committee is also charged with annually reviewing the Western Magnesium Corporation 2021 Equity Incentive Plan (the "2021 Equity
Incentive Plan") and proposing changes thereto, approving any awards of options under the 2021 Equity Incentive Plan and recommending
any other employee benefit plans, incentive awards and perquisites with respect to our executive officers.
57
Composition
of the Compensation Committee
As
of the date of this prospectus, the following are the members of the Compensation Committee:
Name
                                            of Member
Independent
(1)
Rabih
    Ataya
No
Stephen
    Thorlakson
Yes
Jeff
    Wilson
Yes
Notes:
(1)
A
    member of the Compensation Committee is independent if he or she has no direct or indirect 'material relationship' with
    Western Magnesium. A material relationship is a relationship which could, in the view of our board of directors, reasonably interfere
    with the exercise of a member's independent judgment. An executive officer, such as the President or Secretary, is deemed to
    have a material relationship with Western Magnesium.
Compensation
Committee's Charter
Our
board of directors has adopted a written charter for the Compensation Committee, which sets out the Compensation Committee's responsibilities
in detail.
For
additional details on the Compensation Committee, see "Executive Compensation".
Corporate
Governance Committee
The
Corporate Governance committee of our board of directors (the "Corporate Governance Committee") is responsible to develop
and monitor our approach to matters of governance.
Composition
of the Corporate Governance Committee
As
of the date of this prospectus, the following are the members of the Corporate Governance Committee:
Name
                                            of Member
Independent
(1)
Edward
    Lee
No
Stephen
    Thorlakson
Yes
Jeff
    Wilson
Yes
Notes:
(1)
A
    member of the Corporate Governance Committee is independent if he or she has no direct or indirect 'material relationship'
    with Western Magnesium. A material relationship is a relationship which could, in the view of our board of directors, reasonably
    interfere with the exercise of a member's independent judgment. An executive officer, such as the President or Secretary, is
    deemed to have a material relationship with Western Magnesium.
Board
Qualifications
We
believe that each of the members of our board of directors has the experience, qualifications, attributes and skills that make him or
her suitable to serve as our director, in light of our highly regulated magnesium business and the complex nature of our operations.
See above under the heading "Management" for a description of the education and experience of each director.
Mr.
Rabih Ataya's specific qualifications, experience, skills and expertise include:
●
Core
    business skills, including financial and strategic planning;
●
Finance
    and financial reporting expertise; and
●
Operating
    and management experience.
58
Mr.
Sam Ataya's specific qualifications, experience, skills and expertise include:
●
Core
    business skills, including financial and strategic planning;
●
Finance
    and financial reporting expertise; and
●
Operating
    and management experience.
Mr.
Lee's specific qualifications, experience, skills and expertise include:
●
Core
    business skills, including financial and strategic planning;
●
Finance
    and financial reporting expertise; and
●
Operating
    and management experience.
Mr.
O'Rourke's specific qualifications, experience, skills and expertise include:
●
Core
    business skills, including financial and strategic planning;
●
Finance
    and financial reporting expertise; and
●
Operating
    and management experience.
Mr.
Thorlakson's specific qualifications, experience, skills and expertise include:
●
Core
    business skills, including financial and strategic planning;
●
A
    deep understanding of entrepreneurship and of the industry; and
●
Operating
    and management experience.
Mr.
Wilson's specific qualifications, experience, skills and expertise include:
●
Core
    business skills, including financial and strategic planning;
●
A
    deep understanding of entrepreneurship and of the industry; and
●
Operating
    and management experience.
We
believe these qualifications bring a broad set of complementary experience to our board of directors' discharge of its responsibilities.
Director
Independence
For
purposes of this prospectus, the independence of our directors is determined under the corporate governance rules of the Nasdaq Stock
Market ("Nasdaq"). The independence rules of Nasdaq include a series of objective tests, including that an "independent"
person will not be employed by us and will not be engaged in various types of business dealings with us. In addition, our board of directors
is required to make a subjective determination as to each person that no material relationship exists with us either directly or as a
partner, shareholder or officer of an organization that has a relationship with us. It has been determined that two of our directors
are independent persons under the independence rules of Nasdaq: Jeff Wilson and Stephen Thorlakson.
Nomination
of Directors
The
Board is responsible for identifying individuals qualified to become new Board members and recommending to the Board new director nominees
for the next annual meeting of shareholders. New nominees must have a track record in general business management, special expertise
in an area of strategic interest to the Company, the ability to devote the required time, show support for the Company's mission
and strategic objectives, and a willingness to serve.
The
Bylaws of the Company contain advance notice provisions, which include, among other things, a provision that requires advance notice
be given to the Company in circumstances where nominations of persons for election to the Board are made by shareholders.
Board
Leadership Structure and Board's Role in Risk Oversight
Our
board is generally responsible for the oversight of corporate risk in its review and deliberations relating to our activities. Our principal
source of risk falls into two categories, financial and product commercialization. The audit committee oversees management of financial
risks; our board regularly reviews information regarding our cash position, liquidity and operations, as well as the risks associated
with each. The board regularly reviews plans, results and potential risks related to our business. The board is also expected to oversee
risk management as it relates to our compensation plans, policies and practices for all employees including executives and directors,
particularly whether our compensation programs may create incentives for our employees to take excessive or inappropriate risks which
could have a material adverse effect on the Company.
59
Code
of Ethics and Business Conduct
We
have adopted a Code of Ethics and Business Conduct applicable to our directors, officers and employees. We previously filed a copy of
our Code of Ethics and Business Conduct as an exhibit to our Form 10-K for the period ended October 31, 2021. You will be able to review
this document by accessing our public filings at the SEC's web site at
www.sec.gov
. In addition, a copy of the Code of Ethics
and Business Conduct will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain
provisions of our Code of Ethics and Business Conduct in a Current Report on Form 8-K. See "Where You Can Find Additional Information."
Limitation
on Liability and Indemnification of Officers and Directors
Section
145 of the Delaware General Corporation Law (the "DGCL") empowers a Delaware corporation to indemnify any persons who are,
or are threatened to be made, parties to any threatened, pending, or completed legal action, suit, or proceeding, whether civil, criminal,
administrative, or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person
was an officer or director of such corporation, or is or was serving at the request of such corporation as a director, officer, employee,
or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys' fees), judgments, fines,
and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit, or proceeding, provided
that such officer or director acted in good faith and in a manner he reasonably believed to be in or not opposed to the corporation's
best interests, and, for criminal proceedings, had no reasonable cause to believe his conduct was illegal. A Delaware corporation may
indemnify officers and directors in an action by or in the right of the corporation under the same conditions, except that no indemnification
is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation in the performance of his
duty. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation
must indemnify him against the expenses which such officer or director actually and reasonably incurred.
Our
bylaws, as amended, provide that we will indemnify our directors and officers to the fullest extent permitted by Delaware law, except
that no indemnification will be provided to a director, officer, employee, or agent if the indemnification sought is in connection with
a proceeding initiated by such person without the authorization of our board of directors. The bylaws, as amended, also provide that
the right of directors and officers to indemnification will be a contract right and will not be exclusive of any other right now possessed
or hereafter acquired under any statute, provision of the certificate of incorporation, bylaw, agreement, vote of stockholders or disinterested
directors or otherwise. The bylaws, as amended, also permit us to secure insurance on behalf of any officer, director, employee, or other
agent for any liability arising out of his or her actions in such capacity, regardless of whether the bylaws, as amended, would permit
indemnification of any such liability.
In
accordance with Section 102(b)(7) of the DGCL, our certificate of incorporation provides that directors will not be personally liable
for monetary damages for breaches of their fiduciary duty as directors. The effect of this provision is to eliminate the personal liability
of directors for monetary damages or actions involving a breach of their fiduciary duty of care, including any actions involving gross
negligence.
We
also maintain director and officer liability insurance to insure our directors and officers against the cost of defense, settlement or
payment of a judgment under specified circumstances.
These
provisions may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action,
if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder's investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.
We
believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced
officers and directors.
60
EXECUTIVE
COMPENSATION
2021
Summary Compensation Table
The
following table summarizes all compensation recorded by us in the past two fiscal years for:
●
our
    principal executive officer or other individual acting in a similar capacity during the fiscal year ended October 31, 2021,
●
our
    two most highly compensated executive officers, other than our principal executive officers, who were serving as executive officers
    at October 31, 2021, and
●
up
    to two additional individuals for whom disclosure would have been provided but for the fact that the individual was not serving as
    an executive officer at October 31, 2021.
For
definitional purposes, these individuals are sometimes referred to as the "named executive officers."
Name
    and Principal Position
Fiscal
                                            Year ended October
31
Salary
($)
Bonus
($)
Stock
                                            Awards
($)
Option
                                            Awards
(1)
($)
Non-Equity
                                            Incentive Plan Compensation
($)
Non-qualified
                                            Deferred Compensation Earnings
($)
All
                                            Other Compensation
($)
Total
($)
Sam
    Ataya
2021
360,000
—
—
2,570,452
—
—
200,188
3,130,640
Director,
    Executive President and CEO
(2)
2020
360,000
37,150
—
70,288
—
—
89,160
556,598
Edward
    Lee
2021
420,000
—
—
3,053,221
—
—
251,023
3,724,244
Director,
    Executive Chairman and former President and CEO
(3)
2020
420,000
—
—
75,711
—
—
—
495,711
Lisa
    Maxwell
2021
192,917
—
—
1,593,783
—
—
144,380
1,931,080
President,
    Global Operations and COO
(4)
2020
120,000
—
—
43,242
—
—
2,600
165,842
Rabih
    Ataya
2021
180,000
—
—
248,897
—
—
55,878
484,775
Director
    and EVP, Special Projects
(5)
2020
180,000
—
—
47,626
—
—
—
227,626
Paul
    Sauvé
2021
186,812
—
—
484,200
—
—
102,701
773,713
EVP,
                                            Operations and CTO
(6)
2020
95,154
—
—
37,373
—
—
—
132,527
Notes:
(1)
The
    amounts reported in the Option Awards column reflects aggregate grant date fair value computed in accordance with ASC Topic 718,
    Compensation—Stock Compensation. These amounts reflect our calculation of the value of these awards at the grant date and do
    not necessarily correspond to the actual value that may ultimately be realized by the named executive officer. Assumptions used in
    the calculation of these amounts are included in Note
14
to our audited consolidated financial statements for the fiscal year
    ended October 31, 2021, which are included elsewhere in this registration statement.
The
2020 Option Award compensation includes the following:
The
2020 Option Award compensation for Sam Ataya reflects the issuance of 650,000 stock options granted on April 24, 2020, which entitles
the holder of each such stock option to purchase one share of our common stock at an exercise price of CAD$0.12 until April 23, 2025,
and vested in full on the grant date.
The
2020 Option Award compensation for Edward Lee reflects the issuance of 700,000 stock options granted on April 24, 2020, which entitles
the holder of each such stock option to purchase one share of our common stock at an exercise price of CAD$0.12 until April 23, 2025,
and vested in full on the grant date.
61
The
2020 Option Award compensation for Lisa Maxwell reflects the issuance of 400,000 stock options granted on April 24, 2020, which entitles
the holder of each such stock option to purchase one share of our common stock at an exercise price of CAD$0.12 until April 23, 2025,
and vested in full on the grant date.
The
2020 Option Award compensation for Rabih Ataya reflects the issuance of:
●
250,000
    stock options granted on November 4, 2019, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.15 until November 3, 2024; and
●
200,000
    stock options granted on April 24, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.12 until April 23, 2025,
These
stock options were fully vested on the grant date.
The
2020 Option Award compensation for Paul Sauvé reflects the issuance of:
●
300,000
    stock options granted on March 27, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.11 until March 26, 2024; and
●
150,000
    stock options granted on April 24, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.12 until April 23, 2025.
These
stock options were fully vested on the grant date.
The
2021 Option Award compensation includes the following:
The
2021 Option Award compensation for Sam Ataya reflects the issuance of:
●
4,500,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2025; and
●
5,000,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.
These
stock options were fully vested on the grant date.
The
2021 Option Award compensation for Edward Lee reflects the issuance of:
●
5,000,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2025; and
●
6,000,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.
The
2021 Option Award compensation for Lisa Maxwell reflects the issuance of:
●
750,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2022; and
●
3,500,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.
These
stock options were fully vested on the grant date.
The
2021 Option Award compensation for Rabih Ataya reflects the issuance of:
●
500,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2022; and
●
500,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.
62
These
stock options were fully vested on the grant date.
The
2021 Option Award compensation for Paul Sauvé reflects the issuance of:
●
750,000
    stock options granted on December 30, 2020, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.13 until December 30, 2022; and
●
1,000,000
    stock options granted on August 30, 2021, which entitles the holder of each such stock option to purchase one share of our common
    stock at an exercise price of CAD$0.70 until August 30, 2026.
These
stock options were fully vested on the grant date.
(2)
Mr.
    Ataya was appointed as our CEO and elected to our board of directors effective September 21, 2018. Mr. Ataya was appointed as our
    President effective January 31, 2020. The compensation disclosed for Mr. Ataya is for his position as our CEO and he was not separately
    compensated as a director. Mr. Ataya's reported 2021 salary includes $90,000 accrued not yet paid. Mr. Ataya's reported
    2021 All Other Compensation includes vacation and benefits of $166,486 accrued not yet paid and consulting fees of $35,772 paid to
    a company where Mr. Ataya is principal. Mr. Ataya's reported 2020 salary includes $75,000 accrued not yet paid. Mr. Ataya's
    reported 2020 All Other Compensation includes consulting fees of $89,160 paid to a company where Mr. Ataya is principal.
(3)
Mr.
    Lee was appointed as our Executive Chairman and CEO on March 24, 2013 and resigned as CEO on September 21, 2018. Mr. Lee was appointed
    as a director on March 29, 2004. The compensation disclosed for Mr. Lee is for his position as our Executive Chairman and he was
    not separately compensated as a director. Mr. Lee's reported 2021 Salary includes $105,000 accrued not yet paid. Mr. Lee's
    reported 2021 All Other Compensation includes vacation and benefits of $254,986 accrued not yet paid. Mr. Lee's reported 2020
    Salary includes $87,500 accrued not yet paid.
(4)
Ms.
    Maxwell was appointed as SVP, Corporate Development on December 1, 2020 and promoted as EVP, Corporate Development effective July
    15, 2021 and as President, Global Operations and COO effective October 1, 2021. Ms. Maxwell's reported 2021 All Other Compensation
    includes benefits of $48,325 accrued not yet paid. Ms. Maxwell's reported 2020 All Other Compensation includes consulting fees
    of $2,600 paid to a company where Ms. Maxwell is principal.
(5)
Mr.
    Ataya was appointed as SVP, Strategy on November 1, 2019 and as a director on March 10, 2020. He was promoted as EVP, Special Projects
    effective October 1, 2021. The compensation disclosed for Mr. Ataya is for his position as our SVP, Strategy and subsequently EVP,
    Special Projects; he was not separately compensated as a director. Mr. Ataya's reported 2021 All Other Compensation includes
    benefits of $29,954 accrued not yet paid.
(6)
Mr.
    Sauvé was appointed as SVP, Technology & Operations on March 23, 2020 and promoted as EVP, Operations and CTO effective
    October 1, 2021. Mr. Sauvé's reported 2021 All Other Compensation includes benefits of $12,075 accrued not yet paid.
Executive
Employment Agreements
We
have employment agreements with Edward Lee, Executive Chairman, Sam Ataya, Executive President and CEO, Lisa Maxwell, President, Global
Operations and COO, Rabih Ataya, EVP, Special Projects, and Paul Sauvé, EVP, Operations and CTO under which compensation was provided
during the most recently completed financial year and/or interim period, or is payable in respect of services provided to us.
Edward
Lee
.
Executive Chairman, Edward Lee signed a contract on April 8, 2022 (the "Lee Contract") with an indefinite term
that may be terminated by us at any time 30 days after written notice to Mr. Lee. Mr. Lee will be paid an annual base salary of USD$420,000
which will be subject to all required deductions. Mr. Lee shall have the opportunity to earn an annual discretionary bonus upon meeting
or exceeding our achievement of annual financial and operating targets and his performance targets. Mr. Lee will also be granted such
stock options as determined by the Board or a committee thereof in its sole discretion and be entitled to participate in our benefits
plans. During Mr. Lee's employment and for a period of one year from the end of Mr. Lee's employment (howsoever occasioned),
Mr. Lee shall not, directly or indirectly, whether as owner, shareholder (except to the extent of a less than 2% ownership interest of
the outstanding shares of a publicly held corporation), director, agent, officer, employee, consultant, independent contractor or in
any other capacity whatsoever of a corporation, partnership, proprietorship, be engaged in, compete with, be financially concerned or
interested with, or employed by any company carrying on the business of development or processing of magnesium anywhere in North or South
America or Europe. Upon the death or disability of Mr. Lee such that, in the view of our directors other than Mr. Lee, Mr. Lee is not
able to carry out his responsibilities, we may terminate Mr. Lee's employment by providing Mr. Lee or his estate with pay and severance
pay, if applicable, in the amount of six (6) months' base salary payable monthly. In the event we terminate Mr. Lee's employment
without cause within 12 months of a Change of Control (as defined below) or Mr. Lee terminates his employment for Good Reason (as defined
below) within 12 months of a Change of Control, Mr. Lee is entitled to receive from us a payment equal to the greater of: (i) a onetime
payment of USD$6 million, less applicable deductions and withholdings; and (ii) any minimum entitlements to written notice of termination,
payment in lieu of such notice, or a combination of written notice and payment in lieu of such notice, at our sole discretion, required
by the
Employment Standards Act
(British Columbia) (the "BCESA").
63
Sam
Ataya
.
Executive President and CEO, Sam Ataya has signed a contract on April 8, 2022 (the "S. Ataya Contract") with
an indefinite term that may be terminated by us at any time 30 days after written notice to Mr. Ataya. Mr. Ataya will be paid an annual
base salary of USD$360,000 which will be subject to all required deductions. Mr. Ataya shall have the opportunity to earn an annual discretionary
bonus upon meeting or exceeding our achievement of annual financial and operating targets and Mr. Ataya's performance targets.
Mr. Ataya will also be granted such stock options as determined by the Board or a committee thereof in its sole discretion and be entitled
to participate in our benefits plans. During Mr. Ataya's employment and for a period of one year from the end of Mr. Ataya's
employment (howsoever occasioned), Mr. Ataya shall not, directly or indirectly, whether as owner, shareholder (except to the extent of
a less than 2% ownership interest of the outstanding shares of a publicly held corporation), director, agent, officer, employee, consultant,
independent contractor or in any other capacity whatsoever of a corporation, partnership, proprietorship, be engaged in, compete with,
be financially concerned or interested with, or employed by any company carrying on the business of development or processing of magnesium
anywhere in North or South America or Europe. Upon the death or disability of Mr. Ataya such that, in the view of our directors other
than Mr. Ataya, Mr. Ataya is not able to carry out his responsibilities, we may terminate Mr. Ataya's employment by providing Mr.
Ataya or his estate with pay and severance pay, if applicable, in the amount of six (6) months' base salary payable monthly. In
the event we terminate Mr. Ataya's employment without cause within 12 months of a Change of Control (as defined below) or Mr. Ataya
terminates his employment for Good Reason (as defined below) within 12 months of a Change of Control, Mr. Ataya is entitled to receive
from us a payment equal to the greater of: (i) a onetime payment of USD$5 million, less applicable deductions and withholdings; and (ii)
any minimum entitlements to written notice of termination, payment in lieu of such notice, or a combination of written notice and payment
in lieu of such notice, at our sole discretion, required by the BCESA.
Lisa
Maxwell
.
President, Global Operations and COO, Lisa Maxwell, has signed a contract on April 8, 2022 (the "Maxwell Contract")
with an indefinite term that may be terminated by us at any time 30 days after written notice to Ms. Maxwell. Ms. Maxwell will be paid
an annual base salary of USD$250,000 which will be subject to all required deductions. Ms. Maxwell will also be granted such stock options
as determined by the Board or a committee thereof in its sole discretion and be entitled to participate in our benefits plans. During
Ms. Maxwell's employment and for a period of one year from the end of her employment (howsoever occasioned), she shall not, directly
or indirectly, whether as owner, shareholder (except to the extent of a less than 2% ownership interest of the outstanding shares of
a publicly held corporation), director, agent, officer, employee, consultant, independent contractor or in any other capacity whatsoever
of a corporation, partnership, proprietorship, be engaged in, compete with, be financially concerned or interested with, or employed
by any company carrying on the business of development or processing of magnesium anywhere in North or South America or Europe. Upon
the death or disability diagnosed by a licensed physician of the Employee such that, in the view of the Company's directors other
than the Employee, the Employee is not able to carry out his essential job functions, the Company may terminate the Employee's
employment by providing the Employee or his estate with pay and severance pay, if applicable, in the amount of six (6) months'
Base Salary payable monthly, and conditioned on the effectiveness of a Release. In the event we terminate Ms. Maxwell's employment
without cause within 12 months of a Change of Control (as defined below) or Ms. Maxwell terminates his employment for Good Reason within
12 months of a Change of Control, she is entitled to receive from us a payment equal to the greater of: (i) a onetime payment of USD$2
million, less applicable deductions and withholdings; and (ii) any minimum entitlements to written notice of termination, payment in
lieu of such notice, or a combination of written notice and payment in lieu of such notice, at our sole discretion, required by the BCESA.
Rabih
Ataya
.
EVP, Special Projects, Rabih Ataya, has signed a contract on November 1, 2019 (the "R. Ataya Contract") and
will be paid an annual base salary of USD$180,000 which will be subject to all required deductions. Mr. Ataya shall have the opportunity
to earn an annual discretionary bonus upon meeting or exceeding our achievement of annual financial and operating targets and Mr. Ataya's
performance targets. Mr. Ataya will also be granted such stock options as determined by the Board or a committee thereof in its sole
discretion and be entitled to participate in our benefits plans. During Mr. Ataya's employment and for a period of one year from
the end of Mr. Ataya's employment (howsoever occasioned), Mr. Ataya shall not, directly or indirectly, whether as owner, shareholder
(except to the extent of a less than 2% ownership interest of the outstanding shares of a publicly held corporation), director, agent,
officer, employee, consultant, independent contractor or in any other capacity whatsoever of a corporation, partnership, proprietorship,
be engaged in, compete with, be financially concerned or interested with, or employed by any company carrying on the business of development
or processing of magnesium anywhere in North or South America or Europe. Upon the death or disability of Mr. Ataya such that, in the
view of our directors other than Mr. Ataya, Mr. Ataya is not able to carry out his responsibilities, we may terminate Mr. Ataya's
employment by providing him or his estate with pay and severance pay, if applicable, in the amount of six month's base salary payable
monthly. In the event we terminate Mr. Ataya's employment without cause within 12 months of a Change of Control or Mr. Ataya terminates
his employment for Good Reason within 12 months of a Change of Control, he is entitled to receive from us six month's base salary
and any minimum entitlements to written notice of termination, payment in lieu of such notice, or a combination of written notice and
payment in lieu of such notice, at our sole discretion, required by the BCESA.
64
Paul
Sauvé
.
EVP, Operations and CTO, Paul Sauvé, has signed a contract on March 23, 2020 (the "Sauvé Contract")
and will be paid an annual base salary of CAD$210,000 which will be subject to all required deductions. Mr. Sauvé's annual
base salary is increased to CAD$240,000 effective January 1, 2021 and to USD$240,000 effective September 1, 2021. Mr. Sauvé shall
have the opportunity to earn an annual discretionary bonus upon meeting or exceeding our achievement of annual financial and operating
targets and Mr. Sauvé's performance targets. Mr. Sauvé will also be granted such stock options as determined by the
Board or a committee thereof in its sole discretion and be entitled to participate in our benefits plans. During Mr. Sauvé's
employment and for a period of one year from the end of Mr. Sauvé's employment (howsoever occasioned), Mr. Sauvé
shall not, directly or indirectly, whether as owner, shareholder (except to the extent of a less than 2% ownership interest of the outstanding
shares of a publicly held corporation), director, agent, officer, employee, consultant, independent contractor or in any other capacity
whatsoever of a corporation, partnership, proprietorship, be engaged in, compete with, be financially concerned or interested with, or
employed by any company carrying on the business of development or processing of magnesium anywhere in North or South America or Europe.
Upon the death or disability of Mr. Sauvé such that, in the view of our directors other than Mr. Sauvé, Mr. Sauvé
is not able to carry out his responsibilities, we may terminate Mr. Sauvé's employment by providing Mr. Sauvé or
his estate with pay and severance pay, if applicable, in the amount of one (1) month's base salary payable monthly. In the event
we terminate Mr. Sauvé's employment without cause within 12 months of a Change of Control (as defined below) or Mr. Sauvé
terminates his employment for Good Reason (as defined below) within 12 months of a Change of Control, Mr. Sauvé is entitled to
receive from us one month's base salary and any minimum entitlements to written notice of termination, payment in lieu of such
notice, or a combination of written notice and payment in lieu of such notice, at our sole discretion, required by the BCESA.
Robert
Ramsey Hamady
.
Our CFO, Robert Ramsey Hamady signed an Executive Employment Agreement effective as of March 7, 2022 (the "Hamady
Agreement") pursuant to which we agreed to pay him
an annual base salary of USD$350,000.
The term of the agreement is for a period of three years and may be terminated by us for cause as defined in the agreement, without cause
effective 60 days after notice or for good reason by Mr. Hamady as defined in the agreement, which includes a "Change in Control."
Mr. Hamady is entitled to receive a USD$25,000 signing bonus on March 15, 2022 and will be eligible to earn an annual discretionary
bonus upon meeting or exceeding our achievement of annual financial and operating targets and Mr. Hamady's performance targets
("Bonus"). The amount of the Bonus, if any, and specific targets for the Bonus will be determined by us in our sole and absolute
discretion. Mr. Hamady was granted stock options to purchase 500,000 shares of our common stock. The stock options vest immediately and
are exercisable at a price of $0.40 per share for a period of five years from the date of grant. Mr. Hamady will be entitled to severance
in the amount of six (6) months of his then base salary if he is terminated without cause by us or he terminates the Hamady Agreement
for "Good Reason" as defined therein, payable in the form of a lump-sum payment. Mr. Hamady's receipt of severance
is subject to his execution and non-revocation of a waiver and release agreement and his cooperation during the one year period following
his termination of employment.
"Change
of Control" is generally defined in the Lee Contract, S. Ataya Contract, Hamady Agreement, Maxwell Contract, R. Ataya Contract
and Sauvé Contract (collectively, the "Management Contracts") as:
(i)
an
    acquisition, directly or indirectly, of voting our securities (including securities of the Company on which conversion will become
    voting securities) by any person or group of persons acting in concert such that such person or group of persons are able for the
    first time to affect materially the control of our company;
(ii)
a
    merger, amalgamation or other business combination of us with or into another entity, or any other corporate reorganization, if more
    than 50% of the combined voting power of the continuing or surviving entity's securities outstanding immediately thereafter
    are owned by persons who were not our security holders immediately prior to such merger, amalgamation, business combination or reorganization;
(iii)
the
    exercise of the voting power of any of all of our securities so as to cause or result in the election of a majority of members of
    the Board who were not previously incumbent directors thereof;
(iv)
the
    completion of a tender offer, an exchange offer, a take-over bid or any other offer or bid by an entity, person or group (other than
    with us or a wholly-owned subsidiary of ours) of more than 50% of our issued and outstanding voting securities; or
(v)
the
    sale, transfer or disposition by us of all or substantially all of our assets.
"Good
Reason" is generally defined in the Management Contracts as:
(i)
a
    material and detrimental change in the title, position, duties and responsibilities, authority or status of the executive with us;
(ii)
a
    material breach by us of the employment agreement; or
(iii)
a
    material reduction of the executive's base salary.
65
Overview
of Executive Compensation
Our
board of directors is authorized to review and approve annually all compensation decisions relating to our executive officers. In accordance
with reduced disclosure rules applicable to emerging growth companies as set forth in Item 402 of Regulation S-K, this section explains
how our compensation program is structured for its Chief Executive Officer and the other executive officers named in the 2021 Summary
Compensation Table (the "named executive officers" or "NEOs").
Compensation
Governance
We
have created a Compensation Committee, the members of which are Stephen Thorlakson, Jeff Wilson and Rabih Ataya.
All
tasks related to developing and monitoring our approach to the compensation of our NEOs and directors are performed initially by the
Compensation Committee and reviewed and approved by the members of the Board. The compensation of the NEOs, directors and our employees
or consultants is recommended and approved by the Board without reference to any specific formula or criteria. NEOs that are also directors
of our company are involved in discussions relating to compensation, and disclose their interest in and abstain from voting on compensation
decisions relating to them, as applicable, in accordance with the applicable corporate legislation. Our compensation program is intended
to attract, motivate, reward and retain the management talent needed to achieve our business objectives of improving overall corporate
performance and creating long term value for our shareholders. The compensation program is intended to reward executive officers on the
basis of individual performance and achievement of corporate objectives, including the advancement of our exploration and development
goals.
Our
current compensation program is comprised of three major components: base salary or fees, short-term incentives such as discretionary
bonuses and long-term incentives such as stock options.
In
making compensation decisions, the Compensation Committee and the Board strive to find a balance between short-term and long-term compensation
and cash versus equity incentive compensation. Base salaries or fees and discretionary cash bonuses primarily reward recent performance
and incentive stock options encourage NEOs and directors to continue to deliver results over a longer period of time and serve as a retention
tool. The annual salary or fee for each NEO, as applicable, is recommended by the Compensation Committee and determined by the Board
based on the level of responsibility and experience of the individual, the relative importance of the position to us, the professional
qualifications of the individual and the performance of the individual over time. The NEOs' performances and salaries or fees are
to be reviewed periodically. Increases in salary or fees are to be evaluated on an individual basis and are performance and market-based.
The amount and award of cash bonuses to key executives and senior management is discretionary, depending on, among other factors, the
financial targeted goal, employee retention and advancement within our company. The Executive Chairman and CEO make the recommendation
which is then sent to the Board for their approval. A peer group is not used to determine compensation.
Pension
Plan Benefits
The
Company does not have any pension, defined benefit, defined contribution or deferred compensation plans in place.
Long-Term
Equity Incentive Awards
The
long-term component of compensation for executive officers, including the Named Executive Officers, will be based on equity awards issued
pursuant to the Western Magnesium Corporation 2021 Equity Incentive Plan (the "2021 Equity Incentive Plan") that was approved
by our shareholders on June 11, 2021. The 2021 Equity Incentive Plan permits the grant of the following (collectively, the "Awards"):
(i) nonqualified stock options ("NQSOs") and incentive stock options ("ISOs") (collectively, "Options");
(ii) stock appreciate rights ("SARs"); (iii) restricted stock ("Restricted Stock") and restricted stock units
("RSUs"); (iv) performance awards; (v) dividend equivalents; and (vi) other stock-based awards. This component of compensation
is intended to reinforce management's commitment to long term improvements in our performance.
The
purpose of the 2021 Equity Incentive Plan is to enable us and certain of our subsidiaries to obtain and retain services of the eligible
participants, which is essential to our long-term success. The granting of Options and other Awards under the 2021 Equity Incentive Plan
is intended to promote our long-term financial interests and growth and the long-term financial interests and growth of our subsidiaries
by attracting and retaining management and other personnel and key service providers with the training, experience and ability to enable
them to make a substantial contribution to the success of our business. Moreover, the 2021 Equity Incentive Plan aims to align the interests
of eligible participants with those of our shareholders through opportunities for increased equity-based ownership in our company.
66
Outstanding
Equity Awards at 2021 Fiscal Year-End
The
following table sets forth outstanding equity awards for our named executive officers at fiscal 2021 year-end.
Option
    Awards
Name
    and Principal Position
Number
    of
Securities
Underlying
Unexercised
Options –
Exercisable (#)
Number
    of
Securities
Underlying
Unexercised
Options –
Un-exercisable (#)
Equity
                                            Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)
Option
    Exercise
Price (CAD$)
Option
    Expiration
Date
Number
    of
Shares or Units
of Stock That
Have Not
Vested (#)
Market
    Value of
Shares or Units
of Stock That
Have Not
Vested ($)
Equity
    Incentive
Plan Awards:
Number of
Unearned
Shares, Units or
Other Rights
That Have Not
Vested (#)
Sam
    Ataya
3,000,000
—
—
0.05
2023-12-03
—
—
—
Director,
2,000,000
—
—
0.12
2024-05-22
—
—
—
Executive
650,000
—
—
0.12
2025-04-23
—
—
—
President
4,500,000
—
—
0.13
2025-12-30
—
—
—
and
    CEO
5,000,000
—
—
0.70
2026-08-30
—
—
—
Edward
    Lee
250,000
—
—
0.05
2022-03-27
—
—
—
Director,
750,000
—
—
0.05
2023-08-12
—
—
—
Executive
850,000
—
—
0.05
2023-12-03
—
—
—
Chairman
    and
2,300,000
—
—
0.12
2024-05-22
—
—
—
former
    President
700,000
—
—
0.12
2025-04-23
—
—
—
and
    CEO
5,000,000
—
—
0.13
2025-12-30
—
—
—
6,000,000
—
—
0.70
2026-08-30
—
—
—
Lisa
    Maxwell
250,000
—
—
0.05
2022-03-27
—
—
—
President,
    Global
300,000
—
—
0.05
2023-12-03
—
—
—
Operations
    and
500,000
—
—
0.12
2024-05-22
—
—
—
COO
400,000
—
—
0.12
2025-04-23
—
—
—
750,000
—
—
0.13
2022-12-30
—
—
—
3,500,000
—
—
0.70
2026-08-30
—
—
—
Rabih
    Ataya
250,000
—
—
0.12
2024-05-22
—
—
—
Director
    and EVP,
250,000
—
—
0.15
2024-11-03
—
—
—
Special
    Projects
200,000
—
—
0.12
2025-04-23
—
—
—
500,000
—
—
0.13
2022-12-30
—
—
—
500,000
—
—
0.70
2026-08-30
—
—
—
Paul
    Sauvé
100,000
—
—
0.11
2025-03-26
—
—
—
EVP,
    Operations
150,000
—
—
0.12
2025-04-23
—
—
—
and
    CTO
750,000
—
—
0.13
2022-12-30
—
—
—
1,000,000
—
—
0.70
2026-08-30
—
—
—
67
Retirement
Benefit Plans
We
do not have any pension, defined benefit, defined contribution or deferred compensation plans in place.
Termination
and Change of Control Benefits
Except
as described below, we do not have any contract, agreement, plan or arrangement that provides for payments to a named executive officer
at, following or in connection with a termination (whether voluntary, involuntary or constructive), resignation, retirement, a change
of control of our company or a change in a named executive officer's responsibilities.
For
each of the foregoing agreements, the following table summarizes the estimated incremental payments that are triggered by, or result
from, change of control, severance, termination or constructive dismissal (assuming such events had occurred on or before October 31,
2021):
NEO
    or Director
Payout
    for Termination Without Cause by the Company / Change of Control
(1)
/ Good Reason
(2)
Sam
    Ataya,
Director, Executive President and CEO
$
5,000,000
Rabih
    Ataya,
EVP, Special Projects
$
90,000
Lisa
    Maxwell,
President, Global Operations and COO
$
2,000,000
Edward
    Lee,
Director and Executive Chairman
$
6,000,000
Paul
    Sauvé,
EVP, Operations and CTO
$
20,000
Notes:
(1)
Termination
    by us without cause within 12 months of a Change of Control.
(2)
Termination
    by the Executive for Good Reason within 12 months of a Change of Control.
Director
Compensation
The
following table sets forth all compensation paid to or earned by each of our directors during fiscal year 2021, except for compensation
with respect to Messrs. Sam Ataya, Lee, Rabih Ataya, and O'Rourke. Information with respect to the compensation of these current
and former directors is included above in the "2021 Summary Compensation Table" except for O'Rourke. As our executive
officers, none of these directors (other than as described above) received any compensation for service as a director during fiscal year
2021.
Fiscal
2021 Director Compensation Table
Name
Fees
                                            Earned
or
                                            Paid
in
                                            Cash
(1)
($)
Stock
Awards
($)
Option
Awards
(2)
($)
Non-Equity
Incentive
Plan
Compensation
($)
Non-qualified
Deferred
Compensation
Earnings
($)
All
                                            Other
Compensation
($)
Total
($)
Michael
                                            Pickholz
Former
                                            Director
(3)
—
—
96,904
—
—
106,320
203,224
Stephen
                                            Thorlakson
Current
                                            Director
—
—
149,291
—
—
—
149,291
Jeff
                                            Wilson
Current
                                            Director
—
—
143,885
—
—
—
143,885
Notes:
(1)
Director
    cash compensation during the fiscal year ended October 31, 2021.
68
(2)
The
    amounts reported in the Stock Awards and the Option Awards columns reflect aggregate grant date fair value computed in accordance
    with ASC Topic 718, Compensation—Stock Compensation. These amounts reflect our calculation of the value of these awards at
    the grant date and do not necessarily correspond to the actual value that may ultimately be realized by the named executive officer.
    Assumptions used in the calculation of these amounts are included in Note
14
to our audited consolidated financial statements
    for the fiscal year ended October 31, 2021, which are included elsewhere in this registration statement.
(3)
Mr.
    Pickholz was appointed as a director on October 18, 2018 and resigned on November 27, 2020. Mr. Pickholz's reported All Other
    Compensation for 2021 was consulting fees for consulting services provided and he was not separately compensated as a director.
Securities
Authorized for Issuance under Equity Compensation Plans
The
following table sets forth securities authorized for issuance under any equity compensation plans approved by our stockholders as well
as any equity compensation plans not approved by our stockholders as of October 31, 2021.
Number
                                            of securities
to
                                            be issued upon
exercise
                                            of
outstanding
                                            options,
warrant
                                            and rights
Weighted-average
exercise
                                            price of
outstanding
                                            options,
warrants
                                            and rights
Number
                                            of securities
remaining
                                            available
for
                                            future issuance
under
                                            equity
compensation
                                            plans
Plan
    Category
(#)
(CAD$)
(#)
Equity
    compensation plans approved by security holders
61,260,000
$
0.33
5,892,368
Equity
    compensation plans not approved by security holders
–
–
–
Total
61,260,000
$
0.33
5,892,368
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The
following table sets forth the beneficial ownership of our common stock as of May 16, 2022 for (i) each member of our board of directors,
(ii) each named executive officer, (iii) each person known to us to be the beneficial owner of more than 5% of our securities and (iv)
the members of our board of directors and our executive officers as a group.
Unless
otherwise noted, the business address for each of the beneficial owners is c/o Western Magnesium Corporation, 8180 Greensboro Drive,
Suite 720, McLean, Virginia, United States 22102.
Common
    Stock
Name,
    Position and Address of Beneficial Owner
No.
                                            of Shares of
Common
                                            Stock
Beneficially
                                            Owned
%
                                            of
Common
                                            Stock
(1)
Rabih
                                            Ataya
(2)
Director
                                            and EVP, Special Projects
1,700,000
0.39
%
Sam
                                            Ataya
(3)
Director,
                                            Executive President and CEO
25,082,655
5.54
%
Edward
                                            Lee
(4)
Director,
                                            Executive Chairman and former President and CEO
17,014,850
3.75
%
Lisa
                                            Maxwell
(5)
President,
                                            Global Operations and COO
5,609,000
1.27
%
Robert
                                            Ramsey Hamady
(6)
CFO
500,000
0.11
%
Peter
                                            O'Rourke
(7)
Director
                                            and President, US Operations
1,500,000
0.34
%
Paul
                                            Sauvé
(8)
EVP,
                                            Operations and CTO
2,040,837
0.46
%
Stephen
                                            Thorlakson
(9)
Director
3,249,791
0.74
%
Jeff
                                            Wilson
(10)
Director
1,650,000
0.38
%
All
    directors and executive officers as a group
58,347,133
12.12
%
Five
    Percent Shareholders:
Alpha
    Capital Anstalt
(11)
46,255,011
9.59
%
Notes:
(1)
The
    percentages in the table have been calculated on the basis of treating as outstanding for a particular person, all shares of our
    capital stock outstanding on May 16, 2022. On May 16, 2022, there were 437,926,611 shares of our common stock outstanding. To calculate
    a stockholder's percentage of beneficial ownership, we include in the denominator the common stock outstanding and all shares
    of our common stock issuable to that person in the event of the exercise of outstanding options, warrants and other derivative securities
    owned by that person which are exercisable within 60 days of May 16, 2022. Common stock warrants and derivative securities held by
    other stockholders are disregarded in this calculation. Therefore, the denominator used in calculating beneficial ownership among
    our stockholders may differ. Unless we have indicated otherwise, each person named in the table has sole voting power and sole investment
    power for the shares listed opposite such person's name.
69
(2)
Includes
    the following: (i) no shares of common stock, (ii) 450,000 options to purchase common stock at an exercise price of CAD$0.12 per
    share, (iii) 250,000 options to purchase common stock at an exercise price of CAD$0.15 per share, (iv) 500,000 options to purchase
    common stock at an exercise price of CAD$0.13 per share, and (v) 500,000 options to purchase common stock at an exercise of CAD$0.70
    per share. The stock options fully vested upon award.
(3)
Includes
    the following: (i) 769,230 shares of common stock, (ii) 9,163,425 shares of common stock issued to a company where Mr. Ataya is principal,
    (iii) 3,000,000 options to purchase common stock at an exercise price of CAD$0.05 per share, (iv) 2,650,000 options to purchase common
    stock at an exercise price of CAD$0.12 per share, (v) 4,500,000 options to purchase common stock at an exercise price of CAD$0.13
    per share, and (vi) 5,000,000 options to purchase common stock at an exercise of CAD$0.70 per share. The stock options fully vested
    upon award.
(4)
Includes
    the following: (i) 1,414,850 shares of common stock, (ii) 1,600,000 options to purchase common stock at an exercise price of CAD$0.05
    per share, (iii) 3,000,000 options to purchase common stock at an exercise price of CAD$0.12 per share, (iv) 5,000,000 options to
    purchase common stock at an exercise price of CAD$0.13 per share and (v) 6,000,000 options to purchase common stock at an exercise
    price of CAD$0.70 per share. The stock options fully vested upon award.
(5)
Includes
    the following: (i) 159,000 shares of common stock, (ii) 300,000 options to purchase common stock at an exercise price of CAD$0.05
    per share, (iii) 900,000 options to purchase common stock at an exercise price of CAD$0.12 per share, (iv) 750,000 options to purchase
    common stock at an exercise price of CAD$0.13 per share, and (v) 3,500,000 options to purchase common stock at an exercise price
    of CAD$0.70 per share. The stock options fully vested upon award.
(6)
Includes
    the following: (i) no shares of common stock, and (ii) 500,000 options to purchase common stock at an exercise price of CAD$0.40
    per share. The stock options fully vested upon award.
(7)
Includes
    the following: (i) 500,000 shares of common stock, (ii) 500,000 options to purchase common stock at an exercise price of CAD$0.13
    per share, and (iii) 500,000 options to purchase common stock at an exercise price of CAD$0.70 per share. The stock options fully
    vested upon award.
(8)
Includes
    the following: (i) 40,837 shares of common stock, (ii) 100,000 options to purchase common stock at an exercise price of CAD$0.11
    per share, (iii) 150,000 options to purchase common stock at an exercise price of CAD$0.15 per share, (iv) 750,000 options to purchase
    common stock at an exercise price of CAD$0.13 per share, and (v) 1,000,000 options to purchase common stock at an exercise price
    of CAD$0.70 per share. The stock options fully vested upon award.
(9)
Includes
    the following: (i) 2,249,791 shares of common stock, (ii) 400,000 options to purchase common stock at an exercise price of CAD$0.12
    per share, (iii) 300,000 options to purchase common stock at an exercise price of CAD$0.13 per share, and (iv) 300,000 options to
    purchase common stock at an exercise price of CAD$0.70 per share. The stock options fully vested upon award.
(10)
Includes
    the following: (i) 550,000 shares of common stock, (ii) 250,000 options to purchase common stock at an exercise price of CAD$0.05
    per share, (iii) 350,000 options to purchase common stock at an exercise price of CAD$0.12 per share, (iv) 200,000 options to purchase
    common stock at an exercise price of CAD$0.13 per share, and (v) 300,000 options to purchase common stock at an exercise price of
    CAD$0.70 per share. The stock options fully vested upon award.
70
(11)
Includes
    the following: (i) 1,774,500 shares of common stock held and 9,000,000 shares of common stock issuable upon conversion of a 12% convertible
    note in the original principal amount of $1,500,000 issued on June 15, 2021 with a current principal balance of $900,000 plus
    accrued interest of $207,222 (the "June 2021 Convertible Debenture"), (ii) 3,000,000 Class A Warrants held and 5,536,110
    Class A Warrants issuable upon conversion of the June 2021 Convertible Debenture to purchase common stock at an exercise price
    of $0.13 until June 10, 2026, (iii) 3,000,000 Class B Warrants held and 5,536,110 Class B Warrants issuable upon conversion
    of the June 2021 Convertible Debenture to purchase common stock at an exercise price of $0.19 until June 10, 2026, (iv) 8,168,037
    shares of common stock issuable upon conversion of a 15% convertible note in the original principal amount of $2,000,000 plus
    accrued interest of $450,411 issued on April 14, 2022 (the "April 2022 Convertible Debenture"), and (v) 8,168,037
    warrants issuable upon conversion of the April 2022 Convertible Debenture to purchase common stock at an exercise price of $0.40
    for a period of five years after the date of issuance.   The address for Alpha Capital Anstalt is Altenbach 8, FL-9490
    Vaduz, Liechtenstein. The Debentures and Warrants are subject to a beneficial ownership transaction which restrict Alpha Capital
    Anstalt's ability to convert any portion of the Convertible Debentures or exercise the Warrants if it would result in Alpha
    Capital Anstalt owning in excess of 9.99% of the outstanding shares of the Company's common stock.
CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
In
addition to the compensation arrangements, including employment, termination of employment and change in control arrangements and indemnification
arrangements, discussed in "Executive Compensation" above, the following is a description of each transaction since November
1, 2020 and each currently proposed transaction in which:
●
We
    have been or will be a participant;
●
the
    amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed
    fiscal years; and
●
any
    of our directors, executive officers or beneficial owners of more than 5% of our capital stock, or any immediate family member of,
    or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest.
Related
parties include any person who is or was (since the beginning of the last fiscal year, even if such person does not presently serve in
that role) our executive officer or director, any shareholder owning more than 5% of any class of our voting securities or an immediate
family member of any such person.
Any
potential related party transaction that requires approval will be reviewed and overseen by the Audit Committee, and the Audit Committee
will consider such factors as it deems appropriate to determine whether to approve, ratify or disapprove the related party transaction.
The Audit Committee may approve the related party transaction only if it determines in good faith that, under all of the circumstances,
the transaction is in the best interests of us and our shareholders.
Transactions
with Related Parties
(1)
Sam Ataya
Mr.
Ataya is a director, Executive President and Chief Executive Officer of the Company. Mr. Ataya is also principal of The Stirling Group
("Stirling"). Stirling is a consulting company that provides us with management and operational services and has been involved
in facilitating payment of expenses related to the ongoing construction of our planned magnesium research and development pilot plant
and to obtain necessary permits and authorizations to construct and operate the facility.
During
the fiscal year ending October 31, 2021, we provided advances to Stirling on our behalf for anticipated future costs related to our planned
magnesium research and development pilot plant and other administrative expenses (the "Pilot Plant Advances"). During the
fiscal year ended October 31, 2021, we advanced Stirling the aggregate amount of $987,912, of which Stirling used $696,431 for costs
and expenses leaving a balance of $291,481 as of October 31, 2021. During the three months ended January 31, 2022, we advanced Stirling
the aggregate amount of $300,000 related to Pilot Plant Advances, of which Stirling used $79,793 for costs and expenses, including a
foreign exchange effect of $13,193, leaving a balance of $524,881 as of January 31, 2022.
The
Company has entered into a sublease agreement with Stirling for our Canadian office at 580 Hornby Street, Suite 900, Vancouver, British
Columbia, Canada V6C 3B6. The lease had a two-year term from April 1, 2019 to March 31, 2021 and required a monthly payment of CAD$9,345
for a total of CAD$224,280. The sublease agreement has been renewed for another two-year term from April 1, 2021 to March 31, 2023 and
requires a monthly payment of CAD$9,794 for a total of CAD$235,056.
71
Pursuant
to an agreement entered on August 29, 2018 between the Company and Stirling, and which was approved by the TSXV on September 12, 2018,
Stirling is eligible to receive up to 5% of the issued and outstanding common shares of the Company as at August 28, 2018 for up to $5
million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued 9,163,425
common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614) as share issue costs.
During
the fiscal year ended October 31, 2019, the Company received an unsecured loan of CAD$150,000 (USD equivalent $112,895) from Mr. Ataya.
The loan bore interest at 18% and was due on demand. During the fiscal year ended October 31, 2020, the loan was increased by an additional
CAD$60,000 (USD equivalent $44,588) to CAD$210,000 (USD equivalent $157,483) and was due on September 24, 2021. During the fiscal year
ended October 31, 2021, we have repaid the entire principal balance and all interests accrued in the amount of CAD$26,724 (USD equivalent
$19,944).
(2)
Lisa Maxwell
Ms.
Maxwell is President, Global Operations and COO of the Company. Ms. Maxwell is also principal of Sequoia Corporate Services Inc. ("Sequoia").
Sequoia is a consulting company that provides us with management and operational services and has been involved in facilitating payment
of expenses related to the ongoing construction of our planned magnesium research and development pilot plant and to obtain necessary
permits and authorizations to construct and operate the facility.
During
the current fiscal year ending October 31, 2021, we provided Pilot Plant Advances to Sequoia. During the fiscal year ended October 31,
2021, we advanced Sequoia the aggregate amount of $2,292,912, of which Sequoia used $2,097,931 of such advances for costs and expenses
leaving a balance of $194,981 as of October 31, 2021. During the three months ended January 31, 2022, we advanced Sequoia the aggregate
amount of $522,335 related to Pilot Plant Advances, of which Sequoia used $675,390 for costs and expenses, including a negative foreign
exchange effect of $1,066, leaving a balance of $40,860 as of January 31, 2022.
Director
Independence
For
a description of director independence of our board members, see "Management – Director Independence" on page 59
of this prospectus.
DESCRIPTION
OF SECURITIES
The
following is a description of our capital stock and the material provisions of our certificate of incorporation, our amended and restated
certificate of incorporation, bylaws (as amended) and other agreements to which we and our shareholders are parties, in each case as
of the date of this prospectus.
General
Our
authorized capital stock consists of 1,000,000,000 shares of common stock, par value $0.001 per share. As of the date of this prospectus,
there were 437,926,611 shares of our common stock issued and outstanding held of record by 678 stockholders.   At our June
11, 2021 annual and special meeting of shareholders, our shareholders approved a special resolution authorizing us to amend and restate
our Certificate of Incorporation, to include (a) an amendment for the purpose of authorizing up to 100,000,000 shares of undesignated
preferred stock, and (b) certain other corporate maintenance matters (the "Amended and Restated Certificate of Incorporation").
We filed the Amended and Restated Certificate of Incorporation on May 13, 2022. Any designation of preferences and rights of the preferred
stock requires the TSXV's approval. Following TSXV approval, our board of directors may from time to time authorize by resolution
the issuance of any or all shares of our common stock or preferred stock authorized in accordance with the terms and conditions set forth
in the amended and restated certificate of incorporation for such purposes, in such amounts, to such persons, corporations, or entities,
for such consideration and in the case of the preferred stock, in one or more series, all as our board of directors in its discretion
may determine and without any vote or other action by the stockholders, except as otherwise required by law.
A
description of the material terms and provisions of our certificate of incorporation affecting the rights of holders of our capital stock
is set forth below. The description is intended as a summary only.
Common
Stock
Voting
.
The holders of our common stock are entitled to one vote for each outstanding share of common stock owned by that stockholder on
every matter properly submitted to the stockholders for their vote. Stockholders are not entitled to vote cumulatively for the election
of directors. Except for the election of directors, which are elected by a plurality vote, a majority vote of common stockholders is
generally required to take action under our certificate of incorporation and bylaws, as amended.
72
Conversion,
Redemption and Preemptive Rights
. Holders of our common stock have no conversion, redemption, preemptive, subscription or similar
rights.
Dividend
Rights
. Subject to the rights of holders of preferred stock, holders of our common stock shall be entitled to receive such cash
dividends as may be declared thereon by our board of directors from time to time out of assets of funds of our company legally available
for the payment of dividends.
Preferred
Stock
The
Amended and Restated Certificate of Incorporation
authorizes to issue up to 100,000,000 shares of preferred stock. Subject to TSXV approval, our board of directors
will have the authority to issue this preferred stock in one or more series and to fix the number of shares and the relative rights,
conversion rights, voting rights and terms of redemption (including sinking fund provisions) and liquidation preferences, without further
vote or action by the stockholders. If shares of preferred stock with voting rights are issued, such issuance could affect the voting
rights of the holders of our common stock by increasing the number of outstanding shares having voting rights, and by the creation of
class or series voting rights. If our board of directors authorized the issuance of shares of preferred stock with conversion rights,
the number of shares of common stock outstanding could potentially be increased by up to the authorized amount. Issuance of preferred
stock could, under certain circumstances, have the effect of delaying or preventing a change in control of our company and may adversely
affect the rights of the holders of our common stock. Also, preferred stock could have preferences over our common stock (and other series
of preferred stock) with respect to dividend and liquidation rights. We currently have no plans to issue any preferred stock.
Warrants
In
conjunction with a private offering of securities between February 22, 2017 and May 10, 2017, we issued 13,051,460 warrants with an exercise
price of CAD$0.05 per share. These warrants are exercisable for a period of five years after the date of issuance. In connection with
this transaction, we issued 263,626 broker's warrants with an exercise price of CAD$0.05 per share for a period of five years.
As of the date of this prospectus, 11,686,260 warrants were exercised and 1,365,200 warrants were expired unexercised, and 209,901 broker
warrants were exercised and 53,725 broker warrants were expired unexercised. The warrants were subject to an acceleration clause in the
years three, four and five whereby the Company had the right, upon provision of thirty days' written notice, to require a holder
to exercise the warrants within 30 days should the closing price of our common stock exceeds the exercise price of the warrants by 25%
of more for at least ten consecutive trading days.
In
conjunction with a private offering of securities on August 15, 2017, we issued 1,570,000 warrants with an exercise price of CAD$0.05
per share. These warrants are exercisable for a period of five years after the date of issuance. As of the date of this prospectus, all
of these warrants were exercised. The warrants were subject to an acceleration clause in the years three, four and five whereby the Company
had the right, upon provision of thirty days' written notice, to require a holder to exercise the warrants within 30 days should
the closing price of our common stock exceeds CAD$0.0625 per share for at least ten consecutive trading days.
In
conjunction with a private offering of securities on January 20, 2020, we issued 3,643,791 warrants with an exercise price of CAD$0.21
per share. These warrants are exercisable for a period of one year after the date of issuance. Subsequent to October 31, 2020, we extended
the expiration date of the warrants to August 31, 2021. As of the date of this prospectus, 3,118,618 warrants were exercised and 525,173
warrants were expired unexercised.
In
conjunction with a private offering of securities between November 20, 2020 and April 27, 2021, we issued 25,787,255 warrants with an
exercise price of CAD$0.19 per share. These warrants are exercisable for a period of one year after the date of issuance. As of the date
of this prospectus, 21,469,859 warrants were exercised and 4,317,396 warrants were expired unexercised.
In
conjunction with a private offering of securities between May 28, 2021 and June 17, 2021, we issued 23,076,926 warrants with an exercise
price of CAD$0.19 per share. These warrants are exercisable for a period of one year after the date of issuance. As of the date of this
prospectus, 20,724,364 of these warrants are outstanding.
In
conjunction with a private offering of securities on July 16, 2021, we issued 4,350,000 warrants with an exercise price of CAD$0.30 per
share. These warrants are exercisable for a period of one year after the date of issuance. As of the date of this prospectus, 4,289,040
of these warrants are outstanding.
In
conjunction with a private offering of securities on August 11, 2021, we issued 3,827,601 warrants with an exercise price of CAD$0.65
(USD$0.52) per share. These warrants are exercisable for a period of eighteen months after the date of issuance. As of the date of this
prospectus, 3,827,601 of these warrants are outstanding.
73
In
conjunction with a private offering of securities on November 26, 2021, we issued 1,375,499 warrants with an exercise price of $0.75
per share. These warrants are exercisable for a period of one year after the date of issuance. As of the date of this prospectus, 1,375,499
of these warrants are outstanding.
In
conjunction with partial conversions of the June 2021 Convertible Debenture between November 3, 2021 and April 27, 2022, we issued 3,000,000
Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 3,000,000 Class B Warrants exercisable at a price of $0.19
until June 10, 2026.
In
conjunction with conversion of the July 2021 Convertible Debenture on April 22, 2022, we issued 933,333 warrants with an exercise price
of CAD$0.20 per share. These warrants are exercisable for a period of two years after the date of issuance.
In
conjunction with a private offering of securities on May 9, 2022, we issued 1,727,000 warrants with an exercise price of $0.45 per share.
These warrants are exercisable for a period of one year after the date of issuance. As of the date of this prospectus, 1,727,000 of these
warrants are outstanding.
Provisions
of our Amended and Restated Certificate of Incorporation that May Have an Anti-Takeover Effect
Other
than our authorized but unissued common stock and "blank-check" preferred stock following the filing of the Amended and Restated
Certificate of Incorporation available for future issuance without stockholder approval, as described under "Common Stock"
and "Preferred Stock" above, our certificate of incorporation does not contain any provisions that may be deemed to have
an anti-takeover effect or may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider to be in
its best interests, including attempts that might result in a premium being paid over the market price for the shares held by stockholders.
Delaware
Takeover Statute
In
general, Section 203 of the Delaware General Corporation Law prohibits a Delaware corporation that is a public company from engaging
in any "business combination" (as defined below) with any "interested stockholder" (defined generally as an entity
or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with
such entity or person) for a period of three years following the date that such stockholder became an interested stockholder, unless:
(1) prior to such date, our board of directors of the corporation approved either the business combination or the transaction that resulted
in the stockholder becoming an interested stockholder; (2) on consummation of the transaction that resulted in the stockholder becoming
an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time
the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned (x) by persons who
are directors and also officers and (y) by employee stock plans in which employee participants do not have the right to determine confidentially
whether shares held subject to the plan will be tendered in a tender or exchange offer; or (3) on or subsequent to such date, the business
combination is approved by our board of directors and authorized at an annual or special meeting of stockholders, and not by written
consent, by the affirmative vote of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder.
Section
203 of the Delaware General Corporation Law defines "business combination" to include: (1) any merger or consolidation involving
the corporation and the interested stockholder; (2) any sale, transfer, pledge or other disposition of 10% or more of the assets of the
corporation involving the interested stockholder; (3) subject to certain exceptions, any transaction that results in the issuance or
transfer by the corporation of any stock of the corporation to the interested stockholder; (4) any transaction involving the corporation
that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by
the interested stockholder; or (5) the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges
or other financial benefits provided by or through the corporation.
Potential
for Anti-Takeover Effects
While
certain provisions of Delaware law may have an anti-takeover effect, these provisions are intended to enhance the likelihood of continuity
and stability in the composition of our board of directors and in the policies formulated by the board, and to discourage certain types
of transactions that may involve an actual or threatened change of control. In that regard, these provisions are designed to reduce our
vulnerability to an unsolicited acquisition proposal. The provisions also are intended to discourage certain tactics that may be used
in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and,
as a consequence, they also may inhibit fluctuations in the market price of our common stock that could result from actual or rumored
takeover attempts. Such provisions also may have the effect of preventing changes in our management.
74
Choice
of Forum
Our
bylaws, as amended, provide that the Court of Chancery of the State of Delaware will be the exclusive forum for any derivative action
or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising
under the Delaware General Corporation Law, our certificate of incorporation or our bylaws, as amended; any action to interpret, apply,
enforce or determine the validity of our certificate of incorporation or our bylaws, as amended; and any action asserting a claim against
us that is governed by the internal affairs doctrine.
These
exclusive forum provisions may limit a stockholder's ability to bring certain claims in a judicial forum that it finds favorable
for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors,
officers and other employees. Alternatively, if a court were to find either exclusive forum provision in our bylaws, as amended, to be
inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving such action in
other jurisdictions, all of which could have a material adverse effect on our business, financial condition, and results of operations.
These
exclusive forum provisions will not apply, however, to actions arising under the Securities Act or the Exchange Act.
Transfer
Agent and Registrar
The
transfer agent for our shares of common stock is Odyssey Trust Company, United Kingdom Building, 409 Granville Street, Suite 350, Vancouver,
British Columbia, Canada.
SELLING
SECURITYHOLDER
The
Selling Securityholder may offer and sell, from time to time, any or all of the shares of our common stock underlying the Convertible
Debentures and Warrants and all the shares of our common stock registered for resale covered by this prospectus.
Selling
Securityholder is offering for resale the issuance of 19,240,256 shares of our common stock underlying the Convertible Debentures,
which entitle the holder to convert the principal and interest under the Convertible Debentures at a price of $0.10 per share for $900,000
principal amount convertible debentures and $0.30 per share for a $2,000,000 principal amount convertible debenture, (ii) the issuance
by the Company of an aggregate of 25,240,256 shares of our common stock underlying the Warrants, which entitle the holder to purchase
one share of our common stock at an exercise price of $0.13 per share for 8,536,110 warrants, $0.19 per share for 8,536,110
warrants and $0.40 per share for 8,168,037 warrants and 1,774,500 shares of Common Stock which we issued to the Selling Securityholder
upon the partial exercise of the Convertible Debentures, are being registered by the registration statement of which this prospectus
forms a part pursuant to registration rights granted to the Selling Securityholder in connection with the issuances of such Convertible
Debentures and Warrants. See the section entitled "Plan of Distribution" for further information regarding the Selling Securityholder'
method of distributing these securities. For purposes of this prospectus, we have assumed a conversion price of the Convertible Debentures
of $0.10 per share for principal amount $900,000 and $0.30 per share of our common stock for $2,000,000 principal amount. For purposes
of this prospectus, we have assumed an exercise price of the Warrants of $0.13 per share of our common stock for 8,536,110 warrants,
$0.19 per share of our common stock for 8,536,110 warrants and $0.40 per share of our common stock for 8,168,037 warrants.
The
following table provides, as of May 16, 2022, information regarding the beneficial ownership of our common stock, Warrants and Convertible
Debentures held by the Selling Securityholder, the securities that may be sold by the Selling Securityholder under this prospectus and
the number and percentage of securities that the Selling Securityholder will beneficially own after this offering. Applicable percentages
are based on 19,240,256 shares of our common stock underlying the Convertible Debentures, 25,240,256 shares of our common
stock underlying the Warrants as of May 16, 2022 and 1,774,500 shares of our Common Stock held which we issued to the Selling Securityholder
upon the partial exercise of the Convertible Debentures.
The
Selling Securityholder is not making any representation that any shares of our common stock covered by this prospectus will be offered
for sale. Because the Selling Securityholder may dispose of all, none or some portion of their securities, no estimate can be given as
to the number of securities that will be beneficially owned by a Selling Securityholder upon termination of this offering. For purposes
of the table below, however, we have assumed that after termination of this offering none of the securities covered by this prospectus
will be beneficially owned by the Selling Securityholder and further assumed that the Selling Securityholder will not acquire beneficial
ownership of any additional securities during the offering. In addition, the Selling Securityholder may have sold, transferred or otherwise
disposed of, or may sell, transfer or otherwise dispose of, at any time and from time to time, our securities in transactions exempt
from the registration requirements of the Securities Act after the date on which the information in the table is presented.
We
may amend or supplement this prospectus from time to time in the future to update or change this Selling Securityholder list and the
securities that may be resold.
75
See
the section entitled "Plan of Distribution" for further information regarding the stockholders' method of distributing
these shares.
Number
    of Shares of Common Stock Beneficially Owned Prior to Offering
Maximum
    Number of Common Stock to be Offered Pursuant to this
Number
    of Shares of Common Stock Beneficially Owned after Offering
Name
    of Selling Stockholder
Number
    (1)
Percent
    (2)
Prospectus
    (3)
Number
Percent
    (2)
Alpha
    Capital Anstalt (4)
46,255,011
9.59
%
46,255,011
0
0
%
(1)
The
    amounts and percentages of our common stock beneficially owned are determined in accordance with the SEC's rules, pursuant
    to which a person is deemed to be a "beneficial owner" of a security if that person has or shares voting or investment
    power or has the right to acquire such power within 60 days through exercise of any option, warrant or other right. Securities that
    can be so acquired are deemed to be outstanding for purposes of computing such person's ownership percentage, but not for purposes
    of computing any other person's percentage. Under these rules, more than one person may be deemed beneficial owner of the same
    securities, and a person may be deemed to be a beneficial owner of securities as to which such person has no economic interest. Except
    as otherwise indicated in these footnotes, each of the beneficial owners has, to our knowledge, sole voting and investment power
    with respect to the indicated shares of our common stock.
(2)
Based
    on 437,926,611 shares of common stock issued and outstanding as of May 16, 2022.
(3)
The
    shares of our common stock shown in this column includes shares of our common stock that are offered for resale by the Selling Securityholder
    pursuant to this prospectus.
(4)
The
    number of shares of our common stock beneficially owned by Alpha Capital Anstalt ("Alpha Capital") includes (a) 1,774,500
    shares of our common stock held, (b) 19,240,256 shares of our common stock issuable upon conversion of Convertible Debentures
    held by Alpha Capital, which Convertible Debentures are subject to, as applicable, certain beneficial ownership limitations, which
    provide that a holder of such Convertible Debentures will not have the right to convert any portion thereof if such holder, together
    with its affiliates, would beneficially own in excess of 9.99%, of the number of shares of our common stock outstanding immediately
    after giving effect to such conversion, provided that upon at least 61 days' prior notice to us, such holder may increase or
    decrease such limitation, and (c) 25,240,256 shares of our common stock issuable upon exercise of the Warrants held by Alpha
    Capital, which Warrants are subject to, as applicable, certain beneficial ownership limitations, which provide that a holder of such
    warrants will not have the right to exercise any portion thereof if such holder, together with its affiliates, would beneficially
    own in excess of 9.99% of the number of shares of our common stock outstanding immediately after giving effect to such exercise,
    provided that upon at least 61 days' prior notice to us, such holder may increase or decrease such limitation. Alpha Capital
    is the record and beneficial owner of the securities set forth in the table. Konrad Ackerman, a Director of Alpha Capital has
voting
    control and investment discretion over the securities reported herein that are held by
Alpha Capital. The address of Alpha
    Capital is
Altenbach 8, FL-9490 Vaduz, Liechtenstein.
PLAN
OF DISTRIBUTION
We
are registering the shares of our common stock that may be issued upon conversion of the Convertible Debentures issued pursuant to the
2021 SPA and the 2022 SPA and upon exercise of the Warrants issued pursuant to the terms of the 2021 SPA and the 2022 SPA to permit the
resale of these shares of our common stock by the holders of such shares and Warrants from time to time after the date of this prospectus.
We will not receive any of the proceeds from the sale by the Selling Securityholder of the shares of our common stock. We will bear all
fees and expenses incident to our obligation to register the shares of our common stock.
The
Selling Securityholder may sell all or a portion of the shares of our common stock it beneficially owns and offered hereby from time
to time directly or through one or more underwriters, broker-dealers or agents. If the shares of our common stock are sold through underwriters
or broker-dealers, the Selling Securityholder will be responsible for underwriting discounts or commissions or agent's commissions.
The shares of our common stock may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the
sale, at varying prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions, which may
involve crosses or block transactions, pursuant to one or more of the following methods:
●
on
    any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;
●
in
    the over-the-counter market;
●
in
    transactions otherwise than on these exchanges or systems or in the over-the-counter market;
●
through
    the writing of options, whether such options are listed on an options exchange or otherwise;
76
●
ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;
●
block
    trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as
    principal to facilitate the transaction;
●
purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;
●
an
    exchange distribution in accordance with the rules of the applicable exchange;
●
privately
    negotiated transactions;
●
short
    sales effected after the effective date of this Registration Statement;
●
sales
    pursuant to Rule 144;
●
broker-dealers
    may agree with the selling securityholder to sell a specified number of such shares at a stipulated price per share;
●
a
    combination of any such methods of sale; and
●
any
    other method permitted pursuant to applicable law.
If
the Selling Securityholder effects such transactions by selling shares of our common stock to or through underwriters, broker-dealers
or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from
the Selling Securityholder or commissions from purchasers of the shares of our common stock for whom they may act as agent or to whom
they may sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be
in excess of those customary in the types of transactions involved). In connection with sales of the shares of our common stock or otherwise,
the Selling Securityholder may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares
of our common stock in the course of hedging in positions they assume. The Selling Securityholder may also sell shares of our common
stock short and deliver shares of our common stock covered by this prospectus to close out short positions and to return borrowed shares
in connection with such short sales. The Selling Securityholder may also loan or pledge shares of our common stock to broker-dealers
that in turn may sell such shares.
The
Selling Securityholder may pledge or grant a security interest in some or all of the shares of our common stock, Convertible Debentures
or Warrants owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer
and sell the shares of our common stock from time to time pursuant to this prospectus or any amendment to this prospectus under Rule
424(b)(3) or other applicable provision of the Securities Act of 1933, as amended, amending, if necessary, the list of Selling Securityholder
to include the pledgee, transferee or other successors in interest as Selling Securityholder under this prospectus. The Selling Securityholder
also may transfer and donate the shares of our common stock in other circumstances in which case the transferees, donees, pledgees or
other successors in interest will be the selling beneficial owners for purposes of this prospectus.
The
Selling Securityholder and any broker-dealer participating in the distribution of the shares of our common stock may be deemed to be
"underwriters" within the meaning of the Securities Act, and any commission paid, or any discounts or concessions allowed
to, any such broker-dealer may be deemed to be underwriting commissions or discounts under the Securities Act. At the time a particular
offering of the shares of our common stock is made, a prospectus supplement, if required, will be distributed which will set forth the
aggregate amount of shares of our common stock being offered and the terms of the offering, including the name or names of any broker-dealers
or agents, any discounts, commissions and other terms constituting compensation from the Selling Securityholder and any discounts, commissions
or concessions allowed or re-allowed or paid to broker-dealers.
Under
the securities laws of some states, the shares of our common stock may be sold in such states only through registered or licensed brokers
or dealers. In addition, in some states the shares of our common stock may not be sold unless such shares have been registered or qualified
for sale in such state or an exemption from registration or qualification is available and is complied with.
There
can be no assurance that any selling stockholder will sell any or all of the shares of our common stock registered pursuant to the registration
statement, of which this prospectus forms a part.
The
Selling Securityholder and any other person participating in such distribution will be subject to applicable provisions of the Exchange
Act and the rules and regulations thereunder, including, without limitation, Regulation M of the Exchange Act, which may limit the timing
of purchases and sales of any of the shares of our common stock by the Selling Securityholder and any other participating person. Regulation
M may also restrict the ability of any person engaged in the distribution of the shares of our common stock to engage in market-making
activities with respect to the shares of our common stock. All of the foregoing may affect the marketability of the shares of our common
stock and the ability of any person or entity to engage in market-making activities with respect to the shares of our common stock.
77
We
will pay all expenses of the registration of the shares of our common stock pursuant to the Registration Rights Agreement, estimated
to be $42,179 in total, including, without limitation, SEC filing fees and expenses of compliance with state securities or "blue
sky" laws; provided, however, that a selling stockholder will pay all underwriting discounts and selling commissions, if any. We
will indemnify the Selling Securityholder against liabilities, including some liabilities under the Securities Act, in accordance with
the Registration Rights Agreement, or the Selling Securityholder will be entitled to contribution. We may be indemnified by the Selling
Securityholder against civil liabilities, including liabilities under the Securities Act, that may arise from any written information
furnished to us by the selling stockholder specifically for use in this prospectus, in accordance with the Registration Rights Agreement,
or we may be entitled to contribution.
Once
sold under the registration statement, of which this prospectus forms a part, the shares of our common stock will be freely tradable
in the hands of persons other than our affiliates.
SHARES
ELIGIBLE FOR FUTURE SALE
We
cannot predict the effect, if any, that market sales of shares of our common stock or the availability of shares of our common stock
for sale will have on the market price of our common stock prevailing from time to time. Future sales of our common stock in the public
market, or the availability of such shares for sale in the public market, could adversely affect market prices prevailing from time to
time. The availability for sale of a substantial number of shares of our common stock acquired through the exercise of outstanding warrants
could materially adversely affect the market price of our common stock. In addition, sales of our common stock in the public market after
the restrictions lapse as described below, or the perception that those sales may occur, could cause the prevailing market price to decrease
or to be lower than it might be in the absence of those sales or perceptions.
Sale
of Restricted Shares
As
of May 16, 2022, there were 437,926,611 shares of common stock issued and outstanding. Of the approximately 437,926,611 shares of our
common stock outstanding as of May 16, 2022, approximately 302,627,434 shares are tradable without restriction. These remaining shares
are "restricted securities" within the meaning of Rule 144 under the Securities Act.
Rule
144
In
general, under Rule 144, as currently in effect, a person (or persons whose shares are required to be aggregated), including a person
who may be deemed an "affiliate" of a company, who has beneficially owned restricted securities for at least six months may
sell, within any three-month period, a number of shares that does not exceed the greater of: (1) 1% of the then-outstanding shares of
common stock, or (2) if and when the common stock is listed on a national securities exchange, the average weekly trading volume of the
common stock during the four calendar weeks preceding the date on which notice of such sale was filed under Rule 144. Sales under Rule
144 are also subject to certain requirements as to the manner of sale, notice, and availability of current public information about our
company. A person who is not deemed to have been an affiliate of us at any time during the 90 days preceding a sale by such person, and
who has beneficially owned the restricted shares for at least one year, is entitled to sell such shares under Rule 144 without regard
to any of the restrictions described above.
We
cannot estimate the number of shares of our common stock that our existing stockholders will elect to sell under Rule 144.
Transfer
Agent
The
transfer agent for our shares of common stock is Odyssey Trust Company, United Kingdom Building, 409 Granville Street, Suite 350, Vancouver,
British Columbia, Canada.
MATERIAL
UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
The
following is a discussion of the material U.S. federal income tax considerations generally applicable to the acquisition, ownership and
disposition of our common stock and warrants. This discussion is limited to certain U.S. federal income tax considerations to beneficial
owners of our securities who hold the securities as a capital asset within the meaning of Section 1221 of the U.S. Internal Revenue Code
of 1986, as amended (the "Code"). This discussion does not describe all of the tax consequences that may be relevant to you
in light of your particular circumstances, including the alternative minimum tax, the Medicare contribution tax on certain investment
income and the different consequences that may apply if you are subject to special rules that apply to certain types of investors, such
as:
●
financial
    institutions or financial services entities;
●
broker-dealers;
●
insurance
    companies;
78
●
governments
    or agencies or instrumentalities thereof;
●
regulated
    investment companies;
●
real
    estate investment trusts;
●
expatriates
    or former long-term residents of the United States;
●
persons
    that actually or constructively own five percent or more of our voting shares;
●
persons
    that acquired our securities pursuant to an exercise of employee share options, in connection with employee share incentive plans
    or otherwise as compensation;
●
dealers
    or traders subject to a mark to market method of accounting with respect to the securities;
●
persons
    holding the securities as part of a "straddle," hedge, constructive sale, conversion or other integrated or similar transaction;
●
U.S.
    holders (as defined below) whose functional currency is not the U.S. dollar;
●
partnerships
    or other pass through entities for U.S. federal income tax purposes; and
●
tax
    exempt entities.
If
you are a partnership for U.S. federal income tax purposes, the U.S. federal income tax treatment of your partners will generally depend
on the status of the partners and your activities.
This
discussion is based on the Code and administrative pronouncements, judicial decisions and final, temporary and proposed Treasury regulations
as of the date hereof, changes to any of which subsequent to the date of this prospectus may affect the tax consequences described herein.
This discussion does not address any aspect of state, local or non-U.S. taxation, or any U.S. tax law other than the U.S. federal income
tax (such as gift, estate or Medicare contribution taxes) or except as discussed below, any tax reporting obligations of a holder of
our securities. This discussion also assumes that any distribution made (or deemed made on our securities and any consideration received
(or deemed received) by a holder from the sale or other disposition of our securities will be in U.S. dollars.
We
have not sought, and will not seek, a ruling from the Internal Revenue Service (the "IRS") as to any U.S. federal income
tax consequence described herein. The IRS may disagree with the discussion herein, and its determination may be upheld by a court. Moreover,
there can be no assurance that future legislation, regulations, administrative rulings or court decisions will not adversely affect the
accuracy of the statements in this discussion.
THIS
DISCUSSION IS ONLY A SUMMARY OF THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR SECURITIES.
EACH PROSPECTIVE INVESTOR IN OUR SECURITIES IS URGED TO CONSULT ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO
SUCH INVESTOR OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR SECURITIES, INCLUDING THE APPLICABILITY AND EFFECT OF ANY STATE, LOCAL,
AND NON-U.S. TAX LAWS, AS WELL AS U.S. FEDERAL TAX LAWS AND ANY APPLICABLE TAX TREATIES.
Personal
Holding Company Status
We
could be subject to a second level of U.S. federal income tax on a portion of our income if we are determined to be a personal holding
company, or PHC, for U.S. federal income tax purposes. A U.S. corporation generally will be classified as a PHC for U.S. federal income
tax purposes in a given taxable year if (i) at any time during the last half of such taxable year, five or fewer individuals (without
regard to their citizenship or residency and including as individuals for this purpose certain entities such as certain tax-exempt organizations,
pension funds and charitable trusts) own or are deemed to own (pursuant to certain constructive ownership rules) more than 50% of the
stock of the corporation by value and (ii) at least 60% of the corporation's adjusted ordinary gross income, as determined for
U.S. federal income tax purposes, for such taxable year consists of PHC income (which includes, among other things, dividends, interest,
certain royalties, annuities and, under certain circumstances, rents).
Depending
on the date and size of our transactions, at least 60% of our adjusted ordinary gross income may consist of PHC income as discussed above.
In addition, depending on the concentration of our stock in the hands of individuals, including the members of our sponsor and certain
tax-exempt organizations, pension funds and charitable trusts, more than 50% of our stock may be owned or deemed owned (pursuant to the
constructive ownership rules) by such persons during the last half of a taxable year. Thus, no assurance can be given that we will not
become a PHC following this offering or in the future. If we are or were to become a PHC in a given taxable year, we would be subject
to an additional PHC tax, currently 20%, on our undistributed PHC income, which generally includes our taxable income, subject to certain
adjustments. The PHC requirements may apply to us in the taxable year of the offering and/or future taxable years.
79
U.S.
Holders
This
section applies to you if you are a "U.S. holder." A U.S. holder is a beneficial owner of our securities who or that is,
for U.S. federal income tax purposes:
●
an
    individual who is a citizen or resident of the United States;
●
a
    corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized in or under the laws of the
    United States, any state thereof or the District of Columbia;
●
an
    estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or
●
a
    trust if (i) a court within the United States is able to exercise primary supervision over the administration of the trust and one
    or more U.S. persons have the authority to control all substantial decisions of the trust, or (ii) it has in effect a valid election
    to be treated as a U.S. person.
Taxation
of Distributions.
If we pay cash distributions to U.S. holders of shares of our common stock, such distributions generally will
be treated as a dividend for U.S. federal income tax purposes to the extent the distribution is paid out of our current or accumulated
earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of current and accumulated earnings
and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the U.S. holder's
adjusted tax basis in our common stock. Any remaining excess will be treated as gain realized on the sale or other disposition of the
common stock and will be treated as described under "U.S. holders — Gain or Loss on Sale, Taxable Exchange or Other Taxable
Disposition of Our Securities" below.
Dividends
we pay to a U.S. holder that is a taxable corporation generally will qualify for the dividends received deduction if the requisite holding
period is satisfied. With certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment
interest deduction limitations), and provided certain holding period requirements are met, dividends we pay to a non-corporate U.S. holder
generally will constitute "qualified dividends" that will be subject to tax at the maximum tax rate accorded to long-term
capital gains.
Gain
or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Our Securities.
Upon a sale or other taxable disposition of
our securities which, in general, would include a redemption of common stock or warrants, a U.S. holder generally will recognize capital
gain or loss in an amount equal to the difference between the amount realized and the U.S. holder's adjusted tax basis in such
securities. Any such capital gain or loss generally will be long-term capital gain or loss if the U.S. holder's holding period
for the securities so disposed of exceeds one year. Long-term capital gains recognized by non-corporate U.S. holders will be eligible
to be taxed at reduced rates. The deductibility of capital losses is subject to various limitations that are not described herein because
a discussion of such limitations depends on each U.S. holder's particular facts and circumstances.
Generally,
the amount of gain or loss recognized by a U.S. holder is an amount equal to the difference between (i) the sum of the amount of cash
and the fair market value of any property received in such disposition and (ii) the U.S. holder's adjusted tax basis in its securities
so disposed of. A U.S. holder's adjusted tax basis in its common stock or warrants generally will equal the U.S. holder's
acquisition cost less, in the case of a share of common stock, any prior distributions treated as a return of capital.
Exercise
or Lapse of a Warrant.
Except as discussed below with respect to the cashless exercise of a warrant, a U.S. holder generally
will not recognize taxable gain or loss from the acquisition of common stock upon exercise of a warrant for cash. The U.S. holder's
tax basis in the share of our common stock received upon exercise of the warrant generally will be an amount equal to the sum of the
U.S. holder's initial investment in the warrant and the exercise price. It is unclear whether a U.S. holder's holding period
for the shares of common stock received upon exercise of the warrants will commence on the date of exercise of the warrant or the day
following the date of exercise of the warrants; in either case, the holding period will not include the period during which the U.S.
holder held the warrants. If a warrant is allowed to lapse unexercised, a U.S. holder generally will recognize a capital loss equal to
such holder's tax basis in the warrant.
The
tax consequences of a cashless exercise of a warrant are not clear under current tax law. A cashless exercise may be tax-free, either
because the exercise is not a realization event or because the exercise is treated as a recapitalization for U.S. federal income tax
purposes. In either tax-free situation, a U.S. holder's basis in the common stock received would equal the holder's basis
in the warrant. If the cashless exercise were treated as not being a realization event, it is unclear whether a U.S. holder's holding
period for the shares of common stock would be treated as commencing on the date of exercise of the warrant or the day following the
date of exercise of the warrant. If the cashless exercise were treated as a recapitalization, the holding period of the common stock
would include the holding period of the warrant.
It
is also possible that a cashless exercise could be treated in part as a taxable exchange in which gain or loss would be recognized. In
such event, a U.S. holder could be deemed to have surrendered warrants equal to the number of common shares having a value equal to the
exercise price for the total number of warrants to be exercised. The U.S. holder would recognize capital gain or loss in an amount equal
to the difference between the fair market value the warrants deemed surrendered and the U.S. holder's tax basis in the warrants
deemed surrendered. In this case, a U.S. holder's tax basis in the common stock received would equal the sum of the fair market
value of the warrants deemed surrendered and the U.S. holder's tax basis in the warrants exercised. It is unclear whether a U.S.
holder's holding period for the shares of common stock would commence on the date of exercise of the warrant or the day following
the date of exercise of the warrant.
80
Due
to the absence of authority on the U.S. federal income tax treatment of a cashless exercise, there can be no assurance which, if any,
of the alternative tax consequences and holding periods described above would be adopted by the IRS or a court of law. Accordingly, U.S.
holders should consult their tax advisors regarding the tax consequences of a cashless exercise.
Possible
Constructive Distributions.
The terms of each warrant provide for an adjustment to the number of shares of common stock for
which the warrant may be exercised or to the exercise price of the warrant in certain events, as discussed in the section of this prospectus
captioned "Description of Securities — Warrants — Public Stockholders' Warrants." An adjustment which has
the effect of preventing dilution generally is not taxable. The U.S. holders of the warrants would, however, be treated as receiving
a constructive distribution from us if, for example, the adjustment increases the warrant holders' proportionate interest in our
assets or earnings and profits (e.g., through an increase in the number of shares of common stock that would be obtained upon exercise)
as a result of a distribution of cash to the holders of shares of our common stock which is taxable to the U.S. holders of such shares
as described under "U.S. holders — Taxation of Distributions" above. For example, if the exercise price of the warrants
is decreased as a result of certain taxable dividends paid to holders of the common stock (as contemplated by the terms of the warrant
in certain circumstances), then the amount by which such exercise was decreased could be considered an increase in the warrant holder's
proportionate interest in our assets or earnings and profits, which may result in a constructive distribution to holders of the warrants.
Such constructive distribution would be subject to tax as described under that section in the same manner as if the U.S. holders of the
warrants received a cash distribution from us equal to the fair market value of such increased interest. For certain information reporting
purposes, we are required to determine the date and amount of any such constructive distributions. Recently proposed Treasury regulations,
which we may rely on prior to the issuance of final regulations, specify how the date and amount of constructive distributions are determined.
Information
Reporting and Backup Withholding.
In general, information reporting requirements may apply to dividends paid to a U.S. holder and
to the proceeds of the sale or other disposition of our securities, unless the U.S. holder is an exempt recipient. Backup withholding
may apply to such payments if the U.S. holder fails to provide a taxpayer identification number, a certification of exempt status or
has been notified by the IRS that it is subject to backup withholding (and such notification has not been withdrawn).
Any
amounts withheld under the backup withholding rules will be allowed as a refund or a credit against a U.S. holder's U.S. federal
income tax liability provided the required information is timely furnished to the IRS.
Non-U.S.
Holders
This
section applies to you if you are a "Non-U.S. holder." A Non-U.S. holder is a beneficial owner of our securities who or that
is, for U.S. federal income tax purposes:
●
a
    non resident alien individual, other than certain former citizens and residents of the United States subject to U.S. tax as expatriates;
●
a
    foreign corporation; or
●
an
    estate or trust that is not a U.S. holder;
but
does not include an individual who is present in the United States for 183 days or more in the taxable year of disposition. If you are
such an individual, you should consult your tax advisor regarding the U.S. federal income tax consequences of the sale or other disposition
of a security.
Taxation
of Distributions.
In general, any distributions we make to a Non-U.S. holder of shares of our common stock, to the extent paid
out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles), will constitute dividends
for U.S. federal income tax purposes and, provided such dividends are not effectively connected with the Non-U.S. holder's conduct
of a trade or business within the United States, we will be required to withhold tax from the gross amount of the dividend at a rate
of 30%, unless such Non-U.S. holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides
proper certification of its eligibility for such reduced rate (usually on an IRS Form W-8BEN or W-8BEN-E). Any distribution not constituting
a dividend will be treated first as reducing (but not below zero) the Non-U.S. holder's adjusted tax basis in its shares of our
common stock and, to the extent such distribution exceeds the Non-U.S. holder's adjusted tax basis, as gain realized from the sale
or other disposition of the common stock, which will be treated as described under "Non-U.S. holders — Gain on Sale, Taxable
Exchange or Other Taxable Disposition of Our Securities" below. In addition, if we determine that we are classified as a "United
States real property holding corporation" (see "Non-U.S. holders — Gain on Sale, Taxable Exchange or Other Taxable
Disposition of Our Securities" below), we will withhold 15% of any distribution that exceeds our current and accumulated earnings
and profits.
The
withholding tax does not apply to dividends paid to a Non-U.S. holder who provides a Form W-8ECI, certifying that the dividends are effectively
connected with the Non-U.S. holder's conduct of a trade or business within the United States. Instead, the effectively connected
dividends will be subject to regular U.S. federal income tax as if the Non-U.S. holder were a U.S. resident, subject to an applicable
income tax treaty providing otherwise. A Non-U.S. corporation receiving effectively connected dividends may also be subject to an additional
"branch profits tax" imposed at a rate of 30% (or a lower treaty rate).
81
Exercise
of a Warrant.
The U.S. federal income tax treatment of a Non-U.S. holder's exercise of a warrant, or the lapse of a warrant
held by a Non-U.S. holder, generally will correspond to the U.S. federal income tax treatment of the exercise or lapse of a warrant by
a U.S. holder, as described under "U.S. holders — Exercise or Lapse of a Warrant" above, although to the extent a cashless
exercise results in a taxable exchange, the consequences would be similar to those described below in "Non-U.S. holders —
Gain on Sale, Taxable Exchange or Other Taxable Disposition of Our Securities."
Gain
on Sale, Taxable Exchange or Other Taxable Disposition of Our Securities.
A Non-U.S. holder generally will not be subject to
U.S. federal income or withholding tax in respect of gain recognized on a sale, taxable exchange or other taxable disposition of our
securities unless:
●
the
    gain is effectively connected with the conduct of a trade or business by the Non-U.S. holder within the United States (and, under
    certain income tax treaties, is attributable to a United States permanent establishment or fixed base maintained by the Non-U.S.
    holder); or
●
we
    are or have been a "U.S. real property holding corporation" for U.S. federal income tax purposes at any time during the
    shorter of the five-year period ending on the date of disposition or the period that the Non-U.S. holder held our securities, and,
    in the case where shares of our common stock are regularly traded on an established securities market, the Non-U.S. holder has owned,
    directly or constructively, more than 5% of our common stock at any time within the shorter of the five-year period preceding the
    disposition or such Non-U.S. holder's holding period for the shares of our common stock. There can be no assurance that our
    common stock will be treated as regularly traded on an established securities market for this purpose.
Unless
an applicable treaty provides otherwise, gain described in the first bullet point above will be subject to tax at generally applicable
U.S. federal income tax rates as if the Non-U.S. holder were a U.S. resident. Any gains described in the first bullet point above of
a Non-U.S. holder that is a foreign corporation may also be subject to an additional "branch profits tax" at a 30% rate (or
lower treaty rate).
If
the second bullet point above applies to a Non-U.S. holder, gain recognized by such holder on the sale, exchange or other disposition
of our securities will be subject to tax at generally applicable U.S. federal income tax rates. In addition, a buyer of our securities
from such holder may be required to withhold U.S. federal income tax at a rate of 15% of the amount realized upon such disposition. We
will be classified as a U.S. real property holding corporation if the fair market value of our "U.S. real property interests"
equals or exceeds 50% of the sum of the fair market value of our worldwide real property interests plus our other assets used or held
for use in a trade or business, as determined for U.S. federal income tax purposes.
Information
Reporting and Backup Withholding
. Information returns will be filed with the IRS in connection with payments of dividends and
the proceeds from a sale or other disposition of our securities. A Non-U.S. holder may have to comply with certification procedures to
establish that it is not a United States person in order to avoid information reporting and backup withholding requirements. The certification
procedures required to claim a reduced rate of withholding under a treaty will satisfy the certification requirements necessary to avoid
the backup withholding as well. The amount of any backup withholding from a payment to a Non-U.S. holder will be allowed as a credit
against such holder's U.S. federal income tax liability and may entitle such holder to a refund, provided that the required information
is timely furnished to the IRS.
FATCA
Withholding Taxes.
Provisions commonly referred to as "FATCA" impose withholding of 30% on payments of dividends
(including constructive dividends) on our securities, and, beginning January 1, 2019, sales or other disposition proceeds from our securities
to "foreign financial institutions" (which is broadly defined for this purpose and in general includes investment vehicles)
and certain other Non-U.S. entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership
by U.S. persons of interests in or accounts with those entities) have been satisfied, or an exemption applies (typically certified as
to by the delivery of a properly completed IRS Form W-8BEN-E). If FATCA withholding is imposed, a beneficial owner of the payment that
is not a foreign financial institution (or that is a foreign financial institution entitled to a reduced rate of withholding tax with
respect to such payment under an income tax treaty) generally may be entitled to a refund or credit of any amounts withheld by filing
a U.S. federal income tax return and providing certain other information to the IRS (which may entail significant administrative burden).
Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA
may be subject to different rules. Prospective investors should consult their tax advisers regarding the effects of FATCA on their investment
in our securities.
LEGAL
MATTERS
The
validity of the securities offered by this prospectus will be passed upon for us by Anthony L.G., PLLC, 625 N. Flagler Drive, Suite 600,
West Palm Beach, Florida 33401.
82
EXPERTS
Our
balance sheets as of October 31, 2021 and October 31, 2020 and the related statement of operations, changes in stockholders' equity
and cash flows for the years ended October 31, 2021 and 2020 included in this prospectus have been audited by Dale Matheson Carr-Hilton
LaBonte LLP, independent registered public accounting firm, as indicated in their report (which report expresses an unqualified opinion
and includes an explanatory paragraph related to our ability to continue as a going concern) with respect thereto, and has been so included
in reliance upon the report of such firm given on their authority as experts in accounting and auditing.
DISCLOSURE
OF COMMISSION'S POSITION ON INDEMNIFICATION FOR
SECURITIES
ACT LIABILITIES
Our
directors and officers are indemnified as provided by Delaware law, our certificate of incorporation and our bylaws. We have agreed to
indemnify each of our directors and certain officers against certain liabilities, including liabilities under the Securities Act. Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons
pursuant to the provisions described above, or otherwise, we have been advised that in the opinion of the SEC, such indemnification is
against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than our payment of expenses incurred or paid by our director, officer or controlling person in the successful
defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act
and will be governed by the final adjudication of such issue.
WHERE
YOU CAN FIND ADDITIONAL INFORMATION
We
have filed with the SEC the registration statement on Form S-1 under the Securities Act for the securities offered by this prospectus.
This prospectus, which is a part of the registration statement, does not contain all of the information in the registration statement
and the exhibits filed with it, portions of which have been omitted as permitted by SEC rules and regulations. For further information
concerning us and the securities offered by this prospectus, we refer to the registration statement and to the exhibits filed with it.
Statements contained in this prospectus as to the content of any contract or other document referred to are not necessarily complete.
In each instance, we refer you to the copy of the contracts and/or other documents filed as exhibits to the registration statement.
The
registration statement on Form S-1, of which this prospectus forms a part, including exhibits, is available at the SEC's website
at
http://www.sec.gov
. You may also read and copy any document we file with, or furnish to, the SEC at its public reference facilities:
Public
    Reference Room Office
100
    F Street, N.E.
Room
    1580
Washington,
    D.C. 20549
You
may also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E.,
Room 1580, Washington, D.C. 20549. Callers in the United States can also call (202) 551-8090 for further information on the operations
of the public reference facilities.
83
INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS
Audited
    financial statements for the years ended October 31, 2021 and 2020
Report of Independent Registered Public Accounting Firm
F- 3
Consolidated Balance Sheets as of October 31, 2021 and 2020 (Audited)
F-
    4
Consolidated Statements of Loss and Comprehensive Loss for the years ended October 31, 2021 and 2020 (Audited)
F-
    5
Consolidated Statements of Shareholders Deficit for the years ended October 31, 2021 and 2020 (Audited)
F-
    6
Consolidated Statements of Cash Flows for the years ended October 31, 2021 and 2020 (Audited)
F-
    7
Notes to Audited Consolidated Financial Statements for the years ended October 31, 2021 and 2020
F-
    8
Interim
    financial statements for the three months ended January 31, 2022
Consolidated Balance Sheets as of January 31, 2022 (Unaudited) and October 31, 2021 (Audited)
F-
    37
Consolidated Statements of Loss and Comprehensive Loss for the three months ended January 31, 2022 and 2021 (Unaudited)
F-
    38
Consolidated Statements of Shareholders Deficit for the three months ended January 31, 2022 and 2021 (Unaudited)
F-
    39
Consolidated Statements of Cash Flows for the three months ended January 31, 2022 and 2021(Unaudited)
F-
    40
Notes to Unaudited Consolidated Financial Statements
F-
    41
F-
1
WESTERN
MAGNESIUM CORPORATION
CONSOLIDATED
FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
(Expressed
in US Dollars)
F-
2
Report
of Independent Registered Public Accounting Firm
To
the shareholders and the board of directors of Western Magnesium Corporation
Opinion
on the Consolidated Financial Statements
We
have audited the accompanying consolidated balance sheets of Western Magnesium Corporation (the "Company") as of October
31, 2021 and 2020, the related consolidated statements of loss and comprehensive loss, shareholders' deficit, and cash flows, for
the years then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the
financial statements present fairly, in all material respects, the financial position of the Company as of October 31, 2021 and 2020,
and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted
in the United States of America.
Going
Concern
The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
1 to the financial statements, the Company has not generated revenues since inception, has incurred losses in developing its business,
and further losses are anticipated. The Company requires additional funds to meet its obligations and the costs of its operations. These
factors raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in this regard
are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty
Basis
for Opinion
These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting in accordance with
the standards of the PCAOB. As part of our audits we are required to obtain an understanding of internal control over financial reporting
but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting.
Accordingly, we express no such opinion in accordance with the standards of the PCAOB.
Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.
"DMCL"
DALE
MATHESON CARR-HILTON LABONTE LLP
CHARTERED
PROFESSIONAL ACCOUNTANTS
We
have served as the Company's auditor since 2013
Vancouver,
Canada
February
4, 2022
F-
3
WESTERN
MAGNESIUM CORPORATION
Consolidated
Balance Sheets
As
at October 31, 2021 and 2020
Expressed
in US Dollars
October 31, 2021
October 31, 2020
Note
$
$
ASSETS
Current assets
Cash
462,360
39,571
Amounts receivable
151,485
4,579
Prepayments
133,647
115,109
Deposits held by related parties
9[a]
486,462
–
1,233,954
159,259
Non-current assets
Property, plant and equipment
5
2,574,704
79,436
Right-of-use assets
6
598,575
373,987
Mineral property costs
8
93,453
93,453
Reclamation deposits
2,826
2,628
Other deposits
10,000
–
TOTAL ASSETS
4,513,512
708,763
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current liabilities
Accounts payable and accrued liabilities
1,989,316
1,169,817
Due to related parties
9[b]
1,026,817
843,990
Lease obligations – current
7
192,045
143,709
Promissory note
11
–
60,567
Provision for flow through share issuances
12
233,285
216,924
Convertible debenture
13
107
96,318
Convertible debenture – derivative liability
13
7,449,700
20,123
10,891,270
2,551,448
Non-current liabilities
Lease obligations – non-current
7
392,280
237,218
Total liabilities
11,283,550
2,788,666
Shareholders' deficit
Capital stock
Authorized:
1
billion common stock at par value of $
0.001
Issued and paid:
392,943,398
(2020 –
323,419,527
)
14
29,842,167
21,322,022
Additional paid-in-capital
14
15,186,480
4,182,037
Obligations to issue shares
14
209,827
596,872
Accumulated other comprehensive income
121,109
399,175
Deficit
(
52,129,621
)
(
28,580,009
)
Total shareholders' deficit
(
6,770,038
)
(
2,079,903
)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT
4,513,512
708,763
Nature of operations and going concern
[note 1]
Contingent liabilities and commitments
[note 10]
Subsequent events
[note 19]
The
accompanying notes are an integral part of these consolidated financial statements.
F-
4
WESTERN
MAGNESIUM CORPORATION
Consolidated
Statements of Loss and Comprehensive Loss
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars
2021
2020
Notes
$
$
Expenses (recoveries)
Bank charges
15,287
10,764
Computer system and software
94,426
58,230
Consulting and management fees
9[d]
914,617
598,574
Depreciation
5, 6
229,902
86,706
Due diligence expenses
5,565
25,776
Engineering expenses
105,706
569,145
Foreign exchange gain
(
109,054
)
(
10,685
)
Interest and accretion
13
74,319
60,638
Investor relations
280,249
237,874
Legal and professional fees
889,175
138,916
Office and general
180,348
185,553
Property maintenance fees
15,069
15,098
Facilities and rent
187,832
50,304
Salaries and benefits
9[c]
3,168,008
1,797,783
Stock-based compensation
9[c], 14
11,051,124
666,259
Shareholder communications
127,747
54,554
Subsidies and recoveries
(
41,735
)
-
Transfer agent and regulatory fees
107,098
64,371
Travel expenses
409,528
104,880
17,705,211
4,714,740
Other items
Change in fair value of derivative liability
13
(
5,701,270
)
4,979
Loss on recognition of debt host liability
13
(
140,943
)
–
Gain on sale of assets previously written off
8
–
37,156
Write-off of equipment
5
(
2,188
)
–
(
5,844,401
)
42,135
Net loss for the year
(
23,549,612
)
(
4,672,605
)
Other comprehensive loss
Foreign currency translation
(
278,066
)
(
76,806
)
Comprehensive loss for the year
(
23,827,678
)
(
4,749,411
)
Basic and diluted loss per common share
(
0.07
)
(
0.01
)
Weighted average number of common shares outstanding – basic and diluted
356,656,854
312,450,631
The
accompanying notes are an integral part of these consolidated financial statements.
F-
5
WESTERN
MAGNESIUM CORPORATION
Consolidated
Statements of Shareholders' Deficit
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars
Common shares
Additional
paid-in
capital
Obligation
to issue
shares
Accumulated
other
comprehensive
income (loss)
Accumulated
deficit
Shareholders'
deficit
Number
$
$
$
$
$
$
Balance, October 31, 2019
278,939,075
18,587,118
3,535,553
39,722
475,981
(
23,907,404
)
(
1,269,030
)
Shares issued pursuant to
private placements [note 14[b]]
3,643,791
416,719
–
(
39,722
)
–
–
376,997
Shares issued on warrants exercised
[note 14[b]]
40,336,661
2,313,284
–
–
–
–
2,313,284
Shares issued on options exercised
[note 14[b]]
500,000
46,176
(
19,775
)
–
–
–
26,401
Share issue costs
[note 14[b]]
–
(
41,275
)
–
–
–
–
(
41,275
)
Stock-based compensation
[note 14[d]]
–
–
666,259
–
–
–
666,259
Share subscriptions
[note 14[f]]
–
–
–
596,872
–
–
596,872
Foreign currency translation
–
–
–
–
(
76,806
)
–
(
76,806
)
Net loss for the year
–
–
–
–
–
(
4,672,605
)
(
4,672,605
)
Balance, October 31, 2020
323,419,527
21,322,022
4,182,037
596,872
399,175
(
28,580,009
)
(
2,079,903
)
Shares issued pursuant to
private placements [note 14[b]]
56,979,482
7,438,041
–
(
596,872
)
–
–
6,841,169
Shares issued on warrants exercised
[note 14[b]]
7,014,969
891,811
(
4,291
)
–
–
–
887,520
Shares issued on options exercised
[note 14[b]]
2,630,000
262,666
(
121,932
)
–
–
–
140,734
Shares issued for convertible debenture
[notes 13[a] and 14[b]]
1,360,959
162,829
–
–
–
–
162,829
Shares issued for equipment
[note 14[b]]
1,538,461
305,832
–
–
–
–
305,832
Share issue costs
[note 14[b]]
–
(
541,034
)
–
–
–
–
(
541,034
)
Stock-based compensation
[note 14[d]]
–
–
11,051,124
–
–
–
11,051,124
Equity component of convertible debenture
[note 13[b]]
79,542
79,542
Share subscriptions
[note 14[f]]
–
–
–
209,827
–
–
209,827
Foreign currency translation
–
–
–
–
(
278,066
)
–
(
278,066
)
Net loss for the year
–
–
–
–
–
(
23,549,612
)
(
23,549,612
)
Balance, October 31, 2021
392,943,398
29,842,167
15,186,480
209,827
121,109
(
52,129,621
)
(
6,770,038
)
The
accompanying notes are an integral part of these consolidated financial statements.
F-
6
WESTERN
MAGNESIUM CORPORATION
Consolidated
Statements of Cash Flows
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars
2021
2020
$
$
OPERATING ACTIVITIES
Net loss for the year
(
23,549,612
)
(
4,672,605
)
Add (subtract) items not affecting cash:
Accrued interest and accretion
25,331
53,605
Change in fair value of derivative liability
5,701,270
(
4,979
)
Loss on recognition of debt host liability
140,943
–
Depreciation of property, plant and equipment
44,148
20,871
Depreciation of right-of-use assets
185,754
65,835
Foreign exchange gain
(
198,371
)
(
55,080
)
Gain on sale of exploration and evaluation assets
–
(
37,156
)
Interest expense on lease obligations
25,319
7,033
Stock-based compensation
11,051,124
666,259
Write-off of equipment
2,188
–
Changes in non-cash working capital items relating to operations:
Amounts receivable
(
144,283
)
15,500
Prepayments
(
9,703
)
(
35,317
)
Deposits held by related parties
(
478,902
)
–
Accounts payable and accrued liabilities
719,906
510,773
Due to related parties
117,321
194,727
Cash used in operating activities
(
6,367,567
)
(
3,270,534
)
INVESTING ACTIVITIES
Purchase of property, plant and equipment
(
2,056,566
)
(
18,172
)
Other deposits
(
10,000
)
–
Proceeds from sale of exploration and evaluation assets
–
37,157
Cash provided by (used in) investing activities
(
2,066,566
)
18,985
FINANCING ACTIVITIES
Proceeds from issuance of shares, net of share issuance costs
7,328,389
2,715,129
Proceeds from share subscriptions
209,827
557,150
Proceeds from convertible debenture
1,579,542
111,470
Payments of promissory note
(
65,761
)
(
56,478
)
Payments of lease obligations
(
201,562
)
(
69,448
)
Cash provided by financing activities
8,850,435
3,257,823
Change in cash for the year
416,302
6,274
Cash, beginning of the year
39,571
33,649
Effect of foreign exchange on cash
6,487
(
352
)
Cash and cash equivalents, end of the year
462,360
39,571
Other non-cash transactions:
Shares issued for conversion of debt and equipment
468,661
–
ROU asset addition by way of lease obligation
351,886
437,812
Other cash flow disclosures:
Cash paid during the period for interest
13,204
28,199
The
accompanying notes are an integral part of these consolidated financial statements.
F-
7
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
1.
NATURE
    OF OPERATIONS AND GOING CONCERN
Western
Magnesium Corporation (the "Company", or "WMC") was incorporated under the laws of British Columbia on March
24, 1966. On May 14, 2019, the Company discontinued from the jurisdiction of the Business Corporations Act (British Columbia) and domesticated
under the General Corporation Law of the State of Delaware under the name "Western Magnesium Corporation". The Company is
a reporting issuer in Canada and in the United States, listed for trading in Canada on the TSX Venture Exchange (the "TSX-V")
under the symbol "WMG.V", in the United States on the OTCQB tier of the OTC Markets (the "OTCQB") under the symbol
"MLYF", and in Germany on the Frankfurt Stock Exchange under the symbol "3WM". The Company has developed proprietary
magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium metal.
As
at October 31, 2021, the Company had an accumulated deficit of $
52,129,621
(October 31, 2020 – $
28,580,009
) and working capital
deficiency of $
9,657,316
(October 31, 2020 – $
2,392,189
). For the year ended October 31, 2021, the Company reported a comprehensive
loss of $
23,827,678
(2020 – $
4,749,411
). The Company is considered to be in the development stage. It has not yet achieved profitable
operations and expects to incur further losses in the development of its business. The Company has financed its activities and operations
through equity issuances and debt financing and expects to continue to do so to the extent such instruments are issuable under terms
acceptable to the Company and until such time as its operations provide positive cash flows.
These
consolidated financial statements (the "Financial Statements") have been prepared under the assumption that the Company will
continue as a going concern. The going concern basis of presentation assumes that the Company will be able to meet its obligations and
continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in
the normal course of business. Management believes that the going concern assumption is appropriate for these Financial Statements based
on its continuing ability to raise financings through share and debt issuances. If future financing is unavailable or if for any reason
the Company is unable to continue as a going concern, it could impact the Company's ability to realize its assets at their recognized
values and to meet its obligations in the ordinary course of business at the amounts stated in these Financial Statements. These Financial
Statements do not give effect to adjustments that would be necessary to the carrying values and classifications of assets and liabilities
should the Company be unable to continue as a going concern. If the going concern assumption is not used, the adjustments required to
report the Company's assets and liabilities on a liquidation basis could be material to these Financial Statements. These factors
indicate the existence of a material uncertainty that cast substantial doubt on the Company's ability to continue as a going concern.
In
March 2020, the World Health Organization declared COVID-19 a global pandemic. In order to combat the spread of COVID-19, governments
worldwide, including the Unites States and Canada, have enacted emergency measures including travel bans, legally enforced or self-imposed
quarantine periods, social distancing and business and organization closures. These measures have adversely affected workforces, economies,
and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant but could affect
the Company's ability to raise financings in the future and restrict travel. Management continues to monitor the situation.
F-
8
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
2.
BASIS
    OF PRESENTATION
These
Financial Statements comprise the financial statements of Western Magnesium Corporation and its wholly owned subsidiaries, Western Magnesium
Canada Corporation, incorporated in British Columbia, Canada and Western Magnesium Corp., incorporated in the State of Nevada in the
United States.
[a]
Accounting
    standards
The
accompanying Financial Statements have been prepared by the Company in accordance with accounting principles generally accepted in the
United States of America ("US GAAP") on the basis that the Company will continue as a going concern, which assumes that the
Company will be able to meet its obligations and continue its operations for the next year. Realization values may be substantially different
from carrying values as shown and these Financial Statements do not give effect to adjustments that would be necessary to the carrying
values and classification of assets and liabilities should the Company be unable to continue as a going concern.
These
Financial Statements have been prepared on a historical cost basis except for financial instruments that have been measured at fair value.
In addition, these Financial Statements have been prepared using the accrual basis of accounting, except for cash flow information.
[b]
Functional
    and presentation currency
These
Financial Statements are presented in United States dollars ("US dollars" or "USD"), except where otherwise indicated.
The functional currency of each entity of the Company is as follows:
Entity
Functional
    Currency
Western
    Magnesium Corporation
Canadian
    dollars ("CA$")
Western
    Magnesium Canada Corporation
Canadian
    dollars
Western
    Magnesium Corp.
United
    States dollars
The
accounts of the Company, and those of its subsidiary Western Magnesium Canada Corporation, have been translated to US dollars.
[c]
Critical
    accounting estimates and judgments
Significant
Estimates and Assumptions
The
preparation of these Financial Statements in accordance with US GAAP requires the Company to make estimates and assumptions concerning
the future. Management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors,
including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted
for prospectively in the period in which the estimates are revised.
Estimates
and assumptions where there is potential risk of material adjustments to assets and liabilities in future accounting periods include
the useful lives of property, plant and equipment, the recoverability of the carrying value of exploration and evaluation assets, fair
value measurements for financial instruments, discount rates for leases, the recoverability and measurement of deferred tax assets and
liabilities and contingent liabilities.
Significant
Judgments
The
preparation of these Financial Statements in accordance with US GAAP requires the Company to make judgments, apart from those involving
estimates, in applying accounting policies. The most significant judgments in applying the Company's Financial Statements include:
-
the
    assessment of the Company's ability to continue as a going concern and whether there are events or conditions that may give
    rise to substantial doubt;
-
whether
    there are indicators of impairment of the Company's exploration and evaluation assets and other non-current assets;
-
the
    classification of financial instruments; and
-
determination
    of functional currency.
F-
9
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
3.
SIGNIFICANT
    ACCOUNTING POLICIES
The
accounting policies set out below have been applied consistently to all periods presented in these Financial Statements by the Company
and its subsidiaries.
[a]
Principles
    of consolidation
These
Financial Statements include the accounts of the Company and its wholly owned and controlled subsidiaries as described in
note 2
.
Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so
as to obtain benefits from its activities. The financial statements of the subsidiaries are included in these consolidated financial
statements from the date that control commences until the date that control ceases. All inter-company transactions and balances have
been eliminated upon consolidation.
[b]
Foreign
    currency
Items
included in the financial statements of each consolidated entity are measured using the currency of the primary economic environment
in which the entity operates (the "functional currency"). Foreign currency transactions are translated into the functional
currency using the prevailing exchange rates on the dates of transactions. Foreign exchange gains and losses resulting from the settlement
of such transactions and from the translation of monetary assets and liabilities not denominated in the functional currency of an entity
are recognized in the statements of loss and comprehensive loss.
Assets
and liabilities of the Company and its subsidiary with a functional currency in Canadian dollars are translated at the period end rates
of exchange, and the results of its operations are translated at average rates of exchange for the period. Equity transactions have been
translated using historical rates in effect on the date that each transaction occurred. The resulting translation adjustments are included
in accumulated other comprehensive income or loss as shareholders' equity or deficit. Additionally, foreign exchange gains and
losses related to certain intercompany loans that are permanent in nature are included in accumulated other comprehensive income or loss.
[c]
Cash
    and cash equivalents
Cash
and cash equivalents include highly liquid financial instruments that are readily convertible into cash with original maturities of three
months or less.
[d]
Property,
    plant and equipment
Property,
plant and equipment ("PP&E") is carried at cost, less accumulated depreciation and accumulated impairment losses.
The
cost of an item of PP&E consists of the purchase price, any costs directly attributable to bringing the asset to the location and
condition necessary for its intended use and an initial estimate of the costs of dismantling and removing the item and restoring the
site on which it is located.
Depreciation
is provided at rates calculated to write off the cost of PP&E, less their estimated residual value. The depreciation rates and method
applicable to each category of property, plant and equipment are as follows:
Class
Rate
Computer
    equipment
55%
    declining balance
Furniture
20%
    declining balance
Plant
    equipment
20%
    declining balance
Furnace
To
    be determined
Leasehold
    improvement
Term
    of lease
Right-of-use
    assets
Term
    of lease
F-
10
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
An
item of PP&E is derecognized upon disposal or when no future economic benefits are expected to arise from the continued use of the
asset. Any gain or loss arising on disposal of the asset, determined as the difference between the net disposal proceeds and the carrying
amount of the asset, is recognized in profit or loss in the consolidated statements of loss and comprehensive loss.
Where
an item of PP&E comprises major components with different useful lives, the components are accounted for as separate items. Expenditures
incurred to replace a component of an item of PP&E that is accounted for separately, including major inspection and overhaul expenditures,
are capitalized.
[e]
Reclamation
    deposits
The
Company maintains cash deposits, as required by regulatory bodies, as assurance for the funding of decommissioning costs. These funds
are restricted to that purpose and are not available to the Company until the reclamation obligations have been fulfilled and are therefore
classified as long-term assets.
[f]
Research
    and development
Expenditures
on research activities taken to develop a pyro metallurgical process to extract and recover magnesium metal from dolomite are expensed
as incurred. Development expenditures are expensed in the period incurred.
[g]
Mineral
    property acquisition and exploration assets
Mineral
property acquisition costs are capitalized when incurred. Acquisition costs include cash consideration and the fair market value of shares
issued on the acquisition of mineral property claims.
Costs
related to the development of mineral reserves are capitalized when it has been determined an ore body can be economically developed.
The development stage begins when an ore body is determined to be economically recoverable based on proven and probable reserves and
appropriate permits are in place, and ends when the production stage or exploitation of reserves begins. Major mine development expenditures
are capitalized, including primary development costs such as costs of building access ways, tailings impoundment, development of water
supply and infrastructure developments.
Exploration
costs include those relating to activities carried out (a) in search of previously unidentified mineral deposits, or (b) at undeveloped
concessions. Pre-development activities involve costs incurred in the exploration stage that may ultimately benefit production that are
expensed due to the lack of evidence of economic development, which is necessary to demonstrate future recoverability of these expenses.
Secondary development costs are incurred for preparation of an ore body for production in a specific ore block or work area, providing
a relatively short-lived benefit only to the mine area they relate to, and not to the ore body as a whole. All exploration costs have
been expensed.
Once
production has commenced, capitalized costs will be depleted using the units-of-production method over the estimated life of the proven
and probable reserves. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to the consolidated
statements of loss and comprehensive loss in that period.
The
carrying cost of mineral properties is assessed for impairment whenever information or circumstances indicate the potential for impairment.
Such evaluations compare estimated future net cash flows with carrying costs and future obligations on an undiscounted basis. If it is
determined that the future undiscounted cash flows are less than the carrying value of the property, a write down to the estimated fair
value is charged to the consolidated statements of loss and comprehensive loss for the period. Where estimates of future net cash flows
are not available and where other conditions suggest impairment, management assesses if the carrying value can be recovered.
F-
11
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
Management
conducted an impairment test on its mineral properties for recoverability and impairment loss during the years ended October 31, 2021
and 2020 and determined that its mineral properties were not impaired.
For
significant development projects, interest is capitalized as part of the historical cost of developing and constructing assets in accordance
with ASC 835-20. Interest is capitalized until the asset is ready for service. Capitalized interest is determined by multiplying the
Company's weighted-average borrowing cost on general debt by the average amount of qualifying costs incurred. Once an asset subject
to interest capitalization is completed and placed in service, the associated capitalized interest is expensed through depletion or impairment.
[h]
Impairment
    of non-financial assets
Non-financial
assets are evaluated at the end of each reporting period by management for indicators that carrying value is impaired and may not be
recoverable. When indicators of impairment are present, non-financial assets are tested for impairment as an individual asset, as part
of an asset group or at the reporting unit ("RU") level. An asset group is the lowest level for which there are identifiable
cash flows (i.e. both cash inflows and cash outflows) that are largely independent of the net cash flows of other groups of assets. An
RU is an operating segment or one level below an operating segment if certain conditions are met. Impairment tests for non-financial
assets subject to depreciation or amortization are applied to individual assets if possible. If this is not possible, then these assets
are tested for impairment at the asset group level.
An
impairment loss is triggered for non-financial assets only if the asset's, or asset group's, carrying amount exceeds its
recoverable amount (i.e. the carrying amount is greater than the undiscounted cash flows of the asset or asset group). If the carrying
amount is not recoverable, then the impairment loss is the difference between the carrying amount of the asset (asset group) and the
fair value of the asset (asset group). An impairment loss for an asset group is allocated pro rata to the non-financial assets in the
asset group. Impairment losses are recognized in the consolidated statements of loss and comprehensive loss and are not reversed.
[i]
Income
    taxes
The
Company accounts for income taxes using the asset and liability method. The asset and liability method provides that deferred tax assets
and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and
tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured
using the currently enacted tax rates. The Company records a valuation allowance to reduce deferred tax assets to the amount that is
believed more likely than not to be realized.
The
Company has adopted the provisions of FASB ASC 740 "Income Taxes" regarding accounting for uncertainty in income taxes. The
Company initially recognizes tax positions in the financial statements when it is more likely than not the position will be sustained
upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax benefit
that is greater than 50% likely of being realized upon ultimate settlement with the tax authority, assuming full knowledge of the position
and all relevant facts. Application requires numerous estimates based on available information. The Company considers many factors when
evaluating and estimating its tax positions and tax benefits, and its recognized tax positions and tax benefits may not accurately anticipate
actual outcomes. As additional information is obtained, there may be a need to periodically adjust the recognized tax positions and tax
benefits.
These
periodic adjustments may have a material impact on the consolidated statements of loss and comprehensive loss. When applicable, the Company
classifies penalties and interest associated with uncertain tax positions as a component of income tax expense in its consolidated statements
of loss and comprehensive loss.
F-
12
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
[j]
Loss
    per share
Basic
earnings (loss) per share ("EPS") is calculated by dividing profit or loss attributable to ordinary equity holders (numerator)
by the weighted average number of ordinary shares outstanding (denominator) during the period. The denominator is calculated by adjusting
the shares issued at the beginning of the period by the number of shares bought back during the period, multiplied by a time-weighting
factor.
Diluted
EPS is calculated by adjusting the earnings and number of shares for the effects of dilutive options and other dilutive potential units.
The effects of anti-dilutive options and potential units are ignored in calculating diluted EPS. All options and potential units are
considered anti-dilutive when the Company is in a loss position.
[k]
Share-based
    payments
The
Company has an equity-settled share purchase stock option plan that is described in
note 14
. Share-based payments to employees
are measured at the fair value of the instruments issued at the grant date using the Black-Scholes Option Pricing Model, and are expensed
over the vesting period, which is the period over which all of the specific vesting conditions are satisfied. For awards with graded
vesting, the fair value of each tranche is recognized over its respective vesting period.
The
fair value of stock-based payments to non-employees is periodically re-measured until the counterparty performance is complete, and any
change therein is recognized over the vesting period of the award and in the same manner as if the Company had paid cash instead of paying
with or using equity-based instruments. The cost of the stock-based payments to non-employees that are fully vested and non-forfeitable
as at the grant date is measured and recognized at that date, unless there is a contractual term for services in which case such compensation
would be amortized over the contractual term.
The
Company accounts for the granting of stock options to employees using the fair value method whereby all awards to employees will be recorded
at fair value on the date of the grant. The fair value of all stock options is expensed over their vesting period with a corresponding
increase to additional paid-in capital.
Compensation
costs for stock-based payments that do not include performance conditions are recognized on a straight-line basis. Compensation cost
associated with a share-based award having a performance condition is only recognized over the requisite service period if it is probable.
Share-based awards with a performance condition are accrued on an award by award basis.
The
share-based compensation fair value is determined using an estimated forfeiture rate. Compensation ultimately recognized is revised in
subsequent periods to reflect final grant amounts. For employees and consultants who are working on specific capital projects, the share-based
compensation is allocated to projects under development. For the remainder of employees and consultants, the compensation is expensed.
[l]
Decommissioning
    liabilities
The
Company records a liability for the reclamation of its exploration and evaluation interests based on the best estimate of costs for site
closure and reclamation activities that the Company is legally or constructively required to remediate, and the liability is recognized
at the time the environmental disturbance occurs. The resulting costs are capitalized to the corresponding asset. The fair value of the
provision for closure and reclamation liabilities is estimated using expected cash flows, based on engineering and environmental reports
prepared by third party industry specialists, discounted at a pre-tax rate specific to the liability. The capitalized amount is amortized
on the same basis as the related asset. The liability is adjusted for accretion of the discounted obligation and any changes in the amount
or timing of the underlying future cash flows. Significant judgments and estimates are involved in forming expectations of the amount
and timing of future site closure and reclamation cash flows. Future restoration costs are reviewed annually and any changes in the estimate
are reflected in the present value of the provision at the reporting date.
F-
13
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
[m]
Share
    capital
The
Company records proceeds from share issuances net of issuance costs. Shares issued for consideration other than cash are valued at the
quoted price on the date the shares are issued.
[n]
Financial
    instruments
The
Company's classification of its financial instruments is as follows:
Asset
    or Liability
Classification
Cash
Held-for-trading
Amounts
    receivable
Amortized
    cost
Accounts
    payable
Amortized
    cost
Due
    to related parties
Amortized
    cost
Promissory
    note and convertible debenture
Amortized
    cost
Derivative
    liability
Fair
    value through profit and loss ("FVTPL")
The
fair value hierarchy under US GAAP is based on the following three levels of inputs, of which the first two are considered observable
and the last unobservable:
Level
1: Quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level
2: Observable inputs other than Level I, quoted prices for similar assets or liabilities in active prices whose inputs are
observable or whose significant value drivers are observable; and
Level
3: Assets and liabilities whose significant value drivers are unobservable by little or no market activity and that are significant
to the fair value of the assets or liabilities.
The
Company's derivative liability is based on Level 3 inputs in the ASC 820 fair value hierarchy. .
Derivative
Liabilities
The
Company evaluates its financial instruments and other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with ASC 815. The result of this accounting treatment is that the
fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair
value is recorded in the consolidated statements of loss and comprehensive loss. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.
The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value
of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current
or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date.
The
Company uses the Black-Scholes Option Pricing Model to value derivative liabilities. This model uses Level 3 inputs in the fair value
hierarchy established by ASC 820 Fair Value Measurement.
F-
14
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
4.
RECENT
                                            ACCOUNTING PRONOUNCEMENTS
New
Accounting Standards Adopted During the Year
Fair
Value Measurements
In
August 2018, the Financial Accounting Standards Board ("FASB") issued ASU No. 2018-13, "Disclosure Framework—Changes
to the Disclosure Requirements for Fair Value Measurement" which adds the disclosure of the range and weighted average of significant
unobservable inputs used to develop Level 3 fair value measurements. Certain alternatives apply. Effective November 1, 2020, the Company
adopted the new standard. There was no material impact or adjustment to these Financial Statements.
New
Accounting Standards Not Yet Adopted
There
are no new accounting standards not yet adopted by the Company that are expected to have a significant impact on its Financial Statements.
5.
PROPERTY,
    PLANT AND EQUIPMENT
Computer Equipment
Furniture
Leasehold Improvement
Furnace & Plant Equipment
Total
$
$
$
$
$
Cost
Balance, October 31, 2019
22,632
33,584
5,850
27,897
89,963
Additions
9,852
5,672
1,810
838
18,172
Foreign exchange effect
(
166
)
(
340
)
(
50
)
(
322
)
(
878
)
Balance, October 31, 2020
32,318
38,916
7,610
28,413
107,257
Additions
77,955
11,510
129,257
2,278,205
2,496,927
Write-off of equipment
(
4,245
)
–
–
–
(
4,245
)
Foreign exchange effect
3,601
3,116
2,614
38,108
47,439
Balance, October 31, 2021
109,629
53,542
139,481
2,344,726
2,647,378
Accumulated Depreciation
Balance, October 31, 2019
3,184
1,679
1,950
–
6,813
Depreciation expense
11,412
6,598
2,861
–
20,871
Foreign exchange effect
81
49
7
–
137
Balance, October 31, 2020
14,677
8,326
4,818
–
27,821
Depreciation expense
13,907
7,443
8,827
13,971
44,148
Write-off of equipment
(
2,057
)
–
–
–
(
2,057
)
Foreign exchange effect
1,294
745
502
221
2,762
Balance, October 31, 2021
27,821
16,514
14,147
14,192
72,674
Net Book Value
Balance, October 31, 2020
17,641
30,590
2,792
28,413
79,436
Balance, October 31, 2021
81,808
37,028
125,334
2,330,534
2,574,704
F-
15
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
6.
RIGHT-OF-USE
    ASSETS
As
at October 31, 2021, the right-of-use assets are leases for the Company's corporate offices in Vancouver, British Columbia and
McLean, Virginia, and its research and development pilot plant located in Burnaby, British Columbia. These leases terminate on March
31, 2023, February 28, 2025 and September 30, 2023, respectively. The lease for the Company's office in Las Vegas, Nevada ended
on May 31, 2021.
Vancouver Office
Virginia
Office
Nevada Office
Pilot Plant
Total
$
$
$
$
$
Cost
Balance, October 31, 2019
–
–
–
–
–
Initial adoption of ASU 2016-02
60,418
–
23,131
–
83,549
Additions
–
–
–
354,263
354,263
Foreign exchange effect
(
717
)
–
(
275
)
3,686
2,694
Balance, October 31, 2020
59,701
–
22,856
357,949
440,506
Additions
91,237
287,847
–
–
379,084
Foreign exchange effect
5,943
4,544
1,724
26,997
39,208
Balance, October 31, 2021
156,881
292,391
24,580
384,946
858,798
Accumulated Depreciation
Balance, October 31, 2019
–
–
–
–
–
Depreciation expense
41,708
–
14,286
9,841
65,835
Foreign exchange effect
434
–
148
102
684
Balance, October 31, 2020
42,142
–
14,434
9,943
66,519
Depreciation expense
44,259
15,288
8,915
117,292
185,754
Foreign exchange effect
3,876
241
1,231
2,602
7,950
Balance, October 31, 2021
90,277
15,529
24,580
129,837
260,223
Net Book Value
Balance, October 31, 2020
17,559
–
8,422
348,006
373,987
Balance, October 31, 2021
66,604
276,862
–
255,109
598,575
F-
16
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
7.
LEASE
    OBLIGATIONS
On
adoption of ASU 2016-02 on November 1, 2019, the Company recognized lease liabilities of $
83,549
which had previously been classified
as operating leases. The lease liabilities were measured at the present value of the remaining lease payments and discounted using the
lessee's incremental borrowing rate of approximately
7
%.
During
the year ended October 31, 2020, the Company entered into a new operating lease with respect to its research and development pilot plant
located in Burnaby, British Columbia and recognized a lease liability of $
354,263
, which was measured by discounting lease payments using
an incremental borrowing rate of approximately
6
%.
During
the year ended October 31, 2021, the Company renewed its operating lease with respect to its corporate office in Vancouver, British Columbia
and recognized a lease liability of $
91,237
, which was measured by discounting lease payments using an incremental borrowing rate of
approximately
7
%.
During
the year ended October 31, 2021, the Company entered into a new operating lease with respect to its office in McLean,Virginia and recognized
a lease liability of $
260,649
, which was measured by discounting lease payments using an incremental borrowing rate of approximately
7
%.
Vancouver Office
Virginia
Office
Nevada Office
Pilot Plant
Total
$
$
$
$
$
Balance, October 31, 2019
–
–
–
–
–
Initial adoption of ASU 2016-02
60,418
–
23,131
–
83,549
Additions
–
–
–
354,263
354,263
Lease payments
(
43,627
)
–
(
14,990
)
(
10,831
)
(
69,448
)
Interest expenses
2,477
–
1,005
3,551
7,033
Foreign exchange effect
(
1,145
)
–
3,065
3,610
5,530
Balance, October 31, 2020
18,123
–
12,211
350,593
380,927
Additions
91,237
260,649
–
–
351,886
Lease payments
(
47,931
)
(
5,137
)
(
9,457
)
(
139,037
)
(
201,562
)
Interest expenses
3,076
3,019
219
19,005
25,319
Prior period adjustment
–
–
(
3,065
)
–
(
3,065
)
Foreign exchange effect
2,099
4,081
92
24,548
30,820
Balance, October 31, 2021
66,604
262,612
–
255,109
584,325
Which consist of:
Current lease obligation
46,270
16,328
–
129,447
192,045
Non-current lease obligation
20,334
246,284
–
125,662
392,280
Balance, October 31, 2021
66,604
262,612
–
255,109
584,325
F-
17
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
8.
MINERAL PROPERTY COSTS
Beaverdell
    Property
Silverado
    Property
Tami Mosi
Property
Total
$
$
$
$
Balance, October
    31, 2019
1
1
93,452
93,454
Sale of mineral property
(
1
)
–
–
(
1
)
Balance,
    October 31, 2020 and 2021
–
1
93,452
93,453
[a]
Beaverdell
    Property, Greenwood Mining Division, British Columbia, Canada
The
Beaverdell property is located in British Columbia, and was
100
% owned by the Company until the year ended October 31, 2020. During the
year ended October 31, 2020, the Company sold its
100
% interest in and to the mineral property for aggregate proceeds of CA$
50,000
(USD
equivalent $
37,157
) to be paid in two equal tranches: (i) upon signing of the sale agreement (received); and (ii) on or before April
7, 2020 (received). As a result, the Company recognized a gain on sale of $
37,156
during the year ended October 31, 2020. The carrying
value of the property was $
1
.
[b]
Silverado
    Property
,
Nevada, United States
The
Silverado property is located in the Pinto mining district of Nevada, consists of 3 patented mining claims totaling approximately 120
hectares, and is
100
% owned by the Company. The carrying value of the property is $
1
.
[c]
Tami
    Mosi Property, Nevada, United States
The
Company holds a
100
% interest in 81 unpatented lode mining claims totaling approximately
1,637
acres located in White Pine County, Nevada
and four unpatented lode mining claims totaling approximately 10 acres located in the Moor Mining District, Elko County, Nevada. These
mining claims are subject to a
2
% net smelter royalty in favor of the prior owner of the claims.
F-
18
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
9.
RELATED PARTY TRANSACTIONS
[a]
Deposits
    held by related parties
During
the year ended October 31, 2021, the Company provided related parties with advances that were held as deposits for anticipated future
costs related to the Company's planned magnesium research and development pilot plant and other administrative expenses (the "Pilot
Plant Advances"). During the year ended October 31, 2021, the Company provided Pilot Plant Advances to a company controlled by
a director and officer in the aggregate amount of $
987,912
, of which $
696,431
was used for costs and expenses leaving a balance of $
291,481
as of October 31, 2021. During the same period, the Company provided Pilot Plant Advances to a company controlled by an officer in the
aggregate amount of $
2,292,912
, of which $
2,097,931
was used for costs and expenses leaving a balance of $
194,981
as of October 31, 2021.
The aggregate deposits held by related parties were $
486,462
as of October 31, 2021.
[b]
Due
    to related parties
As
at October 31, 2021, balances due to related parties totaled $
1,026,817
(October 31, 2020 – $
843,990
). All advances are unsecured,
non-interest bearing, and have no stated terms of repayment.
October 31, 2021
October 31, 2020
$
$
Wages payable to directors and officers
357,500
161,922
Benefits payable to directors and officers
539,209
–
Fees and expenses payable to directors and officers
127,878
682,068
Interests due to a shareholder
2,230
–
Total
1,026,817
843,990
[c]
Key
    management compensation
As
at October 31, 2021, the Company had twelve executives including eight in senior management. Their aggregate annualized compensation
is approximately $
2.9
million. During the year ended October 31, 2021, the Company incurred salaries, management and consulting fees
totaling $
3,020,102
(2020 – $
1,785,032
) to directors, officers and related companies with directors in common, and stock-based
compensation totaling $
10,248,013
(2020 – $
300,211
) for options granted to directors and officers of the Company.
[d]
Transactions
    with related parties
During
the year ended October 31, 2021, the Company incurred consulting fees of CA$
120,000
(USD equivalent $
95,390
) to a member of senior management.
The Company also incurred consulting fees of CA$
45,000
(USD equivalent $
35,771
) to a company controlled by a director and officer, and
$
20,000
to a company controlled by a director and officer.
F-
19
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
10.
CONTINGENT LIABILITIES AND COMMITMENTS
[a]
Contingent liabilities
[i]
On September 29, 2020, James Sever filed a Notice of Civil Claim against the Company in the Supreme Court of British Columbia (the "Sever
Claim"). The Sever Claim alleges that Mr. Sever had an employment and/or other similar contractual relationship with the Company,
and that the Company breached such contractual relationship by way of constructive dismissal or similar conduct. The Sever Claim seeks
damages in excess of $
2.5
million, certain equity compensation, prejudgment garnishment, costs, interest and other non-monetary relief.
On July 27, 2021, the Company filed a response to the Sever Claim, which included the following pleadings: (a) that the Company was never
properly served with the Sever Claim; (b) that the Company had never had any form of employment, independent or consulting relationship
or agreement with Mr. Sever; (c) that the Company had no debts, liabilities or obligations to Mr. Sever; (d) that to the extent that
Mr. Sever had some form of employment, independent or consulting or similar relationship or agreement as alleged in the Sever Claim,
such contract or relationship, if one existed, was never with the Company and was with some other corporate entity. The Company intends
to vigorously defend against the Sever Claim, and believes that the Sever Claim is without merit. As the Company cannot predict the outcome
of the Sever Claim, no provision has been recognized as there is no present obligation and the probability of an outcome cannot be determined.
[ii]
On December 30, 2020, the Company entered into a settlement agreement with Frank Halliday, a former director and officer of the Company,
whereby the Company has agreed to pay Mr. Halliday termination pay in the amount of CA$
102,001
(USD equivalent $
76,588
) via installment
payments commencing in January 2021 until October 2021. As at October 31, 2020, the Company had recorded a provision for the settlement
amount. As at October 31, 2021, the Company had paid the entire balance, reducing the provision to $nil.
[iii]
On December 31, 2020, GEM Yield Bahamas Limited ("GEM") served the Company with a Notice of Intention to Arbitrate (the "New
York Arbitration Notice") before the American Arbitration Association in New York (the "GEM New York Arbitration").
The New York Arbitration Notice alleges the Company breached a Share Subscription Agreement dated November 15, 2019 entered into between
the Company and GEM (the "GEM Agreement"), among other things, claiming damages of CA$
4.2
million (USD equivalent $
3.4
million).
On January 19, 2021, the Company filed a petition in the New York Supreme Court to stay the GEM New York Arbitration claiming the GEM
Agreement was not valid. On March 19, 2021, the Court in the New York State Action ruled that there was an arbitration clause in the
GEM Agreement but it was up to the arbitrator to determine if the arbitration clause was valid. Following this ruling, the New York State
Action was closed. In June 2021, GEM filed a Statement of Claim in the GEM New York Arbitration, and the Company filed a Statement of
Answer denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company
filed a Modified Statement of Defense and Counterclaims. The Company intends to vigorously defend itself in the GEM New York Arbitration
and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been
recognized in respect to the GEM New York Arbitration as there is no present obligation and the probability of an outcome cannot be determined.
[iv]
On February 8, 2021, GEM instituted another arbitration against the Company before the International Centre for Dispute Resolution in
Montreal Canada (the "GEM Montreal Arbitration") and joined GEM's affiliate, GEM Global Yield LLC SCS ("GEM Global
Yield" together with GEM, the "GEM Parties"). The Statement of Claim filed by the GEM Parties alleges the Company breached
a Share Subscription Agreement dated November 15, 2019 and promissory note, among other things, claiming damages of approximately CA$
4.9
million (USD equivalent $
3.9
million), in addition to costs and expenses, stemming from the Company's alleged failure to issue
to GEM Global Yield warrants to purchase up to
33
million shares of the Company's common stock. The Company filed a Statement of
Defense denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company
filed an Amended Statement of Defense and Cross-claim. The Company intends to vigorously defend itself in the GEM Montreal Arbitration
and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been
recognized in respect to the GEM Montreal Arbitration as there is no present obligation and the probability of an outcome cannot be determined.
F-
20
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
[v]
On April 19, 2021, Lampert Advisors, LLC ("Lampert") filed a Verified Complaint against the Company's wholly owned
subsidiary Western Magnesium Corp., a Nevada corporation ("Western Magnesium – Nevada") in the Supreme Court of the
State of New York, County of New York (the "Lampert Lawsuit"). The complaint filed in the Lampert Lawsuit alleges that Lampert
entered into an agreement with Western Magnesium – Nevada to provide various financial advisory services including acquisition
advisory services and act as an exclusive placement agent for a combination of debt and equity securities (the "Lampert Agreement"),
that it performed all services required under that agreement and that it is owed $
367,227
plus interest at the rate of
9
% from February
3, 2021 and that it has a right of first refusal to act as financial advisor in connection with any debt, equity or debt restructuring
assignments on terms, conditions and compensation customary for Lampert for a transaction of the type contemplated. Although Lampert
claims to have personally served Western Magnesium – Nevada, the Company never received the Summons and Complaint and therefore,
never submitted a response. On September 9, 2021, Lampert filed a Motion seeking the entry of a default judgment (the "Motion").
The Company opposed the Motion and filed a cross-motion to compel Lampert to accept the Company's answer. The Court granted the
Company's cross-motion and denied Lampert's Motion as moot. The Court scheduled a preliminary conference for the parties
on March 30, 2022. The Company intends to vigorously defend against the Lampert Lawsuit, and believes that the Lampert Lawsuit is without
merit. As the Company cannot predict the outcome of the Lampert Lawsuit, no provision has been recognized as there is no present obligation
and the probability of an outcome cannot be determined.
[b]
Commitments
[i]
On November 1, 2016, the Company signed a contract services agreement with Lodestar Management Group, LLC ("Lodestar"), a
US corporate logistics company. Lodestar provides advisory, consulting, negotiation and other management services relating to corporate
management, administrative and/or operational activities of the Company. The term of the contract was for one year and has been renewed
under the same terms on January 1, 2018 and 2019. The Company has agreed to compensate Lodestar in the amount of $
1,800
or CA$
2,500
per
month by either cash or arrangement of the issuance of shares. The number of shares issued will be based on the share price on the day
of issuance that is not lower than the CA$
0.05
per share minimum requirement and will not exceed $
1,800
or CA$
2,500
in value. The shares
will be issued on the last working day of each month for a period of twelve months. During the year ended October 31, 2021, the Company
paid $
21,600
in cash (2020 – $
nil
) and did not issue any shares to Lodestar (2020 – nil). As at October 31, 2021, the outstanding
amounts payable to Lodestar was $
53,491
.
[ii]
During the year ended October 31, 2020, the Company has entered into a lease agreement for its research and development pilot plant in
Burnaby, British Columbia with a lease term from October 1, 2020 to September 30, 2023 at a monthly rent of CA$
20,715
(USD equivalent $
16,727
).
In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its corporate office
in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 at a monthly rent of CA$
9,794
(USD equivalent $
7,909
).
In September 2021, the Company entered into a lease agreement for its office in McLean, Virginia with a lease term from September 14,
2021 to February 28, 2025 at a monthly rent of $
9,113
.
The Company will be abated for the beginning five months and is entitled to a tenant allowance of $
41,010
[notes 6 and 7]
.
[iii]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer is eligible to receive up to
5
% of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $
5
million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
9,163,425
common shares at a price of CA$
0.65
per share with a total fair value of CA$
5,956,226
(USD equivalent $
4,796,832
) as share
issue costs.
11.
PROMISSORY NOTE
During
the year ended October 31, 2019, the Company received a loan of CA$
150,000
(USD equivalent $
112,895
) from a related party. The loan was
unsecured, bore interest at
18
% and was due on demand. During the year ended October 31, 2020, the loan was increased by an additional
CA$
60,000
(USD equivalent $
44,588
) to CA$
210,000
(USD equivalent $
157,483
), and was due on September 24, 2021. During the year ended
October 31, 2021, the Company accrued interest expense of $
1,639
(2020 – $
16,655
) and repaid the entire balance and interest totaling
$
65,761
(2020 – $
101,066
). As at October 31, 2021, the outstanding balance was $
nil
(October 31, 2020 – $
60,567
).
12.
PROVISION FOR FLOW THROUGH SHARE ISSUANCES
The
Company has recorded a provision in the amount of $
233,285
(October 31, 2020 – $
216,924
) for tax and related obligations relating
to flow through share issuances from prior years.
F-
21
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
13.
CONVERTIBLE DEBENTURE
[a]
July 2020 Convertible Debenture
On
July 27, 2020, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$
150,000
(USD equivalent $
112,124
,
the "July 2020 Convertible Debenture"). The note bears interest at
12
%
per annum and is due on the date that is one year following the closing date. The note is convertible into common shares of the Company
at the price which is the greater of CA$
0.15
per common share and the market price on the
date of the conversion notice. Any accrued but unpaid interest will be payable on the earlier of the maturity date and the date of conversion
in cash or common shares. No finder's fees were paid in connection with this private placement. On May 18, 2021, the Company issued
a total of
1,360,959
common shares on the conversion of the July 2020
Convertible Debenture including conversion of accrued interest and
263,973
common shares valued at $
26,286
in transaction costs.
[b]
July
    2021 Convertible Debenture
On
July 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$
100,000
(USD equivalent $
79,542
, the "July 2021 Convertible Debenture") which it received on April 22, 2021. The note bears interest
at
12
% per annum and is due on the date that is one year following the closing date. The note is convertible at a price of CA$
0.12
per
Unit, where each Unit is comprised of one common share and one common share purchase warrant exercisable at a price of CA$
0.20
per common
share for a period of two years. Any accrued but unpaid interest will be payable on the earlier of the maturity date and the date of
conversion in cash or common shares. As at October 31, 2021, the Company incurred contractual interest of CA$
7,299
(USD equivalent $
5,802
).
The July 2021 Convertible Debenture has an
effective interest rate of 1,878%
. The Company has allocated the intrinsic value of the beneficial
conversion feature of the July 2021 Convertible Debenture capped at the face value of CA$
100,000
(USD equivalent $
79,542
) to equity reserves.
[c]
June
    2021 Convertible Debenture
On
June 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of $
1,500,000
(the "June 2021 Convertible Debenture"). The note bears interest at
12
% per annum and matures on
December 10, 2022
. The June
2021 Convertible Debenture is convertible into
15,000,000
units, where each unit consists of (i) one share of the Company' common
stock, (ii)
one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until
June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price
of $0.19 until June 10, 2026 (collectively, the "Class A and B Warrants"). In addition, the conversion price for accrued
interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion.
As
part of the offering of the June 2021 Convertible Debenture, the Company also entered into the June 10, 2021 Securities Purchase Agreement
(the "Securities Purchase Agreement"), whereby the Company agreed to use commercially reasonable efforts to file a registration
statement with the United States Securities and Exchange Commission (the "SEC") by August 14, 2021, covering the public resale
of the shares of common stock underlying such debenture and, upon its conversion, the Class A and B Warrants issuable upon such conversion
(the "Underlying Shares"), and to use its best efforts to cause the registration statement to be declared effective on October
13, 2021
[note 19[vi]]
.
In
addition to certain covenants contained in the Securities Purchase Agreement, the terms of the June 2021 Convertible Debenture contain
certain negative covenants by the Company, including, among others, sell or offer to sell any securities with non-fixed or floating price
features, issue any common stock or common stock equivalents at a price lower than the Conversion Price herein then in effect, or issue
any equity or debt instruments with anti-dilution provisions.
F-
22
WESTERN
                         MAGNESIUM CORPORATION
NOTES
                         TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed in US Dollars, except where otherwise indicated
In
the event the Company issues or sells any common stock or common stock equivalents with terms that the purchaser holding the outstanding
June 2021 Convertible Debenture (the "Convertible Debenture Holder") or the Class A and B Warrants reasonably believes are
more favorable to such holder than the terms of the June 2021 Convertible Debenture or the Class A and B Warrants, then upon notice to
the Company by such holder within five trading days after notice to such holder by the Company, the Company will use commercially reasonable
efforts to obtain the approval of the TSX-V and any additional required regulatory approval to amend the terms of the June 2021 Convertible
Debenture or the Class A and B Warrants as required, as the case may be, so as to give such holder the benefit of such more favorable
terms or conditions.
The
conversion price of the June 2021 Convertible Debenture and the exercise price of the Class A and B Warrants are subject to proportional
adjustment in the event of stock splits, stock dividends and similar corporate events, including merger or consolidation of the Company
or in a "Fundamental Transaction" as defined in the June 2021 Convertible Debenture.
The
Company has granted the holders certain rights of first refusal on its future offerings for as long as the June 2021 Convertible Debenture
or the Class A and B Warrants are outstanding.
The
Company may prepay and satisfy the June 2021 Convertible Debenture so long as an event of default has not occurred, upon 20 days'
prior written notice received by the Company to the holder, by paying 125% of the amounts owed on the June 2021 Convertible Debenture,
including all principal, interest and other fees. The holder of this debenture may, however, convert all or a portion of the debenture
during the 20-day notice period.
As
at October 31, 2021, the Company incurred contractual interest of $
70,521
.
Subsequent
to October 31, 2021, the Company issued an aggregate
3,000,000
units on partial conversion of the June 2021 Convertible Debenture, for
a total of
3,000,000
common shares,
1,500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
1,500,000
Class
B Warrants exercisable at a price of $
0.19
until June 10, 2026
[note 19[iii]]
.
[d]
Debt Host Liability and Embedded Derivative Liability
The
July 2020 Convertible Debenture and the June 2021 Convertible Debenture were determined to be hybrid financial instruments comprised
of a debt host liability and an embedded derivative liability, as under the conversion feature the number of shares that will or may
be issued to settle the notes may vary. The Company uses the Black-Scholes Option Pricing Model based on different default risks and
assumptions. The debt host liability of the convertible note will be measured at amortized cost, with the embedded derivative liability
measured at fair value through profit and loss.
On
issuance date of the July 2020 Convertible Debenture, the fair value of its debt host liability was determined to be $
87,083
and the
respective embedded derivative liability was valued at $
25,041
. Fair value adjustments were made to the embedded derivative liability
of the July 2020 Convertible Debenture on conversion date of May 18, 2021. As at October 31, 2021, the amortized cost of the July 2020
Convertible Debenture's debt host liability was $
nil
(October 31, 2020 – $
96,318
) and the fair value of the embedded derivative
liability was $
nil
(October 31, 2020 – $
20,123
), resulting in a combined value of $
nil
(October 31, 2020 – $
116,441
). The
July 2020 Convertible Debenture had an effective interest rate of
37
%.
On
issuance date of the June 2021 Convertible Debenture, the embedded derivative liability was valued at $
1,646,600
which exceeded the
face value of the note itself of $
1,500,000
, the debt host liability was then assigned a face value of $
1
, with an immediate loss of
$
146,601
on recognition of the debt host liability. As at October 31, 2021, the amortized cost of the June 2021 Convertible
Debenture's debt host liability was $
44
(October 31, 2020 – $
nil
) and the fair value of the embedded derivative
liability was $
7,449,700
(October 31, 2020 – $
nil
), resulting in a combined value of $
7,449,744
(October 31, 2020 –
$
nil
). The June 2021 Convertible Debenutre has an effective interest rate of
1,448
%
F-
23
WESTERN
                         MAGNESIUM CORPORATION
NOTES
                         TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed in US Dollars, except where otherwise indicated
The
inputs used in the Black-Scholes Option Pricing Model are as follows:
October 31,
June 15,
July 27,
2021
2021
2020
Risk free rate of interest
1.08
%
0.31
%
0.26
%
Expected life in years
1.11
years
1.50
year
0.74
year
Conversion exercise price
$
0.10
$
0.10
CA$
0.15
Underlying share price of the Company
CA$
0.73
CA$
0.23
CA$
0.13
Expected volatility
107.62
%
87.17
%
82.54
%
Expected dividend rate
Nil
Nil
Nil
July 2020 Convertible Debenture
June 2021 Convertible Debenture
July 2021 Convertible Debenture
Total
$
$
$
$
Debt Host Liability
Value of debt host liability recognized
87,083
–
–
87,083
Accretion and interest expense
8,751
–
–
8,751
Foreign currency translation
484
–
–
484
Balance, October 31, 2020
96,318
–
–
96,318
Value of debt host liability recognized
–
1
–
1
Accretion and interest expense
23,587
43
63
23,693
Conversion
(
125,560
)
–
–
(
125,560
)
Foreign currency translation
5,655
–
–
5,655
Balance, October 31, 2021
–
44
63
107
Embedded Derivative Liability
Fair value of embedded derivative liability recognized
25,041
–
–
25,041
Fair value adjustment
(
4,979
)
–
–
(
4,979
)
Foreign currency translation
61
–
–
61
Balance, October 31, 2020
20,123
–
–
20,123
Fair value of embedded derivative liability recognized
–
1,646,600
–
1,646,600
Fair value adjustment
(
16,058
)
5,717,328
–
5,701,270
Conversion
(
5,247
)
–
–
(
5,247
)
Foreign currency translation
1,182
85,772
–
86,954
Balance, October 31, 2021
–
7,449,700
–
7,449,700
Combined Value of Convertible Debenture
Balance, October 31, 2020
116,441
–
–
116,441
Balance, October 31, 2021
–
7,449,744
63
7,449,807
F-
24
WESTERN
                         MAGNESIUM CORPORATION
NOTES
                         TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed in US Dollars, except where otherwise indicated
14.
SHARE CAPITAL
[a]
Authorized
    capital
The
authorized share capital consists of
1,000,000,000
common voting shares at par value of $
0.001
.
[b]
Common
    shares issued
Fiscal
2020
[i]
On December 20, 2019, the Company exercised its right to call, subject to acceleration provisions, all outstanding common share purchase
warrants set to expire between May 7, 2020 and May 13, 2021. The expiry was amended to January 19, 2020. This expiry date was then extended
to
February 19, 2020
. As of February 19, 2020, any unexercised warrants were extinguished. In all,
35,472,661
warrants at an average
price of CA$
0.08
per common share were exercised and
24,794,484
expired unexercised. A further
4,864,000
warrants were also exercised
during the year at CA$
0.05
per common share.
[ii]
On January 17, 2020, the Company closed a non-brokered private placement consisting of
3,643,792
units at a price of CA$
0.15
per unit
for gross proceeds of CA$
546,569
(USD equivalent $
416,719
), of which CA$
52,922
(USD equivalent $
39,722
) was recorded as advance share
subscriptions received prior to October 31, 2019.
Each unit consists of one common share and one common share purchase warrant exercisable
at a price of CA$0.21 per common share for a period of one year. The expiration date of these common share purchase warrants was subsequently
extended to August 31, 2021. These common share purchase warrants were subject to an expiry acceleration provision, upon thirty days'
written notice, should the price of the Company's common shares exceed CA$0.30 for at least ten consecutive trading days.
The fair
value of the common shares was equal to the total proceeds raised and as a result, no amount was allocated to the fair value of the common
share purchase warrants. Finder's fees of $
41,275
were paid or accrued in connection with the placement.
[iii]
On May 26, 2020, the Company issued a total of
500,000
common shares on the exercise of stock options for gross proceeds of CA$
37,000
(USD equivalent $
26,401
) and re-classified $
19,775
from equity reserves to share capital.
[iv]
On September 10, 2020, the Company announced a non-brokered private placement of up to
53,846,154
units at a price of CA$
0.13
per unit
to raise gross proceeds of up to CA$
7,000,000
.
Each unit is comprised of one common share and one common share purchase warrant exercisable
at CA$0.19 per common share for a period of one year.
As at October 31, 2020, the Company had received advance share subscriptions of
CA$
747,392
(USD equivalent $
596,872
)
[note 14[f]]
.
Fiscal
2021
[i]
In connection with the non-brokered private placement announced on September 10, 2020:
On
November 20, 2020, the Company closed the first tranche of the non-brokered private placement, issuing
5,599,171
units at a price of
CA$
0.13
per unit for gross proceeds of CA$
727,892
(USD equivalent $
556,876
), which had been received prior to October 31, 2020 and recorded
as an obligation to issue shares.
On
January 15, 2021, the Company closed the second tranche of the non-brokered private placement, consisting of
7,337,914
units at a price
of CA$
0.13
per unit for gross proceeds of CA$
953,930
(USD equivalent $
749,435
), of which $
39,996
had been received prior to October 31,
2020 and recorded as an obligation to issue shares.
On
January 29, 2021, the Company closed the third tranche of the non-brokered private placement consisting of
5,382,303
units at a price
of CA$
0.13
per unit for gross proceeds of CA$
699,699
(USD equivalent $
547,496
).
F-
25
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
On
March 24, 2021, the Company closed the fourth tranche of the non-brokered private placement consisting of
6,554,172
units at a price
of CA$
0.13
per unit for gross proceeds of CA$
852,042
(USD equivalent $
678,270
).
On
April 27, 2021, the Company closed the fifth and final tranche of the non-brokered private placement consisting of
851,395
units at a
price of CA$
0.13
per unit for gross proceeds of CA$
110,681
(USD equivalent $
89,237
).
In
total, the Company issued an aggregate
25,724,955
units at a price of CA$
0.13
per unit for aggregate gross proceeds of CA$
3,344,244
(USD
equivalent $
2,621,314
).
Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire
a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche.
The
Company incurred aggregate share issue costs of $
195,614
.
[ii]
On May 5, 2021, the Company announced a non-brokered private placement priced at CA$
0.13
per unit to raise gross proceeds of up to CA$
3,000,000
.
On May 28, 2021, the Company closed the first tranche of the non-brokered private placement issuing
5,223,420
units at a price of CA$
0.13
per unit for gross proceeds of $
679,044
(USD equivalent $
561,844
). On June 17, 2021, the Company closed the second and final tranche
of the non-brokered private placement consisting of
17,853,506
units at a price of CA$
0.13
per unit for gross proceeds of CA$
2,320,956
(USD equivalent $
1,880,687
). The Company issued total of
23,076,926
units at a price of CA$
0.13
per unit for total gross proceeds of
CA$
3,000,000
(USD equivalent $
2,442,531
).
Each unit issued consists of one common share and one common share purchase warrant entitling
the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective
financing tranche.
The Company incurred aggregate share issue costs of $
154,336
.
[iii]
On May 18, 2021, the Company issued a total of
1,360,959
common shares on the conversion of the July 2020 Convertible Debenture including
accrued interest and
263,973
common shares valued at $
26,286
in transaction costs.
[iv]
On June 7, 2021, the Company issued
1,538,461
common shares at a price of CA$
0.24
per share with a total fair value of CA$
369,231
(USD
equivalent $
305,832
) for equipment.
[v]
On July 16, 2021, the Company closed a non-brokered private placement and issued
4,350,000
units at a price of CA$
0.20
per unit for gross
proceeds of CA$
870,000
(USD equivalent $
690,860
).
Each unit consists of one common share and one common share purchase warrant entitling
the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing.
The Company
incurred aggregate share issue costs of $
48,319
.
[vi]
On August 11, 2021, the Company closed a non-brokered private placement and issued
3,827,601
units at a price of CA$
0.55
(US$
0.44
) per
unit for gross proceeds of CA$
2,105,180
(USD equivalent $
1,683,336
).
Each unit consists of one common share and one common share purchase
warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 (US$0.52) for a period of eighteen months
from the date of closing.
The Company incurred aggregate share issue costs of $
116,479
.
[vii]
During the year ended October 31, 2021, the Company issued a total of
7,014,969
common shares on the exercise of common share purchase
warrants at a price ranging from CA$
0.05
to CA$
0.21
per share for gross proceeds of CA$
1,120,130
(USD equivalent $
887,520
). A total of
525,173
warrants expired unexercised.
[viii]
During the year ended October 31, 2021, the Company issued a total of
2,630,000
common shares on the exercise of stock options at a price
ranging from CA$
0.05
to CA$
0.16
per share for gross proceeds of CA$
175,800
(USD equivalent $
140,734
).
[ix]
With respect to the exercises of common share purchase warrants and options, the Company reclassified $
4,291
and $
121,932
, respectively,
from equity reserves to share capital during the year ended October 31, 2021.
F-
26
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
[x]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer is eligible to receive up to
5
% of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $
5
million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
9,163,425
common shares at a price of CA$
0.65
per share with a total fair value of CA$
5,956,226
(USD equivalent $
4,796,832
) as share
issue costs.
[c]
Common share purchase warrants
A
summary of the changes in the Company's common share purchase warrants during the year ended October 31, 2021 are as follows:
Expiry Date
Exercise
Price
                                                                                                                                                                                                                                                                             (CA$)
Weighted
Average
Life
(Years)
October 31,
2020
Granted
Exercised
Expired/
Cancelled
October 31,
2021
August 31, 2021*
0.21
–
3,643,791
-
(
3,118,618
)
(
525,173
)
–
November 22, 2021
0.19
0.14
–
5,599,171
(
1,439,150
)
–
4,160,021
January 17, 2022
0.19
0.29
–
7,337,914
(
70,000
)
–
7,267,914
January 31, 2022
0.19
0.33
–
5,382,303
–
–
5,382,303
February 21, 2022
0.05
0.39
1,505,200
–
–
–
1,505,200
March 24, 2022
0.19
0.48
–
6,554,172
(
212,300
)
–
6,341,872
March 27, 2022
0.05
0.49
1,482,025
–
(
500,000
)
–
982,025
April 27, 2022
0.19
0.57
–
851,395
(
60,000
)
–
791,395
May 9, 2022
0.05
0.61
2,368,626
–
(
554,901
)
–
1,813,725
May 30, 2022
0.19
0.66
–
5,223,420
–
–
5,223,420
June 17, 2022
0.19
0.71
–
17,853,506
(
150,000
)
–
17,703,506
July 18, 2022
0.30
0.79
–
4,350,000
–
–
4,350,000
August 14, 2022
0.05
0.87
1,110,000
–
(
910,000
)
–
200,000
February 13, 2023
0.65
1.37
–
3,827,601
–
–
3,827,601
Total
10,109,642
56,979,482
(
7,014,969
)
(
525,173
)
59,548,982
Weighted average exercise price
CA$
0.11
CA$
0.23
CA$
0.16
CA$
0.21
CA$
0.22
*
The Company received approval of the TSX-V on January 13, 2021
and amended the expiry date of
3,643,791
warrants, extending the expiry date from January
17, 2021 to August 31, 2021, subject to acceleration if the closing price of the Company's shares exceeds CA$
0.30
per common share for at least
10
consecutive trading days.
A
summary of the changes in the Company's common share purchase warrants during the year ended October 31, 2020 are as follows:
Expiry Date
Exercise
Price
(CA$)
Weighted
Average
Life
(Years)
October
31,
2019
Granted
Exercised
Expired/
Cancelled
October
31,
2020
January 17, 2021
0.21
–
–
3,643,791
–
–
3,643,791
February 21, 2022
0.05
2.31
1,505,200
–
–
–
1,505,200
March 27, 2022
0.05
2.41
3,426,025
–
(
1,944,000
)
–
1,482,025
May 9, 2022
0.05
2.52
5,088,626
–
(
2,720,000
)
–
2,368,626
August 14, 2022
0.05
2.79
1,310,000
–
(
200,000
)
–
1,110,000
May 7, 2020*
0.07
–
3,100,000
–
(
3,000,000
)
(
100,000
)
–
October 4, 2020*
0.08
–
5,016,000
–
(
3,425,000
)
(
1,591,000
)
–
November 30, 2020*
0.08
–
6,169,926
–
(
3,091,383
)
(
3,078,543
)
–
January 23, 2021*
0.08
–
6,388,435
–
(
3,409,160
)
(
2,979,275
)
–
March 29, 2021*
0.08
–
8,188,046
–
(
4,496,710
)
(
3,691,336
)
–
May 13, 2021*
0.08
–
31,404,738
–
(
18,050,408
)
(
13,354,330
)
–
Total
71,596,996
3,643,791
(
40,336,661
)
(
24,794,484
)
10,109,642
Weighted average exercise price
CA$
0.07
CA$
0.21
CA$
0.08
CA$
0.08
CA$
0.11
*
On December 20, 2019, the Company exercised its right to call,
subject to acceleration provisions, all outstanding warrants set to expire between May 7, 2020 and May 13, 2021. The expiry was amended
to January 19, 2020. This expiry date was then extended to February 19, 2020. Any unexercised warrants were voided and of no value after
February 19, 2020.
F-
27
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
[d]
Stock options
The
Company has adopted an incentive stock option plan, effective on August 8, 2017 and as amended on August 8, 2018, under the rules of
the TSX-V pursuant to which it is authorized to grant stock options to executive officers, directors, employees and consultants, enabling
them to acquire up to
20
%
of the total shares outstanding of the Company (the "2017 Stock Option Plan"). Under the 2017 Stock
Option Plan, the option exercise price of any option granted shall not be less than the discounted market price of the Company's
common shares. For the purposes of the 2017 Stock Option Plan, the discounted market price is calculated in accordance with the policies
of the TSX-V at the time of the grant of the options.
Stock options granted are subject to a maximum term of 5 years. All options granted
shall vest immediately, except for those options granted to persons performing investor relations activities for the Company.
Pursuant
to the policies of the TSX-V, shares issued upon the exercise of options are restricted from trading during the 4-month period subsequent
to the exercise of options.
On
June 11, 2021, the Company adopted the 2021 Equity Incentive Plan which replaces the 2017 Stock Option for providing stock-based compensation
to directors, officers, employees, consultants, and advisors of the Company and no further options will be granted under the 2017 Stock
Option Plan. Under the 2021 Equity Incentive Plan, the Company is authorized to issue up
27,312,368
shares of the Company. In addition,
any common shares reserved for issuance under the 2017 Stock Option Plan that are forfeited as a result of the expiration or termination
of any awards under that plan after the date of adoption of the 2021 Equity Incentive Plan will be added to the 2021 Equity Incentive
Plan. During the year ended October 31, 2021,
1,730,000
stock options forfeited under the 2017 Stock Option Plan were added to the 2021
Equity Incentive Plan. The 2021 Equity Incentive Plan provides for various equity-based and cash-based incentive awards, including incentive
stock options, non-statutory stock options, stock appreciation rights, restricted stock and restricted stock units, performance awards,
dividend equivalents and other equity-based or cash-based awards.
During
the year ended October 31, 2020, the Company granted
6,600,000
stock options pursuant to its 2017 Stock Option Plan to its directors,
officers, employees and consultants. These options are exercisable at a price ranging from CA$
0.11
to CA$
0.16
per share for a period
of
two
to
five years
.
On
December 30, 2020, the Company granted
15,650,000
stock options pursuant to its 2017 Stock Option Plan to its directors, officers, employees
and consultants at a price of CA$
0.13
per share, of which
9,500,000
were exercisable for a period of five years and
6,150,000
were exercisable
for a period of two years. However, these options exceeded the maximum allowed under the Company's 2017 Stock Option Plan. On June
11, 2021, the Company received shareholders' approval to amend the Company's 2017 Stock Option Plan to increase the number
of common shares reserved for issuance under such plan and rectified the grant of these options.
On
August 30, 2021, the Company granted
21,700,000
incentive stock options pursuant to its 2021 Equity Incentive Plan to its directors,
officers, employees and consultants. These options are exercisable at a price of CA$
0.70
per share for a period of
five years
.
On
October 1, 2021, the Company granted
1,450,000
incentive stock options pursuant to its 2021 Equity Incentive Plan to its officer and
employee and consultants. These options are exercisable at a price of CA$
0.50
per share for a period of
five years
.
F-
28
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
As
at October 31, 2021, the maximum number of common shares available under the 2021 Equity Incentive Plan was
29,042,368
, of which
5,892,368
remained available for grant thereunder.
During
the year ended October 31, 2021, the Company recognized a net stock-based compensation totaling $
11,051,124
(2020 – $
666,259
) in
relation to the grant of its stock options.
The
weighted average grant date fair value of the stock options granted during the year ended October 31, 2021 was CA$
0.36
(2020 –
CA$
0.14
) per option. Option pricing models require the use of highly subjective estimates and assumptions including expected stock price
volatility. Changes in the underlying assumptions can materially affect the fair value estimates. The fair value of stock options was
estimated on the measurement date using the Black-Scholes Option Pricing Model. The assumptions used to calculate the fair value were
as follows:
2021
2020
Risk free rate of interest
0.20
% –
1.07
%
0.43
% –
1.51
%
Expected life of options
2
to
5
years
5
years
Exercise price of options
CA$
0.13
– CA$
0.70
CA$
0.11
– CA$
0.16
Expected annualized volatility
130.88
% –
140.05
%
120.13
% –
188.46
%
Expected dividend rate
Nil
Nil
A
summary of the changes in the Company's stock options during the year ended October 31, 2021 are as follows:
Expiry Date
Exercise
Price
(CA$)
Weighted Average Life (Years)
Outstanding
as at
October 31,
2020
Granted
Exercised
Expired/
Cancelled
Outstanding
as at
October 31,
2021
Vested
as at
October 31,
2021
February 11, 2021
0.05
–
800,000
–
–
(
800,000
)
–
–
August 16, 2021
0.05
–
600,000
–
(
600,000
)
–
–
–
March 27, 2022
0.05
0.40
1,750,000
–
(
250,000
)
–
1,500,000
1,500,000
August 26, 2022
0.13
–
500,000
–
–
(
500,000
)
–
–
December 30, 2022
0.13
1.16
–
6,150,000
(
100,000
)
(
50,000
)
6,000,000
5,837,500
April 19, 2023
0.05
–
800,000
–
–
(
800,000
)
–
–
August 12, 2023
0.05
1.78
3,120,000
–
(
600,000
)
(
230,000
)
2,290,000
2,290,000
December 3, 2023
0.05
2.09
7,000,000
–
(
550,000
)
–
6,450,000
6,450,000
May 22, 2024
0.12
2.56
7,950,000
–
–
(
50,000
)
7,900,000
7,900,000
November 3, 2024
0.15
3.01
700,000
–
–
–
700,000
700,000
November 24, 2024
0.16
3.07
900,000
–
(
30,000
)
(
550,000
)
320,000
320,000
March 26, 2025
0.11
3.40
300,000
–
(
200,000
)
–
100,000
100,000
April 23, 2025
0.12
3.48
4,000,000
–
(
300,000
)
(
350,000
)
3,350,000
3,350,000
December 30, 2025
0.13
4.17
–
9,500,000
–
–
9,500,000
9,500,000
August 30, 2026
0.70
4.83
–
21,700,000
–
–
21,700,000
21,400,000
October 1, 2026
0.50
4.92
–
1,450,000
–
–
1,450,000
1,450,000
Total
28,420,000
38,800,000
(
2,630,000
)
(
3,330,000
)
61,260,000
60,797,500
Weighted average exercise price
CA$
0.09
CA$
0.46
CA$
0.07
CA$
0.09
CA$
0.33
CA$
0.32
Aggregate intrinsic value
$
19,994,025
$
19,908,026
Weighted average remaining life
3.46
3.46
F-
29
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
A
summary of the changes in the Company's nonvested stock options during the year ended October 31, 2021 are as follows:
Expiry Date
Fair Value Per Share
(CA$)
Weighted Average Life (Years)
Nonvested
as at
October 31,
2020
Granted
Vested
Expired/
Cancelled
Nonvested
as at
October 31,
2021
December 30, 2022
0.07
1.16
–
650,000
487,500
–
162,500
August 30, 2026
0.56
4.83
–
300,000
–
–
300,000
Total
–
950,000
487,500
–
462,500
Weighted
                                            average grant date fair value
– per option
–
CA$
0.22
CA$
0.07
–
CA$
0.39
Weighted
                                            average grant date fair value
– total
–
$
170,781
$
26,650
–
$
144,131
A
summary of the changes in the Company's stock options during the year ended October 31, 2020 are as follows:
Expiry Date
Exercise
Price
(CA$)
Weighted Average Life (Years)
Outstanding
as at
October 31,
2019
Granted
Exercised
Expired/
Cancelled
Outstanding
as at
October 31,
2020
Vested
as at
October 31,
2020
May 31, 2020
0.08
–
400,000
–
(
400,000
)
–
–
–
June 3, 2020
0.05
–
550,000
–
–
(
550,000
)
–
–
February 11, 2021
0.05
0.53
1,300,000
–
–
(
500,000
)
800,000
800,000
August 16, 2021
0.05
1.04
1,200,000
–
–
(
600,000
)
600,000
600,000
March 27, 2022
0.05
1.65
2,000,000
–
–
(
250,000
)
1,750,000
1,750,000
August 26, 2022
0.13
–
–
500,000
–
–
500,000
–
April 19, 2023
0.05
2.72
800,000
–
–
–
800,000
800,000
August 12, 2023
0.05
3.03
3,780,000
–
(
100,000
)
(
560,000
)
3,120,000
3,120,000
December 3, 2023
0.05
3.35
9,600,000
–
–
(
2,600,000
)
7,000,000
7,000,000
May 22, 2024
0.12
3.81
10,000,000
–
–
(
2,050,000
)
7,950,000
7,950,000
November 3, 2024
0.15
4.27
–
700,000
–
–
700,000
700,000
November 24, 2024
0.16
4.32
–
900,000
–
–
900,000
775,000
March 26, 2025
0.11
4.66
–
300,000
–
–
300,000
300,000
April 23, 2025
0.12
4.73
–
4,200,000
–
(
200,000
)
4,000,000
3,625,000
Total
29,630,000
6,600,000
(
500,000
)
(
7,310,000
)
28,420,000
27,420,000
Weighted average exercise price
CA$
0.07
CA$
0.13
CA$
0.07
CA$
0.07
CA$
0.09
CA$
0.09
Aggregate intrinsic value
$
801,922
$
866,441
Weighted average remaining life
3.18
3.18
The
intrinsic value of options exercised during the year ended October 31, 2021 was $
962,936
(2020 – $
28,533
).
[e]
Share-based
    payments and other reserves
The
share-based payments and other reserves are used to recognize the fair value of stock options granted to executive officers, directors,
employees and consultants as part of their remuneration, as well as those of broker warrants issued in relation to the Company's
financings. When stock options and broker warrants are subsequently exercised, the fair value of such stock options and broker warrants
in reserves is credited to share capital.
Common
share purchase warrants attached to units as part of a unit placement are assigned a $nil value. The residual method is used to calculate
the fair value of the warrant component of units issued, whereby the residual of the private placement proceeds less the fair value of
the share component is assigned as the fair value of the warrants.
F-
30
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
In
addition, the Company has allocated the intrinsic value of the beneficial conversion feature of the July 2021 Convertible Debenture capped
at the face value of CA$
100,000
(USD equivalent $
79,542
) to equity reserves.
[f]
Obligations
    to issue shares
As
at October 31, 2021, the Company received advance share subscriptions in the amount of $
209,827
(October 31, 2020 – $
596,872
) in
respect of a non-brokered private placement closed subsequent to the year
[note 19[iv]]
.
[g]
Dilutive
    common shares
For
the year ended October 31, 2021, potentially dilutive common shares relating to common share purchase warrants and options outstanding
totaling
120,808,982
(2020 –
38,529,642
) were not included in the computation of loss per share as the effect would be anti-dilutive.
15.
CAPITAL MANAGEMENT
The
Company classifies the components of shareholders' equity as capital, which at October 31, 2021, was a deficiency of $
6,770,038
(October 31, 2020 – $
2,079,903
). When managing capital, the Company's objective is to ensure the entity continues as a going
concern and advance stakeholders' interests. Management adjusts the capital structure as necessary in order to support its business
and technology development. The Company's board of directors does not establish qualitative return on capital criteria for management,
but rather relies on the expertise of the Company's management to sustain future development of the business. The Company focuses
on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and the development
of a full-scale commercial magnesium production facility. The Company is considered to be in the development stage and is dependent upon
external financing to fund its activities. In order to carry out its business development activities and pay for administrative costs,
the Company will spend its existing working capital and raise additional amounts as needed. Management reviews its capital management
approach on an ongoing basis and believes that this approach, given the relative size of the Company, is appropriate. There were no changes
in the Company's approach to capital management during the period. The Company is not subject to any externally imposed capital
requirements.
F-
31
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
16.
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
The
Company's classification of its financial instruments is as follows:
Financial
    Instruments
Measurement
Method
Associated
    Risk
Fair
    Value at
October
    31, 2021
($)
Cash
FVTPL
Credit
    and currency
462,360
Amounts
    receivable
Amortized
    cost
Credit
    and currency
151,485
Deposits
    held by related parties
Amortized
    cost
Credit
    and currency
486,462
Accounts
    payable and accrued liabilities
Amortized
    cost
Currency
1,989,316
Due
    to related parties
Amortized
    cost
Currency
1,026,817
Convertible
    debenture
Amortized
    cost
Currency
107
Convertible
    debenture - derivative liability
FVTPL
Currency
7,449,700
[a]
Fair
    value
The
fair value of financial instruments is the amount of consideration that would be agreed upon in an arm's length transaction between
knowledgeable, willing parties who are under no compulsion to act. The fair value of current financial instruments except derivative
liability approximates their carrying values as long as they are short-term in nature or bear interest at market rates.
[b]
Fair
    value hierarchy
Financial
instruments that are held at fair value are categorized based on a valuation hierarchy which is determined by the valuation methodology
utilized. The fair value hierarchy under US GAAP is based on the following three levels of inputs, of which the first two are considered
observable and the last unobservable:
Level
1
– Quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level
2
– Observable inputs other than Level 1, quoted prices for similar assets or liabilities in active prices whose inputs are
observable or whose significant value drivers are observable; and
Level
3
– Assets and liabilities whose significant value drivers are unobservable by little or no market activity and that are significant
to the fair value of the assets or liabilities.
Cash
and cash equivalents are valued using a market approach based upon unadjusted quoted prices for identical assets in an active market
obtained from securities exchanges. As at October 31, 2021, the fair value of cash and cash equivalents held by the Company was based
on Level 1 of the fair value hierarchy. There were no transfers between Levels 1 and 2 during the period.
The
Company evaluates its financial instruments and other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with ASC 815. The result of this accounting treatment is that the
fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair
value is recorded in the consolidated statements of loss and comprehensive loss. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.
The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value
of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current
or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date.
F-
32
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
The
Company uses the Black-Scholes Option Pricing Model to value derivative liabilities. This model uses Level 3 inputs in the fair value
hierarchy established by ASC 820 Fair Value Measurement. The inputs used in determining the fair value of the embedded derivative are
disclosed in
note 13[d]
.
[c]
Financial
    risk management
The
Company's board of directors has the overall responsibility for the establishment and oversight of the Company's risk management
framework. The Company's risk management policies are established to identify and analyze the risks faced by the Company, to set
appropriate risk limits and controls, and to monitor risks and adherence to limits. Risk management policies and systems are reviewed
regularly to reflect changes in market conditions and in response to the Company's activities. Management regularly monitors compliance
with the Company's risk management policies and procedures and reviews the adequacy of the risk management framework in relation
to the risks faced by the Company.
In
the normal course of operations, the Company is exposed to various risks such interest rate, foreign exchange, commodity, credit, and
liquidity. To manage these risks, management determines what activities must be undertaken to minimize potential exposure to risks. The
objectives of the Company in managing risks are as follows:
●
Maintaining
    sound financial condition:
●
Financing
    operations; and
●
Ensuring
    liquidity to all operations.
In
order to satisfy these objectives, the Company has adopted the following policies:
●
Prepare
    budget documents at prevailing market rates to ensure clear corporate alignment to performance management and achievement of targets;
●
Recognize
    and observe the extent of operating risk within the business; and
●
Identify
    the magnitude of the impact of market risk factors on the overall risk of the business and take advantage of natural risk reductions
    that arise from these relationships.
[i]
Interest
    rate risk
Interest
rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in the market interest rates.
The Company is exposed to interest rate risk on its cash on deposits with banks and, from time to time, on its holdings of short-term
investments. As of October 31, 2021, the Company had $
462,360
(October 31, 2020 − $
39,571
) of cash on deposits with banks. The
Company had
no
short-term investment as at October 31, 2021 and October 31, 2020. Given the level of cash and cash equivalents held by
the Company, fluctuations in the market interest rates had no significant impact on its interest income during the year ended October
31, 2021.
[ii]
Foreign
    currency risk
The
Company is exposed to foreign currency risk on fluctuations related to cash, deposits held by related parties, accounts payable, due
to related parties and convertible debenture that are denominated in US dollars. The Company has not entered into foreign exchange derivative
contracts. A significant change in the currency exchange rates between the Canadian dollar relative to the US dollar could have a material
effect on the Company's financial position, results of operations, or cash flows.
F-
33
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
Based
on the Company net exposures as at October 31, 2021, assuming that all other variables remain constant, a
5%
appreciation or deterioration
of the Canadian dollar against the US dollar would result in an increase or decrease of $
262,941
in the Company's net income (loss)
and comprehensive income (loss).
October 31, 2021
$
Cash
186,627
Deposits held by related parties
486,462
Accounts payable and accrued liabilities
(
773,011
)
Due to related parties
(
467,500
)
Convertible debenture
(
1,500,000
)
Total
(
2,067,422
)
[iii]
Commodity
    price risk
The
value of the Company's magnesium production business and its exploration and evaluation assets are dependent on the price of magnesium
and the outlook for this mineral. Market prices for these metals historically have fluctuated widely and are affected by numerous factors
outside the Company's control, including but not limited to, levels of worldwide production, short-term changes in supply and demand,
industrial and retail demand, as well as certain other factors related specifically to magnesium. If magnesium prices decline for a prolonged
period below the cost of production, it may not be economically feasible to continue towards production.
[iv]
Credit
    risk
Credit
risk is the risk of loss if counterparties do not fulfill their contractual obligations and arises principally from trade receivables.
The Company's credit risk is primarily attributable to cash, and deposits held by related parties. The Company limits its exposure
to credit risk on cash as these financial instruments are held with major Canadian and international banks. Amounts receivable consist
primarily of GST due from the Federal Government of Canada. Management believes the credit risk concentration with respect to amounts
receivable is remote. The carrying amount of financial assets recorded in the financial statements, net of any allowances, represents
the Company's maximum exposure to credit risk.
[v]
Liquidity
    risk
Liquidity
risk is the risk that the Company will not be able to meet its financial obligations as they come due. The Company's exposure to
liquidity risk is dependent on its purchasing commitments and obligations and its ability to raise funds to meet commitments and sustain
operations. The Company manages liquidity risk by continuously monitoring its actual and forecasted working capital requirements to ensure
there is capital to meet short-term and long-term obligations. As of October 31, 2021 and October 31, 2020, the Company had working capital
deficiency of $
9,657,316
and $
2,392,189
, respectively. As disclosed in
note 1
of these Financial Statements, the ability of the
Company to continue as a going concern is dependent on many factors. The Company's cash is primarily deposited in bank accounts
and held as deposits by certain related parties. The Company anticipates that its cash on hand and deposits, together with expected funds
raised from private placements and on exercises of common share purchase warrants and stock options, as well as debt financing, will
provide sufficient financial resources to carry out its operations through the next twelve months. However, additional funding will be
required. There can be no assurance that the Company will be able to raise the funds necessary to continue future operations. Liquidity
risk has been assessed as high.
F-
34
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
17.
SEGMENTED INFORMATION
The
Company focuses on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and
the development of a full-scale commercial magnesium production facility. The Company also owns mining claims for the exploration and
development of mineral property interests. Geographic information for the Company's assets is as follows:
October 31, 2021
October 31, 2020
$
$
Canada – property, plant and equipment
2,546,383
79,436
United States – property, plant and equipment
28,321
–
United States – mineral property costs
93,453
93,453
2,668,157
172,889
Canada – other assets
1,554,827
533,815
United States – other assets
290,528
2,059
1,845,355
535,874
Total Assets
4,513,512
708,763
18.
INCOME TAX
Significant
items resulting in the difference between the Company's income tax rate and the federal statutory rate are as follows:
2021
2020
$
$
Loss for the year
(
23,549,612
)
(
4,672,605
)
Effective statutory rate
33.02
%
31.21
%
Expected income tax recovery at statutory rate
(
7,778,880
)
(
1,458,320
)
Net adjustment for deductible and non-deductible amounts
2,636,262
250,196
Foreign exchange effect
(
9,867
)
(
175,597
)
Valuation allowance
5,152,485
1,383,721
Deferred income tax provision (recovery)
–
–
The
Company's deferred tax assets and liabilities are as follows:
2021
2020
$
$
Non-capital loss carry-forwards
5,340,578
2,600,561
Property and equipment
(
159,673
)
(
123,561
)
Lease liability
180,812
103,789
Convertible debenture
(
509,985
)
–
Convertible debenture – derivative liability
2,532,898
–
Exploration and evaluation asset
359,700
-
Share issue costs
-
11,056
Valuation allowance
(
7,744,330
)
(
2,591,845
)
Deferred income tax asset (liability)
–
–
The
Company has approximately $
13,439,000
net operating losses in the US and $
3,515,000
in Canada that, under certain circumstances, can
be used to reduce the taxable income of future years. These losses expire at various dates through 2042.
F-
35
WESTERN MAGNESIUM CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
For
the Years Ended October 31, 2021 and 2020
Expressed
in US Dollars, except where otherwise indicated
19.
SUBSEQUENT EVENTS
[i]
Subsequent to October 31, 2021, upon exercise of common share purchase warrants, the Company issued an aggregate
15,159,448
common shares
at a price CA$
0.19
per share for gross proceeds of CA$
2,880,295
,
200,000
common shares at a price of CA$
0.05
per share for gross proceeds
of CA$
10,000
, and
30,000
common shares at a price of CA$
0.30
per share for gross proceeds of CA$
9,000
. A total of
2,428,363
warrants
expired unexercised.
[ii]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer is eligible to receive up to
5
%
of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $
5
million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
9,163,425
common shares at a price of CA$
0.65
per share with a total fair value of CA$
5,956,226
(USD equivalent $
4,796,832
) as share
issue costs.
[iii]
On November 4, 2021, the Company issued
1,000,000
units on partial conversion of the June 2021 Convertible Debenture, for a total of
1,000,000
common shares,
500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
500,000
Class B Warrants exercisable
at a price of $
0.19
until June 10, 2026. On December 13, 2021, the the Company issued a further
1,000,000
units on partial conversion
of the June 2021 Convertible Debenture, for a total of
1,000,000
common shares,
500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
500,000
Class B Warrants exercisable at a price of $
0.19
until June 10, 2026. On January 20, 2022, the the Company
issued a further
1,000,000
units on partial conversion of the June 2021 Convertible Debenture, for a total of
1,000,000
common shares,
500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
500,000
Class B Warrants exercisable at a price of
$
0.19
until June 10, 2026.
[iv]
On November 26, 2021, the Company closed a non-brokered private placement and issued
1,375,499
units at a price of $
0.55
per unit for
gross proceeds of $
756,524
. Each unit consists of one common share and one common share purchase warrant entitling the holder thereof
to acquire a further common share at a price of $
0.75
for a period of one year from the date of closing.
[v]
On December 3, 2021, the Company granted
250,000
incentive stock options pursuant to its 2021 Equity Incentive Plan to an employee. These
options are exercisable at a price of CA$
0.58
per share for a period of
five years
.
[vi]
On December 13, 2021, the Company's Form 10 Registration Statement filed with the US SEC was declared effective, and the Company
will be subject to the reporting requirements of the Securities Exchange Act of 1934 (the "Exchange Act").
F-
36
WESTERN
MAGNESIUM CORPORATION
Unaudited
Interim Condensed Consolidated Balance Sheets
January 31, 2022
October 31, 2021
Note
$
$
(Audited)
ASSETS
Current assets
Cash
772,522
462,360
Amounts receivable
235,821
151,485
Prepayments
127,872
133,647
Deposits held by related parties
8[a]
565,741
486,462
1,701,956
1,233,954
Non-current assets
Property, plant and equipment
4
3,159,244
2,574,704
Right-of-use assets
5
533,093
598,575
Mineral property costs
7
93,453
93,453
Reclamation deposits
2,752
2,826
Other deposits
10,000
10,000
TOTAL ASSETS
5,500,498
4,513,512
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current liabilities
Accounts payable and accrued liabilities
2,552,509
1,989,316
Due to related parties
8[b]
1,092,786
1,026,817
Lease obligations – current
6
220,309
192,045
Provision for flow through share issuances
11
227,140
233,285
Convertible debenture
12
221,599
7,449,807
Derivative liability
12[e]
8,288,387
–
12,602,730
10,891,270
Non-current liabilities
Lease obligations – non-current
6
320,045
392,280
Total liabilities
12,922,775
11,283,550
Shareholders' deficit
Capital stock Authorized:
1
billion common stock at par value of $
0.001
Issued and paid:
421,871,770
(2021 –
392,943,398
)
13
36,637,228
29,842,167
Additional paid-in-capital
13
22,684,015
15,186,480
Obligations to issue shares
13
46,741
209,827
Accumulated other comprehensive income
285,889
121,109
Deficit
(
67,076,150
)
(
52,129,621
)
Total shareholders' deficit
(
7,422,277
)
(
6,770,038
)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT
5,500,498
4,513,512
Nature of operations and going concern
[note 1]
Contingent liabilities and commitments
[note 9]
Subsequent events
[note 17]
The
accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.
F-
37
WESTERN
MAGNESIUM CORPORATION
Unaudited
Interim Condensed Consolidated Statements of Loss and Comprehensive Income
Three Months Ended January 31,
2022
2021
Note
$
$
Expenses (recoveries)
Bank charges
3,264
2,562
Business development
45,552
–
Computer system and software
11,651
60,089
Consulting and management fees
8[d]
197,927
67,101
Depreciation
4, 5
109,340
51,326
Engineering expenses (recoveries)
118,373
(
63,612
)
Foreign exchange loss
167,474
49,920
Interest and accretion
12
322,280
18,574
Investor relations
106,378
51,876
Legal and professional fees
606,848
23,744
Office and general
56,080
37,454
Facilities and rent
63,669
15,085
Salaries and benefits
8[c]
995,542
735,648
Stock-based compensation
13[d]
131,575
1,048,990
Shareholder communications
33,201
–
Subsidies and recoveries
(
31,102
)
–
Transfer agent and regulatory fees
23,017
8,883
Travel expenses
84,116
836
3,045,185
2,108,476
Other items
Change in fair value of derivative liabilities
12
(
11,559,791
)
(
14,534
)
Loss on recognition of debt host liability
12
(
341,553
)
–
(
11,901,344
)
(
14,534
)
Net loss for the period
(
14,946,529
)
(
2,123,010
)
Other comprehensive gain (loss)
Foreign currency translation
164,780
(
87,762
)
Comprehensive loss for the period
(
14,781,749
)
(
2,210,772
)
Basic and diluted loss per common share
(
0.04
)
(
0.01
)
Weighted average number of common shares outstanding – basic and diluted
410,834,167
329,203,182
The
accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.
F-
38
WESTERN
MAGNESIUM CORPORATION
Unaudited
Interim Condensed Consolidated Statements of Shareholders' Deficit
Common shares
Additional
paid-in capital
Obligation to issue shares
Accumulated other comprehensive income (loss)
Accumulated deficit
Shareholders' deficit
Number
$
$
$
$
$
$
Balance, October 31, 2020
323,419,527
21,322,022
4,182,037
596,872
399,175
(
28,580,009
)
(
2,079,903
)
Shares issued pursuant to
private placements [note 13[b]]
18,319,388
1,853,806
–
(
596,872
)
–
–
1,256,934
Stock-based compensation
[note 13[d]]
–
–
1,048,990
–
–
–
1,048,900
Foreign currency translation
–
–
–
–
(
87,762
)
–
(
87,762
)
Net loss for the period
–
–
–
–
–
(
2,123,010
)
(
2,123,010
)
Balance, January 31, 2021
341,738,915
23,175,828
5,231,027
–
311,413
(
30,703,019
)
(
1,984,751
)
Balance, October 31, 2021
392,943,398
29,842,167
15,186,480
209,827
121,109
(
52,129,621
)
(
6,770,038
)
Shares issued pursuant to
private placements [note 13[b]]
1,375,499
756,524
–
(
209,827
)
–
–
546,697
Shares issued on warrants exercised
[notes 12[e] and 13[b]]
15,389,448
5,774,998
–
–
–
–
5,774,998
Shares issued for convertible debenture
[notes 12[c] and 13[b]]
3,000,000
300,000
–
–
–
–
300,000
Shares issued for finder's fees
[note 13[b]]
9,163,425
–
–
–
–
–
–
Share issue costs
[note 13[b]]
–
(
36,461
)
–
–
–
–
(
36,461
)
Stock-based compensation
[note 13[d]]
–
–
131,575
–
–
–
131,575
Effects of change in functional currency on convertible debentures
[notes 12[d]]
–
–
7,370,159
–
–
–
7,370,159
Effects of change in functional currency on broker warrants
[notes 12[e]]
–
–
(
4,198
)
–
–
–
(
4,198
)
Share subscriptions
[note 13[f]]
–
–
–
46,741
–
–
46,741
Foreign currency translation
–
–
–
–
164,780
–
164,780
Net loss for the period
–
–
–
–
–
(
14,946,529
)
(
14,946,529
)
Balance, January 31, 2022
421,871,770
36,637,228
22,684,015
46,741
285,889
(
67,076,150
)
(
7,422,277
)
The
accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.
F-
39
WESTERN
MAGNESIUM CORPORATION
Unaudited
Interim Condensed Consolidated Statements of Cash Flows
Three Months Ended January 31,
2022
2021
$
$
OPERATING ACTIVITIES
Net loss for the period
(
14,946,529
)
(
2,123,010
)
Add (subtract) items not affecting cash:
Accrued interest and accretion
9,773
10,803
Amortization of debt discount
300,034
–
Change in fair value of derivative liability
11,559,791
14,534
Loss on recognition of debt host liability
341,553
–
Depreciation of property, plant and equipment
50,434
4,039
Depreciation of right-of-use assets
58,906
47,287
Foreign exchange loss
153,408
7,213
Interest expense on lease obligations
9,240
5,700
Stock-based compensation
131,575
1,048,990
Changes in non-cash working capital items relating to operations:
Amounts receivable
(
88,738
)
(
13,694
)
Prepayments
2,266
(
12,380
)
Deposits held by related parties
(
92,521
)
–
Accounts payable and accrued liabilities
619,673
19,196
Due to related parties
92,233
958
Cash used in operating activities
(
1,798,902
)
(
990,364
)
INVESTING ACTIVITIES
Purchase of property, plant and equipment
(
687,385
)
(
167,559
)
Cash used in investing activities
(
687,385
)
(
167,559
)
FINANCING ACTIVITIES
Proceeds from issuance of shares, net of share issuance costs
2,804,182
1,256,934
Proceeds from share subscriptions
46,741
–
Payments of promissory note
–
(
27,202
)
Payments of lease obligations
(
46,636
)
(
49,310
)
Cash provided by financing activities
2,804,287
1,180,422
Change in cash for the period
318,000
22,499
Cash, beginning of the period
462,360
39,571
Effect of foreign exchange on cash
(
7,838
)
1,320
Cash, end of the period
772,522
63,390
The
accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.
F-
40
WESTERN
MAGNESIUM CORPORATION
Notes
to Unaudited Interim Condensed Consolidated Financial Statements
1.
NATURE OF OPERATIONS AND GOING CONCERN
Western
Magnesium Corporation (the "Company", or "WMC") was incorporated under the laws of British Columbia on March
24, 1966. On May 14, 2019, the Company discontinued from the jurisdiction of the Business Corporations Act (British Columbia) and domesticated
under the General Corporation Law of the State of Delaware under the name "Western Magnesium Corporation". The Company is
a reporting issuer in Canada and in the United States, listed for trading in Canada on the TSX Venture Exchange (the "TSX-V")
under the symbol "WMG.V", in the United States on the OTCQB tier of the OTC Markets (the "OTCQB") under the symbol
"MLYF", and in Germany on the Frankfurt Stock Exchange under the symbol "3WM". The Company has developed proprietary
magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium metal.
As
at January 31, 2022, the Company had an accumulated deficit of $
67,076,150
(October 31, 2021 – $
52,129,621
)
and working capital deficiency of $
10,900,774
(October 31, 2021 – $
9,657,316
).
For the three months ended January 31, 2022, the Company reported a comprehensive loss of $
14,781,749
(2021 – $
2,210,772
).
The Company is considered to be in the development stage. It has not yet achieved profitable operations and expects to incur further
losses in the development of its business. The Company has financed its activities and operations through equity issuances and debt financing
and expects to continue to do so to the extent such instruments are issuable under terms acceptable to the Company and until such time
as its operations provide positive cash flows.
These
unaudited condensed consolidated interim financial statements (the "Interim Financial Statements") have been prepared under
the assumption that the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will
be able to meet its obligations and continue its operations for the foreseeable future and be able to realize its assets and discharge
its liabilities and commitments in the normal course of business. Management believes that the going concern assumption is appropriate
for these Interim Financial Statements based on its continuing ability to raise financings through share and debt issuances. If future
financing is unavailable or if for any reason the Company is unable to continue as a going concern, it could impact the Company's
ability to realize its assets at their recognized values and to meet its obligations in the ordinary course of business at the amounts
stated in these Interim Financial Statements. These Interim Financial Statements do not give effect to adjustments that would be necessary
to the carrying values and classifications of assets and liabilities should the Company be unable to continue as a going concern. If
the going concern assumption is not used, the adjustments required to report the Company's assets and liabilities on a liquidation
basis could be material to these Interim Financial Statements. These factors indicate the existence of a material uncertainty that cast
substantial doubt on the Company's ability to continue as a going concern.
In
March 2020, the World Health Organization declared COVID-19 a global pandemic. In order to combat the spread of COVID-19, governments
worldwide, including the Unites States and Canada, have enacted emergency measures including travel bans, legally enforced or self-imposed
quarantine periods, social distancing and business and organization closures. These measures have adversely affected workforces, economies,
and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant but could affect
the Company's ability to raise financings in the future and restrict travel. Management continues to monitor the situation.
F-
41
2.
BASIS OF PRESENTATION
These
Interim Financial Statements comprise the financial statements of Western Magnesium Corporation and its wholly owned subsidiaries, Western
Magnesium Corp., incorporated in Nevada, United States and Western Magnesium Canada Corporation, incorporated in British Columbia, Canada.
[a]
Accounting standards
The
accompanying Interim Financial Statements have been prepared by the Company in accordance with accounting principles generally accepted
in the United States of America ("US GAAP") on the basis that the Company will continue as a going concern, which assumes
that the Company will be able to meet its obligations and continue its operations for the next year. Realization values may be substantially
different from carrying values as shown and these Financial Statements do not give effect to adjustments that would be necessary to the
carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern.
These
Interim Financial Statements have been prepared on a historical cost basis except for financial instruments that have been measured at
fair value. In addition, these Interim Financial Statements have been prepared using the accrual basis of accounting, except for cash
flow information. They do not include all the information required for full annual financial statements, and should be read in conjunction
with the Company's audited consolidated financial statements and the notes thereto for the year ended October 31, 2021 (the "Fiscal
2021 Financial Statements").
[b]
Functional and presentation currency
These
Interim Financial Statements are presented in United States dollars ("US dollars" or "US$"), except where otherwise
indicated. The functional currency of each entity of the Company is as follows:
Entity
Functional
    Currency
Western
    Magnesium Corporation
United
    States dollars
Western
    Magnesium Corp.
United
    States dollars
Western
    Magnesium Canada Corporation
Canadian
    dollars ("CA$")
During
the period ended January 31, 2022, significant changes in economic facts and circumstances have occurred in Western Magnesium Corporation's
operations which resulted in the change of its functional currency to the United States dollars from the Canadian dollars effective November
1, 2021. For both monetary and non-monetary assets and liabilities, translated balances at the end of the prior period become the new
accounting basis. The rate on the date of change becomes the historical rate at which non-monetary assets and liabilities are translated
in subsequent years. There is no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded cumulative
translation adjustments are not reversed. Effects of change in functional currency included the reclassifications of convertible debentures
and warrants and broker warrants
[notes 12[d] and [e]]
.
The
accounts of the Company's subsidiary Western Magnesium Canada Corporation have been translated to United States dollars.
F-
42
[c]
Critical accounting estimates and judgments
Significant
Estimates and Assumptions
The
preparation of these Interim Financial Statements in accordance with US GAAP requires the Company to make estimates and assumptions concerning
the future. Management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors,
including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted
for prospectively in the period in which the estimates are revised.
Estimates
and assumptions where there is potential risk of material adjustments to assets and liabilities in future accounting periods include
the useful lives of property, plant and equipment, recoverability of the carrying value of exploration and evaluation assets, fair value
measurements for financial instruments, discount rates for leases, recoverability and measurement of deferred tax assets and liabilities,
and contingent liabilities.
Significant
Judgments
The
preparation of these Interim Financial Statements in accordance with US GAAP requires the Company to make judgments, apart from those
involving estimates, in applying accounting policies. The most significant judgments in applying the Company's Interim Financial
Statements include:
-
the
    assessment of the Company's ability to continue as a going concern and whether there are events or conditions that may give
    rise to substantial doubt;
-
whether
    there are indicators of impairment of the Company's exploration and evaluation assets and other non-current assets;
-
the
    classification of financial instruments; and
-
determination
    of functional currency.
3.
RECENT ACCOUNTING PRONOUNCEMENTS
New
Accounting Standards Adopted During the Periods
In
December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ("ASU 2019-12"),
which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general
principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for
fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Effective
November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to these Interim Financial Statements.
In
January 2020, the FASB issued ASU 2020-01, Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint
Ventures (Topic 323), and Derivatives and Hedging (Topic 815) ("ASU 2020-01"), which is intended to clarify the interactions
of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic
323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is effective for
fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Effective
November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to these Interim Financial Statements.
New
Accounting Standards Not Yet Adopted
In
August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
– Contracts in Entity's Own Equity (Subtopic 815-40) ("ASU 2020-06"). ASU 2020-06 eliminates the beneficial conversion
and cash conversion accounting models for convertible instruments and supersedes the respective guidance within ASC 470-20 and ASC 740-10-55-51,
which will result in more instruments to be accounted for as a single instrument rather than having their proceeds allocated between
liability and equity accounting units. As smaller reporting companies as defined by the United States Securities and Exchange Commission
(the "SEC"), ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those
fiscal years, with early adoption permitted. The Company is currently evaluating the effect of adopting these updates on its financial
statements.
F-
43
4.
PROPERTY, PLANT AND EQUIPMENT
Computer Equipment
Furniture
Leasehold Improvement
Furnace & Plant Equipment
Vehicle
Total
$
$
$
$
$
$
Cost
Balance, October 31, 2020
32,318
38,916
7,610
28,413
–
107,257
Additions
77,955
11,510
129,257
2,278,205
–
2,496,927
Write-off of equipment
(
4,245
)
–
–
–
–
(
4,245
)
Foreign exchange effect
3,601
3,116
2,614
38,108
–
47,439
Balance, October 31, 2021
109,629
53,542
139,481
2,344,726
–
2,647,378
Additions
–
2,171
21,932
634,067
29,215
687,385
Foreign exchange effect
–
(
230
)
(
3,611
)
(
49,144
)
(
136
)
(
53,121
)
Balance, January 31, 2022
109,629
53,483
157,802
2,929,649
29,079
3,281,642
Accumulated Depreciation
Balance, October 31, 2020
14,677
8,326
4,818
–
–
27,821
Depreciation expense
13,907
7,443
8,827
13,971
–
44,148
Write-off of equipment
(
2,057
)
–
–
–
–
(
2,057
)
Foreign exchange effect
1,294
745
502
221
–
2,762
Balance, October 31, 2021
27,821
16,514
14,147
14,192
–
72,674
Depreciation expense
8,794
1,880
4,656
34,374
730
50,434
Foreign exchange effect
–
(
35
)
(
230
)
(
442
)
(
3
)
(
710
)
Balance, January 31, 2022
36,615
18,359
18,573
48,124
727
122,398
Net Book Value
Balance, October 31, 2020
17,641
30,590
2,792
28,413
–
79,436
Balance, October 31, 2021
81,808
37,028
125,334
2,330,534
–
2,574,704
Balance, January 31, 2022
73,014
37,124
139,229
2,881,525
28,352
3,159,244
5.
RIGHT-OF-USE ASSETS
As
at January 31, 2022, the right-of-use assets are leases for the Company's corporate offices in Vancouver, British Columbia and
McLean, Virginia, and its research and development pilot plant located in Burnaby, British Columbia. These leases terminate on March
31, 2023, February 28, 2025 and September 30, 2023, respectively. The lease for the Company's office in Las Vegas, Nevada ended
on May 31, 2021.
F-
44
Vancouver Office
Virginia
Office
Nevada Office
Pilot Plant
Total
$
$
$
$
$
Cost
Balance, October 31, 2020
59,701
–
22,856
357,949
440,506
Additions
91,237
287,847
–
–
379,084
Foreign exchange effect
5,943
4,544
1,724
26,997
39,208
Balance, October 31, 2021
156,881
292,391
24,580
384,946
858,798
Foreign exchange effect
–
–
–
(
10,139
)
(
10,139
)
Balance, January 31, 2022
156,881
292,391
24,580
374,807
848,659
Accumulated Depreciation
Balance, October 31, 2020
42,142
–
14,434
9,943
66,519
Depreciation expense
44,259
15,288
8,915
117,292
185,754
Foreign exchange effect
3,876
241
1,231
2,602
7,950
Balance, October 31, 2021
90,277
15,529
24,580
129,837
260,223
Depreciation expense
11,021
16,935
–
30,950
58,906
Foreign exchange effect
–
–
–
(
3,563
)
(
3,563
)
Balance, January 31, 2022
101,298
32,464
24,580
157,224
315,566
Net Book Value
Balance, October 31, 2020
17,559
–
8,422
348,006
373,987
Balance, October 31, 2021
66,604
276,862
–
255,109
598,575
Balance, January 31, 2022
55,583
259,927
–
217,583
533,093
6.
LEASE OBLIGATIONS
On
adoption of ASU 2016-02 on November 1, 2019, the Company recognized lease liabilities of $
83,549
which had previously been classified
as operating leases. The lease liabilities were measured at the present value of the remaining lease payments and discounted using the
lessee's incremental borrowing rate of approximately
7
%.
During
the year ended October 31, 2020, the Company entered into a new operating lease with respect to its research and development pilot plant
located in Burnaby, British Columbia and recognized a lease liability of $
354,263
, which was measured by discounting lease payments using
an incremental borrowing rate of approximately
6
%.
During
the year ended October 31, 2021, the Company renewed its operating lease with respect to its corporate office in Vancouver, British Columbia
and recognized a lease liability of $
91,237
, which was measured by discounting lease payments using an incremental borrowing rate of
approximately
7
%.
During
the year ended October 31, 2021, the Company entered into a new operating lease with respect to its office in McLean, Virginia and recognized
a lease liability of $
260,649
, which was measured by discounting lease payments using an incremental borrowing rate of approximately
7
%.
F-
45
Vancouver Office
Virginia
Office
Nevada Office
Pilot Plant
Total
$
$
$
$
$
Balance, October 31, 2020
18,123
–
12,211
350,593
380,927
Additions
91,237
260,649
–
–
351,886
Lease payments
(
47,931
)
(
5,137
)
(
9,457
)
(
139,037
)
(
201,562
)
Interest expenses
3,076
3,019
219
19,005
25,319
Prior period adjustment
–
–
(
3,065
)
–
(
3,065
)
Foreign exchange effect
2,099
4,081
92
24,548
30,820
Balance, October 31, 2021
66,604
262,612
–
255,109
584,325
Lease payments
(
12,097
)
–
–
(
34,538
)
(
46,635
)
Interest expenses
1,076
4,575
–
3,589
9,240
Foreign exchange effect
–
–
–
(
6,576
)
(
6,576
)
Balance, January 31, 2022
55,583
267,187
–
217,584
540,354
Which consist of:
Current lease obligation
47,548
44,823
–
127,938
220,309
Non-current lease obligation
8,035
222,364
–
89,646
320,045
Balance, January 31, 2022
55,583
267,187
–
217,584
540,354
7.
MINERAL PROPERTY COSTS
As
at January 31, 2022, the Company had the following mining claims:
[a]
Silverado Property
,
Nevada, United States
The
Silverado property is located in the Pinto mining district of Nevada, consists of 3 patented mining claims totaling approximately
120
hectares, and is
100
% owned by the Company. The carrying value of the property is $
1
.
[b]
Tami Mosi Property, Nevada, United States
The
Company holds a
100
% interest in 81 unpatented lode mining claims totaling approximately
1,637
acres located in White Pine County, Nevada
and four unpatented lode mining claims totaling approximately
10
acres located in the Moor Mining District, Elko County, Nevada. These
mining claims are subject to a
2
% net smelter royalty in favor of the prior owner of the claims. The carrying value of the property is
$
93,452
.
F-
46
8.
RELATED PARTY TRANSACTIONS
[a]
Deposits held by related parties
The
Company provided related parties with advances that were held as deposits for anticipated future costs related to the Company's
planned magnesium research and development pilot plant and other administrative expenses (the "Pilot Plant Advances"). As
at January 31, 2022, the Company had the following deposits held by related parties:
Related Party
A
[i]
Related Party
B
[ii]
Total
$
$
$
Balance, October 31, 2020
–
–
–
Advances
987,912
2,292,912
3,280,824
Costs and expenses
(
696,431
)
(
2,097,931
)
(
2,794,362
)
Balance, October 31, 2021
291,481
194,981
486,462
Advances
300,000
522,335
822,335
Costs and expenses
(
79,793
)
(
675,390
)
(
755,183
)
Foreign exchange effect
13,193
(
1,066
)
12,127
Balance, January 31, 2022
524,881
40,860
565,741
[i]
Related Party A is a company controlled by a director and
officer.
[ii]
Related Party B is a company controlled by an officer.
[b]
Due to related parties
As
at January 31, 2022, balances due to related parties totaled $
1,092,786
(October 31, 2021 – $
1,026,817
). All advances are unsecured,
non-interest bearing, and have no stated terms of repayment.
January 31, 2022
October 31, 2021
$
$
Wages payable to directors and officers
357,500
357,500
Benefits payable to directors and officers
581,854
539,209
Fees and expenses payable to directors and officers
151,261
127,878
Interests due to a shareholder
2,171
2,230
Total
1,092,786
1,026,817
[c]
Key management compensation
As
at January 31, 2022, the Company had twelve executives including eight in senior management. Their aggregate annualized compensation
is approximately $
2.9
million. During the three months ended January 31, 2022, the Company incurred salaries, benefits, and consulting
fees totaling $
747,589
to directors and officers of the Company. There were no stock options granted to directors or officers of the
Company during the period.
[d]
Transactions with related parties
[i]
During the three months ended January 31, 2022, the Company incurred consulting fees of CA$
30,000
(USD equivalent $
23,587
) to a member
of senior management.
[ii]
In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its corporate office
in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 at a monthly rent of CA$
9,794
(USD equivalent $
7,700
).
[iii]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer is eligible to receive up to
5
% of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $
5
million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
9,163,425
common shares at a price of CA$
0.65
per share with a total fair value of CA$
5,956,226
(USD equivalent $
4,796,832
) as share
issue costs.
F-
47
9.
CONTINGENT LIABILITIES AND COMMITMENTS
[a]
Contingent liabilities
[i]
On September 29, 2020, James Sever filed a Notice of Civil Claim against the Company in the Supreme Court of British Columbia (the "Sever
Claim"). The Sever Claim alleges that Mr. Sever had an employment and/or other similar contractual relationship with the Company,
and that the Company breached such contractual relationship by way of constructive dismissal or similar conduct. The Sever Claim seeks
damages in excess of $
2.5
million, certain equity compensation, prejudgment garnishment, costs, interest and other non-monetary relief.
On July 27, 2021, the Company filed a response to the Sever Claim, which included the following pleadings: (a) that the Company was never
properly served with the Sever Claim; (b) that the Company had never had any form of employment, independent or consulting relationship
or agreement with Mr. Sever; (c) that the Company had no debts, liabilities or obligations to Mr. Sever; (d) that to the extent that
Mr. Sever had some form of employment, independent or consulting or similar relationship or agreement as alleged in the Sever Claim,
such contract or relationship, if one existed, was never with the Company and was with some other corporate entity. The Company intends
to vigorously defend against the Sever Claim, and believes that the Sever Claim is without merit. As the Company cannot predict the outcome
of the Sever Claim, no provision has been recognized as there is no present obligation and the probability of an outcome cannot be determined.
[ii]
On December 31, 2020, GEM Yield Bahamas Limited ("GEM") served the Company with a Notice of Intention to Arbitrate (the "New
York Arbitration Notice") before the American Arbitration Association in New York (the "GEM New York Arbitration").
The New York Arbitration Notice alleges the Company breached a Share Subscription Agreement dated November 15, 2019 entered into between
the Company and GEM (the "GEM Agreement"), among other things, claiming damages of CA$
4.2
million (USD equivalent $
3.4
million).
On January 19, 2021, the Company filed a petition in the New York Supreme Court to stay the GEM New York Arbitration claiming the GEM
Agreement was not valid. On March 19, 2021, the Court in the New York State Action ruled that there was an arbitration clause in the
GEM Agreement but it was up to the arbitrator to determine if the arbitration clause was valid. Following this ruling, the New York State
Action was closed. In June 2021, GEM filed a Statement of Claim in the GEM New York Arbitration, and the Company filed a Statement of
Answer denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company
filed a Modified Statement of Defense and Counterclaims. The Company intends to vigorously defend itself in the GEM New York Arbitration
and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been
recognized in respect to the GEM New York Arbitration as there is no present obligation and the probability of an outcome cannot be determined.
[iii]
On February 8, 2021, GEM instituted another arbitration against the Company before the International Centre for Dispute Resolution in
Montreal Canada (the "GEM Montreal Arbitration") and joined GEM's affiliate, GEM Global Yield LLC SCS ("GEM Global
Yield" together with GEM, the "GEM Parties"). The Statement of Claim filed by the GEM Parties alleges the Company breached
a Share Subscription Agreement dated November 15, 2019 and promissory note, among other things, claiming damages of approximately CA$
4.9
million (USD equivalent $
3.9
million), in addition to costs and expenses, stemming from the Company's alleged failure to issue
to GEM Global Yield warrants to purchase up to
33
million shares of the Company's common stock. The Company filed a Statement of
Defense denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company
filed an Amended Statement of Defense and Cross-claim. The Company intends to vigorously defend itself in the GEM Montreal Arbitration
and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been
recognized in respect to the GEM Montreal Arbitration as there is no present obligation and the probability of an outcome cannot be determined.
F-
48
[iv]
On April 19, 2021, Lampert Advisors, LLC ("Lampert") filed a Verified Complaint against the Company's wholly owned
subsidiary Western Magnesium Corp., a Nevada corporation ("Western Magnesium – Nevada") in the Supreme Court of the
State of New York, County of New York (the "Lampert Lawsuit"). The complaint filed in the Lampert Lawsuit alleges that Lampert
entered into an agreement with Western Magnesium – Nevada to provide various financial advisory services including acquisition
advisory services and act as an exclusive placement agent for a combination of debt and equity securities (the "Lampert Agreement"),
that it performed all services required under that agreement and that it is owed $
367,227
plus interest at the rate of
9
% from February
3, 2021 and that it has a right of first refusal to act as financial advisor in connection with any debt, equity or debt restructuring
assignments on terms, conditions and compensation customary for Lampert for a transaction of the type contemplated. Although Lampert
claims to have personally served Western Magnesium – Nevada, the Company never received the Summons and Complaint and therefore,
never submitted a response. On September 9, 2021, Lampert filed a Motion seeking the entry of a default judgment (the "Motion").
The Company opposed the Motion and filed a cross-motion to compel Lampert to accept the Company's answer. The Court granted the
Company's cross-motion and denied Lampert's Motion as moot. The Court scheduled a preliminary conference for the parties
on March 30, 2022. The Company intends to vigorously defend against the Lampert Lawsuit, and believes that the Lampert Lawsuit is without
merit. As the Company cannot predict the outcome of the Lampert Lawsuit, no provision has been recognized as there is no present obligation
and the probability of an outcome cannot be determined.
[b]
Commitments
[i]
On November 1, 2016, the Company signed a contract services agreement with Lodestar Management Group, LLC ("Lodestar"), a
US corporate logistics company. Lodestar provides advisory, consulting, negotiation and other management services relating to corporate
management, administrative and/or operational activities of the Company. The term of the contract was for one year and has been renewed
under the same terms on January 1, 2018 and 2019. The Company has agreed to compensate Lodestar in the amount of $
1,800
or CA$
2,500
per
month by either cash or arrangement of the issuance of shares. The number of shares issued will be based on the share price on the day
of issuance that is not lower than the CA$
0.05
per share minimum requirement and will not exceed $
1,800
or CA$
2,500
in value. The shares
will be issued on the last working day of each month for a period of twelve months. During the three months ended January 31, 2022, the
Company did not make any cash payment (2021 – $
nil
) or issue any shares (2021 –
nil
) to Lodestar. As at January 31, 2022,
the outstanding amounts payable to Lodestar was $
53,491
(October 31, 2021 – $
53,491
).
[ii]
During the year ended October 31, 2020, the Company has entered into a lease agreement for its research and development pilot plant in
Burnaby, British Columbia with a lease term from October 1, 2020 to September 30, 2023 at a monthly rent of CA$
20,715
(USD equivalent
$
16,727
). In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its corporate
office in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 at a monthly rent of CA$
9,794
(USD equivalent
$
7,909
). In September 2021, the Company entered into a lease agreement for its office in McLean, Virginia with a lease term from September
14, 2021 to February 28, 2025 at a monthly rent of $
9,113
. The Company will be abated for the beginning five months and is entitled to
a tenant allowance of $
41,010
[notes 5 and 6]
.
F-
49
10.
PROMISSORY NOTE
During
the year ended October 31, 2019, the Company received a loan of CA$
150,000
(USD equivalent $
112,895
) from a related party. The loan was
unsecured, bore interest at
18
% and was due on demand. During the year ended October 31, 2020, the loan was increased by an additional
CA$
60,000
(USD equivalent $
44,588
) to CA$
210,000
(USD equivalent $
157,483
), and was due on September 24, 2021. During the year ended
October 31, 2021, the Company accrued interest expense of $
1,639
(2020 – $
16,655
) and repaid the entire balance and interest totaling
$
65,761
(2020 – $
101,066
).
11.
PROVISION FOR FLOW THROUGH SHARE ISSUANCES
The
Company has recorded a provision in the amount of $
227,140
(October 31, 2021 – $
233,285
) for tax and related obligations relating
to flow through share issuances from prior years.
12.
CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY
[a]
July 2020 Convertible Debenture
On
July 27, 2020, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$
150,000
(USD equivalent $
112,124
, the "July 2020 Convertible Debenture"). The note bears interest at
12
% per annum and is due on
the date that is one year following the closing date. The note is convertible into common shares of the Company at the price which is
the greater of CA$
0.15
per common share and the market price on the date of the conversion notice. Any accrued but unpaid interest will
be payable on the earlier of the maturity date and the date of conversion in cash or common shares. No finder's fees were paid
in connection with this private placement. On May 18, 2021, the Company issued a total of
1,360,959
common shares on the conversion of
the July 2020 Convertible Debenture including conversion of accrued interest and
263,973
common shares valued at $
26,286
in transaction
costs. The July 2020 Convertible Debenture had an effective interest rate of
37
%.
[b]
July 2021 Convertible Debenture
On
July 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$
100,000
(USD equivalent $
79,542
, the "July 2021 Convertible Debenture") which it received on April 22, 2021. The note bears interest
at
12
% per annum and is due on the date that is one year following the closing date. The note is convertible at a price of CA$
0.12
per
Unit, where each Unit is comprised of one common share and one common share purchase warrant exercisable at a price of CA$
0.20
per common
share for a period of two years. Any accrued but unpaid interest will be payable on the earlier of the maturity date and the date of
conversion in cash or common shares.
As
at January 31, 2022, the Company incurred contractual interest of CA$
9,337
(USD equivalent $
7,375
) [2021 – CA$
7,299
(USD equivalent
$
5,802
)]. The July 2021 Convertible Debenture has an
effective interest rate of 608.98%
.
[c]
June 2021 Convertible Debenture
On
June 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of $
1,500,000
(the "June 2021 Convertible Debenture"). The note bears interest at
12
% per annum and matures on
December 10, 2022
. The June
2021 Convertible Debenture is convertible into
15,000,000
units, where each unit consists of
(i) one share of the Company' common
stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until
June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price
of $0.19 until June 10, 2026 (collectively, the "Class A and B Warrants"). In addition, the conversion price for accrued
interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion
.
F-
50
As
part of the offering of the June 2021 Convertible Debenture, the Company also entered into the June 10, 2021 Securities Purchase Agreement
(the "Securities Purchase Agreement"), whereby the Company agreed to use commercially reasonable efforts to file a registration
statement with the United States Securities and Exchange Commission (the "SEC") by August 14, 2021, covering the public resale
of the shares of common stock underlying such debenture and, upon its conversion, the Class A and B Warrants issuable upon such conversion
(the "Underlying Shares"), and to use its best efforts to cause the registration statement to be declared effective on October
13, 2021. On December 13, 2021, the Company's Form 10 Registration Statement filed with the SEC was declared effective.
In
addition to certain covenants contained in the Securities Purchase Agreement, the terms of the June 2021 Convertible Debenture contain
certain negative covenants by the Company, including, among others, sell or offer to sell any securities with non-fixed or floating price
features, issue any common stock or common stock equivalents at a price lower than the Conversion Price herein then in effect, or issue
any equity or debt instruments with anti-dilution provisions.
In
the event the Company issues or sells any common stock or common stock equivalents with terms that the purchaser holding the outstanding
June 2021 Convertible Debenture (the "Convertible Debenture Holder") or the Class A and B Warrants reasonably believes are
more favorable to such holder than the terms of the June 2021 Convertible Debenture or the Class A and B Warrants, then upon notice to
the Company by such holder within five trading days after notice to such holder by the Company, the Company will use commercially reasonable
efforts to obtain the approval of the TSX-V and any additional required regulatory approval to amend the terms of the June 2021 Convertible
Debenture or the Class A and B Warrants as required, as the case may be, so as to give such holder the benefit of such more favorable
terms or conditions.
The
conversion price of the June 2021 Convertible Debenture and the exercise price of the Class A and B Warrants are subject to proportional
adjustment in the event of stock splits, stock dividends and similar corporate events, including merger or consolidation of the Company
or in a "Fundamental Transaction" as defined in the June 2021 Convertible Debenture.
The
Company has granted the holders certain rights of first refusal on its future offerings for as long as the June 2021 Convertible Debenture
or the Class A and B Warrants are outstanding.
The
Company may prepay and satisfy the June 2021 Convertible Debenture so long as an event of default has not occurred, upon 20 days'
prior written notice received by the Company to the holder, by paying 125% of the amounts owed on the June 2021 Convertible Debenture,
including all principal, interest and other fees. The holder of this debenture may, however, convert all or a portion of the debenture
during the 20-day notice period.
F-
51
During
the three months ended January 31, 2022, the Company issued an aggregate
3,000,000
units on partial conversion of the June 2021 Convertible
Debenture, for a total of
3,000,000
common shares,
1,500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
1,500,000
Class B Warrants exercisable at a price of $
0.19
until June 10, 2026
[note 13[b]]
.
As
at January 31, 2022, the Company incurred contractual interest of $
109,808
(2021 – $
70,521
). The June 2021 Convertible Debenture
has an
effective interest rate of 1,348%
.
[d]
Debt Host Liability and Embedded Derivative Liability
Certain
of the Company's convertible debentures were determined to be hybrid financial instruments comprised of a debt host liability and
an embedded derivative liability, as under the conversion feature the number of shares that will or may be issued to settle the notes
may vary. The Company uses the Black-Scholes Option Pricing Model based on different default risks and assumptions. The debt host liability
of the convertible note will be measured at amortized cost, with the embedded derivative liability measured at fair value through profit
and loss.
On
issuance date of the July 2020 Convertible Debenture, the fair value of its debt host liability was determined to be $
87,083
and the
respective embedded derivative liability was valued at $
25,041
. Fair value adjustments were made to the embedded derivative liability
of the July 2020 Convertible Debenture on conversion date of May 18, 2021, resulting in a value of $nil.
On
issuance date of the June 2021 Convertible Debenture, it was determined to be a hybrid financial instrument comprised of a debt host
liability and an embedded derivative liability. The embedded derivative liability was valued at $
1,646,600
which exceeded the face value
of the note itself of $
1,500,000
, the debt host liability was then assigned a face value of $
1
, with an immediate loss of $
146,601
on
recognition of the debt host liability. As at October 31, 2021, its combined value was $
7,449,744
. On November 1, 2021, the Company's
functional currency change resulted in the reclassification of the June 2021 Convertible Debenture from a hybrid financial instrument
accounted for in accordance with ASU 815-15 to a convertible debt instrument with a beneficial conversion feature accounted for in accordance
with ASU 470-20. The value of the embedded derivative liability was reclassified to additional paid-in capital and continues to amortize
the debt discount as interest costs over the period from the issuance date to the stated maturity date using the effective interest method.
During the three months ended January 31, 2022, the Company recorded interest expense on debt discount of $
300,034
which includes the
full amortization of the portions of the debt which were converted in the period. As at January 31, 2022, the debt discount had a carrying
value of $
1,199,966
.
On
issuance date of the July 2021 Convertible Debenture, it was determined to be a convertible debt instrument with a beneficial conversion
feature accounted for in accordance with ASU 470-20. The Company allocated the intrinsic value of the beneficial conversion feature of
the July 2021 Convertible Debenture capped at the face value of CA$
100,000
(USD equivalent $
79,542
) to additional paid-in capital. On
November 1, 2021, the Company's functional currency change resulted in the reclassification of the July 2021 Convertible Debenture
to a hybrid financial instrument accounted for in accordance with ASU 815-15. The embedded derivative liability was valued at CA$
529,400
(USD equivalent $
421,095
), the previous beneficial conversion feature was reversed out of additional paid-in capital, and a loss of CA$
429,400
(USD equivalent $
341,553
) was recognized in the statement of loss and comprehensive loss. As at January 31, 2022, the amortized cost
of the July 2021 Convertible Debenture's debt host liability was CA$
11,780
(USD equivalent $
9,262
) and the fair value of the embedded
derivative liability was CA$
269,300
(USD equivalent $
211,730
), with a combined value of CA$
281,080
(USD equivalent $
220,992
).
F-
52
The
inputs used in the Black-Scholes Option Pricing Model are as follows:
January 31,
November 1,
October 31,
June 15,
July 27,
2022
2021
2021
2021
2020
Risk free rate of interest
1.51
%
1.07
%
1.08
%
0.31
%
0.26
%
Expected life in years
0.45
years
0.70
years
1.11
years
1.50
year
0.74
year
Conversion exercise price
CA$
0.12
CA$
0.12
$
0.10
$
0.10
CA$
0.15
Underlying share price of the Company
CA$
0.44
CA$
0.75
$
0.59
$
0.19
CA$
0.13
Expected volatility
109.11
%
124.34
%
107.62
%
87.17
%
82.54
%
Expected dividend rate
Nil
Nil
Nil
Nil
Nil
July 2020 Convertible Debenture
June 2021 Convertible Debenture
July 2021 Convertible Debenture
Total
$
$
$
$
Debt Host Liability
Balance, October 31, 2020
96,318
–
–
96,318
Value of debt host liability recognized
–
1
–
1
Accretion and interest expense
23,587
43
63
23,693
Conversion
(
125,560
)
–
–
(
125,560
)
Foreign currency translation
5,655
–
–
5,655
Balance, October 31, 2021
–
44
63
107
Effects of change in functional currency
–
1,500,000
–
1,500,000
Accretion and interest expense
–
529
9,244
9,773
Conversion
–
(
300,000
)
–
(
300,000
)
Foreign currency translation
–
–
(
45
)
(
45
)
Balance, January 31, 2022
–
1,200,573
9,262
1,209,835
Embedded Derivative Liability
Balance, October 31, 2020
20,123
–
–
20,123
Fair value of embedded derivative liability recognized
–
1,646,600
–
1,646,600
Fair value adjustment
(
16,058
)
5,717,328
–
5,701,270
Conversion
(
5,247
)
–
–
(
5,247
)
Foreign currency translation
1,182
85,772
–
86,954
Balance, October 31, 2021
–
7,449,700
–
7,449,700
Effects of change in functional currency
–
(
7,449,700
)
421,094
(
7,028,606
)
Fair value adjustment
–
–
(
205,450
)
(
205,450
)
Foreign currency translation
–
–
(
3,914
)
(
3,914
)
Balance, January 31, 2022
–
–
211,730
211,730
Debt Discount
Balance, October 31, 2021
–
–
–
–
Effects of change in functional currency
–
(
1,500,000
)
–
(
1,500,000
)
Amortization
–
300,034
–
300,034
Balance, January 31, 2022
–
(
1,199,966
)
–
(
1,199,966
)
Combined Value of Convertible Debenture
Balance, October 31, 2020
116,441
–
–
116,441
Balance, October 31, 2021
–
7,449,744
63
7,449,807
Balance, January 31, 2022
–
607
220,992
221,599
F-
53
[e]
Derivative Liability – Warrants and Broker Warrants
On
November 1, 2021, the Company's functional currency change resulted in the reclassification of its outstanding warrants and broker
warrants denominated in the Canadian dollars as derivative liabilities measured at fair value through profit and loss. The previous
value of outstanding broker warrants was reversed out of additional paid-in capital, and the derivative liability of warrants
and broker warrants were valued at $
26,956,177
and $
76,811
,
respectively. During the three months ended January 31, 2022, upon exercise of common share purchase warrants, a value of $
3,481,052
was reclassified from derivative liability
to share capital. As at January 31, 2022, the derivative liability of warrants and broker warrants were valued at $
8,246,718
and $
41,670
,
respectively, resulting in a net loss in the quarter of $
11,765,241
.
The Company uses the Black-Scholes Option Pricing Model based on default risks and assumptions as appropriate.
13.
SHARE CAPITAL
[a]
Authorized capital
The
authorized share capital consists of
1,000,000,000
common voting shares at par value of $
0.001
.
[b]
Common shares issued
Fiscal
2021
[i]
In connection with the non-brokered private placement announced on September 10, 2020:
On
November 20, 2020, the Company closed the first tranche of the non-brokered private placement, issuing
5,599,171
units at a price of
CA$
0.13
per unit for gross proceeds of CA$
727,892
(USD equivalent $
556,876
), which had been received prior to October 31, 2020 and recorded
as an obligation to issue shares.
On
January 15, 2021, the Company closed the second tranche of the non-brokered private placement, consisting of
7,337,914
units at a price
of CA$
0.13
per unit for gross proceeds of CA$
953,930
(USD equivalent $
749,435
), of which $
39,996
had been received prior to October 31,
2020 and recorded as an obligation to issue shares.
On
January 29, 2021, the Company closed the third tranche of the non-brokered private placement consisting of
5,382,303
units at a price
of CA$
0.13
per unit for gross proceeds of CA$
699,699
(USD equivalent $
547,496
).
On
March 24, 2021, the Company closed the fourth tranche of the non-brokered private placement consisting of
6,554,172
units at a price
of CA$
0.13
per unit for gross proceeds of CA$
852,042
(USD equivalent $
678,270
).
On
April 27, 2021, the Company closed the fifth and final tranche of the non-brokered private placement consisting of
851,395
units at a
price of CA$
0.13
per unit for gross proceeds of CA$
110,681
(USD equivalent $
89,237
).
F-
54
In
total, the Company issued an aggregate
25,724,955
units at a price of CA$
0.13
per unit for aggregate gross proceeds of CA$
3,344,244
(USD
equivalent $
2,621,314
).
Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire
a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche
. The
Company incurred aggregate share issue costs of $
195,614
.
[ii]
On May 5, 2021, the Company announced a non-brokered private placement priced at CA$
0.13
per unit to raise gross proceeds of up to CA$
3,000,000
.
On May 28, 2021, the Company closed the first tranche of the non-brokered private placement issuing
5,223,420
units at a price of CA$
0.13
per unit for gross proceeds of $
679,044
(USD equivalent $
561,844
). On June 17, 2021, the Company closed the second and final tranche
of the non-brokered private placement consisting of
17,853,506
units at a price of CA$
0.13
per unit for gross proceeds of CA$
2,320,956
(USD equivalent $
1,880,687
). The Company issued total of
23,076,926
units at a price of CA$
0.13
per unit for total gross proceeds of
CA$
3,000,000
(USD equivalent $
2,442,531
).
Each unit issued consists of one common share and one common share purchase warrant entitling
the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective
financing tranche
. The Company incurred aggregate share issue costs of $
154,336
.
[iii]
On May 18, 2021, the Company issued a total of
1,360,959
common shares on the conversion of the July 2020 Convertible Debenture including
accrued interest and
263,973
common shares valued at $
26,286
in transaction costs.
[iv]
On June 7, 2021, the Company issued
1,538,461
common shares at a price of CA$
0.24
per share with a total fair value of CA$
369,231
(USD
equivalent $
305,832
) for equipment.
[v]
On July 16, 2021, the Company closed a non-brokered private placement and issued
4,350,000
units at a price of CA$
0.20
per unit for gross
proceeds of CA$
870,000
(USD equivalent $
690,860
).
Each unit consists of one common share and one common share purchase warrant entitling
the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing
. The Company
incurred aggregate share issue costs of $
48,319
.
[vi]
On August 11, 2021, the Company closed a non-brokered private placement and issued
3,827,601
units at a price of CA$
0.55
(US$
0.44
) per
unit for gross proceeds of CA$
2,105,180
(USD equivalent $
1,683,336
).
Each unit consists of one common share and one common share purchase
warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 (US$0.52) for a period of eighteen months
from the date of closing
. The Company incurred aggregate share issue costs of $
124,923
.
[vii]
During the year ended October 31, 2021, the Company issued a total of
7,014,969
common shares on the exercise of common share purchase
warrants at a price ranging from CA$
0.05
to CA$
0.21
per share for gross proceeds of CA$
1,120,130
(USD equivalent $
887,520
). A total of
525,173
warrants expired unexercised.
[viii]
During the year ended October 31, 2021, the Company issued a total of
2,630,000
common shares on the exercise of stock options at a price
ranging from CA$
0.05
to CA$
0.16
per share for gross proceeds of CA$
175,800
(USD equivalent $
140,734
).
[ix]
With respect to the exercises of common share purchase warrants and options, the Company reclassified $
4,291
and $
121,932
,
respectively, from additional paid-in capital to share capital during the year ended October 31, 2021.
F-
55
Fiscal
2022
[i]
Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by
a director and officer was eligible to receive up to 5% of the issued and outstanding common shares of the Company as at August 28, 2018
for up to $
5
million raised. During the year ended October 31, 2021, the commitment was met. On November 3, 2021, the Company issued
9,163,425
common shares at a price of CA$
0.65
per share with a total fair value of CA$
5,956,226
(USD equivalent $
4,796,832
) as share
issue costs.
[ii]
On November 4, 2021, the Company issued
1,000,000
units on partial conversion of the June 2021
Convertible Debenture, for a total of
1,000,000
common shares,
500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
500,000
Class B Warrants exercisable at a price of $
0.19
until June 10, 2026. On December 13, 2021, the
Company issued a further
1,000,000
units on partial conversion of the June 2021
Convertible Debenture, for a total of
1,000,000
common shares,
500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
500,000
Class B Warrants exercisable at a price of $
0.19
until June 10, 2026. On January 20, 2022, the
Company issued a further
1,000,000
units on partial conversion of the June 2021
Convertible Debenture, for a total of
1,000,000
common shares,
500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
500,000
Class B Warrants exercisable at a price of $
0.19
until June 10, 2026. The Company incurred aggregate
share issue costs of $
1,361
.
[iii]
On November 26, 2021, the Company closed a non-brokered private placement and issued
1,375,499
units at a price of $
0.55
per unit for
gross proceeds of $
756,524
. Each unit consists of one common share and one common share purchase warrant entitling the holder thereof
to acquire a further common share at a price of $
0.75
for a period of one year from the date of closing. The Company incurred aggregate
share issue costs of $
26,656
.
[iv]
During the three months ended January 31, 2022, upon exercise of common share purchase warrants, the Company issued an aggregate
15,159,448
common shares at a price CA$
0.19
per share for gross proceeds of CA$
2,880,295
(USD equivalent $
2,279,136
),
200,000
common shares at a
price of CA$
0.05
per share for gross proceeds of CA$
10,000
(USD equivalent $
7,830
), and
30,000
common shares at a price of CA$
0.30
per
share for gross proceeds of CA$
9,000
(USD equivalent $
6,981
). The Company issued a total of
15,389,448
common shares for gross proceeds
of CA$
2,899,295
(USD equivalent $
2,293,946
). A total of
2,428,363
warrants expired unexercised.
F-
56
[c]
Common share purchase warrants
A
summary of the changes in the Company's common share purchase warrants during the three months ended January 31, 2022 are as follows:
Expiry Date
Exercise
Price
($)
Weighted Average Life (Years)
October 31,
2021
Granted
Exercised
Expired/
Cancelled
January 31,
2022
November 22, 2021
CA$
0.19
–
4,160,021
–
(
4,080,573
)
(
79,448
)
–
January 17, 2022
CA$
0.19
–
7,267,914
–
(
5,959,396
)
(
1,308,518
)
–
January 31, 2022
CA$
0.19
–
5,382,303
–
(
4,341,906
)
(
1,040,397
)
–
February 21, 2022
CA$
0.05
0.06
1,505,200
–
–
–
1,505,200
March 24, 2022
CA$
0.19
0.14
6,341,872
–
(
570,046
)
–
5,771,826
March 27, 2022
CA$
0.05
0.15
982,025
–
–
–
982,025
April 27, 2022
CA$
0.19
0.24
791,395
–
(
50,000
)
–
741,395
May 9, 2022
CA$
0.05
0.27
1,813,725
–
–
–
1,813,725
May 30, 2022
CA$
0.19
0.33
5,223,420
–
(
47,527
)
–
5,175,893
June 17, 2022
CA$
0.19
0.38
17,703,506
–
(
110,000
)
–
17,593,506
July 18, 2022
CA$
0.30
0.46
4,350,000
–
(
30,000
)
–
4,320,000
August 14, 2022
CA$
0.05
0.53
200,000
–
(
200,000
)
–
–
February 13, 2023
CA$
0.65
1.04
3,827,601
–
–
–
3,827,601
Subtotal
59,548,982
–
(
15,389,448
)
(
2,428,363
)
41,731,171
Weighted average exercise price
CA$
0.22
–
CA$
0.19
CA$
0.19
CA$
0.23
November 27, 2022
US$
0.75
0.82
–
1,375,499
–
–
1,375,499
June 10, 2026
US$
0.13
4.36
–
1,500,000
–
–
1,500,000
June 10, 2026
US$
0.19
4.36
–
1,500,000
–
–
1,500,000
Subtotal
–
4,375,499
–
–
4,375,499
Weighted average exercise price
–
US$
0.35
–
–
US$
0.35
Total
59,548,982
4,375,499
(
15,389,448
)
(
2,428,363
)
46,106,670
A
summary of the changes in the Company's common share purchase warrants during the three months ended January 31, 2021 are as follows:
Expiry Date
Exercise
Price
($)
Weighted Average Life (Years)
October 31,
2020
Granted
Exercised
Expired/
Cancelled
January 31,
2021
August 31, 2021
*
CA$
0.21
0.58
3,643,791
-
–
–
3,643,791
November 22, 2021
CA$
0.19
0.80
–
5,599,171
–
–
5,599,171
January 17, 2022
CA$
0.19
0.96
–
7,337,914
–
–
7,337,914
January 31, 2022
CA$
0.19
0.99
–
5,382,303
–
–
5,382,303
February 21, 2022
CA$
0.05
1.06
1,505,200
–
–
–
1,505,200
March 27, 2022
CA$
0.05
1.15
1,482,025
–
–
–
1,482,025
May 9, 2022
CA$
0.05
1.27
2,368,626
–
–
–
2,368,626
August 14, 2022
CA$
0.05
1.53
1,110,000
–
–
–
1,110,000
Total
10,109,642
18,319,388
–
–
28,429,030
Weighted average exercise price
CA$
0.11
CA$
0.19
–
–
CA$
0.16
*
The Company received approval of the TSX-V on January 13, 2021
and amended the expiry date of
3,643,791
warrants,
extending the expiry date from January 17, 2021 to August 31, 2021
, subject to acceleration if the closing price of the Company's shares exceeds CA$
0.30
per common share for at least
10
consecutive trading days.
[d]
Stock options
The
Company has adopted an incentive stock option plan, effective on August 8, 2017 and as amended on August 8, 2018, under the rules of
the TSX-V pursuant to which it is authorized to grant stock options to executive officers, directors, employees and consultants, enabling
them to acquire up to
20
% of the total shares outstanding of the Company (the "2017 Stock Option Plan"). Under the 2017 Stock
Option Plan, the option exercise price of any option granted shall not be less than the discounted market price of the Company's
common shares. For the purposes of the 2017 Stock Option Plan, the discounted market price is calculated in accordance with the policies
of the TSX-V at the time of the grant of the options.
Stock options granted are subject to a maximum term of 5 years. All options granted
shall vest immediately, except for those options granted to persons performing investor relations activities for the Company
. Pursuant
to the policies of the TSX-V, shares issued upon the exercise of options are restricted from trading during the 4-month period subsequent
to the exercise of options.
F-
57
On
June 11, 2021, the Company adopted the 2021 Equity Incentive Plan which replaces the 2017 Stock Option for providing stock-based compensation
to directors, officers, employees, consultants, and advisors of the Company and no further options will be granted under the 2017 Stock
Option Plan. Under the 2021 Equity Incentive Plan, the Company is authorized to issue up
27,312,368
shares of the Company. In addition,
any common shares reserved for issuance under the 2017 Stock Option Plan that are forfeited as a result of the expiration or termination
of any awards under that plan after the date of adoption of the 2021 Equity Incentive Plan will be added to the 2021 Equity Incentive
Plan. As of January 31, 2022,
3,730,000
stock options forfeited under the 2017 Stock Option Plan were added to the 2021 Equity Incentive
Plan (October 31, 2021 –
1,730,000
). The 2021 Equity Incentive Plan provides for various equity-based and cash-based incentive
awards, including incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock and restricted stock
units, performance awards, dividend equivalents and other equity-based or cash-based awards.
On
December 30, 2020, the Company granted
15,650,000
stock options pursuant to its 2017 Stock Option Plan to its directors, officers, employees
and consultants at a price of CA$
0.13
per share, of which
9,500,000
were exercisable for a period of five years and
6,150,000
were exercisable
for a period of two years. However, these options exceeded the maximum allowed under the Company's 2017 Stock Option Plan. On June
11, 2021, the Company received shareholders' approval to amend the Company's 2017 Stock Option Plan to increase the number
of common shares reserved for issuance under such plan and rectified the grant of these options.
On
August 30, 2021, the Company granted
21,700,000
incentive stock options pursuant to its 2021 Equity Incentive Plan to its directors,
officers, employees and consultants. These options are exercisable at a price of CA$
0.70
per share for a period of
five years
.
On
October 1, 2021, the Company granted
1,450,000
incentive stock options pursuant to its 2021 Equity Incentive Plan to its officer and
employee and consultants. These options are exercisable at a price of CA$
0.50
per share for a period of
five years
.
On
December 3, 2021, the Company granted
250,000
incentive stock options pursuant to its 2021 Equity Incentive Plan to an employee. These
options are exercisable at a price of CA$
0.58
per share for a period of
five years
.
As
at January 31, 2022, the maximum number of common shares available under the 2021 Equity Incentive Plan was
31,042,368
, of which
7,642,368
remained available for grant thereunder.
During
the three months January 31, 2022, the Company recognized a stock-based compensation totaling $
131,575
(2021 – $
1,048,990
) in relation
to the grant of its stock options.
The
weighted average grant date fair value of the stock options granted during the three months ended January 31, 2022 was CA$
0.50
(2021
– CA$
0.09
) per option. Option pricing models require the use of highly subjective estimates and assumptions including expected
stock price volatility. Changes in the underlying assumptions can materially affect the fair value estimates. The fair value of stock
options was estimated on the measurement date using the Black-Scholes Option Pricing Model. The assumptions used to calculate the fair
value were as follows:
2022
2021
Risk free rate of interest
1.34
%
0.20
% –
1.07
%
Expected life of options
5
years
2
to
5
years
Exercise price of options
CA$
0.58
CA$
0.13
– CA$
0.70
Expected annualized volatility
136.08
%
130.88
% –
140.05
%
Expected dividend rate
Nil
Nil
F-
58
A
summary of the changes in the Company's stock options during the three months ended January 31, 2022 are as follows:
Expiry Date
Exercise
Price
(CA$)
Weighted Average Life (Years)
Outstanding
as at
October 31,
2021
Granted
Exercised
Expired/
Cancelled
Outstanding
as at
January 31,
2022
Vested
as at
January 31,
2022
March 27, 2022
0.05
0.15
1,500,000
–
–
(
250,000
)
1,250,000
1,250,000
December 30, 2022
0.13
0.91
6,000,000
–
–
–
6,000,000
6,000,000
August 12, 2023
0.05
1.53
2,290,000
–
–
(
750,000
)
1,540,000
1,540,000
December 3, 2023
0.05
1.84
6,450,000
–
–
(
500,000
)
5,950,000
5,950,000
May 22, 2024
0.12
2.31
7,900,000
–
–
(
500,000
)
7,400,000
7,400,000
November 3, 2024
0.15
2.76
700,000
–
–
–
700,000
700,000
November 24, 2024
0.16
2.82
320,000
–
–
–
320,000
320,000
March 26, 2025
0.11
3.15
100,000
–
–
–
100,000
100,000
April 23, 2025
0.12
3.23
3,350,000
–
–
–
3,350,000
3,350,000
December 30, 2025
0.13
3.92
9,500,000
–
–
–
9,500,000
9,500,000
August 30, 2026
0.70
4.58
21,700,000
–
–
–
21,700,000
21,475,000
October 1, 2026
0.50
4.67
1,450,000
–
–
–
1,450,000
1,450,000
December 3, 2026
0.58
4.84
–
250,000
–
–
250,000
250,000
Total
61,260,000
250,000
–
(
2,000,000
)
59,510,000
59,285,000
Weighted average exercise price
CA$
0.33
CA$
0.58
–
CA$
0.07
CA$
0.34
CA$
0.33
Aggregate intrinsic value
$
19,994,025
$
4,886,548
$
4,93,542
Weighted average remaining life
3.46
3.27
3.26
A
summary of the changes in the Company's nonvested stock options during the year ended January 31, 2022 are as follows:
Expiry Date
Fair Value Per Share
(CA$)
Weighted Average Life (Years)
Nonvested
as at
October 31,
2021
Granted
Vested
Expired/
Cancelled
Nonvested
as at
January 31,
2022
December 30, 2022
0.07
1.16
162,500
–
(
162,500
)
–
–
August 30, 2026
0.56
4.83
300,000
–
(
75,000
)
–
225,000
Total
462,500
–
(
237,500
)
–
225,000
Weighted average grant date fair value – per option
CA$
0.39
–
CA$
0.22
–
CA$
0.56
Weighted average grant date fair value – total
$
144,131
–
$
41,571
–
$
98,764
F-
59
A
summary of the changes in the Company's stock options during the three months ended January 31, 2021 are as follows:
Expiry Date
Exercise
Price
(CA$)
Weighted Average Life (Years)
Outstanding
as at
October 31,
2020
Granted
Exercised
Expired/
Cancelled
Outstanding
as at
January 31,
2021
Vested
as at
January 31,
2021
February 11, 2021
0.05
0.03
800,000
–
–
–
800,000
800,000
August 16, 2021
0.05
0.54
600,000
–
–
–
600,000
600,000
March 27, 2022
0.05
1.15
1,750,000
–
–
–
1,750,000
1,750,000
August 26, 2022
0.13
–
500,000
–
–
(
500,000
)
–
–
December 30, 2022
0.13
1.91
–
6,150,000
–
–
6,150,000
5,500,000
April 19, 2023
0.05
2.21
800,000
–
–
–
800,000
800,000
August 12, 2023
0.05
2.53
3,120,000
–
–
–
3,120,000
3,120,000
December 3, 2023
0.05
2.84
7,000,000
–
–
–
7,000,000
7,000,000
May 22, 2024
0.12
3.31
7,950,000
–
–
–
7,950,000
7,950,000
November 3, 2024
0.15
3.76
700,000
–
–
–
700,000
700,000
November 24, 2024
0.16
3.82
900,000
–
–
–
900,000
900,000
March 26, 2025
0.11
4.15
300,000
–
–
–
300,000
300,000
April 23, 2025
0.12
4.23
4,000,000
–
–
(
300,000
)
3,700,000
3,512,500
December 30, 2025
0.13
4.92
–
9,500,000
–
–
9,500,000
9,500,000
Total
28,420,000
15,650,000
–
(
800,000
)
43,270,000
42,432,500
Weighted average exercise price
CA$
0.09
CA$
0.13
–
CA$
0.13
CA$
0.10
CA$
0.10
Aggregate intrinsic value
$
801,922
$
743,918
$
801,892
Weighted average remaining life
3.18
3.23
3.24
The
intrinsic value of options exercised during the three months ended January 31, 2022 was $
nil
(2021 – $
nil
) as no options were exercised
during the period.
[e]
Share-based payments and other reserves
The
share-based payments and other reserves are used to recognize the fair value of stock options granted to directors, officers, employees
and consultants as part of their remuneration, as well as those of broker warrants issued in relation to the Company's financings.
When stock options and broker warrants are subsequently exercised, the fair value of such stock options and broker warrants in additional
paid-in capital is credited to share capital.
Common
share purchase warrants attached to units as part of a unit placement were assigned a $nil value. The residual method is used to calculate
the fair value of the warrant component of units issued, whereby the residual of the private placement proceeds less the fair value of
the share component is assigned as the fair value of the warrants.
On
November 1, 2021, the Company's functional currency change resulted in the reclassification of its outstanding warrants and broker
warrants denominated in the Canadian dollars as derivative liabilities. The previous value of outstanding broker warrants was
reversed out of additional paid-in capital. On November 1, 2021, the Company's functional currency change resulted in the
reclassification of the June 2021 Convertible Debenture from a hybrid financial instrument to a convertible debt instrument with a beneficial
conversion feature. The value of the embedded derivative liability was reclassified to additional paid-in capital.
[f]
Obligations to issue shares
As
at January 31, 2022, the Company received advance share subscriptions in the amount of $
46,741
(October 31, 2021 – $
209,827
) in
respect of warrants exercised subsequent to the period.
[g]
Dilutive common shares
As
at January 31, 2022, potentially dilutive common shares relating to common share purchase warrants and options outstanding totaling
105,616,670
(October 31, 2021 –
120,808,982
) were not included in the computation of loss per share as the effect would be anti-dilutive.
F-
60
14.
CAPITAL MANAGEMENT
The
Company classifies the components of shareholders' equity as capital, which at January 31, 2022, was a deficiency of $
7,422,277
(October 31, 2021 – $
6,770,038
). When managing capital, the Company's objective is to ensure the entity continues as a going
concern and advance stakeholders' interests. Management adjusts the capital structure as necessary in order to support its business
and technology development. The Company's board of directors does not establish qualitative return on capital criteria for management,
but rather relies on the expertise of the Company's management to sustain future development of the business. The Company focuses
on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and the development
of a full-scale commercial magnesium production facility. The Company is considered to be in the development stage and is dependent upon
external financing to fund its activities. In order to carry out its business development activities and pay for administrative costs,
the Company will spend its existing working capital and raise additional amounts as needed. Management reviews its capital management
approach on an ongoing basis and believes that this approach, given the relative size of the Company, is appropriate. There were no changes
in the Company's approach to capital management during the period. The Company is not subject to any externally imposed capital
requirements.
15.
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
The
Company's classification of its financial instruments is as follows:
Financial Instruments
Measurement
Method
Associated Risk
Fair Value at
January 31, 2022
($)
Cash
FVTPL
Credit and currency
772,522
Amounts receivable
Amortized cost
Credit and currency
235,821
Deposits held by related parties
Amortized cost
Credit and currency
565,741
Accounts payable and accrued liabilities
Amortized cost
Currency
2,552,509
Due to related parties
Amortized cost
Currency
1,092,786
Convertible debenture
Amortized cost
and FVTPL
Currency
221,599
Derivative liability – warrants
FVTPL
Currency
8,288,387
[a]
Fair value
The
fair value of financial instruments is the amount of consideration that would be agreed upon in an arm's length transaction between
knowledgeable, willing parties who are under no compulsion to act. The fair value of current financial instruments except derivative
liability approximates their carrying values as long as they are short-term in nature or bear interest at market rates.
F-
61
[b]
Fair value hierarchy
Financial
instruments that are held at fair value are categorized based on a valuation hierarchy which is determined by the valuation methodology
utilized. The fair value hierarchy under US GAAP is based on the following three levels of inputs, of which the first two are considered
observable and the last unobservable:
Level
1
– Quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level
2
– Observable inputs other than Level 1, quoted prices for similar assets or liabilities in active prices whose inputs are
observable or whose significant value drivers are observable; and
Level
3
– Assets and liabilities whose significant value drivers are unobservable by little or no market activity and that are significant
to the fair value of the assets or liabilities.
Cash
and cash equivalents are valued using a market approach based upon unadjusted quoted prices for identical assets in an active market
obtained from securities exchanges. As at January 31, 2022, the fair value of cash and cash equivalents held by the Company was based
on Level 1 of the fair value hierarchy. There were no transfers between Levels 1 and 2 during the period.
The
Company evaluates its financial instruments and other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with ASC 815. The result of this accounting treatment is that the
fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair
value is recorded in the consolidated statements of loss and comprehensive loss. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.
The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value
of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current
or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date.
The
Company uses the Black-Scholes Option Pricing Model to value derivative liabilities. This model uses Level 3 inputs in the fair value
hierarchy established by ASC 820 Fair Value Measurement. The inputs used in determining the fair value of the embedded derivative are
disclosed in
note 12[d]
.
[c]
Financial risk management
The
Company's board of directors has the overall responsibility for the establishment and oversight of the Company's risk management
framework. The Company's risk management policies are established to identify and analyze the risks faced by the Company, to set
appropriate risk limits and controls, and to monitor risks and adherence to limits. Risk management policies and systems are reviewed
regularly to reflect changes in market conditions and in response to the Company's activities. Management regularly monitors compliance
with the Company's risk management policies and procedures and reviews the adequacy of the risk management framework in relation
to the risks faced by the Company.
F-
62
In
the normal course of operations, the Company is exposed to various risks such interest rate, foreign exchange, commodity, credit, and
liquidity. To manage these risks, management determines what activities must be undertaken to minimize potential exposure to risks. The
objectives of the Company in managing risks are as follows:
●
Maintaining
                                            sound financial condition:
●
Financing
                                            operations; and
●
Ensuring
                                            liquidity to all operations.
In
order to satisfy these objectives, the Company has adopted the following policies:
●
Prepare
                                            budget documents at prevailing market rates to ensure clear corporate alignment to performance
                                            management and achievement of targets;
●
Recognize
                                            and observe the extent of operating risk within the business; and
●
Identify
                                            the magnitude of the impact of market risk factors on the overall risk of the business and
                                            take advantage of natural risk reductions that arise from these relationships.
[i]
Interest rate risk
Interest
rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in the market interest rates.
The Company is exposed to interest rate risk on its cash on deposits with banks and, from time to time, on its holdings of short-term
investments. As of January 31, 2022, the Company had $
772,522
(October 31, 2021 − $
462,360
) of cash on deposits with banks. The
Company had
no
short-term investment as at January 31, 2022 and October 31, 2021. Given the level of cash and cash equivalents held by
the Company, fluctuations in the market interest rates had no significant impact on its interest income for the three months ended January
31, 2022.
[ii]
Foreign currency risk
The
Company is exposed to foreign currency risk on fluctuations related to cash, amounts receivable, accounts payable, due to related parties
and convertible debenture that are denominated in Canadian dollars. The Company has not entered into foreign exchange derivative contracts.
A significant change in the currency exchange rates between the US dollar relative to the Canadian dollar could have a material effect
on the Company's financial position, results of operations, or cash flows.
Based
on the Company net exposures as at January 31, 2022, assuming that all other variables remain constant, a
5
% appreciation or deterioration
of the Canadian dollar against the US dollar would result in an increase or decrease of $
88,138
in the Company's net income (loss)
and comprehensive income (loss).
January 31, 2022
CA$
Cash
498,538
Amounts receivable
299,940
Accounts payable and accrued liabilities
(
2,210,900
)
Due to related parties
(
729,621
)
Convertible debenture
(
100,000
)
Total
(
2,242,043
)
F-
63
[iii]
Commodity price risk
The
value of the Company's magnesium production business and its exploration and evaluation assets are dependent on the price of magnesium
and the outlook for this mineral. Market prices for these metals historically have fluctuated widely and are affected by numerous factors
outside the Company's control, including but not limited to, levels of worldwide production, short-term changes in supply and demand,
industrial and retail demand, as well as certain other factors related specifically to magnesium. If magnesium prices decline for a prolonged
period below the cost of production, it may not be economically feasible to continue towards production.
[iv]
Credit risk
Credit
risk is the risk of loss if counterparties do not fulfill their contractual obligations and arises principally from trade receivables.
The Company's credit risk is primarily attributable to cash, and deposits held by related parties. The Company limits its exposure
to credit risk on cash as these financial instruments are held with major Canadian and international banks. Amounts receivable consist
primarily of GST due from the Federal Government of Canada. Management believes the credit risk concentration with respect to amounts
receivable is remote. The carrying amount of financial assets recorded in the financial statements, net of any allowances, represents
the Company's maximum exposure to credit risk.
[v]
Liquidity risk
Liquidity
risk is the risk that the Company will not be able to meet its financial obligations as they come due. The Company's exposure to
liquidity risk is dependent on its purchasing commitments and obligations and its ability to raise funds to meet commitments and sustain
operations. The Company manages liquidity risk by continuously monitoring its actual and forecasted working capital requirements to ensure
there is capital to meet short-term and long-term obligations. As of January 31, 2022 and October 31, 2021, the Company had working capital
deficiency of $
10,900,774
and $
9,657,316
, respectively. As disclosed in
note 1
of these Interim Financial Statements, the ability
of the Company to continue as a going concern is dependent on many factors. The Company's cash is primarily deposited in bank accounts
and held as deposits by certain related parties. The Company anticipates that its cash on hand and deposits, together with expected funds
raised from private placements and on exercises of common share purchase warrants and stock options, as well as debt financing, will
provide sufficient financial resources to carry out its operations through the next twelve months. However, additional funding will be
required. There can be no assurance that the Company will be able to raise the funds necessary to continue future operations. Liquidity
risk has been assessed as high.
16.
SEGMENTED INFORMATION
The
Company focuses on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and
the development of a full-scale commercial magnesium production facility. The Company also owns mining claims for the exploration and
development of mineral property interests. Geographic information for the Company's assets is as follows:
January 31, 2022
October 31, 2021
$
$
Canada – property, plant and equipment
3,128,142
2,546,383
United States – property, plant and equipment
31,101
28,321
United States – mineral property costs
93,453
93,453
3,252,696
2,668,157
Canada – other assets
838,067
1,554,827
United States – other assets
1,409,734
290,528
2,247,801
1,845,355
Total Assets
5,500,498
4,513,512
F-
64
17.
SUBSEQUENT EVENTS
On
March 10, 2022, the Company issued
1,000,000
units on partial conversion of the June 2021 Convertible Debenture, for a total of
1,000,000
common shares,
500,000
Class A Warrants exercisable at a price of $
0.13
until June 10, 2026, and
500,000
Class B Warrants exercisable
at a price of $
0.19
until June 10, 2026.
Subsequent
to January 31, 2022, upon exercise of common share purchase warrants, the Company issued an aggregate
1,793,657
common shares at a price
CA$
0.19
per share for gross proceeds of CA$
340,795
, and
1,082,025
common shares at a price of CA$
0.05
per share for gross proceeds of
CA$
54,101
. A total of
1,305,200
warrants expired unexercised.
Subsequent
to January 31, 2022, the Company announced the appointment of a new Chief Financial Officer of the Company and the grant of
500,000
incentive
stock options pursuant to its 2021 Equity Incentive Plan exercisable at a price of CA$
0.40
per share for a period of
five years
.
F-
65
WESTERN
MAGNESIUM CORPORATION
19,240,256
Shares of Common Stock Underlying Convertible Debentures
25,240,256
Shares of Common Stock Underlying Warrants
1,774,500
Shares of Common Stock for Resale by Selling Securityholder
PROSPECTUS
__________,
2022
Through
and including [●], 2022 (the 40th day after the date of this offering), all dealers effecting transactions in these securities,
whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer's obligation
to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.
PART
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
Item 13.
Other Expenses of Issuance and Distribution
The
following table sets forth the costs and expenses payable by us in connection with the issuance and distribution of the securities being
registered hereunder. No expenses will be borne by the Selling Stockholder. All of the amounts shown are estimates, except for the SEC
registration fee.
Type
Amount
SEC
    registration Fee
$
929
Legal
    fees and expenses*
35,000
Accounting
    fees and expenses*
4,000
Printing
    expenses*
1,500
Miscellaneous
    expense*
750
Total
    expenses*
$
42,179
Item 14.
Indemnification of Directors and Officers.
Our
certificate of incorporation provides that all of our directors, officers, employees and agents shall be entitled to be indemnified by
us to the fullest extent permitted by the Delaware General Corporation Law (the "DGCL"). Section 145 of the DGCL concerning
indemnification of officers, directors, employees and agents is set forth below.
Section
145. Indemnification of officers, directors, employees and agents; insurance.
(a)
A
    corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened,
    pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by
    or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the
    corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation,
    partnership, joint venture, trust or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts
    paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person
    acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation,
    and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person's conduct was unlawful.
    The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or
    its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person
    reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or
    proceeding, had reasonable cause to believe that the person's conduct was unlawful.
(b)
A
    corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened,
    pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact
    that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
    as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses
    (including attorneys' fees) actually and reasonably incurred by the person in connection with the defense or settlement of
    such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the
    best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to
    which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery
    or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability
    but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which
    the Court of Chancery or such other court shall deem proper.
(c)
To
    the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense
    of any action, suit or proceeding referred to in subsections (a) and (b) of this section, or in defense of any claim, issue or matter
    therein, such person shall be indemnified against expenses (including attorneys' fees) actually and reasonably incurred by
    such person in connection therewith.
(d)
Any
    indemnification under subsections (a) and (b) of this section (unless ordered by a court) shall be made by the corporation only as
    authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or
    agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a) and
    (b) of this section. Such determination shall be made, with respect to a person who is a director or officer at the time of such
    determination, (1) by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than
    a quorum, or (2) by a committee of such directors designated by majority vote of such directors, even though less than a quorum,
    or (3) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (4)
    by the stockholders.
II-
1
(e)
Expenses
    (including attorneys' fees) incurred by an officer or director in defending any civil, criminal, administrative or investigative
    action, suit or proceeding may be paid by the corporation in advance of the final disposition of such action, suit or proceeding
    upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined
    that such person is not entitled to be indemnified by the corporation as authorized in this section. Such expenses (including attorneys'
    fees) incurred by former officers and directors or other employees and agents may be so paid upon such terms and conditions, if any,
    as the corporation deems appropriate.
(f)
The
    indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this section shall not
    be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any
    bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person's official
    capacity and as to action in another capacity while holding such office. A right to indemnification or to advancement of expenses
    arising under a provision of the certificate of incorporation or a bylaw shall not be eliminated or impaired by an amendment to such
    provision after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative
    action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the
    time of such act or omission explicitly authorizes such elimination or impairment after such action or omission has occurred.
(g)
A
    corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee
    or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of
    another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and
    incurred by such person in any such capacity, or arising out of such person's status as such, whether or not the corporation
    would have the power to indemnify such person against such liability under this section.
(h)
For
    purposes of this section, references to "the corporation" shall include, in addition to the resulting corporation, any
    constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate
    existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that
    any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request
    of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust
    or other enterprise, shall stand in the same position under this section with respect to the resulting or surviving corporation as
    such person would have with respect to such constituent corporation if its separate existence had continued.
(i)
For
    purposes of this section, references to "other enterprises" shall include employee benefit plans; references to "fines"
    shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to "serving at
    the request of the corporation" shall include any service as a director, officer, employee or agent of the corporation which
    imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its
    participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the
    interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner "not opposed
    to the best interests of the corporation" as referred to in this section.
(j)
The
    indemnification and advancement of expenses provided by, or granted pursuant to, this section shall, unless otherwise provided when
    authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the
    benefit of the heirs, executors and administrators of such a person.
(k)
The
    Court of Chancery is hereby vested with exclusive jurisdiction to hear and determine all actions for advancement of expenses or indemnification
    brought under this section or under any by law, agreement, vote of stockholders or disinterested directors, or otherwise. The Court
    of Chancery may summarily determine a corporation's obligation to advance expenses (including attorneys' fees).
Our
certificate of incorporation also permits us to maintain insurance on behalf of any officer, director or employee for any liability arising
out of his or her actions, regardless of whether Delaware law would permit such indemnification. We have purchased a policy of directors'
and officers' liability insurance that insures our officers and directors against the cost of defense, settlement or payment of
a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.
These
provisions may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action,
if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder's investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.
II-
2
Any
repeal or amendment of provisions of our certificate of incorporation affecting indemnification rights, whether by our board of directors,
stockholders or by changes in applicable law, or the adoption of any other provisions inconsistent therewith, will (unless otherwise
required by law) be prospective only, except to the extent such amendment or change in law permits us to provide broader indemnification
rights on a retroactive basis, and will not in any way diminish or adversely affect any right or protection existing thereunder with
respect to any act or omission occurring prior to such repeal or amendment or adoption of such inconsistent provision.
The
registrant also intends to enter into indemnification agreements with its future directors and executive officers. The registrant has
purchased directors' and officers' liability insurance. The registrant believes that this insurance is necessary to attract
and retain qualified directors and officers.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons
pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment of expenses incurred or paid by a director, officer or controlling person in a successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, we will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to the court of
appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act
and will be governed by the final adjudication of such issue.
Item 15.
Recent Sales of Unregistered Securities.
The
following is a summary of transactions by us since November 1, 2018 involving unregistered issuances of our common equity securities.
Included are new issues, securities issued in exchange for property, services or other securities, securities issued upon conversion
from our other share classes and new securities resulting from the modification of outstanding securities. We issued all of the securities
listed below pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities
Act"), or Regulation D or Regulation S promulgated thereunder.
Common
Stock
During
the Fiscal Year ended October 31, 2019
On
November 30, 2018, in connection with a non-brokered private placement, 7,699,760 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$384,988 (USD equivalent $289,443). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days' written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 145,960 shares of common stock were issued to agents at a price of CAD$0.05 for a
fair value of CAD$7,298 (USD equivalent $5,487). Finder's fees of $18,097 were paid in cash.
On
January 23, 2019, in connection with a non-brokered private placement, 6,348,435 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$317,422 (USD equivalent $237,805). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days' written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 597,001 shares of common stock at a price of CAD$0.05 for a fair value of CAD$29,850
(USD equivalent $22,363) and 40,000 broker's warrants exercisable at a price of CAD$0.08 per share for a period of two years were
issued to agents. Finder's fees of $5,530 were paid in cash.
On
March 29, 2019, in connection with a non-brokered private placement, 11,750,464 units were issued to private investors at a price of
CAD$0.05 per share for gross proceeds of CAD$587,523 (USD equivalent $439,664). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were
subject to an acceleration clause whereby the Company had the right, upon provision of thirty days' written notice, to require
a holder to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive
trading days. In connection with this transaction, 218,287 shares of common stock were issued to agents at a price of CAD$0.05 for a
fair value of CAD$10,914 (USD equivalent $8,168). Finder's fees of $28,262 were paid in cash.
II-
3
On
May 13, 2019, in connection with a non-brokered private placement, 34,712,595 units were issued to private investors at a price of CAD$0.05
per share for gross proceeds of CAD$1,735,630 (USD equivalent $1,289,053). Each unit consists of one common share and one common share
purchase warrant exercisable into one common share at a price of CAD$0.08 per share for a period of two years. The warrants were subject
to an acceleration clause whereby the Company had the right, upon provision of thirty days' written notice, to require a holder
to exercise the warrants should the closing price of our common stock exceeds CAD$0.10 per share for at least ten consecutive trading
days. Finder's fees of $94,216 were paid in cash.
On
September 6, 2019, 328,571 shares of common stock were issued to a non-arm's length party for settlement of debt at a price of
CAD$0.175 per share for a fair value of CAD$57,500 (USD equivalent $43,647).
During
the fiscal year ended October 31, 2019, an aggregate of 3,455,235 shares of common stock were issued to private investors upon the exercise
of warrants at a price of CAD$0.05 per share for gross proceeds of CAD$172,762 (USD equivalent $131,071).
During
the fiscal year ended October 31, 2019, an aggregate of 11,600,109 shares of common stock were issued to private investors upon the exercise
of warrants at a price of CAD$0.08 per share for gross proceeds of CAD$928,009 (USD equivalent $706,111).
During
the fiscal year ended October 31, 2019, an aggregate of 1,100,000 shares of common stock were issued to certain officers and consultants
upon the exercise of options at a price CAD$0.05 per share for gross proceeds of CAD$55,000 (USD equivalent $41,553). Upon exercise,
CAD$36,750 (USD equivalent $27,723) previously recorded in reserves was reclassified to share capital.
During
the fiscal year ended October 31, 2019, in consideration of services provided to the Company, an aggregate of 150,000 shares of common
stock were issued to a service provider at a price of CAD$0.05 per share for a fair value of CAD$7,500 (USD equivalent 5,668).
During
the Fiscal Year ended October 31, 2020
On
December 20, 2019, the Company exercised its right to call all outstanding common share purchase warrants set to expire between May 7,
2020 and May 13, 2021 to expiry on January 19, 2020, and then extended the expiration date to February 19, 2020. Any unexercised warrants
were voided and of no value after February 19, 2020. From November 13, 2019 through March 11, 2020, an aggregate of 32,472,661shares
of common stock were issued to private investors upon the exercise of warrants at a price of CAD$0.08 per share for gross proceeds of
CAD$2,597,813 (USD equivalent $1,969,797), an aggregate of 3,000,000 shares of common stock were issued to private investors upon the
exercise of warrants at a price of CAD$0.07 per share for gross proceeds of CAD$210,000 (USD equivalent $158,718), and a further 4,864,000
shares of common stock were issued to private investors upon the exercise of warrants at a price of CAD$0.05 per share for gross proceeds
of CAD$243,200 (USD equivalent $184,769). 24,794,484 warrants expired unexercised.
On
January 17, 2020, in connection with a non-brokered private placement, 3,643,791 units were issued to private investors at a price of
CAD$0.15 per share for gross proceeds of CAD$546,569 (USD equivalent $416,719). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.21 per share for a period of one year. Subsequent to October
31, 2020, we extended the expiration date of the warrants to August 31, 2021. The warrants were subject to an acceleration clause whereby
the Company had the right, upon provision of thirty days' written notice, to require a holder to exercise the warrants should the
closing price of our common stock exceeds CAD$0.30 per share for at least ten consecutive trading days. Finder's fees of $41,275
were paid in cash.
On
May 26, 2020, 100,000 shares of common stock were issued to a consultant upon the exercise of options at a price CAD$0.05 per share for
gross proceeds of CAD$5,000 (USD equivalent 3,568).
On
May 26, 2020, 400,000 shares of common stock were issued to a consultant upon the exercise of options at a price CAD$0.08 per share for
gross proceeds of CAD$32,000 (USD equivalent $22,833). Upon exercise, CAD$27,715 (USD equivalent $19,775) previously recorded in equity
reserves was reclassified to share capital.
During
the Fiscal Year ended October 31, 2021
On
November 20, 2020, in connection with a non-brokered private placement, 5,599,171 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$727,892 (USD equivalent $556,876). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
January 15, 2021, in connection with a non-brokered private placement, 7,337,914 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$953,930 (USD equivalent $749,435). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
II-
4
On
January 29, 2021, in connection with a non-brokered private placement, 5,382,303 units were issued to private investors at a price of
CAD$0.13 per share for gross proceeds of CAD$699,699 (USD equivalent $547,496). Each unit consists of one common share and one common
share purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
March 24, 2021, in connection with a non-brokered private placement, 6,554,172 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$852,042 (USD equivalent $678,270). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
April 27, 2021, in connection with a non-brokered private placement, 851,395 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$110,681 (USD equivalent $89,237). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
May 18, 2021, in connection with the conversion of the July 2020 Convertible Debenture including accrued interest and transaction costs,
a total of 1,360,959 common shares were issued to private investors with a value of $162,829.
On
May 28, 2021, in connection with a non-brokered private placement, 5,223,420 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$679,044 (USD equivalent $561,844). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
June 7, 2021, in consideration of equipment, 1,538,461 common shares were issued to Industrial Surplus Supplies Ltd. at a price of CAD$0.24
per share for a fair value of CAD$369,231 (USD equivalent $305,832).
On
June 17, 2021, in connection with a non-brokered private placement, 17,853,506 units were issued to private investors at a price of CAD$0.13
per share for gross proceeds of CAD$2,320,956 (USD equivalent $1,880,687). Each unit consists of one common share and one common share
purchase warrant exercisable into one common share at a price of CAD$0.19 per share for a period of one year.
On
July 16, 2021, in connection with a non-brokered private placement, 4,350,000 units were issued to private investors at a price of CAD$0.20
per share for gross proceeds of CAD$870,000 (USD equivalent $690,860). Each unit consists of one common share and one common share purchase
warrant exercisable into one common share at a price of CAD$0.30 per share for a period of one year.
On
August 11, 2021, in connection with a non-brokered private placement, 3,827,601 units were issued to private investors at a price of
CAD$0.55 (USD$0.44) per share for gross proceeds of CAD$2,105,180 (USD equivalent $1,683,336). Each unit consists of one common share
and one common share purchase warrant exercisable into one common share at a price of CAD$0.65 (USD$0.52) per share for a period of eighteen
months.
During
the fiscal year ended October 31, 2021, the Company issued to private investors upon the exercise of common share purchase warrants an
aggregate 1,964,901 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$98,245 (USD equivalent $77,896), an aggregate
1,931,450 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$366,976 (USD equivalent $292,890), and an aggregate
3,118,618 common shares at a price of CAD$0.21 per share for gross proceeds of CAD$654,910 (USD equivalent $516,735). Upon exercise,
CAD$5,333 (USD equivalent $4,291) previously recorded in equity reserves was reclassified to share capital.
During
the fiscal year ended October 31, 2021, the Company issued to certain directors, officers, employees and consultants upon the exercise
of options an aggregate 2,000,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$100,000 (USD equivalent $80,058),
an aggregate 200,000 common shares at a price of CAD$0.11 per share for gross proceeds of CAD$22,000 (USD equivalent $17,456), an aggregate
300,000 common shares at a price of CAD$0.12 per share for gross proceeds of CAD$36,000 (USD equivalent $29,096), an aggregate 100,000
common shares at a price of CAD$0.13 per share for gross proceeds of CAD$13,000 (USD equivalent $10,315), and an aggregate 30,000 common
shares at a price of CAD$0.16 per share for gross proceeds of CAD$4,800 (USD equivalent $3,809). Upon exercise, CAD$152,218 (USD equivalent
$121,932) previously recorded in equity reserves was reclassified to share capital.
During
the three months ended January 31, 2022
Pursuant
to an agreement entered on August 29, 2018 and which was approved by the TSXV on September 12, 2018, a company controlled by Sam Ataya,
a director and officer of our Company, is eligible to receive up to 5% of the issued and outstanding common shares of the Company as
at August 28, 2018 for up to $5 million raised. During the fiscal year ended October 31, 2021, the commitment was met. On November 3,
2021, the Company issued 9,163,425 common shares at a price of CAD$0.65 per share for a fair value of CA$5,956,226 (USD equivalent $4,809,614)
as share issue costs.
II-
5
On
November 4, 2021, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling Securityholder
1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable
at a price of $0.19 until June 10, 2026.
On
November 26, 2021, in connection with a non-brokered private placement, 1,375,499 units were issued to private investors at a price of
$0.55 per unit for gross proceeds of $756,524. Each unit consists of one common share and one common share purchase warrant exercisable
into one common share at a price of $0.75 per share for a period of one year.
On
December 13, 2021, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling
Securityholder 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class
B Warrants exercisable at a price of $0.19 until June 10, 2026.
On
January 20, 2022, in connection with a conversion of $100,000 principal under the 2021 Debenture, the Company issued to the Selling Securityholder
1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable
at a price of $0.19 until June 10, 2026.
During
the three months ended January 31, 2022, upon the exercise of common share purchase warrants the Company issued to private investors
an aggregate 15,159,448 common shares at a price of CAD$0.19 per share for gross proceeds of CAD$2,880,295 (USD equivalent $2,279,136),
200,000 common shares at a price of CAD$0.05 per share for gross proceeds of CAD$10,000 (USD equivalent $7,830), and 30,000 common shares
at a price of CAD$0.30 per share for gross proceeds of CAD$9,000 (USD equivalent $6,981). A total of 2,428,363 warrants expired unexercised.
Debt
Securities
During
the fiscal year ended October 31, 2019, we received an unsecured loan of CAD$150,000 (USD equivalent $112,895) from a director and officer.
The loan bore interest at 18% and was due on demand. During the fiscal year ended October 31, 2020, the loan was increased by an additional
CAD$60,000 (USD equivalent $44,588), to CAD$210,000 (USD equivalent $157,483), and was due on September 24, 2021. During the fiscal year
ended October 31, 2021, we have made repayments of the entire balance of principal and all interests accrued.
On
July 27, 2020, we issued to a private investor a CAD$150,000 (USD equivalent $112,124, the "July 2020 Convertible Debenture")
principal amount 12% convertible debenture convertible at the option of the holder to our common stock at the greater of CAD$0.15 per
share and the market price on the date of the conversion notice. Any accrued but unpaid interest will be payable on the earlier of the
maturity date and the date of conversion in cash or shares of our common stock. The net proceeds from this transaction were used to fund
working capital and general corporate purposes. On May 18, 2021, 1,360,959 shares of common stock were issued in connection with the
conversion of the July 2020 Convertible Debenture including conversion of accrued interest and 263,973 common shares valued at $26,286
in transaction costs.
On
June 15, 2021, we issued an unsecured convertible note in the principal amount of $1,500,000 (the "June 2021 Convertible Debenture").
The June 2021 Convertible Debenture bears interest at 12% per annum and matures on December 10, 2022. The June 2021 Convertible Debenture
is convertible into 15,000,000 units, where each unit consists of (i) one share of our common stock, (ii) one-half of one Class A common
stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one
Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively,
the "Class A and B Warrants"). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii)
the minimum conversion price permitted by the TSXV at the time of conversion (should our common stock then be listed on such exchange).
On
July 15, 2021, we issued to a private investor a CAD$100,000 (USD equivalent $79,542, the "July 2021 Convertible Debenture")
principal amount 12% convertible debenture convertible at the option of the holder to common shares at a price of CAD$0.12 per share
and common share purchase warrants exercisable at a price of CAD$0.20 per share for a period of two years. Any accrued but unpaid interest
will be payable on the earlier of the maturity date and the date of conversion in cash or common shares. The net proceeds from this transaction
were used to fund working capital and general corporate purposes.
Other
Issuances
On
December 5, 2018, 9,600,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and
consultants as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.05 per share. These options
vested immediately on the grant date and expire 5 years after the grant date.
II-
6
On
May 23, 2019, 10,000,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.12 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.
During
the fiscal year ended October 31, 2019, we extended the expiration date of 400,000 options from May 9, 2019 to May 31, 2020.
On
November 4, 2019, 700,000 options to purchase shares of our common stock were granted to certain officer, employee and consultant as
additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.15 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.
On
November 25, 2019, 900,000 options to purchase shares of our common stock were granted to certain employees and consultants as additional
compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.16 per share. 400,000 options vested immediately on
the grant date and 500,000 options vest 25% every three-month period. These options expire 5 years after the grant date.
On
March 27, 2020, 300,000 options to purchase shares of our common stock were granted to an officer as additional compensation pursuant
to our 2017 Stock Option Plan at an exercise price of CAD$0.11 per share. These options vested immediately on the grant date and expire
5 years after the grant date.
On
April 24, 2020, 4,200,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.12 per share. 3,750,000 options vested
immediately on the grant date and 450,000 options vest 25% every three-month period. These options expire five years after the grant
date.
On
August 26, 2020, 500,000 options to purchase shares of our common stock were granted to certain consultant as additional compensation
pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.13 per share. These options vest 25% every three-month period and
expire 2 years after the grant date.
On
December 30, 2020, 15,650,000 options to purchase shares of our common stock were granted to certain directors, officers, employees and
consultants as additional compensation pursuant to our 2017 Stock Option Plan at an exercise price of CAD$0.13 per share. 15,000,000
options vested immediately on the grant date and 650,000 options vest 25% every three-month period. 9,500,000 of these options expire
five years after the grant date and 6,150,000 of these options expire two years after the grant date.
On
August 30, 2021, 21,700,000 options to purchase common shares were granted to certain directors, officers, employees and consultants
as additional compensation pursuant to our 2021 Equity Incentive Plan at an exercise price of CAD$0.70 per share. 21,400,000 options
vested immediately on the grant date and 300,000 options vest 25% every three-month period. These options expire 5 years after the grant
date.
On
October 1, 2021, 1,450,000 options to purchase common shares were granted to certain officer, employee and consultants as additional
compensation pursuant to our 2021 Equity Incentive Plan at an exercise price of CAD$0.50 per share. These options vested immediately
on the grant date and expire 5 years after the grant date.
On
December 3, 2021, 250,000 options to purchase common shares were granted to an employee as additional compensation pursuant to our 2021
Equity Incentive Plan at an exercise price of CAD$0.58 per share. These options vested immediately on the grant date and expire 5 years
after the grant date.
Item 16.
Exhibits and Financial Statement Schedules
(a)
Exhibits.
The list of exhibits preceding the signature page of this registration statement is incorporated herein by reference.
(b)
Financial
    Statements.
See page F-1 for an index to the financial statements and schedules included in the registration statement.
Item 17.
Undertakings
Insofar
as indemnification for liabilities arising under the Securities Act "may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that
a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
II-
7
(a)
Rule
    415 Offering. The undersigned registrant hereby undertakes:
(1)
To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)
To
    include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii)
To
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
    if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set
    forth in the "Calculation of Registration Fee" table in the effective registration statement.
(iii)
To
    include any material information with respect to the plan of distribution not previously disclosed in the registration statement
    or any material change to such information in the registration statement;
(2)
That,
    for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
    to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
    be deemed to be the initial bona fide offering thereof.
(3)
To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering.
(i)
The
    undersigned Registrant hereby undertakes that it will:
a.
for
    determining any liability under the Securities Act of 1933, treat the information omitted from the form of prospectus filed as part
    of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant under Rule
    424(b)(1), or (4) or 497(h) under the Securities Act of 1933 as part of this registration statement as of the time the Commission
    declared it effective.
b.
for
    determining any liability under the Securities Act of 1933, treat each post-effective amendment that contains a form of prospectus
    as a new registration statement for the securities offered in the registration statement, and that offering of the securities at
    that time as the initial bona fide offering of those securities.
That,
for the purpose of determining liability under the Securities Act of 1933 to any purchaser, if the registrant is subject to Rule 430C,
each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements
relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration
statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into
the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of
sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part
of the registration statement or made in any such document immediately prior to such date of first use.
II-
8
EXHIBIT
INDEX
Exhibit
    No.
Exhibit
3.1(i)(a)
Certificate of Domestication of Nevada Clean Magnesium Inc. and Certificate of Incorporation of Western Magnesium Corporation dated as of May 9, 2019 (incorporated by reference to Exhibit 3.1(i) to the Company's Registration Statement on Form 10 (File No. 000-56323)).
3.1(i)(b)*
Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware on May 13, 2022.
3.1(ii)
Bylaws, as amended on April 22, 2021 (incorporated by reference to Exhibit 3.1(ii) to the Company's Registration Statement on Form 10 (File No. 000-56323)).
3.1(iii)
Amendment No. 2 to Bylaws of Western Magnesium Corporation effective November 17, 2021 (incorporated by reference to Exhibit 3.1(iii) to the Company's Annual Report on Form 10-K filed on February 15, 2022).
4.1
Form of Representative's Warrant (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
4.2^
Convertible Debenture Due December 10, 2022, Principal Amount $1,500,000 issued on June 10, 2021 (incorporated by reference to Exhibit 4.2(ii) to the Company's Registration Statement on Form 10 (File No. 000-56323)).
4.3
12% Convertible Note, Principal Amount CDN$100,000 issued on July 15, 2021 (incorporated by reference to Exhibit 4.3 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
4.4
Form of Convertible Debenture due October 14, 2023, Principal Amount $2,000,000 issued on April 14, 2022 (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on April 20, 2022).
5.1*
Opinion of Anthony L.G., PLLC.
10.1†
Form of Incentive Stock Option Agreement (incorporated by reference to Exhibit 10.1 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.2†
2017 Stock Option Plan, adopted on August 8, 2017 (incorporated by reference to Exhibit 10.2 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.3†
Executive Employment Agreement between James Sever and Western Magnesium Corporation (formerly, Nevada Clean Magnesium Inc.) dated April 30, 2019 (incorporated by reference to Exhibit 10.3 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.4†
Executive Employment Agreement between Edward Lee and Western Magnesium Corporation (formerly, Nevada Clean Magnesium Inc.) dated as of May 3, 2019 (incorporated by reference to Exhibit 10.4 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.5†
Executive Employment Agreement between Sam Ataya and Western Magnesium Corporation (formerly, Nevada Clean Magnesium Inc.) dated as of May 3, 2019 (incorporated by reference to Exhibit 10.5 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.6
Letter Agreement regarding Short Term Promissory Note in favor of Sam Ataya dated September 24, 2019 (incorporated by reference to Exhibit 10.6 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.7†
Executive Employment Agreement between Rabih Ataya and Western Magnesium Canada Corporation dated as of November 1, 2019 (incorporated by reference to Exhibit 10.7 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.8
Share Subscription Agreement between Western Magnesium Corporation, GEM Yield Bahamas Limited, GEM Global Yield LLC SCS and the Share Lenders dated November 2019 (incorporated by reference to Exhibit 10.8 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.9†
Executive Employment Agreement between Paul Sauvé and Western Magnesium Canada Corporation dated as of March 23, 2020 (incorporated by reference to Exhibit 10.9 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.10†
Employment Agreement between Karim Alameddine and Western Magnesium Canada Corporation dated as of April 28, 2020 (incorporated by reference to Exhibit 10.10 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.11
Amendment to Short-Term Promissory Note issued by Western Magnesium Corporation in favor of Sam Ataya dated April 30, 2020 (incorporated by reference to Exhibit 10.11 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.12†
Executive Employment Agreement between Lisa Maxwell and Western Magnesium Canada Corporation dated as of December 1, 2020 (incorporated by reference to Exhibit 10.12 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.13†
Employee Agreement between Andrea Chan and Western Magnesium Canada Corporation dated as of March 15, 2021 (incorporated by reference to Exhibit 10.13 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.14
Form of Private Placement Subscription Agreement (Units) (incorporated by reference to Exhibit 10.14 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.15
Form of Private Placement Subscription Agreement (Convertible Notes) (incorporated by reference to Exhibit 10.15 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
II-
9
10.16^
Securities Purchase Agreement between Western Magnesium Corporation and an investor dated June 10, 2021 (incorporated by reference to Exhibit 10.16 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.17†
2021 Equity Incentive Plan, adopted on June 11, 2021 (incorporated by reference to Exhibit 10.17 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.18†
Employment Agreement between Western Magnesium Corporation and Michael E. Rutkowski dated August 16, 2021 (incorporated by reference to Exhibit 10.18 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10,19^
Unit 102 – 5140 North Fraser Way, Burnaby, BC Lease between Valens Holdings Inc. and Western Magnesium Canada Corporation dated August 1, 2020 (incorporated by reference to Exhibit 10.19 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.20
Real Estate Option Agreement between Western Magnesium Corporation and Harrison County Community Improvement Corporation effective as of August 4, 2021 (incorporated by reference to Exhibit 10.20 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.21^
Internally Heated Lab Furnace Fabrication Agreement between Industrial Surplus Ltd. and Western Magnesium Corp. dated July 24, 2020 (incorporated by reference to Exhibit 10.21 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
10.22†
Executive Employment Agreement between Western Magnesium Corporation and Robert Ramsey Hamady effective as of March 7, 2022 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on March 8, 2022).
10.23^
Securities Purchase Agreement between Western Magnesium Corporation and an investor dated April 14, 2022 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on April 20, 2022).
10.24
Form of 2022 Warrant (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on April 20, 2022).
10.25^
Registration Rights Agreement between Western Magnesium Corporation and an investor dated April 14, 2022 (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on April 20, 2022).
10.26*†
Executive
    Employment Agreement between Western Magnesium Canada Corporation and Edward Lee effective as of April 8, 2022.
10.27*†
Executive
    Employment Agreement between Western Magnesium Corporation and Sam Ataya effective as of April 8, 2022.
10.28*†
Executive
    Employment Agreement between Western Magnesium Canada Corporation and Lisa Maxwell effective as of April 8, 2022.
14.1
Code of Ethics (incorporate by reference to Exhibit 14.1 to the Company's Form 10-K filed on February 15, 2022).
21.1
List of Subsidiaries (incorporated by reference to Exhibit 10.2 to the Company's Registration Statement on Form 10 (File No. 000-56323)).
23.1*
Consent of Dale Matheson Carr-Hilton Labonte LLP.
23.2*
Consent of Anthony L.G., PLLC (included in Exhibit 5.1).
24.1*
Power of Attorney (included on the signature page).
107*
Filing fee table.
*
Filed
    herewith
^
Certain
    confidential information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively
    harmful if publicly disclosed.
†
Includes
    management contracts and compensation plans and arrangements
II-
10
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of McLean, State of Virginia, on May 24,
2022.
WESTERN
    MAGNESIUM CORPORATION
By:
/s/
    Sam Ataya
Sam
    Ataya
Chief
                                            Executive Officer
(Principal
    Executive Officer)
POWER
OF ATTORNEY
KNOW
ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Sam Ataya as his or her true and lawful
attorneys-in-fact and agents, each with the full power of substitution, for him or her in his or her name, place or stead, in any and
all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to sign any
registration statement for the same offering covered by this Registration Statement that is to be effective upon filing pursuant to Rule
462(b) promulgated under the Securities Act of 1933, as amended, and all post-effective amendments thereto, and to file the same, with
exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact
and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the
premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that said attorneys-in-fact
and agents, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant
to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities held
on May 24, 2022.
Name
Position
Date
/s/
    Sam Ataya
Chief
    Executive Officer, Executive Director and Executive
May
    24, 2022
Sam
    Ataya
President
    (Principal Executive Officer)
/s/
    Robert Ramsey Hamady
Chief
    Financial Officer (Principal Financial and Accounting Officer)
May
    24, 2022
Robert
    Ramsey Hamady
/s/
    Rabih Ataya
Director
    and Executive Vice President, Special Projects
May
    24, 2022
Rabih
    Ataya
/s/
    Edward Lee
Director
    and Executive Chairman
May
    24, 2022
Edward
    Lee
/s/
    Peter O'Rourke
Director
    and President, U.S. Operations
May
    24, 2022
Peter
    O'Rourke
/s/
    Stephen Thorlakson
Director
May
    24, 2022
Stephen
    Thorlakson
/s/
    Jeff Wilson
Director
May
    24, 2022
Jeff
Wilson
II-
11